[{"name":"app.R","content":"#\n# This is a Shiny web application. You can run the application by clicking\n# the 'Run App' button above.\n#\n# Find out more about building applications with Shiny here:\n#\n#    https://shiny.posit.co/\n#\n\nlibrary(shiny)\nlibrary(plotly)\nlibrary(dplyr)\nlibrary(stringi)\nlibrary(readxl)\nlibrary(shinyjs)\n\n# Workaround for Chromium Issue 468227\ndownloadButton <- function(...) {\n  tag <- shiny::downloadButton(...)\n  tag$attribs$download <- NULL\n  tag\n}\n\njoinRef <- function(data, ref) {\n  if(\"Group\" %in% colnames(data)) {\n    group_index <- which(colnames(data) == \"Group\")\n    colnames(data)[group_index] <- \"Group.X\"\n  }\n  data <- left_join(data, ref, by = \"term_name\")\n  data\n}\n\nplotPieChart <- function(data, ref, title=\"Pie Chart\", by_gene_weight = FALSE) {\n  groups <- c(\"cell adhesion\",\n              \"cell cycle\",\n              \"cell death\",\n              \"cellular component organization\",\n              \"ER/endosome/lysosome related process\",\n              \"gene regulation\",\n              \"immune system process\",\n              \"metabolic process\",\n              \"morphogenesis/development\",\n              \"multicellular organismal process\",\n              \"neural related process\",\n              \"other\",\n              \"protein modification/signaling\",\n              \"receptor related process\",\n              \"response to stimulus\",\n              \"stress response\",\n              \"transport\",\n              \"viral related process\"\n  )\n  colors <- c(\"#3ef5f0\",\"#7030a0\",\"#808080\",\"#b4c7e7\",\"#2e75b6\",\"#f8cbad\",\"#ff0000\",\n              \"#ff00ff\",\"#548235\",\"#be73b8\",\"#009999\",\"#f2f2f2\",\"#cccc00\",\"#cfffc4\",\"#ffff00\",\n              \"#ff8000\",\"#00ff00\",\"#00b0f0\"\n  )\n  \n  if(is.null(data)) {\n    return(NULL)\n  }\n  if(\"Group\" %in% colnames(data)) {\n    group_index <- which(colnames(data) == \"Group\")\n    colnames(data)[group_index] <- \"Group.X\"\n  }\n  data <- left_join(data, ref, by = \"term_name\")\n  group_index <- which(colnames(data) == \"Group\")\n  df <- data.frame(Category = names(table(data[,group_index])), Value = as.vector(unname(table(data[,group_index]))))\n  colors_df <- data.frame(groups = groups, colors = colors)[which(groups %in% df$Category),]\n  if(by_gene_weight == TRUE) {\n    unique_genes <- unique(unlist(stri_split(paste0(data$intersection, collapse = \",\"), regex = \",\")))\n    \n    annotation_matrix = matrix(0, nrow = nrow(data), ncol = length(unique_genes))\n    rownames(annotation_matrix) <- data$term_id\n    colnames(annotation_matrix) <- unique_genes\n    for(r in 1:nrow(data)) {\n      genes <- unlist(stri_split(data$intersection[r], regex = \",\"))\n      annotation_matrix[data$term_id[r],genes] <- 1\n    }\n    colsums <- colSums(annotation_matrix)\n    annotation_matrix <- t(t(annotation_matrix) / colsums)\n    tmp_df <- cbind(data, data.frame(value=rowSums(annotation_matrix)))\n    df <- data.frame(Category=colors_df$groups, Value=rep(NA, nrow(colors_df)))\n    for(i in 1:nrow(colors_df)) {\n      code <- colors_df$groups[i]\n      df$Value[i] <- sum(tmp_df$value[which(tmp_df$Group == code)])\n    }\n    #df <- data.frame(Category = names(table(data[,group_index])), Value = as.vector(unname(table(data[,group_index]))))\n  }\n  fig <- plot_ly(df, labels = ~Category, values = ~Value, type = 'pie',\n                 textinfo='percent',\n                 hoverinfo = 'text',\n                 text = ~paste0(Category),\n                 marker = list(colors = colors_df$colors,\n                               line = list(color = '#FFFFFF', width = 1)))\n  fig <- fig %>% layout(title = title,\n                        xaxis = list(showgrid = FALSE, zeroline = FALSE, showticklabels = FALSE),\n                        yaxis = list(showgrid = FALSE, zeroline = FALSE, showticklabels = FALSE))\n  return(fig)\n}\n\nclassification.look.up <- read.csv(\"www/data/ViGOCat_classification.csv\")\n# Define UI for application that draws a histogram\nui <- fluidPage(\n    useShinyjs(),\n    titlePanel(\"Upload and Validate Data\"),\n    tags$head(\n        tags$link(rel = \"stylesheet\", type = \"text/css\", href = \"style.css\"),\n        tags$style(HTML(\"\n          .sidebar { width: 25% !important; min-width: 200px; }\n          .main-panel { width: 75% !important; }\n        \"))\n    ),\n    sidebarLayout(\n        sidebarPanel(\n        class = \"sidebar\",\n        fileInput(\n          inputId = \"upload_file\",\n          label = \"Upload CSV, TSV, or Excel File\",\n          accept = c(\".csv\", \".tsv\", \".xls\", \".xlsx\")\n        ),\n        \n        textInput(\"termname_col\", \"Term Name:\", value = \"term_name\"),\n        textInput(\"intersection_col\", \"Intersection (Optional):\", value = \"intersection\"),\n        \n        wellPanel(\n          strong(\"Check Input:\"),\n          div(verbatimTextOutput(\"check_result\"), \n              style = \"height: 70px; overflow-y: auto; border: 1px solid #ddd; padding: 5px; background-color: #f9f9f9;\")\n        ),\n        \n        checkboxInput(\"gene_weights\", \"Gene Weights\", value = FALSE),\n        \n        tags$script(\"$('#gene_weights').prop('disabled', true);\"),\n        \n        actionButton(\"check_btn\", \"Check Columns\", class = \"btn-primary\")\n        ),\n\n        # Show a plot of the generated distribution\n        mainPanel(\n          plotlyOutput('plot'),\n          tags$div(id = \"spinner\", style = \"display:none; color: #2c3e50; font-weight: bold; margin-top: 10px;\",\n                   \"Preparing your download...\"),\n          div(\n            downloadButton(\"download_csv\", \"Download Annotated CSV\"),\n            actionButton(\"prepare_svg\", \"Prepare & Download SVG\"),\n          ),\n          tags$a(id = \"download_link\", href = \"\", download = \"merged_image.svg\", style = \"display:none\", \"Click to download\"),\n        )\n    ),\n    div(\n      id=\"overlay\",\n      class = \"overlay\",\n      div(\n        class = \"loader\"\n      )\n    )\n)\n\njs_code <- \"\nShiny.addCustomMessageHandler('toggleCheckbox', function(enable) {\n  $('#gene_weights').prop('disabled', !enable);\n});\nShiny.addCustomMessageHandler('showOverlay', function(message) {\n  if (message) {\n    document.getElementById('overlay').style.display = 'flex!important';\n  } else {\n    document.getElementById('overlay').style.display = 'none';\n  }\n});\nShiny.addCustomMessageHandler('getSVG', function(message) {\n  document.getElementById('spinner').style.display = 'block';\n  var width = document.getElementsByClassName('main-svg').item(0).getAttribute(\\\"width\\\")\n  var height = document.getElementsByClassName('main-svg').item(0).getAttribute(\\\"height\\\")\n  var mergedSVG = '<svg xmlns=\\\"http://www.w3.org/2000/svg\\\" width=\\\"'+width+'\\\" height=\\\"'+height+'\\\" viewBox=\\\"0 0 '+width+' '+height+'\\\">';\n  for (var i = 0; i < document.getElementsByClassName('main-svg').length; i++) {\n    mergedSVG += document.getElementsByClassName('main-svg').item(i).innerHTML\n  }\n  \n  mergedSVG += '<\/svg>';\n  Shiny.setInputValue('svg_data', mergedSVG, {priority: 'event'});\n});\n\nShiny.addCustomMessageHandler('triggerDownload', function(svg_string) {\n  document.getElementById('spinner').style.display = 'none';\n  const blob = new Blob([svg_string], { type: 'image/svg+xml' });\n  const url = URL.createObjectURL(blob);\n  const link = document.getElementById('download_link');\n  link.href = url;\n  console.log('DOWNLOAD TRIGGERED')\n  link.click();\n});\n\"\n\nui <- tagList(\n  tags$head(tags$script(HTML(js_code))),\n  ui\n)\n\nget_file_extension <- function(filename) {\n  sub(\".*\\\\.([^.]+)$\", \"\\\\1\", filename)\n}\n\n# Define server logic required to draw a histogram\nserver <- function(input, output, session) {\n\n  data_reactive <- reactiveVal()\n  \n  observeEvent(input$upload_file, {\n    req(input$upload_file)\n    \n    file_path <- input$upload_file$datapath\n    ext <- tolower(get_file_extension(file_path))\n    \n    df <- switch(ext,\n                 csv  = read.csv(file_path),\n                 tsv  = read.delim(file_path),\n                 xls  = read_excel(file_path),\n                 xlsx = read_excel(file_path),\n                 {\n                   showNotification(\"Unsupported file type\", type = \"error\")\n                   return(NULL)\n                 }\n    )\n    data_reactive(df)\n  })\n  \n  observeEvent(input$check_btn, {\n    \n  })\n  \n  observe({\n    req(data_reactive(), input$termname_col)\n    \n    df_recieved <- data_reactive()\n    \n    termname_col <- trimws(input$termname_col)\n    intersection_col <- trimws(input$intersection_col)\n    \n    missing_cols <- c()\n    \n    \n    if (termname_col == \"\" || !(termname_col %in% names(df_recieved))) {\n      missing_cols <- c(missing_cols, paste(\"❌ Mandatory column missing:\", termname_col))\n    }\n    \n    \n    intersection_present <- FALSE\n    if (intersection_col != \"\"){\n      if(!(intersection_col %in% names(df_recieved))) {\n        missing_cols <- c(missing_cols, paste(\"⚠️ Optional column missing:\", intersection_col))\n        missing_cols <- c(missing_cols, paste(\"❌ Gene Weight disabled!\"))\n      } else {\n        intersection_present <- TRUE\n      }\n    }\n    \n    \n    result <- if (length(missing_cols) == 0) {\n      \"✅ All specified columns are present!\"\n    } else {\n      paste(missing_cols, collapse = \"\\n\")\n    }\n    \n    output$check_result <- renderText({ result })\n    if(termname_col != \"\" && termname_col %in% names(df_recieved)) {\n      runjs(\"document.getElementById('overlay').style.display = 'flex';\")\n      plotly_plot <- plotPieChart(df_recieved, classification.look.up, title = \"\", by_gene_weight = input$gene_weights)\n      \n      #runjs(\"document.getElementById('categorization_done_div').style.visibility = 'visible';\")\n      runjs(\"document.getElementById('overlay').style.display = 'none';\")\n      #runjs(\"document.getElementById('visible_when_gsea_done').style.visibility = 'visible';\")\n      \n      output$plot <- renderPlotly(\n        {\n          plotly_plot\n        }\n      )\n    }\n    session$sendCustomMessage(type = \"toggleCheckbox\", intersection_present)\n  })\n  \n  svg_content <- reactiveVal(\"\")\n  \n  observe({\n    if (!is.null(input$svg_data)) {\n      svg_content(input$svg_data)\n    }\n  })\n  \n  observeEvent(input$prepare_svg, {\n    session$sendCustomMessage(\"getSVG\", list())\n  })\n  \n  observeEvent(input$svg_data, {\n    if (nzchar(input$svg_data)) {\n      session$sendCustomMessage(\"triggerDownload\", input$svg_data)\n    }\n  })\n  output$download_csv <- downloadHandler(\n    filename = function() {\n      paste(\"annotated_\", Sys.Date(), \".csv\", sep=\"\")\n    },\n    content = function(file) {\n      data <- joinRef(data_reactive(), classification.look.up)\n      write.csv(data, file, row.names=FALSE)\n    },\n    contentType = \"text/csv\"\n  )\n}\n\n# Run the application \nshinyApp(ui = ui, server = server)\n","type":"text"},{"name":"www/data/ViGOCat_classification.csv","content":"term_name,Group,QC\n'de novo' post-translational protein folding,protein modification/signaling,+\n'de novo' protein folding,protein modification/signaling,+\n14-3-3 protein binding,other,+\n17-beta-hydroxysteroid dehydrogenase (NAD+) activity,metabolic process,+\n2'-deoxyribonucleotide metabolic process,metabolic process,+\n2-oxoglutarate metabolic process,metabolic process,+\n\"2 iron, 2 sulfur cluster binding\",metabolic process,+\n3'-5'-RNA exonuclease activity,cell cycle,+\n3'-5' DNA helicase activity,cell cycle,+\n3'-UTR-mediated mRNA destabilization,gene regulation,+\n\"4 iron, 4 sulfur cluster binding\",metabolic process,+\nacetyl-CoA biosynthetic process,metabolic process,+\nacetyl-CoA metabolic process,metabolic process,+\nacetylation-dependent protein binding,protein modification/signaling,+\nacetylglucosaminyltransferase activity,metabolic process,+\nactin binding,cellular component organization,+\nactin cytoskeleton organization,cellular component organization,+\nactin filament,cellular component organization,+\nactin filament-based movement,cellular component organization,+\nactin filament-based process,cellular component organization,+\nactin filament-based transport,transport,+\nactin filament binding,cellular component organization,+\nactin filament bundle assembly,cellular component organization,+\nactin filament depolymerization,cellular component organization,+\nactin filament organization,cellular component organization,+\nactin filament severing,cellular component organization,+\naction potential,neural related process,+\nactivated T cell proliferation,immune system process,+\nactivation of cysteine-type endopeptidase activity,metabolic process,+\nactivation of cysteine-type endopeptidase activity involved in apoptotic process,cell death,+\nactivation of GTPase activity,protein modification/signaling,+\nactivation of immune response,immune system process,+\nactivation of innate immune response,immune system process,+\nactivation of Janus kinase activity,protein modification/signaling,+\nactivation of NF-kappaB-inducing kinase activity,immune system process,+\nactivation of protein kinase activity,protein modification/signaling,+\nactive transmembrane transporter activity,transport,+\nactivin binding,other,+\nactomyosin,cellular component organization,+\nactomyosin structure organization,cellular component organization,+\nacute-phase response,stress response,+\nacute inflammatory response,immune system process,+\nacute inflammatory response to antigenic stimulus,immune system process,+\nacylglycerol metabolic process,metabolic process,+\nacylglycerol O-acyltransferase activity,metabolic process,+\nacyltransferase activity,metabolic process,+\n\"acyltransferase activity, transferring groups other than amino-acyl groups\",metabolic process,+\nadaptation of signaling pathway,protein modification/signaling,+\nadaptive immune response,immune system process,+\nadaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,immune system process,+\nadenyl-nucleotide exchange factor activity,other,+\nadenyl nucleotide binding,metabolic process,+\nadenyl ribonucleotide binding,metabolic process,+\nadherens junction,cell adhesion,+\nadherens junction organization,cell adhesion,+\nadipose tissue development,morphogenesis/development,+\nADP binding,metabolic process,+\nADP metabolic process,metabolic process,+\nadult behavior,neural related process,+\naerobic electron transport chain,metabolic process,+\naerobic respiration,metabolic process,+\nalcohol binding,other,+\nalcohol biosynthetic process,metabolic process,+\nalcohol metabolic process,metabolic process,+\naldehyde dehydrogenase (NAD+) activity,metabolic process,+\nalditol:NADP+ 1-oxidoreductase activity,metabolic process,+\naldo-keto reductase (NADP) activity,metabolic process,+\nalpha-amino acid biosynthetic process,metabolic process,+\nalpha-amino acid catabolic process,metabolic process,+\nalpha-amino acid metabolic process,metabolic process,+\nalpha-beta T cell activation,immune system process,+\nalpha-beta T cell activation involved in immune response,immune system process,+\nalpha-beta T cell differentiation,immune system process,+\nalpha-beta T cell differentiation involved in immune response,immune system process,+\nalpha-beta T cell proliferation,immune system process,+\nalpha-tubulin binding,cellular component organization,+\n\"alternative mRNA splicing, via spliceosome\",gene regulation,+\nameboidal-type cell migration,other,+\namelogenesis,morphogenesis/development,+\namide binding,protein modification/signaling,+\namide biosynthetic process,metabolic process,+\namide transport,transport,+\namine biosynthetic process,metabolic process,+\namino acid activation,metabolic process,+\namino acid biosynthetic process,metabolic process,+\namino acid catabolic process,metabolic process,+\namino acid metabolic process,metabolic process,+\namino sugar metabolic process,metabolic process,+\naminoacyltransferase activity,metabolic process,+\naminoglycan biosynthetic process,metabolic process,+\nAMP binding,metabolic process,+\namyloid-beta clearance,neural related process,+\namyloid-beta metabolic process,neural related process,+\namyloid fibril formation,neural related process,+\namyloid precursor protein catabolic process,metabolic process,+\namyloid precursor protein metabolic process,metabolic process,+\nanatomical structure formation involved in morphogenesis,morphogenesis/development,+\nanatomical structure homeostasis,multicellular organismal process,+\nanatomical structure maturation,morphogenesis/development,+\nangiogenesis,morphogenesis/development,+\nangiogenesis involved in wound healing,morphogenesis/development,+\nanimal organ formation,multicellular organismal process,+\nanimal organ morphogenesis,morphogenesis/development,+\nanion binding,other,+\nannealing activity,cell cycle,+\nanoikis,cell death,+\nanterior/posterior pattern specification,morphogenesis/development,+\nantigen processing and presentation,immune system process,+\nantigen processing and presentation of endogenous peptide antigen,immune system process,+\nantigen processing and presentation of exogenous peptide antigen,immune system process,+\nantigen processing and presentation of peptide antigen,immune system process,+\nantigen processing and presentation of peptide antigen via MHC class I,immune system process,+\nantigen receptor-mediated signaling pathway,immune system process,+\nantimicrobial humoral immune response mediated by antimicrobial peptide,immune system process,+\nantimicrobial humoral response,immune system process,+\nantiviral innate immune response,viral related process,+\naorta development,morphogenesis/development,+\naortic valve development,morphogenesis/development,+\napical junction complex,cell adhesion,+\napical part of cell,cellular component organization,+\napoptotic cell clearance,transport,+\napoptotic mitochondrial changes,cell death,+\napoptotic process involved in development,cell death,+\napoptotic signaling pathway,cell death,+\naromatic compound biosynthetic process,metabolic process,+\nartery development,morphogenesis/development,+\nartery morphogenesis,morphogenesis/development,+\naspartate family amino acid biosynthetic process,metabolic process,+\nastrocyte activation,neural related process,+\nastrocyte development,neural related process,+\nastrocyte differentiation,neural related process,+\nATP-dependent activity,other,+\n\"ATP-dependent activity, acting on RNA\",other,+\nATP-dependent chromatin remodeler activity,cell cycle,+\nATP-dependent DNA damage sensor activity,stress response,+\nATP biosynthetic process,metabolic process,+\nATP hydrolysis activity,metabolic process,+\nATP metabolic process,metabolic process,+\nATP synthesis coupled electron transport,metabolic process,+\nATPase binding,metabolic process,+\nATPase regulator activity,protein modification/signaling,+\natrioventricular canal development,morphogenesis/development,+\natrioventricular valve morphogenesis,morphogenesis/development,+\nattachment of mitotic spindle microtubules to kinetochore,cell cycle,+\nattachment of spindle microtubules to kinetochore,cell cycle,+\nautonomic nervous system development,morphogenesis/development,+\nautophagosome assembly,cellular component organization,+\nautophagosome maturation,metabolic process,+\nautophagosome organization,cellular component organization,+\nautophagy,metabolic process,+\nautophagy of mitochondrion,metabolic process,+\naxis elongation,morphogenesis/development,+\naxo-dendritic transport,transport,+\naxon ensheathment,neural related process,+\naxon guidance,neural related process,+\naxonogenesis,neural related process,+\nB cell differentiation,immune system process,+\nB cell homeostasis,immune system process,+\nB cell proliferation,immune system process,+\nbasal part of cell,cellular component organization,+\nbasal RNA polymerase II transcription machinery binding,gene regulation,+\nbase-excision repair,stress response,+\nbasement membrane,cellular component organization,+\nbasement membrane organization,cellular component organization,+\nbehavior,neural related process,+\nbehavioral response to cocaine,neural related process,+\nbeta-catenin-TCF complex,gene regulation,+\nbeta-catenin binding,cell adhesion,+\nbiogenic amine biosynthetic process,metabolic process,+\nbiogenic amine metabolic process,metabolic process,+\nbiological process involved in interaction with host,response to stimulus,+\nbiological process involved in interaction with symbiont,response to stimulus,+\nbiological process involved in symbiotic interaction,response to stimulus,+\nbitter taste receptor activity,receptor related process,+\nblastocyst development,morphogenesis/development,+\nblastocyst formation,morphogenesis/development,+\nblood circulation,multicellular organismal process,+\nblood coagulation,multicellular organismal process,+\nblood vessel development,morphogenesis/development,+\nblood vessel diameter maintenance,multicellular organismal process,+\nblood vessel endothelial cell migration,multicellular organismal process,+\nblood vessel endothelial cell proliferation involved in sprouting angiogenesis,cell cycle,+\nblood vessel morphogenesis,morphogenesis/development,+\nblood vessel remodeling,morphogenesis/development,+\nBMP signaling pathway,protein modification/signaling,+\nbone development,morphogenesis/development,+\nbone mineralization,multicellular organismal process,+\nbone morphogenesis,morphogenesis/development,+\nbone remodeling,morphogenesis/development,+\nbone trabecula morphogenesis,morphogenesis/development,+\nbranched-chain amino acid catabolic process,metabolic process,+\nbranching involved in blood vessel morphogenesis,morphogenesis/development,+\nbranching involved in mammary gland duct morphogenesis,morphogenesis/development,+\nbranching morphogenesis of an epithelial tube,morphogenesis/development,+\nbrown fat cell differentiation,morphogenesis/development,+\nbrush border,cellular component organization,+\nC-acyltransferase activity,metabolic process,+\nC4-dicarboxylate transmembrane transporter activity,transport,+\ncadherin binding,cell adhesion,+\ncadherin binding involved in cell-cell adhesion,cell adhesion,+\ncalcium-dependent protein binding,protein modification/signaling,+\ncalcium-mediated signaling,protein modification/signaling,+\ncalcium ion binding,other,+\ncalcium ion homeostasis,other,+\ncalcium ion transmembrane import into cytosol,transport,+\ncalcium ion transport,transport,+\ncalmodulin binding,protein modification/signaling,+\ncamera-type eye development,morphogenesis/development,+\ncAMP response element binding,gene regulation,+\ncanonical glycolysis,metabolic process,+\ncanonical Wnt signaling pathway,receptor related process,+\ncarbohydrate biosynthetic process,metabolic process,+\ncarbohydrate derivative biosynthetic process,metabolic process,+\ncarbohydrate derivative catabolic process,metabolic process,+\ncarbohydrate derivative transport,transport,+\ncarbohydrate metabolic process,metabolic process,+\ncarbohydrate transmembrane transport,transport,+\ncarbohydrate transport,transport,+\n\"carbon-nitrogen ligase activity, with glutamine as amido-N-donor\",metabolic process,+\ncarbon-oxygen lyase activity,metabolic process,+\ncarboxylic acid biosynthetic process,metabolic process,+\ncarboxylic acid catabolic process,metabolic process,+\ncarboxylic acid metabolic process,metabolic process,+\ncarboxylic acid transmembrane transport,transport,+\ncarboxylic acid transmembrane transporter activity,transport,+\ncardiac chamber development,morphogenesis/development,+\ncardiac chamber morphogenesis,morphogenesis/development,+\ncardiac muscle cell apoptotic process,cell death,+\ncardiac muscle cell proliferation,cell cycle,+\ncardiac muscle hypertrophy,multicellular organismal process,+\ncardiac muscle tissue development,morphogenesis/development,+\ncardiac myofibril assembly,cellular component organization,+\ncardiac septum development,morphogenesis/development,+\ncardiac ventricle development,morphogenesis/development,+\ncardiocyte differentiation,morphogenesis/development,+\n\"catalytic activity, acting on a nucleic acid\",metabolic process,+\n\"catalytic activity, acting on DNA\",gene regulation,+\n\"catalytic activity, acting on RNA\",gene regulation,+\ncatalytic step 2 spliceosome,gene regulation,+\nCCR chemokine receptor binding,immune system process,+\n\"CD4-positive, alpha-beta T cell activation\",immune system process,+\n\"CD4-positive, alpha-beta T cell differentiation\",immune system process,+\n\"CD4-positive, alpha-beta T cell differentiation involved in immune response\",immune system process,+\nCDP-diacylglycerol metabolic process,metabolic process,+\ncell-cell adhesion,cell adhesion,+\ncell-cell adhesion via plasma-membrane adhesion molecules,cell adhesion,+\ncell-cell fusion,cellular component organization,+\ncell-cell junction organization,cellular component organization,+\ncell-cell signaling by wnt,protein modification/signaling,+\ncell-matrix adhesion,cell adhesion,+\ncell-substrate adhesion,cell adhesion,+\ncell-substrate junction,cell adhesion,+\ncell-substrate junction assembly,cellular component organization,+\ncell-substrate junction organization,cellular component organization,+\ncell activation involved in immune response,immune system process,+\ncell adhesion mediated by integrin,cell adhesion,+\ncell adhesion mediator activity,cell adhesion,+\ncell adhesion molecule binding,cell adhesion,+\ncell adhesion molecule production,cell adhesion,+\ncell chemotaxis,response to stimulus,+\ncell cortex,cellular component organization,+\ncell cycle checkpoint signaling,cell cycle,+\ncell cycle DNA replication,cell cycle,+\ncell cycle G1/S phase transition,cell cycle,+\ncell cycle G2/M phase transition,cell cycle,+\ncell cycle phase transition,cell cycle,+\ncell death,cell death,+\ncell differentiation involved in kidney development,morphogenesis/development,+\ncell differentiation involved in metanephros development,morphogenesis/development,+\ncell division,cell cycle,+\ncell fate commitment,morphogenesis/development,+\ncell growth,cellular component organization,+\ncell junction assembly,cellular component organization,+\ncell junction disassembly,cellular component organization,+\ncell junction maintenance,cellular component organization,+\ncell junction organization,cellular component organization,+\ncell killing,immune system process,+\ncell maturation,morphogenesis/development,+\ncell migration,multicellular organismal process,+\ncell migration involved in sprouting angiogenesis,multicellular organismal process,+\ncell morphogenesis,morphogenesis/development,+\ncell motility,other,+\ncell projection assembly,cellular component organization,+\ncell projection membrane,cellular component organization,+\ncell proliferation involved in kidney development,cell cycle,+\ncell redox homeostasis,other,+\ncell surface pattern recognition receptor signaling pathway,immune system process,+\ncell surface toll-like receptor signaling pathway,immune system process,+\ncellular aldehyde metabolic process,metabolic process,+\ncellular component assembly involved in morphogenesis,morphogenesis/development,+\ncellular component disassembly,cellular component organization,+\ncellular component maintenance,cellular component organization,+\ncellular detoxification,response to stimulus,+\ncellular extravasation,immune system process,+\ncellular glucuronidation,metabolic process,+\ncellular homeostasis,other,+\ncellular ketone metabolic process,metabolic process,+\ncellular lipid catabolic process,metabolic process,+\ncellular metabolic compound salvage,metabolic process,+\ncellular modified amino acid biosynthetic process,metabolic process,+\ncellular modified amino acid metabolic process,metabolic process,+\ncellular nitrogen compound catabolic process,metabolic process,+\ncellular pigmentation,morphogenesis/development,+\ncellular respiration,metabolic process,+\ncellular response to abiotic stimulus,response to stimulus,+\ncellular response to alcohol,response to stimulus,+\ncellular response to aldehyde,response to stimulus,+\ncellular response to amino acid starvation,stress response,+\ncellular response to amyloid-beta,stress response,+\ncellular response to angiotensin,response to stimulus,+\ncellular response to arsenic-containing substance,response to stimulus,+\ncellular response to biotic stimulus,response to stimulus,+\ncellular response to cAMP,response to stimulus,+\ncellular response to chemical stress,stress response,+\ncellular response to chemokine,response to stimulus,+\ncellular response to corticosteroid stimulus,response to stimulus,+\ncellular response to cytokine stimulus,immune system process,+\ncellular response to decreased oxygen levels,stress response,+\ncellular response to dexamethasone stimulus,response to stimulus,+\ncellular response to dsRNA,immune system process,+\ncellular response to environmental stimulus,response to stimulus,+\ncellular response to epidermal growth factor stimulus,response to stimulus,+\ncellular response to estrogen stimulus,response to stimulus,+\ncellular response to external stimulus,response to stimulus,+\ncellular response to extracellular stimulus,response to stimulus,+\ncellular response to fatty acid,response to stimulus,+\ncellular response to fibroblast growth factor stimulus,response to stimulus,+\ncellular response to fluid shear stress,stress response,+\ncellular response to glucocorticoid stimulus,response to stimulus,+\ncellular response to glucose starvation,stress response,+\ncellular response to growth factor stimulus,response to stimulus,+\ncellular response to heat,stress response,+\ncellular response to hepatocyte growth factor stimulus,response to stimulus,+\ncellular response to hydrogen peroxide,stress response,+\ncellular response to hypoxia,stress response,+\ncellular response to increased oxygen levels,response to stimulus,+\ncellular response to inorganic substance,response to stimulus,+\ncellular response to insulin stimulus,response to stimulus,+\ncellular response to interferon-beta,immune system process,+\ncellular response to interleukin-1,immune system process,+\ncellular response to interleukin-17,immune system process,+\ncellular response to interleukin-4,immune system process,+\ncellular response to interleukin-6,immune system process,+\ncellular response to interleukin-7,immune system process,+\ncellular response to ionizing radiation,stress response,+\ncellular response to ketone,response to stimulus,+\ncellular response to lectin,response to stimulus,+\ncellular response to leucine,response to stimulus,+\ncellular response to leukemia inhibitory factor,immune system process,+\ncellular response to light stimulus,response to stimulus,+\ncellular response to lipid,response to stimulus,+\ncellular response to lipopolysaccharide,immune system process,+\ncellular response to lipoprotein particle stimulus,response to stimulus,+\ncellular response to mechanical stimulus,response to stimulus,+\ncellular response to metal ion,response to stimulus,+\ncellular response to molecule of bacterial origin,immune system process,+\ncellular response to monoamine stimulus,response to stimulus,+\ncellular response to nerve growth factor stimulus,response to stimulus,+\ncellular response to nitrogen compound,response to stimulus,+\ncellular response to nitrogen starvation,stress response,+\ncellular response to nutrient,response to stimulus,+\ncellular response to nutrient levels,response to stimulus,+\ncellular response to organic cyclic compound,response to stimulus,+\ncellular response to organonitrogen compound,response to stimulus,+\ncellular response to osmotic stress,stress response,+\ncellular response to oxidative stress,stress response,+\ncellular response to oxygen levels,stress response,+\ncellular response to peptide,response to stimulus,+\ncellular response to peptide hormone stimulus,response to stimulus,+\ncellular response to prostaglandin E stimulus,response to stimulus,+\ncellular response to reactive oxygen species,stress response,+\ncellular response to retinoic acid,response to stimulus,+\ncellular response to salt,response to stimulus,+\ncellular response to starvation,stress response,+\ncellular response to sterol depletion,stress response,+\ncellular response to topologically incorrect protein,stress response,+\ncellular response to toxic substance,response to stimulus,+\ncellular response to transforming growth factor beta stimulus,immune system process,+\ncellular response to tumor necrosis factor,immune system process,+\ncellular response to type I interferon,immune system process,+\ncellular response to type II interferon,immune system process,+\ncellular response to unfolded protein,stress response,+\ncellular response to UV,stress response,+\ncellular response to vascular endothelial growth factor stimulus,response to stimulus,+\ncellular response to virus,viral related process,+\ncellular response to xenobiotic stimulus,response to stimulus,+\ncellular senescence,stress response,+\ncentral nervous system neuron development,neural related process,+\ncentral nervous system neuron differentiation,neural related process,+\ncentromere complex assembly,cell cycle,+\ncentrosome cycle,cell cycle,+\ncentrosome separation,cell cycle,+\ncerebellar cortex development,morphogenesis/development,+\nchannel activity,transport,+\nchaperone-mediated autophagy,metabolic process,+\nchaperone-mediated protein complex assembly,cellular component organization,+\nchaperone-mediated protein folding,protein modification/signaling,+\nchaperone cofactor-dependent protein refolding,other,+\nchemical homeostasis,other,+\nchemokine-mediated signaling pathway,receptor related process,+\nchemokine production,immune system process,+\nchemokine receptor binding,immune system process,+\nchemotaxis,response to stimulus,+\ncholesterol binding,metabolic process,+\ncholesterol biosynthetic process,metabolic process,+\ncholesterol homeostasis,other,+\ncholesterol transport,transport,+\nchondrocyte development,morphogenesis/development,+\nchondrocyte differentiation,morphogenesis/development,+\nchondrocyte proliferation,cell cycle,+\nchondroitin sulfate proteoglycan biosynthetic process,metabolic process,+\nchordate embryonic development,morphogenesis/development,+\nchromatin binding,gene regulation,+\nchromatin DNA binding,gene regulation,+\nchromatin organization,cell cycle,+\nchromatin remodeling,cell cycle,+\nchromosome condensation,cell cycle,+\nchromosome localization,cell cycle,+\nchromosome organization,cell cycle,+\nchromosome organization involved in meiotic cell cycle,cell cycle,+\nchromosome segregation,cell cycle,+\nchromosome separation,cell cycle,+\nchronic inflammatory response,stress response,+\ncilium-dependent cell motility,other,+\ncilium assembly,cellular component organization,+\ncilium or flagellum-dependent cell motility,other,+\ncilium organization,cellular component organization,+\ncircadian regulation of gene expression,gene regulation,+\ncircadian rhythm,other,+\ncirculatory system process,multicellular organismal process,+\nclathrin-dependent endocytosis,transport,+\nclathrin adaptor activity,transport,+\nclathrin binding,cellular component organization,+\nCoA-ligase activity,metabolic process,+\ncoagulation,multicellular organismal process,+\ncoated vesicle membrane,cellular component organization,+\ncochlea development,morphogenesis/development,+\ncoenzyme A metabolic process,metabolic process,+\ncognition,neural related process,+\ncollagen-activated signaling pathway,receptor related process,+\ncollagen-activated tyrosine kinase receptor signaling pathway,receptor related process,+\ncollagen-containing extracellular matrix,cellular component organization,+\ncollagen binding,cellular component organization,+\ncollagen metabolic process,metabolic process,+\ncollateral sprouting,morphogenesis/development,+\ncolumnar/cuboidal epithelial cell differentiation,morphogenesis/development,+\ncommissural neuron axon guidance,neural related process,+\nconnective tissue development,morphogenesis/development,+\nconnective tissue replacement,multicellular organismal process,+\nconstitutive heterochromatin formation,gene regulation,+\nCOPII-coated ER to Golgi transport vesicle,ER/endosome/lysosome related process,+\nCOPII-coated vesicle budding,transport,+\ncopper ion homeostasis,other,+\ncopper ion transport,transport,+\ncore mediator complex,gene regulation,+\ncore promoter sequence-specific DNA binding,gene regulation,+\ncornified envelope,morphogenesis/development,+\ncoronary vasculature development,morphogenesis/development,+\ncoronary vasculature morphogenesis,morphogenesis/development,+\ncortical actin cytoskeleton,cellular component organization,+\ncortical actin cytoskeleton organization,cellular component organization,+\ncortical cytoskeleton organization,cellular component organization,+\ncorticosteroid receptor signaling pathway,receptor related process,+\ncranial nerve development,immune system process,+\ncristae formation,cellular component organization,+\nCXCR chemokine receptor binding,immune system process,+\ncyclic nucleotide binding,other,+\ncyclin-dependent protein serine/threonine kinase regulator activity,cell cycle,+\ncyclin binding,cell cycle,+\ncysteine-type endopeptidase regulator activity involved in apoptotic process,cell death,+\ncysteine-type peptidase activity,cell death,+\ncysteine metabolic process,metabolic process,+\ncytochrome-c oxidase activity,metabolic process,+\ncytochrome complex assembly,cellular component organization,+\ncytokine-mediated signaling pathway,immune system process,+\ncytokine activity,immune system process,+\ncytokine binding,immune system process,+\ncytokine production,immune system process,+\ncytokine production involved in immune response,immune system process,+\ncytokine receptor activity,immune system process,+\ncytokine receptor binding,immune system process,+\ncytoplasmic ribonucleoprotein granule,cellular component organization,+\ncytoplasmic sequestering of protein,other,+\ncytoplasmic sequestering of transcription factor,gene regulation,+\ncytoplasmic side of membrane,cellular component organization,+\ncytoplasmic translation,gene regulation,+\ncytoplasmic translational initiation,gene regulation,+\ncytoskeletal motor activity,other,+\ncytoskeletal protein binding,cellular component organization,+\ncytoskeleton-dependent intracellular transport,transport,+\ncytosolic transport,transport,+\ndamaged DNA binding,stress response,+\ndecidualization,multicellular organismal process,+\ndefense response to bacterium,stress response,+\ndefense response to Gram-negative bacterium,stress response,+\ndefense response to Gram-positive bacterium,immune system process,+\ndefense response to protozoan,stress response,+\ndefense response to symbiont,stress response,+\ndefense response to virus,viral related process,+\ndefinitive hemopoiesis,morphogenesis/development,+\ndemethylation,protein modification/signaling,+\ndendrite morphogenesis,neural related process,+\ndendritic cell chemotaxis,neural related process,+\ndendritic cell differentiation,morphogenesis/development,+\ndendritic shaft,neural related process,+\ndendritic spine,neural related process,+\ndendritic spine development,neural related process,+\ndeoxyribonucleoside metabolic process,metabolic process,+\ndeoxyribonucleotide metabolic process,metabolic process,+\ndeoxyribose phosphate biosynthetic process,metabolic process,+\ndeoxyribose phosphate metabolic process,metabolic process,+\ndephosphorylation,protein modification/signaling,+\ndesensitization of G protein-coupled receptor signaling pathway,receptor related process,+\ndetection of mechanical stimulus involved in sensory perception of pain,neural related process,+\ndetoxification,response to stimulus,+\ndevelopment of primary female sexual characteristics,morphogenesis/development,+\ndevelopment of primary male sexual characteristics,morphogenesis/development,+\ndevelopment of primary sexual characteristics,morphogenesis/development,+\ndevelopmental cell growth,morphogenesis/development,+\ndevelopmental growth,morphogenesis/development,+\ndevelopmental growth involved in morphogenesis,morphogenesis/development,+\ndevelopmental induction,morphogenesis/development,+\ndevelopmental maturation,morphogenesis/development,+\ndicarboxylic acid metabolic process,metabolic process,+\ndicarboxylic acid transport,transport,+\ndiencephalon development,neural related process,+\ndigestive system development,morphogenesis/development,+\ndigestive system process,multicellular organismal process,+\ndigestive tract development,morphogenesis/development,+\ndiol biosynthetic process,metabolic process,+\ndistal axon,neural related process,+\ndistal tubule development,morphogenesis/development,+\nditerpenoid biosynthetic process,metabolic process,+\nditerpenoid metabolic process,metabolic process,+\nDNA-binding transcription activator activity,gene regulation,+\n\"DNA-binding transcription activator activity, RNA polymerase II-specific\",gene regulation,+\nDNA-binding transcription factor binding,gene regulation,+\nDNA-binding transcription repressor activity,gene regulation,+\n\"DNA-binding transcription repressor activity, RNA polymerase II-specific\",gene regulation,+\nDNA-directed 5'-3' RNA polymerase activity,gene regulation,+\nDNA-directed DNA polymerase activity,cell cycle,+\nDNA-templated DNA replication,cell cycle,+\nDNA-templated DNA replication maintenance of fidelity,cell cycle,+\nDNA-templated transcription elongation,gene regulation,+\nDNA-templated transcription initiation,gene regulation,+\nDNA-templated transcription termination,gene regulation,+\nDNA biosynthetic process,cell cycle,+\nDNA conformation change,cell cycle,+\nDNA damage checkpoint signaling,cell cycle,+\nDNA damage response,stress response,+\n\"DNA damage response, signal transduction by p53 class mediator\",stress response,+\n\"DNA damage response, signal transduction resulting in transcription\",stress response,+\nDNA dealkylation,gene regulation,+\nDNA double-strand break processing,stress response,+\nDNA duplex unwinding,cell cycle,+\nDNA exonuclease activity,cell cycle,+\nDNA geometric change,cell cycle,+\nDNA integration,other,+\nDNA integrity checkpoint signaling,cell cycle,+\nDNA ligation,cell cycle,+\nDNA methylation-dependent heterochromatin formation,gene regulation,+\nDNA modification,gene regulation,+\nDNA polymerase binding,cell cycle,+\nDNA recombination,cell cycle,+\nDNA repair,stress response,+\nDNA replication,cell cycle,+\nDNA replication checkpoint signaling,cell cycle,+\nDNA replication initiation,cell cycle,+\nDNA replication origin binding,cell cycle,+\nDNA secondary structure binding,gene regulation,+\nDNA strand elongation,cell cycle,+\nDNA strand elongation involved in DNA replication,cell cycle,+\nDNA unwinding involved in DNA replication,cell cycle,+\ndolichol-linked oligosaccharide biosynthetic process,metabolic process,+\ndopamine receptor signaling pathway,receptor related process,+\ndouble-strand break repair,stress response,+\ndouble-strand break repair via break-induced replication,stress response,+\ndouble-strand break repair via homologous recombination,stress response,+\ndouble-strand break repair via nonhomologous end joining,stress response,+\ndouble-stranded RNA binding,immune system process,+\ndynein light intermediate chain binding,cellular component organization,+\nearly endosome,ER/endosome/lysosome related process,+\nearly endosome to late endosome transport,ER/endosome/lysosome related process,+\nectodermal placode development,morphogenesis/development,+\nelectron transport chain,metabolic process,+\nembryo development ending in birth or egg hatching,morphogenesis/development,+\nembryo implantation,multicellular organismal process,+\nembryonic eye morphogenesis,morphogenesis/development,+\nembryonic hemopoiesis,morphogenesis/development,+\nembryonic organ development,morphogenesis/development,+\nembryonic organ morphogenesis,morphogenesis/development,+\nendocardium development,morphogenesis/development,+\nendochondral bone morphogenesis,morphogenesis/development,+\nendocrine hormone secretion,multicellular organismal process,+\nendocrine system development,morphogenesis/development,+\nendocytic recycling,transport,+\nendocytic vesicle,ER/endosome/lysosome related process,+\nendocytosis,transport,+\nendoderm development,morphogenesis/development,+\nendodermal cell differentiation,morphogenesis/development,+\nendolysosomal toll-like receptor signaling pathway,immune system process,+\nendomembrane system organization,cellular component organization,+\nendonuclease activity,metabolic process,+\nendopeptidase activity,cell death,+\nendopeptidase complex,cell death,+\nendopeptidase regulator activity,metabolic process,+\nendoplasmic reticulum-Golgi intermediate compartment,ER/endosome/lysosome related process,+\nendoplasmic reticulum calcium ion homeostasis,ER/endosome/lysosome related process,+\nendoplasmic reticulum exit site,ER/endosome/lysosome related process,+\nendoplasmic reticulum lumen,ER/endosome/lysosome related process,+\nendoplasmic reticulum organization,ER/endosome/lysosome related process,+\nendoplasmic reticulum quality control compartment,ER/endosome/lysosome related process,+\nendoplasmic reticulum to cytosol transport,ER/endosome/lysosome related process,+\nendoplasmic reticulum to Golgi vesicle-mediated transport,ER/endosome/lysosome related process,+\nendoplasmic reticulum tubular network organization,ER/endosome/lysosome related process,+\nendoplasmic reticulum unfolded protein response,stress response,+\nendosomal lumen acidification,ER/endosome/lysosome related process,+\nendosomal transport,ER/endosome/lysosome related process,+\nendosome organization,ER/endosome/lysosome related process,+\nendothelial cell apoptotic process,cell death,+\nendothelial cell development,morphogenesis/development,+\nendothelial cell differentiation,morphogenesis/development,+\nendothelial cell migration,multicellular organismal process,+\nendothelial cell proliferation,cell cycle,+\nendothelium development,morphogenesis/development,+\nenergy derivation by oxidation of organic compounds,metabolic process,+\nenergy homeostasis,multicellular organismal process,+\nensheathment of neurons,neural related process,+\nentrainment of circadian clock,response to stimulus,+\nentry into host,other,+\nenzyme-linked receptor protein signaling pathway,receptor related process,+\nenzyme activator activity,metabolic process,+\nenzyme inhibitor activity,protein modification/signaling,+\neosinophil migration,immune system process,+\nephrin receptor signaling pathway,receptor related process,+\nepiboly,morphogenesis/development,+\nepiboly involved in wound healing,stress response,+\nepidermal cell differentiation,morphogenesis/development,+\nepidermal growth factor receptor binding,receptor related process,+\nepidermal growth factor receptor signaling pathway,receptor related process,+\nepidermis development,morphogenesis/development,+\nepigenetic regulation of gene expression,gene regulation,+\nepithelial cell-cell adhesion,cell adhesion,+\nepithelial cell apoptotic process,cell death,+\nepithelial cell development,morphogenesis/development,+\nepithelial cell differentiation,morphogenesis/development,+\nepithelial cell migration,multicellular organismal process,+\nepithelial cell proliferation,cell cycle,+\nepithelial cell proliferation involved in liver morphogenesis,cell cycle,+\nepithelial to mesenchymal transition,morphogenesis/development,+\nepithelial tube morphogenesis,morphogenesis/development,+\nepithelium migration,multicellular organismal process,+\nER-associated misfolded protein catabolic process,ER/endosome/lysosome related process,+\nER-nucleus signaling pathway,ER/endosome/lysosome related process,+\nERAD pathway,ER/endosome/lysosome related process,+\nERBB signaling pathway,receptor related process,+\nERBB2 signaling pathway,receptor related process,+\nERBB4 signaling pathway,receptor related process,+\nERK1 and ERK2 cascade,protein modification/signaling,+\nerythrocyte differentiation,morphogenesis/development,+\nerythrocyte homeostasis,multicellular organismal process,+\nestablishment of cell polarity,cellular component organization,+\nestablishment of chromosome localization,cell cycle,+\nestablishment of mitotic spindle localization,cell cycle,+\nestablishment of organelle localization,cellular component organization,+\nestablishment of planar polarity,cellular component organization,+\nestablishment of planar polarity of embryonic epithelium,cellular component organization,+\nestablishment of protein localization to membrane,transport,+\nestablishment of protein localization to vacuole,transport,+\nestablishment of RNA localization,transport,+\nestablishment of sister chromatid cohesion,cell cycle,+\nestablishment of skin barrier,multicellular organismal process,+\nestablishment of spindle localization,cell cycle,+\nestablishment of tissue polarity,multicellular organismal process,+\nestablishment of vesicle localization,transport,+\nestablishment or maintenance of apical/basal cell polarity,cellular component organization,+\nestablishment or maintenance of bipolar cell polarity,cellular component organization,+\nestablishment or maintenance of cell polarity,cellular component organization,+\nestablishment or maintenance of epithelial cell apical/basal polarity,cellular component organization,+\nethanol metabolic process,metabolic process,+\nether biosynthetic process,metabolic process,+\nexcitatory synapse,neural related process,+\nexecution phase of apoptosis,cell death,+\nexocytosis,transport,+\n\"exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters\",cell cycle,+\nexopeptidase activity,protein modification/signaling,+\nexport across plasma membrane,transport,+\nexternal encapsulating structure organization,cellular component organization,+\nexternal side of plasma membrane,cellular component organization,+\nextracellular exosome biogenesis,morphogenesis/development,+\nextracellular matrix binding,cell adhesion,+\nextracellular matrix constituent secretion,transport,+\nextracellular matrix disassembly,cellular component organization,+\nextracellular matrix organization,cellular component organization,+\nextracellular structure organization,cellular component organization,+\nextracellular vesicle biogenesis,cellular component organization,+\nextrinsic apoptotic signaling pathway,cell death,+\nextrinsic apoptotic signaling pathway in absence of ligand,cell death,+\nextrinsic apoptotic signaling pathway via death domain receptors,cell death,+\nextrinsic component of membrane,cellular component organization,+\nextrinsic component of organelle membrane,cellular component organization,+\neye development,morphogenesis/development,+\neyelid development in camera-type eye,morphogenesis/development,+\nface development,morphogenesis/development,+\nfacultative heterochromatin formation,gene regulation,+\nfat cell differentiation,morphogenesis/development,+\nfatty-acyl-CoA binding,metabolic process,+\nfatty-acyl-CoA metabolic process,metabolic process,+\nfatty acid beta-oxidation,metabolic process,+\nfatty acid beta-oxidation using acyl-CoA oxidase,metabolic process,+\nfatty acid biosynthetic process,metabolic process,+\nfatty acid derivative catabolic process,metabolic process,+\nfatty acid derivative metabolic process,metabolic process,+\nfatty acid metabolic process,metabolic process,+\nFc-epsilon receptor signaling pathway,receptor related process,+\nFc receptor mediated stimulatory signaling pathway,immune system process,+\nFc receptor signaling pathway,immune system process,+\nfeeding behavior,neural related process,+\nfemale gamete generation,multicellular organismal process,+\nfemale gonad development,morphogenesis/development,+\nfemale meiotic nuclear division,cell cycle,+\nfemale pregnancy,multicellular organismal process,+\nfemale sex differentiation,morphogenesis/development,+\nfibrillar center,cellular component organization,+\nfibrinolysis,multicellular organismal process,+\nfibroblast apoptotic process,cell death,+\nfibroblast growth factor binding,response to stimulus,+\nfibroblast growth factor receptor signaling pathway,receptor related process,+\nfibroblast migration,multicellular organismal process,+\nfibroblast proliferation,cell cycle,+\nficolin-1-rich granule,immune system process,+\nficolin-1-rich granule lumen,immune system process,+\nfilopodium,cellular component organization,+\nflavin adenine dinucleotide binding,metabolic process,+\nfluid transport,transport,+\nfoam cell differentiation,morphogenesis/development,+\nfolic acid-containing compound metabolic process,metabolic process,+\nforebrain development,morphogenesis/development,+\nformation of cytoplasmic translation initiation complex,cellular component organization,+\nformation of primary germ layer,morphogenesis/development,+\nformation of translation preinitiation complex,cellular component organization,+\nG-protein alpha-subunit binding,protein modification/signaling,+\nG protein-coupled acetylcholine receptor signaling pathway,neural related process,+\nG protein-coupled neurotransmitter receptor activity,neural related process,+\nG protein-coupled purinergic nucleotide receptor signaling pathway,receptor related process,+\nG protein-coupled receptor binding,receptor related process,+\nG protein activity,protein modification/signaling,+\nG0 to G1 transition,cell cycle,+\nG1/S transition of mitotic cell cycle,cell cycle,+\nG2/M transition of mitotic cell cycle,cell cycle,+\nGABA-ergic synapse,neural related process,+\ngastrulation,morphogenesis/development,+\nGDP binding,protein modification/signaling,+\ngeneral transcription initiation factor activity,gene regulation,+\ngeneral transcription initiation factor binding,gene regulation,+\ngeneration of precursor metabolites and energy,metabolic process,+\ngenitalia morphogenesis,morphogenesis/development,+\ngerminal center formation,immune system process,+\ngland development,morphogenesis/development,+\ngland morphogenesis,morphogenesis/development,+\nglandular epithelial cell differentiation,morphogenesis/development,+\nglial cell activation,neural related process,+\nglial cell apoptotic process,cell death,+\nglial cell development,neural related process,+\nglial cell differentiation,morphogenesis/development,+\nglial cell proliferation,cell cycle,+\ngliogenesis,morphogenesis/development,+\nglomerular mesangium development,morphogenesis/development,+\nglomerulus development,morphogenesis/development,+\nglomerulus vasculature development,morphogenesis/development,+\nglucan metabolic process,metabolic process,+\nglucocorticoid receptor signaling pathway,receptor related process,+\nglucose homeostasis,metabolic process,+\nglucose metabolic process,metabolic process,+\nglucose transmembrane transport,transport,+\nglucosyltransferase activity,metabolic process,+\nglucuronate metabolic process,metabolic process,+\nglutamate receptor activity,neural related process,+\nglutamatergic synapse,neural related process,+\nglutamine metabolic process,metabolic process,+\nglutathione metabolic process,metabolic process,+\nglutathione peroxidase activity,metabolic process,+\nglutathione transferase activity,metabolic process,+\nglycerophospholipid catabolic process,metabolic process,+\nglycerophospholipid metabolic process,metabolic process,+\nglycolipid biosynthetic process,metabolic process,+\nglycolytic process,metabolic process,+\nglycolytic process through glucose-6-phosphate,metabolic process,+\nglycoprotein catabolic process,metabolic process,+\nglycoprotein metabolic process,metabolic process,+\nglycosaminoglycan biosynthetic process,metabolic process,+\nglycoside metabolic process,metabolic process,+\nglycosyl compound metabolic process,metabolic process,+\nGolgi apparatus subcompartment,ER/endosome/lysosome related process,+\nGolgi localization,transport,+\nGolgi lumen acidification,ER/endosome/lysosome related process,+\nGolgi membrane,ER/endosome/lysosome related process,+\nGolgi organization,ER/endosome/lysosome related process,+\nGolgi stack,ER/endosome/lysosome related process,+\nGolgi to plasma membrane transport,transport,+\nGolgi vesicle transport,transport,+\ngonad development,morphogenesis/development,+\ngranulocyte chemotaxis,immune system process,+\ngranulocyte differentiation,immune system process,+\ngranulocyte migration,immune system process,+\ngrowth,morphogenesis/development,+\ngrowth factor activity,protein modification/signaling,+\ngrowth factor binding,response to stimulus,+\ngrowth factor receptor binding,receptor related process,+\ngrowth plate cartilage development,morphogenesis/development,+\nGTP binding,protein modification/signaling,+\nGTP metabolic process,metabolic process,+\nGTPase binding,protein modification/signaling,+\nGTPase regulator activity,protein modification/signaling,+\nguanyl-nucleotide exchange factor activity,protein modification/signaling,+\nhair cycle,multicellular organismal process,+\nhair cycle process,multicellular organismal process,+\nhair follicle development,morphogenesis/development,+\nhair follicle morphogenesis,morphogenesis/development,+\nhead development,morphogenesis/development,+\nheart contraction,multicellular organismal process,+\nheart development,morphogenesis/development,+\nheart formation,morphogenesis/development,+\nheart morphogenesis,morphogenesis/development,+\nheart process,multicellular organismal process,+\nheart valve development,morphogenesis/development,+\nheat shock protein binding,protein modification/signaling,+\nhelicase activity,cell cycle,+\nhematopoietic or lymphoid organ development,morphogenesis/development,+\nhematopoietic progenitor cell differentiation,immune system process,+\nhemostasis,multicellular organismal process,+\nhepaticobiliary system development,morphogenesis/development,+\nhepatocyte apoptotic process,cell death,+\nhepatocyte differentiation,morphogenesis/development,+\nhepatocyte proliferation,cell cycle,+\nheterochromatin formation,gene regulation,+\nheterocycle catabolic process,metabolic process,+\nheterotypic cell-cell adhesion,cell adhesion,+\nhexose transmembrane transport,transport,+\nhexosyltransferase activity,protein modification/signaling,+\nhindlimb morphogenesis,neural related process,+\nhippo signaling,protein modification/signaling,+\nhistone acetyltransferase activity,gene regulation,+\nhistone acetyltransferase binding,gene regulation,+\nhistone acetyltransferase complex,gene regulation,+\nhistone binding,gene regulation,+\nhistone deacetylase binding,gene regulation,+\nhistone H2A ubiquitination,gene regulation,+\nhistone H3-K36 methylation,gene regulation,+\nhistone H3-K4 methylation,gene regulation,+\nhistone H3-K4 trimethylation,gene regulation,+\nhistone H4-K16 acetylation,gene regulation,+\nhistone H4 acetylation,gene regulation,+\nhistone kinase activity,gene regulation,+\nhistone lysine demethylation,gene regulation,+\nhistone methylation,gene regulation,+\nhistone methyltransferase complex,gene regulation,+\nhistone modification,gene regulation,+\nhistone modifying activity,gene regulation,+\nhistone ubiquitination,protein modification/signaling,+\nhomeostasis of number of cells,multicellular organismal process,+\nhomocysteine metabolic process,metabolic process,+\nhomologous recombination,cell cycle,+\nhomophilic cell adhesion via plasma membrane adhesion molecules,cell adhesion,+\nhomotypic cell-cell adhesion,cell adhesion,+\nhormone-mediated signaling pathway,protein modification/signaling,+\nhormone metabolic process,metabolic process,+\nhormone secretion,transport,+\nhormone transport,transport,+\nhumoral immune response,immune system process,+\n\"hydrolase activity, acting on acid anhydrides\",metabolic process,+\n\"hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides\",metabolic process,+\n\"hydrolase activity, acting on ester bonds\",metabolic process,+\n\"hydroxymethyl-, formyl- and related transferase activity\",metabolic process,+\nhyperosmotic response,stress response,+\nhypotonic response,stress response,+\nI-kappaB phosphorylation,immune system process,+\nidentical protein binding,protein modification/signaling,+\nimmune effector process,immune system process,+\nimmune response-activating cell surface receptor signaling pathway,immune system process,+\nimmune response-activating signaling pathway,immune system process,+\nimmune response-regulating cell surface receptor signaling pathway,immune system process,+\nimmune response-regulating signaling pathway,immune system process,+\nimmune system development,immune system process,+\nIMP biosynthetic process,metabolic process,+\nIMP metabolic process,metabolic process,+\nimport across plasma membrane,transport,+\nimport into cell,transport,+\nimport into nucleus,transport,+\nin utero embryonic development,morphogenesis/development,+\ninclusion body,cellular component organization,+\ninflammatory cell apoptotic process,cell death,+\ninflammatory response,immune system process,+\ninflammatory response to antigenic stimulus,immune system process,+\ninhibitory postsynaptic potential,neural related process,+\ninnate immune response-activating signaling pathway,immune system process,+\ninnate immune response activating cell surface receptor signaling pathway,immune system process,+\ninner cell mass cell proliferation,cell cycle,+\ninner mitochondrial membrane organization,cellular component organization,+\ninnervation,neural related process,+\ninorganic anion transport,transport,+\ninositol phosphate phosphatase activity,protein modification/signaling,+\ninsulin-like growth factor I binding,response to stimulus,+\ninsulin-like growth factor receptor signaling pathway,receptor related process,+\ninsulin receptor signaling pathway,receptor related process,+\nintegrated stress response signaling,stress response,+\nintegrin-mediated signaling pathway,protein modification/signaling,+\nintegrin binding,cell adhesion,+\nintercalated disc,cell adhesion,+\ninterferon-alpha production,immune system process,+\ninterferon-beta production,immune system process,+\ninterferon-mediated signaling pathway,immune system process,+\ninterleukin-1-mediated signaling pathway,immune system process,+\ninterleukin-1 beta production,immune system process,+\ninterleukin-1 production,immune system process,+\ninterleukin-10 production,immune system process,+\ninterleukin-12 production,immune system process,+\ninterleukin-13 production,immune system process,+\ninterleukin-17 production,immune system process,+\ninterleukin-2 production,immune system process,+\ninterleukin-4 production,immune system process,+\ninterleukin-5 production,immune system process,+\ninterleukin-6-mediated signaling pathway,immune system process,+\ninterleukin-6 production,immune system process,+\ninterleukin-8 production,immune system process,+\nintermediate filament cytoskeleton organization,cellular component organization,+\nintermediate filament organization,cellular component organization,+\ninterstrand cross-link repair,stress response,+\nintestinal epithelial cell development,morphogenesis/development,+\nintestinal epithelial cell differentiation,morphogenesis/development,+\nintra-Golgi vesicle-mediated transport,ER/endosome/lysosome related process,+\nintracellular cholesterol transport,transport,+\nintracellular iron ion homeostasis,response to stimulus,+\nintracellular lipid transport,transport,+\nintracellular protein-containing complex,other,+\nintracellular protein transmembrane transport,transport,+\nintracellular protein transport,transport,+\nintracellular receptor signaling pathway,receptor related process,+\nintracellular sodium ion homeostasis,other,+\nintracellular steroid hormone receptor signaling pathway,receptor related process,+\nintracellular sterol transport,transport,+\nintraciliary transport,transport,+\nintrinsic apoptotic signaling pathway,cell death,+\nintrinsic apoptotic signaling pathway by p53 class mediator,cell death,+\nintrinsic apoptotic signaling pathway in response to DNA damage,cell death,+\nintrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,cell death,+\nintrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,cell death,+\nintrinsic apoptotic signaling pathway in response to oxidative stress,cell death,+\nIRE1-mediated unfolded protein response,stress response,+\nIRES-dependent viral translational initiation,viral related process,+\niron-sulfur cluster assembly,cellular component organization,+\niron coordination entity transport,transport,+\niron ion transmembrane transport,transport,+\niron ion transport,transport,+\nisomerase activity,metabolic process,+\nisoprenoid biosynthetic process,metabolic process,+\nisoprenoid metabolic process,metabolic process,+\nJNK cascade,stress response,+\nJUN kinase kinase kinase activity,protein modification/signaling,+\nkeratinocyte differentiation,morphogenesis/development,+\nkeratinocyte proliferation,cell cycle,+\nketone catabolic process,metabolic process,+\nkidney development,morphogenesis/development,+\nkidney epithelium development,morphogenesis/development,+\nkidney mesenchyme development,morphogenesis/development,+\nkidney vasculature development,morphogenesis/development,+\nkinase activity,protein modification/signaling,+\nkinase binding,protein modification/signaling,+\nkinase inhibitor activity,protein modification/signaling,+\nkinase regulator activity,protein modification/signaling,+\nkinetochore organization,cell cycle,+\nL-serine metabolic process,metabolic process,+\nlabyrinthine layer morphogenesis,morphogenesis/development,+\nlactation,multicellular organismal process,+\nlamellipodium,cellular component organization,+\nlamellipodium organization,cellular component organization,+\nlaminin binding,other,+\nlate endosome,ER/endosome/lysosome related process,+\nlate endosome to vacuole transport,ER/endosome/lysosome related process,+\nlateral plasma membrane,cellular component organization,+\nlearning,neural related process,+\nlearning or memory,neural related process,+\nlens development in camera-type eye,morphogenesis/development,+\nlens fiber cell differentiation,morphogenesis/development,+\nleukocyte activation involved in immune response,immune system process,+\nleukocyte activation involved in inflammatory response,immune system process,+\nleukocyte adhesion to vascular endothelial cell,immune system process,+\nleukocyte apoptotic process,cell death,+\nleukocyte cell-cell adhesion,immune system process,+\nleukocyte chemotaxis,immune system process,+\nleukocyte degranulation,immune system process,+\nleukocyte differentiation,immune system process,+\nleukocyte homeostasis,immune system process,+\nleukocyte mediated cytotoxicity,immune system process,+\nleukocyte mediated immunity,immune system process,+\nleukocyte migration,immune system process,+\nleukocyte proliferation,immune system process,+\nleukocyte tethering or rolling,immune system process,+\nleukotriene metabolic process,immune system process,+\nligand-activated transcription factor activity,gene regulation,+\n\"ligase activity, forming carbon-nitrogen bonds\",metabolic process,+\nlimb development,morphogenesis/development,+\nlimb morphogenesis,morphogenesis/development,+\nlipase inhibitor activity,metabolic process,+\nlipid binding,other,+\nlipid droplet,cellular component organization,+\nlipid droplet organization,cellular component organization,+\nlipid export from cell,transport,+\nlipid homeostasis,other,+\nlipid localization,cellular component organization,+\nlipid phosphorylation,metabolic process,+\nlipid storage,cellular component organization,+\nlipid transport,transport,+\nlipopolysaccharide-mediated signaling pathway,immune system process,+\nlipoprotein biosynthetic process,metabolic process,+\nlipoprotein metabolic process,metabolic process,+\nlipoprotein particle receptor binding,receptor related process,+\nliver development,morphogenesis/development,+\nliver morphogenesis,morphogenesis/development,+\nliver regeneration,morphogenesis/development,+\nlocalization within membrane,cellular component organization,+\nlong-chain fatty acid metabolic process,metabolic process,+\nlow-density lipoprotein particle receptor binding,receptor related process,+\nlung alveolus development,morphogenesis/development,+\nlung morphogenesis,morphogenesis/development,+\nlyase activity,metabolic process,+\nlymph vessel development,morphogenesis/development,+\nlymph vessel morphogenesis,morphogenesis/development,+\nlymphocyte activation,immune system process,+\nlymphocyte activation involved in immune response,immune system process,+\nlymphocyte apoptotic process,immune system process,+\nlymphocyte chemotaxis,immune system process,+\nlymphocyte costimulation,immune system process,+\nlymphocyte differentiation,immune system process,+\nlymphocyte homeostasis,immune system process,+\nlymphocyte mediated immunity,immune system process,+\nlymphocyte migration,immune system process,+\nlymphocyte proliferation,immune system process,+\nlymphoid progenitor cell differentiation,immune system process,+\nlysophosphatidic acid acyltransferase activity,metabolic process,+\nlysophospholipid acyltransferase activity,metabolic process,+\nlysosomal protein catabolic process,metabolic process,+\nlysosomal transport,ER/endosome/lysosome related process,+\nlysosome organization,ER/endosome/lysosome related process,+\nmacroautophagy,metabolic process,+\nmacromolecule localization,transport,+\nmacromolecule methylation,metabolic process,+\nmacrophage activation,immune system process,+\nmacrophage activation involved in immune response,immune system process,+\nmacrophage chemotaxis,immune system process,+\nmacrophage cytokine production,immune system process,+\nmacrophage derived foam cell differentiation,morphogenesis/development,+\nmacrophage differentiation,immune system process,+\nmacrophage migration,immune system process,+\nmagnesium ion binding,protein modification/signaling,+\nmagnesium ion transmembrane transport,transport,+\nmagnesium ion transport,transport,+\nmain axon,neural related process,+\nmaintenance of blood-brain barrier,multicellular organismal process,+\nmaintenance of cell number,morphogenesis/development,+\nmaintenance of gastrointestinal epithelium,multicellular organismal process,+\nmaintenance of location,other,+\nmaintenance of location in cell,cellular component organization,+\nmaintenance of organelle location,cellular component organization,+\nmaintenance of protein localization in endoplasmic reticulum,ER/endosome/lysosome related process,+\nmaintenance of protein localization in organelle,cellular component organization,+\nmaintenance of protein location,cellular component organization,+\nmaintenance of protein location in nucleus,transport,+\nmaintenance of synapse structure,neural related process,+\nmale genitalia development,morphogenesis/development,+\nmale gonad development,morphogenesis/development,+\nmale sex differentiation,morphogenesis/development,+\nmammary gland development,morphogenesis/development,+\nmammary gland duct morphogenesis,morphogenesis/development,+\nmammary gland epithelium development,morphogenesis/development,+\nmammary gland morphogenesis,morphogenesis/development,+\nmannosyltransferase activity,metabolic process,+\nMAP kinase kinase activity,protein modification/signaling,+\nMAP kinase kinase kinase activity,protein modification/signaling,+\nMAPK cascade,protein modification/signaling,+\nmaternal behavior,neural related process,+\nmaternal placenta development,morphogenesis/development,+\nmaternal process involved in female pregnancy,morphogenesis/development,+\nmaturation of 5.8S rRNA,metabolic process,+\n\"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)\",gene regulation,+\nmaturation of LSU-rRNA,metabolic process,+\n\"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)\",gene regulation,+\nmaturation of SSU-rRNA,gene regulation,+\nmature B cell differentiation involved in immune response,immune system process,+\nMDA-5 signaling pathway,immune system process,+\nmediator complex,gene regulation,+\nmeiosis I,cell cycle,+\nmeiosis I cell cycle process,cell cycle,+\nmeiotic cell cycle,cell cycle,+\nmeiotic cell cycle phase transition,cell cycle,+\nmeiotic cell cycle process,cell cycle,+\nmeiotic chromosome segregation,cell cycle,+\nmeiotic nuclear division,cell cycle,+\nmeiotic spindle organization,cell cycle,+\nmelanosome transport,transport,+\nmembrane docking,other,+\nmembrane fission,cellular component organization,+\nmembrane fusion,cellular component organization,+\nmembrane lipid catabolic process,metabolic process,+\nmembrane lipid metabolic process,metabolic process,+\nmembrane organization,cellular component organization,+\nmembrane protein proteolysis,metabolic process,+\nmembrane raft,cellular component organization,+\nmembrane raft organization,cellular component organization,+\nmemory,neural related process,+\nmesenchymal cell differentiation,morphogenesis/development,+\nmesenchymal cell migration,multicellular organismal process,+\nmesenchyme morphogenesis,morphogenesis/development,+\nmesoderm development,morphogenesis/development,+\nmesoderm formation,morphogenesis/development,+\nmesodermal cell differentiation,morphogenesis/development,+\nmetal cluster binding,metabolic process,+\nmetallochaperone activity,transport,+\nmetalloendopeptidase inhibitor activity,metabolic process,+\nmetanephric collecting duct development,morphogenesis/development,+\nmetanephric glomerulus development,morphogenesis/development,+\nmetanephros development,morphogenesis/development,+\nmetaphase/anaphase transition of cell cycle,cell cycle,+\nmetaphase/anaphase transition of mitotic cell cycle,cell cycle,+\nmethionine biosynthetic process,metabolic process,+\nmicroglial cell activation,immune system process,+\nmicrotubule,cellular component organization,+\nmicrotubule cytoskeleton organization,cellular component organization,+\nmicrotubule cytoskeleton organization involved in mitosis,cell cycle,+\nmicrotubule nucleation,cellular component organization,+\nmicrotubule organizing center organization,cellular component organization,+\nmicrotubule plus-end binding,cellular component organization,+\nmicrotubule polymerization,cellular component organization,+\nmicrovillus,cellular component organization,+\nmicrovillus assembly,cellular component organization,+\nmicrovillus organization,cellular component organization,+\nminus-end-directed microtubule motor activity,cellular component organization,+\nmiRNA binding,gene regulation,+\nmiRNA metabolic process,metabolic process,+\nmiRNA processing,gene regulation,+\nmiRNA transcription,gene regulation,+\nmisfolded protein binding,other,+\nmismatch repair,stress response,+\nmitochondrial ATP synthesis coupled electron transport,metabolic process,+\nmitochondrial DNA replication,cell cycle,+\n\"mitochondrial electron transport, cytochrome c to oxygen\",metabolic process,+\n\"mitochondrial electron transport, NADH to ubiquinone\",metabolic process,+\n\"mitochondrial electron transport, ubiquinol to cytochrome c\",metabolic process,+\nmitochondrial fusion,cellular component organization,+\nmitochondrial gene expression,gene regulation,+\nmitochondrial genome maintenance,cellular component organization,+\nmitochondrial membrane organization,cellular component organization,+\nmitochondrial respiratory chain complex assembly,cellular component organization,+\nmitochondrial respiratory chain complex I assembly,cellular component organization,+\nmitochondrial RNA metabolic process,metabolic process,+\nmitochondrial translation,gene regulation,+\nmitochondrial transmembrane transport,transport,+\nmitochondrial transport,transport,+\nmitochondrion morphogenesis,morphogenesis/development,+\nmitochondrion organization,cellular component organization,+\nmitogen-activated protein kinase binding,protein modification/signaling,+\nmitophagy,cellular component organization,+\nmitotic cell cycle,cell cycle,+\nmitotic cell cycle checkpoint signaling,cell cycle,+\nmitotic cell cycle phase transition,cell cycle,+\nmitotic chromosome condensation,cell cycle,+\nmitotic cytokinesis,cell cycle,+\nmitotic DNA integrity checkpoint signaling,protein modification/signaling,+\nmitotic G1 DNA damage checkpoint signaling,cell cycle,+\nmitotic G1/S transition checkpoint signaling,cell cycle,+\nmitotic G2 DNA damage checkpoint signaling,cell cycle,+\nmitotic G2/M transition checkpoint,cell cycle,+\nmitotic nuclear division,cell cycle,+\nmitotic sister chromatid cohesion,cell cycle,+\nmitotic sister chromatid segregation,cell cycle,+\nmitotic sister chromatid separation,cell cycle,+\nmitotic spindle assembly,cell cycle,+\nmitotic spindle assembly checkpoint signaling,cell cycle,+\nmitotic spindle checkpoint signaling,cell cycle,+\nmitotic spindle organization,cell cycle,+\nmitral valve development,morphogenesis/development,+\nmodification-dependent macromolecule catabolic process,metabolic process,+\nmodification-dependent protein binding,protein modification/signaling,+\nmodification-dependent protein catabolic process,metabolic process,+\nmodification of postsynaptic structure,neural related process,+\nmodified amino acid binding,protein modification/signaling,+\nmodulation by host of symbiont process,other,+\nmodulation by host of viral genome replication,viral related process,+\nmodulation by host of viral process,viral related process,+\nmodulation by symbiont of entry into host,response to stimulus,+\nmodulation of chemical synaptic transmission,neural related process,+\nmodulation of excitatory postsynaptic potential,neural related process,+\nmolecular adaptor activity,protein modification/signaling,+\nmolecular function inhibitor activity,other,+\nmolecular transducer activity,protein modification/signaling,+\nmolting cycle,morphogenesis/development,+\nmolting cycle process,morphogenesis/development,+\nmonoatomic anion transmembrane transport,transport,+\nmonocarboxylic acid biosynthetic process,metabolic process,+\nmonocarboxylic acid catabolic process,metabolic process,+\nmonocarboxylic acid metabolic process,metabolic process,+\nmonocarboxylic acid transport,transport,+\nmonocyte chemotaxis,immune system process,+\nmonocyte differentiation,immune system process,+\nmononuclear cell differentiation,immune system process,+\nmononuclear cell migration,immune system process,+\nmononuclear cell proliferation,immune system process,+\nmonooxygenase activity,metabolic process,+\nmonosaccharide binding,metabolic process,+\nmonosaccharide biosynthetic process,metabolic process,+\nmonosaccharide catabolic process,metabolic process,+\nmonosaccharide metabolic process,metabolic process,+\nmonosaccharide transmembrane transport,transport,+\nmonoubiquitinated protein deubiquitination,protein modification/signaling,+\nmorphogenesis of a branching epithelium,morphogenesis/development,+\nmorphogenesis of a branching structure,morphogenesis/development,+\nmorphogenesis of a polarized epithelium,morphogenesis/development,+\nmorphogenesis of an epithelial fold,morphogenesis/development,+\nmorphogenesis of an epithelium,morphogenesis/development,+\nmorphogenesis of embryonic epithelium,morphogenesis/development,+\nmotor neuron axon guidance,neural related process,+\nmovement in host,other,+\nmRNA 3'-end processing,gene regulation,+\nmRNA 3'-UTR AU-rich region binding,gene regulation,+\nmRNA 5'-UTR binding,gene regulation,+\nmRNA binding,gene regulation,+\nmRNA catabolic process,metabolic process,+\nmRNA export from nucleus,transport,+\nmRNA metabolic process,gene regulation,+\nmRNA methylation,gene regulation,+\nmRNA processing,gene regulation,+\n\"mRNA splicing, via spliceosome\",gene regulation,+\nmRNA transcription,gene regulation,+\nmucopolysaccharide metabolic process,metabolic process,+\nmucosal immune response,immune system process,+\nmulti-multicellular organism process,multicellular organismal process,+\nmulti-organism reproductive process,other,+\nmulticellular organism growth,multicellular organismal process,+\nmuscle cell apoptotic process,cell death,+\nmuscle cell differentiation,morphogenesis/development,+\nmuscle cell migration,multicellular organismal process,+\nmuscle cell proliferation,cell cycle,+\nmuscle contraction,multicellular organismal process,+\nmuscle hypertrophy,multicellular organismal process,+\nmuscle organ development,morphogenesis/development,+\nmuscle structure development,morphogenesis/development,+\nmuscle system process,multicellular organismal process,+\nmuscle tissue development,morphogenesis/development,+\nMyD88-dependent toll-like receptor signaling pathway,immune system process,+\nMyD88-independent toll-like receptor signaling pathway,immune system process,+\nmyelin maintenance,cellular component organization,+\nmyelination,neural related process,+\nmyeloid cell activation involved in immune response,immune system process,+\nmyeloid cell development,immune system process,+\nmyeloid cell differentiation,immune system process,+\nmyeloid cell homeostasis,immune system process,+\nmyeloid dendritic cell activation,immune system process,+\nmyeloid dendritic cell differentiation,neural related process,+\nmyeloid leukocyte activation,immune system process,+\nmyeloid leukocyte cytokine production,immune system process,+\nmyeloid leukocyte differentiation,immune system process,+\nmyeloid leukocyte mediated immunity,immune system process,+\nmyeloid leukocyte migration,immune system process,+\nmyoblast differentiation,morphogenesis/development,+\nmyoblast fusion,morphogenesis/development,+\nmyoblast proliferation,cell cycle,+\nmyofibril,cellular component organization,+\nmyosin binding,cellular component organization,+\nmyosin V binding,transport,+\nmyotube differentiation,morphogenesis/development,+\nN-terminal protein amino acid acetylation,protein modification/signaling,+\nNAD binding,metabolic process,+\nNAD biosynthetic process,metabolic process,+\nNAD metabolic process,metabolic process,+\nNAD(P)H dehydrogenase (quinone) activity,metabolic process,+\nNAD+ ADP-ribosyltransferase activity,metabolic process,+\nNADH dehydrogenase (ubiquinone) activity,metabolic process,+\nNADH dehydrogenase complex assembly,cellular component organization,+\nNADH metabolic process,metabolic process,+\nNADP binding,metabolic process,+\nNADP metabolic process,metabolic process,+\nNADPH binding,metabolic process,+\nNADPH regeneration,metabolic process,+\nnatural killer cell activation,immune system process,+\nnatural killer cell differentiation,immune system process,+\nnatural killer cell mediated cytotoxicity,immune system process,+\nnatural killer cell mediated immunity,immune system process,+\nncRNA metabolic process,gene regulation,+\nncRNA processing,gene regulation,+\nnecroptotic process,cell death,+\nnegative adaptation of signaling pathway,protein modification/signaling,+\nnegative chemotaxis,immune system process,+\nnegative regulation of adaptive immune response,immune system process,+\nnegative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,immune system process,+\nnegative regulation of alpha-beta T cell activation,immune system process,+\nnegative regulation of alpha-beta T cell differentiation,immune system process,+\nnegative regulation of amide metabolic process,metabolic process,+\nnegative regulation of angiogenesis,morphogenesis/development,+\nnegative regulation of animal organ morphogenesis,morphogenesis/development,+\nnegative regulation of antigen receptor-mediated signaling pathway,immune system process,+\nnegative regulation of apoptotic process,cell death,+\nnegative regulation of apoptotic signaling pathway,cell death,+\nnegative regulation of autophagy,metabolic process,+\nnegative regulation of axon extension,neural related process,+\nnegative regulation of axonogenesis,neural related process,+\nnegative regulation of B cell activation,immune system process,+\nnegative regulation of binding,gene regulation,+\nnegative regulation of blood coagulation,stress response,+\nnegative regulation of blood pressure,multicellular organismal process,+\nnegative regulation of blood vessel endothelial cell migration,multicellular organismal process,+\nnegative regulation of canonical Wnt signaling pathway,protein modification/signaling,+\nnegative regulation of carbohydrate metabolic process,metabolic process,+\nnegative regulation of cardiac muscle hypertrophy,multicellular organismal process,+\nnegative regulation of catabolic process,metabolic process,+\nnegative regulation of catalytic activity,protein modification/signaling,+\nnegative regulation of cell-cell adhesion,cell adhesion,+\nnegative regulation of cell-matrix adhesion,cell adhesion,+\nnegative regulation of cell-substrate adhesion,cell adhesion,+\nnegative regulation of cell activation,morphogenesis/development,+\nnegative regulation of cell adhesion,cell adhesion,+\nnegative regulation of cell cycle,cell cycle,+\nnegative regulation of cell cycle G1/S phase transition,cell cycle,+\nnegative regulation of cell cycle G2/M phase transition,cell cycle,+\nnegative regulation of cell cycle phase transition,cell cycle,+\nnegative regulation of cell cycle process,cell cycle,+\nnegative regulation of cell development,morphogenesis/development,+\nnegative regulation of cell differentiation,morphogenesis/development,+\nnegative regulation of cell division,cell cycle,+\nnegative regulation of cell growth,cellular component organization,+\nnegative regulation of cell killing,immune system process,+\nnegative regulation of cell migration,multicellular organismal process,+\nnegative regulation of cell motility,other,+\nnegative regulation of cell population proliferation,cell cycle,+\nnegative regulation of cell projection organization,cellular component organization,+\nnegative regulation of cellular biosynthetic process,metabolic process,+\nnegative regulation of cellular component organization,cellular component organization,+\nnegative regulation of cellular metabolic process,metabolic process,+\nnegative regulation of cellular response to growth factor stimulus,response to stimulus,+\nnegative regulation of chemokine production,immune system process,+\nnegative regulation of chemotaxis,response to stimulus,+\nnegative regulation of chromosome organization,cell cycle,+\nnegative regulation of chromosome segregation,cell cycle,+\nnegative regulation of chromosome separation,cell cycle,+\nnegative regulation of coagulation,immune system process,+\nnegative regulation of cold-induced thermogenesis,multicellular organismal process,+\nnegative regulation of collagen metabolic process,metabolic process,+\nnegative regulation of cyclin-dependent protein kinase activity,cell cycle,+\nnegative regulation of cysteine-type endopeptidase activity,cell death,+\nnegative regulation of cysteine-type endopeptidase activity involved in apoptotic process,cell death,+\nnegative regulation of cytokine-mediated signaling pathway,immune system process,+\nnegative regulation of cytokine production,immune system process,+\nnegative regulation of defense response,stress response,+\nnegative regulation of dephosphorylation,metabolic process,+\nnegative regulation of developmental growth,morphogenesis/development,+\nnegative regulation of developmental process,morphogenesis/development,+\nnegative regulation of DNA-binding transcription factor activity,gene regulation,+\nnegative regulation of DNA-templated transcription,gene regulation,+\nnegative regulation of DNA binding,gene regulation,+\nnegative regulation of DNA biosynthetic process,cell cycle,+\nnegative regulation of DNA metabolic process,cell cycle,+\nnegative regulation of DNA replication,cell cycle,+\nnegative regulation of double-strand break repair via homologous recombination,stress response,+\nnegative regulation of endopeptidase activity,protein modification/signaling,+\nnegative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,cell death,+\nnegative regulation of endothelial cell apoptotic process,cell death,+\nnegative regulation of endothelial cell migration,multicellular organismal process,+\nnegative regulation of endothelial cell proliferation,cell cycle,+\nnegative regulation of epidermal growth factor receptor signaling pathway,receptor related process,+\nnegative regulation of epithelial cell apoptotic process,cell death,+\nnegative regulation of epithelial cell differentiation,morphogenesis/development,+\nnegative regulation of epithelial cell migration,multicellular organismal process,+\nnegative regulation of epithelial cell proliferation,cell cycle,+\nnegative regulation of ERBB signaling pathway,receptor related process,+\nnegative regulation of ERK1 and ERK2 cascade,protein modification/signaling,+\nnegative regulation of extrinsic apoptotic signaling pathway,cell death,+\nnegative regulation of extrinsic apoptotic signaling pathway in absence of ligand,cell death,+\nnegative regulation of extrinsic apoptotic signaling pathway via death domain receptors,cell death,+\nnegative regulation of fat cell differentiation,morphogenesis/development,+\nnegative regulation of fibroblast growth factor receptor signaling pathway,receptor related process,+\nnegative regulation of G protein-coupled receptor signaling pathway,receptor related process,+\nnegative regulation of G1/S transition of mitotic cell cycle,cell cycle,+\nnegative regulation of G2/M transition of mitotic cell cycle,cell cycle,+\nnegative regulation of gene expression,gene regulation,+\n\"negative regulation of gene expression, epigenetic\",gene regulation,+\nnegative regulation of growth,cellular component organization,+\nnegative regulation of GTPase activity,metabolic process,+\nnegative regulation of hematopoietic progenitor cell differentiation,immune system process,+\nnegative regulation of hemopoiesis,immune system process,+\nnegative regulation of hemostasis,multicellular organismal process,+\nnegative regulation of histone methylation,gene regulation,+\nnegative regulation of hydrolase activity,metabolic process,+\nnegative regulation of immune effector process,immune system process,+\nnegative regulation of immune response,immune system process,+\nnegative regulation of immune system process,immune system process,+\nnegative regulation of inclusion body assembly,cellular component organization,+\nnegative regulation of inflammatory response,immune system process,+\nnegative regulation of innate immune response,immune system process,+\nnegative regulation of interleukin-1 beta production,immune system process,+\nnegative regulation of interleukin-1 production,immune system process,+\nnegative regulation of interleukin-2 production,immune system process,+\nnegative regulation of interleukin-8 production,immune system process,+\nnegative regulation of intracellular protein transport,transport,+\nnegative regulation of intracellular signal transduction,protein modification/signaling,+\nnegative regulation of intracellular transport,transport,+\nnegative regulation of intrinsic apoptotic signaling pathway,cell death,+\nnegative regulation of kinase activity,protein modification/signaling,+\nnegative regulation of leukocyte activation,immune system process,+\nnegative regulation of leukocyte apoptotic process,cell death,+\nnegative regulation of leukocyte cell-cell adhesion,immune system process,+\nnegative regulation of leukocyte differentiation,immune system process,+\nnegative regulation of leukocyte mediated cytotoxicity,immune system process,+\nnegative regulation of leukocyte mediated immunity,immune system process,+\nnegative regulation of leukocyte migration,immune system process,+\nnegative regulation of leukocyte proliferation,immune system process,+\nnegative regulation of lipid biosynthetic process,metabolic process,+\nnegative regulation of lipid localization,cellular component organization,+\nnegative regulation of lipid storage,cellular component organization,+\nnegative regulation of lipid transport,transport,+\nnegative regulation of locomotion,other,+\nnegative regulation of lymphocyte activation,immune system process,+\nnegative regulation of lymphocyte apoptotic process,immune system process,+\nnegative regulation of lymphocyte differentiation,immune system process,+\nnegative regulation of lymphocyte mediated immunity,immune system process,+\nnegative regulation of lymphocyte proliferation,immune system process,+\nnegative regulation of macromolecule biosynthetic process,metabolic process,+\nnegative regulation of macrophage activation,immune system process,+\nnegative regulation of macrophage derived foam cell differentiation,morphogenesis/development,+\nnegative regulation of MAP kinase activity,protein modification/signaling,+\nnegative regulation of MAPK cascade,protein modification/signaling,+\nnegative regulation of metaphase/anaphase transition of cell cycle,cell cycle,+\nnegative regulation of mitochondrial membrane permeability,cellular component organization,+\nnegative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,cell death,+\nnegative regulation of mitochondrion organization,cellular component organization,+\nnegative regulation of mitotic cell cycle,cell cycle,+\nnegative regulation of mitotic cell cycle phase transition,cell cycle,+\nnegative regulation of mitotic metaphase/anaphase transition,cell cycle,+\nnegative regulation of mitotic nuclear division,cell cycle,+\nnegative regulation of mitotic sister chromatid segregation,cell cycle,+\nnegative regulation of mitotic sister chromatid separation,cell cycle,+\nnegative regulation of mononuclear cell proliferation,immune system process,+\nnegative regulation of motor neuron apoptotic process,cell death,+\nnegative regulation of mRNA metabolic process,gene regulation,+\nnegative regulation of mRNA processing,gene regulation,+\nnegative regulation of muscle cell differentiation,morphogenesis/development,+\nnegative regulation of myeloid cell differentiation,immune system process,+\nnegative regulation of myeloid leukocyte differentiation,immune system process,+\nnegative regulation of nervous system development,neural related process,+\nnegative regulation of neurogenesis,neural related process,+\nnegative regulation of neuron apoptotic process,cell death,+\nnegative regulation of neuron projection development,neural related process,+\nnegative regulation of NF-kappaB transcription factor activity,gene regulation,+\nnegative regulation of nitric oxide metabolic process,metabolic process,+\nnegative regulation of nuclear division,cell cycle,+\nnegative regulation of nucleocytoplasmic transport,transport,+\nnegative regulation of organelle assembly,cellular component organization,+\nnegative regulation of organelle organization,cellular component organization,+\nnegative regulation of peptidase activity,metabolic process,+\nnegative regulation of peptidyl-threonine phosphorylation,protein modification/signaling,+\nnegative regulation of peptidyl-tyrosine phosphorylation,protein modification/signaling,+\nnegative regulation of phosphate metabolic process,metabolic process,+\nnegative regulation of phosphorus metabolic process,metabolic process,+\nnegative regulation of phosphorylation,protein modification/signaling,+\nnegative regulation of programmed cell death,cell death,+\nnegative regulation of protein-containing complex assembly,cellular component organization,+\nnegative regulation of protein acetylation,protein modification/signaling,+\nnegative regulation of protein binding,protein modification/signaling,+\nnegative regulation of protein catabolic process,metabolic process,+\nnegative regulation of protein depolymerization,cellular component organization,+\nnegative regulation of protein kinase activity,protein modification/signaling,+\nnegative regulation of protein localization,transport,+\nnegative regulation of protein localization to membrane,cellular component organization,+\nnegative regulation of protein metabolic process,metabolic process,+\nnegative regulation of protein modification process,protein modification/signaling,+\nnegative regulation of protein phosphorylation,protein modification/signaling,+\nnegative regulation of protein polymerization,cellular component organization,+\nnegative regulation of protein tyrosine kinase activity,protein modification/signaling,+\nnegative regulation of protein ubiquitination,protein modification/signaling,+\nnegative regulation of proteolysis,metabolic process,+\nnegative regulation of proteolysis involved in protein catabolic process,metabolic process,+\nnegative regulation of Ras protein signal transduction,protein modification/signaling,+\nnegative regulation of reactive oxygen species metabolic process,stress response,+\nnegative regulation of receptor signaling pathway via JAK-STAT,receptor related process,+\nnegative regulation of receptor signaling pathway via STAT,receptor related process,+\nnegative regulation of release of cytochrome c from mitochondria,cell death,+\nnegative regulation of response to biotic stimulus,response to stimulus,+\nnegative regulation of response to cytokine stimulus,immune system process,+\nnegative regulation of response to endoplasmic reticulum stress,stress response,+\nnegative regulation of response to external stimulus,response to stimulus,+\nnegative regulation of response to wounding,immune system process,+\nnegative regulation of Rho protein signal transduction,protein modification/signaling,+\nnegative regulation of RNA splicing,gene regulation,+\nnegative regulation of secretion,transport,+\nnegative regulation of sequestering of calcium ion,other,+\nnegative regulation of signal transduction in absence of ligand,protein modification/signaling,+\nnegative regulation of sister chromatid segregation,cell cycle,+\nnegative regulation of small GTPase mediated signal transduction,protein modification/signaling,+\nnegative regulation of small molecule metabolic process,metabolic process,+\nnegative regulation of smooth muscle cell proliferation,cell cycle,+\nnegative regulation of smooth muscle contraction,multicellular organismal process,+\nnegative regulation of sodium ion transport,transport,+\nnegative regulation of stem cell differentiation,morphogenesis/development,+\nnegative regulation of stem cell population maintenance,morphogenesis/development,+\nnegative regulation of striated muscle cell differentiation,morphogenesis/development,+\nnegative regulation of substrate adhesion-dependent cell spreading,cell adhesion,+\nnegative regulation of synaptic transmission,neural related process,+\n\"negative regulation of synaptic transmission, glutamatergic\",neural related process,+\nnegative regulation of T cell activation,immune system process,+\nnegative regulation of T cell apoptotic process,immune system process,+\nnegative regulation of T cell cytokine production,immune system process,+\nnegative regulation of T cell differentiation,immune system process,+\nnegative regulation of T cell mediated immunity,immune system process,+\nnegative regulation of T cell proliferation,immune system process,+\nnegative regulation of T cell receptor signaling pathway,immune system process,+\nnegative regulation of tissue remodeling,multicellular organismal process,+\nnegative regulation of transcription by RNA polymerase II,gene regulation,+\nnegative regulation of transferase activity,protein modification/signaling,+\nnegative regulation of transforming growth factor beta production,immune system process,+\nnegative regulation of translation,gene regulation,+\nnegative regulation of translational initiation,gene regulation,+\nnegative regulation of transmembrane transport,transport,+\nnegative regulation of transport,transport,+\nnegative regulation of type I interferon-mediated signaling pathway,immune system process,+\nnegative regulation of type I interferon production,immune system process,+\nnegative regulation of type II interferon production,immune system process,+\nnegative regulation of tyrosine phosphorylation of STAT protein,protein modification/signaling,+\nnegative regulation of ubiquitin-protein transferase activity,protein modification/signaling,+\nnegative regulation of vascular associated smooth muscle cell proliferation,cell cycle,+\nnegative regulation of vasculature development,morphogenesis/development,+\nnegative regulation of viral entry into host cell,viral related process,+\nnegative regulation of viral genome replication,viral related process,+\nnegative regulation of viral life cycle,viral related process,+\nnegative regulation of viral process,viral related process,+\nnegative regulation of Wnt signaling pathway,protein modification/signaling,+\nnegative regulation of wound healing,immune system process,+\nnephron development,morphogenesis/development,+\nnerve development,neural related process,+\nneural crest cell development,morphogenesis/development,+\nneural crest cell differentiation,morphogenesis/development,+\nneural crest cell migration,morphogenesis/development,+\nneural nucleus development,neural related process,+\nneural tube closure,morphogenesis/development,+\nneural tube development,morphogenesis/development,+\nneuroinflammatory response,immune system process,+\nneuromuscular junction,neural related process,+\nneuromuscular process,neural related process,+\nneuron apoptotic process,cell death,+\nneuron cell-cell adhesion,neural related process,+\nneuron cellular homeostasis,neural related process,+\nneuron migration,neural related process,+\nneuron projection arborization,neural related process,+\nneuron projection development,neural related process,+\nneuron projection extension,neural related process,+\nneuron projection guidance,neural related process,+\nneuron projection membrane,neural related process,+\nneuron projection organization,neural related process,+\nneuron recognition,neural related process,+\nneuron to neuron synapse,neural related process,+\nneuropeptide binding,neural related process,+\nneuropeptide receptor binding,neural related process,+\nneurotransmitter receptor activity,neural related process,+\nneurotransmitter transport,neural related process,+\nneurotransmitter uptake,neural related process,+\nneurotrophin signaling pathway,protein modification/signaling,+\nneutral amino acid transport,transport,+\nneutrophil chemotaxis,immune system process,+\nneutrophil homeostasis,immune system process,+\nneutrophil mediated immunity,immune system process,+\nneutrophil migration,immune system process,+\nNF-kappaB binding,immune system process,+\nnicotinamide nucleotide biosynthetic process,metabolic process,+\nnicotinamide nucleotide metabolic process,metabolic process,+\nnitric-oxide synthase biosynthetic process,metabolic process,+\nnitric oxide biosynthetic process,metabolic process,+\nnitric oxide metabolic process,metabolic process,+\nnitrogen compound transport,transport,+\nnon-canonical Wnt signaling pathway,protein modification/signaling,+\nnon-membrane-bounded organelle assembly,cellular component organization,+\nnon-membrane spanning protein tyrosine kinase activity,protein modification/signaling,+\nnon-motile cilium assembly,cellular component organization,+\nnonribosomal peptide biosynthetic process,metabolic process,+\nNotch binding,receptor related process,+\nNotch signaling pathway,protein modification/signaling,+\nnuclear-transcribed mRNA catabolic process,gene regulation,+\n\"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay\",gene regulation,+\n\"nuclear-transcribed mRNA catabolic process, exonucleolytic\",metabolic process,+\n\"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay\",gene regulation,+\nnuclear-transcribed mRNA poly(A) tail shortening,gene regulation,+\nnuclear androgen receptor binding,receptor related process,+\nnuclear body,cellular component organization,+\nnuclear chromosome segregation,cell cycle,+\nnuclear division,cell cycle,+\nnuclear DNA replication,cell cycle,+\nnuclear envelope,cellular component organization,+\nnuclear envelope organization,cellular component organization,+\nnuclear export,transport,+\nnuclear glucocorticoid receptor binding,receptor related process,+\nnuclear inclusion body,cellular component organization,+\nnuclear membrane,cellular component organization,+\nnuclear membrane disassembly,cellular component organization,+\nnuclear migration,transport,+\nnuclear pore,cellular component organization,+\nnuclear pore nuclear basket,cellular component organization,+\nnuclear pore organization,cellular component organization,+\nnuclear receptor binding,receptor related process,+\nnuclear receptor coactivator activity,receptor related process,+\nnuclear retinoid X receptor binding,gene regulation,+\nnuclear speck,gene regulation,+\nnuclear steroid receptor activity,receptor related process,+\nnuclear thyroid hormone receptor binding,receptor related process,+\nnuclear transport,transport,+\nnuclease activity,metabolic process,+\nnucleic acid binding,gene regulation,+\nnucleic acid transport,transport,+\nnucleobase-containing compound biosynthetic process,metabolic process,+\nnucleobase-containing compound catabolic process,metabolic process,+\nnucleobase-containing compound transport,transport,+\nnucleobase biosynthetic process,metabolic process,+\nnucleobase metabolic process,metabolic process,+\nnucleocytoplasmic carrier activity,transport,+\nnucleocytoplasmic transport,transport,+\nnucleolus organization,cellular component organization,+\nnucleoside-triphosphatase regulator activity,metabolic process,+\nnucleoside diphosphate biosynthetic process,metabolic process,+\nnucleoside diphosphate metabolic process,metabolic process,+\nnucleoside metabolic process,metabolic process,+\nnucleoside monophosphate biosynthetic process,metabolic process,+\nnucleoside monophosphate catabolic process,metabolic process,+\nnucleoside monophosphate metabolic process,metabolic process,+\nnucleoside phosphate biosynthetic process,metabolic process,+\nnucleoside phosphate catabolic process,metabolic process,+\nnucleoside phosphate metabolic process,metabolic process,+\nnucleoside triphosphate biosynthetic process,metabolic process,+\nnucleoside triphosphate metabolic process,metabolic process,+\nnucleosome assembly,cellular component organization,+\nnucleosome binding,gene regulation,+\nnucleosome organization,cellular component organization,+\n\"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway\",receptor related process,+\nnucleotide-binding oligomerization domain containing 2 signaling pathway,immune system process,+\nnucleotide-binding oligomerization domain containing signaling pathway,immune system process,+\nnucleotide-excision repair,stress response,+\nnucleotide-sugar metabolic process,metabolic process,+\nnucleotide biosynthetic process,metabolic process,+\nnucleotide catabolic process,metabolic process,+\nnucleotidyltransferase activity,metabolic process,+\nnucleus organization,cellular component organization,+\nodontogenesis,morphogenesis/development,+\nolefinic compound metabolic process,metabolic process,+\noligopeptide transport,transport,+\noligosaccharide metabolic process,metabolic process,+\none-carbon metabolic process,metabolic process,+\noocyte development,morphogenesis/development,+\noocyte differentiation,morphogenesis/development,+\noocyte maturation,morphogenesis/development,+\noogenesis,morphogenesis/development,+\norgan growth,morphogenesis/development,+\norganelle assembly,cellular component organization,+\norganelle fission,cellular component organization,+\norganelle fusion,cellular component organization,+\norganelle inheritance,cellular component organization,+\norganelle localization,cellular component organization,+\norganelle outer membrane,cellular component organization,+\norganic acid biosynthetic process,metabolic process,+\norganic acid catabolic process,metabolic process,+\norganic acid transmembrane transport,transport,+\norganic acid transmembrane transporter activity,transport,+\norganic anion transmembrane transporter activity,transport,+\norganic anion transport,transport,+\norganic cyclic compound binding,metabolic process,+\norganic cyclic compound biosynthetic process,metabolic process,+\norganic hydroxy compound biosynthetic process,metabolic process,+\norganic hydroxy compound metabolic process,metabolic process,+\norganic hydroxy compound transport,transport,+\norganonitrogen compound catabolic process,metabolic process,+\norganophosphate catabolic process,metabolic process,+\nossification,morphogenesis/development,+\nosteoblast development,morphogenesis/development,+\nosteoblast differentiation,morphogenesis/development,+\nosteoblast proliferation,cell cycle,+\nosteoclast differentiation,morphogenesis/development,+\noutflow tract morphogenesis,morphogenesis/development,+\noutflow tract septum morphogenesis,morphogenesis/development,+\novulation,multicellular organismal process,+\novulation cycle,morphogenesis/development,+\novulation cycle process,multicellular organismal process,+\noxidative demethylation,metabolic process,+\noxidative phosphorylation,metabolic process,+\noxidoreductase activity,metabolic process,+\n\"oxidoreductase activity, acting on a heme group of donors\",metabolic process,+\n\"oxidoreductase activity, acting on a sulfur group of donors\",metabolic process,+\n\"oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor\",metabolic process,+\n\"oxidoreductase activity, acting on CH-OH group of donors\",metabolic process,+\n\"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor\",metabolic process,+\n\"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen\",metabolic process,+\n\"oxidoreductase activity, acting on the aldehyde or oxo group of donors\",metabolic process,+\n\"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor\",metabolic process,+\n\"oxidoreductase activity, acting on the CH-CH group of donors\",metabolic process,+\n\"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor\",metabolic process,+\noxoacid metabolic process,metabolic process,+\nP-body,other,+\nP-body assembly,cellular component organization,+\np38MAPK cascade,protein modification/signaling,+\np53 binding,protein modification/signaling,+\npancreas development,morphogenesis/development,+\npattern recognition receptor signaling pathway,immune system process,+\npattern specification process,morphogenesis/development,+\nPDZ domain binding,protein modification/signaling,+\npeptidase complex,metabolic process,+\npeptide-lysine-N-acetyltransferase activity,protein modification/signaling,+\npeptide biosynthetic process,metabolic process,+\npeptide hormone processing,metabolic process,+\npeptide metabolic process,metabolic process,+\npeptide transport,transport,+\npeptidyl-arginine methylation,protein modification/signaling,+\npeptidyl-cysteine modification,protein modification/signaling,+\npeptidyl-lysine modification,protein modification/signaling,+\npeptidyl-lysine trimethylation,protein modification/signaling,+\npeptidyl-proline hydroxylation,metabolic process,+\npeptidyl-serine modification,protein modification/signaling,+\npeptidyl-serine phosphorylation,protein modification/signaling,+\npeptidyl-threonine dephosphorylation,protein modification/signaling,+\npeptidyl-threonine modification,protein modification/signaling,+\npeptidyl-threonine phosphorylation,protein modification/signaling,+\npeptidyl-tyrosine autophosphorylation,protein modification/signaling,+\npeptidyl-tyrosine dephosphorylation,protein modification/signaling,+\npeptidyl-tyrosine modification,protein modification/signaling,+\npeptidyl-tyrosine phosphorylation,protein modification/signaling,+\nperikaryon,neural related process,+\nperipheral nervous system development,neural related process,+\nphagocytic vesicle membrane,cellular component organization,+\nphagocytosis,immune system process,+\nphagophore assembly site,cellular component organization,+\npharyngeal system development,morphogenesis/development,+\nphosphatase activity,protein modification/signaling,+\nphosphatase binding,protein modification/signaling,+\nphosphatase regulator activity,protein modification/signaling,+\nphosphate ion homeostasis,other,+\nphosphate ion transport,transport,+\nphosphatidic acid metabolic process,metabolic process,+\nphosphatidylcholine acyl-chain remodeling,metabolic process,+\nphosphatidylcholine binding,metabolic process,+\nphosphatidylcholine biosynthetic process,metabolic process,+\nphosphatidylcholine catabolic process,metabolic process,+\nphosphatidylinositol-3-phosphate binding,protein modification/signaling,+\nphosphatidylinositol-mediated signaling,protein modification/signaling,+\nphosphatidylinositol 3-kinase regulator activity,protein modification/signaling,+\nphosphatidylinositol binding,protein modification/signaling,+\nphosphatidylinositol biosynthetic process,metabolic process,+\nphosphatidylinositol bisphosphate binding,protein modification/signaling,+\nphosphatidylinositol monophosphate phosphatase activity,metabolic process,+\nphosphatidylinositol phosphate biosynthetic process,metabolic process,+\nphosphatidylserine binding,protein modification/signaling,+\nphosphatidylserine metabolic process,metabolic process,+\nphospholipase inhibitor activity,metabolic process,+\nphospholipid binding,protein modification/signaling,+\nphospholipid biosynthetic process,metabolic process,+\nphospholipid metabolic process,metabolic process,+\nphospholipid transporter activity,transport,+\nphosphoprotein binding,protein modification/signaling,+\nphosphoprotein phosphatase activity,protein modification/signaling,+\nphosphoric ester hydrolase activity,metabolic process,+\n\"phosphotransferase activity, alcohol group as acceptor\",metabolic process,+\npigment granule,cellular component organization,+\npigment metabolic process,metabolic process,+\npigmentation,other,+\npinocytosis,transport,+\nplacenta development,morphogenesis/development,+\nplasma lipoprotein particle clearance,multicellular organismal process,+\nplasma membrane bounded cell projection assembly,cellular component organization,+\nplasma membrane organization,cellular component organization,+\nplasma membrane repair,stress response,+\nplasma membrane signaling receptor complex,receptor related process,+\nplasma membrane tubulation,cellular component organization,+\nplasminogen activation,metabolic process,+\nplatelet-derived growth factor receptor-beta signaling pathway,receptor related process,+\nplatelet-derived growth factor receptor binding,receptor related process,+\nplatelet-derived growth factor receptor signaling pathway,immune system process,+\nplatelet activation,immune system process,+\nplatelet alpha granule,immune system process,+\nplatelet formation,morphogenesis/development,+\nplatelet morphogenesis,morphogenesis/development,+\nplus-end-directed microtubule motor activity,transport,+\nPML body,cellular component organization,+\npodosome,cellular component organization,+\npolarized epithelial cell differentiation,morphogenesis/development,+\npolyol metabolic process,metabolic process,+\npolysaccharide metabolic process,metabolic process,+\npolyubiquitin modification-dependent protein binding,protein modification/signaling,+\npore complex assembly,cellular component organization,+\nporphyrin-containing compound metabolic process,metabolic process,+\npositive chemotaxis,response to stimulus,+\npositive regulation by host of viral process,viral related process,+\npositive regulation by host of viral transcription,viral related process,+\npositive regulation of actin filament polymerization,cellular component organization,+\npositive regulation of actin nucleation,cellular component organization,+\npositive regulation of acute inflammatory response,immune system process,+\npositive regulation of adaptive immune response,immune system process,+\npositive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,immune system process,+\npositive regulation of alpha-beta T cell activation,immune system process,+\npositive regulation of alpha-beta T cell differentiation,immune system process,+\npositive regulation of alpha-beta T cell proliferation,immune system process,+\npositive regulation of amide metabolic process,metabolic process,+\npositive regulation of angiogenesis,morphogenesis/development,+\npositive regulation of animal organ morphogenesis,morphogenesis/development,+\npositive regulation of apoptotic process,cell death,+\npositive regulation of apoptotic signaling pathway,cell death,+\npositive regulation of ATP-dependent activity,metabolic process,+\npositive regulation of ATP biosynthetic process,metabolic process,+\npositive regulation of autophagy,metabolic process,+\npositive regulation of autophagy of mitochondrion,metabolic process,+\npositive regulation of autophagy of mitochondrion in response to mitochondrial depolarization,stress response,+\npositive regulation of axonogenesis,neural related process,+\npositive regulation of binding,other,+\npositive regulation of biomineral tissue development,morphogenesis/development,+\npositive regulation of blood circulation,multicellular organismal process,+\npositive regulation of blood vessel endothelial cell migration,multicellular organismal process,+\npositive regulation of BMP signaling pathway,protein modification/signaling,+\npositive regulation of calcium ion transport,transport,+\npositive regulation of carbohydrate metabolic process,metabolic process,+\npositive regulation of cardiac muscle hypertrophy,multicellular organismal process,+\npositive regulation of cartilage development,morphogenesis/development,+\npositive regulation of catabolic process,metabolic process,+\n\"positive regulation of CD4-positive, alpha-beta T cell activation\",immune system process,+\n\"positive regulation of CD4-positive, alpha-beta T cell differentiation\",immune system process,+\npositive regulation of cell-cell adhesion,cell adhesion,+\npositive regulation of cell-matrix adhesion,cell adhesion,+\npositive regulation of cell-substrate adhesion,cell adhesion,+\npositive regulation of cell activation,morphogenesis/development,+\npositive regulation of cell adhesion,cell adhesion,+\npositive regulation of cell cycle,cell cycle,+\npositive regulation of cell cycle checkpoint,cell cycle,+\npositive regulation of cell cycle G1/S phase transition,cell cycle,+\npositive regulation of cell cycle G2/M phase transition,cell cycle,+\npositive regulation of cell cycle phase transition,cell cycle,+\npositive regulation of cell cycle process,cell cycle,+\npositive regulation of cell development,morphogenesis/development,+\npositive regulation of cell differentiation,morphogenesis/development,+\npositive regulation of cell division,cell cycle,+\npositive regulation of cell growth,cellular component organization,+\npositive regulation of cell junction assembly,cellular component organization,+\npositive regulation of cell killing,immune system process,+\npositive regulation of cell migration,multicellular organismal process,+\npositive regulation of cell migration involved in sprouting angiogenesis,multicellular organismal process,+\npositive regulation of cell motility,other,+\npositive regulation of cell population proliferation,cell cycle,+\npositive regulation of cell projection organization,cellular component organization,+\npositive regulation of cellular biosynthetic process,metabolic process,+\npositive regulation of cellular catabolic process,metabolic process,+\npositive regulation of cellular component biogenesis,cellular component organization,+\npositive regulation of cellular response to transforming growth factor beta stimulus,immune system process,+\npositive regulation of chemokine production,immune system process,+\npositive regulation of chemotaxis,immune system process,+\npositive regulation of cholesterol efflux,transport,+\npositive regulation of chromatin binding,gene regulation,+\npositive regulation of chromosome segregation,cell cycle,+\npositive regulation of chromosome separation,cell cycle,+\npositive regulation of cold-induced thermogenesis,multicellular organismal process,+\npositive regulation of cysteine-type endopeptidase activity,cell death,+\npositive regulation of cysteine-type endopeptidase activity involved in apoptotic process,cell death,+\npositive regulation of cytokine-mediated signaling pathway,immune system process,+\npositive regulation of cytokine production,immune system process,+\npositive regulation of cytokine production involved in immune response,immune system process,+\npositive regulation of cytokine production involved in inflammatory response,immune system process,+\npositive regulation of cytokinesis,cell cycle,+\npositive regulation of defense response,stress response,+\npositive regulation of defense response to virus by host,viral related process,+\npositive regulation of dendrite development,neural related process,+\npositive regulation of dephosphorylation,metabolic process,+\npositive regulation of developmental growth,morphogenesis/development,+\npositive regulation of DNA-binding transcription factor activity,gene regulation,+\npositive regulation of DNA-directed DNA polymerase activity,cell cycle,+\npositive regulation of DNA-templated transcription initiation,gene regulation,+\n\"positive regulation of DNA-templated transcription, elongation\",gene regulation,+\npositive regulation of DNA binding,gene regulation,+\npositive regulation of DNA biosynthetic process,cell cycle,+\npositive regulation of DNA metabolic process,cell cycle,+\npositive regulation of DNA recombination,cell cycle,+\npositive regulation of DNA repair,stress response,+\npositive regulation of DNA replication,cell cycle,+\npositive regulation of double-strand break repair via homologous recombination,stress response,+\npositive regulation of endocytosis,transport,+\npositive regulation of endopeptidase activity,cell death,+\npositive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,cell death,+\npositive regulation of endothelial cell apoptotic process,cell death,+\npositive regulation of endothelial cell chemotaxis,response to stimulus,+\npositive regulation of endothelial cell migration,multicellular organismal process,+\npositive regulation of endothelial cell proliferation,cell cycle,+\npositive regulation of epidermal growth factor receptor signaling pathway,receptor related process,+\npositive regulation of epithelial cell migration,multicellular organismal process,+\npositive regulation of epithelial cell proliferation,cell cycle,+\npositive regulation of epithelial to mesenchymal transition,morphogenesis/development,+\npositive regulation of ERBB signaling pathway,receptor related process,+\npositive regulation of ERK1 and ERK2 cascade,protein modification/signaling,+\npositive regulation of erythrocyte differentiation,morphogenesis/development,+\npositive regulation of establishment of protein localization to mitochondrion,cellular component organization,+\npositive regulation of excitatory postsynaptic potential,neural related process,+\npositive regulation of exocytosis,transport,+\npositive regulation of extracellular matrix organization,cellular component organization,+\npositive regulation of extrinsic apoptotic signaling pathway,cell death,+\npositive regulation of extrinsic apoptotic signaling pathway via death domain receptors,cell death,+\npositive regulation of fat cell differentiation,morphogenesis/development,+\npositive regulation of fatty acid metabolic process,metabolic process,+\npositive regulation of fibroblast proliferation,cell cycle,+\npositive regulation of filopodium assembly,cellular component organization,+\npositive regulation of G protein-coupled receptor signaling pathway,receptor related process,+\npositive regulation of G1/S transition of mitotic cell cycle,cell cycle,+\npositive regulation of G2/M transition of mitotic cell cycle,cell cycle,+\npositive regulation of gene expression,gene regulation,+\npositive regulation of glial cell proliferation,neural related process,+\npositive regulation of gliogenesis,neural related process,+\npositive regulation of glomerulus development,morphogenesis/development,+\npositive regulation of glycogen metabolic process,metabolic process,+\npositive regulation of glycoprotein metabolic process,metabolic process,+\npositive regulation of growth,cellular component organization,+\npositive regulation of heart contraction,multicellular organismal process,+\npositive regulation of heart rate,multicellular organismal process,+\npositive regulation of hemopoiesis,immune system process,+\npositive regulation of heterochromatin formation,gene regulation,+\npositive regulation of histone acetylation,gene regulation,+\npositive regulation of homotypic cell-cell adhesion,cell adhesion,+\npositive regulation of hormone secretion,transport,+\npositive regulation of hydrolase activity,metabolic process,+\npositive regulation of icosanoid secretion,transport,+\npositive regulation of immune effector process,immune system process,+\npositive regulation of immune response,immune system process,+\npositive regulation of inflammatory response,immune system process,+\npositive regulation of innate immune response,immune system process,+\npositive regulation of integrin-mediated signaling pathway,protein modification/signaling,+\npositive regulation of interferon-alpha production,immune system process,+\npositive regulation of interferon-beta production,immune system process,+\npositive regulation of interleukin-1 beta production,immune system process,+\npositive regulation of interleukin-1 production,immune system process,+\npositive regulation of interleukin-10 production,immune system process,+\npositive regulation of interleukin-12 production,immune system process,+\npositive regulation of interleukin-17 production,immune system process,+\npositive regulation of interleukin-2 production,immune system process,+\npositive regulation of interleukin-4 production,immune system process,+\npositive regulation of interleukin-6 production,immune system process,+\npositive regulation of interleukin-8 production,immune system process,+\npositive regulation of intracellular protein transport,transport,+\npositive regulation of intracellular signal transduction,protein modification/signaling,+\npositive regulation of intracellular transport,transport,+\npositive regulation of intrinsic apoptotic signaling pathway,cell death,+\npositive regulation of JNK cascade,stress response,+\npositive regulation of kidney development,morphogenesis/development,+\npositive regulation of kinase activity,protein modification/signaling,+\npositive regulation of leukocyte activation,immune system process,+\npositive regulation of leukocyte adhesion to vascular endothelial cell,immune system process,+\npositive regulation of leukocyte apoptotic process,cell death,+\npositive regulation of leukocyte cell-cell adhesion,immune system process,+\npositive regulation of leukocyte chemotaxis,immune system process,+\npositive regulation of leukocyte differentiation,immune system process,+\npositive regulation of leukocyte mediated cytotoxicity,immune system process,+\npositive regulation of leukocyte mediated immunity,immune system process,+\npositive regulation of leukocyte migration,immune system process,+\npositive regulation of leukocyte proliferation,immune system process,+\npositive regulation of lipid biosynthetic process,metabolic process,+\npositive regulation of lipid localization,cellular component organization,+\npositive regulation of lipid storage,cellular component organization,+\npositive regulation of lipid transport,transport,+\npositive regulation of locomotion,other,+\npositive regulation of lymphocyte activation,immune system process,+\npositive regulation of lymphocyte chemotaxis,immune system process,+\npositive regulation of lymphocyte differentiation,immune system process,+\npositive regulation of lymphocyte mediated immunity,immune system process,+\npositive regulation of lymphocyte migration,immune system process,+\npositive regulation of lymphocyte proliferation,immune system process,+\npositive regulation of macroautophagy,immune system process,+\npositive regulation of macrophage activation,immune system process,+\npositive regulation of macrophage cytokine production,immune system process,+\npositive regulation of macrophage migration,immune system process,+\npositive regulation of MAP kinase activity,protein modification/signaling,+\npositive regulation of MAPK cascade,protein modification/signaling,+\npositive regulation of meiotic cell cycle,cell cycle,+\npositive regulation of mesenchymal cell proliferation,cell cycle,+\npositive regulation of miRNA metabolic process,metabolic process,+\npositive regulation of miRNA transcription,gene regulation,+\npositive regulation of mitochondrial calcium ion concentration,other,+\npositive regulation of mitochondrial translation,gene regulation,+\npositive regulation of mitochondrion organization,cellular component organization,+\npositive regulation of mitotic cell cycle,cell cycle,+\npositive regulation of mitotic cell cycle phase transition,cell cycle,+\npositive regulation of mitotic nuclear division,cell cycle,+\npositive regulation of mitotic sister chromatid separation,cell cycle,+\npositive regulation of monoatomic ion transport,transport,+\npositive regulation of mononuclear cell migration,immune system process,+\npositive regulation of mononuclear cell proliferation,immune system process,+\npositive regulation of monooxygenase activity,metabolic process,+\npositive regulation of morphogenesis of an epithelium,morphogenesis/development,+\npositive regulation of mRNA catabolic process,metabolic process,+\npositive regulation of mRNA processing,gene regulation,+\n\"positive regulation of mRNA splicing, via spliceosome\",gene regulation,+\npositive regulation of multicellular organism growth,multicellular organismal process,+\npositive regulation of muscle contraction,multicellular organismal process,+\npositive regulation of myeloid cell differentiation,immune system process,+\npositive regulation of myeloid leukocyte cytokine production involved in immune response,immune system process,+\npositive regulation of myeloid leukocyte differentiation,immune system process,+\npositive regulation of myeloid leukocyte mediated immunity,immune system process,+\npositive regulation of natural killer cell activation,immune system process,+\npositive regulation of natural killer cell mediated cytotoxicity,immune system process,+\npositive regulation of nervous system development,neural related process,+\npositive regulation of neurogenesis,neural related process,+\npositive regulation of neuron apoptotic process,cell death,+\npositive regulation of neuron projection development,neural related process,+\npositive regulation of neurotransmitter transport,neural related process,+\npositive regulation of NF-kappaB transcription factor activity,gene regulation,+\npositive regulation of nitric oxide biosynthetic process,metabolic process,+\npositive regulation of nitric oxide metabolic process,metabolic process,+\npositive regulation of nitrogen compound metabolic process,metabolic process,+\npositive regulation of Notch signaling pathway,protein modification/signaling,+\npositive regulation of nuclear-transcribed mRNA poly(A) tail shortening,gene regulation,+\npositive regulation of nucleocytoplasmic transport,transport,+\npositive regulation of organelle assembly,cellular component organization,+\npositive regulation of organelle organization,cellular component organization,+\npositive regulation of osteoblast differentiation,morphogenesis/development,+\npositive regulation of oxidoreductase activity,metabolic process,+\npositive regulation of pattern recognition receptor signaling pathway,immune system process,+\npositive regulation of peptidase activity,metabolic process,+\npositive regulation of peptidyl-lysine acetylation,protein modification/signaling,+\npositive regulation of peptidyl-tyrosine phosphorylation,protein modification/signaling,+\npositive regulation of phagocytosis,immune system process,+\npositive regulation of phosphatase activity,protein modification/signaling,+\npositive regulation of phosphate metabolic process,metabolic process,+\npositive regulation of phospholipase activity,metabolic process,+\npositive regulation of phosphorylation,protein modification/signaling,+\npositive regulation of positive chemotaxis,immune system process,+\npositive regulation of production of molecular mediator of immune response,immune system process,+\npositive regulation of programmed cell death,cell death,+\npositive regulation of proteasomal protein catabolic process,metabolic process,+\npositive regulation of proteasomal ubiquitin-dependent protein catabolic process,metabolic process,+\npositive regulation of protein-containing complex assembly,cellular component organization,+\npositive regulation of protein-containing complex disassembly,cellular component organization,+\npositive regulation of protein binding,other,+\npositive regulation of protein catabolic process,metabolic process,+\npositive regulation of protein deacetylation,protein modification/signaling,+\npositive regulation of protein exit from endoplasmic reticulum,ER/endosome/lysosome related process,+\npositive regulation of protein export from nucleus,transport,+\npositive regulation of protein kinase activity,protein modification/signaling,+\npositive regulation of protein localization,cellular component organization,+\npositive regulation of protein localization to cell periphery,cellular component organization,+\npositive regulation of protein localization to membrane,transport,+\npositive regulation of protein localization to nucleus,transport,+\npositive regulation of protein localization to plasma membrane,transport,+\npositive regulation of protein metabolic process,metabolic process,+\npositive regulation of protein modification by small protein conjugation or removal,protein modification/signaling,+\npositive regulation of protein modification process,protein modification/signaling,+\npositive regulation of protein phosphorylation,protein modification/signaling,+\npositive regulation of protein secretion,transport,+\npositive regulation of protein serine/threonine kinase activity,protein modification/signaling,+\npositive regulation of protein tyrosine kinase activity,protein modification/signaling,+\npositive regulation of protein ubiquitination,protein modification/signaling,+\npositive regulation of proteolysis,metabolic process,+\npositive regulation of reactive oxygen species metabolic process,stress response,+\npositive regulation of receptor internalization,receptor related process,+\npositive regulation of receptor signaling pathway via JAK-STAT,receptor related process,+\npositive regulation of receptor signaling pathway via STAT,receptor related process,+\npositive regulation of regulatory T cell differentiation,immune system process,+\npositive regulation of release of cytochrome c from mitochondria,cell death,+\npositive regulation of response to biotic stimulus,response to stimulus,+\npositive regulation of response to cytokine stimulus,immune system process,+\npositive regulation of response to endoplasmic reticulum stress,stress response,+\npositive regulation of response to external stimulus,response to stimulus,+\npositive regulation of response to wounding,immune system process,+\npositive regulation of RIG-I signaling pathway,immune system process,+\npositive regulation of RNA metabolic process,metabolic process,+\npositive regulation of secretion by cell,transport,+\npositive regulation of signal transduction by p53 class mediator,protein modification/signaling,+\npositive regulation of signaling receptor activity,receptor related process,+\npositive regulation of SMAD protein signal transduction,protein modification/signaling,+\npositive regulation of smooth muscle cell apoptotic process,cell death,+\npositive regulation of smooth muscle cell proliferation,cell cycle,+\npositive regulation of sodium ion transport,transport,+\npositive regulation of sprouting angiogenesis,morphogenesis/development,+\npositive regulation of stem cell population maintenance,morphogenesis/development,+\npositive regulation of steroid metabolic process,metabolic process,+\npositive regulation of stress-activated MAPK cascade,stress response,+\npositive regulation of stress-activated protein kinase signaling cascade,stress response,+\npositive regulation of striated muscle cell differentiation,morphogenesis/development,+\npositive regulation of superoxide anion generation,response to stimulus,+\npositive regulation of supramolecular fiber organization,cellular component organization,+\npositive regulation of synapse assembly,neural related process,+\npositive regulation of synaptic transmission,neural related process,+\npositive regulation of syncytium formation by plasma membrane fusion,morphogenesis/development,+\npositive regulation of T-helper cell differentiation,immune system process,+\npositive regulation of T cell activation,immune system process,+\npositive regulation of T cell apoptotic process,immune system process,+\npositive regulation of T cell cytokine production,immune system process,+\npositive regulation of T cell differentiation,immune system process,+\npositive regulation of T cell mediated immunity,immune system process,+\npositive regulation of T cell migration,immune system process,+\npositive regulation of T cell proliferation,immune system process,+\npositive regulation of telomerase activity,cell cycle,+\npositive regulation of telomerase RNA localization to Cajal body,transport,+\npositive regulation of telomere capping,cell cycle,+\npositive regulation of telomere maintenance via telomerase,cell cycle,+\npositive regulation of transcription by RNA polymerase I,gene regulation,+\npositive regulation of transcription by RNA polymerase III,gene regulation,+\npositive regulation of transcription elongation by RNA polymerase II,gene regulation,+\npositive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,stress response,+\npositive regulation of transcription initiation by RNA polymerase II,gene regulation,+\npositive regulation of transferase activity,metabolic process,+\npositive regulation of transforming growth factor beta production,immune system process,+\npositive regulation of transforming growth factor beta receptor signaling pathway,receptor related process,+\npositive regulation of translation,gene regulation,+\npositive regulation of translational initiation,gene regulation,+\npositive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,receptor related process,+\npositive regulation of transport,transport,+\npositive regulation of tumor necrosis factor production,immune system process,+\npositive regulation of tumor necrosis factor superfamily cytokine production,immune system process,+\npositive regulation of type 2 immune response,immune system process,+\npositive regulation of type I interferon-mediated signaling pathway,immune system process,+\npositive regulation of type I interferon production,immune system process,+\npositive regulation of type II interferon production,immune system process,+\npositive regulation of tyrosine phosphorylation of STAT protein,protein modification/signaling,+\npositive regulation of ubiquitin-dependent protein catabolic process,metabolic process,+\npositive regulation of ubiquitin-protein transferase activity,protein modification/signaling,+\npositive regulation of ubiquitin protein ligase activity,protein modification/signaling,+\npositive regulation of vacuole organization,cellular component organization,+\npositive regulation of vascular associated smooth muscle cell migration,multicellular organismal process,+\npositive regulation of vascular associated smooth muscle cell proliferation,cell cycle,+\npositive regulation of vascular endothelial growth factor production,gene regulation,+\npositive regulation of vascular permeability,multicellular organismal process,+\npositive regulation of vasculature development,morphogenesis/development,+\npositive regulation of viral genome replication,viral related process,+\npositive regulation of viral life cycle,viral related process,+\npositive regulation of viral process,viral related process,+\npositive regulation of Wnt signaling pathway,protein modification/signaling,+\npositive regulation of wound healing,immune system process,+\npost-embryonic development,morphogenesis/development,+\npost-Golgi vesicle-mediated transport,ER/endosome/lysosome related process,+\npost-translational protein modification,protein modification/signaling,+\npost-translational protein targeting to endoplasmic reticulum membrane,ER/endosome/lysosome related process,+\npostreplication repair,stress response,+\npostsynapse,neural related process,+\npostsynapse organization,neural related process,+\npostsynaptic cytoskeleton organization,cellular component organization,+\npostsynaptic membrane,neural related process,+\npostsynaptic modulation of chemical synaptic transmission,neural related process,+\npostsynaptic neurotransmitter receptor internalization,neural related process,+\npotassium ion homeostasis,other,+\npotassium ion import across plasma membrane,transport,+\npre-mRNA intronic binding,gene regulation,+\nprecatalytic spliceosome,gene regulation,+\npresynapse assembly,neural related process,+\npresynapse organization,neural related process,+\npresynaptic membrane,neural related process,+\nprimary active transmembrane transporter activity,transport,+\nprimary alcohol metabolic process,metabolic process,+\npro-B cell differentiation,immune system process,+\nproduction of molecular mediator involved in inflammatory response,immune system process,+\nproduction of molecular mediator of immune response,immune system process,+\nprogesterone metabolic process,metabolic process,+\nprogrammed cell death involved in cell development,cell death,+\nprogrammed necrotic cell death,cell death,+\nproline-rich region binding,other,+\npromoter-specific chromatin binding,gene regulation,+\nprostaglandin transport,transport,+\nprostanoid metabolic process,metabolic process,+\nprostate gland development,morphogenesis/development,+\nprostate gland epithelium morphogenesis,morphogenesis/development,+\nprostate gland growth,morphogenesis/development,+\nprostate gland morphogenesis,morphogenesis/development,+\nprotease binding,metabolic process,+\nproteasomal protein catabolic process,metabolic process,+\nproteasome-mediated ubiquitin-dependent protein catabolic process,metabolic process,+\nproteasome accessory complex,metabolic process,+\nproteasome assembly,cellular component organization,+\nproteasome binding,metabolic process,+\nproteasome complex,metabolic process,+\nproteasome core complex,metabolic process,+\nproteasome regulatory particle,metabolic process,+\nprotein-containing complex disassembly,cellular component organization,+\nprotein-containing complex localization,cellular component organization,+\nprotein-disulfide reductase (NAD(P)) activity,metabolic process,+\nprotein-DNA complex,gene regulation,+\nprotein-DNA complex assembly,gene regulation,+\nprotein-DNA complex disassembly,gene regulation,+\nprotein-folding chaperone binding,protein modification/signaling,+\nprotein-macromolecule adaptor activity,protein modification/signaling,+\nprotein-RNA complex organization,cellular component organization,+\nprotein acetylation,protein modification/signaling,+\nprotein acylation,protein modification/signaling,+\nprotein autophosphorylation,protein modification/signaling,+\nprotein autoprocessing,protein modification/signaling,+\nprotein autoubiquitination,protein modification/signaling,+\nprotein binding involved in heterotypic cell-cell adhesion,cell adhesion,+\nprotein carrier chaperone,cellular component organization,+\nprotein catabolic process in the vacuole,metabolic process,+\nprotein complex involved in cell adhesion,cell adhesion,+\nprotein complex oligomerization,cellular component organization,+\nprotein deacetylation,protein modification/signaling,+\nprotein deglycosylation,metabolic process,+\nprotein demethylase activity,protein modification/signaling,+\nprotein demethylation,protein modification/signaling,+\nprotein deneddylation,protein modification/signaling,+\nprotein dephosphorylation,protein modification/signaling,+\nprotein destabilization,protein modification/signaling,+\nprotein domain specific binding,protein modification/signaling,+\nprotein exit from endoplasmic reticulum,ER/endosome/lysosome related process,+\nprotein export from nucleus,transport,+\nprotein folding,protein modification/signaling,+\nprotein folding in endoplasmic reticulum,ER/endosome/lysosome related process,+\nprotein heterodimerization activity,protein modification/signaling,+\nprotein heterotetramerization,cellular component organization,+\nprotein homodimerization activity,protein modification/signaling,+\nprotein homotetramerization,cellular component organization,+\nprotein import into nucleus,transport,+\nprotein insertion into ER membrane,ER/endosome/lysosome related process,+\nprotein insertion into mitochondrial outer membrane,cellular component organization,+\nprotein K11-linked ubiquitination,protein modification/signaling,+\nprotein K48-linked ubiquitination,protein modification/signaling,+\nprotein K63-linked ubiquitination,protein modification/signaling,+\nprotein kinase activator activity,protein modification/signaling,+\nprotein kinase activity,protein modification/signaling,+\nprotein kinase binding,protein modification/signaling,+\nprotein kinase C binding,protein modification/signaling,+\nprotein kinase complex,protein modification/signaling,+\nprotein kinase regulator activity,protein modification/signaling,+\nprotein lipidation,protein modification/signaling,+\nprotein localization to cell-cell junction,transport,+\nprotein localization to cell cortex,transport,+\nprotein localization to cell junction,cellular component organization,+\nprotein localization to cell periphery,cellular component organization,+\nprotein localization to cell surface,transport,+\nprotein localization to centrosome,transport,+\nprotein localization to chromosome,transport,+\n\"protein localization to chromosome, centromeric region\",cellular component organization,+\nprotein localization to cilium,transport,+\nprotein localization to condensed chromosome,cell cycle,+\nprotein localization to cytoskeleton,cellular component organization,+\nprotein localization to endoplasmic reticulum,ER/endosome/lysosome related process,+\nprotein localization to endosome,ER/endosome/lysosome related process,+\nprotein localization to lysosome,ER/endosome/lysosome related process,+\nprotein localization to microtubule cytoskeleton,cellular component organization,+\nprotein localization to nuclear envelope,transport,+\nprotein localization to nucleolus,transport,+\nprotein localization to nucleus,transport,+\nprotein localization to phagophore assembly site,cellular component organization,+\nprotein localization to plasma membrane,transport,+\nprotein localization to vacuole,transport,+\nprotein maturation,metabolic process,+\nprotein maturation by iron-sulfur cluster transfer,metabolic process,+\nprotein methylation,protein modification/signaling,+\nprotein modification by small protein conjugation,protein modification/signaling,+\nprotein modification by small protein removal,protein modification/signaling,+\nprotein monoubiquitination,protein modification/signaling,+\nprotein N-linked glycosylation,protein modification/signaling,+\nprotein N-linked glycosylation via asparagine,protein modification/signaling,+\nprotein neddylation,protein modification/signaling,+\nprotein O-linked glycosylation,protein modification/signaling,+\nprotein peptidyl-prolyl isomerization,protein modification/signaling,+\nprotein polyubiquitination,protein modification/signaling,+\nprotein processing,protein modification/signaling,+\nprotein refolding,other,+\nprotein secretion,transport,+\nprotein self-association,protein modification/signaling,+\nprotein serine kinase activity,protein modification/signaling,+\nprotein serine/threonine kinase activator activity,protein modification/signaling,+\nprotein serine/threonine kinase activity,protein modification/signaling,+\nprotein serine/threonine/tyrosine kinase activity,protein modification/signaling,+\nprotein stabilization,other,+\nprotein sumoylation,protein modification/signaling,+\nprotein targeting,transport,+\nprotein targeting to lysosome,ER/endosome/lysosome related process,+\nprotein targeting to membrane,transport,+\nprotein targeting to mitochondrion,transport,+\nprotein targeting to vacuole,transport,+\nprotein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,transport,+\nprotein tyrosine kinase activator activity,protein modification/signaling,+\nprotein tyrosine kinase activity,protein modification/signaling,+\nprotein tyrosine kinase binding,protein modification/signaling,+\nprotein tyrosine phosphatase activity,protein modification/signaling,+\nprotein tyrosine/serine/threonine phosphatase activity,protein modification/signaling,+\nproteoglycan binding,cellular component organization,+\nproteoglycan biosynthetic process,metabolic process,+\nproteoglycan metabolic process,metabolic process,+\nproteolysis involved in protein catabolic process,metabolic process,+\nproton-transporting two-sector ATPase complex assembly,cellular component organization,+\nproton motive force-driven ATP synthesis,metabolic process,+\nproton motive force-driven mitochondrial ATP synthesis,metabolic process,+\nproton transmembrane transport,transport,+\nprotoporphyrinogen IX metabolic process,metabolic process,+\npseudouridine synthase activity,metabolic process,+\npseudouridine synthesis,metabolic process,+\npteridine-containing compound biosynthetic process,metabolic process,+\npulmonary valve development,morphogenesis/development,+\npurine-containing compound biosynthetic process,metabolic process,+\npurine-containing compound metabolic process,metabolic process,+\npurine deoxyribonucleotide metabolic process,metabolic process,+\npurine nucleobase metabolic process,metabolic process,+\npurine nucleoside triphosphate biosynthetic process,metabolic process,+\npurine nucleoside triphosphate metabolic process,metabolic process,+\npurine nucleotide binding,other,+\npurine nucleotide biosynthetic process,metabolic process,+\npurine nucleotide metabolic process,metabolic process,+\npurine ribonucleoside triphosphate biosynthetic process,metabolic process,+\npurine ribonucleoside triphosphate metabolic process,metabolic process,+\npurine ribonucleotide biosynthetic process,metabolic process,+\npurine ribonucleotide metabolic process,metabolic process,+\npurine ribonucleotide transmembrane transporter activity,transport,+\npyridine-containing compound biosynthetic process,metabolic process,+\npyridine-containing compound metabolic process,metabolic process,+\npyridine nucleotide biosynthetic process,metabolic process,+\npyridine nucleotide metabolic process,metabolic process,+\npyrimidine-containing compound catabolic process,metabolic process,+\npyrimidine-containing compound metabolic process,metabolic process,+\npyrimidine nucleoside monophosphate biosynthetic process,metabolic process,+\npyrimidine nucleoside triphosphate biosynthetic process,metabolic process,+\npyrimidine nucleoside triphosphate metabolic process,metabolic process,+\npyrimidine nucleotide metabolic process,metabolic process,+\npyrimidine ribonucleoside monophosphate biosynthetic process,metabolic process,+\npyruvate metabolic process,metabolic process,+\nquaternary ammonium group binding,metabolic process,+\nquinone metabolic process,metabolic process,+\nR-SMAD binding,receptor related process,+\nRap protein signal transduction,protein modification/signaling,+\nRas protein signal transduction,protein modification/signaling,+\nreactive nitrogen species metabolic process,metabolic process,+\nreactive oxygen species metabolic process,metabolic process,+\nreceptor-mediated endocytosis,receptor related process,+\nreceptor catabolic process,metabolic process,+\nreceptor ligand activity,receptor related process,+\nreceptor metabolic process,metabolic process,+\nreceptor signaling pathway via JAK-STAT,receptor related process,+\nreceptor signaling pathway via STAT,receptor related process,+\nrecombinational repair,stress response,+\nrecycling endosome membrane,ER/endosome/lysosome related process,+\nregeneration,morphogenesis/development,+\nregulated exocytosis,transport,+\nregulation of actin cytoskeleton organization,cellular component organization,+\nregulation of actin filament-based process,cellular component organization,+\nregulation of actin filament depolymerization,cellular component organization,+\nregulation of actin filament organization,cellular component organization,+\nregulation of action potential,neural related process,+\nregulation of actomyosin structure organization,cellular component organization,+\nregulation of acute inflammatory response,immune system process,+\nregulation of adaptive immune response,immune system process,+\nregulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,immune system process,+\nregulation of aerobic respiration,metabolic process,+\nregulation of alpha-beta T cell activation,immune system process,+\nregulation of alpha-beta T cell differentiation,immune system process,+\nregulation of alpha-beta T cell proliferation,immune system process,+\n\"regulation of alternative mRNA splicing, via spliceosome\",gene regulation,+\nregulation of amide metabolic process,metabolic process,+\nregulation of amyloid fibril formation,cellular component organization,+\nregulation of anatomical structure morphogenesis,morphogenesis/development,+\nregulation of anatomical structure size,cellular component organization,+\nregulation of androgen receptor signaling pathway,receptor related process,+\nregulation of angiogenesis,morphogenesis/development,+\nregulation of animal organ morphogenesis,morphogenesis/development,+\nregulation of anoikis,cell death,+\nregulation of antigen receptor-mediated signaling pathway,immune system process,+\nregulation of apoptotic signaling pathway,cell death,+\nregulation of astrocyte differentiation,neural related process,+\nregulation of ATP-dependent activity,other,+\nregulation of autophagy,cell death,+\nregulation of autophagy of mitochondrion,cell death,+\nregulation of axon regeneration,neural related process,+\nregulation of axonogenesis,neural related process,+\nregulation of B cell proliferation,immune system process,+\nregulation of behavior,neural related process,+\nregulation of bile acid metabolic process,metabolic process,+\nregulation of binding,gene regulation,+\nregulation of biological process involved in symbiotic interaction,other,+\nregulation of biomineral tissue development,morphogenesis/development,+\nregulation of biosynthetic process,metabolic process,+\nregulation of blood circulation,multicellular organismal process,+\nregulation of blood pressure,multicellular organismal process,+\nregulation of blood vessel endothelial cell migration,multicellular organismal process,+\nregulation of body fluid levels,multicellular organismal process,+\nregulation of brown fat cell differentiation,morphogenesis/development,+\nregulation of calcium ion transport,transport,+\nregulation of cAMP-mediated signaling,protein modification/signaling,+\nregulation of carbohydrate catabolic process,metabolic process,+\nregulation of carbohydrate metabolic process,metabolic process,+\nregulation of cardiac conduction,multicellular organismal process,+\nregulation of cardiocyte differentiation,morphogenesis/development,+\nregulation of catabolic process,metabolic process,+\n\"regulation of CD4-positive, alpha-beta T cell activation\",immune system process,+\n\"regulation of CD4-positive, alpha-beta T cell differentiation\",immune system process,+\nregulation of cell-cell adhesion,cell adhesion,+\nregulation of cell-cell adhesion mediated by cadherin,cell adhesion,+\nregulation of cell-matrix adhesion,cell adhesion,+\nregulation of cell-substrate adhesion,cell adhesion,+\nregulation of cell-substrate junction organization,cellular component organization,+\nregulation of cell activation,morphogenesis/development,+\nregulation of cell adhesion,cell adhesion,+\nregulation of cell adhesion mediated by integrin,cell adhesion,+\nregulation of cell cycle,cell cycle,+\nregulation of cell cycle checkpoint,cell cycle,+\nregulation of cell cycle G2/M phase transition,cell cycle,+\nregulation of cell cycle phase transition,cell cycle,+\nregulation of cell cycle process,cell cycle,+\nregulation of cell division,cell cycle,+\nregulation of cell fate specification,morphogenesis/development,+\nregulation of cell growth,cellular component organization,+\nregulation of cell junction assembly,cellular component organization,+\nregulation of cell killing,immune system process,+\nregulation of cell migration involved in sprouting angiogenesis,multicellular organismal process,+\nregulation of cell morphogenesis,morphogenesis/development,+\nregulation of cell projection assembly,cellular component organization,+\nregulation of cell projection size,cellular component organization,+\nregulation of cell proliferation involved in kidney development,cell cycle,+\nregulation of cell shape,cellular component organization,+\nregulation of cell size,cellular component organization,+\nregulation of cellular biosynthetic process,metabolic process,+\nregulation of cellular catabolic process,metabolic process,+\nregulation of cellular component biogenesis,cellular component organization,+\nregulation of cellular component size,cellular component organization,+\nregulation of cellular ketone metabolic process,metabolic process,+\nregulation of cellular localization,cellular component organization,+\nregulation of cellular pH,other,+\nregulation of cellular respiration,metabolic process,+\nregulation of cellular response to growth factor stimulus,response to stimulus,+\nregulation of cellular response to heat,response to stimulus,+\nregulation of cellular response to stress,stress response,+\nregulation of cellular response to transforming growth factor beta stimulus,response to stimulus,+\nregulation of centriole replication,cell cycle,+\nregulation of centrosome cycle,cell cycle,+\nregulation of chemokine production,immune system process,+\nregulation of chemotaxis,immune system process,+\nregulation of cholesterol efflux,transport,+\nregulation of cholesterol metabolic process,metabolic process,+\nregulation of cholesterol storage,cellular component organization,+\nregulation of chondrocyte differentiation,morphogenesis/development,+\nregulation of chromatin organization,cell cycle,+\nregulation of chromosome organization,cell cycle,+\nregulation of chromosome segregation,cell cycle,+\nregulation of chromosome separation,cell cycle,+\nregulation of cold-induced thermogenesis,multicellular organismal process,+\nregulation of collagen biosynthetic process,metabolic process,+\nregulation of collagen metabolic process,metabolic process,+\nregulation of complement activation,immune system process,+\nregulation of cyclin-dependent protein kinase activity,cell cycle,+\nregulation of cyclin-dependent protein serine/threonine kinase activity,protein modification/signaling,+\nregulation of cysteine-type endopeptidase activity,cell death,+\nregulation of cysteine-type endopeptidase activity involved in apoptotic process,cell death,+\nregulation of cytokine-mediated signaling pathway,immune system process,+\nregulation of cytokine production,immune system process,+\nregulation of cytokine production involved in immune response,immune system process,+\nregulation of cytokinesis,cell cycle,+\nregulation of cytoplasmic translation,gene regulation,+\nregulation of cytoplasmic transport,transport,+\nregulation of defense response,stress response,+\nregulation of defense response to virus,viral related process,+\nregulation of defense response to virus by host,viral related process,+\nregulation of dendrite development,morphogenesis/development,+\nregulation of dephosphorylation,protein modification/signaling,+\nregulation of developmental growth,morphogenesis/development,+\nregulation of DNA-binding transcription factor activity,gene regulation,+\nregulation of DNA-directed DNA polymerase activity,cell cycle,+\nregulation of DNA-templated DNA replication,cell cycle,+\nregulation of DNA-templated DNA replication initiation,cell cycle,+\nregulation of DNA-templated transcription,gene regulation,+\nregulation of DNA-templated transcription elongation,gene regulation,+\nregulation of DNA-templated transcription in response to stress,stress response,+\nregulation of DNA-templated transcription initiation,gene regulation,+\nregulation of DNA binding,gene regulation,+\nregulation of DNA biosynthetic process,cell cycle,+\nregulation of DNA damage checkpoint,cell cycle,+\nregulation of DNA demethylation,gene regulation,+\nregulation of DNA metabolic process,cell cycle,+\nregulation of DNA methylation,gene regulation,+\nregulation of DNA repair,stress response,+\nregulation of DNA replication,cell cycle,+\nregulation of DNA strand elongation,cell cycle,+\nregulation of double-strand break repair,stress response,+\nregulation of early endosome to late endosome transport,ER/endosome/lysosome related process,+\nregulation of embryonic development,morphogenesis/development,+\nregulation of endocytosis,transport,+\nregulation of endopeptidase activity,cell death,+\nregulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,cell death,+\nregulation of endoplasmic reticulum unfolded protein response,stress response,+\nregulation of endothelial cell apoptotic process,cell death,+\nregulation of endothelial cell differentiation,morphogenesis/development,+\nregulation of endothelial cell migration,multicellular organismal process,+\nregulation of endothelial cell proliferation,cell cycle,+\nregulation of epidermal cell differentiation,morphogenesis/development,+\nregulation of epidermal growth factor receptor signaling pathway,receptor related process,+\nregulation of epidermis development,morphogenesis/development,+\nregulation of epithelial cell apoptotic process,cell death,+\nregulation of epithelial cell differentiation,morphogenesis/development,+\nregulation of epithelial cell migration,multicellular organismal process,+\nregulation of epithelial cell proliferation,cell cycle,+\nregulation of ERAD pathway,ER/endosome/lysosome related process,+\nregulation of ERBB signaling pathway,receptor related process,+\nregulation of ERK1 and ERK2 cascade,protein modification/signaling,+\nregulation of erythrocyte differentiation,morphogenesis/development,+\nregulation of establishment of cell polarity,cellular component organization,+\nregulation of establishment of planar polarity,cellular component organization,+\nregulation of execution phase of apoptosis,cell death,+\nregulation of exit from mitosis,cell cycle,+\nregulation of extracellular matrix organization,cellular component organization,+\nregulation of extrinsic apoptotic signaling pathway,cell death,+\nregulation of extrinsic apoptotic signaling pathway in absence of ligand,cell death,+\nregulation of extrinsic apoptotic signaling pathway via death domain receptors,cell death,+\nregulation of fat cell differentiation,morphogenesis/development,+\nregulation of fatty acid metabolic process,metabolic process,+\nregulation of fatty acid oxidation,metabolic process,+\nregulation of Fc receptor mediated stimulatory signaling pathway,immune system process,+\nregulation of fibroblast growth factor receptor signaling pathway,receptor related process,+\nregulation of fibroblast migration,multicellular organismal process,+\nregulation of fibroblast proliferation,cell cycle,+\nregulation of focal adhesion assembly,cell adhesion,+\nregulation of G protein-coupled receptor signaling pathway,receptor related process,+\nregulation of G0 to G1 transition,cell cycle,+\nregulation of G1/S transition of mitotic cell cycle,cell cycle,+\nregulation of G2/M transition of mitotic cell cycle,cell cycle,+\nregulation of gastrulation,morphogenesis/development,+\nregulation of generation of precursor metabolites and energy,metabolic process,+\nregulation of glial cell differentiation,neural related process,+\nregulation of glial cell proliferation,cell cycle,+\nregulation of gliogenesis,neural related process,+\nregulation of granulocyte chemotaxis,immune system process,+\nregulation of growth,morphogenesis/development,+\nregulation of GTPase activity,protein modification/signaling,+\nregulation of hair cycle,multicellular organismal process,+\nregulation of heart contraction,multicellular organismal process,+\nregulation of heart rate,multicellular organismal process,+\nregulation of helicase activity,cell cycle,+\nregulation of hematopoietic stem cell differentiation,morphogenesis/development,+\nregulation of hemopoiesis,immune system process,+\nregulation of heterochromatin formation,gene regulation,+\nregulation of heterochromatin organization,gene regulation,+\nregulation of histone acetylation,gene regulation,+\nregulation of histone H3-K4 methylation,gene regulation,+\nregulation of histone methylation,gene regulation,+\nregulation of homotypic cell-cell adhesion,cell adhesion,+\nregulation of hormone biosynthetic process,metabolic process,+\nregulation of hormone metabolic process,metabolic process,+\nregulation of hydrogen peroxide metabolic process,immune system process,+\nregulation of hydrolase activity,metabolic process,+\nregulation of icosanoid secretion,transport,+\nregulation of immune effector process,immune system process,+\nregulation of immune response,immune system process,+\nregulation of inflammatory response,immune system process,+\nregulation of inflammatory response to antigenic stimulus,immune system process,+\nregulation of innate immune response,immune system process,+\nregulation of insulin-like growth factor receptor signaling pathway,receptor related process,+\nregulation of insulin receptor signaling pathway,receptor related process,+\nregulation of integrin-mediated signaling pathway,protein modification/signaling,+\nregulation of integrin activation,cellular component organization,+\nregulation of interferon-alpha production,immune system process,+\nregulation of interferon-beta production,immune system process,+\nregulation of interleukin-1 beta production,immune system process,+\nregulation of interleukin-1 production,immune system process,+\nregulation of interleukin-10 production,immune system process,+\nregulation of interleukin-12 production,immune system process,+\nregulation of interleukin-13 production,immune system process,+\nregulation of interleukin-17 production,immune system process,+\nregulation of interleukin-2 production,immune system process,+\nregulation of interleukin-4 production,immune system process,+\nregulation of interleukin-5 production,immune system process,+\nregulation of interleukin-6 production,immune system process,+\nregulation of interleukin-8 production,immune system process,+\nregulation of intracellular estrogen receptor signaling pathway,receptor related process,+\nregulation of intracellular protein transport,transport,+\nregulation of intracellular steroid hormone receptor signaling pathway,receptor related process,+\nregulation of intracellular transport,transport,+\nregulation of intrinsic apoptotic signaling pathway,cell death,+\nregulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,cell death,+\nregulation of IRE1-mediated unfolded protein response,protein modification/signaling,+\nregulation of isotype switching to IgG isotypes,immune system process,+\nregulation of JNK cascade,stress response,+\nregulation of JUN kinase activity,protein modification/signaling,+\nregulation of keratinocyte differentiation,morphogenesis/development,+\nregulation of kidney development,morphogenesis/development,+\nregulation of lamellipodium assembly,cellular component organization,+\nregulation of leukocyte activation,immune system process,+\nregulation of leukocyte adhesion to vascular endothelial cell,immune system process,+\nregulation of leukocyte apoptotic process,cell death,+\nregulation of leukocyte cell-cell adhesion,immune system process,+\nregulation of leukocyte chemotaxis,immune system process,+\nregulation of leukocyte differentiation,immune system process,+\nregulation of leukocyte mediated cytotoxicity,immune system process,+\nregulation of leukocyte mediated immunity,immune system process,+\nregulation of leukocyte migration,immune system process,+\nregulation of leukocyte proliferation,immune system process,+\nregulation of lipid biosynthetic process,metabolic process,+\nregulation of lipid kinase activity,protein modification/signaling,+\nregulation of lipid localization,cellular component organization,+\nregulation of lipid metabolic process,metabolic process,+\nregulation of lipid storage,cellular component organization,+\nregulation of lipid transport,transport,+\nregulation of lipoprotein lipase activity,metabolic process,+\nregulation of lipoprotein metabolic process,metabolic process,+\nregulation of lymphocyte activation,immune system process,+\nregulation of lymphocyte apoptotic process,immune system process,+\nregulation of lymphocyte chemotaxis,immune system process,+\nregulation of lymphocyte differentiation,immune system process,+\nregulation of lymphocyte mediated immunity,immune system process,+\nregulation of lymphocyte migration,immune system process,+\nregulation of lymphocyte proliferation,immune system process,+\nregulation of macroautophagy,immune system process,+\nregulation of macrophage activation,immune system process,+\nregulation of macrophage apoptotic process,cell death,+\nregulation of macrophage cytokine production,immune system process,+\nregulation of macrophage derived foam cell differentiation,morphogenesis/development,+\nregulation of MAP kinase activity,protein modification/signaling,+\nregulation of MAPK cascade,protein modification/signaling,+\nregulation of meiotic cell cycle,cell cycle,+\nregulation of meiotic nuclear division,cell cycle,+\nregulation of membrane permeability,transport,+\nregulation of membrane potential,other,+\nregulation of metaphase/anaphase transition of cell cycle,cell cycle,+\nregulation of MHC class II biosynthetic process,immune system process,+\nregulation of microtubule-based process,other,+\nregulation of microvillus organization,cellular component organization,+\nregulation of miRNA metabolic process,metabolic process,+\nregulation of miRNA transcription,gene regulation,+\nregulation of mitochondrial depolarization,other,+\nregulation of mitochondrial fission,cellular component organization,+\nregulation of mitochondrial gene expression,gene regulation,+\nregulation of mitochondrial membrane permeability,transport,+\nregulation of mitochondrial membrane potential,transport,+\nregulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,cell death,+\nregulation of mitochondrion organization,cellular component organization,+\nregulation of mitotic cell cycle,cell cycle,+\nregulation of mitotic cell cycle phase transition,cell cycle,+\nregulation of mitotic cell cycle spindle assembly checkpoint,cell cycle,+\nregulation of mitotic metaphase/anaphase transition,cell cycle,+\nregulation of mitotic nuclear division,cell cycle,+\nregulation of mitotic sister chromatid segregation,cell cycle,+\nregulation of mitotic sister chromatid separation,cell cycle,+\nregulation of mitotic spindle checkpoint,cell cycle,+\nregulation of mitotic spindle organization,cell cycle,+\nregulation of monoatomic anion transmembrane transport,transport,+\nregulation of monoatomic ion transmembrane transport,transport,+\nregulation of mononuclear cell migration,immune system process,+\nregulation of mononuclear cell proliferation,immune system process,+\nregulation of monooxygenase activity,metabolic process,+\nregulation of morphogenesis of a branching structure,morphogenesis/development,+\nregulation of morphogenesis of an epithelium,morphogenesis/development,+\nregulation of mRNA metabolic process,gene regulation,+\nregulation of mRNA processing,gene regulation,+\n\"regulation of mRNA splicing, via spliceosome\",gene regulation,+\nregulation of multicellular organism growth,multicellular organismal process,+\nregulation of muscle adaptation,multicellular organismal process,+\nregulation of muscle cell apoptotic process,cell death,+\nregulation of muscle cell differentiation,morphogenesis/development,+\nregulation of myeloid cell differentiation,immune system process,+\nregulation of myeloid leukocyte differentiation,immune system process,+\nregulation of myoblast fusion,morphogenesis/development,+\nregulation of natural killer cell activation,immune system process,+\nregulation of natural killer cell mediated cytotoxicity,immune system process,+\nregulation of natural killer cell mediated immunity,immune system process,+\nregulation of necroptotic process,cell death,+\nregulation of nervous system development,neural related process,+\nregulation of nervous system process,neural related process,+\nregulation of neurogenesis,neural related process,+\nregulation of neuroinflammatory response,immune system process,+\nregulation of neuron apoptotic process,cell death,+\nregulation of neuron differentiation,neural related process,+\nregulation of neuron projection development,neural related process,+\nregulation of neurotransmitter transport,neural related process,+\nregulation of neutrophil chemotaxis,immune system process,+\nregulation of neutrophil migration,immune system process,+\nregulation of nitric-oxide synthase biosynthetic process,metabolic process,+\nregulation of nitric oxide biosynthetic process,metabolic process,+\nregulation of nitric oxide metabolic process,metabolic process,+\nregulation of non-canonical Wnt signaling pathway,protein modification/signaling,+\nregulation of non-motile cilium assembly,cellular component organization,+\nregulation of Notch signaling pathway,protein modification/signaling,+\nregulation of nuclear cell cycle DNA replication,cell cycle,+\nregulation of nuclear division,cell cycle,+\nregulation of nuclease activity,metabolic process,+\nregulation of nucleobase-containing compound metabolic process,metabolic process,+\nregulation of nucleobase-containing compound transport,transport,+\nregulation of nucleocytoplasmic transport,transport,+\nregulation of nucleotide-excision repair,stress response,+\nregulation of odontogenesis of dentin-containing tooth,morphogenesis/development,+\nregulation of organelle assembly,cellular component organization,+\nregulation of organic acid transport,transport,+\nregulation of ossification,morphogenesis/development,+\nregulation of osteoblast differentiation,morphogenesis/development,+\nregulation of osteoblast proliferation,cell cycle,+\nregulation of osteoclast differentiation,morphogenesis/development,+\nregulation of oxidative stress-induced intrinsic apoptotic signaling pathway,cell death,+\nregulation of oxidoreductase activity,metabolic process,+\nregulation of p38MAPK cascade,protein modification/signaling,+\nregulation of pattern recognition receptor signaling pathway,immune system process,+\nregulation of peptidase activity,metabolic process,+\nregulation of peptidyl-serine phosphorylation,protein modification/signaling,+\nregulation of peptidyl-tyrosine phosphorylation,protein modification/signaling,+\nregulation of pH,other,+\nregulation of phagocytosis,immune system process,+\nregulation of phospholipase A2 activity,metabolic process,+\nregulation of phospholipid biosynthetic process,metabolic process,+\nregulation of phospholipid metabolic process,metabolic process,+\nregulation of plasma membrane bounded cell projection organization,cellular component organization,+\nregulation of plasma membrane organization,cellular component organization,+\nregulation of plasminogen activation,protein modification/signaling,+\nregulation of platelet-derived growth factor receptor signaling pathway,receptor related process,+\nregulation of platelet activation,multicellular organismal process,+\nregulation of platelet aggregation,multicellular organismal process,+\nregulation of positive chemotaxis,immune system process,+\nregulation of post-transcriptional gene silencing,gene regulation,+\nregulation of production of molecular mediator of immune response,immune system process,+\nregulation of programmed necrotic cell death,cell death,+\nregulation of proteasomal protein catabolic process,metabolic process,+\nregulation of protein-containing complex disassembly,cellular component organization,+\nregulation of protein acetylation,protein modification/signaling,+\nregulation of protein autophosphorylation,protein modification/signaling,+\nregulation of protein binding,protein modification/signaling,+\nregulation of protein catabolic process,metabolic process,+\nregulation of protein catabolic process in the vacuole,metabolic process,+\nregulation of protein deacetylation,protein modification/signaling,+\nregulation of protein deubiquitination,protein modification/signaling,+\nregulation of protein K63-linked ubiquitination,protein modification/signaling,+\nregulation of protein localization to cell periphery,cellular component organization,+\nregulation of protein localization to membrane,transport,+\nregulation of protein localization to nucleus,transport,+\nregulation of protein localization to plasma membrane,cellular component organization,+\nregulation of protein maturation,protein modification/signaling,+\nregulation of protein modification by small protein conjugation or removal,protein modification/signaling,+\nregulation of protein polyubiquitination,protein modification/signaling,+\nregulation of protein processing,protein modification/signaling,+\nregulation of protein secretion,transport,+\nregulation of protein serine/threonine kinase activity,protein modification/signaling,+\nregulation of protein stability,protein modification/signaling,+\nregulation of protein targeting,transport,+\nregulation of protein targeting to membrane,cellular component organization,+\nregulation of protein targeting to mitochondrion,transport,+\nregulation of protein tyrosine kinase activity,protein modification/signaling,+\nregulation of protein ubiquitination,protein modification/signaling,+\nregulation of proteolysis,metabolic process,+\nregulation of proteolysis involved in protein catabolic process,metabolic process,+\nregulation of proton transport,transport,+\nregulation of Ras protein signal transduction,protein modification/signaling,+\nregulation of reactive oxygen species metabolic process,stress response,+\nregulation of receptor internalization,receptor related process,+\nregulation of receptor localization to synapse,neural related process,+\nregulation of receptor signaling pathway via JAK-STAT,receptor related process,+\nregulation of receptor signaling pathway via STAT,receptor related process,+\nregulation of regulatory T cell differentiation,immune system process,+\nregulation of release of cytochrome c from mitochondria,cell death,+\nregulation of release of sequestered calcium ion into cytosol,transport,+\nregulation of reproductive process,other,+\nregulation of response to biotic stimulus,response to stimulus,+\nregulation of response to cytokine stimulus,immune system process,+\nregulation of response to endoplasmic reticulum stress,stress response,+\nregulation of response to external stimulus,response to stimulus,+\nregulation of response to oxidative stress,stress response,+\nregulation of response to reactive oxygen species,stress response,+\nregulation of response to wounding,immune system process,+\n\"regulation of retrograde protein transport, ER to cytosol\",ER/endosome/lysosome related process,+\nregulation of Rho protein signal transduction,protein modification/signaling,+\nregulation of RIG-I signaling pathway,immune system process,+\nregulation of RNA binding,gene regulation,+\nregulation of RNA biosynthetic process,gene regulation,+\nregulation of RNA metabolic process,metabolic process,+\nregulation of RNA splicing,gene regulation,+\nregulation of rRNA processing,gene regulation,+\nregulation of secretion,multicellular organismal process,+\nregulation of secretion by cell,transport,+\nregulation of sequestering of calcium ion,other,+\nregulation of signal transduction by p53 class mediator,protein modification/signaling,+\nregulation of signaling receptor activity,receptor related process,+\nregulation of sister chromatid segregation,cell cycle,+\nregulation of skeletal muscle cell differentiation,morphogenesis/development,+\nregulation of SMAD protein signal transduction,protein modification/signaling,+\nregulation of small GTPase mediated signal transduction,protein modification/signaling,+\nregulation of small molecule metabolic process,metabolic process,+\nregulation of smooth muscle cell migration,multicellular organismal process,+\nregulation of smooth muscle cell proliferation,cell cycle,+\nregulation of sodium ion transmembrane transport,transport,+\nregulation of sodium ion transport,transport,+\nregulation of spindle assembly,cell cycle,+\nregulation of spindle checkpoint,cell cycle,+\nregulation of spindle organization,cell cycle,+\nregulation of sprouting angiogenesis,morphogenesis/development,+\nregulation of stem cell differentiation,morphogenesis/development,+\nregulation of stem cell population maintenance,morphogenesis/development,+\nregulation of stem cell proliferation,cell cycle,+\nregulation of steroid hormone secretion,transport,+\nregulation of steroid metabolic process,metabolic process,+\nregulation of stress-activated MAPK cascade,stress response,+\nregulation of stress-activated protein kinase signaling cascade,stress response,+\nregulation of synapse organization,neural related process,+\nregulation of synapse structure or activity,neural related process,+\nregulation of synaptic plasticity,neural related process,+\nregulation of syncytium formation by plasma membrane fusion,cellular component organization,+\nregulation of system process,multicellular organismal process,+\nregulation of systemic arterial blood pressure by hormone,multicellular organismal process,+\nregulation of T-helper 1 type immune response,immune system process,+\nregulation of T-helper 17 type immune response,immune system process,+\nregulation of T-helper cell differentiation,immune system process,+\nregulation of T cell activation,immune system process,+\nregulation of T cell apoptotic process,immune system process,+\nregulation of T cell cytokine production,immune system process,+\nregulation of T cell differentiation,immune system process,+\nregulation of T cell differentiation in thymus,immune system process,+\nregulation of T cell mediated cytotoxicity,immune system process,+\nregulation of T cell mediated immunity,immune system process,+\nregulation of T cell migration,immune system process,+\nregulation of T cell proliferation,immune system process,+\nregulation of telomere capping,cell cycle,+\nregulation of telomere maintenance,cell cycle,+\nregulation of toll-like receptor 4 signaling pathway,immune system process,+\nregulation of toll-like receptor signaling pathway,immune system process,+\nregulation of trans-synaptic signaling,neural related process,+\nregulation of transcription by RNA polymerase I,gene regulation,+\nregulation of transcription by RNA polymerase III,gene regulation,+\nregulation of transcription elongation by RNA polymerase II,gene regulation,+\nregulation of transcription from RNA polymerase II promoter in response to stress,stress response,+\nregulation of transcription initiation by RNA polymerase II,gene regulation,+\nregulation of transferase activity,metabolic process,+\nregulation of transforming growth factor beta production,immune system process,+\nregulation of transforming growth factor beta receptor signaling pathway,receptor related process,+\nregulation of translation in response to stress,stress response,+\nregulation of translational initiation,gene regulation,+\nregulation of translational initiation in response to stress,stress response,+\nregulation of transmembrane receptor protein serine/threonine kinase signaling pathway,receptor related process,+\nregulation of transmembrane transport,transport,+\nregulation of transmission of nerve impulse,neural related process,+\nregulation of transporter activity,transport,+\nregulation of trophoblast cell migration,morphogenesis/development,+\nregulation of tube diameter,multicellular organismal process,+\nregulation of tube size,multicellular organismal process,+\nregulation of tubulin deacetylation,protein modification/signaling,+\nregulation of tumor necrosis factor-mediated signaling pathway,immune system process,+\nregulation of tumor necrosis factor production,immune system process,+\nregulation of tumor necrosis factor superfamily cytokine production,immune system process,+\nregulation of type 2 immune response,immune system process,+\nregulation of type I interferon-mediated signaling pathway,immune system process,+\nregulation of type I interferon production,immune system process,+\nregulation of type II interferon production,immune system process,+\nregulation of tyrosine phosphorylation of STAT protein,protein modification/signaling,+\nregulation of ubiquitin-dependent protein catabolic process,metabolic process,+\nregulation of vacuole organization,cellular component organization,+\nregulation of vascular associated smooth muscle cell proliferation,cell cycle,+\nregulation of vascular endothelial cell proliferation,cell cycle,+\nregulation of vascular endothelial growth factor production,gene regulation,+\nregulation of vascular endothelial growth factor receptor signaling pathway,receptor related process,+\nregulation of vascular permeability,multicellular organismal process,+\nregulation of vasculature development,morphogenesis/development,+\nregulation of vesicle-mediated transport,transport,+\nregulation of viral entry into host cell,viral related process,+\nregulation of viral genome replication,viral related process,+\nregulation of viral life cycle,viral related process,+\nregulation of viral process,viral related process,+\nregulation of viral transcription,viral related process,+\nregulation of wound healing,immune system process,+\nregulatory ncRNA processing,gene regulation,+\nregulatory T cell differentiation,immune system process,+\nrelaxation of cardiac muscle,multicellular organismal process,+\nrelease of cytochrome c from mitochondria,cell death,+\nrelease of sequestered calcium ion into cytosol,transport,+\nrenal sodium ion transport,transport,+\nrenal system development,morphogenesis/development,+\nrenal system process,multicellular organismal process,+\nrenal system vasculature development,morphogenesis/development,+\nrenal vesicle morphogenesis,morphogenesis/development,+\nreplication fork processing,cell cycle,+\nreproductive structure development,morphogenesis/development,+\nrespiratory burst,immune system process,+\nrespiratory electron transport chain,metabolic process,+\nrespiratory system development,morphogenesis/development,+\nrespiratory tube development,morphogenesis/development,+\nresponse to acid chemical,response to stimulus,+\nresponse to activity,response to stimulus,+\nresponse to alcohol,response to stimulus,+\nresponse to alkaloid,response to stimulus,+\nresponse to amine,response to stimulus,+\nresponse to amyloid-beta,response to stimulus,+\nresponse to angiotensin,response to stimulus,+\nresponse to antibiotic,response to stimulus,+\nresponse to arsenic-containing substance,response to stimulus,+\nresponse to axon injury,stress response,+\nresponse to bacterium,immune system process,+\nresponse to BMP,response to stimulus,+\nresponse to cadmium ion,response to stimulus,+\nresponse to cAMP,response to stimulus,+\nresponse to carbohydrate,response to stimulus,+\nresponse to chemokine,immune system process,+\nresponse to cold,stress response,+\nresponse to corticosteroid,response to stimulus,+\nresponse to corticosterone,response to stimulus,+\nresponse to cytokine,immune system process,+\nresponse to decreased oxygen levels,stress response,+\nresponse to dexamethasone,response to stimulus,+\nresponse to dsRNA,immune system process,+\nresponse to endoplasmic reticulum stress,stress response,+\nresponse to epidermal growth factor,response to stimulus,+\nresponse to estradiol,response to stimulus,+\nresponse to estrogen,response to stimulus,+\nresponse to ethanol,response to stimulus,+\nresponse to exogenous dsRNA,immune system process,+\nresponse to extracellular stimulus,response to stimulus,+\nresponse to fatty acid,response to stimulus,+\nresponse to fibroblast growth factor,response to stimulus,+\nresponse to fluid shear stress,stress response,+\nresponse to gamma radiation,stress response,+\nresponse to glucocorticoid,response to stimulus,+\nresponse to growth factor,response to stimulus,+\nresponse to growth hormone,response to stimulus,+\nresponse to heat,stress response,+\nresponse to hormone,response to stimulus,+\nresponse to hydrogen peroxide,stress response,+\nresponse to hyperoxia,stress response,+\nresponse to hypoxia,stress response,+\nresponse to increased oxygen levels,response to stimulus,+\nresponse to inorganic substance,response to stimulus,+\nresponse to insulin,response to stimulus,+\nresponse to interferon-alpha,immune system process,+\nresponse to interferon-beta,immune system process,+\nresponse to interleukin-1,immune system process,+\nresponse to interleukin-18,immune system process,+\nresponse to interleukin-4,immune system process,+\nresponse to interleukin-6,immune system process,+\nresponse to ionizing radiation,stress response,+\nresponse to iron ion,response to stimulus,+\nresponse to ischemia,stress response,+\nresponse to ketone,response to stimulus,+\nresponse to L-glutamate,response to stimulus,+\nresponse to lead ion,response to stimulus,+\nresponse to lectin,response to stimulus,+\nresponse to leucine,response to stimulus,+\nresponse to leukemia inhibitory factor,response to stimulus,+\nresponse to lipid,response to stimulus,+\nresponse to lipopolysaccharide,immune system process,+\nresponse to manganese ion,response to stimulus,+\nresponse to mechanical stimulus,response to stimulus,+\nresponse to metal ion,response to stimulus,+\nresponse to mitochondrial depolarisation,stress response,+\nresponse to molecule of bacterial origin,response to stimulus,+\nresponse to monosaccharide,response to stimulus,+\nresponse to muramyl dipeptide,response to stimulus,+\nresponse to muscle activity,response to stimulus,+\nresponse to muscle stretch,response to stimulus,+\nresponse to nerve growth factor,neural related process,+\nresponse to nutrient,response to stimulus,+\nresponse to nutrient levels,response to stimulus,+\nresponse to organic cyclic compound,response to stimulus,+\nresponse to organophosphorus,response to stimulus,+\nresponse to osmotic stress,stress response,+\nresponse to oxidative stress,stress response,+\nresponse to oxygen levels,stress response,+\nresponse to peptide,response to stimulus,+\nresponse to peptide hormone,response to stimulus,+\nresponse to progesterone,response to stimulus,+\nresponse to protozoan,response to stimulus,+\nresponse to purine-containing compound,response to stimulus,+\nresponse to radiation,stress response,+\nresponse to reactive oxygen species,stress response,+\nresponse to retinoic acid,response to stimulus,+\nresponse to salt,response to stimulus,+\nresponse to starvation,stress response,+\nresponse to steroid hormone,response to stimulus,+\nresponse to sterol,response to stimulus,+\nresponse to temperature stimulus,response to stimulus,+\nresponse to topologically incorrect protein,response to stimulus,+\nresponse to toxic substance,response to stimulus,+\nresponse to transforming growth factor beta,immune system process,+\nresponse to tumor cell,response to stimulus,+\nresponse to tumor necrosis factor,immune system process,+\nresponse to type I interferon,immune system process,+\nresponse to type II interferon,immune system process,+\nresponse to unfolded protein,stress response,+\nresponse to UV,stress response,+\nresponse to virus,viral related process,+\nresponse to vitamin,response to stimulus,+\nresponse to vitamin D,response to stimulus,+\nresponse to wounding,immune system process,+\nresponse to X-ray,stress response,+\nresponse to xenobiotic stimulus,response to stimulus,+\nretina development in camera-type eye,morphogenesis/development,+\nretinal ganglion cell axon guidance,neural related process,+\nretinal rod cell differentiation,morphogenesis/development,+\nretinoic acid metabolic process,metabolic process,+\nretinoic acid receptor signaling pathway,receptor related process,+\n\"retrograde protein transport, ER to cytosol\",ER/endosome/lysosome related process,+\n\"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum\",ER/endosome/lysosome related process,+\nRho protein signal transduction,protein modification/signaling,+\nrhythmic process,other,+\nribonucleoprotein complex binding,gene regulation,+\nribonucleoprotein complex biogenesis,cellular component organization,+\nribonucleoside diphosphate metabolic process,metabolic process,+\nribonucleoside monophosphate biosynthetic process,metabolic process,+\nribonucleoside monophosphate catabolic process,metabolic process,+\nribonucleoside triphosphate biosynthetic process,metabolic process,+\nribonucleoside triphosphate metabolic process,metabolic process,+\nribonucleoside triphosphate phosphatase activity,metabolic process,+\nribonucleotide biosynthetic process,metabolic process,+\nribonucleotide metabolic process,metabolic process,+\nribose phosphate biosynthetic process,metabolic process,+\nribose phosphate metabolic process,metabolic process,+\nribosomal large subunit biogenesis,cellular component organization,+\nribosomal small subunit assembly,cellular component organization,+\nribosomal small subunit binding,gene regulation,+\nribosomal small subunit biogenesis,cellular component organization,+\nribosomal subunit export from nucleus,transport,+\nribosome assembly,cellular component organization,+\nribosome biogenesis,gene regulation,+\nRIG-I signaling pathway,immune system process,+\nRNA 3'-end processing,gene regulation,+\nRNA 5'-end processing,gene regulation,+\nRNA binding,gene regulation,+\nRNA biosynthetic process,gene regulation,+\nRNA capping,gene regulation,+\nRNA decapping,gene regulation,+\nRNA export from nucleus,transport,+\nRNA helicase activity,gene regulation,+\nRNA localization,transport,+\nRNA modification,gene regulation,+\nRNA polymerase binding,gene regulation,+\nRNA polymerase II-specific DNA-binding transcription factor binding,gene regulation,+\nRNA polymerase II core promoter sequence-specific DNA binding,gene regulation,+\nRNA polymerase II preinitiation complex assembly,gene regulation,+\nRNA polymerase II transcription regulator complex,gene regulation,+\nRNA processing,gene regulation,+\n\"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile\",gene regulation,+\nRNA stem-loop binding,gene regulation,+\nRNA transport,transport,+\nrRNA binding,gene regulation,+\nrRNA metabolic process,metabolic process,+\nrRNA modification,gene regulation,+\nrRNA processing,gene regulation,+\nrRNA transcription,metabolic process,+\nRSC-type complex,gene regulation,+\nruffle,cellular component organization,+\nruffle membrane,cellular component organization,+\nruffle organization,cellular component organization,+\nS-adenosylmethionine metabolic process,metabolic process,+\nS100 protein binding,other,+\nsalivary gland development,morphogenesis/development,+\nsarcomere organization,cellular component organization,+\nSchaffer collateral - CA1 synapse,neural related process,+\nSchwann cell differentiation,neural related process,+\nsecond-messenger-mediated signaling,protein modification/signaling,+\nsecondary active transmembrane transporter activity,transport,+\nsecondary alcohol biosynthetic process,metabolic process,+\nsecretion,transport,+\nsecretory granule membrane,immune system process,+\nsegmentation,morphogenesis/development,+\nsemaphorin-plexin signaling pathway involved in axon guidance,neural related process,+\nseminiferous tubule development,morphogenesis/development,+\nsensory perception of mechanical stimulus,neural related process,+\nsensory perception of pain,neural related process,+\nsensory system development,neural related process,+\nsequence-specific double-stranded DNA binding,gene regulation,+\nsequence-specific mRNA binding,gene regulation,+\nsequence-specific single stranded DNA binding,gene regulation,+\nsequestering of calcium ion,other,+\nserine-type endopeptidase inhibitor activity,cell death,+\nserine family amino acid biosynthetic process,metabolic process,+\nserine family amino acid metabolic process,metabolic process,+\nserine transmembrane transporter activity,transport,+\nserine transport,transport,+\nSertoli cell differentiation,morphogenesis/development,+\nsex differentiation,morphogenesis/development,+\nSH3 domain binding,protein modification/signaling,+\nsialyltransferase activity,metabolic process,+\nsignal peptide processing,protein modification/signaling,+\nsignal release,protein modification/signaling,+\nsignal transduction by p53 class mediator,protein modification/signaling,+\nsignal transduction in absence of ligand,protein modification/signaling,+\nsignal transduction in response to DNA damage,stress response,+\nsignaling adaptor activity,protein modification/signaling,+\nsignaling receptor activity,receptor related process,+\nsignaling receptor binding,receptor related process,+\nsignaling receptor complex adaptor activity,receptor related process,+\nsignaling receptor ligand precursor processing,receptor related process,+\nsingle-stranded DNA binding,gene regulation,+\nsingle-stranded DNA helicase activity,cell cycle,+\nsingle-stranded RNA binding,gene regulation,+\nsister chromatid cohesion,cell cycle,+\nsister chromatid segregation,cell cycle,+\nskeletal muscle cell differentiation,morphogenesis/development,+\nskeletal muscle organ development,morphogenesis/development,+\nskeletal muscle satellite cell proliferation,cell cycle,+\nskeletal muscle tissue development,morphogenesis/development,+\nskeletal system development,morphogenesis/development,+\nskeletal system morphogenesis,morphogenesis/development,+\nskin development,morphogenesis/development,+\nskin epidermis development,morphogenesis/development,+\nsleep,neural related process,+\nSMAD binding,protein modification/signaling,+\nsmall GTPase binding,protein modification/signaling,+\nsmall GTPase mediated signal transduction,protein modification/signaling,+\nsmall molecule binding,metabolic process,+\nsmall molecule biosynthetic process,metabolic process,+\nsmall molecule catabolic process,metabolic process,+\nsmall nucleolar ribonucleoprotein complex assembly,cellular component organization,+\nsmooth muscle cell apoptotic process,cell death,+\nsmooth muscle cell differentiation,morphogenesis/development,+\nsmooth muscle cell proliferation,cell cycle,+\nsmooth muscle tissue development,morphogenesis/development,+\nSNAP receptor activity,receptor related process,+\nSNARE binding,transport,+\nsno(s)RNA 3'-end processing,gene regulation,+\nsno(s)RNA processing,gene regulation,+\nsnoRNA binding,gene regulation,+\nsnRNA 3'-end processing,gene regulation,+\nsnRNA transcription,gene regulation,+\nsocial behavior,neural related process,+\nsodium ion homeostasis,other,+\nsodium ion transmembrane transport,transport,+\nsodium ion transport,transport,+\nsomatic diversification of immune receptors,immune system process,+\nsomatic hypermutation of immunoglobulin genes,immune system process,+\nsomatic recombination of immunoglobulin gene segments,immune system process,+\nsomite development,morphogenesis/development,+\nsomitogenesis,morphogenesis/development,+\nspecific granule,immune system process,+\nspectrin binding,cellular component organization,+\nsphingolipid catabolic process,metabolic process,+\nsphingolipid metabolic process,metabolic process,+\nspindle assembly,cell cycle,+\nspindle assembly checkpoint signaling,cell cycle,+\nspindle checkpoint signaling,cell cycle,+\nspindle elongation,cell cycle,+\nspindle localization,cell cycle,+\nspindle midzone assembly,cell cycle,+\nspindle organization,cell cycle,+\nspliceosomal complex,gene regulation,+\nspongiotrophoblast layer development,morphogenesis/development,+\nsprouting angiogenesis,morphogenesis/development,+\nSREBP signaling pathway,stress response,+\nstem cell development,morphogenesis/development,+\nstem cell differentiation,morphogenesis/development,+\nstem cell division,cell cycle,+\nstem cell population maintenance,morphogenesis/development,+\nstem cell proliferation,cell cycle,+\nsteroid binding,protein modification/signaling,+\nsteroid metabolic process,metabolic process,+\nsterol binding,other,+\nsterol biosynthetic process,metabolic process,+\nsterol homeostasis,other,+\nsterol transporter activity,transport,+\nstimulatory C-type lectin receptor signaling pathway,receptor related process,+\nstress-activated MAPK cascade,stress response,+\nstress-activated protein kinase signaling cascade,stress response,+\nstress fiber assembly,cellular component organization,+\nstress granule assembly,stress response,+\nstriated muscle cell differentiation,morphogenesis/development,+\nstriated muscle cell proliferation,cell cycle,+\nstriated muscle tissue development,morphogenesis/development,+\nstriatum development,morphogenesis/development,+\nstructural constituent of chromatin,cell cycle,+\nstructural constituent of cytoskeleton,cellular component organization,+\nstructural constituent of nuclear pore,cellular component organization,+\nsubstantia nigra development,morphogenesis/development,+\nsubstrate-dependent cell migration,response to stimulus,+\nsubstrate adhesion-dependent cell spreading,response to stimulus,+\nsulfur amino acid biosynthetic process,metabolic process,+\nsulfur amino acid metabolic process,metabolic process,+\nsulfur compound binding,other,+\nsulfur compound biosynthetic process,metabolic process,+\nsulfur compound catabolic process,metabolic process,+\nsulfur compound metabolic process,metabolic process,+\nsulfur compound transport,transport,+\nsuppression of viral release by host,viral related process,+\nsupramolecular fiber organization,cellular component organization,+\nsurfactant homeostasis,multicellular organismal process,+\nsymporter activity,transport,+\nsynapse assembly,neural related process,+\nsynapse organization,neural related process,+\n\"synaptic transmission, dopaminergic\",neural related process,+\n\"synaptic transmission, GABAergic\",neural related process,+\n\"synaptic transmission, glutamatergic\",neural related process,+\nsynaptic vesicle endocytosis,neural related process,+\nsynaptic vesicle exocytosis,neural related process,+\nsynaptic vesicle lumen acidification,neural related process,+\nsynaptic vesicle maturation,neural related process,+\nsynaptic vesicle transport,neural related process,+\nsyncytium formation,morphogenesis/development,+\nsyncytium formation by plasma membrane fusion,morphogenesis/development,+\nsyntaxin-1 binding,neural related process,+\nt-circle formation,cellular component organization,+\nT-helper 1 type immune response,immune system process,+\nT-helper 17 cell differentiation,immune system process,+\nT-helper 17 type immune response,immune system process,+\nT-helper cell differentiation,immune system process,+\nT cell activation,immune system process,+\nT cell activation involved in immune response,immune system process,+\nT cell apoptotic process,immune system process,+\nT cell chemotaxis,immune system process,+\nT cell costimulation,immune system process,+\nT cell cytokine production,immune system process,+\nT cell differentiation,immune system process,+\nT cell differentiation in thymus,immune system process,+\nT cell differentiation involved in immune response,immune system process,+\nT cell homeostasis,immune system process,+\nT cell mediated cytotoxicity,immune system process,+\nT cell mediated immunity,immune system process,+\nT cell migration,immune system process,+\nT cell proliferation,immune system process,+\nT cell receptor signaling pathway,immune system process,+\ntau-protein kinase activity,protein modification/signaling,+\ntau protein binding,protein modification/signaling,+\ntaxis,other,+\ntelencephalon development,morphogenesis/development,+\ntelomerase RNA binding,cell cycle,+\ntelomerase RNA localization,cell cycle,+\ntelomere capping,cell cycle,+\ntelomere maintenance,cell cycle,+\ntelomere maintenance in response to DNA damage,stress response,+\ntelomere maintenance via recombination,cell cycle,+\ntelomere organization,cell cycle,+\ntemperature homeostasis,response to stimulus,+\nterpenoid metabolic process,metabolic process,+\ntetrahydrofolate interconversion,metabolic process,+\ntetrapyrrole metabolic process,metabolic process,+\nthiolester hydrolase activity,metabolic process,+\nthrombin-activated receptor signaling pathway,receptor related process,+\nthymocyte apoptotic process,cell death,+\nthymus development,morphogenesis/development,+\ntight junction,cell adhesion,+\ntissue homeostasis,multicellular organismal process,+\ntissue migration,multicellular organismal process,+\ntissue morphogenesis,morphogenesis/development,+\ntissue regeneration,morphogenesis/development,+\ntissue remodeling,morphogenesis/development,+\ntolerance induction,immune system process,+\ntoll-like receptor 2 signaling pathway,immune system process,+\ntoll-like receptor 3 signaling pathway,immune system process,+\ntoll-like receptor 4 signaling pathway,immune system process,+\ntoll-like receptor 9 signaling pathway,immune system process,+\nToll-like receptor binding,immune system process,+\ntoll-like receptor signaling pathway,immune system process,+\ntonic smooth muscle contraction,multicellular organismal process,+\nTOR signaling,protein modification/signaling,+\ntrabecula formation,morphogenesis/development,+\ntrachea development,morphogenesis/development,+\ntrachea morphogenesis,morphogenesis/development,+\ntrans-Golgi network,ER/endosome/lysosome related process,+\ntranscription by RNA polymerase I,gene regulation,+\ntranscription by RNA polymerase II,gene regulation,+\ntranscription coactivator activity,gene regulation,+\ntranscription coactivator binding,gene regulation,+\ntranscription coregulator activity,gene regulation,+\ntranscription coregulator binding,gene regulation,+\ntranscription corepressor activity,gene regulation,+\ntranscription elongation by RNA polymerase II,gene regulation,+\ntranscription factor binding,gene regulation,+\ntranscription initiation-coupled chromatin remodeling,gene regulation,+\ntranscription initiation at RNA polymerase II promoter,gene regulation,+\ntranscription preinitiation complex assembly,gene regulation,+\ntranscription regulator complex,gene regulation,+\ntranscription repressor complex,gene regulation,+\ntranscytosis,transport,+\ntransepithelial transport,transport,+\n\"transferase activity, transferring alkyl or aryl (other than methyl) groups\",metabolic process,+\n\"transferase activity, transferring one-carbon groups\",metabolic process,+\n\"transferase activity, transferring phosphorus-containing groups\",protein modification/signaling,+\ntransferase complex,protein modification/signaling,+\n\"transferase complex, transferring phosphorus-containing groups\",protein modification/signaling,+\ntransforming growth factor beta production,immune system process,+\ntransforming growth factor beta receptor signaling pathway,immune system process,+\ntransition metal ion binding,other,+\ntransition metal ion transport,transport,+\n\"translation factor activity, RNA binding\",gene regulation,+\ntranslation regulator activity,gene regulation,+\n\"translation regulator activity, nucleic acid binding\",gene regulation,+\ntranslational initiation,gene regulation,+\ntranslational termination,gene regulation,+\ntransmembrane receptor protein kinase activity,receptor related process,+\ntransmembrane receptor protein phosphatase activity,receptor related process,+\ntransmembrane receptor protein serine/threonine kinase activity,receptor related process,+\ntransmembrane receptor protein serine/threonine kinase signaling pathway,protein modification/signaling,+\ntransmembrane receptor protein tyrosine kinase activator activity,receptor related process,+\ntransmembrane receptor protein tyrosine kinase activity,receptor related process,+\ntransmembrane receptor protein tyrosine kinase signaling pathway,receptor related process,+\ntransmembrane receptor protein tyrosine phosphatase activity,receptor related process,+\ntransmembrane transporter binding,transport,+\ntransmission of nerve impulse,neural related process,+\ntransport across blood-brain barrier,transport,+\ntransport of virus,viral related process,+\ntransport vesicle,transport,+\ntransporter activity,transport,+\ntricarboxylic acid cycle,metabolic process,+\ntricarboxylic acid metabolic process,metabolic process,+\ntriglyceride metabolic process,metabolic process,+\ntRNA-specific ribonuclease activity,gene regulation,+\ntRNA 5'-end processing,gene regulation,+\ntRNA 5'-leader removal,gene regulation,+\ntRNA aminoacylation,metabolic process,+\ntRNA aminoacylation for protein translation,metabolic process,+\ntRNA binding,gene regulation,+\ntRNA catabolic process,metabolic process,+\ntRNA metabolic process,metabolic process,+\ntRNA methylation,protein modification/signaling,+\ntRNA processing,gene regulation,+\n\"tRNA splicing, via endonucleolytic cleavage and ligation\",gene regulation,+\ntubulin binding,cellular component organization,+\ntubulin deacetylation,protein modification/signaling,+\ntumor necrosis factor-mediated signaling pathway,immune system process,+\ntumor necrosis factor production,immune system process,+\ntumor necrosis factor receptor binding,immune system process,+\ntumor necrosis factor receptor superfamily binding,receptor related process,+\ntumor necrosis factor superfamily cytokine production,immune system process,+\ntype 2 immune response,immune system process,+\ntype B pancreatic cell proliferation,cell cycle,+\ntype I interferon-mediated signaling pathway,immune system process,+\ntype I interferon production,immune system process,+\ntype II interferon-mediated signaling pathway,immune system process,+\ntype II interferon production,immune system process,+\ntyrosine phosphorylation of STAT protein,protein modification/signaling,+\nU12-type spliceosomal complex,gene regulation,+\nU2-type catalytic step 2 spliceosome,gene regulation,+\nU2-type precatalytic spliceosome,gene regulation,+\nU2-type prespliceosome assembly,gene regulation,+\nU2-type spliceosomal complex,gene regulation,+\nU3 snoRNA binding,gene regulation,+\nubiquitin-dependent ERAD pathway,ER/endosome/lysosome related process,+\nubiquitin-dependent protein catabolic process,metabolic process,+\nubiquitin-like protein binding,protein modification/signaling,+\nubiquitin-like protein conjugating enzyme activity,metabolic process,+\nubiquitin-like protein conjugating enzyme binding,protein modification/signaling,+\nubiquitin-like protein ligase binding,protein modification/signaling,+\nubiquitin-like protein transferase activity,protein modification/signaling,+\nubiquitin-specific protease binding,metabolic process,+\nubiquitin binding,protein modification/signaling,+\nubiquitin conjugating enzyme binding,protein modification/signaling,+\nubiquitin protein ligase activity,protein modification/signaling,+\nubiquitin protein ligase binding,protein modification/signaling,+\nubiquitin recycling,other,+\nUDP-glycosyltransferase activity,metabolic process,+\nUMP metabolic process,metabolic process,+\nunfolded protein binding,protein modification/signaling,+\nunsaturated fatty acid metabolic process,metabolic process,+\nureteric bud development,morphogenesis/development,+\nurogenital system development,morphogenesis/development,+\nuronic acid metabolic process,metabolic process,+\nuterus development,morphogenesis/development,+\nV(D)J recombination,immune system process,+\nvacuolar acidification,cellular component organization,+\nvacuolar membrane,cellular component organization,+\nvacuolar transport,transport,+\nvacuole organization,cellular component organization,+\nvascular associated smooth muscle cell proliferation,cell cycle,+\nvascular associated smooth muscle contraction,multicellular organismal process,+\nvascular endothelial growth factor production,gene regulation,+\nvascular endothelial growth factor receptor binding,receptor related process,+\nvascular endothelial growth factor receptor signaling pathway,receptor related process,+\nvascular endothelial growth factor signaling pathway,protein modification/signaling,+\nvascular process in circulatory system,multicellular organismal process,+\nvascular transport,transport,+\nvasculature development,morphogenesis/development,+\nvasculogenesis,morphogenesis/development,+\nventricular septum development,morphogenesis/development,+\nventricular septum morphogenesis,morphogenesis/development,+\nventricular system development,morphogenesis/development,+\nvesicle-mediated transport between endosomal compartments,ER/endosome/lysosome related process,+\nvesicle-mediated transport in synapse,transport,+\nvesicle-mediated transport to the plasma membrane,transport,+\nvesicle budding from membrane,viral related process,+\nvesicle localization,transport,+\nvesicle lumen,cellular component organization,+\nvesicle organization,cellular component organization,+\nvesicle tethering,transport,+\nviral entry into host cell,viral related process,+\nviral gene expression,viral related process,+\nviral genome replication,viral related process,+\nviral life cycle,viral related process,+\nviral process,viral related process,+\nviral protein processing,viral related process,+\nviral release from host cell,viral related process,+\nviral RNA genome replication,viral related process,+\nviral transcription,viral related process,+\nvirus receptor activity,viral related process,+\nvisual system development,morphogenesis/development,+\nvitamin B6 binding,metabolic process,+\nvitamin binding,metabolic process,+\nvitamin metabolic process,metabolic process,+\nvitamin transport,transport,+\nwater-soluble vitamin metabolic process,metabolic process,+\nwater transport,transport,+\nWnt signaling pathway,protein modification/signaling,+\n\"Wnt signaling pathway, calcium modulating pathway\",protein modification/signaling,+\nwound healing,immune system process,+\n\"wound healing, spreading of cells\",morphogenesis/development,+\n\"wound healing, spreading of epidermal cells\",morphogenesis/development,+\nxenobiotic export from cell,transport,+\nxenobiotic metabolic process,metabolic process,+\nxenobiotic transmembrane transport,transport,+\nxenobiotic transmembrane transporter activity,transport,+\nxenophagy,stress response,+\nzinc ion binding,other,+\nzymogen activation,protein modification/signaling,+\n'de novo' AMP biosynthetic process,metabolic process,0.894\n'de novo' CTP biosynthetic process,metabolic process,0.756\n'de novo' GDP-L-fucose biosynthetic process,metabolic process,0.858\n'de novo' IMP biosynthetic process,metabolic process,0.774\n'de novo' L-methionine biosynthetic process,metabolic process,0.964\n'de novo' NAD biosynthetic process,metabolic process,0.988\n'de novo' NAD biosynthetic process from tryptophan,metabolic process,0.888\n'de novo' UMP biosynthetic process,metabolic process,0.846\n'de novo' XMP biosynthetic process,metabolic process,0.892\n'de novo' actin filament nucleation,cellular component organization,0.382\n'de novo' cotranslational protein folding,cellular component organization,0.354\n'de novo' pyrimidine nucleobase biosynthetic process,metabolic process,0.792\n(1->3)-beta-D-glucan binding,metabolic process,0.232\n(3R)-3-hydroxydecanoyl-[acyl-carrier-protein] dehydratase activity,metabolic process,0.606\n(3R)-3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity,metabolic process,0.638\n(3R)-hydroxyacyl-CoA dehydrogenase (NAD) activity,metabolic process,0.932\n(3R)-hydroxyacyl-[acyl-carrier-protein] dehydratase activity,metabolic process,0.896\n(3R)-hydroxymyristoyl-[acyl-carrier-protein] dehydratase activity,metabolic process,0.624\n(3R)-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity,metabolic process,0.638\n(4S)-4-hydroxy-2-oxoglutarate aldolase activity,metabolic process,0.516\n(N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity,metabolic process,0.896\n(R)-2-hydroxyglutarate dehydrogenase activity,metabolic process,0.902\n(R)-3-amino-2-methylpropionate-pyruvate transaminase activity,metabolic process,0.896\n(R)-carnitine transmembrane transport,transport,0.27\n(R)-carnitine transmembrane transporter activity,transport,0.674\n(R)-carnitine transport,transport,0.932\n(R)-limonene 6-monooxygenase activity,metabolic process,0.932\n\"(R,R)-butanediol dehydrogenase activity\",metabolic process,0.928\n(S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido) succinate lyase (fumarate-forming) activity,metabolic process,0.872\n(S)-2-hydroxy-acid oxidase activity,metabolic process,0.894\n(S)-3-amino-2-methylpropionate transaminase activity,metabolic process,0.894\n(S)-citramalyl-CoA lyase activity,metabolic process,0.894\n(S)-limonene 6-monooxygenase activity,metabolic process,0.932\n(S)-limonene 7-monooxygenase activity,metabolic process,0.932\n\"1,2-diacylglycerol acylhydrolase activity\",metabolic process,0.912\n\"1,3-diacylglycerol acylhydrolase activity\",metabolic process,0.912\n\"1,4-alpha-glucan branching enzyme activity\",metabolic process,0.562\n\"1,4-alpha-glucan branching enzyme activity (using a glucosylated glycogenin as primer for glycogen synthesis)\",metabolic process,0.896\n\"1,4-alpha-oligoglucan phosphorylase activity\",metabolic process,0.854\n\"1,5-anhydro-D-fructose reductase activity\",metabolic process,0.934\n\"1,8-cineole 2-exo-monooxygenase activity\",metabolic process,0.932\n\"1-(4-iodo-2,5-dimethoxyphenyl)propan-2-amine binding\",receptor related process,0.476\n1-acyl-2-lysophosphatidylserine acylhydrolase activity,metabolic process,0.89\n1-acylglycerol-3-phosphate O-acyltransferase activity,metabolic process,0.888\n1-acylglycerophosphocholine O-acyltransferase activity,metabolic process,0.888\n1-acylglycerophosphoethanolamine O-acyltransferase activity,metabolic process,0.896\n1-acylglycerophosphoserine O-acyltransferase activity,metabolic process,0.548\n1-alkenyl-2-acylglycerol choline phosphotransferase activity,metabolic process,0.896\n1-alkenylglycerophosphocholine O-acyltransferase activity,metabolic process,0.898\n1-alkenylglycerophosphoethanolamine O-acyltransferase activity,metabolic process,0.894\n1-alkyl-2-acetylglycerophosphocholine esterase activity,metabolic process,0.896\n1-alkyl-2-acetylglycerophosphocholine esterase complex,metabolic process,0.378\n1-alkylglycerophosphocholine O-acetyltransferase activity,metabolic process,0.896\n1-alkylglycerophosphocholine O-acyltransferase activity,metabolic process,0.898\n\"1-alpha,25-dihydroxyvitamin D3 23-hydroxylase activity\",metabolic process,0.74\n\"1-alpha,25-dihydroxyvitamin D3 24-hydroxylase activity\",metabolic process,0.542\n\"1-phosphatidyl-1D-myo-inositol 3,5-bisphosphate metabolic process\",metabolic process,0.996\n\"1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate biosynthetic process\",metabolic process,0.886\n\"1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate metabolic process\",metabolic process,0.996\n1-phosphatidylinositol 4-kinase activity,metabolic process,0.796\n1-phosphatidylinositol binding,metabolic process,0.308\n1-phosphatidylinositol-3-kinase activity,metabolic process,0.75\n1-phosphatidylinositol-3-kinase regulator activity,metabolic process,0.346\n1-phosphatidylinositol-3-phosphate 5-kinase activity,metabolic process,0.79\n\"1-phosphatidylinositol-4,5-bisphosphate 3-kinase activity\",metabolic process,0.766\n1-phosphatidylinositol-4-phosphate 3-kinase activity,metabolic process,0.766\n1-phosphatidylinositol-4-phosphate 5-kinase activity,metabolic process,0.776\n1-phosphatidylinositol-5-kinase activity,metabolic process,0.79\n1-phosphatidylinositol-5-phosphate 4-kinase activity,metabolic process,0.786\n1-pyrroline dehydrogenase activity,metabolic process,0.93\n1-pyrroline-5-carboxylate dehydrogenase activity,metabolic process,0.308\n10-formyltetrahydrofolate biosynthetic process,metabolic process,0.89\n10-formyltetrahydrofolate catabolic process,metabolic process,0.88\n10-formyltetrahydrofolate metabolic process,metabolic process,0.964\n10-hydroxy-9-(phosphonooxy)octadecanoate phosphatase activity,metabolic process,0.848\n11-beta-hydroxysteroid dehydrogenase (NAD+) activity,metabolic process,0.928\n11-beta-hydroxysteroid dehydrogenase (NADP+) activity,metabolic process,0.934\n11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity,metabolic process,0.984\n11-cis retinal binding,metabolic process,0.238\n\"11-cis-retinal 3,4-desaturase activity\",metabolic process,0.924\n11-cis-retinol dehydrogenase,metabolic process,0.586\n11-cis-retinol dehydrogenase activity,metabolic process,0.934\n12-hydroxyheptadecatrienoic acid synthase activity,metabolic process,0.898\n13-lipoxin reductase activity,metabolic process,0.934\n13-prostaglandin reductase activity,metabolic process,0.926\n15-hydroxyprostaglandin dehydrogenase (NAD+) activity,metabolic process,0.918\n15-hydroxyprostaglandin dehydrogenase (NADP+) activity,metabolic process,0.934\n15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity,metabolic process,0.936\n15-oxoprostaglandin 13-oxidase activity,metabolic process,0.934\n16-hydroxypalmitate dehydrogenase activity,metabolic process,0.934\n\"17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity\",metabolic process,0.934\n17-alpha-hydroxyprogesterone aldolase activity,metabolic process,0.896\n17-beta-hydroxysteroid dehydrogenase (NADP+) activity,metabolic process,0.934\n17-beta-ketosteroid reductase activity,metabolic process,0.934\n17-hydroxyprogesterone 21-hydroxylase activity,metabolic process,0.924\n18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase activity,metabolic process,0.894\n18S rRNA aminocarboxypropyltransferase activity,metabolic process,0.894\n\"2',3'-cyclic GMP-AMP binding\",gene regulation,0.25\n\"2',3'-cyclic GMP-AMP synthase activity\",metabolic process,0.728\n\"2',3'-cyclic-nucleotide 2'-phosphodiesterase activity\",metabolic process,0.856\n\"2',3'-cyclic-nucleotide 3'-phosphodiesterase activity\",metabolic process,0.854\n2'-5'-oligoadenylate synthetase activity,metabolic process,0.55\n2'-deoxyadenosine deaminase activity,metabolic process,0.868\n2'-deoxyribonucleotide biosynthetic process,metabolic process,0.994\n\"2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity\",metabolic process,0.85\n\"2,3-dihydro-2,3-dihydroxybenzoate dehydrogenase activity\",metabolic process,0.928\n\"2,3-diketo-5-methylthiopentyl-1-phosphate enolase activity\",metabolic process,0.894\n\"2,4-dienoyl-CoA reductase (NADPH) activity\",metabolic process,0.934\n2-(3-amino-3-carboxypropyl)histidine synthase activity,metabolic process,0.844\n2-acylglycerol O-acyltransferase activity,metabolic process,0.89\n2-acylglycerol-3-phosphate O-acyltransferase activity,metabolic process,0.9\n2-acylglycerophosphocholine O-acyltransferase activity,metabolic process,0.894\n2-alkenal reductase (NADP+) activity,metabolic process,0.9\n2-alkenal reductase [NAD(P)+] activity,metabolic process,0.974\n2-aminoadipate transaminase activity,metabolic process,0.896\n\"2-decaprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity\",metabolic process,0.884\n2-hydroxy-3-keto-5-methylthiopentenyl-1-phosphate phosphatase activity,metabolic process,0.85\n2-hydroxy-ATP hydrolase activity,metabolic process,0.878\n2-hydroxy-dATP hydrolase activity,metabolic process,0.878\n2-hydroxyacyl-CoA lyase activity,metabolic process,0.868\n2-hydroxyacylsphingosine 1-beta-galactosyltransferase activity,metabolic process,0.896\n2-hydroxyglutarate dehydrogenase activity,metabolic process,0.93\n2-hydroxyphytanoyl-CoA lyase activity,metabolic process,0.896\n2-iminobutanoate deaminase activity,metabolic process,0.9\n2-iminobutanoate/2-iminopropanoate deaminase,metabolic process,0.504\n2-iminopropanoate deaminase activity,metabolic process,0.9\n2-methylacyl-CoA dehydrogenase activity,metabolic process,0.92\n\"2-octaprenyl-6-methoxy-1,4-benzoquinone methylase activity\",metabolic process,0.896\n2-octaprenyl-6-methoxyphenol hydroxylase activity,metabolic process,0.9\n2-oxobutyrate biosynthetic process,metabolic process,0.866\n2-oxobutyrate catabolic process,metabolic process,0.846\n2-oxobutyrate metabolic process,metabolic process,0.984\n2-oxoglutaramate amidase activity,metabolic process,0.9\n2-oxoglutarate-dependent dioxygenase activity,metabolic process,0.702\n\"2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity\",metabolic process,0.898\n20-aldehyde-leukotriene B4 20-monooxygenase activity,metabolic process,0.924\n20-hydroxy-leukotriene B4 omega oxidase activity,metabolic process,0.924\n23S rRNA (adenine(1618)-N(6))-methyltransferase activity,metabolic process,0.882\n24-hydroxycholesterol 7alpha-hydroxylase activity,metabolic process,0.92\n25-hydroxycholecalciferol-23-hydroxylase activity,metabolic process,0.924\n25-hydroxycholecalciferol-24-hydroxylase activity,metabolic process,0.53\n25-hydroxycholesterol 7alpha-hydroxylase activity,metabolic process,0.932\n27-hydroxycholesterol 7-alpha-monooxygenase activity,metabolic process,0.93\n\"3 iron, 4 sulfur cluster binding\",metabolic process,0.602\n3' overhang single-stranded DNA endodeoxyribonuclease activity,metabolic process,0.524\n\"3'(2'),5'-bisphosphate nucleotidase activity\",metabolic process,0.856\n\"3',5'-cyclic-AMP phosphodiesterase activity\",metabolic process,0.856\n\"3',5'-cyclic-GMP phosphodiesterase activity\",metabolic process,0.844\n\"3',5'-cyclic-nucleotide phosphodiesterase activity\",metabolic process,0.808\n\"3',5'-nucleotide bisphosphate phosphatase activity\",metabolic process,0.85\n3'-5' DNA/RNA helicase activity,transport,0.17\n3'-5' RNA helicase activity,gene regulation,0.366\n3'-5' exonuclease activity,cell cycle,0.55\n3'-5'-DNA exonuclease activity,cell cycle,0.486\n3'-UTR-mediated mRNA stabilization,gene regulation,0.336\n3'-flap endonuclease activity,metabolic process,0.234\n3'-flap-structured DNA binding,gene regulation,0.376\n3'-nucleotidase activity,metabolic process,0.852\n3'-phospho-5'-adenylyl sulfate transmembrane transport,transport,0.682\n3'-phosphoadenosine 5'-phosphosulfate binding,metabolic process,0.198\n3'-phosphoadenosine 5'-phosphosulfate biosynthetic process,metabolic process,0.758\n3'-phosphoadenosine 5'-phosphosulfate metabolic process,metabolic process,0.952\n3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity,cellular component organization,0.3\n3'-phosphoadenosine 5'-phosphosulfate transport,transport,0.868\n3'-tRNA processing endoribonuclease activity,metabolic process,0.402\n3'-tyrosyl-DNA phosphodiesterase activity,metabolic process,0.436\n\"3,4-dihydroxy-5-polyprenylbenzoic acid O-methyltransferase activity\",metabolic process,0.92\n\"3-alpha,7-alpha,12-alpha-trihydroxycholestan-26-al 26-oxidoreductase activity\",metabolic process,0.93\n3-beta-hydroxy-delta5-steroid dehydrogenase activity,metabolic process,0.928\n3-beta-hydroxysteroid dehydrogenase/C4-decarboxylase activity,metabolic process,0.928\n3-chloroallyl aldehyde dehydrogenase activity,metabolic process,0.9\n3-dehydrosphinganine reductase activity,metabolic process,0.934\n3-demethoxyubiquinol 3-hydroxylase activity,metabolic process,0.9\n3-demethylubiquinol-10 3-O-methyltransferase activity,metabolic process,0.896\n3-demethylubiquinol-n 3-O-methyltransferase activity,metabolic process,0.88\n3-demethylubiquinone-9 3-O-methyltransferase activity,metabolic process,0.838\n3-deoxyglucosone dehydrogenase activity,metabolic process,0.926\n3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity,metabolic process,0.896\n3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity,metabolic process,0.928\n3-hydroxyacyl-CoA dehydratase activity,metabolic process,0.902\n3-hydroxyacyl-CoA dehydrogenase activity,metabolic process,0.966\n\"3-hydroxyanthranilate 3,4-dioxygenase activity\",metabolic process,0.896\n3-hydroxybutyrate dehydrogenase activity,metabolic process,0.928\n3-hydroxyisobutyrate dehydrogenase activity,metabolic process,0.928\n3-hydroxyisobutyryl-CoA hydrolase activity,metabolic process,0.898\n3-hydroxykynureninase activity,metabolic process,0.898\n3-hydroxypropionyl-CoA dehydratase activity,metabolic process,0.888\n3-keto sterol reductase activity,metabolic process,0.904\n3-keto-sphinganine metabolic process,metabolic process,0.832\n3-mercaptopyruvate sulfurtransferase activity,metabolic process,0.896\n3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity,metabolic process,0.896\n\"3-methylcrotonyl-CoA carboxylase complex, mitochondrial\",cellular component organization,0.288\n3-oxo-5-alpha-steroid 4-dehydrogenase activity,metabolic process,0.9\n3-oxo-5alpha-steroid 4-dehydrogenase (NADP+),metabolic process,0.93\n3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity,metabolic process,0.674\n3-oxoacyl-[acyl-carrier-protein] synthase activity,metabolic process,0.594\n3-phosphoinositide-dependent protein kinase activity,metabolic process,0.602\n3-phosphoinositide-dependent protein kinase binding,protein modification/signaling,0.46\n\"3-sulfino-L-alanine: proton, glutamate antiporter activity\",metabolic process,0.516\n3M complex,cellular component organization,0.33\n\"3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity\",metabolic process,0.904\n\"3alpha,7alpha,12alpha-trihydroxy-5beta-cholestanoyl-CoA 24-hydroxylase activity\",metabolic process,0.906\n3beta-hydroxy-5beta-steroid dehydrogenase activity,metabolic process,0.934\n4-alpha-glucanotransferase activity,metabolic process,0.644\n4-alpha-hydroxytetrahydrobiopterin dehydratase activity,metabolic process,0.902\n4-aminobutyrate transaminase activity,metabolic process,0.882\n4-aminobutyrate transaminase complex,cellular component organization,0.272\n4-aminobutyrate:2-oxoglutarate transaminase activity,metabolic process,0.87\n4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase activity,metabolic process,0.882\n4-hydroxy-2-oxoglutarate aldolase activity,metabolic process,0.896\n4-hydroxy-3-all-trans-hexaprenylbenzoate oxygenase activity,metabolic process,0.39\n4-hydroxybenzoate decaprenyltransferase activity,metabolic process,0.874\n4-hydroxybenzoate nonaprenyltransferase activity,metabolic process,0.874\n4-hydroxybenzoate octaprenyltransferase activity,metabolic process,0.874\n4-hydroxybutyrate receptor activity,cellular component organization,0.174\n4-hydroxyphenylpyruvate dioxygenase activity,metabolic process,0.896\n4-hydroxyproline catabolic process,metabolic process,0.87\n4-hydroxyproline metabolic process,metabolic process,0.964\n4-nitrophenol 2-monooxygenase activity,metabolic process,0.93\n4-nitrophenol metabolic process,metabolic process,0.83\n4-oxoproline reductase activity,metabolic process,0.928\n4-trimethylammoniobutyraldehyde dehydrogenase activity,metabolic process,0.928\n4alpha-carboxy-4beta-methyl-5alpha-cholesta-8-en-3beta-ol:NAD(P)+ 3-oxidoreductase (decarboxylating) activity,metabolic process,0.936\n4alpha-carboxy-5alpha-cholesta-8-en-3beta-ol:NAD(P)+ 3-dehydrogenase (decarboxylating) activity,metabolic process,0.936\n5'-(N(7)-methyl 5'-triphosphoguanosine)-[mRNA] diphosphatase activity,metabolic process,0.802\n5'-(N(7)-methylguanosine 5'-triphospho)-[mRNA] hydrolase activity,metabolic process,0.81\n5'-3' DNA exonuclease activity,metabolic process,0.48\n5'-3' DNA helicase activity,cell cycle,0.184\n5'-3' DNA/RNA helicase activity,cellular component organization,0.182\n5'-3' RNA exonuclease activity,metabolic process,0.344\n5'-3' RNA helicase activity,gene regulation,0.358\n5'-3' RNA polymerase activity,metabolic process,0.48\n5'-3' exonuclease activity,metabolic process,0.544\n5'-adenylyl sulfate transmembrane transport,transport,0.674\n5'-deoxynucleotidase activity,metabolic process,0.526\n5'-deoxyribose-5-phosphate lyase activity,metabolic process,0.418\n5'-flap endonuclease activity,metabolic process,0.242\n5'-nucleotidase activity,metabolic process,0.806\n5'-tyrosyl-DNA phosphodiesterase activity,metabolic process,0.436\n\"5(S)-hydroxyperoxy-6E,8Z,11Z,14Z-icosatetraenoic acid binding\",metabolic process,0.416\n\"5,10-methylenetetrahydrofolate-dependent methyltransferase activity\",metabolic process,0.918\n5-amino-4-imidazole carboxylate lyase activity,metabolic process,0.882\n5-aminolevulinate synthase activity,metabolic process,0.894\n5-aminolevulinic acid import across plasma membrane,transport,0.448\n5-aminolevulinic acid transmembrane transporter activity,metabolic process,0.32\n5-formyltetrahydrofolate cyclo-ligase activity,metabolic process,0.752\n\"5-hydroxy-6E,8Z,11Z,14Z-icosatetraenoic acid binding\",metabolic process,0.416\n5-hydroxy-L-tryptophan decarboxylase activity,metabolic process,0.854\n5-methylcytosine catabolic process,metabolic process,0.818\n5-methylcytosine metabolic process,metabolic process,0.934\n5-methyltetrahydrofolate-dependent methyltransferase activity,metabolic process,0.88\n\"5-oxo-6E,8Z,11Z,14Z-icosatetraenoic acid binding\",metabolic process,0.416\n5-oxoprolinase (ATP-hydrolyzing) activity,metabolic process,0.762\n5-phosphoribose 1-diphosphate biosynthetic process,metabolic process,0.888\n5-phosphoribose 1-diphosphate metabolic process,metabolic process,0.96\n5.8S rRNA binding,gene regulation,0.512\n5S class rRNA transcription by RNA polymerase III,gene regulation,0.512\n5S rDNA binding,gene regulation,0.794\n5S rRNA binding,gene regulation,0.742\n\"5alpha-androstane-3beta,17beta-diol dehydrogenase activity\",metabolic process,0.938\n\"5beta-cholestane-3alpha,7alpha-diol 12alpha-hydroxylase activity\",metabolic process,0.932\n\"6,7-dihydropteridine reductase activity\",metabolic process,0.934\n6-phosphofructo-2-kinase activity,metabolic process,0.796\n\"6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex\",metabolic process,0.384\n6-phosphofructokinase activity,metabolic process,0.798\n6-phosphofructokinase complex,cellular component organization,0.288\n6-phosphogluconolactonase activity,metabolic process,0.9\n6-pyruvoyltetrahydropterin synthase activity,metabolic process,0.88\n\"7,8-dihydroneopterin 3'-triphosphate biosynthetic process\",metabolic process,0.89\n7-beta-hydroxysteroid dehydrogenase (NADP+) activity,metabolic process,0.934\n7-dehydrocholesterol reductase activity,metabolic process,0.934\n7-methylguanosine RNA capping,gene regulation,0.678\n7-methylguanosine cap hypermethylation,gene regulation,0.254\n7-methylguanosine mRNA capping,gene regulation,0.574\n7S RNA binding,gene regulation,0.398\n7SK snRNA binding,gene regulation,0.572\n7SK snRNP,gene regulation,0.49\n7alpha-hydroxycholest-4-en-3-one 12alpha-hydroxylase activity,metabolic process,0.932\n8-hydroxy-2'-deoxyguanosine DNA binding,metabolic process,0.25\n8-hydroxy-dADP phosphatase activity,metabolic process,0.852\n\"8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity\",metabolic process,0.55\n\"8-oxo-7,8-dihydroguanine DNA N-glycosylase activity\",metabolic process,0.56\n\"8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity\",metabolic process,0.688\n8-oxo-GDP phosphatase activity,metabolic process,0.852\n8-oxo-dGDP phosphatase activity,metabolic process,0.852\n9+0 motile cilium,cellular component organization,0.392\n9+0 non-motile cilium,cellular component organization,0.56\n9+2 motile cilium,cellular component organization,0.526\n9+2 non-motile cilium,cellular component organization,0.622\n\"9,10 (9', 10')-carotenoid-cleaving dioxygenase activity\",metabolic process,0.576\n9-cis-retinoic acid biosynthetic process,metabolic process,0.892\n9-cis-retinoic acid metabolic process,metabolic process,0.954\n90S preribosome,cellular component organization,0.384\n90S preribosome assembly,gene regulation,0.41\nA axonemal microtubule,cellular component organization,0.306\nA band,cellular component organization,0.356\nA-type (transient outward) potassium channel activity,cellular component organization,0.226\nA1 adenosine receptor binding,receptor related process,0.494\nA2A adenosine receptor binding,receptor related process,0.484\nABC-type bile acid transporter activity,metabolic process,0.48\nABC-type fatty-acyl-CoA transporter activity,metabolic process,0.778\nABC-type glutathione S-conjugate transporter activity,metabolic process,0.742\nABC-type heme transporter activity,metabolic process,0.762\nABC-type iron-sulfur cluster transporter activity,metabolic process,0.762\nABC-type manganese transporter activity,metabolic process,0.482\nABC-type oligopeptide transporter activity,metabolic process,0.762\nABC-type peptide antigen transporter activity,metabolic process,0.738\nABC-type peptide transporter activity,metabolic process,0.394\nABC-type polyamine transporter activity,metabolic process,0.44\nABC-type putrescine transporter activity,metabolic process,0.762\nABC-type sterol transporter activity,metabolic process,0.468\nABC-type transporter activity,transport,0.474\nABC-type vitamin B12 transporter activity,metabolic process,0.486\nABC-type xenobiotic transporter activity,metabolic process,0.434\nACF complex,gene regulation,0.54\nACP phosphopantetheine attachment site binding,protein modification/signaling,0.368\nADP biosynthetic process,metabolic process,0.87\nADP catabolic process,metabolic process,0.874\nADP phosphatase activity,metabolic process,0.806\nADP transmembrane transporter activity,transport,0.702\nADP transport,transport,0.9\nADP-D-ribose binding,metabolic process,0.31\nADP-D-ribose modification-dependent protein binding,protein modification/signaling,0.652\nADP-ribose diphosphatase activity,metabolic process,0.902\nADP-ribosyl cyclase activity,metabolic process,0.812\nADP-ribosylarginine hydrolase activity,metabolic process,0.9\nADP-ribosylglutamate hydrolase activity,metabolic process,0.9\nADP-ribosylserine hydrolase activity,metabolic process,0.9\nADP-specific glucokinase activity,metabolic process,0.854\nADP-sugar diphosphatase activity,metabolic process,0.904\nADP:inorganic phosphate antiporter activity,metabolic process,0.502\nAF-1 domain binding,receptor related process,0.414\nAF-2 domain binding,protein modification/signaling,0.318\nAIM2 inflammasome complex,cellular component organization,0.23\nAIM2 inflammasome complex assembly,cellular component organization,0.672\nAIP1-IRE1 complex,protein modification/signaling,0.418\nAMP biosynthetic process,metabolic process,0.994\nAMP catabolic process,metabolic process,0.886\nAMP deaminase activity,metabolic process,0.9\nAMP metabolic process,metabolic process,0.986\nAMP phosphorylation,metabolic process,0.332\nAMP salvage,metabolic process,0.852\nAMP transmembrane transporter activity,metabolic process,0.282\nAMP transport,transport,0.736\nAMP-activated protein kinase activity,metabolic process,0.57\nAMPA glutamate receptor activity,receptor related process,0.332\nAMPA glutamate receptor clustering,cellular component organization,0.218\nAMPA glutamate receptor complex,cellular component organization,0.206\nAMPA selective glutamate receptor signaling pathway,receptor related process,0.462\nANPR-A receptor complex,receptor related process,0.236\nAP-1 adaptor complex,cellular component organization,0.366\nAP-1 adaptor complex binding,gene regulation,0.272\nAP-2 adaptor complex,cellular component organization,0.286\nAP-2 adaptor complex binding,gene regulation,0.262\nAP-3 adaptor complex,cellular component organization,0.326\nAP-3 adaptor complex binding,gene regulation,0.284\nAP-4 adaptor complex,cellular component organization,0.518\nAP-5 adaptor complex,cellular component organization,0.52\nAP-type membrane coat adaptor complex,cellular component organization,0.328\nARF protein signal transduction,protein modification/signaling,0.482\nASAP complex,gene regulation,0.446\nASTRA complex,cellular component organization,0.362\nATAC complex,gene regulation,0.268\nATF1-ATF4 transcription factor complex,gene regulation,0.206\nATF4-CREB1 transcription factor complex,gene regulation,0.292\nATF6-mediated unfolded protein response,stress response,0.294\nATP adenylyltransferase activity,metabolic process,0.752\nATP binding,metabolic process,0.492\nATP citrate synthase activity,metabolic process,0.748\nATP diphosphatase activity,metabolic process,0.832\nATP export,transport,0.418\nATP generation from poly-ADP-D-ribose,morphogenesis/development,0.2\nATP transmembrane transporter activity,transport,0.71\nATP transport,transport,0.902\nATP-activated inward rectifier potassium channel activity,metabolic process,0.228\nATP-binding cassette (ABC) transporter complex,transport,0.364\nATP-dependent DNA/DNA annealing activity,cellular component organization,0.218\nATP-dependent FeS chaperone activity,protein modification/signaling,0.26\nATP-dependent H2AZ histone chaperone activity,gene regulation,0.21\nATP-dependent NAD(P)H-hydrate dehydratase activity,metabolic process,0.768\n\"ATP-dependent activity, acting on DNA\",cell cycle,0.414\nATP-dependent diacylglycerol kinase activity,metabolic process,0.794\nATP-dependent histone chaperone activity,protein modification/signaling,0.288\nATP-dependent peptidase activity,metabolic process,0.482\nATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity,metabolic process,0.772\nATP-dependent polynucleotide 5'-hydroxyl-kinase activity,metabolic process,0.602\nATP-dependent polyribonucleotide 5'-hydroxyl-kinase activity,metabolic process,0.794\nATP-dependent protein binding,protein modification/signaling,0.378\nATP-dependent protein disaggregase activity,protein modification/signaling,0.324\nATP-dependent protein folding chaperone,protein modification/signaling,0.384\nATP-dependent protein-DNA unloader activity,cell cycle,0.18\nATP-gated ion channel activity,transport,0.38\nATP:ADP antiporter activity,metabolic process,0.872\nATP:inorganic phosphate antiporter activity,metabolic process,0.496\nATPase activator activity,protein modification/signaling,0.388\n\"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism\",transport,0.494\nATPase complex,gene regulation,0.302\nATPase dependent transmembrane transport complex,transport,0.448\nATPase inhibitor activity,gene regulation,0.302\nATPase inhibitor complex,cellular component organization,0.23\nATPase-coupled carboxylic acid transmembrane transporter activity,transport,0.538\nATPase-coupled inorganic anion transmembrane transporter activity,transport,0.456\nATPase-coupled intramembrane lipid transporter activity,transport,0.448\nATPase-coupled ion transmembrane transporter activity,transport,0.474\nATPase-coupled lipid transmembrane transporter activity,transport,0.494\nATPase-coupled monoatomic cation transmembrane transporter activity,transport,0.486\nATPase-coupled monocarboxylic acid transmembrane transporter activity,transport,0.544\nATPase-coupled organic acid transmembrane transporter activity,transport,0.522\nATPase-coupled transmembrane transporter activity,transport,0.484\nATR-ATRIP complex,protein modification/signaling,0.426\nAV node cell action potential,cellular component organization,0.21\nAV node cell to bundle of His cell communication,cell cycle,0.156\nAV node cell to bundle of His cell communication by electrical coupling,protein modification/signaling,0.346\nAV node cell to bundle of His cell signaling,cellular component organization,0.17\nAV node cell-bundle of His cell adhesion involved in cell communication,cell adhesion,0.31\nAc-Asp-Glu binding,metabolic process,0.232\nAla-tRNA(Thr) hydrolase activity,metabolic process,0.544\nAnxA2-p11 complex,protein modification/signaling,0.356\nArp2/3 complex binding,protein modification/signaling,0.334\nArp2/3 complex-mediated actin nucleation,cellular component organization,0.458\nArp2/3 protein complex,cellular component organization,0.38\nAtg1/ULK1 kinase complex,protein modification/signaling,0.378\nAtg12 activating enzyme activity,metabolic process,0.402\nAtg12 transferase activity,metabolic process,0.59\nAtg12-Atg5-Atg16 complex,cellular component organization,0.362\nAtg8 activating enzyme activity,metabolic process,0.402\nAtg8-family ligase activity,metabolic process,0.298\nB cell activation,immune system process,0.898\nB cell activation involved in immune response,immune system process,0.87\nB cell adhesion,cell adhesion,0.286\nB cell affinity maturation,immune system process,0.242\nB cell antigen processing and presentation,immune system process,0.722\nB cell apoptotic process,immune system process,0.586\nB cell chemotaxis,immune system process,0.712\nB cell costimulation,receptor related process,0.318\nB cell cytokine production,immune system process,0.58\nB cell homeostatic proliferation,cell cycle,0.244\nB cell lineage commitment,morphogenesis/development,0.452\nB cell mediated immunity,immune system process,0.944\nB cell negative selection,immune system process,0.46\nB cell proliferation involved in immune response,cell cycle,0.356\nB cell receptor apoptotic signaling pathway,cell death,0.49\nB cell receptor complex,immune system process,0.242\nB cell receptor signaling pathway,immune system process,0.782\nB cell receptor transport into membrane raft,transport,0.584\nB cell receptor transport within lipid bilayer,transport,0.614\nB cell selection,immune system process,0.524\nB cell tolerance induction,immune system process,0.566\nB-1 B cell differentiation,immune system process,0.756\nB-1 B cell homeostasis,immune system process,0.474\nB-1 B cell lineage commitment,immune system process,0.19\nB-1a B cell differentiation,morphogenesis/development,0.384\nB-WICH complex,gene regulation,0.612\nBAD-BCL-2 complex,protein modification/signaling,0.29\nBAK complex,protein modification/signaling,0.294\nBAT3 complex,ER/endosome/lysosome related process,0.322\nBAT3 complex binding,metabolic process,0.344\nBAX complex,protein modification/signaling,0.294\nBBSome,cellular component organization,0.348\nBBSome binding,metabolic process,0.232\nBCOR complex,gene regulation,0.326\nBH domain binding,protein modification/signaling,0.344\nBH3 domain binding,protein modification/signaling,0.264\nBIM-BCL-2 complex,protein modification/signaling,0.288\nBIM-BCL-xl complex,protein modification/signaling,0.288\nBLOC complex,cellular component organization,0.354\nBLOC-1 complex,cellular component organization,0.368\nBLOC-2 complex,cellular component organization,0.338\nBLOC-2 complex binding,cellular component organization,0.294\nBLOC-3 complex,cellular component organization,0.336\nBMP binding,protein modification/signaling,0.314\nBMP receptor activity,protein modification/signaling,0.224\nBMP receptor binding,receptor related process,0.406\nBMP receptor complex,protein modification/signaling,0.246\nBORC complex,cellular component organization,0.276\nBRCA1-A complex,gene regulation,0.222\nBRCA1-B complex,cell cycle,0.226\nBRCA1-BARD1 complex,cellular component organization,0.252\nBRCA1-C complex,cell cycle,0.238\nBRCA2-MAGE-D1 complex,protein modification/signaling,0.308\nBRE binding,gene regulation,0.518\nBRISC complex,protein modification/signaling,0.302\nBarr body,cellular component organization,0.3\nBcl-2 family protein complex,protein modification/signaling,0.19\nBcl3-Bcl10 complex,protein modification/signaling,0.306\nBcl3/NF-kappaB2 complex,gene regulation,0.216\nBergmann glial cell differentiation,morphogenesis/development,0.398\nC zone,protein modification/signaling,0.258\nC-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity,metabolic process,0.934\nC-4 methylsterol oxidase activity,metabolic process,0.898\nC-5 methylation of cytosine,metabolic process,0.334\nC-5 sterol desaturase activity,metabolic process,0.932\nC-8 sterol isomerase activity,metabolic process,0.882\nC-C chemokine binding,protein modification/signaling,0.284\nC-C chemokine receptor CCR7 signaling pathway,receptor related process,0.726\nC-C chemokine receptor activity,receptor related process,0.358\nC-C motif chemokine 19 receptor activity,receptor related process,0.204\nC-C motif chemokine 21 receptor activity,receptor related process,0.212\nC-X-C chemokine binding,protein modification/signaling,0.34\nC-X-C chemokine receptor CXCR4 signaling pathway,receptor related process,0.73\nC-X-C chemokine receptor activity,receptor related process,0.368\nC-X-C motif chemokine 12 receptor activity,receptor related process,0.206\nC-X3-C chemokine binding,metabolic process,0.252\nC-X3-C chemokine receptor activity,receptor related process,0.17\nC-acetyltransferase activity,metabolic process,0.876\nC-fiber,cellular component organization,0.184\nC-methyltransferase activity,metabolic process,0.928\nC-palmitoyltransferase activity,metabolic process,0.946\nC-rich single-stranded DNA binding,metabolic process,0.21\nC-terminal protein amino acid modification,protein modification/signaling,0.71\nC-terminal protein deglutamylation,protein modification/signaling,0.566\nC-terminal protein lipidation,protein modification/signaling,0.654\nC-terminal protein methylation,protein modification/signaling,0.356\nC/EBP complex,immune system process,0.308\nC21-steroid hormone biosynthetic process,metabolic process,0.954\nC21-steroid hormone metabolic process,metabolic process,0.972\nC2H2 zinc finger domain binding,protein modification/signaling,0.252\nC3HC4-type RING finger domain binding,protein modification/signaling,0.418\nC4-dicarboxylate transport,transport,0.958\nC5L2 anaphylatoxin chemotactic receptor binding,receptor related process,0.502\nC5a anaphylatoxin chemotactic receptor binding,receptor related process,0.49\nCA3 pyramidal cell dendrite,cellular component organization,0.22\nCAAX-box protein maturation,protein modification/signaling,0.476\nCAAX-box protein processing,protein modification/signaling,0.394\nCAAX-protein geranylgeranyltransferase activity,metabolic process,0.492\nCAAX-protein geranylgeranyltransferase complex,cellular component organization,0.328\nCAF-1 complex,cellular component organization,0.336\nCAK-ERCC2 complex,protein modification/signaling,0.478\nCAMKK-AMPK signaling cascade,protein modification/signaling,0.49\nCARD domain binding,protein modification/signaling,0.224\nCARD8 inflammasome complex assembly,cellular component organization,0.69\nCAT tailing,cellular component organization,0.29\nCBM complex,protein modification/signaling,0.516\nCCA tRNA nucleotidyltransferase activity,metabolic process,0.598\nCCAAT-binding factor complex,gene regulation,0.448\nCCACCA tRNA nucleotidyltransferase activity,metabolic process,0.784\nCCR1 chemokine receptor binding,receptor related process,0.458\nCCR10 chemokine receptor binding,receptor related process,0.458\nCCR2 chemokine receptor binding,receptor related process,0.45\nCCR3 chemokine receptor binding,receptor related process,0.484\nCCR4 chemokine receptor binding,receptor related process,0.484\nCCR4-NOT complex,gene regulation,0.372\nCCR4-NOT complex binding,metabolic process,0.224\nCCR4-NOT core complex,cellular component organization,0.302\nCCR5 chemokine receptor binding,receptor related process,0.454\nCCR6 chemokine receptor binding,receptor related process,0.48\nCCR7 chemokine receptor binding,receptor related process,0.468\nCD24 biosynthetic process,metabolic process,0.548\nCD27 receptor binding,receptor related process,0.41\nCD4 biosynthetic process,metabolic process,0.768\nCD4 receptor binding,receptor related process,0.4\n\"CD4-positive or CD8-positive, alpha-beta T cell lineage commitment\",immune system process,0.43\n\"CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation\",immune system process,0.874\n\"CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response\",immune system process,0.508\n\"CD4-positive, CD25-positive, alpha-beta regulatory T cell lineage commitment\",immune system process,0.336\n\"CD4-positive, alpha-beta T cell costimulation\",receptor related process,0.302\n\"CD4-positive, alpha-beta T cell cytokine production\",immune system process,0.912\n\"CD4-positive, alpha-beta T cell lineage commitment\",immune system process,0.438\n\"CD4-positive, alpha-beta T cell proliferation\",immune system process,0.872\nCD40 receptor binding,receptor related process,0.494\nCD40 receptor complex,receptor related process,0.34\nCD40 signaling pathway,receptor related process,0.526\nCD8 receptor binding,receptor related process,0.466\n\"CD8-positive, alpha-beta T cell activation\",immune system process,0.83\n\"CD8-positive, alpha-beta T cell differentiation\",immune system process,0.756\n\"CD8-positive, alpha-beta T cell differentiation involved in immune response\",immune system process,0.558\n\"CD8-positive, alpha-beta T cell extravasation\",immune system process,0.762\n\"CD8-positive, alpha-beta T cell lineage commitment\",immune system process,0.208\n\"CD8-positive, alpha-beta T cell proliferation\",immune system process,0.798\n\"CD8-positive, alpha-beta cytotoxic T cell extravasation\",morphogenesis/development,0.204\n\"CD8-positive, alpha-beta intraepithelial T cell differentiation\",morphogenesis/development,0.468\n\"CD8-positive, gamma-delta intraepithelial T cell differentiation\",morphogenesis/development,0.474\nCD80 biosynthetic process,metabolic process,0.556\nCD86 biosynthetic process,metabolic process,0.574\nCD95 death-inducing signaling complex,receptor related process,0.348\nCDP biosynthetic process,metabolic process,0.888\nCDP metabolic process,metabolic process,0.998\nCDP phosphatase activity,metabolic process,0.85\nCDP-alcohol phosphatidyltransferase activity,metabolic process,0.852\nCDP-choline pathway,metabolic process,0.304\nCDP-diacylglycerol biosynthetic process,metabolic process,0.85\nCDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase activity,metabolic process,0.896\nCDP-diacylglycerol-inositol 3-phosphatidyltransferase activity,metabolic process,0.896\nCDP-diacylglycerol-serine O-phosphatidyltransferase activity,metabolic process,0.896\nCDP-glycerol diphosphatase activity,metabolic process,0.9\nCENP-A containing chromatin,cellular component organization,0.394\nCENP-A containing chromatin assembly,cellular component organization,0.238\nCENP-A containing nucleosome,cellular component organization,0.206\nCERF complex,gene regulation,0.622\nCGRP receptor complex,receptor related process,0.426\nCH domain binding,protein modification/signaling,0.518\nCHD-type complex,gene regulation,0.358\nCHOP-ATF3 complex,protein modification/signaling,0.274\nCHOP-ATF4 complex,gene regulation,0.256\nCHOP-C/EBP complex,gene regulation,0.242\nCHRAC,gene regulation,0.572\nCIA complex,cellular component organization,0.312\nCLOCK-BMAL transcription complex,gene regulation,0.404\nCMG complex,cell cycle,0.228\nCMP biosynthetic process,metabolic process,0.998\nCMP catabolic process,metabolic process,0.894\nCMP kinase activity,metabolic process,0.796\nCMP metabolic process,metabolic process,1\nCMP-N-acetylneuraminate biosynthetic process,metabolic process,0.87\nCMP-N-acetylneuraminate metabolic process,metabolic process,0.942\nCMP-N-acetylneuraminate transmembrane transport,transport,0.73\nCMP-N-acetylneuraminate transmembrane transporter activity,cellular component organization,0.278\nCNTFR-CLCF1 complex,immune system process,0.258\nCOP9 signalosome,cellular component organization,0.328\nCOP9 signalosome assembly,cellular component organization,0.626\nCOPI coating of Golgi vesicle,cellular component organization,0.562\nCOPI vesicle coat,cellular component organization,0.41\nCOPI-coated Golgi to ER transport vesicle,ER/endosome/lysosome related process,0.33\nCOPI-coated vesicle,cellular component organization,0.432\nCOPI-coated vesicle budding,cellular component organization,0.286\nCOPI-coated vesicle membrane,cellular component organization,0.616\nCOPII receptor activity,receptor related process,0.206\nCOPII vesicle coat,cellular component organization,0.262\nCOPII vesicle coating,transport,0.268\nCOPII-coated vesicle cargo loading,transport,0.202\nCORVET complex,cellular component organization,0.318\nCP2 mannose-ethanolamine phosphotransferase activity,metabolic process,0.826\nCRD-mediated mRNA stability complex,gene regulation,0.388\nCRD-mediated mRNA stabilization,gene regulation,0.362\nCRLF-CLCF1 complex,immune system process,0.3\nCSF1-CSF1R complex,receptor related process,0.33\nCST complex,cellular component organization,0.244\nCTP binding,metabolic process,0.23\nCTP biosynthetic process,metabolic process,1\nCTP catabolic process,metabolic process,0.892\nCTP metabolic process,metabolic process,1\nCTP salvage,cellular component organization,0.218\nCTP synthase activity,metabolic process,0.75\nCTPase activity,metabolic process,0.798\nCURI complex,gene regulation,0.356\nCUT catabolic process,metabolic process,0.758\nCUT metabolic process,metabolic process,0.7\nCX3C chemokine receptor binding,receptor related process,0.468\nCXCL12-activated CXCR4 signaling pathway,receptor related process,0.58\nCXCR1 chemokine receptor binding,receptor related process,0.49\nCXCR3 chemokine receptor binding,receptor related process,0.446\nCXCR4 chemokine receptor binding,receptor related process,0.492\nCXCR5 chemokine receptor binding,receptor related process,0.48\nCajal body,gene regulation,0.46\nCajal body organization,cellular component organization,0.52\nCajal-Retzius cell differentiation,morphogenesis/development,0.34\nCatSper complex,cellular component organization,0.244\nCdc42 protein signal transduction,protein modification/signaling,0.466\nCdc73/Paf1 complex,gene regulation,0.682\nCoA carboxylase activity,metabolic process,0.726\nCoA hydrolase activity,metabolic process,0.846\nCoA pyrophosphatase activity,metabolic process,0.88\nCoA-transferase activity,metabolic process,0.924\nCry-Per complex,gene regulation,0.382\nCtf18 RFC-like complex,cell cycle,0.33\nCul2-RING ubiquitin ligase complex,protein modification/signaling,0.348\nCul3-RING ubiquitin ligase complex,protein modification/signaling,0.372\nCul4-RING E3 ubiquitin ligase complex,metabolic process,0.296\nCul4A-RING E3 ubiquitin ligase complex,protein modification/signaling,0.364\nCul4B-RING E3 ubiquitin ligase complex,cellular component organization,0.244\nCul5-RING ubiquitin ligase complex,protein modification/signaling,0.36\nCul7-RING ubiquitin ligase complex,protein modification/signaling,0.36\nD-alanine catabolic process,metabolic process,0.88\nD-alanine metabolic process,metabolic process,0.994\nD-alanine transport,transport,0.706\nD-amino acid biosynthetic process,metabolic process,0.996\nD-amino acid catabolic process,metabolic process,0.992\nD-amino acid metabolic process,metabolic process,0.994\nD-amino acid transmembrane transporter activity,transport,0.784\nD-amino acid transport,transport,0.926\nD-amino-acid oxidase activity,metabolic process,0.898\nD-aminoacyl-tRNA deacylase activity,metabolic process,0.606\nD-aspartate import across plasma membrane,transport,0.304\nD-aspartate oxidase activity,metabolic process,0.9\nD-aspartate transmembrane transporter activity,cellular component organization,0.274\nD-aspartate transport,transport,0.948\nD-dopachrome decarboxylase activity,metabolic process,0.896\nD-erythro-sphingosine kinase activity,metabolic process,0.792\nD-gluconate catabolic process,metabolic process,0.896\nD-gluconate metabolic process,metabolic process,0.982\nD-glucose transmembrane transporter activity,transport,0.676\nD-glucuronate catabolic process,metabolic process,0.86\nD-glucuronate metabolic process,metabolic process,0.98\nD-glucuronate transmembrane transport,transport,0.282\nD-glucuronate transmembrane transporter activity,cellular component organization,0.302\nD-glutamate cyclase activity,metabolic process,0.9\nD-lactate dehydrogenase (cytochrome) activity,metabolic process,0.896\nD-lactate dehydrogenase activity,metabolic process,0.928\nD-loop DNA binding,gene regulation,0.538\nD-ribitol-5-phosphate cytidylyltransferase activity,metabolic process,0.874\nD-ribose catabolic process,metabolic process,0.892\nD-ribose metabolic process,metabolic process,0.974\nD-ribulokinase activity,metabolic process,0.796\nD-ribulose-phosphate 3-epimerase activity,metabolic process,0.896\nD-serine ammonia-lyase activity,metabolic process,0.896\nD-serine biosynthetic process,metabolic process,0.886\nD-serine catabolic process,metabolic process,0.902\nD-serine metabolic process,metabolic process,0.998\nD-serine transport,transport,0.706\nD-sorbitol dehydrogenase (acceptor) activity,metabolic process,0.902\nD-tyrosyl-tRNA(Tyr) deacylase activity,metabolic process,0.692\nD-xylose 1-dehydrogenase (NADP+) activity,metabolic process,0.934\nD-xylose catabolic process,metabolic process,0.986\nD-xylose metabolic process,metabolic process,0.988\nD-xylulose reductase activity,metabolic process,0.928\nD1 dopamine receptor binding,receptor related process,0.486\nD2 dopamine receptor binding,receptor related process,0.496\nD3 dopamine receptor binding,receptor related process,0.5\nD3 vitamins binding,metabolic process,0.336\nD4 dopamine receptor binding,receptor related process,0.502\nD5 dopamine receptor binding,receptor related process,0.496\nDAPK1-calmodulin complex,protein modification/signaling,0.268\nDBIRD complex,gene regulation,0.5\nDCT cell differentiation,morphogenesis/development,0.932\nDEAD/H-box RNA helicase binding,gene regulation,0.504\nDH domain binding,cellular component organization,0.264\nDN2 thymocyte differentiation,morphogenesis/development,0.644\nDN3 thymocyte differentiation,morphogenesis/development,0.68\nDN4 thymocyte differentiation,morphogenesis/development,0.674\nDNA (cytosine-5-)-methyltransferase activity,metabolic process,0.664\n\"DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates\",metabolic process,0.728\nDNA 5'-adenosine monophosphate hydrolase activity,metabolic process,0.632\nDNA ADP-ribosylation,protein modification/signaling,0.228\nDNA N-glycosylase activity,metabolic process,0.536\nDNA alkylation,gene regulation,0.57\nDNA binding,gene regulation,0.63\nDNA binding domain binding,protein modification/signaling,0.314\n\"DNA binding, bending\",gene regulation,0.546\nDNA catabolic process,metabolic process,0.39\nDNA clamp loader activity,cellular component organization,0.34\nDNA clamp unloader activity,cellular component organization,0.324\nDNA clamp unloading,cellular component organization,0.252\nDNA cytosine deamination,protein modification/signaling,0.328\n\"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest\",cell cycle,0.418\n\"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator\",protein modification/signaling,0.198\nDNA damage sensor activity,stress response,0.332\nDNA dealkylation involved in DNA repair,metabolic process,0.262\nDNA deamination,gene regulation,0.496\nDNA demethylase activity,metabolic process,0.532\nDNA demethylation,gene regulation,0.706\nDNA double-strand break attachment to nuclear envelope,cell cycle,0.194\nDNA double-strand break processing involved in repair via single-strand annealing,cell cycle,0.172\nDNA end binding,cell cycle,0.198\nDNA endonuclease activity,metabolic process,0.54\n\"DNA endonuclease activity, producing 3'-phosphomonoesters\",metabolic process,0.604\nDNA endoreduplication,cell cycle,0.332\n\"DNA exonuclease activity, producing 5'-phosphomonoesters\",cell cycle,0.472\nDNA hairpin binding,gene regulation,0.19\nDNA helicase activity,cell cycle,0.548\nDNA insertion or deletion binding,gene regulation,0.546\nDNA ligase (ATP) activity,metabolic process,0.82\nDNA ligase III-XRCC1 complex,protein modification/signaling,0.214\nDNA ligase IV complex,gene regulation,0.218\nDNA ligase activity,metabolic process,0.554\nDNA ligation involved in DNA recombination,cell cycle,0.25\nDNA ligation involved in DNA repair,cell cycle,0.438\nDNA metabolic process,cell cycle,0.51\nDNA methylation,gene regulation,0.56\nDNA methylation on adenine,metabolic process,0.374\nDNA methylation on cytosine,gene regulation,0.476\nDNA methylation on cytosine within a CG sequence,metabolic process,0.296\nDNA nuclease activity,metabolic process,0.492\nDNA nucleotidylexotransferase activity,metabolic process,0.858\nDNA polymerase III complex,cellular component organization,0.268\nDNA polymerase activity,metabolic process,0.508\nDNA polymerase complex,metabolic process,0.284\nDNA polymerase processivity factor activity,cell cycle,0.258\nDNA polymerase processivity factor complex,gene regulation,0.198\nDNA primase activity,gene regulation,0.348\nDNA protection,metabolic process,0.248\nDNA recombinase assembly,cellular component organization,0.754\nDNA recombinase auxiliary factor complex,protein modification/signaling,0.306\nDNA recombinase complex,cellular component organization,0.252\nDNA recombinase mediator complex,gene regulation,0.224\nDNA repair complex,metabolic process,0.178\nDNA repair complex assembly,cellular component organization,0.792\nDNA repair-dependent chromatin remodeling,metabolic process,0.226\nDNA replication factor A complex,cell cycle,0.23\nDNA replication factor C complex,cell cycle,0.302\nDNA replication preinitiation complex,gene regulation,0.24\nDNA replication preinitiation complex assembly,cellular component organization,0.442\nDNA replication proofreading,cell cycle,0.26\nDNA replication termination,cell cycle,0.526\n\"DNA replication, Okazaki fragment processing\",cell cycle,0.418\n\"DNA replication, removal of RNA primer\",gene regulation,0.388\n\"DNA replication, synthesis of RNA primer\",gene regulation,0.428\nDNA replication-dependent chromatin assembly,cellular component organization,0.228\nDNA replication-dependent chromatin disassembly,cell cycle,0.278\nDNA rewinding,protein modification/signaling,0.298\nDNA strand elongation involved in cell cycle DNA replication,cell cycle,0.648\nDNA strand elongation involved in mitotic DNA replication,cell cycle,0.698\nDNA strand elongation involved in nuclear cell cycle DNA replication,cell cycle,0.706\nDNA strand exchange activity,metabolic process,0.376\nDNA strand resection involved in replication fork processing,cell cycle,0.236\nDNA synthesis involved in DNA repair,cell cycle,0.34\nDNA synthesis involved in DNA replication,cell cycle,0.352\nDNA synthesis involved in UV-damage excision repair,cell cycle,0.186\nDNA synthesis involved in mitotic DNA replication,cell cycle,0.344\nDNA template activity,gene regulation,0.452\nDNA topoisomerase III-beta-TDRD3 complex,gene regulation,0.366\nDNA topoisomerase activity,metabolic process,0.446\nDNA topoisomerase binding,metabolic process,0.194\n\"DNA topoisomerase type I (single strand cut, ATP-independent) activity\",metabolic process,0.39\n\"DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity\",metabolic process,0.414\n\"DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) complex\",gene regulation,0.278\nDNA topological change,cellular component organization,0.206\nDNA translocase activity,cell cycle,0.308\nDNA transposition,cell cycle,0.374\nDNA-(abasic site) binding,cell cycle,0.196\nDNA-(apurinic or apyrimidinic site) endonuclease activity,metabolic process,0.44\nDNA-3'-diphospho-5'-guanosine diphosphatase,metabolic process,0.9\nDNA-3-methyladenine glycosylase activity,metabolic process,0.628\nDNA-3-methylbase glycosylase activity,metabolic process,0.546\nDNA-3-methylguanine glycosylase activity,metabolic process,0.628\nDNA-7-methyladenine glycosylase activity,metabolic process,0.626\nDNA-7-methylguanine glycosylase activity,metabolic process,0.626\nDNA-DNA tethering activity,gene regulation,0.446\nDNA-N1-methyladenine dioxygenase activity,metabolic process,0.548\nDNA-binding transcription factor activity,gene regulation,0.838\n\"DNA-binding transcription factor activity, RNA polymerase II-specific\",gene regulation,0.836\nDNA-dependent protein kinase activity,metabolic process,0.528\nDNA-dependent protein kinase complex,protein modification/signaling,0.282\nDNA-dependent protein kinase-DNA ligase 4 complex,protein modification/signaling,0.25\nDNA-directed RNA polymerase complex,gene regulation,0.544\nDNA-methyltransferase activity,metabolic process,0.694\nDNA-templated transcription,gene regulation,0.874\nDNA-templated transcription open complex formation,cellular component organization,0.438\nDNA-templated transcriptional start site selection,gene regulation,0.678\nDNA-templated viral transcription,gene regulation,0.19\nDNA/DNA annealing activity,gene regulation,0.346\nDNA/RNA helicase activity,gene regulation,0.422\nDNA/RNA hybrid binding,gene regulation,0.51\nDRM complex,gene regulation,0.194\nDSIF complex,gene regulation,0.502\nDUBm complex,protein modification/signaling,0.334\nDbf4-dependent protein kinase complex,protein modification/signaling,0.238\nDerlin-1 retrotranslocation complex,protein modification/signaling,0.306\nDerlin-1-VIMP complex,ER/endosome/lysosome related process,0.344\nDom34-Hbs1 complex,cellular component organization,0.33\nDsl1/NZR complex,cellular component organization,0.28\nE-box binding,gene regulation,0.416\nEARP complex,cellular component organization,0.348\nEGF-domain serine glucosyltransferase activity,metabolic process,0.638\nEGF-domain serine xylosyltransferase activity,metabolic process,0.47\nEH domain binding,protein modification/signaling,0.32\nEKC/KEOPS complex,protein modification/signaling,0.254\nEMC complex,ER/endosome/lysosome related process,0.326\nEMILIN complex,cellular component organization,0.376\nEP4 subtype prostaglandin E2 receptor binding,receptor related process,0.502\nER membrane insertion complex,cellular component organization,0.248\nER overload response,stress response,0.392\nER retention sequence binding,protein modification/signaling,0.252\nER to Golgi ceramide transport,transport,0.296\nER to Golgi transport vesicle membrane,ER/endosome/lysosome related process,0.524\nER ubiquitin ligase complex,metabolic process,0.264\nER-dependent peroxisome localization,ER/endosome/lysosome related process,0.334\nER-dependent peroxisome organization,cellular component organization,0.54\nERBB2-EGFR signaling pathway,receptor related process,0.444\nERBB2-ERBB3 signaling pathway,receptor related process,0.394\nERBB2-ERBB4 signaling pathway,receptor related process,0.422\nERBB3 signaling pathway,receptor related process,0.858\nERBB3:ERBB2 complex,receptor related process,0.354\nERBB4-ERBB4 signaling pathway,receptor related process,0.598\nERCC4-ERCC1 complex,cellular component organization,0.348\nERK5 cascade,protein modification/signaling,0.424\nESC/E(Z) complex,protein modification/signaling,0.304\nESCRT I complex,protein modification/signaling,0.3\nESCRT II complex,cellular component organization,0.22\nESCRT III complex,cellular component organization,0.27\nESCRT III complex assembly,cellular component organization,0.668\nESCRT III complex disassembly,cellular component organization,0.518\nESCRT complex,cellular component organization,0.258\nESCRT complex assembly,cellular component organization,0.958\nESCRT complex disassembly,cellular component organization,0.786\nESCRT-0 complex,cellular component organization,0.312\nEdg-2 lysophosphatidic acid receptor binding,receptor related process,0.426\nElg1 RFC-like complex,cell cycle,0.298\nErbB-2 class receptor binding,receptor related process,0.45\nErbB-3 class receptor binding,receptor related process,0.454\nF-actin capping protein complex,cellular component organization,0.394\nF-box domain binding,protein modification/signaling,0.38\nFACIT collagen trimer,cellular component organization,0.28\nFACT complex,gene regulation,0.426\nFAD binding,metabolic process,0.566\nFAD biosynthetic process,metabolic process,0.9\nFAD metabolic process,metabolic process,0.992\nFAD transmembrane transport,transport,0.564\nFAD transmembrane transporter activity,metabolic process,0.34\nFAD transport,transport,0.794\nFAD-AMP lyase (cyclizing) activity,metabolic process,0.898\nFAD-dependent H3K4me/H3K4me3 demethylase activity,metabolic process,0.576\nFANCM-MHF complex,protein modification/signaling,0.264\nFAR/SIN/STRIPAK complex,protein modification/signaling,0.352\nFAT10 activating enzyme activity,metabolic process,0.4\nFATZ binding,protein modification/signaling,0.308\nFBXO family protein binding,protein modification/signaling,0.412\nFFAT motif binding,protein modification/signaling,0.2\nFHA domain binding,protein modification/signaling,0.448\nFHF complex,protein modification/signaling,0.292\nFK506 binding,metabolic process,0.224\nFMN adenylyltransferase activity,metabolic process,0.82\nFMN binding,metabolic process,0.452\nFMN biosynthetic process,metabolic process,0.872\nFMN metabolic process,metabolic process,0.98\nFMN transmembrane transporter activity,transport,0.428\nFactor XII activation,cellular component organization,0.196\nFanconi anaemia nuclear complex,protein modification/signaling,0.362\nFas signaling pathway,receptor related process,0.552\nFas-activated serine/threonine kinase activity,metabolic process,0.602\nFasL biosynthetic process,metabolic process,0.65\nFc receptor complex,cellular component organization,0.266\nFc receptor mediated inhibitory signaling pathway,immune system process,0.582\nFc receptor-mediated immune complex endocytosis,receptor related process,0.288\nFc-epsilon receptor I complex,immune system process,0.286\nFc-gamma receptor I complex binding,receptor related process,0.424\nFc-gamma receptor III complex,immune system process,0.282\nFc-gamma receptor signaling pathway,immune system process,0.694\nFc-gamma receptor signaling pathway involved in phagocytosis,receptor related process,0.362\nFlemming body,cellular component organization,0.346\nG protein-coupled ADP receptor activity,cellular component organization,0.276\nG protein-coupled ATP receptor activity,cellular component organization,0.278\nG protein-coupled GABA receptor activity,cellular component organization,0.212\nG protein-coupled GABA receptor complex,receptor related process,0.3\nG protein-coupled UDP receptor activity,receptor related process,0.222\nG protein-coupled UTP receptor activity,receptor related process,0.224\nG protein-coupled acetylcholine receptor activity,cellular component organization,0.264\nG protein-coupled adenosine receptor activity,cellular component organization,0.246\nG protein-coupled adenosine receptor signaling pathway,receptor related process,0.48\nG protein-coupled amine receptor activity,neural related process,0.332\nG protein-coupled bile acid receptor activity,cellular component organization,0.232\nG protein-coupled chemoattractant receptor activity,receptor related process,0.362\nG protein-coupled enkephalin receptor activity,cellular component organization,0.17\nG protein-coupled estrogen receptor activity,cellular component organization,0.266\nG protein-coupled glutamate receptor activity,receptor related process,0.466\nG protein-coupled glutamate receptor binding,receptor related process,0.41\nG protein-coupled glutamate receptor signaling pathway,receptor related process,0.764\nG protein-coupled neurotensin receptor activity,protein modification/signaling,0.268\nG protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration,neural related process,0.278\nG protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential,neural related process,0.316\nG protein-coupled neurotransmitter receptor activity involved in regulation of presynaptic membrane potential,receptor related process,0.254\nG protein-coupled nucleotide receptor binding,receptor related process,0.458\nG protein-coupled opioid receptor activity,receptor related process,0.392\nG protein-coupled opioid receptor signaling pathway,receptor related process,0.772\nG protein-coupled peptide receptor activity,receptor related process,0.34\nG protein-coupled photoreceptor activity,cellular component organization,0.268\nG protein-coupled purinergic nucleotide receptor activity,receptor related process,0.388\nG protein-coupled purinergic receptor signaling pathway,receptor related process,0.762\nG protein-coupled pyrimidinergic nucleotide receptor activity,receptor related process,0.386\nG protein-coupled receptor activity,neural related process,0.342\nG protein-coupled receptor activity involved in regulation of postsynaptic membrane potential,neural related process,0.364\nG protein-coupled receptor catabolic process,metabolic process,0.742\nG protein-coupled receptor complex,receptor related process,0.336\nG protein-coupled receptor dimeric complex,receptor related process,0.302\nG protein-coupled receptor heterodimeric complex,receptor related process,0.242\nG protein-coupled receptor homodimeric complex,transport,0.216\nG protein-coupled receptor internalization,transport,0.588\nG protein-coupled receptor kinase activity,protein modification/signaling,0.454\nG protein-coupled receptor signaling pathway,receptor related process,0.248\nG protein-coupled receptor signaling pathway coupled to cGMP nucleotide second messenger,receptor related process,0.424\nG protein-coupled receptor signaling pathway involved in heart process,receptor related process,0.462\n\"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger\",receptor related process,0.472\nG protein-coupled serotonin receptor activity,neural related process,0.35\nG protein-coupled serotonin receptor binding,receptor related process,0.448\nG protein-coupled serotonin receptor complex,receptor related process,0.31\nG protein-coupled serotonin receptor signaling pathway,receptor related process,0.682\nG-protein activated inward rectifier potassium channel activity,metabolic process,0.2\nG-protein beta-subunit binding,gene regulation,0.188\nG-protein beta/gamma-subunit complex,cellular component organization,0.306\nG-protein beta/gamma-subunit complex binding,cellular component organization,0.252\nG-protein gamma-subunit binding,metabolic process,0.202\nG-quadruplex DNA binding,gene regulation,0.474\nG-quadruplex DNA formation,cellular component organization,0.334\nG-quadruplex DNA unwinding,cellular component organization,0.224\nG-quadruplex RNA binding,gene regulation,0.418\nG-rich single-stranded DNA binding,cell cycle,0.218\nG-rich strand telomeric DNA binding,cell cycle,0.242\nG/U mismatch-specific uracil-DNA glycosylase activity,cellular component organization,0.248\nG1 to G0 transition,cell cycle,0.584\nG1 to G0 transition involved in cell differentiation,cell cycle,0.288\nG2/MI transition of meiotic cell cycle,cell cycle,0.436\nGABA receptor activity,receptor related process,0.444\nGABA receptor binding,receptor related process,0.434\nGABA receptor complex,receptor related process,0.368\nGABA-A receptor activity,receptor related process,0.29\nGABA-A receptor complex,receptor related process,0.314\nGABA-gated chloride ion channel activity,cellular component organization,0.316\nGABAergic neuron differentiation,morphogenesis/development,0.606\nGABAergic neuron differentiation in basal ganglia,morphogenesis/development,0.43\nGAF domain binding,protein modification/signaling,0.364\nGAIT complex,gene regulation,0.224\nGARP complex,cellular component organization,0.42\nGARP complex binding,metabolic process,0.236\nGATOR1 complex,protein modification/signaling,0.398\nGATOR2 complex,protein modification/signaling,0.324\nGBAF complex,gene regulation,0.306\nGBD domain binding,protein modification/signaling,0.364\nGCN2-mediated signaling,protein modification/signaling,0.356\nGDP biosynthetic process,metabolic process,0.888\nGDP catabolic process,metabolic process,0.886\nGDP metabolic process,metabolic process,0.996\nGDP phosphatase activity,metabolic process,0.842\nGDP-4-dehydro-D-rhamnose reductase activity,metabolic process,0.91\nGDP-D-glucose phosphorylase activity,metabolic process,0.85\nGDP-L-fucose biosynthetic process,metabolic process,0.966\nGDP-L-fucose metabolic process,metabolic process,0.948\nGDP-L-fucose salvage,morphogenesis/development,0.222\nGDP-L-fucose synthase activity,metabolic process,0.928\n\"GDP-Man:Man1GlcNAc2-PP-Dol alpha-1,3-mannosyltransferase activity\",metabolic process,0.806\n\"GDP-Man:Man2GlcNAc2-PP-dolichol alpha-1,6-mannosyltransferase activity\",metabolic process,0.896\n\"GDP-Man:Man3GlcNAc2-PP-Dol alpha-1,2-mannosyltransferase activity\",metabolic process,0.806\nGDP-dissociation inhibitor activity,metabolic process,0.418\nGDP-dissociation inhibitor binding,protein modification/signaling,0.578\nGDP-fucose import into Golgi lumen,transport,0.362\nGDP-fucose transmembrane transport,transport,0.916\nGDP-fucose transmembrane transporter activity,metabolic process,0.268\n\"GDP-mannose 3,5-epimerase activity\",metabolic process,0.896\n\"GDP-mannose 4,6-dehydratase activity\",metabolic process,0.9\nGDP-mannose biosynthetic process,metabolic process,0.956\nGDP-mannose hydrolase activity,metabolic process,0.9\nGDP-mannose metabolic process,metabolic process,0.94\nGET complex,ER/endosome/lysosome related process,0.306\nGID complex,protein modification/signaling,0.216\nGINS complex,cell cycle,0.212\nGLI-SUFU complex,receptor related process,0.316\nGMP 5'-nucleotidase activity,metabolic process,0.832\nGMP binding,metabolic process,0.246\nGMP biosynthetic process,metabolic process,0.998\nGMP catabolic process,metabolic process,0.996\nGMP metabolic process,metabolic process,0.998\nGMP reductase activity,metabolic process,0.934\nGMP reductase complex,metabolic process,0.676\nGMP salvage,cellular component organization,0.204\nGMP synthase (glutamine-hydrolyzing) activity,metabolic process,0.834\nGMP synthase activity,metabolic process,0.822\nGPI anchor binding,cellular component organization,0.266\nGPI anchor biosynthetic process,metabolic process,0.796\nGPI anchor metabolic process,metabolic process,0.826\nGPI anchor release,cellular component organization,0.308\nGPI-anchor transamidase activity,metabolic process,0.498\nGPI-anchor transamidase complex,protein modification/signaling,0.326\nGPI-linked ephrin receptor activity,cellular component organization,0.166\nGPI-mannose ethanolamine phosphate phosphodiesterase activity,protein modification/signaling,0.258\n\"GTP 3',8'-cyclase activity\",metabolic process,0.838\nGTP biosynthetic process,metabolic process,0.882\nGTP cyclohydrolase I activity,metabolic process,0.8\nGTP cyclohydrolase activity,metabolic process,0.584\nGTP cyclohydrolase binding,metabolic process,0.244\nGTP diphosphatase activity,metabolic process,0.876\nGTP-dependent protein binding,protein modification/signaling,0.354\nGTP-dependent protein kinase activity,metabolic process,0.5\nGTPase activating protein binding,protein modification/signaling,0.364\nGTPase activator activity,metabolic process,0.35\nGTPase activator complex,metabolic process,0.314\nGTPase activity,metabolic process,0.668\nGTPase complex,metabolic process,0.318\nGTPase inhibitor activity,metabolic process,0.432\nGemini of coiled bodies,cellular component organization,0.244\nGlc3Man9GlcNAc2 oligosaccharide glucosidase activity,metabolic process,0.648\nGolgi apparatus,ER/endosome/lysosome related process,0.276\nGolgi apparatus mannose trimming,protein modification/signaling,0.3\nGolgi calcium ion homeostasis,other,0.504\nGolgi calcium ion transport,transport,0.884\nGolgi cis cisterna,ER/endosome/lysosome related process,0.386\nGolgi cis cisterna membrane,cellular component organization,0.336\nGolgi cisterna,cellular component organization,0.446\nGolgi cisterna membrane,cellular component organization,0.62\nGolgi disassembly,cellular component organization,0.226\nGolgi inheritance,cell cycle,0.194\nGolgi lumen,cellular component organization,0.512\nGolgi medial cisterna,ER/endosome/lysosome related process,0.2\nGolgi medial cisterna membrane,cellular component organization,0.33\nGolgi reassembly,metabolic process,0.16\nGolgi ribbon formation,cellular component organization,0.716\nGolgi to endosome transport,transport,0.414\nGolgi to lysosome transport,transport,0.354\nGolgi to plasma membrane protein transport,transport,0.476\nGolgi to plasma membrane transport vesicle,transport,0.28\nGolgi to secretory granule transport,ER/endosome/lysosome related process,0.346\nGolgi to vacuole transport,transport,0.746\nGolgi trans cisterna,ER/endosome/lysosome related process,0.388\nGolgi trans cisterna membrane,cellular component organization,0.33\nGolgi transport complex,cellular component organization,0.314\nGolgi transport vesicle coating,cellular component organization,0.552\nGolgi vesicle budding,cellular component organization,0.276\nGolgi vesicle docking,cellular component organization,0.24\nGolgi vesicle fusion to target membrane,cellular component organization,0.706\nGolgi vesicle prefusion complex stabilization,protein modification/signaling,0.244\nGolgi-associated vesicle,cellular component organization,0.378\nGolgi-associated vesicle lumen,cellular component organization,0.342\nGolgi-associated vesicle membrane,cellular component organization,0.646\nGq/11-coupled serotonin receptor activity,cellular component organization,0.28\nGrb2-EGFR complex,receptor related process,0.304\nGrb2-Sos complex,protein modification/signaling,0.178\nGtr1-Gtr2 GTPase complex,protein modification/signaling,0.288\nH zone,cellular component organization,0.398\nH3 histone acetyltransferase complex,gene regulation,0.336\nH3K27me3 modified histone binding,gene regulation,0.264\nH3K9me3 modified histone binding,gene regulation,0.26\nH4 histone acetyltransferase complex,gene regulation,0.472\nH4/H2A histone acetyltransferase complex,gene regulation,0.368\nH4K20me3 modified histone binding,gene regulation,0.258\nHAUS complex,cellular component organization,0.378\nHCN channel complex,cellular component organization,0.224\nHECT domain binding,protein modification/signaling,0.31\nHFE-transferrin receptor complex,cellular component organization,0.25\nHIR complex,cellular component organization,0.316\nHLA-A specific activating MHC class I receptor activity,immune system process,0.358\nHLA-B specific inhibitory MHC class I receptor activity,immune system process,0.342\nHLA-E specific inhibitory MHC class Ib receptor activity,protein modification/signaling,0.188\nHLH domain binding,protein modification/signaling,0.322\nHMG box domain binding,protein modification/signaling,0.3\nHNK-1 sulfotransferase activity,metabolic process,0.55\nHOPS complex,cellular component organization,0.306\nHRI-mediated signaling,protein modification/signaling,0.316\nHSP90-CDC37 chaperone complex,protein modification/signaling,0.388\nHULC complex,protein modification/signaling,0.402\nHarderian gland development,morphogenesis/development,0.878\nHis-Purkinje system cell differentiation,morphogenesis/development,0.754\nHis-Purkinje system development,morphogenesis/development,0.876\nHolliday junction resolvase complex,cellular component organization,0.28\nHrd1p ubiquitin ligase ERAD-L complex,protein modification/signaling,0.378\nHrd1p ubiquitin ligase complex,ER/endosome/lysosome related process,0.24\nHsp27 protein binding,protein modification/signaling,0.462\nHsp70 protein binding,protein modification/signaling,0.524\nHsp90 deacetylation,protein modification/signaling,0.44\nHsp90 protein binding,protein modification/signaling,0.524\nI band,cellular component organization,0.404\nI-SMAD binding,protein modification/signaling,0.352\nI-kappaB/NF-kappaB complex,protein modification/signaling,0.276\nICAM-3 receptor activity,immune system process,0.174\nIDP catabolic process,metabolic process,0.884\nIDP metabolic process,metabolic process,0.998\nIDP phosphatase activity,metabolic process,0.85\nIMP 5'-nucleotidase activity,metabolic process,0.832\nIMP catabolic process,metabolic process,0.888\nIMP cyclohydrolase activity,metabolic process,0.9\nIMP dehydrogenase activity,metabolic process,0.92\nIMP salvage,cellular component organization,0.208\nINO80-type complex,gene regulation,0.378\nIP-10 production,immune system process,0.666\nIPAF inflammasome complex,cellular component organization,0.368\nIRE1-RACK1-PP2A complex,protein modification/signaling,0.4\nIRE1-TRAF2-ASK1 complex,ER/endosome/lysosome related process,0.27\nIRES-dependent translational initiation of linear mRNA,cellular component organization,0.282\nISG15 activating enzyme activity,metabolic process,0.4\nISG15 transferase activity,metabolic process,0.596\nISG15-protein conjugation,protein modification/signaling,0.382\nISG15-specific peptidase activity,protein modification/signaling,0.32\nISGF3 complex,cellular component organization,0.236\nISWI-type complex,gene regulation,0.506\nITP catabolic process,metabolic process,0.892\nITP diphosphatase activity,metabolic process,0.878\nITP metabolic process,metabolic process,1\nIgA binding,immune system process,0.31\nIgA immunoglobulin complex,cellular component organization,0.364\n\"IgA immunoglobulin complex, circulating\",cellular component organization,0.4\nIgA receptor activity,immune system process,0.376\nIgD immunoglobulin complex,cellular component organization,0.266\nIgE binding,immune system process,0.324\nIgE immunoglobulin complex,cellular component organization,0.266\nIgE receptor activity,immune system process,0.372\nIgG binding,immune system process,0.338\nIgG immunoglobulin complex,cellular component organization,0.266\nIgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor,immune system process,0.32\nIgG receptor activity,immune system process,0.39\nIgM binding,immune system process,0.316\nIgM immunoglobulin complex,cellular component organization,0.268\n\"IgM immunoglobulin complex, circulating\",cellular component organization,0.254\nIkappaB kinase activity,metabolic process,0.6\nIkappaB kinase complex,protein modification/signaling,0.376\nIkappaB kinase complex binding,protein modification/signaling,0.246\nIno80 complex,protein modification/signaling,0.234\nIntermediate conductance calcium-activated potassium channel activity,metabolic process,0.228\nIre1 complex,gene regulation,0.352\nJAK pathway signal transduction adaptor activity,protein modification/signaling,0.27\nJUN kinase activity,metabolic process,0.454\nJUN kinase binding,metabolic process,0.338\nJUN kinase kinase activity,protein modification/signaling,0.534\nJUN kinase phosphatase activity,metabolic process,0.65\nJUN phosphorylation,protein modification/signaling,0.396\nK11-linked polyubiquitin modification-dependent protein binding,protein modification/signaling,0.542\nK48-linked deubiquitinase activity,protein modification/signaling,0.412\nK48-linked polyubiquitin modification-dependent protein binding,protein modification/signaling,0.516\nK6-linked polyubiquitin modification-dependent protein binding,protein modification/signaling,0.548\nK63-linked deubiquitinase activity,protein modification/signaling,0.396\nK63-linked polyubiquitin modification-dependent protein binding,protein modification/signaling,0.546\nKDEL sequence binding,ER/endosome/lysosome related process,0.288\nKICSTOR complex,protein modification/signaling,0.318\nKit signaling pathway,receptor related process,0.526\nKnl1/Spc105 complex,cell cycle,0.202\nKrueppel-associated box domain binding,protein modification/signaling,0.278\nKu70:Ku80 complex,cellular component organization,0.192\nKupffer's vesicle development,morphogenesis/development,0.724\nL-DOPA binding,metabolic process,0.31\nL-DOPA receptor activity,metabolic process,0.204\nL-alanine catabolic process,metabolic process,0.988\n\"L-alanine catabolic process, by transamination\",metabolic process,0.894\nL-alanine import across plasma membrane,transport,0.32\nL-alanine metabolic process,metabolic process,0.996\nL-alanine transmembrane transport,transport,0.87\nL-alanine transmembrane transporter activity,transport,0.792\nL-alanine transport,transport,0.956\nL-alanine:2-oxoglutarate aminotransferase activity,metabolic process,0.896\nL-alpha-amino acid transmembrane transport,transport,0.89\nL-amino acid transmembrane transporter activity,transport,0.916\nL-amino acid transport,transport,0.918\nL-amino-acid oxidase activity,metabolic process,0.894\nL-aminoadipate-semialdehyde dehydrogenase activity,metabolic process,0.932\nL-arabinose metabolic process,metabolic process,0.868\nL-arginine import across plasma membrane,transport,0.454\nL-arginine transmembrane transport,transport,0.84\nL-arginine transmembrane transporter activity,transport,0.756\nL-ascorbate:sodium symporter activity,metabolic process,0.514\nL-ascorbic acid binding,metabolic process,0.374\nL-ascorbic acid biosynthetic process,metabolic process,0.964\nL-ascorbic acid metabolic process,metabolic process,0.978\nL-ascorbic acid transmembrane transport,transport,0.29\nL-ascorbic acid transmembrane transporter activity,metabolic process,0.286\nL-asparagine biosynthetic process,metabolic process,0.882\nL-asparagine import across plasma membrane,transport,0.46\nL-asparagine metabolic process,metabolic process,0.966\nL-asparagine transmembrane transporter activity,transport,0.754\n\"L-asparagine, sodium:proton antiporter activity\",metabolic process,0.526\nL-asparagine:sodium symporter activity,metabolic process,0.526\nL-aspartate import across plasma membrane,transport,0.476\nL-aspartate transmembrane transport,transport,0.888\nL-aspartate transmembrane transporter activity,transport,0.826\nL-aspartate:2-oxoglutarate aminotransferase activity,metabolic process,0.896\nL-cysteine catabolic process,metabolic process,0.982\nL-cysteine catabolic process to hypotaurine,metabolic process,0.87\nL-cysteine catabolic process to taurine,metabolic process,0.87\nL-cysteine desulfhydrase activity,metabolic process,0.898\nL-cysteine desulfurase complex,metabolic process,0.424\nL-cysteine metabolic process,metabolic process,0.986\nL-cysteine transaminase activity,metabolic process,0.896\nL-cystine L-cysteine-lyase (deaminating),metabolic process,0.886\nL-cystine transmembrane transporter activity,cellular component organization,0.278\nL-cystine transport,transport,0.9\nL-dopa O-methyltransferase activity,metabolic process,0.896\nL-dopa biosynthetic process,metabolic process,0.848\nL-dopa decarboxylase activator activity,metabolic process,0.274\nL-dopa decarboxylase activity,metabolic process,0.854\nL-dopa metabolic process,metabolic process,0.962\nL-fuconate dehydratase activity,metabolic process,0.9\nL-fucose catabolic process,metabolic process,0.872\nL-fucose metabolic process,metabolic process,0.956\nL-fucose mutarotase activity,metabolic process,0.896\nL-glucuronate reductase activity,metabolic process,0.934\nL-glutamate import,transport,0.8\nL-glutamate import across plasma membrane,transport,0.852\nL-glutamate transmembrane transport,transport,0.888\nL-glutamate transmembrane transporter activity,transport,0.822\nL-glutamate uniporter activity,metabolic process,0.268\nL-glutamine aminotransferase activity,metabolic process,0.866\nL-glutamine import across plasma membrane,transport,0.46\nL-glutamine transmembrane transporter activity,transport,0.85\n\"L-glutamine, sodium:proton antiporter activity\",metabolic process,0.526\nL-glutamine:sodium symporter activity,metabolic process,0.526\nL-gulonate 3-dehydrogenase activity,metabolic process,0.928\nL-histidine import across plasma membrane,transport,0.46\nL-histidine transmembrane export from vacuole,transport,0.422\nL-histidine transmembrane transport,transport,0.832\nL-histidine transmembrane transporter activity,transport,0.766\nL-histidine transport,transport,0.948\n\"L-histidine, sodium:proton antiporter activity\",metabolic process,0.526\nL-hydroxyproline transmembrane transporter activity,cellular component organization,0.274\nL-iditol 2-dehydrogenase activity,metabolic process,0.928\nL-iduronidase activity,metabolic process,0.546\nL-isoleucine import across plasma membrane,transport,0.46\nL-isoleucine transaminase activity,metabolic process,0.898\nL-isoleucine transmembrane transporter activity,metabolic process,0.302\nL-kynurenine catabolic process,metabolic process,0.876\nL-kynurenine metabolic process,metabolic process,0.98\nL-kynurenine transmembrane transport,transport,0.422\nL-kynurenine transmembrane transporter activity,cellular component organization,0.278\nL-lactate dehydrogenase activity,metabolic process,0.928\nL-leucine import across plasma membrane,transport,0.46\nL-leucine transaminase activity,metabolic process,0.9\nL-leucine transmembrane transporter activity,metabolic process,0.302\nL-leucine:2-oxoglutarate aminotransferase activity,metabolic process,0.896\nL-lysine catabolic process,metabolic process,0.978\nL-lysine catabolic process to acetyl-CoA,metabolic process,0.972\nL-lysine catabolic process to acetyl-CoA via L-pipecolate,metabolic process,0.83\nL-lysine catabolic process to acetyl-CoA via saccharopine,metabolic process,0.83\nL-lysine import across plasma membrane,transport,0.454\nL-lysine metabolic process,metabolic process,0.978\nL-lysine transmembrane transport,transport,0.872\nL-lysine transmembrane transporter activity,transport,0.772\nL-lysine transport,transport,0.952\nL-lysine:L-arginine antiporter activity,metabolic process,0.526\nL-malate dehydrogenase activity,metabolic process,0.928\nL-methionine biosynthetic process,metabolic process,0.992\nL-methionine salvage,metabolic process,0.79\nL-methionine salvage from S-adenosylmethionine,metabolic process,0.874\nL-methionine salvage from methylthioadenosine,metabolic process,0.332\nL-methionine transmembrane transporter activity,transport,0.726\nL-methionine-(R)-S-oxide reductase activity,metabolic process,0.9\nL-methionine-(S)-S-oxide reductase activity,metabolic process,0.868\nL-methionine:thioredoxin-disulfide S-oxidoreductase activity,metabolic process,0.938\nL-methylmalonyl-CoA metabolic process,metabolic process,0.982\nL-ornithine import across plasma membrane,transport,0.454\nL-ornithine transmembrane transport,transport,0.87\nL-ornithine transmembrane transporter activity,transport,0.776\nL-phenylalaine oxidase activity,metabolic process,0.896\nL-phenylalanine catabolic process,metabolic process,0.988\nL-phenylalanine metabolic process,metabolic process,0.994\nL-phenylalanine transmembrane transporter activity,metabolic process,0.302\nL-phosphoserine phosphatase activity,metabolic process,0.82\nL-pipecolate oxidase activity,metabolic process,0.894\nL-proline biosynthetic process,metabolic process,0.726\nL-proline import across plasma membrane,transport,0.458\nL-proline transmembrane transport,transport,0.846\nL-proline transmembrane transporter activity,metabolic process,0.288\nL-serine ammonia-lyase activity,metabolic process,0.896\nL-serine biosynthetic process,metabolic process,0.898\nL-serine catabolic process,metabolic process,0.896\nL-serine import across plasma membrane,transport,0.424\nL-serine transmembrane transporter activity,metabolic process,0.252\nL-serine transport,transport,0.976\nL-serine-phosphatidylcholine phosphatidyltransferase activity,metabolic process,0.896\nL-serine-phosphatidylethanolamine phosphatidyltransferase activity,metabolic process,0.896\nL-seryl-tRNA(Sec) kinase activity,metabolic process,0.784\nL-threonine ammonia-lyase activity,metabolic process,0.896\nL-threonine catabolic process to glycine,metabolic process,0.854\nL-threonine transmembrane transporter activity,transport,0.818\nL-threonylcarbamoyladenylate synthase,metabolic process,0.832\nL-tryptophan transmembrane transport,transport,0.826\nL-tryptophan transmembrane transporter activity,transport,0.762\nL-type voltage-gated calcium channel complex,metabolic process,0.174\nL-tyrosine aminotransferase activity,metabolic process,0.86\nL-tyrosine transmembrane transporter activity,metabolic process,0.302\nL-tyrosine:2-oxoglutarate aminotransferase activity,metabolic process,0.896\nL-valine transaminase activity,metabolic process,0.898\nL-valine transmembrane transport,transport,0.85\nL-valine transmembrane transporter activity,metabolic process,0.302\nL-xylitol catabolic process,metabolic process,0.99\nL-xylitol metabolic process,metabolic process,0.966\nL-xylulose reductase (NADP+) activity,metabolic process,0.934\nL27 domain binding,protein modification/signaling,0.228\nLBD domain binding,receptor related process,0.376\nLIM domain binding,protein modification/signaling,0.352\nLRR domain binding,protein modification/signaling,0.564\nLUBAC complex,cellular component organization,0.48\nLangerhans cell differentiation,morphogenesis/development,0.544\nLas1 complex,gene regulation,0.4\nLewy body,cellular component organization,0.502\nLewy body core,cellular component organization,0.316\nLewy body corona,cellular component organization,0.444\nLewy body formation,cellular component organization,0.648\nLewy neurite,neural related process,0.222\nLeydig cell differentiation,morphogenesis/development,0.718\nLeydig cell proliferation,cell cycle,0.808\nLsm1-7-Pat1 complex,protein modification/signaling,0.27\nLsm2-8 complex,transport,0.208\nM band,cellular component organization,0.29\nMAD1 complex,cellular component organization,0.334\nMADS box domain binding,protein modification/signaling,0.286\nMAML1-RBP-Jkappa- ICN1 complex,protein modification/signaling,0.252\nMAP kinase activity,protein modification/signaling,0.416\nMAP kinase kinase kinase kinase activity,protein modification/signaling,0.458\nMAP kinase phosphatase activity,protein modification/signaling,0.582\nMAP kinase serine/threonine phosphatase activity,metabolic process,0.674\nMAP kinase tyrosine phosphatase activity,metabolic process,0.574\nMAP kinase tyrosine/serine/threonine phosphatase activity,metabolic process,0.628\nMAP-kinase scaffold activity,protein modification/signaling,0.396\nMAPK export from nucleus,transport,0.34\nMCM complex,cellular component organization,0.212\nMCM complex binding,metabolic process,0.234\nMCM8-MCM9 complex,protein modification/signaling,0.224\nMDM2/MDM4 family protein binding,protein modification/signaling,0.37\nMH1 domain binding,protein modification/signaling,0.334\nMH2 domain binding,protein modification/signaling,0.404\nMHC class I biosynthetic process,metabolic process,0.692\nMHC class I peptide loading complex,cellular component organization,0.406\nMHC class I protein binding,immune system process,0.276\nMHC class I protein complex,immune system process,0.382\nMHC class I protein complex assembly,cellular component organization,0.538\nMHC class I protein complex binding,metabolic process,0.22\nMHC class I receptor activity,immune system process,0.41\nMHC class II biosynthetic process,metabolic process,0.518\nMHC class II protein binding,protein modification/signaling,0.242\n\"MHC class II protein binding, via antigen binding groove\",metabolic process,0.226\nMHC class II protein complex,immune system process,0.224\nMHC class II protein complex assembly,cellular component organization,0.51\nMHC class II protein complex binding,metabolic process,0.192\nMHC class II receptor activity,immune system process,0.264\nMHC class Ib protein binding,protein modification/signaling,0.388\n\"MHC class Ib protein binding, via antigen binding groove\",metabolic process,0.218\nMHC class Ib protein complex,immune system process,0.32\nMHC class Ib protein complex assembly,cellular component organization,0.594\nMHC class Ib protein complex binding,metabolic process,0.222\nMHC class Ib receptor activity,immune system process,0.384\nMHC protein binding,immune system process,0.292\nMHC protein complex,immune system process,0.322\nMHC protein complex assembly,cellular component organization,0.752\nMHC protein complex binding,protein modification/signaling,0.426\nMIB complex,cellular component organization,0.622\nMICOS complex,cellular component organization,0.46\nMIS12/MIND type complex,gene regulation,0.228\nMIT domain binding,protein modification/signaling,0.312\nMKS complex,cellular component organization,0.402\nMLL1 complex,gene regulation,0.366\nMLL1/2 complex,gene regulation,0.512\nMLL3/4 complex,protein modification/signaling,0.338\nMMXD complex,protein modification/signaling,0.216\nMOZ/MORF histone acetyltransferase complex,cellular component organization,0.308\nMPP7-DLG1-LIN7 complex,cellular component organization,0.26\nMRF binding,gene regulation,0.296\nMSL complex,gene regulation,0.316\nMWP complex,protein modification/signaling,0.294\nMad-Max complex,protein modification/signaling,0.258\nMet1-linked polyubiquitin deubiquitinase activity,metabolic process,0.452\nMis6-Sim4 complex,cellular component organization,0.228\nMo-molybdopterin cofactor biosynthetic process,metabolic process,0.954\nMo-molybdopterin cofactor metabolic process,metabolic process,0.956\nMo-molybdopterin cofactor sulfurase activity,metabolic process,0.554\nMon1-Ccz1 complex,cellular component organization,0.266\nMpp10 complex,cellular component organization,0.304\nMre11 complex,protein modification/signaling,0.286\nMullerian duct regression,morphogenesis/development,0.252\nMutLalpha complex,cellular component organization,0.426\nMutLalpha complex binding,metabolic process,0.204\nMutLbeta complex binding,metabolic process,0.224\nMutSalpha complex,cellular component organization,0.412\nMutSalpha complex binding,metabolic process,0.218\nMutSbeta complex,cellular component organization,0.242\nMutSbeta complex binding,metabolic process,0.224\nMyb complex,gene regulation,0.332\nMyc-Max complex,cellular component organization,0.24\n\"N(1),N(12)-diacetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity\",metabolic process,0.9\nN(6)-L-threonylcarbamoyladenine synthase activity,metabolic process,0.878\n\"N,N-dimethylaniline monooxygenase activity\",metabolic process,0.932\nN-(long-chain-acyl)ethanolamine deacylase activity,metabolic process,0.912\nN-acetyl-L-aspartate-L-glutamate ligase activity,metabolic process,0.752\nN-acetyl-beta-D-galactosaminidase activity,metabolic process,0.9\nN-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase activity,metabolic process,0.87\nN-acetylgalactosamine 4-O-sulfotransferase activity,metabolic process,0.878\nN-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity,metabolic process,0.9\nN-acetylgalactosamine kinase activity,metabolic process,0.796\nN-acetylgalactosamine-4-sulfatase activity,metabolic process,0.564\nN-acetylgalactosamine-6-phosphate deacetylase activity,metabolic process,0.9\nN-acetylgalactosamine-6-sulfatase activity,metabolic process,0.564\nN-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity,metabolic process,0.896\nN-acetylglucosamine 6-O-sulfotransferase activity,metabolic process,0.856\nN-acetylglucosamine biosynthetic process,metabolic process,0.778\nN-acetylglucosamine catabolic process,metabolic process,0.774\nN-acetylglucosamine deacetylase activity,metabolic process,0.9\nN-acetylglucosamine kinase activity,metabolic process,0.796\nN-acetylglucosamine metabolic process,metabolic process,0.894\nN-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase activity,metabolic process,0.9\nN-acetylglucosamine-6-phosphate deacetylase activity,metabolic process,0.9\nN-acetylglucosamine-6-sulfatase activity,metabolic process,0.554\nN-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity,metabolic process,0.888\nN-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity,metabolic process,0.896\nN-acetylglucosaminylphosphatidylinositol deacetylase activity,metabolic process,0.552\nN-acetyllactosamine synthase activity,metabolic process,0.884\nN-acetyllactosaminide 3-alpha-galactosyltransferase activity,metabolic process,0.896\n\"N-acetyllactosaminide alpha-2,3-sialyltransferase activity\",metabolic process,0.896\n\"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity\",metabolic process,0.896\n\"N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity\",metabolic process,0.896\nN-acetylmannosamine metabolic process,metabolic process,0.95\nN-acetylmuramoyl-L-alanine amidase activity,metabolic process,0.548\nN-acetylneuraminate 7-O(or 9-O)-acetyltransferase activity,metabolic process,0.892\nN-acetylneuraminate biosynthetic process,metabolic process,0.912\nN-acetylneuraminate catabolic process,metabolic process,0.902\nN-acetylneuraminate lyase activity,metabolic process,0.896\nN-acetylneuraminate metabolic process,metabolic process,0.986\nN-acetylneuraminate synthase activity,metabolic process,0.852\nN-acetylphosphatidylethanolamine-hydrolysing phospholipase activity,metabolic process,0.898\nN-acetyltransferase activity,metabolic process,0.602\nN-acylethanolamine metabolic process,metabolic process,0.856\nN-acylglucosamine 2-epimerase activity,metabolic process,0.896\nN-acylmannosamine kinase activity,metabolic process,0.796\nN-acylneuraminate cytidylyltransferase activity,metabolic process,0.874\nN-acylneuraminate-9-phosphatase activity,metabolic process,0.852\nN-acylneuraminate-9-phosphate synthase activity,metabolic process,0.852\nN-acylphosphatidylethanolamine metabolic process,metabolic process,0.834\nN-acylphosphatidylethanolamine-specific phospholipase D activity,metabolic process,0.484\nN-acylsphingosine amidohydrolase activity,metabolic process,0.862\nN-acylsphingosine galactosyltransferase activity,metabolic process,0.896\nN-acyltransferase activity,metabolic process,0.532\nN-box binding,gene regulation,0.436\nN-formyl peptide receptor activity,cellular component organization,0.166\nN-glycan fucosylation,metabolic process,0.356\nN-glycan processing,metabolic process,0.396\nN-glycan processing to lysosome,protein modification/signaling,0.344\nN-methyltransferase activity,metabolic process,0.784\nN-retinylidene-phosphatidylethanolamine flippase activity,metabolic process,0.334\nN-succinyltransferase activity,metabolic process,0.91\nN-sulfoglucosamine sulfohydrolase activity,metabolic process,0.902\nN-sulfoglucosamine-3-sulfatase activity,metabolic process,0.562\nN-terminal peptidyl-L-cysteine N-palmitoylation,metabolic process,0.328\nN-terminal peptidyl-alanine methylation,protein modification/signaling,0.782\nN-terminal peptidyl-alanine trimethylation,protein modification/signaling,0.368\nN-terminal peptidyl-aspartic acid acetylation,protein modification/signaling,0.324\nN-terminal peptidyl-glutamic acid acetylation,protein modification/signaling,0.362\nN-terminal peptidyl-glutamine acetylation,protein modification/signaling,0.476\nN-terminal peptidyl-glycine N-myristoylation,protein modification/signaling,0.368\nN-terminal peptidyl-glycine methylation,protein modification/signaling,0.37\nN-terminal peptidyl-lysine acetylation,protein modification/signaling,0.836\nN-terminal peptidyl-methionine acetylation,protein modification/signaling,0.372\nN-terminal peptidyl-proline dimethylation,protein modification/signaling,0.756\nN-terminal peptidyl-proline methylation,protein modification/signaling,0.782\nN-terminal peptidyl-serine dimethylation,protein modification/signaling,0.368\nN-terminal peptidyl-serine methylation,protein modification/signaling,0.788\nN-terminal peptidyl-serine trimethylation,protein modification/signaling,0.368\nN-terminal protein N-methyltransferase activity,metabolic process,0.442\nN-terminal protein acetyltransferase complex,metabolic process,0.438\nN-terminal protein amino acid methylation,protein modification/signaling,0.782\nN-terminal protein amino acid modification,protein modification/signaling,0.8\nN-terminal protein lipidation,protein modification/signaling,0.808\nN-terminal protein myristoylation,protein modification/signaling,0.8\nN-terminal protein palmitoylation,protein modification/signaling,0.794\nN1-acetylspermidine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,metabolic process,0.9\nN1-acetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,metabolic process,0.9\nN1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity,metabolic process,0.902\nN4-(beta-N-acetylglucosaminyl)-L-asparaginase activity,metabolic process,0.9\n\"N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity\",metabolic process,0.898\nN6-isopentenyladenosine methylthiotransferase activity,metabolic process,0.516\nN6-methyl-(d)ATP hydrolase activity,metabolic process,0.878\nN6-methyl-AMP deaminase activity,metabolic process,0.882\nN6-threonylcarbomyladenosine methylthiotransferase activity,metabolic process,0.514\nNAADP-sensitive calcium-release channel activity,metabolic process,0.296\nNACHT domain binding,gene regulation,0.224\nNAD DNA ADP-ribosyltransferase activity,metabolic process,0.702\nNAD biosynthesis via nicotinamide riboside salvage pathway,metabolic process,0.89\nNAD catabolic process,metabolic process,0.842\nNAD salvage,immune system process,0.264\nNAD transmembrane transport,transport,0.658\nNAD transmembrane transporter activity,metabolic process,0.274\nNAD transport,transport,0.874\nNAD(P)+ nucleosidase activity,metabolic process,0.798\nNAD(P)+ transhydrogenase (B-specific) activity,metabolic process,0.622\nNAD(P)+ transhydrogenase activity,metabolic process,0.962\nNAD(P)H oxidase H2O2-forming activity,metabolic process,0.948\nNAD+ binding,metabolic process,0.732\nNAD+ diphosphatase activity,metabolic process,0.922\nNAD+ kinase activity,metabolic process,0.844\nNAD+ nucleosidase activity,metabolic process,0.68\n\"NAD+ nucleotidase, cyclic ADP-ribose generating\",metabolic process,0.68\nNAD+ synthase (glutamine-hydrolyzing) activity,metabolic process,0.858\nNAD+- protein-aspartate ADP-ribosyltransferase activity,metabolic process,0.918\nNAD+- protein-cysteine ADP-ribosyltransferase activity,metabolic process,0.932\nNAD+- protein-lysine ADP-ribosyltransferase activity,metabolic process,0.92\nNAD+-histone H2BE35 glutamate ADP-ribosyltransferase activity,metabolic process,0.516\nNAD+-histone H2BS6 serine ADP-ribosyltransferase activity,metabolic process,0.516\nNAD+-histone H3S10 serine ADP-ribosyltransferase activity,metabolic process,0.516\nNAD+-protein ADP-ribosyltransferase activity,metabolic process,0.626\nNAD+-protein-C-terminal glycine ADP-ribosyltransferase activity,metabolic process,0.916\nNAD+-protein-arginine ADP-ribosyltransferase activity,metabolic process,0.922\nNAD+-protein-glutamate ADP-ribosyltransferase activity,metabolic process,0.622\nNAD+-protein-histidine ADP-ribosyltransferase activity,metabolic process,0.914\nNAD+-protein-serine ADP-ribosyltransferase activity,metabolic process,0.622\nNAD+-protein-tyrosine ADP-ribosyltransferase activity,metabolic process,0.914\nNAD-cap decapping,gene regulation,0.52\nNAD-dependent histone H3K18 deacetylase activity,metabolic process,0.556\nNAD-dependent histone H3K56 deacetylase activity,metabolic process,0.556\nNAD-dependent histone H3K9 deacetylase activity,metabolic process,0.548\nNAD-dependent histone H4K16 deacetylase activity,metabolic process,0.534\nNAD-dependent histone deacetylase activity,metabolic process,0.44\nNAD-dependent histone decrotonylase activity,metabolic process,0.67\nNAD-dependent protein biotinidase activity,metabolic process,0.93\nNAD-dependent protein deacetylase activity,protein modification/signaling,0.45\nNAD-dependent protein decrotonylase activity,metabolic process,0.894\nNAD-dependent protein demyristoylase activity,metabolic process,0.928\nNAD-dependent protein depalmitoylase activity,metabolic process,0.928\nNAD-dependent protein lipoamidase activity,metabolic process,0.93\nNAD-retinol dehydrogenase activity,metabolic process,0.928\nNADH binding,metabolic process,0.724\nNADH dehydrogenase (quinone) activity,metabolic process,0.954\nNADH dehydrogenase activity,metabolic process,0.966\nNADH dehydrogenase complex,metabolic process,0.55\nNADH oxidase H202-forming activity,metabolic process,0.918\nNADH oxidation,metabolic process,0.478\nNADH pyrophosphatase activity,metabolic process,0.912\nNADH regeneration,metabolic process,0.414\nNADHX epimerase activity,metabolic process,0.896\nNADP biosynthetic process,metabolic process,0.9\nNADP catabolic process,metabolic process,0.91\nNADP phosphatase activity,metabolic process,0.882\nNADP+ binding,metabolic process,0.754\nNADP-retinol dehydrogenase activity,metabolic process,0.938\nNADPH dehydrogenase (quinone) activity,metabolic process,0.93\nNADPH oxidase H202-forming activity,metabolic process,0.922\nNADPH oxidase complex,protein modification/signaling,0.264\nNADPH oxidation,metabolic process,0.39\nNADPH peroxidase activity,metabolic process,0.932\nNADPH phosphatase activity,metabolic process,0.922\nNADPH-adrenodoxin reductase activity,metabolic process,0.95\nNADPH-hemoprotein reductase activity,metabolic process,0.952\nNADPH:quinone reductase activity,metabolic process,0.934\nNADPHX epimerase activity,metabolic process,0.896\nNEDD8 activating enzyme activity,metabolic process,0.484\nNEDD8 conjugating enzyme activity,metabolic process,0.512\nNEDD8 ligase activity,metabolic process,0.62\nNEDD8 transferase activity,metabolic process,0.576\nNELF complex,gene regulation,0.256\nNF-kappaB complex,gene regulation,0.318\nNF-kappaB p50/p65 complex,cellular component organization,0.326\nNFAT protein binding,immune system process,0.388\nNK T cell activation,immune system process,0.826\nNK T cell differentiation,immune system process,0.406\nNK T cell lineage commitment,immune system process,0.352\nNK T cell proliferation,immune system process,0.834\nNLRP1 inflammasome complex,cellular component organization,0.35\nNLRP1 inflammasome complex assembly,cellular component organization,0.682\nNLRP3 inflammasome complex,cellular component organization,0.322\nNLRP3 inflammasome complex assembly,cellular component organization,0.408\nNLRP6 inflammasome complex,cellular component organization,0.34\nNLRP6 inflammasome complex assembly,cellular component organization,0.692\nNLS-bearing protein import into nucleus,transport,0.478\nNLS-dependent protein nuclear import complex,cellular component organization,0.232\nNMDA glutamate receptor activity,cellular component organization,0.214\nNMDA glutamate receptor clustering,transport,0.2\nNMDA selective glutamate receptor complex,cellular component organization,0.184\nNOS2-CD74 complex,metabolic process,0.278\nNSL complex,gene regulation,0.386\nNURF complex,gene regulation,0.462\nNatA complex,protein modification/signaling,0.328\nNatB complex,metabolic process,0.34\nNatC complex,metabolic process,0.34\nNdc80 complex,cellular component organization,0.318\nNem1-Spo7 phosphatase complex,protein modification/signaling,0.252\nNoRC complex,gene regulation,0.64\nNoc complex,cellular component organization,0.37\nNoc1p-Noc2p complex,cellular component organization,0.496\nNoc2p-Noc3p complex,cellular component organization,0.492\nNoc4p-Nop14p complex,cellular component organization,0.48\nNorrin signaling pathway,receptor related process,0.386\nNotch receptor processing,receptor related process,0.31\nNotch signaling involved in heart development,receptor related process,0.436\nNotch signaling pathway involved in arterial endothelial cell fate commitment,receptor related process,0.478\nNotch signaling pathway involved in heart induction,receptor related process,0.522\nNotch signaling pathway involved in regulation of secondary heart field cardioblast proliferation,receptor related process,0.374\nNotch signaling pathway involved in somitogenesis,protein modification/signaling,0.184\nNuA4 histone acetyltransferase complex,gene regulation,0.216\nNuA4 histone acetyltransferase complex binding,gene regulation,0.244\nNuRD complex,gene regulation,0.456\nNuRD complex binding,gene regulation,0.238\nO-acetyl-ADP-ribose deacetylase activity,metabolic process,0.844\nO-acetyltransferase activity,metabolic process,0.916\nO-acyltransferase activity,metabolic process,0.952\nO-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity,metabolic process,0.468\nO-glycan processing,protein modification/signaling,0.582\n\"O-glycan processing, core 1\",cellular component organization,0.228\n\"O-glycan processing, core 2\",cellular component organization,0.224\n\"O-glycan processing, core 3\",cellular component organization,0.228\nO-methyltransferase activity,metabolic process,0.754\nO-octanoyltransferase activity,metabolic process,0.928\nO-palmitoyltransferase activity,metabolic process,0.948\nO-phospho-L-serine:2-oxoglutarate aminotransferase activity,metabolic process,0.896\nO-phosphoseryl-tRNA(Sec) selenium transferase activity,metabolic process,0.902\nO6-methyl-dGTP hydrolase activity,metabolic process,0.878\nOkazaki fragment processing involved in mitotic DNA replication,cell cycle,0.464\nP granule,cellular component organization,0.54\nP granule organization,cellular component organization,0.754\nP-TEFb complex,gene regulation,0.262\nP-TEFb complex binding,metabolic process,0.226\nP-type calcium transporter activity,transport,0.388\nP-type calcium transporter activity involved in regulation of cardiac muscle cell membrane potential,cellular component organization,0.316\nP-type calcium transporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration,metabolic process,0.188\nP-type calcium transporter activity involved in regulation of presynaptic cytosolic calcium ion concentration,metabolic process,0.192\nP-type divalent copper transporter activity,metabolic process,0.484\nP-type ion transporter activity,transport,0.496\nP-type manganese transporter activity,metabolic process,0.48\nP-type monovalent copper transporter activity,metabolic process,0.484\nP-type potassium transmembrane transporter activity,transport,0.452\nP-type potassium:proton transporter activity,metabolic process,0.48\nP-type proton-exporting transporter activity,transport,0.388\nP-type sodium transporter activity,transport,0.424\nP-type sodium:potassium-exchanging transporter activity,transport,0.402\nP-type transmembrane transporter activity,transport,0.298\nP2Y1 nucleotide receptor binding,receptor related process,0.49\nP450-containing electron transport chain,metabolic process,0.352\n\"PAM complex, Tim23 associated import motor\",cellular component organization,0.34\nPAN complex,cellular component organization,0.356\nPAR polarity complex,transport,0.232\nPAS complex,protein modification/signaling,0.288\nPCNA complex,cellular component organization,0.362\nPCNA-p21 complex,protein modification/signaling,0.29\nPCSK9-AnxA2 complex,cellular component organization,0.286\nPCSK9-LDLR complex,receptor related process,0.28\nPERK-mediated unfolded protein response,stress response,0.296\nPET complex,cellular component organization,0.342\nPH domain binding,protein modification/signaling,0.4\nPML body organization,cellular component organization,0.68\nPOU domain binding,gene regulation,0.246\nPOZ domain binding,protein modification/signaling,0.268\nPR-DUB complex,protein modification/signaling,0.374\nPRC1 complex,gene regulation,0.244\nPTB domain binding,metabolic process,0.216\nPTW/PP1 phosphatase complex,morphogenesis/development,0.238\nPUMA-BCL-xl complex,protein modification/signaling,0.282\nParkin-FBXW7-Cul1 ubiquitin ligase complex,protein modification/signaling,0.368\nPcG protein complex,gene regulation,0.314\nPeBoW complex,cellular component organization,0.28\nPeyer's patch development,morphogenesis/development,0.816\nPeyer's patch morphogenesis,morphogenesis/development,0.416\nPrp19 complex,gene regulation,0.296\nPurkinje myocyte action potential,cellular component organization,0.23\nPurkinje myocyte development,morphogenesis/development,0.864\nPurkinje myocyte differentiation,morphogenesis/development,0.596\nPurkinje myocyte to ventricular cardiac muscle cell communication,cell cycle,0.17\nPurkinje myocyte to ventricular cardiac muscle cell communication by electrical coupling,protein modification/signaling,0.344\nPurkinje myocyte to ventricular cardiac muscle cell signaling,metabolic process,0.168\nPwp2p-containing subcomplex of 90S preribosome,gene regulation,0.218\nPyrin domain binding,metabolic process,0.206\nR-loop processing,cellular component organization,0.226\nR2TP complex,cellular component organization,0.258\nRAGE receptor binding,receptor related process,0.488\nRAVE complex,cellular component organization,0.614\nRES complex,cellular component organization,0.296\nRIG-I binding,receptor related process,0.394\nRING-like zinc finger domain binding,protein modification/signaling,0.308\nRISC complex,gene regulation,0.456\nRISC complex assembly,gene regulation,0.474\nRISC complex binding,metabolic process,0.224\nRISC-loading complex,protein modification/signaling,0.186\nRNA (guanine-N7)-methylation,gene regulation,0.606\nRNA 2'-O-methyltransferase activity,metabolic process,0.646\nRNA 3' uridylation,gene regulation,0.466\nRNA 5'-cap (guanine-N7)-methylation,cellular component organization,0.26\nRNA 5'-methyltransferase activity,metabolic process,0.492\nRNA 7-methylguanosine cap binding,gene regulation,0.526\nRNA N6-methyladenosine methyltransferase complex,gene regulation,0.366\nRNA NAD-cap (NAD-forming) hydrolase activity,metabolic process,0.838\nRNA NAD-cap (NMN-forming) hydrolase activity,metabolic process,0.818\nRNA acetylation,gene regulation,0.604\nRNA cap binding,gene regulation,0.704\nRNA cap binding complex,gene regulation,0.502\nRNA catabolic process,metabolic process,0.696\nRNA destabilization,gene regulation,0.572\nRNA dihydrouridine synthase activity,metabolic process,0.976\nRNA endonuclease activity,metabolic process,0.52\n\"RNA endonuclease activity, producing 3'-phosphomonoesters\",metabolic process,0.55\n\"RNA endonuclease activity, producing 5'-phosphomonoesters\",metabolic process,0.496\nRNA exon ligation,gene regulation,0.622\nRNA exonuclease activity,cell cycle,0.47\n\"RNA exonuclease activity, producing 5'-phosphomonoesters\",cell cycle,0.504\nRNA folding,cellular component organization,0.326\nRNA guanylyltransferase activity,metabolic process,0.564\nRNA import into mitochondrion,transport,0.618\nRNA import into nucleus,transport,0.672\nRNA lariat debranching enzyme activator activity,gene regulation,0.426\nRNA lariat debranching enzyme activity,gene regulation,0.308\nRNA ligase (ATP) activity,metabolic process,0.822\nRNA ligase activity,metabolic process,0.43\nRNA localization to Cajal body,cell cycle,0.494\nRNA localization to chromatin,gene regulation,0.32\nRNA localization to nucleus,cell cycle,0.426\nRNA metabolic process,metabolic process,0.564\nRNA methylation,gene regulation,0.678\nRNA methyltransferase activity,metabolic process,0.636\nRNA nuclear export complex,cellular component organization,0.282\nRNA nuclease activity,metabolic process,0.36\nRNA polymerase I activity,metabolic process,0.328\nRNA polymerase I assembly,cellular component organization,0.504\nRNA polymerase I cis-regulatory region sequence-specific DNA binding,gene regulation,0.654\nRNA polymerase I complex,gene regulation,0.554\nRNA polymerase I core binding,gene regulation,0.532\nRNA polymerase I core factor complex,gene regulation,0.656\nRNA polymerase I core promoter sequence-specific DNA binding,gene regulation,0.48\nRNA polymerase I general transcription initiation factor activity,gene regulation,0.642\nRNA polymerase I general transcription initiation factor binding,gene regulation,0.608\nRNA polymerase I preinitiation complex assembly,gene regulation,0.564\nRNA polymerase I transcription regulator complex,gene regulation,0.742\nRNA polymerase I transcription regulatory region sequence-specific DNA binding,gene regulation,0.834\nRNA polymerase II C-terminal domain binding,gene regulation,0.618\nRNA polymerase II C-terminal domain phosphoserine binding,gene regulation,0.49\nRNA polymerase II CTD heptapeptide repeat kinase activity,protein modification/signaling,0.43\nRNA polymerase II CTD heptapeptide repeat modifying activity,gene regulation,0.376\nRNA polymerase II CTD heptapeptide repeat phosphatase activity,metabolic process,0.398\nRNA polymerase II activity,metabolic process,0.326\nRNA polymerase II cis-regulatory region sequence-specific DNA binding,gene regulation,0.736\nRNA polymerase II complex binding,gene regulation,0.706\nRNA polymerase II core complex assembly,cellular component organization,0.492\nRNA polymerase II general transcription initiation factor activity,gene regulation,0.776\nRNA polymerase II general transcription initiation factor binding,gene regulation,0.712\nRNA polymerase II intronic transcription regulatory region sequence-specific DNA binding,gene regulation,0.586\nRNA polymerase II promoter clearance,gene regulation,0.496\nRNA polymerase II sequence-specific DNA-binding transcription factor recruiting activity,gene regulation,0.304\nRNA polymerase II transcription regulatory region sequence-specific DNA binding,gene regulation,0.866\nRNA polymerase II transcription repressor complex,gene regulation,0.666\n\"RNA polymerase II, core complex\",gene regulation,0.58\n\"RNA polymerase II, holoenzyme\",gene regulation,0.662\nRNA polymerase III activity,gene regulation,0.316\nRNA polymerase III assembly,cellular component organization,0.502\nRNA polymerase III cis-regulatory region sequence-specific DNA binding,gene regulation,0.774\nRNA polymerase III complex,gene regulation,0.56\nRNA polymerase III core binding,gene regulation,0.536\nRNA polymerase III general transcription initiation factor activity,gene regulation,0.564\nRNA polymerase III general transcription initiation factor binding,gene regulation,0.644\nRNA polymerase III preinitiation complex assembly,gene regulation,0.564\nRNA polymerase III transcription regulator complex,gene regulation,0.732\nRNA polymerase III transcription regulatory region sequence-specific DNA binding,gene regulation,0.812\nRNA polymerase III type 1 promoter sequence-specific DNA binding,gene regulation,0.632\nRNA polymerase III type 2 promoter sequence-specific DNA binding,gene regulation,0.654\nRNA polymerase III type 3 promoter sequence-specific DNA binding,gene regulation,0.694\nRNA polymerase activity,metabolic process,0.494\nRNA polymerase complex,gene regulation,0.496\nRNA polymerase core enzyme binding,gene regulation,0.668\nRNA polymerase transcription factor SL1 complex,gene regulation,0.568\nRNA repair,gene regulation,0.356\nRNA secondary structure unwinding,gene regulation,0.414\nRNA sequestering activity,gene regulation,0.29\nRNA splicing,gene regulation,0.896\n\"RNA splicing, via endonucleolytic cleavage and ligation\",gene regulation,0.72\n\"RNA splicing, via transesterification reactions\",gene regulation,0.922\nRNA stabilization,gene regulation,0.688\nRNA strand annealing activity,gene regulation,0.374\nRNA surveillance,gene regulation,0.616\nRNA transmembrane transporter activity,transport,0.524\nRNA trimethylguanosine synthase activity,metabolic process,0.696\nRNA uridylyltransferase activity,metabolic process,0.862\nRNA-3'-phosphate cyclase activity,metabolic process,0.612\nRNA-DNA hybrid ribonuclease activity,gene regulation,0.378\nRNA-dependent RNA polymerase activity,metabolic process,0.532\nRNA-directed DNA polymerase activity,metabolic process,0.474\nRNA-directed RNA polymerase complex,gene regulation,0.426\nRNA-templated DNA biosynthetic process,cell cycle,0.528\nRNA-templated transcription,gene regulation,0.73\nRNAi effector complex,gene regulation,0.362\nRPAP3/R2TP/prefoldin-like complex,gene regulation,0.424\nRQC complex,cellular component organization,0.38\nRS domain binding,transport,0.314\nRSF complex,gene regulation,0.604\nRZZ complex,cellular component organization,0.402\nRab GDP-dissociation inhibitor activity,gene regulation,0.268\nRab geranylgeranyltransferase activity,metabolic process,0.62\nRab protein signal transduction,protein modification/signaling,0.492\nRab-protein geranylgeranyltransferase complex,protein modification/signaling,0.324\nRac protein signal transduction,protein modification/signaling,0.482\nRad17 RFC-like complex,cellular component organization,0.196\nRad51B-Rad51C-Rad51D-XRCC2 complex,cellular component organization,0.282\nRad51C-XRCC3 complex,cellular component organization,0.308\nRad6-Rad18 complex,protein modification/signaling,0.288\nRagulator complex,cellular component organization,0.258\nRal protein signal transduction,protein modification/signaling,0.488\nRan protein signal transduction,protein modification/signaling,0.514\nRas palmitoyltransferase activity,metabolic process,0.596\nRb-E2F complex,gene regulation,0.27\nRecQ family helicase-topoisomerase III complex,gene regulation,0.334\nRho GDP-dissociation inhibitor activity,gene regulation,0.268\nRho GDP-dissociation inhibitor binding,protein modification/signaling,0.366\nRho-dependent protein serine/threonine kinase activity,metabolic process,0.588\nRic1-Rgp1 guanyl-nucleotide exchange factor complex,cellular component organization,0.212\nRix1 complex,cellular component organization,0.282\nRoundabout binding,receptor related process,0.498\nRoundabout signaling pathway,receptor related process,0.61\nS-(hydroxymethyl)glutathione dehydrogenase NAD activity,metabolic process,0.928\nS-(hydroxymethyl)glutathione dehydrogenase NADP activity,metabolic process,0.934\nS-(hydroxymethyl)glutathione dehydrogenase activity,metabolic process,0.984\nS-acetyltransferase activity,metabolic process,0.95\nS-acyltransferase activity,metabolic process,0.942\nS-adenosyl-L-methionine binding,metabolic process,0.232\nS-adenosyl-L-methionine transmembrane transport,transport,0.89\nS-adenosyl-L-methionine transmembrane transporter activity,transport,0.68\nS-adenosyl-L-methionine transport,transport,0.974\nS-adenosyl-L-methionine:S-adenosyl-L-homocysteine antiporter activity,metabolic process,0.896\nS-adenosyl-L-methionine:beta-alanine N-methyltransferase activity,metabolic process,0.896\nS-adenosylhomocysteine metabolic process,metabolic process,0.942\nS-adenosylmethioninamine metabolic process,metabolic process,0.838\nS-adenosylmethionine biosynthetic process,metabolic process,0.836\nS-adenosylmethionine cycle,metabolic process,0.294\nS-adenosylmethionine-dependent methyltransferase activity,metabolic process,0.548\nS-formylglutathione hydrolase activity,metabolic process,0.8\nS-malonyltransferase activity,metabolic process,0.948\nS-methyl-5-thioadenosine phosphorylase activity,metabolic process,0.85\nS-methyl-5-thioribose-1-phosphate isomerase activity,metabolic process,0.896\nS-methylmethionine metabolic process,metabolic process,0.846\nS-methylmethionine-homocysteine S-methyltransferase activity,metabolic process,0.822\nS-methyltransferase activity,metabolic process,0.94\nS-nitrosoglutathione binding,metabolic process,0.26\nS-shaped body morphogenesis,morphogenesis/development,0.9\nS-succinyltransferase activity,metabolic process,0.948\nSA node cell action potential,cellular component organization,0.21\nSA node cell to atrial cardiac muscle cell communication,cell cycle,0.162\nSA node cell to atrial cardiac muscle cell communication by electrical coupling,protein modification/signaling,0.398\nSA node cell to atrial cardiac muscle cell signaling,metabolic process,0.26\nSAGA complex,gene regulation,0.324\nSAGA complex assembly,cellular component organization,0.654\nSAGA-type complex,gene regulation,0.606\nSAM complex,cellular component organization,0.476\nSAM domain binding,protein modification/signaling,0.326\nSCAR complex,protein modification/signaling,0.266\nSCF complex assembly,cellular component organization,0.664\nSCF ubiquitin ligase complex,metabolic process,0.28\nSCF ubiquitin ligase complex binding,metabolic process,0.19\nSCF-dependent proteasomal ubiquitin-dependent protein catabolic process,metabolic process,0.624\nSH2 domain binding,protein modification/signaling,0.554\nSHG alpha-glucan phosphorylase activity,metabolic process,0.902\nSLIK (SAGA-like) complex,gene regulation,0.328\nSMAD protein complex,gene regulation,0.28\nSMAD protein signal transduction,protein modification/signaling,0.348\nSMC family protein binding,protein modification/signaling,0.214\nSMC loading complex,cellular component organization,0.316\nSMN complex,cellular component organization,0.394\nSMN-Gemin2 complex,protein modification/signaling,0.266\nSMN-Sm protein complex,cellular component organization,0.374\nSNARE complex,cellular component organization,0.2\nSNARE complex assembly,cellular component organization,0.594\nSNARE complex disassembly,cellular component organization,0.516\nSOSS complex,cellular component organization,0.216\nSPOTS complex,protein modification/signaling,0.4\nSREBP-SCAP complex,protein modification/signaling,0.264\nSREBP-SCAP complex retention in endoplasmic reticulum,ER/endosome/lysosome related process,0.286\nSREBP-SCAP-Insig complex,protein modification/signaling,0.32\nSRP-dependent cotranslational protein targeting to membrane,receptor related process,0.252\n\"SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition\",protein modification/signaling,0.342\n\"SRP-dependent cotranslational protein targeting to membrane, translocation\",ER/endosome/lysosome related process,0.226\nSTAT family protein binding,immune system process,0.392\nSTING complex,immune system process,0.33\nSUMO activating enzyme activity,metabolic process,0.366\nSUMO activating enzyme complex,metabolic process,0.374\nSUMO binding,protein modification/signaling,0.54\nSUMO conjugating enzyme activity,metabolic process,0.518\nSUMO ligase activity,metabolic process,0.6\nSUMO ligase complex,metabolic process,0.292\nSUMO polymer binding,protein modification/signaling,0.288\nSUMO transferase activity,metabolic process,0.57\nSUMO-specific endopeptidase activity,metabolic process,0.352\nSUMO-ubiquitin ligase activity,metabolic process,0.484\nSWI/SNF complex,gene regulation,0.28\nSWI/SNF superfamily-type complex,gene regulation,0.382\nScc2-Scc4 cohesin loading complex,cellular component organization,0.25\nSchmidt-Lanterman incisure,cellular component organization,0.244\nSchwann cell chemotaxis,transport,0.332\nSchwann cell development,neural related process,0.47\nSchwann cell migration,neural related process,0.294\nSchwann cell proliferation,cell cycle,0.712\nSchwann cell proliferation involved in axon regeneration,cell cycle,0.594\nScrib-APC-beta-catenin complex,protein modification/signaling,0.244\nSec61 translocon complex,protein modification/signaling,0.25\nSec61 translocon complex binding,metabolic process,0.234\nSec62/Sec63 complex,protein modification/signaling,0.346\nSeh1-associated complex,protein modification/signaling,0.358\nSer-tRNA(Ala) hydrolase activity,metabolic process,0.52\nSertoli cell development,morphogenesis/development,0.886\nSertoli cell fate commitment,morphogenesis/development,0.332\nSertoli cell proliferation,cell cycle,0.678\nSet1C/COMPASS complex,gene regulation,0.274\nShc-EGFR complex,receptor related process,0.276\nShu complex,cellular component organization,0.206\nSin3-type complex,gene regulation,0.276\nSki complex,gene regulation,0.384\nSlx1-Slx4 complex,cellular component organization,0.352\nSm-like protein family complex,gene regulation,0.536\nSmc5-Smc6 complex,cellular component organization,0.204\nSpemann organizer formation,morphogenesis/development,0.682\nSpemann organizer formation at the anterior end of the primitive streak,morphogenesis/development,0.232\nSsh1 translocon complex,protein modification/signaling,0.216\nSwi5-Sfr1 complex,cellular component organization,0.288\nSwr1 complex,gene regulation,0.282\nT cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,immune system process,0.552\nT cell aggregation,immune system process,0.362\nT cell anergy,immune system process,0.422\nT cell antigen processing and presentation,immune system process,0.284\nT cell extravasation,immune system process,0.768\nT cell homeostatic proliferation,immune system process,0.322\nT cell lineage commitment,immune system process,0.53\nT cell meandering migration,immune system process,0.246\nT cell mediated cytotoxicity directed against tumor cell target,immune system process,0.338\nT cell mediated immune response to tumor cell,immune system process,0.86\nT cell proliferation involved in immune response,immune system process,0.812\nT cell receptor V(D)J recombination,immune system process,0.324\nT cell receptor binding,receptor related process,0.354\nT cell receptor complex,receptor related process,0.232\nT cell secretory granule organization,cellular component organization,0.61\nT cell selection,immune system process,0.658\nT cell tolerance induction,immune system process,0.658\nT follicular helper cell differentiation,morphogenesis/development,0.654\nT-helper 1 cell activation,immune system process,0.29\nT-helper 1 cell cytokine production,immune system process,0.514\nT-helper 1 cell differentiation,morphogenesis/development,0.444\nT-helper 1 cell lineage commitment,immune system process,0.422\nT-helper 17 cell chemotaxis,immune system process,0.314\nT-helper 17 cell lineage commitment,immune system process,0.384\nT-helper 2 cell activation,immune system process,0.27\nT-helper 2 cell cytokine production,immune system process,0.558\nT-helper 2 cell differentiation,morphogenesis/development,0.494\nT-helper cell lineage commitment,immune system process,0.48\nT-tubule,cellular component organization,0.336\nT-tubule organization,cellular component organization,0.694\nTAP binding,protein modification/signaling,0.384\nTAP complex,ER/endosome/lysosome related process,0.258\nTAP complex binding,metabolic process,0.22\nTAP1 binding,protein modification/signaling,0.214\nTAP2 binding,protein modification/signaling,0.214\nTBP-class protein binding,gene regulation,0.266\nTCR signalosome,protein modification/signaling,0.244\nTCR signalosome assembly,cellular component organization,0.598\nTEAD-YAP complex,gene regulation,0.246\nTERT-RMRP complex,gene regulation,0.384\nTFIIB-class transcription factor binding,gene regulation,0.59\nTFIID-class transcription factor complex binding,gene regulation,0.576\nTFIIF-class transcription factor complex binding,gene regulation,0.586\nTFIIH-class transcription factor complex binding,gene regulation,0.6\nTFIIIC-class transcription factor complex binding,gene regulation,0.586\nTHO complex,gene regulation,0.502\nTHO complex part of transcription export complex,gene regulation,0.354\nTIM22 mitochondrial import inner membrane insertion complex,cellular component organization,0.412\nTIM23 mitochondrial import inner membrane translocase complex,transport,0.352\nTIR domain binding,receptor related process,0.26\nTIRAP-dependent toll-like receptor 4 signaling pathway,immune system process,0.424\nTIRAP-dependent toll-like receptor signaling pathway,immune system process,0.836\nTMEM240-body,cellular component organization,0.226\nTNFSF11-mediated signaling pathway,receptor related process,0.656\nTOR complex,cellular component organization,0.3\nTORC1 complex,protein modification/signaling,0.384\nTORC1 complex assembly,cellular component organization,0.686\nTORC1 signaling,protein modification/signaling,0.358\nTORC2 complex,protein modification/signaling,0.364\nTORC2 complex binding,metabolic process,0.228\nTORC2 signaling,protein modification/signaling,0.362\nTPR domain binding,protein modification/signaling,0.228\nTRAF-mediated signal transduction,receptor related process,0.236\nTRAF2-GSTP1 complex,protein modification/signaling,0.288\nTRAIL binding,metabolic process,0.14\nTRAIL production,immune system process,0.624\nTRAIL receptor activity,cell death,0.284\nTRAIL-activated apoptotic signaling pathway,receptor related process,0.344\nTRAM-dependent toll-like receptor 4 signaling pathway,immune system process,0.428\nTRAM-dependent toll-like receptor signaling pathway,immune system process,0.844\nTRAMP complex,gene regulation,0.488\nTRAPP complex,cellular component organization,0.33\nTRAPPI protein complex,cellular component organization,0.336\nTRAPPII protein complex,cellular component organization,0.448\nTRAPPIII protein complex,cellular component organization,0.276\nTRC complex,ER/endosome/lysosome related process,0.314\nTRIF-dependent toll-like receptor signaling pathway,immune system process,0.858\nTSC1-TSC2 complex,protein modification/signaling,0.358\nTSC1-TSC2 complex binding,metabolic process,0.236\nTapasin-ERp57 complex,cellular component organization,0.376\nTat protein binding,protein modification/signaling,0.322\nTie signaling pathway,receptor related process,0.634\nToll binding,receptor related process,0.428\nToll signaling pathway,receptor related process,0.556\nToll-like receptor 1-Toll-like receptor 2 protein complex,immune system process,0.248\nToll-like receptor 2 binding,immune system process,0.382\nToll-like receptor 2-Toll-like receptor 6 protein complex,immune system process,0.256\nToll-like receptor 4 binding,immune system process,0.378\nU1 snRNA 3'-end processing,gene regulation,0.204\nU1 snRNA binding,gene regulation,0.6\nU1 snRNP,gene regulation,0.412\nU1 snRNP binding,gene regulation,0.27\nU11 snRNP,gene regulation,0.416\nU11/U12 snRNP,cellular component organization,0.336\nU12 snRNA binding,gene regulation,0.554\nU12 snRNP,gene regulation,0.416\nU2 snRNA 2'-O-methyladenosine m6 methyltransferase activity,metabolic process,0.896\nU2 snRNA 3'-end processing,morphogenesis/development,0.184\nU2 snRNA binding,gene regulation,0.602\nU2 snRNP,gene regulation,0.514\nU2 snRNP binding,gene regulation,0.27\nU2-type catalytic step 1 spliceosome,gene regulation,0.604\nU2-type post-mRNA release spliceosomal complex,immune system process,0.274\nU2-type post-spliceosomal complex,immune system process,0.278\nU2-type prespliceosome,gene regulation,0.314\nU2AF complex,gene regulation,0.456\nU4 snRNA 3'-end processing,gene regulation,0.238\nU4 snRNA binding,gene regulation,0.548\nU4 snRNP,gene regulation,0.414\nU4/U6 snRNP,cellular component organization,0.322\nU4/U6 x U5 tri-snRNP complex,gene regulation,0.318\nU4atac snRNA binding,gene regulation,0.554\nU4atac snRNP,gene regulation,0.416\nU5 snRNA 3'-end processing,gene regulation,0.204\nU5 snRNA binding,gene regulation,0.56\nU5 snRNP,gene regulation,0.432\nU6 2'-O-snRNA methylation,metabolic process,0.296\nU6 snRNA (adenine-(43)-N(6))-methyltransferase activity,metabolic process,0.894\nU6 snRNA 3'-end binding,gene regulation,0.554\nU6 snRNA 3'-end processing,morphogenesis/development,0.184\nU6 snRNA binding,gene regulation,0.786\nU6 snRNP,gene regulation,0.476\nU6atac snRNA binding,gene regulation,0.55\nU6atac snRNP,gene regulation,0.462\nU7 snRNA binding,gene regulation,0.572\nU7 snRNP,cellular component organization,0.288\nUBC13-MMS2 complex,cellular component organization,0.246\nUBC13-UEV1A complex,cellular component organization,0.334\nUDP biosynthetic process,metabolic process,0.89\nUDP catabolic process,metabolic process,0.89\nUDP metabolic process,metabolic process,1\nUDP phosphatase activity,metabolic process,0.85\nUDP-D-xylose biosynthetic process,metabolic process,0.84\nUDP-D-xylose metabolic process,metabolic process,0.948\n\"UDP-D-xylose:beta-D-glucoside alpha-1,3-D-xylosyltransferase activity\",metabolic process,0.498\nUDP-N-acetylgalactosamine diphosphorylase activity,metabolic process,0.874\nUDP-N-acetylgalactosamine metabolic process,metabolic process,0.938\nUDP-N-acetylgalactosamine transmembrane transport,transport,0.626\nUDP-N-acetylgalactosamine transmembrane transporter activity,cellular component organization,0.286\nUDP-N-acetylglucosamine 2-epimerase activity,metabolic process,0.896\nUDP-N-acetylglucosamine 4-epimerase activity,metabolic process,0.896\nUDP-N-acetylglucosamine biosynthetic process,metabolic process,0.732\nUDP-N-acetylglucosamine catabolic process,metabolic process,0.728\nUDP-N-acetylglucosamine diphosphorylase activity,metabolic process,0.874\nUDP-N-acetylglucosamine metabolic process,metabolic process,0.938\nUDP-N-acetylglucosamine transferase complex,metabolic process,0.322\nUDP-N-acetylglucosamine transmembrane transport,transport,0.272\nUDP-N-acetylglucosamine transmembrane transporter activity,cellular component organization,0.286\nUDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity,metabolic process,0.85\nUDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity,metabolic process,0.896\nUDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase complex,cellular component organization,0.348\nUDP-alpha-D-glucose:glucosyl-glycogenin alpha-D-glucosyltransferase activity,metabolic process,0.896\nUDP-galactose transmembrane transport,transport,0.734\nUDP-galactose transmembrane transporter activity,metabolic process,0.268\n\"UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity\",metabolic process,0.896\n\"UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity\",metabolic process,0.872\nUDP-galactosyltransferase activity,metabolic process,0.932\nUDP-glucose 4-epimerase activity,metabolic process,0.896\nUDP-glucose 6-dehydrogenase activity,metabolic process,0.93\nUDP-glucose catabolic process,metabolic process,0.85\nUDP-glucose metabolic process,metabolic process,0.946\nUDP-glucose transmembrane transport,transport,0.656\nUDP-glucose transmembrane transporter activity,metabolic process,0.27\nUDP-glucose:glycoprotein glucosyltransferase activity,metabolic process,0.516\nUDP-glucose:hexose-1-phosphate uridylyltransferase activity,metabolic process,0.896\nUDP-glucosylation,protein modification/signaling,0.228\nUDP-glucosyltransferase activity,metabolic process,0.958\nUDP-glucuronate biosynthetic process,metabolic process,0.866\nUDP-glucuronate decarboxylase activity,metabolic process,0.896\nUDP-glucuronate metabolic process,metabolic process,0.95\nUDP-glucuronic acid transmembrane transport,transport,0.714\nUDP-glucuronic acid transmembrane transporter activity,metabolic process,0.32\nUDP-sugar diphosphatase activity,metabolic process,0.9\nUDP-xylose transmembrane transport,transport,0.73\nUDP-xylose transmembrane transporter activity,metabolic process,0.268\nUDP-xylosyltransferase activity,metabolic process,0.794\nUFD1-NPL4 complex,cellular component organization,0.24\nUFM1 activating enzyme activity,metabolic process,0.416\nUFM1 conjugating enzyme activity,metabolic process,0.516\nUFM1 ligase activity,metabolic process,0.634\nUFM1 transferase activity,metabolic process,0.602\nUMP biosynthetic process,metabolic process,0.998\nUMP catabolic process,metabolic process,0.894\nUMP kinase activity,metabolic process,0.796\nUMP salvage,cellular component organization,0.206\nUMP/dUMP kinase activity,metabolic process,0.668\nURM1 activating enzyme activity,metabolic process,0.4\nUSH2 complex,protein modification/signaling,0.34\nUTP binding,metabolic process,0.282\nUTP biosynthetic process,metabolic process,0.894\nUTP catabolic process,metabolic process,0.894\nUTP diphosphatase activity,metabolic process,0.876\nUTP metabolic process,metabolic process,1\nUTP-C complex,cellular component organization,0.304\nUTP-monosaccharide-1-phosphate uridylyltransferase activity,metabolic process,0.886\nUTP:glucose-1-phosphate uridylyltransferase activity,metabolic process,0.874\nUV protection,morphogenesis/development,0.222\nUV-damage excision repair,cellular component organization,0.212\nV1A vasopressin receptor binding,receptor related process,0.5\nV1B vasopressin receptor binding,receptor related process,0.5\nVCB complex,cellular component organization,0.318\nVCP-NPL4-UFD1 AAA ATPase complex,metabolic process,0.258\nVCP-NPL4-UFD1 AAA ATPase complex assembly,cellular component organization,0.648\nVCP-NSFL1C complex,protein modification/signaling,0.322\nVEGF-A complex,receptor related process,0.37\nVEGF-activated neuropilin signaling pathway,receptor related process,0.73\nVEGF-activated neuropilin signaling pathway involved in axon guidance,neural related process,0.278\nVEGF-activated platelet-derived growth factor receptor signaling pathway,receptor related process,0.764\nWASH complex,cellular component organization,0.316\nWD40-repeat domain binding,protein modification/signaling,0.342\nWICH complex,gene regulation,0.336\nWW domain binding,protein modification/signaling,0.33\nWeibel-Palade body,immune system process,0.226\nWnt protein secretion,transport,0.568\nWnt receptor activity,protein modification/signaling,0.262\nWnt receptor catabolic process,metabolic process,0.518\nWnt signaling pathway involved in digestive tract morphogenesis,receptor related process,0.42\nWnt signaling pathway involved in dorsal/ventral axis specification,receptor related process,0.36\nWnt signaling pathway involved in forebrain neuroblast division,receptor related process,0.428\nWnt signaling pathway involved in heart development,receptor related process,0.358\nWnt signaling pathway involved in kidney development,receptor related process,0.344\nWnt signaling pathway involved in midbrain dopaminergic neuron differentiation,receptor related process,0.332\nWnt signaling pathway involved in somitogenesis,receptor related process,0.35\n\"Wnt signaling pathway, planar cell polarity pathway\",cellular component organization,0.292\nWnt signalosome,protein modification/signaling,0.336\nWnt signalosome assembly,cellular component organization,0.598\nWnt-Frizzled-LRP5/6 complex,protein modification/signaling,0.25\nWnt-Frizzled-LRP5/6 complex assembly,cellular component organization,0.644\nWnt-protein binding,receptor related process,0.18\nX chromosome,cellular component organization,0.532\nX11-like protein binding,protein modification/signaling,0.454\nXMP 5'-nucleosidase activity,metabolic process,0.848\nXMP biosynthetic process,metabolic process,0.998\nXMP metabolic process,metabolic process,0.996\nXPC complex,cellular component organization,0.262\nXTP diphosphatase activity,metabolic process,0.878\nXY body,cellular component organization,0.29\nY chromosome,cell cycle,0.19\nY-form DNA binding,cell cycle,0.226\nZ disc,cellular component organization,0.408\n[2Fe-2S] cluster assembly,metabolic process,0.312\n[3-methyl-2-oxobutanoate dehydrogenase (acetyl-transferring)] kinase activity,metabolic process,0.756\n[4Fe-4S] cluster assembly,metabolic process,0.31\n[acetyl-CoA carboxylase] kinase activity,metabolic process,0.738\n[acyl-carrier-protein] S-acetyltransferase activity,metabolic process,0.634\n[acyl-carrier-protein] S-malonyltransferase activity,metabolic process,0.636\n[heparan sulfate]-glucosamine 3-sulfotransferase 1 activity,metabolic process,0.85\n[heparan sulfate]-glucosamine 3-sulfotransferase 2 activity,metabolic process,0.804\n[heparan sulfate]-glucosamine 3-sulfotransferase 3 activity,metabolic process,0.9\n[heparan sulfate]-glucosamine N-sulfotransferase activity,metabolic process,0.9\n[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity,metabolic process,0.766\n[methionine synthase] reductase activity,metabolic process,0.936\n[phosphorylase] phosphatase activity,metabolic process,0.852\n[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine O-N-acetyl-alpha-D-glucosaminase activity,metabolic process,0.9\n[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine/L-threonine O-N-acetyl-alpha-D-glucosaminase activity,metabolic process,0.9\n[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-threonine O-N-acetyl-alpha-D-glucosaminase activity,metabolic process,0.9\n[protein]-asparagine 3-dioxygenase activity,metabolic process,0.89\n[pyruvate dehydrogenase (lipoamide)] phosphatase regulator activity,metabolic process,0.25\nabducens nerve development,morphogenesis/development,0.93\nabducens nerve formation,morphogenesis/development,0.37\nabducens nerve morphogenesis,morphogenesis/development,0.684\nabducens nucleus development,morphogenesis/development,0.976\nabscisic acid-activated signaling pathway,receptor related process,0.498\nabscission,morphogenesis/development,0.504\nabsorption of visible light,cellular component organization,0.216\nacetaldehyde metabolic process,metabolic process,0.942\nacetate CoA-transferase activity,metabolic process,0.904\nacetate biosynthetic process,metabolic process,0.986\nacetate ester biosynthetic process,metabolic process,0.894\nacetate ester metabolic process,metabolic process,0.884\nacetate ester transmembrane transporter activity,transport,0.648\nacetate ester transport,transport,0.91\nacetate metabolic process,metabolic process,0.98\nacetate transport,transport,0.944\nacetate-CoA ligase activity,metabolic process,0.834\nacetoacetate-CoA ligase activity,metabolic process,0.82\nacetoacetic acid metabolic process,metabolic process,0.976\nacetoacetyl-CoA hydrolase activity,metabolic process,0.898\nacetolactate synthase activity,metabolic process,0.896\nacetolactate synthase complex,metabolic process,0.308\nacetyl-CoA C-acetyltransferase activity,metabolic process,0.896\nacetyl-CoA C-acyltransferase activity,metabolic process,0.912\nacetyl-CoA C-myristoyltransferase activity,metabolic process,0.89\nacetyl-CoA binding,cellular component organization,0.272\nacetyl-CoA biosynthetic process from acetate,metabolic process,0.768\nacetyl-CoA biosynthetic process from pyruvate,metabolic process,0.858\nacetyl-CoA carboxylase activity,metabolic process,0.744\nacetyl-CoA carboxylase complex,metabolic process,0.404\nacetyl-CoA catabolic process,metabolic process,0.992\nacetyl-CoA hydrolase activity,metabolic process,0.896\nacetyl-CoA transmembrane transporter activity,transport,0.462\nacetyl-CoA transport,transport,0.748\nacetyl-CoA:L-glutamate N-acetyltransferase activity,metabolic process,0.892\nacetylalkylglycerol acetylhydrolase activity,metabolic process,0.9\nacetylcholine binding,metabolic process,0.238\nacetylcholine biosynthetic process,metabolic process,0.838\nacetylcholine catabolic process,metabolic process,0.942\nacetylcholine catabolic process in synaptic cleft,metabolic process,0.796\nacetylcholine metabolic process,metabolic process,0.824\nacetylcholine receptor activator activity,receptor related process,0.316\nacetylcholine receptor activity,receptor related process,0.41\nacetylcholine receptor binding,receptor related process,0.466\nacetylcholine receptor inhibitor activity,receptor related process,0.49\nacetylcholine receptor regulator activity,receptor related process,0.342\nacetylcholine receptor signaling pathway,receptor related process,0.414\nacetylcholine secretion,transport,0.608\n\"acetylcholine secretion, neurotransmission\",neural related process,0.23\nacetylcholine transmembrane transporter activity,transport,0.626\nacetylcholine transport,transport,0.84\nacetylcholine uptake,neural related process,0.332\nacetylcholine-gated channel complex,protein modification/signaling,0.184\nacetylcholine-gated monoatomic cation-selective channel activity,metabolic process,0.25\nacetylcholine-mediated vasodilation involved in regulation of systemic arterial blood pressure,protein modification/signaling,0.168\nacetylcholine:proton antiporter activity,metabolic process,0.524\nacetylcholinesterase activity,metabolic process,0.9\nacetylesterase activity,metabolic process,0.842\n\"acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity\",metabolic process,0.684\n\"acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity\",metabolic process,0.684\n\"acetylgalactosaminyl-O-glycosyl-seryl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity\",metabolic process,0.896\n\"acetylgalactosaminyl-O-glycosyl-seryl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity\",metabolic process,0.896\n\"acetylgalactosaminyl-O-glycosyl-threonyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity\",metabolic process,0.896\n\"acetylgalactosaminyl-O-glycosyl-threonyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity\",metabolic process,0.896\nacetylgalactosaminyltransferase activity,metabolic process,0.848\nacetylputrescine deacetylase activity,metabolic process,0.9\nacetylpyruvate hydrolase activity,metabolic process,0.9\nacetylserotonin O-methyltransferase activity,metabolic process,0.894\nacetylspermidine deacetylase activity,metabolic process,0.9\nacetyltransferase activator activity,metabolic process,0.49\nacetyltransferase activity,metabolic process,0.652\nacetyltransferase complex,gene regulation,0.59\nacid phosphatase activity,metabolic process,0.826\nacid secretion,transport,0.572\nacid sphingomyelin phosphodiesterase activity,metabolic process,0.818\nacid-amino acid ligase activity,metabolic process,0.818\nacid-ammonia (or amide) ligase activity,metabolic process,0.848\nacid-sensing ion channel activity,metabolic process,0.21\nacid-thiol ligase activity,metabolic process,0.664\nacidic amino acid transmembrane transporter activity,transport,0.882\nacidic amino acid transport,transport,0.914\nacinar cell differentiation,morphogenesis/development,0.84\nacinar cell proliferation,cell cycle,0.718\nacireductone dioxygenase (Ni2+-requiring) activity,metabolic process,0.798\nacireductone dioxygenase [iron(II)-requiring] activity,metabolic process,0.798\nacireductone synthase activity,metabolic process,0.828\naconitate decarboxylase activity,metabolic process,0.892\naconitate hydratase activity,metabolic process,0.712\nacrosin binding,protein modification/signaling,0.3\nacrosomal lumen,cellular component organization,0.324\nacrosomal matrix,metabolic process,0.488\nacrosomal membrane,cellular component organization,0.268\nacrosomal vesicle,cellular component organization,0.252\nacrosomal vesicle exocytosis,metabolic process,0.416\nacrosome assembly,morphogenesis/development,0.292\nacrosome matrix dispersal,cellular component organization,0.356\nacrosome reaction,cellular component organization,0.346\nactin cap,cellular component organization,0.27\nactin cortical patch localization,cellular component organization,0.294\nactin crosslink formation,cellular component organization,0.404\nactin cytoskeleton,cellular component organization,0.728\nactin filament branching,cellular component organization,0.312\nactin filament bundle,cellular component organization,0.8\nactin filament bundle distribution,cellular component organization,0.676\nactin filament bundle organization,cellular component organization,0.928\nactin filament bundle retrograde transport,cellular component organization,0.434\nactin filament capping,cellular component organization,0.904\nactin filament debranching,cellular component organization,0.35\nactin filament fragmentation,cellular component organization,0.4\nactin filament network formation,cellular component organization,0.58\nactin filament polymerization,cellular component organization,0.718\nactin filament uncapping,cellular component organization,0.824\nactin modification,protein modification/signaling,0.324\nactin monomer binding,cellular component organization,0.214\nactin nucleation,cellular component organization,0.828\nactin phosphorylation,metabolic process,0.402\nactin polymerization or depolymerization,cellular component organization,0.916\nactin polymerization-dependent cell motility,transport,0.168\nactin rod assembly,cellular component organization,0.582\nactin ubiquitination,gene regulation,0.242\nactin-based cell projection,cellular component organization,0.79\nactin-mediated cell contraction,cellular component organization,0.402\nactin-myosin filament sliding,cellular component organization,0.324\nactinin binding,protein modification/signaling,0.434\naction potential initiation,neural related process,0.36\naction potential propagation,neural related process,0.356\n\"activated CD8-positive, alpha-beta T cell apoptotic process\",cell death,0.224\nactivated T cell autonomous cell death,cell death,0.344\nactivating MHC class I receptor activity,immune system process,0.436\nactivating MHC class Ib receptor activity,protein modification/signaling,0.366\nactivating signal cointegrator 1 complex,gene regulation,0.306\nactivation of adenylate cyclase activity,metabolic process,0.244\nactivation of blood coagulation via clotting cascade,morphogenesis/development,0.224\nactivation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c,cell death,0.568\nactivation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,cell death,0.558\nactivation of meiosis,cell cycle,0.59\nactivation of meiosis involved in egg activation,morphogenesis/development,0.216\nactivation of membrane attack complex,cellular component organization,0.304\nactivation of phospholipase A2 activity,metabolic process,0.316\nactivation of phospholipase C activity,receptor related process,0.418\nactivation of phospholipase D activity,morphogenesis/development,0.186\nactivation of plasma proteins involved in acute inflammatory response,protein modification/signaling,0.24\nactivation of prostate induction by androgen receptor signaling pathway,receptor related process,0.462\nactivation of protein kinase A activity,protein modification/signaling,0.412\nactivation of protein kinase B activity,protein modification/signaling,0.396\nactivation of protein kinase C activity,protein modification/signaling,0.428\nactivation of store-operated calcium channel activity,metabolic process,0.168\nactivation of transmembrane receptor protein tyrosine kinase activity,protein modification/signaling,0.352\nactivation-induced cell death of T cells,cell death,0.396\nactive borate transmembrane transporter activity,transport,0.294\nactive monoatomic ion transmembrane transporter activity,transport,0.79\nactivin A complex,cellular component organization,0.318\nactivin complex,cellular component organization,0.366\nactivin receptor activity,receptor related process,0.588\n\"activin receptor activity, type I\",receptor related process,0.534\n\"activin receptor activity, type II\",receptor related process,0.39\nactivin receptor antagonist activity,receptor related process,0.568\nactivin receptor binding,receptor related process,0.412\nactivin receptor complex,receptor related process,0.338\nactivin receptor signaling pathway,receptor related process,0.708\nactivin responsive factor complex,gene regulation,0.296\nactomyosin contractile ring,cellular component organization,0.464\nactomyosin contractile ring assembly,cellular component organization,0.666\nactomyosin contractile ring assembly actin filament organization,cellular component organization,0.506\nactomyosin contractile ring contraction,cell cycle,0.666\nactomyosin contractile ring organization,cellular component organization,0.682\nacute inflammatory response to non-antigenic stimulus,metabolic process,0.196\nacyl binding,metabolic process,0.41\nacyl carnitine transmembrane transport,cellular component organization,0.278\nacyl carnitine transmembrane transporter activity,transport,0.59\nacyl carnitine transport,transport,0.85\nacyl carrier activity,metabolic process,0.318\nacyl-CoA binding,metabolic process,0.732\nacyl-CoA biosynthetic process,metabolic process,0.994\nacyl-CoA dehydrogenase activity,metabolic process,0.966\nacyl-CoA delta5-desaturase activity,metabolic process,0.86\nacyl-CoA desaturase activity,metabolic process,0.83\nacyl-CoA hydrolase activity,metabolic process,0.85\nacyl-CoA metabolic process,metabolic process,0.994\nacyl-CoA oxidase activity,metabolic process,0.962\nacyl-L-homoserine-lactone lactonohydrolase activity,metabolic process,0.9\nacyl-[acyl-carrier-protein] hydrolase activity,metabolic process,0.738\nacyl-coenzyme A diphosphatase activity,metabolic process,0.902\nacylglycerol acyl-chain remodeling,metabolic process,0.692\nacylglycerol biosynthetic process,metabolic process,0.968\nacylglycerol catabolic process,metabolic process,0.986\nacylglycerol homeostasis,other,0.602\nacylglycerol kinase activity,metabolic process,0.798\nacylglycerol lipase activity,metabolic process,0.902\nacylglycerol transport,transport,0.92\nacylglycerone-phosphate reductase activity,metabolic process,0.882\nacyloxyacyl hydrolase activity,metabolic process,0.882\nacylphosphatase activity,metabolic process,0.85\nacylpyruvate hydrolase activity,metabolic process,0.898\n\"acyltransferase activity, acyl groups converted into alkyl on transfer\",metabolic process,0.926\nadaptation of rhodopsin mediated signaling,immune system process,0.232\nadaptive immune memory response,immune system process,0.694\nadaptive immune memory response involving T cells and B cells,immune system process,0.43\nadaptive thermogenesis,multicellular organismal process,0.388\nadaxial/abaxial pattern specification,morphogenesis/development,0.612\nadenine binding,metabolic process,0.248\nadenine biosynthetic process,metabolic process,0.91\nadenine metabolic process,metabolic process,0.932\nadenine nucleotide transmembrane transporter activity,transport,0.724\nadenine nucleotide transport,transport,0.922\nadenine phosphoribosyltransferase activity,metabolic process,0.878\nadenine salvage,morphogenesis/development,0.224\nadenine transmembrane transporter activity,cellular component organization,0.296\nadenine transport,transport,0.934\nadenine/guanine mispair binding,gene regulation,0.212\nadenohypophysis development,morphogenesis/development,0.79\nadenohypophysis morphogenesis,morphogenesis/development,0.682\n\"adenosine 3',5'-bisphosphate transmembrane transport\",transport,0.69\n\"adenosine 3',5'-bisphosphate transmembrane transporter activity\",transport,0.638\nadenosine 5'-(hexahydrogen pentaphosphate) catabolic process,metabolic process,0.896\nadenosine 5'-(hexahydrogen pentaphosphate) metabolic process,metabolic process,0.986\nadenosine 5'-monophosphoramidase activity,metabolic process,0.846\nadenosine biosynthetic process,metabolic process,0.922\nadenosine catabolic process,metabolic process,0.78\nadenosine deaminase activity,metabolic process,0.646\nadenosine kinase activity,metabolic process,0.8\nadenosine metabolic process,metabolic process,0.948\nadenosine receptor binding,receptor related process,0.484\nadenosine to inosine editing,gene regulation,0.612\nadenosine transport,transport,0.722\nadenosine-phosphate deaminase activity,metabolic process,0.666\nadenosylhomocysteinase activity,metabolic process,0.902\nadenosylmethionine decarboxylase activity,metabolic process,0.896\nadenyl deoxyribonucleotide binding,metabolic process,0.582\nadenylate cyclase activator activity,protein modification/signaling,0.206\nadenylate cyclase activity,metabolic process,0.84\nadenylate cyclase binding,metabolic process,0.208\nadenylate cyclase inhibiting G protein-coupled glutamate receptor activity,receptor related process,0.336\nadenylate cyclase inhibitor activity,protein modification/signaling,0.202\nadenylate cyclase regulator activity,metabolic process,0.426\nadenylate cyclase-activating G protein-coupled receptor signaling pathway,receptor related process,0.462\nadenylate cyclase-activating adrenergic receptor signaling pathway,receptor related process,0.654\nadenylate cyclase-activating adrenergic receptor signaling pathway involved in cardiac muscle relaxation,protein modification/signaling,0.336\nadenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,receptor related process,0.512\nadenylate cyclase-activating adrenergic receptor signaling pathway involved in positive regulation of heart rate,receptor related process,0.274\nadenylate cyclase-activating adrenergic receptor signaling pathway involved in regulation of heart rate,receptor related process,0.602\nadenylate cyclase-activating dopamine receptor signaling pathway,receptor related process,0.642\nadenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway,receptor related process,0.602\nadenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway,receptor related process,0.622\nadenylate cyclase-inhibiting G protein-coupled receptor signaling pathway,receptor related process,0.446\nadenylate cyclase-inhibiting adrenergic receptor signaling pathway,receptor related process,0.78\nadenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process,receptor related process,0.318\nadenylate cyclase-inhibiting dopamine receptor signaling pathway,receptor related process,0.632\nadenylate cyclase-inhibiting opioid receptor signaling pathway,receptor related process,0.642\nadenylate cyclase-inhibiting serotonin receptor signaling pathway,receptor related process,0.642\nadenylate cyclase-modulating G protein-coupled receptor signaling pathway,receptor related process,0.342\nadenylate kinase activity,metabolic process,0.798\nadenylosuccinate synthase activity,metabolic process,0.85\nadenylylsulfatase activity,metabolic process,0.904\nadenylylsulfate kinase activity,metabolic process,0.796\nadenylylsulfate-ammonia adenylyltransferase activity,metabolic process,0.9\nadenylyltransferase activity,metabolic process,0.648\nadherens junction assembly,cellular component organization,0.686\nadherens junction disassembly,cellular component organization,0.622\nadherens junction maintenance,cellular component organization,0.72\nadhesion of symbiont to host,morphogenesis/development,0.234\nadhesion of symbiont to host cell,transport,0.274\nadipokinetic hormone binding,metabolic process,0.234\nadipokinetic hormone receptor activity,protein modification/signaling,0.186\nadiponectin binding,metabolic process,0.306\nadiponectin secretion,protein modification/signaling,0.296\nadiponectin-activated signaling pathway,receptor related process,0.59\nadrenal chromaffin cell differentiation,morphogenesis/development,0.724\nadrenal cortex development,morphogenesis/development,0.882\nadrenal cortex formation,morphogenesis/development,0.408\nadrenal gland development,morphogenesis/development,0.92\nadrenergic receptor activity,receptor related process,0.392\nadrenergic receptor binding,receptor related process,0.408\nadrenergic receptor signaling pathway,receptor related process,0.7\nadrenomedullin binding,metabolic process,0.248\nadrenomedullin receptor activity,cellular component organization,0.166\nadrenomedullin receptor binding,receptor related process,0.5\nadrenomedullin receptor complex,receptor related process,0.436\nadrenomedullin receptor signaling pathway,receptor related process,0.478\nadult feeding behavior,morphogenesis/development,0.292\nadult heart development,morphogenesis/development,0.958\nadult locomotory behavior,neural related process,0.506\nadult walking behavior,morphogenesis/development,0.318\nadvanced glycation end-product receptor activity,metabolic process,0.358\naflatoxin catabolic process,metabolic process,0.864\naflatoxin metabolic process,metabolic process,0.96\naggregation of unicellular organisms,morphogenesis/development,0.266\naggrephagy,protein modification/signaling,0.264\naggresome,cellular component organization,0.26\naggresome assembly,cellular component organization,0.6\naggressive behavior,multicellular organismal process,0.508\nagmatinase activity,metabolic process,0.9\nagmatine biosynthetic process,metabolic process,0.64\nalanine catabolic process,metabolic process,0.994\nalanine metabolic process,metabolic process,0.992\nalanine transmembrane transporter activity,transport,0.85\nalanine transport,transport,0.952\nalanine-glyoxylate transaminase activity,metabolic process,0.896\nalanine-oxo-acid transaminase activity,metabolic process,0.894\nalanine-tRNA ligase activity,metabolic process,0.822\nalanine:sodium symporter activity,transport,0.568\nalanyl-tRNA aminoacylation,metabolic process,0.56\nalanylglutamate dipeptidase activity,metabolic process,0.9\nalbendazole monooxygenase activity,metabolic process,0.932\nalcohol catabolic process,metabolic process,0.972\nalcohol dehydrogenase (NAD+) activity,metabolic process,0.972\nalcohol dehydrogenase (NADP+) activity,metabolic process,0.978\nalcohol dehydrogenase [NAD(P)+] activity,metabolic process,0.982\n\"alcohol dehydrogenase activity, zinc-dependent\",metabolic process,0.89\nalcohol sulfotransferase activity,metabolic process,0.868\nalcohol transmembrane transporter activity,transport,0.608\nalcohol-forming long-chain fatty acyl-CoA reductase activity,metabolic process,0.872\nalcohol-forming very long-chain fatty acyl-CoA reductase activity,metabolic process,0.86\naldehyde biosynthetic process,metabolic process,0.976\naldehyde catabolic process,metabolic process,0.976\naldehyde dehydrogenase (NADP+) activity,metabolic process,0.97\naldehyde dehydrogenase [NAD(P)+] activity,metabolic process,0.98\naldehyde oxidase activity,metabolic process,0.952\naldehyde-lyase activity,metabolic process,0.826\nalditol biosynthetic process,metabolic process,0.984\nalditol catabolic process,metabolic process,0.984\nalditol metabolic process,metabolic process,0.986\nalditol phosphate metabolic process,metabolic process,0.9\naldonic acid catabolic process,metabolic process,0.99\naldonic acid metabolic process,metabolic process,0.99\naldose 1-epimerase activity,metabolic process,0.878\naldosterone biosynthetic process,metabolic process,0.856\naldosterone metabolic process,metabolic process,0.99\naldosterone secretion,multicellular organismal process,0.174\naliphatic amine oxidase activity,metabolic process,0.95\nalkali metal ion binding,metabolic process,0.266\nalkaline phosphatase activity,metabolic process,0.85\nalkaloid catabolic process,metabolic process,0.924\nalkaloid metabolic process,metabolic process,0.906\nalkane 1-monooxygenase activity,metabolic process,0.922\nalkanesulfonate binding,metabolic process,0.484\nalkanesulfonate biosynthetic process,metabolic process,0.986\nalkanesulfonate metabolic process,metabolic process,0.974\nalkanesulfonate transmembrane transporter activity,transport,0.768\nalkanesulfonate transport,transport,0.932\nalkenylglycerophosphocholine hydrolase activity,metabolic process,0.9\nalkenylglycerophosphoethanolamine hydrolase activity,metabolic process,0.9\nalkyl hydroperoxide reductase activity,metabolic process,0.926\nalkylbase DNA N-glycosylase activity,metabolic process,0.548\nalkylglycerone-phosphate synthase activity,metabolic process,0.898\nalkylglycerophosphoethanolamine phosphodiesterase activity,metabolic process,0.9\nalkylthioltransferase activity,metabolic process,0.932\n\"all-trans retinal 3,4-desaturase activity\",metabolic process,0.924\nall-trans retinal binding,metabolic process,0.244\nall-trans retinoic acid 18-hydroxylase activity,metabolic process,0.924\n\"all-trans retinoic acid 3,4-desaturase activity\",metabolic process,0.928\nall-trans retinoic acid 4-hydrolase activity,metabolic process,0.924\n\"all-trans retinol 3,4-desaturase activity\",metabolic process,0.924\nall-trans-decaprenyl-diphosphate synthase activity,metabolic process,0.874\nall-trans-nonaprenyl-diphosphate synthase (geranyl-diphosphate specific) activity,metabolic process,0.874\n\"all-trans-retinol 13,14-reductase activity\",metabolic process,0.724\nall-trans-retinol binding,metabolic process,0.238\n\"all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity\",metabolic process,0.906\n\"all-trans-retinyl-palmitate hydrolase, 11-cis retinol forming activity\",metabolic process,0.9\n\"all-trans-retinyl-palmitate hydrolase, all-trans-retinol forming activity\",metabolic process,0.9\nallantoicase activity,metabolic process,0.9\nallantoin catabolic process,metabolic process,0.97\nallantoin metabolic process,metabolic process,0.896\nallantois development,morphogenesis/development,0.99\nallyl-alcohol dehydrogenase activity,metabolic process,0.934\nalpha DNA polymerase:primase complex,gene regulation,0.406\n\"alpha,alpha-trehalase activity\",metabolic process,0.9\n\"alpha-(1,2)-fucosyltransferase activity\",metabolic process,0.868\nalpha-(1->3)-fucosyltransferase activity,metabolic process,0.864\nalpha-(1->6)-fucosyltransferase activity,metabolic process,0.904\n\"alpha-1,2-mannosyltransferase activity\",metabolic process,0.828\n\"alpha-1,3-glucosidase activity\",metabolic process,0.67\n\"alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity\",metabolic process,0.896\n\"alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity\",metabolic process,0.896\n\"alpha-1,3-mannosyltransferase activity\",metabolic process,0.82\n\"alpha-1,4-N-acetylgalactosaminyltransferase activity\",metabolic process,0.572\n\"alpha-1,4-glucosidase activity\",metabolic process,0.676\n\"alpha-1,4-mannosyltransferase activity\",metabolic process,0.54\n\"alpha-1,6-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity\",metabolic process,0.896\n\"alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity\",metabolic process,0.818\n\"alpha-1,6-mannosyltransferase activity\",metabolic process,0.82\nalpha-1B adrenergic receptor binding,receptor related process,0.502\nalpha-2 macroglobulin receptor activity,cellular component organization,0.206\nalpha-2A adrenergic receptor binding,receptor related process,0.49\nalpha-2B adrenergic receptor binding,receptor related process,0.504\nalpha-2C adrenergic receptor binding,receptor related process,0.504\nalpha-L-arabinofuranosidase activity,metabolic process,0.482\nalpha-L-fucosidase activity,metabolic process,0.834\nalpha-N-acetylgalactosaminidase activity,metabolic process,0.482\n\"alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity\",metabolic process,0.896\nalpha-N-acetylglucosaminidase activity,metabolic process,0.476\n\"alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity\",metabolic process,0.896\n\"alpha-N-acetylneuraminyl-2,3-beta-galactosyl-1,3-N-acetyl-galactosaminide 6-alpha-sialyltransferase activity\",metabolic process,0.896\nalpha-actinin binding,protein modification/signaling,0.46\nalpha-adrenergic receptor activity,receptor related process,0.584\nalpha-amino-acid esterase activity,metabolic process,0.896\nalpha-aminoacyl-tRNA binding,metabolic process,0.244\nalpha-amylase activity,metabolic process,0.522\nalpha-beta T cell lineage commitment,immune system process,0.534\nalpha-beta T cell receptor complex,receptor related process,0.24\nalpha-beta intraepithelial T cell differentiation,immune system process,0.776\nalpha-catenin binding,cellular component organization,0.226\nalpha-galactosidase activity,metabolic process,0.676\nalpha-glucosidase activity,metabolic process,0.682\nalpha-glucoside transmembrane transporter activity,transport,0.584\nalpha-glucoside transport,transport,0.69\nalpha-ketoglutarate transmembrane transporter activity,transport,0.546\nalpha-ketoglutarate transport,transport,0.984\nalpha-linolenic acid metabolic process,metabolic process,0.846\nalpha-mannosidase activity,metabolic process,0.684\nalpha-methylacyl-CoA racemase activity,metabolic process,0.896\nalpha-sialidase activity,metabolic process,0.728\nalpha-tocopherol omega-hydroxylase activity,metabolic process,0.932\nalpha-tubulin acetylation,protein modification/signaling,0.252\nalpha1-adrenergic receptor activity,receptor related process,0.35\nalpha2-adrenergic receptor activity,receptor related process,0.348\nalpha9-beta1 integrin-ADAM8 complex,cellular component organization,0.27\nalpha9-beta1 integrin-vascular cell adhesion molecule-1 complex,cellular component organization,0.236\nalphav-beta3 integrin-HMGB1 complex,protein modification/signaling,0.334\nalphav-beta3 integrin-IGF-1-IGF1R complex,receptor related process,0.314\nalphav-beta3 integrin-PKCalpha complex,protein modification/signaling,0.424\nalphav-beta3 integrin-vitronectin complex,cellular component organization,0.28\nalveolar lamellar body,cellular component organization,0.222\nalveolar lamellar body membrane,cellular component organization,0.244\nalveolar primary septum development,morphogenesis/development,0.796\nalveolar secondary septum development,morphogenesis/development,0.864\namacrine cell differentiation,morphogenesis/development,0.628\nameloblast differentiation,morphogenesis/development,0.72\namidase activity,metabolic process,0.904\namide catabolic process,metabolic process,0.934\namide metabolic process,metabolic process,0.838\namide transmembrane transporter activity,transport,0.636\namidine-lyase activity,metabolic process,0.768\namidinotransferase activity,metabolic process,0.892\namidophosphoribosyltransferase activity,metabolic process,0.878\namine N-methyltransferase activity,metabolic process,0.884\namine binding,metabolic process,0.296\namine catabolic process,metabolic process,0.944\namine metabolic process,metabolic process,0.936\namine sulfotransferase activity,metabolic process,0.898\namine transmembrane transporter activity,transport,0.614\namine transport,transport,0.586\namine-lyase activity,metabolic process,0.842\naminergic neurotransmitter loading into synaptic vesicle,transport,0.4\namino acid activation for nonribosomal peptide biosynthetic process,metabolic process,0.758\namino acid binding,metabolic process,0.368\namino acid export across plasma membrane,transport,0.864\namino acid import,transport,0.4\namino acid import across plasma membrane,transport,0.882\namino acid kinase activity,metabolic process,0.686\namino acid neurotransmitter reuptake,transport,0.578\namino acid salvage,metabolic process,0.788\namino acid transmembrane export from vacuole,transport,0.792\namino acid transmembrane transport,transport,0.854\namino acid transmembrane transporter activity,transport,0.846\namino acid transport,transport,0.894\namino acid transport complex,cellular component organization,0.34\namino acid:monoatomic cation antiporter activity,transport,0.602\namino acid:monoatomic cation symporter activity,transport,0.66\namino acid:proton symporter activity,transport,0.556\namino acid:sodium symporter activity,transport,0.592\namino disaccharide catabolic process,metabolic process,0.948\namino disaccharide metabolic process,metabolic process,0.906\namino sugar biosynthetic process,metabolic process,0.988\namino sugar catabolic process,metabolic process,0.98\namino-acid betaine biosynthetic process,metabolic process,0.984\namino-acid betaine catabolic process,metabolic process,0.97\namino-acid betaine metabolic process,metabolic process,0.982\namino-acid betaine transmembrane transporter activity,transport,0.662\namino-acid betaine transport,transport,0.912\namino-acid racemase activity,metabolic process,0.88\naminoacetone:oxygen oxidoreductase(deaminating) activity,metabolic process,0.9\naminoacyl-tRNA editing activity,gene regulation,0.406\naminoacyl-tRNA hydrolase activity,metabolic process,0.852\naminoacyl-tRNA ligase activity,metabolic process,0.566\naminoacyl-tRNA metabolism involved in translational fidelity,metabolic process,0.552\naminoacyl-tRNA synthetase multienzyme complex,metabolic process,0.328\naminoacylase activity,metabolic process,0.896\naminobutyraldehyde dehydrogenase activity,metabolic process,0.926\naminocarboxymuconate-semialdehyde decarboxylase activity,metabolic process,0.896\naminoglycan catabolic process,metabolic process,0.97\naminoglycan metabolic process,metabolic process,0.956\naminoglycoside antibiotic metabolic process,metabolic process,0.98\naminomethyltransferase activity,metabolic process,0.896\naminomuconate-semialdehyde dehydrogenase activity,metabolic process,0.93\naminopeptidase activity,metabolic process,0.526\naminophospholipid flippase activity,transport,0.462\naminophospholipid translocation,cellular component organization,0.246\naminophospholipid transport,transport,0.874\nammon gyrus development,morphogenesis/development,0.908\nammonia assimilation cycle,cell cycle,0.224\nammonia ligase activity,metabolic process,0.692\nammonia-lyase activity,metabolic process,0.804\nammonium homeostasis,other,0.46\nammonium import across plasma membrane,transport,0.5\nammonium ion metabolic process,metabolic process,0.84\nammonium transmembrane transport,transport,0.792\nammonium transmembrane transporter activity,transport,0.532\namniotic stem cell differentiation,morphogenesis/development,0.694\namphisome,cellular component organization,0.298\namphisome membrane,cellular component organization,0.34\namygdala development,morphogenesis/development,0.742\namylase activity,metabolic process,0.72\namylin receptor activity,cellular component organization,0.172\namylin receptor complex,receptor related process,0.312\namylin receptor complex 1,receptor related process,0.344\namylin receptor complex 2,receptor related process,0.36\namylin receptor complex 3,receptor related process,0.39\namylin receptor signaling pathway,receptor related process,0.798\n\"amylo-alpha-1,6-glucosidase activity\",metabolic process,0.606\namyloid precursor protein biosynthetic process,metabolic process,0.702\namyloid-beta binding,protein modification/signaling,0.164\namyloid-beta clearance by cellular catabolic process,cellular component organization,0.186\namyloid-beta clearance by transcytosis,cellular component organization,0.174\namyloid-beta complex,protein modification/signaling,0.23\namyloid-beta formation,protein modification/signaling,0.198\namylopectin biosynthetic process,metabolic process,0.886\namylopectin metabolic process,metabolic process,0.95\nanagen,morphogenesis/development,0.174\n\"anandamide 11,12 epoxidase activity\",metabolic process,0.924\n\"anandamide 14,15 epoxidase activity\",metabolic process,0.924\n\"anandamide 8,9 epoxidase activity\",metabolic process,0.924\nanandamide epoxidase activity,metabolic process,0.806\nanaphase-promoting complex,protein modification/signaling,0.352\nanaphase-promoting complex binding,protein modification/signaling,0.316\nanaphase-promoting complex-dependent catabolic process,metabolic process,0.592\nanastral spindle assembly,cellular component organization,0.512\nanatomical structure arrangement,morphogenesis/development,0.494\nanatomical structure development,morphogenesis/development,0.21\nanatomical structure morphogenesis,morphogenesis/development,0.566\nanatomical structure regression,morphogenesis/development,0.784\nanchoring collagen complex,cellular component organization,0.488\nanchoring junction,cell adhesion,0.468\nandrogen binding,metabolic process,0.246\nandrogen biosynthetic process,metabolic process,0.804\nandrogen catabolic process,metabolic process,0.81\nandrogen metabolic process,metabolic process,0.896\nandrogen receptor signaling pathway,receptor related process,0.768\nandrogen secretion,cellular component organization,0.182\n\"androstan-3-alpha,17-beta-diol dehydrogenase activity\",metabolic process,0.938\nandrosterone dehydrogenase (B-specific) activity,metabolic process,0.916\nandrosterone dehydrogenase activity,metabolic process,0.988\nangiogenesis involved in coronary vascular morphogenesis,morphogenesis/development,0.286\nangiogenic sprout fusion,morphogenesis/development,0.248\nangiogenin-PRI complex,receptor related process,0.502\nangiostatin binding,metabolic process,0.214\nangiotensin maturation,morphogenesis/development,0.218\nangiotensin receptor activity,receptor related process,0.588\nangiotensin receptor binding,receptor related process,0.458\nangiotensin type I receptor activity,receptor related process,0.402\nangiotensin type II receptor activity,receptor related process,0.336\nangiotensin-activated signaling pathway,receptor related process,0.71\nangiotensin-activated signaling pathway involved in heart process,receptor related process,0.468\nangiotensin-mediated drinking behavior,cellular component organization,0.23\nangiotensin-mediated vasoconstriction involved in regulation of systemic arterial blood pressure,cellular component organization,0.206\nangiotensin-mediated vasodilation involved in regulation of systemic arterial blood pressure,multicellular organismal process,0.212\nanimal organ development,morphogenesis/development,0.458\nanimal organ maturation,morphogenesis/development,0.736\nanimal organ regeneration,morphogenesis/development,0.806\nankyrin binding,cellular component organization,0.318\nankyrin repeat binding,protein modification/signaling,0.232\nannulate lamellae,cellular component organization,0.38\nanterior commissure morphogenesis,neural related process,0.346\nanterior compartment pattern formation,morphogenesis/development,0.212\nanterior head development,morphogenesis/development,0.98\nanterior mesonephric tubule development,morphogenesis/development,0.838\nanterior neural tube closure,morphogenesis/development,0.34\nanterior semicircular canal development,morphogenesis/development,0.504\nanterior visceral endoderm cell migration,transport,0.188\nanterior/posterior axis specification,morphogenesis/development,0.44\n\"anterior/posterior axis specification, embryo\",multicellular organismal process,0.31\nanterior/posterior axon guidance,neural related process,0.406\nanterior/posterior pattern specification involved in kidney development,morphogenesis/development,0.61\nanterograde axonal protein transport,transport,0.706\nanterograde axonal transport,transport,0.77\nanterograde axonal transport of mitochondrion,transport,0.4\nanterograde axonal transport of neurotransmitter receptor complex,transport,0.332\nanterograde dendritic transport,transport,0.788\nanterograde dendritic transport of messenger ribonucleoprotein complex,transport,0.412\nanterograde dendritic transport of mitochondrion,transport,0.416\nanterograde dendritic transport of neurotransmitter receptor complex,transport,0.354\nanterograde neuronal dense core vesicle transport,transport,0.326\nanterograde synaptic vesicle transport,transport,0.342\nanterograde trans-synaptic signaling,neural related process,0.766\nanthranilate metabolic process,metabolic process,0.984\nanti-Mullerian hormone receptor activity,cellular component organization,0.196\nanti-Mullerian hormone signaling pathway,receptor related process,0.626\nantibacterial humoral response,immune system process,0.774\nantibacterial innate immune response,immune system process,0.282\nantibacterial peptide biosynthetic process,metabolic process,0.862\nantibacterial peptide production,immune system process,0.592\nantibiotic metabolic process,metabolic process,0.95\nantibody-dependent cellular cytotoxicity,immune system process,0.346\nantifungal humoral response,immune system process,0.33\nantifungal innate immune response,immune system process,0.316\nantigen binding,immune system process,0.502\nantigen processing and presentation following phagocytosis,immune system process,0.35\nantigen processing and presentation of endogenous antigen,immune system process,0.892\nantigen processing and presentation of endogenous peptide antigen via MHC class I,immune system process,0.844\nantigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway,immune system process,0.792\n\"antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent\",immune system process,0.362\n\"antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent\",immune system process,0.406\nantigen processing and presentation of endogenous peptide antigen via MHC class II,immune system process,0.292\nantigen processing and presentation of endogenous peptide antigen via MHC class Ib,immune system process,0.718\nantigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway,immune system process,0.596\n\"antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent\",immune system process,0.3\nantigen processing and presentation of exogenous antigen,immune system process,0.886\nantigen processing and presentation of exogenous peptide antigen via MHC class I,immune system process,0.776\n\"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent\",immune system process,0.244\n\"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent\",immune system process,0.254\nantigen processing and presentation of exogenous peptide antigen via MHC class II,immune system process,0.454\nantigen processing and presentation of exogenous peptide antigen via MHC class Ib,immune system process,0.664\n\"antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent\",immune system process,0.3\nantigen processing and presentation of lipid antigen via MHC class Ib,immune system process,0.6\nantigen processing and presentation of peptide antigen via MHC class II,immune system process,0.848\nantigen processing and presentation of peptide antigen via MHC class Ib,immune system process,0.836\nantigen processing and presentation of peptide or polysaccharide antigen via MHC class II,immune system process,0.828\nantigen processing and presentation of polysaccharide antigen via MHC class II,immune system process,0.256\nantigen processing and presentation via MHC class Ib,immune system process,0.764\n\"antigen processing and presentation, endogenous lipid antigen via MHC class Ib\",immune system process,0.28\n\"antigen processing and presentation, exogenous lipid antigen via MHC class Ib\",immune system process,0.278\nantigen sampling by M cells in mucosal-associated lymphoid tissue,cellular component organization,0.224\nantigen sampling in mucosal-associated lymphoid tissue,immune system process,0.52\nantigen transcytosis by M cells in mucosal-associated lymphoid tissue,transport,0.284\nantimicrobial peptide biosynthetic process,metabolic process,0.868\nantimicrobial peptide production,immune system process,0.574\nantioxidant activity,metabolic process,0.516\nantiporter activity,transport,0.61\nantisense RNA metabolic process,metabolic process,0.686\nantisense RNA transcript catabolic process,metabolic process,0.624\nantral ovarian follicle growth,morphogenesis/development,0.198\naorta morphogenesis,morphogenesis/development,0.914\naorta smooth muscle tissue morphogenesis,morphogenesis/development,0.508\naortic smooth muscle cell differentiation,morphogenesis/development,0.656\naortic valve formation,morphogenesis/development,0.664\naortic valve morphogenesis,morphogenesis/development,0.69\napelin receptor activity,morphogenesis/development,0.172\napelin receptor binding,receptor related process,0.49\napelin receptor signaling pathway,receptor related process,0.648\napical constriction,cellular component organization,0.182\napical cortex,cellular component organization,0.504\napical cytoplasm,cellular component organization,0.228\napical dendrite,cellular component organization,0.376\napical distal dendrite,neural related process,0.378\napical junction assembly,cellular component organization,0.438\napical plasma membrane,cellular component organization,0.518\napical plasma membrane urothelial plaque,cellular component organization,0.3\napical pole of neuron,neural related process,0.354\napical protein localization,transport,0.226\napical tubulobulbar complex,morphogenesis/development,0.26\napicolateral plasma membrane,cellular component organization,0.35\napolipoprotein A-I binding,metabolic process,0.258\napolipoprotein A-I receptor activity,receptor related process,0.36\napolipoprotein A-I receptor binding,receptor related process,0.492\napolipoprotein A-I-mediated signaling pathway,receptor related process,0.566\napolipoprotein B mRNA editing enzyme complex,protein modification/signaling,0.286\napolipoprotein binding,protein modification/signaling,0.354\napolipoprotein receptor activity,receptor related process,0.362\napolipoprotein receptor binding,receptor related process,0.546\napoptosome,cell death,0.368\napoptosome assembly,cell death,0.438\napoptotic DNA fragmentation,cell death,0.368\napoptotic chromosome condensation,cellular component organization,0.242\napoptotic nuclear changes,cell death,0.4\napoptotic process,cell death,0.858\napoptotic process in bone marrow cell,cell death,0.646\napoptotic process in response to mitochondrial fragmentation,cell death,0.232\napoptotic process involved in blood vessel morphogenesis,cell death,0.546\napoptotic process involved in embryonic digit morphogenesis,cell death,0.566\napoptotic process involved in heart morphogenesis,cell death,0.746\napoptotic process involved in luteolysis,cell death,0.64\napoptotic process involved in mammary gland involution,cell death,0.782\napoptotic process involved in metanephric collecting duct development,cell death,0.22\napoptotic process involved in metanephric nephron tubule development,cell death,0.22\napoptotic process involved in morphogenesis,cell death,0.666\napoptotic process involved in outflow tract morphogenesis,cell death,0.536\nappendage development,morphogenesis/development,0.966\nappendage morphogenesis,morphogenesis/development,0.89\narabinose metabolic process,metabolic process,0.878\narachidonate 12(R)-lipoxygenase activity,metabolic process,0.892\narachidonate 12(S)-lipoxygenase activity,metabolic process,0.858\narachidonate 15-lipoxygenase activity,metabolic process,0.876\narachidonate 5-lipoxygenase activity,metabolic process,0.894\narachidonate 8(R)-lipoxygenase activity,metabolic process,0.892\narachidonate 8(S)-lipoxygenase activity,metabolic process,0.882\narachidonate transport,transport,0.948\narachidonate-CoA ligase activity,metabolic process,0.822\n\"arachidonic acid 11,12-epoxygenase activity\",metabolic process,0.91\n\"arachidonic acid 14,15-epoxygenase activity\",metabolic process,0.91\n\"arachidonic acid 5,6-epoxygenase activity\",metabolic process,0.91\narachidonic acid binding,metabolic process,0.42\narachidonic acid epoxygenase activity,metabolic process,0.936\narachidonic acid metabolic process,metabolic process,0.956\narachidonic acid metabolite production involved in inflammatory response,immune system process,0.516\narachidonic acid monooxygenase activity,metabolic process,0.846\narachidonic acid omega-hydroxylase activity,metabolic process,0.926\narachidonic acid secretion,metabolic process,0.216\narachidoyl-CoA:1-dodecanol O-acyltransferase activity,metabolic process,0.902\naralkylamine N-acetyltransferase activity,metabolic process,0.892\narginase activity,metabolic process,0.882\narginine N-methyltransferase activity,metabolic process,0.646\narginine binding,metabolic process,0.306\narginine biosynthetic process,metabolic process,1\narginine biosynthetic process via ornithine,metabolic process,0.872\narginine catabolic process,metabolic process,0.984\narginine catabolic process to glutamate,metabolic process,0.868\narginine catabolic process to ornithine,metabolic process,0.852\narginine catabolic process to proline,metabolic process,0.978\narginine catabolic process to proline via ornithine,metabolic process,0.86\narginine decarboxylase activity,metabolic process,0.896\narginine metabolic process,metabolic process,0.988\narginine-tRNA ligase activity,metabolic process,0.822\nargininosuccinate lyase activity,metabolic process,0.896\nargininosuccinate metabolic process,metabolic process,0.832\nargininosuccinate synthase activity,metabolic process,0.822\narginyl-tRNA aminoacylation,metabolic process,0.552\narginyl-tRNA--protein transferase activity,metabolic process,0.896\narmadillo repeat domain binding,protein modification/signaling,0.308\naromatase activity,metabolic process,0.556\naromatic amino acid family biosynthetic process,metabolic process,0.978\n\"aromatic amino acid family biosynthetic process, prephenate pathway\",metabolic process,0.968\naromatic amino acid family catabolic process,metabolic process,0.976\naromatic amino acid metabolic process,metabolic process,0.98\naromatic amino acid transmembrane transporter activity,transport,0.764\naromatic amino acid transport,transport,0.92\naromatic compound catabolic process,metabolic process,0.936\naromatic-L-amino-acid decarboxylase activity,metabolic process,0.918\narrestin family protein binding,receptor related process,0.398\narsenate ion transmembrane transport,transport,0.272\narsenate reductase (glutaredoxin) activity,metabolic process,0.928\narsenate reductase activity,metabolic process,0.728\narsenite methyltransferase activity,metabolic process,0.896\narsenite transmembrane transporter activity,transport,0.632\narsenite transport,transport,0.728\narsonoacetate metabolic process,metabolic process,0.946\narterial endothelial cell differentiation,morphogenesis/development,0.686\narterial endothelial cell fate commitment,morphogenesis/development,0.348\nartery smooth muscle contraction,multicellular organismal process,0.772\nartery vasodilation involved in baroreceptor response to increased systemic arterial blood pressure,multicellular organismal process,0.15\narticular cartilage development,morphogenesis/development,0.992\naryl hydrocarbon receptor binding,receptor related process,0.508\naryl hydrocarbon receptor complex,receptor related process,0.268\naryl sulfotransferase activity,metabolic process,0.9\narylamine N-acetyltransferase activity,metabolic process,0.892\naryldialkylphosphatase activity,metabolic process,0.848\narylesterase activity,metabolic process,0.898\narylformamidase activity,metabolic process,0.8\narylsulfatase activity,metabolic process,0.892\nascending aorta development,morphogenesis/development,0.744\nascending aorta morphogenesis,morphogenesis/development,0.604\nascending thin limb development,morphogenesis/development,0.948\nascorbate homeostasis,other,0.396\nasialoglycoprotein receptor activity,cellular component organization,0.204\nasparaginase activity,metabolic process,0.9\nasparagine biosynthetic process,metabolic process,0.994\nasparagine catabolic process,metabolic process,0.992\nasparagine catabolic process via L-aspartate,metabolic process,0.85\nasparagine metabolic process,metabolic process,0.99\nasparagine synthase (glutamine-hydrolyzing) activity,metabolic process,0.822\nasparagine transmembrane transport,transport,0.85\nasparagine transport,transport,0.956\nasparagine-tRNA ligase activity,metabolic process,0.822\nasparaginyl-tRNA aminoacylation,metabolic process,0.558\naspartate 1-decarboxylase activity,metabolic process,0.896\naspartate N-acetyltransferase activity,metabolic process,0.892\naspartate binding,metabolic process,0.322\naspartate biosynthetic process,metabolic process,0.904\naspartate carbamoyltransferase activity,metabolic process,0.844\naspartate catabolic process,metabolic process,0.994\naspartate dehydrogenase activity,metabolic process,0.932\naspartate family amino acid catabolic process,metabolic process,0.99\naspartate family amino acid metabolic process,metabolic process,0.994\naspartate metabolic process,metabolic process,0.99\naspartate secretion,transport,0.684\naspartate transmembrane transport,transport,0.764\naspartate-tRNA ligase activity,metabolic process,0.822\naspartate-tRNA(Asn) ligase activity,metabolic process,0.822\n\"aspartate:glutamate, proton antiporter activity\",metabolic process,0.516\n\"aspartic endopeptidase activity, intramembrane cleaving\",metabolic process,0.354\naspartic-type endopeptidase activity,metabolic process,0.51\naspartic-type endopeptidase inhibitor activity,metabolic process,0.282\naspartic-type peptidase activity,metabolic process,0.456\naspartoacylase activity,metabolic process,0.91\naspartyl-tRNA aminoacylation,metabolic process,0.566\nassembly of actomyosin apparatus involved in cytokinesis,cellular component organization,0.638\nassembly of actomyosin apparatus involved in mitotic cytokinesis,cell cycle,0.494\nassembly of large subunit precursor of preribosome,cellular component organization,0.664\nassociative learning,neural related process,0.572\naster,cellular component organization,0.632\nastral microtubule,cellular component organization,0.302\nastral microtubule nucleation,cellular component organization,0.324\nastral microtubule organization,cellular component organization,0.644\nastrocyte activation involved in immune response,immune system process,0.392\nastrocyte cell migration,immune system process,0.292\nastrocyte chemotaxis,transport,0.292\nastrocyte end-foot,cellular component organization,0.48\nastrocyte fate commitment,morphogenesis/development,0.672\nastrocyte projection,cellular component organization,0.392\nastrocyte-dopaminergic neuron signaling,neural related process,0.194\nasymmetric Golgi ribbon formation,cellular component organization,0.608\nasymmetric cell division,morphogenesis/development,0.522\nasymmetric neuroblast division,morphogenesis/development,0.554\nasymmetric protein localization involved in cell fate determination,cellular component organization,0.198\nasymmetric stem cell division,cell cycle,0.414\nasymmetric synapse,neural related process,0.818\n\"asymmetric, glutamatergic, excitatory synapse\",neural related process,0.534\natrial cardiac muscle cell action potential,cellular component organization,0.2\natrial cardiac muscle cell development,morphogenesis/development,0.84\natrial cardiac muscle cell differentiation,morphogenesis/development,0.596\natrial cardiac muscle cell membrane repolarization,transport,0.31\natrial cardiac muscle cell to AV node cell communication,cell cycle,0.154\natrial cardiac muscle cell to AV node cell communication by electrical coupling,protein modification/signaling,0.354\natrial cardiac muscle cell to AV node cell signaling,cellular component organization,0.174\natrial cardiac muscle tissue development,morphogenesis/development,0.978\natrial cardiac muscle tissue morphogenesis,morphogenesis/development,0.742\natrial septum development,morphogenesis/development,0.946\natrial septum morphogenesis,morphogenesis/development,0.906\natrial septum primum morphogenesis,morphogenesis/development,0.746\natrial septum secundum morphogenesis,morphogenesis/development,0.74\natrioventricular bundle cell differentiation,morphogenesis/development,0.624\natrioventricular canal morphogenesis,morphogenesis/development,0.608\natrioventricular node cell development,morphogenesis/development,0.912\natrioventricular node cell differentiation,morphogenesis/development,0.71\natrioventricular node cell fate commitment,morphogenesis/development,0.266\natrioventricular node development,morphogenesis/development,0.88\natrioventricular valve development,morphogenesis/development,0.964\natrioventricular valve formation,morphogenesis/development,0.862\nattachment of GPI anchor to protein,metabolic process,0.44\nattachment of meiotic spindle microtubules to kinetochore,cell cycle,0.63\nauditory behavior,multicellular organismal process,0.49\nauditory receptor cell development,morphogenesis/development,0.9\nauditory receptor cell fate commitment,morphogenesis/development,0.296\nauditory receptor cell fate determination,morphogenesis/development,0.284\nauditory receptor cell fate specification,morphogenesis/development,0.53\nauditory receptor cell morphogenesis,receptor related process,0.258\nauditory receptor cell stereocilium organization,cellular component organization,0.638\nautocrine signaling,receptor related process,0.434\nautolysosome,metabolic process,0.296\nautolysosome lumen,gene regulation,0.228\nautophagic cell death,cell death,0.61\nautophagosome,cellular component organization,0.528\nautophagosome lumen,cellular component organization,0.216\nautophagosome membrane,cellular component organization,0.704\nautophagosome membrane docking,cellular component organization,0.256\nautophagosome-endosome fusion,cellular component organization,0.308\nautophagosome-lysosome fusion,cellular component organization,0.222\nautophagy of peroxisome,metabolic process,0.414\nautosome,cellular component organization,0.242\nauxin metabolic process,metabolic process,0.918\navascular cornea development in camera-type eye,morphogenesis/development,0.808\naxial mesoderm development,morphogenesis/development,0.988\naxial mesoderm formation,morphogenesis/development,0.384\naxial mesoderm morphogenesis,morphogenesis/development,0.73\naxial mesodermal cell differentiation,morphogenesis/development,0.684\naxial mesodermal cell fate commitment,morphogenesis/development,0.198\naxial mesodermal cell fate specification,morphogenesis/development,0.528\naxis elongation involved in somitogenesis,morphogenesis/development,0.486\naxis specification,morphogenesis/development,0.656\naxo-dendritic protein transport,transport,0.772\naxolemma,cellular component organization,0.236\naxon,neural related process,0.558\naxon arborization,morphogenesis/development,0.504\naxon choice point recognition,neural related process,0.398\naxon cytoplasm,cellular component organization,0.252\naxon development,neural related process,0.722\naxon ensheathment in central nervous system,neural related process,0.536\naxon extension,neural related process,0.564\naxon extension involved in axon guidance,neural related process,0.316\naxon extension involved in regeneration,neural related process,0.362\naxon guidance receptor activity,neural related process,0.178\naxon hillock,neural related process,0.392\naxon initial segment,neural related process,0.446\naxon midline choice point recognition,neural related process,0.444\naxon regeneration,neural related process,0.472\naxon target recognition,cellular component organization,0.136\naxon terminus,neural related process,0.574\naxonal fasciculation,neural related process,0.41\naxonal growth cone,neural related process,0.274\naxonal spine,cellular component organization,0.188\naxonal transport,transport,0.826\naxonal transport of messenger ribonucleoprotein complex,transport,0.882\naxonal transport of mitochondrion,transport,0.862\naxonemal basal plate,cellular component organization,0.32\naxonemal central apparatus,cellular component organization,0.384\naxonemal central apparatus assembly,cellular component organization,0.584\naxonemal central pair projection,cellular component organization,0.312\naxonemal dynein complex,metabolic process,0.302\naxonemal dynein complex assembly,cellular component organization,0.906\naxonemal microtubule,cellular component organization,0.542\naxonemal microtubule depolymerization,protein modification/signaling,0.212\naxonemal outer doublet,cellular component organization,0.216\naxoneme,cellular component organization,0.252\naxoneme assembly,cellular component organization,0.602\naxonogenesis involved in innervation,neural related process,0.318\nazole transmembrane transport,transport,0.836\nazole transmembrane transporter activity,transport,0.736\nazole:proton antiporter activity,transport,0.492\nazurophil granule,metabolic process,0.316\nazurophil granule lumen,metabolic process,0.25\nazurophil granule membrane,metabolic process,0.296\nbBAF complex,gene regulation,0.29\nbHLH transcription factor binding,morphogenesis/development,0.238\nbanded collagen fibril,cellular component organization,0.476\nbarbed-end actin filament capping,cellular component organization,0.482\nbarbed-end actin filament uncapping,cellular component organization,0.388\nbaroreceptor response to decreased systemic arterial blood pressure,morphogenesis/development,0.168\nbaroreceptor response to increased systemic arterial blood pressure,multicellular organismal process,0.164\nbasal body patch,cellular component organization,0.192\nbasal cortex,cellular component organization,0.4\nbasal dendrite,neural related process,0.388\nbasal dendrite arborization,morphogenesis/development,0.594\nbasal dendrite development,morphogenesis/development,0.984\nbasal dendrite morphogenesis,neural related process,0.36\nbasal ectoplasmic specialization,morphogenesis/development,0.254\nbasal plasma membrane,cellular component organization,0.596\nbasal protein localization,transport,0.222\nbasal transcription machinery binding,gene regulation,0.774\nbasal tubulobulbar complex,cellular component organization,0.258\nbase conversion or substitution editing,gene regulation,0.544\n\"base-excision repair, AP site formation\",gene regulation,0.304\n\"base-excision repair, AP site formation via deaminated base removal\",cellular component organization,0.264\n\"base-excision repair, DNA ligation\",cell cycle,0.242\n\"base-excision repair, gap-filling\",transport,0.14\nbasement membrane assembly,cellular component organization,0.79\nbasement membrane assembly involved in embryonic body morphogenesis,cellular component organization,0.474\nbasement membrane collagen trimer,cellular component organization,0.43\nbasement membrane constituent secretion,transport,0.666\nbasement membrane disassembly,cellular component organization,0.832\nbasic amino acid transmembrane transport,transport,0.848\nbasic amino acid transmembrane transporter activity,transport,0.786\nbasic amino acid transport,transport,0.954\nbasolateral part of cell,cellular component organization,0.206\nbasolateral plasma membrane,cellular component organization,0.544\nbasolateral protein secretion,protein modification/signaling,0.2\nbasophil activation,immune system process,0.706\nbasophil activation involved in immune response,immune system process,0.552\nbasophil chemotaxis,immune system process,0.454\nbasophil differentiation,morphogenesis/development,0.664\nbasophil homeostasis,immune system process,0.304\nbehavioral defense response,immune system process,0.316\nbehavioral fear response,neural related process,0.314\nbehavioral response to acetic acid induced pain,immune system process,0.176\nbehavioral response to chemical pain,multicellular organismal process,0.248\nbehavioral response to ethanol,neural related process,0.284\nbehavioral response to formalin induced pain,immune system process,0.198\nbehavioral response to nicotine,neural related process,0.238\nbehavioral response to nutrient,multicellular organismal process,0.35\nbehavioral response to pain,multicellular organismal process,0.244\nbehavioral response to starvation,neural related process,0.178\nbent DNA binding,metabolic process,0.206\nbenzaldehyde dehydrogenase (NAD+) activity,metabolic process,0.926\nbenzaldehyde dehydrogenase (NADP+) activity,metabolic process,0.932\nbenzaldehyde dehydrogenase [NAD(P)+] activity,metabolic process,0.968\nbenzene metabolic process,metabolic process,0.966\nbenzene-containing compound metabolic process,metabolic process,0.982\nbenzoate metabolic process,metabolic process,0.968\nbenzoate-CoA ligase activity,metabolic process,0.82\nbenzodiazepine receptor activity,cellular component organization,0.168\nbenzodiazepine receptor binding,receptor related process,0.502\nbenzoyl-CoA metabolic process,metabolic process,1\nbeta selection,receptor related process,0.204\n\"beta,beta-carotene-9',10'-cleaving oxygenase activity\",metabolic process,0.896\nbeta-1 adrenergic receptor binding,receptor related process,0.48\n\"beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity\",metabolic process,0.896\n\"beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity\",metabolic process,0.89\n\"beta-1,3-galactosyltransferase activity\",metabolic process,0.842\n\"beta-1,4-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity\",metabolic process,0.892\n\"beta-1,4-mannosyltransferase activity\",metabolic process,0.858\nbeta-2 adrenergic receptor binding,receptor related process,0.484\nbeta-2-microglobulin binding,metabolic process,0.204\nbeta-3 adrenergic receptor binding,receptor related process,0.498\n\"beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminide alpha-2,3- sialyltransferase\",metabolic process,0.876\nbeta-N-acetylgalactosaminidase activity,metabolic process,0.48\nbeta-N-acetylglucosaminidase activity,metabolic process,0.482\n\"beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity\",metabolic process,0.886\nbeta-N-acetylhexosaminidase activity,metabolic process,0.69\nbeta-N-acetylhexosaminidase complex,protein modification/signaling,0.286\nbeta-adrenergic receptor activity,receptor related process,0.524\nbeta-adrenergic receptor kinase activity,metabolic process,0.612\nbeta-alanine biosynthetic process,metabolic process,0.982\nbeta-alanine biosynthetic process via 3-ureidopropionate,metabolic process,0.846\nbeta-alanine metabolic process,metabolic process,0.972\nbeta-alanine transmembrane transporter activity,metabolic process,0.308\nbeta-alanine transport,transport,0.72\nbeta-aspartyl-peptidase activity,metabolic process,0.442\n\"beta-carotene 15,15'-dioxygenase activity\",metabolic process,0.896\nbeta-carotene metabolic process,metabolic process,0.994\nbeta-catenin destruction complex,protein modification/signaling,0.382\nbeta-catenin destruction complex binding,metabolic process,0.234\nbeta-catenin destruction complex disassembly,cellular component organization,0.518\nbeta-catenin-ICAT complex,gene regulation,0.296\nbeta-catenin-TCF complex assembly,cellular component organization,0.624\nbeta-catenin-TCF7L2 complex,gene regulation,0.376\nbeta-endorphin receptor activity,protein modification/signaling,0.198\nbeta-fructofuranosidase activity,metabolic process,0.854\nbeta-galactosidase activity,metabolic process,0.684\n\"beta-galactoside (CMP) alpha-2,3-sialyltransferase activity\",metabolic process,0.89\n\"beta-galactoside alpha-2,3-sialyltransferase activity\",metabolic process,0.584\n\"beta-galactoside alpha-2,6-sialyltransferase activity\",metabolic process,0.878\n\"beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity\",metabolic process,0.896\nbeta-glucosidase activity,metabolic process,0.716\nbeta-glucoside catabolic process,metabolic process,0.98\nbeta-glucoside metabolic process,metabolic process,0.996\nbeta-glucuronidase activity,metabolic process,0.9\nbeta-lactamase activity,metabolic process,0.81\nbeta-maltose 4-alpha-glucanotransferase activity,metabolic process,0.9\nbeta-mannosidase activity,metabolic process,0.69\nbeta-tubulin binding,cellular component organization,0.43\nbeta-ureidopropionase activity,metabolic process,0.896\nbeta1-adrenergic receptor activity,receptor related process,0.302\nbeta2-adrenergic receptor activity,receptor related process,0.312\nbeta3-adrenergic receptor activity,receptor related process,0.31\nbetaine-aldehyde dehydrogenase activity,metabolic process,0.93\nbetaine-homocysteine S-methyltransferase activity,metabolic process,0.896\nbicarbonate binding,metabolic process,0.232\nbicarbonate transmembrane transporter activity,transport,0.658\nbicarbonate transport,transport,0.728\nbicarbonate:monoatomic anion antiporter activity,transport,0.536\nbicellular tight junction,cell adhesion,0.36\nbicellular tight junction assembly,cellular component organization,0.478\nbile acid and bile salt transport,transport,0.922\nbile acid binding,metabolic process,0.412\nbile acid biosynthetic process,metabolic process,0.864\nbile acid catabolic process,metabolic process,0.89\nbile acid conjugation,metabolic process,0.292\nbile acid metabolic process,metabolic process,0.978\nbile acid receptor activity,receptor related process,0.48\nbile acid secretion,metabolic process,0.262\nbile acid signaling pathway,receptor related process,0.632\nbile acid transmembrane transporter activity,transport,0.636\nbile acid:sodium symporter activity,metabolic process,0.526\nbile-salt sulfotransferase activity,metabolic process,0.9\nbiliberdin reductase NAD+ activity,metabolic process,0.928\nbilirubin conjugation,metabolic process,0.886\nbilirubin transmembrane transporter activity,transport,0.634\nbilirubin transport,transport,0.728\nbiliverdin reductase (NAD(P)+) activity,metabolic process,0.986\nbiliverdin reductase (NADP+) activity,metabolic process,0.934\nbinding,metabolic process,0.384\nbinding of sperm to zona pellucida,metabolic process,0.374\nbioactive lipid receptor activity,receptor related process,0.31\nbiofilm formation,cellular component organization,0.2\nbiofilm matrix disassembly,cellular component organization,0.29\nbiofilm matrix organization,cellular component organization,0.892\nbiological phase,cell cycle,0.41\nbiological process involved in interspecies interaction between organisms,response to stimulus,0.232\nbiological process involved in intraspecies interaction between organisms,neural related process,0.398\nbiological regulation,metabolic process,0.408\nbiological_process,metabolic process,0.35\nbiomineral tissue development,morphogenesis/development,0.498\nbiosynthetic process,metabolic process,0.828\nbiosynthetic process of antibacterial peptides active against Gram-negative bacteria,metabolic process,0.756\nbiosynthetic process of antibacterial peptides active against Gram-positive bacteria,metabolic process,0.738\nbiotin binding,metabolic process,0.55\nbiotin carboxylase activity,metabolic process,0.524\nbiotin import across plasma membrane,transport,0.464\nbiotin metabolic process,metabolic process,0.968\nbiotin transmembrane transporter activity,metabolic process,0.432\nbiotin transport,transport,0.856\nbiotin-[acetyl-CoA-carboxylase] ligase activity,metabolic process,0.764\nbiotin-[methylcrotonoyl-CoA-carboxylase] ligase activity,metabolic process,0.82\nbiotin-[methylmalonyl-CoA-carboxytransferase] ligase activity,metabolic process,0.822\nbiotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity,metabolic process,0.82\nbiotin-protein ligase activity,metabolic process,0.564\nbiotinidase activity,metabolic process,0.898\nbiphenyl catabolic process,metabolic process,0.82\nbiphenyl metabolic process,metabolic process,0.884\nbis(5'-adenosyl)-hexaphosphatase activity,metabolic process,0.904\nbis(5'-adenosyl)-pentaphosphatase activity,metabolic process,0.904\nbis(5'-adenosyl)-triphosphatase activity,metabolic process,0.844\nbis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity,metabolic process,0.884\nbis(5'-nucleosyl)-tetraphosphatase (symmetrical) activity,metabolic process,0.856\nbis(5'-nucleosyl)-tetraphosphatase activity,metabolic process,0.786\nbisphosphoglycerate 3-phosphatase activity,metabolic process,0.832\nbisphosphoglycerate mutase activity,metabolic process,0.846\nblastocyst growth,cell cycle,0.552\nblastocyst hatching,cellular component organization,0.238\nblastoderm segmentation,morphogenesis/development,0.37\nbleb,cell death,0.232\nbleb assembly,cellular component organization,0.262\n\"blood coagulation, common pathway\",cellular component organization,0.192\n\"blood coagulation, fibrin clot formation\",metabolic process,0.266\n\"blood coagulation, intrinsic pathway\",protein modification/signaling,0.208\nblood microparticle,cellular component organization,0.358\nblood microparticle formation,morphogenesis/development,0.414\nblood vessel endothelial cell delamination,cell adhesion,0.326\nblood vessel endothelial cell differentiation,morphogenesis/development,0.884\nblood vessel endothelial cell fate commitment,morphogenesis/development,0.662\nblood vessel endothelial cell fate specification,morphogenesis/development,0.578\nblood vessel lumenization,morphogenesis/development,0.856\nblood vessel maturation,morphogenesis/development,0.522\nblue light photoreceptor activity,metabolic process,0.174\nblue light signaling pathway,receptor related process,0.222\nbody fluid secretion,transport,0.476\nbody morphogenesis,morphogenesis/development,0.852\nbombesin receptor activity,cellular component organization,0.17\nbombesin receptor binding,receptor related process,0.408\nbombesin receptor signaling pathway,receptor related process,0.678\nbone cell development,morphogenesis/development,0.77\nbone growth,morphogenesis/development,0.612\nbone marrow development,morphogenesis/development,0.906\nbone maturation,morphogenesis/development,0.544\nbone mineralization involved in bone maturation,morphogenesis/development,0.648\nbone regeneration,cellular component organization,0.198\nbone resorption,morphogenesis/development,0.298\nbone trabecula formation,morphogenesis/development,0.622\nborate transmembrane transport,transport,0.858\nborate transport,transport,0.966\nbounding membrane of organelle,ER/endosome/lysosome related process,0.232\nbox C/D RNA 3'-end processing,gene regulation,0.444\nbox C/D RNA binding,gene regulation,0.572\nbox C/D RNA metabolic process,metabolic process,0.63\nbox C/D RNA processing,gene regulation,0.814\nbox C/D RNP complex,gene regulation,0.404\nbox C/D snoRNP assembly,cellular component organization,0.492\nbox C/D snoRNP complex binding,metabolic process,0.236\nbox H/ACA RNA 3'-end processing,gene regulation,0.424\nbox H/ACA RNA metabolic process,metabolic process,0.638\nbox H/ACA RNA processing,gene regulation,0.786\nbox H/ACA RNP complex,gene regulation,0.5\nbox H/ACA scaRNP complex,cellular component organization,0.338\nbox H/ACA snoRNA binding,gene regulation,0.562\nbox H/ACA snoRNP assembly,cellular component organization,0.502\nbox H/ACA snoRNP complex,cellular component organization,0.356\nbox H/ACA telomerase RNP complex,gene regulation,0.244\nbradykinin catabolic process,metabolic process,0.82\nbradykinin receptor activity,cellular component organization,0.17\nbradykinin receptor binding,receptor related process,0.49\nbrahma complex,cellular component organization,0.272\nbrain development,morphogenesis/development,0.714\nbrain morphogenesis,morphogenesis/development,0.43\nbrain renin-angiotensin system,multicellular organismal process,0.218\nbrain segmentation,cellular component organization,0.19\nbrain-derived neurotrophic factor binding,metabolic process,0.212\nbrain-derived neurotrophic factor receptor activity,receptor related process,0.204\nbrain-derived neurotrophic factor receptor signaling pathway,receptor related process,0.496\nbrainstem development,morphogenesis/development,0.738\nbranch elongation involved in mammary gland duct branching,morphogenesis/development,0.668\nbranch elongation involved in salivary gland morphogenesis,morphogenesis/development,0.326\nbranch elongation involved in ureteric bud branching,morphogenesis/development,0.278\nbranch elongation of an epithelium,morphogenesis/development,0.788\nbranched-chain amino acid biosynthetic process,metabolic process,0.996\nbranched-chain amino acid metabolic process,metabolic process,0.996\nbranched-chain amino acid transmembrane transporter activity,transport,0.766\nbranched-chain amino acid transport,transport,0.934\nbranched-chain amino acid:sodium symporter activity,metabolic process,0.516\nbranched-chain-amino-acid transaminase activity,metabolic process,0.866\nbranching involved in labyrinthine layer morphogenesis,morphogenesis/development,0.614\nbranching involved in lymph vessel morphogenesis,morphogenesis/development,0.288\nbranching involved in pancreas morphogenesis,morphogenesis/development,0.83\nbranching involved in prostate gland morphogenesis,morphogenesis/development,0.826\nbranching involved in salivary gland morphogenesis,morphogenesis/development,0.83\nbranching involved in ureteric bud morphogenesis,morphogenesis/development,0.792\nbranching morphogenesis of a nerve,morphogenesis/development,0.558\nbranchiomeric skeletal muscle development,morphogenesis/development,0.892\nbranchiomotor neuron axon guidance,neural related process,0.348\nbrassinosteroid biosynthetic process,metabolic process,0.878\nbrassinosteroid metabolic process,metabolic process,0.946\nbrexanolone catabolic process,metabolic process,0.896\nbrexanolone metabolic process,metabolic process,0.968\nbronchiole development,morphogenesis/development,0.896\nbronchiole morphogenesis,morphogenesis/development,0.476\nbronchus cartilage development,morphogenesis/development,0.982\nbronchus development,morphogenesis/development,0.976\nbronchus morphogenesis,morphogenesis/development,0.5\nbrown fat cell proliferation,cell cycle,0.78\nbrush border assembly,cellular component organization,0.414\nbrush border membrane,cellular component organization,0.432\nbub1-bub3 complex,cellular component organization,0.29\nbubble DNA binding,cell cycle,0.23\nbud dilation involved in lung branching,morphogenesis/development,0.342\nbud elongation involved in lung branching,morphogenesis/development,0.434\nbud outgrowth involved in lung branching,morphogenesis/development,0.278\nbundle of His cell action potential,cellular component organization,0.214\nbundle of His cell to Purkinje myocyte communication,cell adhesion,0.156\nbundle of His cell to Purkinje myocyte communication by electrical coupling,protein modification/signaling,0.34\nbundle of His cell to Purkinje myocyte signaling,metabolic process,0.252\nbundle of His cell-Purkinje myocyte adhesion involved in cell communication,cell adhesion,0.374\nbundle of His development,morphogenesis/development,0.872\nbutanol dehydrogenase activity,metabolic process,0.928\nbutyrate catabolic process,metabolic process,0.902\nbutyrate metabolic process,metabolic process,0.988\nbutyrate-CoA ligase activity,metabolic process,0.84\nbutyryl-CoA catabolic process,metabolic process,0.89\nbutyryl-CoA dehydrogenase activity,metabolic process,0.892\nc-di-GMP signaling,protein modification/signaling,0.2\ncAMP binding,metabolic process,0.266\ncAMP biosynthetic process,metabolic process,0.852\ncAMP catabolic process,metabolic process,0.85\ncAMP metabolic process,metabolic process,0.982\ncAMP response element binding protein binding,protein modification/signaling,0.348\ncAMP transport,transport,0.424\ncAMP-dependent protein kinase activity,metabolic process,0.592\ncAMP-dependent protein kinase complex,metabolic process,0.316\ncAMP-dependent protein kinase inhibitor activity,protein modification/signaling,0.4\ncAMP-dependent protein kinase regulator activity,protein modification/signaling,0.61\ncAMP-mediated signaling,protein modification/signaling,0.296\ncGAS/STING signaling pathway,immune system process,0.356\ncGMP binding,gene regulation,0.232\ncGMP biosynthetic process,metabolic process,0.824\ncGMP catabolic process,metabolic process,0.86\ncGMP metabolic process,metabolic process,0.994\ncGMP transport,transport,0.424\ncGMP-dependent protein kinase activity,metabolic process,0.6\ncGMP-inhibited cyclic-nucleotide phosphodiesterase activity,metabolic process,0.814\ncGMP-mediated signaling,protein modification/signaling,0.29\ncGMP-stimulated cyclic-nucleotide phosphodiesterase activity,metabolic process,0.814\ncadmium ion binding,metabolic process,0.19\ncadmium ion transmembrane transport,transport,0.404\ncadmium ion transmembrane transporter activity,transport,0.61\ncadmium ion transport,transport,0.982\ncaffeine oxidase activity,metabolic process,0.906\ncalcidiol 1-monooxygenase activity,metabolic process,0.932\ncalcidiol binding,metabolic process,0.236\ncalcineurin complex,metabolic process,0.256\ncalcineurin-NFAT signaling cascade,protein modification/signaling,0.326\ncalcineurin-mediated signaling,immune system process,0.226\ncalcitonin binding,metabolic process,0.14\ncalcitonin catabolic process,metabolic process,0.858\ncalcitonin family binding,protein modification/signaling,0.222\ncalcitonin family receptor activity,receptor related process,0.612\ncalcitonin family receptor complex,receptor related process,0.308\ncalcitonin family receptor signaling pathway,receptor related process,0.788\ncalcitonin gene-related peptide binding,metabolic process,0.246\ncalcitonin gene-related peptide receptor activity,cellular component organization,0.176\ncalcitonin gene-related peptide receptor signaling pathway,receptor related process,0.48\ncalcitonin receptor activity,cellular component organization,0.276\ncalcitonin receptor binding,receptor related process,0.498\ncalcitriol binding,metabolic process,0.27\ncalcitriol biosynthetic process from calciol,metabolic process,0.23\ncalcium activated galactosylceramide scrambling,cellular component organization,0.186\ncalcium activated phosphatidylcholine scrambling,cellular component organization,0.186\ncalcium activated phosphatidylserine scrambling,cellular component organization,0.186\ncalcium activated phospholipid scrambling,transport,0.442\ncalcium channel activity,transport,0.556\ncalcium channel complex,transport,0.3\ncalcium channel inhibitor activity,metabolic process,0.23\ncalcium channel regulator activity,metabolic process,0.246\ncalcium export from the mitochondrion,transport,0.778\ncalcium import into the mitochondrion,transport,0.828\ncalcium ion binding involved in regulation of cytosolic calcium ion concentration,protein modification/signaling,0.21\ncalcium ion binding involved in regulation of postsynaptic cytosolic calcium ion concentration,protein modification/signaling,0.202\ncalcium ion binding involved in regulation of presynaptic cytosolic calcium ion concentration,protein modification/signaling,0.208\ncalcium ion export,transport,0.432\ncalcium ion export across plasma membrane,transport,0.466\ncalcium ion import,transport,0.338\ncalcium ion import across plasma membrane,transport,0.46\ncalcium ion import into cytosol,transport,0.36\ncalcium ion import into sarcoplasmic reticulum,transport,0.34\ncalcium ion regulated lysosome exocytosis,cellular component organization,0.194\ncalcium ion sensor activity,metabolic process,0.174\ncalcium ion sequestering activity,transport,0.22\ncalcium ion transmembrane transport,transport,0.866\ncalcium ion transmembrane transport via high voltage-gated calcium channel,transport,0.284\ncalcium ion transmembrane transport via low voltage-gated calcium channel,transport,0.274\ncalcium ion transmembrane transporter activity,transport,0.61\ncalcium ion transport from cytosol to endoplasmic reticulum,transport,0.29\ncalcium ion transport into cytosol,transport,0.318\ncalcium ion-regulated exocytosis of neurotransmitter,transport,0.464\ncalcium ion-transporting ATPase complex,metabolic process,0.424\ncalcium oxalate binding,metabolic process,0.328\ncalcium sensitive guanylate cyclase activator activity,metabolic process,0.192\n\"calcium, potassium:sodium antiporter activity\",metabolic process,0.52\ncalcium- and calmodulin-dependent protein kinase complex,cellular component organization,0.382\ncalcium- and calmodulin-responsive adenylate cyclase activity,metabolic process,0.802\ncalcium-activated potassium channel activity,transport,0.524\ncalcium-dependent ATPase activity,metabolic process,0.686\ncalcium-dependent activation of synaptic vesicle fusion,cellular component organization,0.23\ncalcium-dependent carbohydrate binding,metabolic process,0.266\ncalcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules,cell adhesion,0.316\ncalcium-dependent cell-matrix adhesion,cell adhesion,0.214\ncalcium-dependent cysteine-type endopeptidase activity,metabolic process,0.458\ncalcium-dependent cysteine-type endopeptidase inhibitor activity,metabolic process,0.398\ncalcium-dependent phospholipase A2 activity,metabolic process,0.854\ncalcium-dependent phospholipase C activity,metabolic process,0.824\ncalcium-dependent phospholipid binding,metabolic process,0.274\ncalcium-dependent protein kinase activity,protein modification/signaling,0.456\ncalcium-dependent protein kinase inhibitor activity,protein modification/signaling,0.4\ncalcium-dependent protein kinase regulator activity,protein modification/signaling,0.616\ncalcium-dependent protein serine/threonine kinase activity,protein modification/signaling,0.486\ncalcium-dependent protein serine/threonine phosphatase activity,metabolic process,0.446\ncalcium-dependent protein serine/threonine phosphatase regulator activity,protein modification/signaling,0.4\ncalcium-dependent self proteolysis,protein modification/signaling,0.296\ncalcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules,cell adhesion,0.286\ncalcium-independent cell-matrix adhesion,cell adhesion,0.22\ncalcium-independent phospholipase A2 activity,metabolic process,0.876\ncalcium-induced calcium release activity,transport,0.504\ncalcium-ion regulated exocytosis,transport,0.576\ncalcium-mediated signaling using extracellular calcium source,protein modification/signaling,0.258\ncalcium-mediated signaling using intracellular calcium source,protein modification/signaling,0.282\ncalcium-release channel activity,transport,0.454\ncalcium:manganese antiporter activity,metabolic process,0.89\ncalcium:monoatomic cation antiporter activity,transport,0.486\ncalcium:monoatomic cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration,metabolic process,0.188\ncalcium:proton antiporter activity,metabolic process,0.53\ncalcium:sodium antiporter activity,transport,0.456\ncalcium:sodium antiporter activity involved in regulation of cardiac muscle cell membrane potential,metabolic process,0.376\ncalmodulin dependent kinase signaling pathway,protein modification/signaling,0.362\n\"calmodulin-activated 3',5'-cyclic-GMP phosphodiesterase activity\",metabolic process,0.752\n\"calmodulin-activated dual specificity 3',5'-cyclic-GMP, 3',5'-cyclic-AMP phosphodiesterase activity\",metabolic process,0.77\ncalmodulin-dependent protein kinase activity,protein modification/signaling,0.522\ncalmodulin-dependent protein phosphatase activity,metabolic process,0.58\ncalmodulin-lysine N-methyltransferase activity,metabolic process,0.896\ncalpain complex,cellular component organization,0.27\ncalyx of Held,neural related process,0.328\ncamera-type eye morphogenesis,morphogenesis/development,0.746\ncamera-type eye photoreceptor cell differentiation,morphogenesis/development,0.782\ncamera-type eye photoreceptor cell fate commitment,morphogenesis/development,0.574\ncanalicular bile acid transmembrane transporter activity,transport,0.526\ncanalicular bile acid transport,metabolic process,0.296\ncannabinoid biosynthetic process,metabolic process,0.888\ncannabinoid receptor activity,metabolic process,0.232\ncannabinoid receptor binding,receptor related process,0.476\ncannabinoid signaling pathway,receptor related process,0.624\ncanonical NF-kappaB signal transduction,immune system process,0.314\ncanonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,receptor related process,0.352\ncanonical Wnt signaling pathway involved in heart development,receptor related process,0.382\ncanonical Wnt signaling pathway involved in mesenchymal stem cell differentiation,receptor related process,0.304\ncanonical Wnt signaling pathway involved in metanephric kidney development,receptor related process,0.386\ncanonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,neural related process,0.212\ncanonical Wnt signaling pathway involved in negative regulation of apoptotic process,cell death,0.302\ncanonical Wnt signaling pathway involved in neural crest cell differentiation,receptor related process,0.414\ncanonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation,receptor related process,0.312\ncanonical Wnt signaling pathway involved in osteoblast differentiation,receptor related process,0.316\ncanonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation,cell cycle,0.276\ncanonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition,receptor related process,0.304\ncanonical Wnt signaling pathway involved in regulation of cell proliferation,receptor related process,0.38\ncanonical Wnt signaling pathway involved in regulation of type B pancreatic cell proliferation,receptor related process,0.272\ncanonical Wnt signaling pathway involved in stem cell proliferation,protein modification/signaling,0.192\ncanonical inflammasome complex,protein modification/signaling,0.194\ncanonical inflammasome complex assembly,cellular component organization,0.794\ncap mRNA methylation,gene regulation,0.732\ncap-dependent translational initiation,cellular component organization,0.198\ncap-independent translational initiation,gene regulation,0.402\ncap-independent translational initiation of linear mRNA,cellular component organization,0.238\ncap1 mRNA methylation,gene regulation,0.282\ncap2 mRNA methylation,gene regulation,0.282\ncarbamoyl phosphate biosynthetic process,metabolic process,0.796\ncarbamoyl phosphate metabolic process,metabolic process,0.974\ncarbamoyl-phosphate synthase (ammonia) activity,metabolic process,0.748\ncarbamoyl-phosphate synthase (glutamine-hydrolyzing) activity,metabolic process,0.754\ncarbohydrate binding,metabolic process,0.498\ncarbohydrate catabolic process,metabolic process,0.98\ncarbohydrate derivative binding,other,0.364\ncarbohydrate derivative metabolic process,metabolic process,0.896\ncarbohydrate derivative transmembrane transporter activity,transport,0.698\ncarbohydrate homeostasis,metabolic process,0.568\ncarbohydrate import across plasma membrane,transport,0.836\ncarbohydrate kinase activity,metabolic process,0.708\ncarbohydrate mediated signaling,protein modification/signaling,0.278\ncarbohydrate phosphatase activity,metabolic process,0.79\ncarbohydrate phosphorylation,metabolic process,0.392\ncarbohydrate response element binding,gene regulation,0.46\ncarbohydrate transmembrane transporter activity,transport,0.722\ncarbohydrate:monoatomic cation symporter activity,transport,0.564\ncarbohydrate:proton symporter activity,transport,0.502\ncarbon catabolite activation of transcription,gene regulation,0.486\ncarbon catabolite activation of transcription from RNA polymerase II promoter,gene regulation,0.47\ncarbon catabolite regulation of transcription,gene regulation,0.482\ncarbon catabolite regulation of transcription from RNA polymerase II promoter,gene regulation,0.474\ncarbon dioxide transmembrane transport,cellular component organization,0.266\ncarbon dioxide transmembrane transporter activity,cellular component organization,0.278\ncarbon dioxide transport,transport,0.97\ncarbon monoxide binding,metabolic process,0.232\ncarbon tetrachloride metabolic process,metabolic process,0.852\ncarbon-carbon lyase activity,metabolic process,0.678\ncarbon-nitrogen lyase activity,metabolic process,0.636\n\"carbon-oxygen lyase activity, acting on phosphates\",metabolic process,0.786\ncarbon-sulfur lyase activity,metabolic process,0.846\ncarbonate dehydratase activity,metabolic process,0.898\ncarbonyl reductase (NADPH) activity,metabolic process,0.934\ncarboxy-lyase activity,metabolic process,0.716\ncarboxy-terminal domain protein kinase complex,protein modification/signaling,0.36\ncarboxyl- or carbamoyltransferase activity,metabolic process,0.908\ncarboxyl-O-methyltransferase activity,metabolic process,0.746\ncarboxylesterase activity,metabolic process,0.872\ncarboxylic acid binding,metabolic process,0.44\ncarboxylic acid transport,transport,0.92\ncarboxylic ester hydrolase activity,metabolic process,0.642\ncarboxypeptidase activity,metabolic process,0.55\ncardiac Troponin complex,cellular component organization,0.324\ncardiac atrium development,morphogenesis/development,0.942\ncardiac atrium formation,morphogenesis/development,0.832\ncardiac atrium morphogenesis,morphogenesis/development,0.902\ncardiac cell development,morphogenesis/development,0.802\ncardiac cell fate commitment,morphogenesis/development,0.54\ncardiac cell fate determination,morphogenesis/development,0.628\ncardiac cell fate specification,morphogenesis/development,0.608\ncardiac chamber ballooning,cellular component organization,0.212\ncardiac chamber formation,morphogenesis/development,0.872\ncardiac conduction,multicellular organismal process,0.702\ncardiac conduction system development,morphogenesis/development,0.91\ncardiac endothelial cell differentiation,morphogenesis/development,0.882\ncardiac endothelial to mesenchymal transition,cellular component organization,0.288\ncardiac epithelial to mesenchymal transition,morphogenesis/development,0.72\ncardiac fibroblast cell development,morphogenesis/development,0.888\ncardiac fibroblast cell differentiation,morphogenesis/development,0.826\ncardiac jelly development,morphogenesis/development,0.974\ncardiac left ventricle formation,morphogenesis/development,0.582\ncardiac left ventricle morphogenesis,morphogenesis/development,0.51\ncardiac muscle adaptation,multicellular organismal process,0.468\ncardiac muscle cell action potential,neural related process,0.17\ncardiac muscle cell action potential involved in contraction,cellular component organization,0.176\ncardiac muscle cell contraction,cellular component organization,0.322\ncardiac muscle cell development,morphogenesis/development,0.826\ncardiac muscle cell differentiation,morphogenesis/development,0.756\ncardiac muscle cell fate commitment,morphogenesis/development,0.678\ncardiac muscle cell membrane repolarization,transport,0.31\ncardiac muscle cell myoblast differentiation,morphogenesis/development,0.636\ncardiac muscle cell-cardiac muscle cell adhesion,cell adhesion,0.648\ncardiac muscle contraction,multicellular organismal process,0.362\ncardiac muscle hypertrophy in response to stress,multicellular organismal process,0.27\ncardiac muscle myoblast proliferation,cell cycle,0.808\ncardiac muscle thin filament assembly,cellular component organization,0.544\ncardiac muscle tissue growth,morphogenesis/development,0.722\ncardiac muscle tissue growth involved in heart morphogenesis,morphogenesis/development,0.44\ncardiac muscle tissue morphogenesis,morphogenesis/development,0.904\ncardiac muscle tissue regeneration,morphogenesis/development,0.198\ncardiac myofibril,cellular component organization,0.2\ncardiac neural crest cell development involved in heart development,morphogenesis/development,0.886\ncardiac neural crest cell development involved in outflow tract morphogenesis,morphogenesis/development,0.674\ncardiac neural crest cell differentiation involved in heart development,morphogenesis/development,0.762\ncardiac neural crest cell migration involved in outflow tract morphogenesis,morphogenesis/development,0.33\ncardiac neuron differentiation,morphogenesis/development,0.522\ncardiac pacemaker cell development,morphogenesis/development,0.912\ncardiac pacemaker cell differentiation,morphogenesis/development,0.902\ncardiac pacemaker cell fate commitment,morphogenesis/development,0.674\ncardiac right atrium morphogenesis,morphogenesis/development,0.4\ncardiac right ventricle formation,morphogenesis/development,0.6\ncardiac right ventricle morphogenesis,morphogenesis/development,0.446\ncardiac septum cell differentiation,morphogenesis/development,0.758\ncardiac septum morphogenesis,morphogenesis/development,0.948\ncardiac vascular smooth muscle cell development,morphogenesis/development,0.93\ncardiac vascular smooth muscle cell differentiation,morphogenesis/development,0.872\ncardiac ventricle formation,morphogenesis/development,0.858\ncardiac ventricle morphogenesis,morphogenesis/development,0.942\ncardioblast anterior-lateral migration,morphogenesis/development,0.222\ncardioblast cell fate commitment,morphogenesis/development,0.274\ncardioblast cell fate specification,morphogenesis/development,0.554\ncardioblast differentiation,morphogenesis/development,0.862\ncardioblast migration,morphogenesis/development,0.362\ncardioblast migration to the midline involved in heart field formation,morphogenesis/development,0.344\ncardioblast proliferation,cell cycle,0.642\ncardiogenic plate morphogenesis,morphogenesis/development,0.724\ncardiolipin acyl-chain remodeling,metabolic process,0.61\ncardiolipin binding,metabolic process,0.228\ncardiolipin biosynthetic process,metabolic process,0.864\ncardiolipin hydrolase activity,metabolic process,0.598\ncardiolipin metabolic process,metabolic process,0.952\ncardiolipin synthase (CMP-forming),metabolic process,0.884\ncardiolipin synthase activity,metabolic process,0.884\ncargo adaptor activity,receptor related process,0.22\ncargo receptor activity,transport,0.17\ncargo receptor ligand activity,receptor related process,0.244\ncarnitine O-acetyltransferase activity,metabolic process,0.892\ncarnitine O-acyltransferase activity,metabolic process,0.928\ncarnitine O-octanoyltransferase activity,metabolic process,0.892\ncarnitine O-palmitoyltransferase activity,metabolic process,0.892\ncarnitine biosynthetic process,metabolic process,0.772\ncarnitine catabolic process,metabolic process,0.762\ncarnitine metabolic process,metabolic process,0.902\n\"carnitine metabolic process, CoA-linked\",metabolic process,0.866\ncarnitine shuttle,metabolic process,0.288\ncarnitine transmembrane transport,transport,0.798\ncarnitine transmembrane transporter activity,transport,0.582\ncarnitine transport,transport,0.912\ncarnosine N-methyltransferase activity,metabolic process,0.896\ncarnosine biosynthetic process,metabolic process,0.892\ncarnosine metabolic process,metabolic process,0.954\ncarnosine synthase activity,metabolic process,0.822\ncarotene catabolic process,metabolic process,0.99\ncarotene metabolic process,metabolic process,0.996\ncarotenoid biosynthetic process,metabolic process,0.988\ncarotenoid catabolic process,metabolic process,0.992\ncarotenoid dioxygenase activity,metabolic process,0.788\ncarotenoid metabolic process,metabolic process,0.996\ncarotenoid transport,transport,0.698\ncarotid body glomus cell differentiation,morphogenesis/development,0.734\ncartilage condensation,morphogenesis/development,0.324\ncartilage development,morphogenesis/development,0.938\ncartilage development involved in endochondral bone morphogenesis,morphogenesis/development,0.94\ncartilage homeostasis,other,0.208\ncartilage morphogenesis,morphogenesis/development,0.884\ncaspase binding,protein modification/signaling,0.312\ncaspase complex,cell death,0.476\ncatabolic process,metabolic process,0.696\ncatagen,cell cycle,0.242\ncatalase activity,metabolic process,0.896\ncatalase complex,cellular component organization,0.302\ncatalytic activity,metabolic process,0.43\n\"catalytic activity, acting on a glycoprotein\",metabolic process,0.648\n\"catalytic activity, acting on a protein\",protein modification/signaling,0.448\n\"catalytic activity, acting on a rRNA\",gene regulation,0.43\n\"catalytic activity, acting on a tRNA\",metabolic process,0.376\ncatalytic complex,metabolic process,0.296\ncatalytic step 1 spliceosome,gene regulation,0.644\ncatechol O-methyltransferase activity,metabolic process,0.896\ncatechol-containing compound biosynthetic process,metabolic process,0.974\ncatechol-containing compound catabolic process,metabolic process,0.954\ncatechol-containing compound metabolic process,metabolic process,0.944\ncatecholamine binding,gene regulation,0.258\ncatecholamine biosynthetic process,metabolic process,0.948\ncatecholamine catabolic process,metabolic process,0.948\ncatecholamine metabolic process,metabolic process,0.948\ncatecholamine secretion,transport,0.604\ncatecholamine transport,transport,0.562\ncatecholamine uptake,transport,0.662\ncatecholamine uptake involved in synaptic transmission,transport,0.488\ncatenin complex,cellular component organization,0.288\ncatenin-TCF7L2 complex,gene regulation,0.394\ncation binding,metabolic process,0.192\ncation channel complex,transport,0.35\ncation-transporting ATPase complex,transport,0.312\ncaudate nucleus development,morphogenesis/development,0.706\ncaveola,cellular component organization,0.27\ncaveola assembly,cellular component organization,0.546\ncaveola neck,cellular component organization,0.494\ncaveolar macromolecular signaling complex,protein modification/signaling,0.406\ncaveolin-mediated endocytosis,transport,0.756\ncell activation,morphogenesis/development,0.486\ncell adhesion,cell adhesion,0.766\ncell adhesion involved in heart morphogenesis,cell adhesion,0.344\ncell adhesion involved in sprouting angiogenesis,cell adhesion,0.234\ncell adhesive protein binding involved in AV node cell-bundle of His cell communication,protein modification/signaling,0.252\ncell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication,protein modification/signaling,0.226\ncell aggregation,morphogenesis/development,0.3\ncell body,neural related process,0.486\ncell body fiber,neural related process,0.36\ncell body membrane,neural related process,0.418\ncell chemotaxis to fibroblast growth factor,transport,0.198\ncell chemotaxis to vascular endothelial growth factor,transport,0.21\ncell communication,metabolic process,0.184\ncell communication by chemical coupling,protein modification/signaling,0.294\ncell communication by electrical coupling,protein modification/signaling,0.236\ncell communication by electrical coupling involved in cardiac conduction,protein modification/signaling,0.204\ncell communication involved in cardiac conduction,cell adhesion,0.232\ncell competition in a multicellular organism,multicellular organismal process,0.214\ncell cortex region,cellular component organization,0.502\ncell cycle,cell cycle,0.79\ncell cycle DNA replication initiation,cell cycle,0.65\ncell cycle DNA replication maintenance of fidelity,cell cycle,0.678\ncell cycle DNA replication termination,cell cycle,0.582\ncell cycle comprising mitosis without cytokinesis,cell cycle,0.758\ncell cycle process,cell cycle,0.764\ncell cycle switching,cell cycle,0.762\n\"cell cycle switching, mitotic to meiotic cell cycle\",cell cycle,0.746\ncell dedifferentiation,morphogenesis/development,0.662\ncell dedifferentiation involved in phenotypic switching,morphogenesis/development,0.564\ncell development,morphogenesis/development,0.302\ncell differentiation,morphogenesis/development,0.246\ncell differentiation in hindbrain,morphogenesis/development,0.754\ncell differentiation in spinal cord,morphogenesis/development,0.676\ncell differentiation involved in embryonic placenta development,morphogenesis/development,0.866\ncell differentiation involved in phenotypic switching,morphogenesis/development,0.706\ncell differentiation involved in salivary gland development,morphogenesis/development,0.804\ncell division site,cell cycle,0.332\ncell envelope organization,cellular component organization,0.678\ncell fate commitment involved in formation of primary germ layer,morphogenesis/development,0.742\ncell fate commitment involved in pattern specification,morphogenesis/development,0.35\ncell fate determination,morphogenesis/development,0.524\ncell fate determination involved in pattern specification,morphogenesis/development,0.572\ncell fate specification,morphogenesis/development,0.584\ncell fate specification involved in pattern specification,morphogenesis/development,0.608\ncell gliding,cell cycle,0.162\ncell growth involved in cardiac muscle cell development,morphogenesis/development,0.828\ncell junction,neural related process,0.256\ncell leading edge,cellular component organization,0.53\ncell migration in diencephalon,transport,0.186\ncell migration in hindbrain,neural related process,0.226\ncell migration involved in coronary angiogenesis,morphogenesis/development,0.252\ncell migration involved in coronary vasculogenesis,morphogenesis/development,0.196\ncell migration involved in endocardial cushion formation,morphogenesis/development,0.238\ncell migration involved in gastrulation,morphogenesis/development,0.22\ncell migration involved in heart development,morphogenesis/development,0.624\ncell migration involved in heart formation,morphogenesis/development,0.372\ncell migration involved in kidney development,morphogenesis/development,0.59\ncell migration involved in mesendoderm migration,morphogenesis/development,0.208\ncell migration involved in metanephros development,morphogenesis/development,0.59\ncell migration involved in somitogenic axis elongation,morphogenesis/development,0.202\ncell migration involved in vasculogenesis,morphogenesis/development,0.23\ncell migration to the midline involved in heart development,morphogenesis/development,0.53\ncell morphogenesis involved in neuron differentiation,neural related process,0.488\ncell motility involved in cerebral cortex radial glia guided migration,transport,0.194\ncell part morphogenesis,neural related process,0.466\ncell periphery,cell adhesion,0.114\ncell pole,cellular component organization,0.306\ncell population proliferation,cell cycle,0.288\ncell projection,cellular component organization,0.3\ncell projection morphogenesis,neural related process,0.61\ncell projection organization,cellular component organization,0.442\ncell proliferation in bone marrow,cell cycle,0.782\ncell proliferation in external granule layer,cell cycle,0.67\ncell proliferation in forebrain,cell cycle,0.592\ncell proliferation in hindbrain,cell cycle,0.77\ncell proliferation in midbrain,cell cycle,0.784\ncell proliferation involved in embryonic placenta development,cell cycle,0.824\ncell proliferation involved in heart morphogenesis,cell cycle,0.65\ncell proliferation involved in heart valve development,cell cycle,0.554\ncell proliferation involved in heart valve morphogenesis,cell cycle,0.316\ncell proliferation involved in mesonephros development,cell cycle,0.838\ncell proliferation involved in metanephros development,cell cycle,0.84\ncell proliferation involved in outflow tract morphogenesis,cell cycle,0.722\ncell recognition,neural related process,0.35\ncell septum assembly,cellular component organization,0.712\ncell surface,immune system process,0.212\ncell surface bile acid receptor signaling pathway,receptor related process,0.562\ncell surface receptor signaling pathway,receptor related process,0.132\ncell surface receptor signaling pathway involved in heart development,receptor related process,0.356\ncell tip,cellular component organization,0.39\ncell tip growth,morphogenesis/development,0.748\ncell trailing edge,transport,0.334\ncell trailing edge membrane,cellular component organization,0.524\ncell volume homeostasis,cellular component organization,0.56\ncell wall glycoprotein biosynthetic process,metabolic process,0.9\ncell wall macromolecule metabolic process,metabolic process,0.828\ncell wall mannoprotein biosynthetic process,metabolic process,0.612\ncell wall organization or biogenesis,cellular component organization,0.644\ncell-cell adhesion in response to extracellular stimulus,cell adhesion,0.226\ncell-cell adhesion involved in gastrulation,cell adhesion,0.566\ncell-cell adhesion involved in neuronal-glial interactions involved in cerebral cortex radial glia guided migration,neural related process,0.302\ncell-cell adhesion involved in synapse maturation,neural related process,0.218\ncell-cell adhesion mediated by cadherin,cell adhesion,0.156\ncell-cell adhesion mediated by integrin,cell adhesion,0.254\ncell-cell adhesion mediator activity,cell adhesion,0.598\ncell-cell contact zone,cell adhesion,0.428\ncell-cell junction,cell adhesion,0.366\ncell-cell junction assembly,cellular component organization,0.76\ncell-cell junction disassembly,cellular component organization,0.774\ncell-cell junction maintenance,cellular component organization,0.7\ncell-cell recognition,morphogenesis/development,0.226\ncell-cell signaling,protein modification/signaling,0.216\ncell-cell signaling involved in cardiac conduction,protein modification/signaling,0.15\ncell-cell signaling involved in cell fate commitment,morphogenesis/development,0.17\ncell-cell signaling involved in kidney development,morphogenesis/development,0.492\ncell-cell signaling involved in lung development,morphogenesis/development,0.43\ncell-cell signaling involved in mammary gland development,morphogenesis/development,0.59\ncell-cell signaling involved in metanephros development,morphogenesis/development,0.482\ncell-cell signaling via exosome,protein modification/signaling,0.192\ncell-matrix adhesion involved in ameboidal cell migration,transport,0.282\ncell-matrix adhesion mediator activity,cell adhesion,0.282\ncell-substrate junction disassembly,cellular component organization,0.774\ncellobiose catabolic process,metabolic process,0.896\ncellobiose glucosidase activity,metabolic process,0.9\ncellobiose metabolic process,metabolic process,0.942\ncellular alkene metabolic process,metabolic process,0.968\ncellular anatomical entity,metabolic process,0.336\ncellular aromatic compound metabolic process,metabolic process,0.802\ncellular biogenic amine catabolic process,metabolic process,0.928\ncellular biosynthetic process,metabolic process,0.85\ncellular catabolic process,metabolic process,0.784\ncellular component assembly,cellular component organization,0.508\ncellular component biogenesis,cellular component organization,0.48\ncellular component disassembly involved in execution phase of apoptosis,cellular component organization,0.446\ncellular component morphogenesis,neural related process,0.404\ncellular component organization,cellular component organization,0.358\ncellular component organization or biogenesis,cellular component organization,0.34\ncellular defense response,immune system process,0.292\ncellular detoxification of aldehyde,metabolic process,0.27\ncellular detoxification of cadmium ion,morphogenesis/development,0.18\ncellular detoxification of hydrogen peroxide,morphogenesis/development,0.236\ncellular detoxification of metal ion,cellular component organization,0.256\ncellular detoxification of methylglyoxal,metabolic process,0.264\ncellular detoxification of nitrogen compound,metabolic process,0.304\ncellular developmental process,morphogenesis/development,0.218\ncellular heat acclimation,cellular component organization,0.158\ncellular hyperosmotic response,stress response,0.628\ncellular hyperosmotic salinity response,response to stimulus,0.614\ncellular hypotonic response,stress response,0.6\ncellular hypotonic salinity response,response to stimulus,0.674\ncellular ketone body metabolic process,metabolic process,0.922\ncellular lipid biosynthetic process,metabolic process,0.936\ncellular lipid metabolic process,metabolic process,0.902\ncellular localization,cellular component organization,0.404\ncellular macromolecule localization,transport,0.434\ncellular metabolic process,metabolic process,0.704\ncellular modified amino acid catabolic process,metabolic process,0.98\ncellular nitrogen compound biosynthetic process,metabolic process,0.892\ncellular nitrogen compound metabolic process,metabolic process,0.804\ncellular organofluorine metabolic process,metabolic process,0.712\ncellular organohalogen metabolic process,metabolic process,0.776\ncellular oxidant detoxification,response to stimulus,0.222\ncellular pigment accumulation,immune system process,0.262\ncellular process,metabolic process,0.332\ncellular process involved in reproduction in multicellular organism,cell cycle,0.188\ncellular response to 1-oleoyl-sn-glycerol 3-phosphate,response to stimulus,0.872\n\"cellular response to 2,3,7,8-tetrachlorodibenzodioxine\",response to stimulus,0.874\ncellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine,response to stimulus,0.874\n\"cellular response to 3,3',5-triiodo-L-thyronine\",response to stimulus,0.86\ncellular response to ATP,response to stimulus,0.87\ncellular response to BMP stimulus,response to stimulus,0.742\ncellular response to L-arginine,response to stimulus,0.87\ncellular response to L-ascorbic acid,response to stimulus,0.87\ncellular response to L-glutamate,response to stimulus,0.864\ncellular response to L-glutamine,response to stimulus,0.872\ncellular response to L-phenylalanine derivative,response to stimulus,0.932\ncellular response to Thyroglobulin triiodothyronine,response to stimulus,0.876\ncellular response to Thyroid stimulating hormone,response to stimulus,0.874\ncellular response to UV-A,response to stimulus,0.838\ncellular response to UV-B,response to stimulus,0.8\ncellular response to UV-C,response to stimulus,0.838\ncellular response to X-ray,response to stimulus,0.54\ncellular response to abscisic acid stimulus,response to stimulus,0.868\ncellular response to absence of light,response to stimulus,0.756\ncellular response to acetylcholine,response to stimulus,0.836\ncellular response to acid chemical,response to stimulus,0.746\ncellular response to acidic pH,response to stimulus,0.596\ncellular response to actinomycin D,response to stimulus,0.844\ncellular response to aldosterone,response to stimulus,0.872\ncellular response to alkaline pH,response to stimulus,0.83\ncellular response to alkaloid,response to stimulus,0.872\ncellular response to aluminum ion,response to stimulus,0.858\ncellular response to amine stimulus,response to stimulus,0.894\ncellular response to amino acid stimulus,response to stimulus,0.842\ncellular response to ammonium ion,response to stimulus,0.864\ncellular response to anisomycin,response to stimulus,0.852\ncellular response to anoxia,response to stimulus,0.87\ncellular response to antibiotic,response to stimulus,0.866\ncellular response to arsenite ion,response to stimulus,0.934\ncellular response to arsenite(3-),response to stimulus,0.872\ncellular response to azide,response to stimulus,0.876\ncellular response to bacterial lipopeptide,response to stimulus,0.8\ncellular response to bacterial lipoprotein,response to stimulus,0.816\ncellular response to bile acid,response to stimulus,0.846\ncellular response to bisphenol A,response to stimulus,0.86\ncellular response to bleomycin,response to stimulus,0.874\ncellular response to blue light,response to stimulus,0.734\ncellular response to brain-derived neurotrophic factor stimulus,response to stimulus,0.822\ncellular response to butyrate,response to stimulus,0.866\ncellular response to cGMP,response to stimulus,0.874\ncellular response to cadmium ion,response to stimulus,0.868\ncellular response to caffeine,response to stimulus,0.842\ncellular response to calcium ion,response to stimulus,0.836\ncellular response to caloric restriction,response to stimulus,0.734\ncellular response to camptothecin,response to stimulus,0.852\ncellular response to carbohydrate stimulus,response to stimulus,0.868\ncellular response to carbon dioxide,response to stimulus,0.88\ncellular response to catecholamine stimulus,response to stimulus,0.894\ncellular response to chemical stimulus,response to stimulus,0.324\ncellular response to chloroquine,response to stimulus,0.856\ncellular response to cholesterol,response to stimulus,0.876\ncellular response to cisplatin,response to stimulus,0.872\ncellular response to cobalt ion,response to stimulus,0.852\ncellular response to cocaine,response to stimulus,0.872\ncellular response to cold,stress response,0.562\ncellular response to copper ion,response to stimulus,0.816\ncellular response to copper ion starvation,response to stimulus,0.758\ncellular response to corticosterone stimulus,response to stimulus,0.714\ncellular response to corticotropin-releasing hormone stimulus,response to stimulus,0.85\ncellular response to cortisol stimulus,response to stimulus,0.674\ncellular response to cycloheximide,response to stimulus,0.838\ncellular response to cytochalasin B,response to stimulus,0.878\ncellular response to dehydroepiandrosterone,response to stimulus,0.866\ncellular response to diacyl bacterial lipopeptide,response to stimulus,0.782\ncellular response to diamide,response to stimulus,0.882\ncellular response to disaccharide stimulus,response to stimulus,0.938\ncellular response to dithiothreitol,response to stimulus,0.876\ncellular response to dopamine,response to stimulus,0.816\ncellular response to dsDNA,response to stimulus,0.834\ncellular response to electrical stimulus,response to stimulus,0.874\ncellular response to endogenous stimulus,response to stimulus,0.792\ncellular response to endothelin,response to stimulus,0.872\ncellular response to epinephrine stimulus,response to stimulus,0.736\ncellular response to ergosterol,response to stimulus,0.874\ncellular response to erythropoietin,response to stimulus,0.862\ncellular response to estradiol stimulus,response to stimulus,0.856\ncellular response to ethanol,response to stimulus,0.874\ncellular response to ether,response to stimulus,0.928\ncellular response to exogenous dsRNA,response to stimulus,0.476\ncellular response to external biotic stimulus,response to stimulus,0.87\ncellular response to flavonoid,response to stimulus,0.954\ncellular response to fluoride,response to stimulus,0.87\ncellular response to folic acid,response to stimulus,0.862\ncellular response to follicle-stimulating hormone stimulus,response to stimulus,0.858\ncellular response to forskolin,response to stimulus,0.874\ncellular response to fructose stimulus,response to stimulus,0.866\ncellular response to gamma radiation,response to stimulus,0.466\ncellular response to genistein,response to stimulus,0.88\ncellular response to gibberellin stimulus,response to stimulus,0.878\ncellular response to glial cell derived neurotrophic factor,response to stimulus,0.81\ncellular response to glucagon stimulus,response to stimulus,0.872\ncellular response to glucose stimulus,response to stimulus,0.772\ncellular response to glyceraldehyde,response to stimulus,0.872\ncellular response to glycine,response to stimulus,0.836\ncellular response to glycoprotein,response to stimulus,0.924\ncellular response to glyoxal,response to stimulus,0.862\ncellular response to gonadotropin stimulus,response to stimulus,0.872\ncellular response to gonadotropin-releasing hormone,response to stimulus,0.88\ncellular response to granulocyte macrophage colony-stimulating factor stimulus,response to stimulus,0.782\ncellular response to gravity,response to stimulus,0.88\ncellular response to growth hormone stimulus,response to stimulus,0.766\ncellular response to heparin,response to stimulus,0.868\ncellular response to hexose stimulus,response to stimulus,0.874\ncellular response to high density lipoprotein particle stimulus,response to stimulus,0.874\ncellular response to high light intensity,response to stimulus,0.872\ncellular response to histamine,response to stimulus,0.736\ncellular response to hormone stimulus,response to stimulus,0.912\ncellular response to human chorionic gonadotropin stimulus,response to stimulus,0.868\ncellular response to hydrogen sulfide,response to stimulus,0.84\ncellular response to hydroperoxide,response to stimulus,0.682\ncellular response to hydrostatic pressure,response to stimulus,0.77\ncellular response to hydroxyisoflavone,response to stimulus,0.936\ncellular response to hydroxyurea,response to stimulus,0.812\ncellular response to hyperoxia,response to stimulus,0.83\ncellular response to indole-3-methanol,response to stimulus,0.868\ncellular response to insulin-like growth factor stimulus,response to stimulus,0.882\ncellular response to interferon-alpha,response to stimulus,0.542\ncellular response to interleukin-11,response to stimulus,0.862\ncellular response to interleukin-12,response to stimulus,0.746\ncellular response to interleukin-13,response to stimulus,0.828\ncellular response to interleukin-15,response to stimulus,0.724\ncellular response to interleukin-18,response to stimulus,0.66\ncellular response to interleukin-2,response to stimulus,0.65\ncellular response to interleukin-21,response to stimulus,0.866\ncellular response to interleukin-3,response to stimulus,0.868\ncellular response to interleukin-8,response to stimulus,0.846\ncellular response to interleukin-9,response to stimulus,0.71\ncellular response to ionomycin,response to stimulus,0.856\ncellular response to iron ion,response to stimulus,0.912\ncellular response to iron ion starvation,stress response,0.57\ncellular response to iron(III) ion,response to stimulus,0.88\ncellular response to isoquinoline alkaloid,response to stimulus,0.844\ncellular response to jasmonic acid stimulus,response to stimulus,0.866\ncellular response to laminar fluid shear stress,stress response,0.716\ncellular response to lead ion,response to stimulus,0.864\ncellular response to leptin stimulus,response to stimulus,0.726\ncellular response to leptomycin B,response to stimulus,0.88\ncellular response to leucine starvation,response to stimulus,0.704\ncellular response to light intensity,response to stimulus,0.77\ncellular response to lipid hydroperoxide,response to stimulus,0.818\ncellular response to lipoteichoic acid,response to stimulus,0.658\ncellular response to lithium ion,response to stimulus,0.85\ncellular response to low-density lipoprotein particle stimulus,response to stimulus,0.886\ncellular response to luteinizing hormone stimulus,response to stimulus,0.864\ncellular response to macrophage colony-stimulating factor stimulus,response to stimulus,0.7\ncellular response to magnesium ion,response to stimulus,0.868\ncellular response to magnetism,response to stimulus,0.88\ncellular response to manganese ion,response to stimulus,0.888\ncellular response to mercury ion,response to stimulus,0.868\ncellular response to methyl methanesulfonate,response to stimulus,0.876\ncellular response to methylglyoxal,response to stimulus,0.842\ncellular response to mineralocorticoid stimulus,response to stimulus,0.936\ncellular response to misfolded protein,response to stimulus,0.794\ncellular response to molecule of fungal origin,response to stimulus,0.792\ncellular response to monosaccharide stimulus,response to stimulus,0.892\ncellular response to morphine,response to stimulus,0.826\ncellular response to muramyl dipeptide,response to stimulus,0.776\ncellular response to mycophenolic acid,response to stimulus,0.844\ncellular response to mycotoxin,response to stimulus,0.874\ncellular response to nicotine,response to stimulus,0.844\ncellular response to nitric oxide,response to stimulus,0.798\ncellular response to nitrogen levels,stress response,0.544\ncellular response to nitroglycerin,response to stimulus,0.874\ncellular response to nitrosative stress,response to stimulus,0.554\ncellular response to non-ionic osmotic stress,response to stimulus,0.782\ncellular response to norepinephrine stimulus,response to stimulus,0.742\ncellular response to oleic acid,response to stimulus,0.872\ncellular response to organic substance,response to stimulus,0.376\ncellular response to oxidised low-density lipoprotein particle stimulus,response to stimulus,0.792\ncellular response to oxygen radical,response to stimulus,0.68\ncellular response to oxygen-containing compound,response to stimulus,0.644\ncellular response to oxygen-glucose deprivation,response to stimulus,0.718\ncellular response to pH,response to stimulus,0.748\ncellular response to parathyroid hormone stimulus,response to stimulus,0.834\ncellular response to peptidoglycan,response to stimulus,0.694\ncellular response to phenylpropanoid,response to stimulus,0.926\ncellular response to pheromone,response to stimulus,0.88\ncellular response to phorbol 13-acetate 12-myristate,response to stimulus,0.86\ncellular response to phosphate starvation,response to stimulus,0.696\ncellular response to platelet-derived growth factor stimulus,response to stimulus,0.794\ncellular response to potassium ion,response to stimulus,0.866\ncellular response to potassium ion starvation,response to stimulus,0.76\ncellular response to progesterone stimulus,response to stimulus,0.842\ncellular response to prolactin,response to stimulus,0.874\ncellular response to prostaglandin D stimulus,response to stimulus,0.862\ncellular response to prostaglandin stimulus,response to stimulus,0.898\ncellular response to purine-containing compound,response to stimulus,0.886\ncellular response to puromycin,response to stimulus,0.874\ncellular response to putrescine,response to stimulus,0.874\ncellular response to pyrimidine ribonucleotide,response to stimulus,0.874\ncellular response to radiation,stress response,0.574\ncellular response to raffinose,response to stimulus,0.87\ncellular response to rapamycin,response to stimulus,0.878\ncellular response to reactive nitrogen species,response to stimulus,0.758\ncellular response to redox state,response to stimulus,0.698\ncellular response to salt stress,stress response,0.542\ncellular response to selenite ion,response to stimulus,0.866\ncellular response to serotonin,response to stimulus,0.874\ncellular response to sodium arsenite,response to stimulus,0.864\ncellular response to sodium dodecyl sulfate,response to stimulus,0.88\ncellular response to sorbitol,response to stimulus,0.858\ncellular response to staurosporine,response to stimulus,0.87\ncellular response to stem cell factor stimulus,response to stimulus,0.806\ncellular response to steroid hormone stimulus,response to stimulus,0.888\ncellular response to sterol,response to stimulus,0.92\ncellular response to stimulus,metabolic process,0.2\ncellular response to stress,stress response,0.538\ncellular response to sucrose stimulus,response to stimulus,0.88\ncellular response to superoxide,response to stimulus,0.76\ncellular response to temperature stimulus,response to stimulus,0.868\ncellular response to testosterone stimulus,response to stimulus,0.878\ncellular response to tetrahydrofolate,response to stimulus,0.836\ncellular response to thyroid hormone stimulus,response to stimulus,0.81\ncellular response to thyrotropin-releasing hormone,response to stimulus,0.862\ncellular response to thyroxine stimulus,response to stimulus,0.728\ncellular response to triacyl bacterial lipopeptide,response to stimulus,0.806\ncellular response to trichostatin A,response to stimulus,0.862\ncellular response to triglyceride,response to stimulus,0.884\ncellular response to tumor cell,response to stimulus,0.786\ncellular response to type III interferon,response to stimulus,0.71\ncellular response to vasopressin,response to stimulus,0.86\ncellular response to very-low-density lipoprotein particle stimulus,response to stimulus,0.876\ncellular response to vitamin,response to stimulus,0.862\ncellular response to vitamin B1,response to stimulus,0.882\ncellular response to vitamin D,response to stimulus,0.894\ncellular response to vitamin E,response to stimulus,0.896\ncellular response to vitamin K,response to stimulus,0.824\ncellular response to water deprivation,response to stimulus,0.688\ncellular response to water stimulus,response to stimulus,0.9\ncellular response to wortmannin,response to stimulus,0.878\ncellular response to zinc ion,response to stimulus,0.826\ncellular response to zinc ion starvation,response to stimulus,0.782\ncellular stress response to acid chemical,response to stimulus,0.684\ncellular stress response to acidic pH,response to stimulus,0.644\ncellular_component,metabolic process,0.396\ncellularization,morphogenesis/development,0.776\ncellularization cleavage furrow,cellular component organization,0.38\ncementum mineralization,cellular component organization,0.2\ncentral B cell tolerance induction,cellular component organization,0.22\ncentral element,cellular component organization,0.362\ncentral nervous system development,morphogenesis/development,0.514\ncentral nervous system formation,morphogenesis/development,0.326\ncentral nervous system interneuron axonogenesis,neural related process,0.354\ncentral nervous system maturation,morphogenesis/development,0.394\ncentral nervous system morphogenesis,morphogenesis/development,0.576\ncentral nervous system myelin formation,cellular component organization,0.242\ncentral nervous system myelin maintenance,morphogenesis/development,0.3\ncentral nervous system myelination,neural related process,0.5\ncentral nervous system neuron axonogenesis,neural related process,0.52\ncentral nervous system projection neuron axonogenesis,neural related process,0.46\ncentral nervous system segmentation,neural related process,0.144\ncentral nervous system vasculogenesis,morphogenesis/development,0.47\ncentral region of growth cone,neural related process,0.222\ncentral tolerance induction,immune system process,0.58\ncentral tolerance induction to self antigen,transport,0.154\ncentralspindlin complex,protein modification/signaling,0.236\ncentriolar satellite,cellular component organization,0.254\ncentriolar subdistal appendage,cellular component organization,0.406\ncentriole,cell cycle,0.348\ncentriole assembly,cellular component organization,0.706\ncentriole elongation,morphogenesis/development,0.272\ncentriole replication,cell cycle,0.258\ncentriole-centriole cohesion,morphogenesis/development,0.244\ncentromeric DNA binding,metabolic process,0.21\ncentromeric sister chromatid cohesion,cell cycle,0.692\ncentrosomal corona,cellular component organization,0.4\ncentrosome,cell cycle,0.292\ncentrosome duplication,cellular component organization,0.278\ncentrosome localization,transport,0.522\ncentrosome-templated microtubule nucleation,morphogenesis/development,0.304\nceramidase activity,metabolic process,0.91\nceramide 1-phosphate binding,metabolic process,0.246\nceramide 1-phosphate transfer activity,cellular component organization,0.254\nceramide 1-phosphate transport,transport,0.736\nceramide binding,cellular component organization,0.314\nceramide biosynthetic process,metabolic process,0.958\nceramide catabolic process,metabolic process,0.976\nceramide cholinephosphotransferase activity,metabolic process,0.896\nceramide floppase activity,metabolic process,0.324\nceramide glucosyltransferase activity,metabolic process,0.892\nceramide kinase activity,metabolic process,0.798\nceramide metabolic process,metabolic process,0.958\nceramide phosphoethanolamine biosynthetic process,metabolic process,0.87\nceramide phosphoethanolamine metabolic process,metabolic process,0.97\nceramide phosphoethanolamine synthase activity,metabolic process,0.896\nceramide transfer activity,transport,0.344\nceramide translocation,cellular component organization,0.222\nceramide transport,transport,0.932\nceramide-1-phosphate phosphatase activity,metabolic process,0.85\ncerebellar Golgi cell to granule cell synapse,cellular component organization,0.172\ncerebellar Purkinje cell differentiation,morphogenesis/development,0.534\ncerebellar Purkinje cell layer development,morphogenesis/development,0.764\ncerebellar Purkinje cell layer formation,neural related process,0.288\ncerebellar Purkinje cell layer maturation,morphogenesis/development,0.352\ncerebellar Purkinje cell layer morphogenesis,morphogenesis/development,0.38\ncerebellar Purkinje cell layer structural organization,neural related process,0.304\ncerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation,morphogenesis/development,0.232\ncerebellar climbing fiber to Purkinje cell synapse,cellular component organization,0.224\ncerebellar cortex formation,morphogenesis/development,0.41\ncerebellar cortex maturation,morphogenesis/development,0.43\ncerebellar cortex morphogenesis,morphogenesis/development,0.55\ncerebellar cortex structural organization,morphogenesis/development,0.342\ncerebellar granular layer development,morphogenesis/development,0.75\ncerebellar granular layer formation,neural related process,0.332\ncerebellar granular layer maturation,morphogenesis/development,0.376\ncerebellar granular layer morphogenesis,morphogenesis/development,0.378\ncerebellar granular layer structural organization,neural related process,0.324\ncerebellar granule cell differentiation,morphogenesis/development,0.608\ncerebellar granule cell precursor proliferation,cell cycle,0.404\ncerebellar granule cell precursor tangential migration,morphogenesis/development,0.178\ncerebellar granule cell to Purkinje cell synapse,cellular component organization,0.186\ncerebellar molecular layer development,morphogenesis/development,0.912\ncerebellar molecular layer formation,morphogenesis/development,0.426\ncerebellar molecular layer morphogenesis,morphogenesis/development,0.592\ncerebellar mossy fiber,neural related process,0.262\ncerebellar neuron development,morphogenesis/development,0.624\ncerebellum development,morphogenesis/development,0.77\ncerebellum formation,morphogenesis/development,0.358\ncerebellum maturation,morphogenesis/development,0.442\ncerebellum morphogenesis,morphogenesis/development,0.592\ncerebellum structural organization,morphogenesis/development,0.326\ncerebellum vasculature development,morphogenesis/development,0.996\ncerebellum vasculature morphogenesis,morphogenesis/development,0.426\ncerebral cortex GABAergic interneuron development,morphogenesis/development,0.64\ncerebral cortex GABAergic interneuron differentiation,morphogenesis/development,0.596\ncerebral cortex GABAergic interneuron fate commitment,morphogenesis/development,0.55\ncerebral cortex GABAergic interneuron migration,neural related process,0.236\ncerebral cortex cell migration,morphogenesis/development,0.156\ncerebral cortex development,morphogenesis/development,0.71\ncerebral cortex neuron differentiation,morphogenesis/development,0.448\ncerebral cortex radial glia-guided migration,neural related process,0.33\ncerebral cortex radially oriented cell migration,morphogenesis/development,0.256\ncerebral cortex regionalization,morphogenesis/development,0.238\ncerebral cortex tangential migration,morphogenesis/development,0.192\ncerebral cortex tangential migration using cell-cell interactions,neural related process,0.232\ncerebroside transfer activity,metabolic process,0.234\ncerebroside-sulfatase activity,metabolic process,0.902\ncerebrospinal fluid circulation,cellular component organization,0.196\ncerebrospinal fluid secretion,cellular component organization,0.224\ncervix development,morphogenesis/development,0.988\nchannel activator activity,metabolic process,0.238\nchannel inhibitor activity,metabolic process,0.276\nchannel regulator activity,metabolic process,0.204\nchaperone mediated protein folding independent of cofactor,protein modification/signaling,0.25\nchaperone-mediated autophagy translocation complex,cellular component organization,0.3\nchaperone-mediated autophagy translocation complex disassembly,cellular component organization,0.542\nchaperonin-containing T-complex,protein modification/signaling,0.286\ncharged-tRNA amino acid modification,gene regulation,0.596\ncheckpoint clamp complex,cellular component organization,0.274\nchemical synaptic transmission,neural related process,0.77\n\"chemical synaptic transmission, postsynaptic\",neural related process,0.56\nchemoattractant activity,receptor related process,0.232\nchemoattractant activity involved in axon guidance,neural related process,0.168\nchemoattraction of axon,neural related process,0.282\nchemoattraction of serotonergic neuron axon,neural related process,0.22\nchemokine (C-C motif) ligand 1 production,immune system process,0.646\nchemokine (C-C motif) ligand 12 binding,metabolic process,0.224\nchemokine (C-C motif) ligand 19 binding,metabolic process,0.242\nchemokine (C-C motif) ligand 19 signaling pathway,receptor related process,0.7\nchemokine (C-C motif) ligand 2 binding,metabolic process,0.224\nchemokine (C-C motif) ligand 20 production,immune system process,0.548\nchemokine (C-C motif) ligand 21 binding,metabolic process,0.242\nchemokine (C-C motif) ligand 21 signaling pathway,receptor related process,0.716\nchemokine (C-C motif) ligand 4 production,immune system process,0.634\nchemokine (C-C motif) ligand 5 binding,immune system process,0.234\nchemokine (C-C motif) ligand 5 production,immune system process,0.652\nchemokine (C-C motif) ligand 7 binding,metabolic process,0.224\nchemokine (C-X-C motif) ligand 1 production,immune system process,0.616\nchemokine (C-X-C motif) ligand 12 signaling pathway,receptor related process,0.704\nchemokine (C-X-C motif) ligand 2 production,immune system process,0.676\nchemokine (C-X-C motif) ligand 9 production,immune system process,0.642\nchemokine activity,immune system process,0.564\nchemokine binding,immune system process,0.426\nchemokine receptor activity,immune system process,0.412\nchemokine receptor antagonist activity,receptor related process,0.388\nchemokine receptor transport out of membrane raft,transport,0.322\nchemokine receptor transport within lipid bilayer,transport,0.598\nchemorepellent activity,transport,0.218\nchemorepulsion involved in interneuron migration from the subpallium to the cortex,protein modification/signaling,0.174\nchemorepulsion involved in postnatal olfactory bulb interneuron migration,cellular component organization,0.25\nchemorepulsion of axon,neural related process,0.292\nchemorepulsion of branchiomotor axon,neural related process,0.256\nchemorepulsion of dopaminergic neuron axon,neural related process,0.252\nchemosensory behavior,multicellular organismal process,0.438\nchenodeoxycholate 7-alpha-dehydrogenase (NAD+) activity,metabolic process,0.928\nchenodeoxycholic acid binding,metabolic process,0.308\nchiasma,metabolic process,0.248\nchiasma assembly,cellular component organization,0.36\nchitin binding,metabolic process,0.278\nchitin catabolic process,metabolic process,0.95\nchitin metabolic process,metabolic process,0.956\nchitinase activity,metabolic process,0.68\nchitobiosyldiphosphodolichol beta-mannosyltransferase activity,metabolic process,0.896\nchitosome,metabolic process,0.394\nchloramphenicol O-acetyltransferase activity,metabolic process,0.892\nchlordecone reductase activity,metabolic process,0.936\nchloride channel activity,transport,0.592\nchloride channel complex,transport,0.332\nchloride channel inhibitor activity,metabolic process,0.26\nchloride channel regulator activity,metabolic process,0.29\nchloride ion binding,metabolic process,0.226\nchloride ion homeostasis,other,0.782\nchloride transmembrane transport,transport,0.35\nchloride transmembrane transporter activity,transport,0.716\nchloride transport,transport,0.97\nchloride-activated potassium channel activity,cellular component organization,0.198\nchloride:bicarbonate antiporter activity,transport,0.534\nchloride:monoatomic cation symporter activity,transport,0.534\ncholangiocyte apoptotic process,cell death,0.246\ncholangiocyte proliferation,cell cycle,0.682\ncholate 7-alpha-dehydrogenase activity,metabolic process,0.928\ncholate-CoA ligase activity,metabolic process,0.822\ncholecystokinin receptor activity,receptor related process,0.188\ncholecystokinin receptor binding,receptor related process,0.474\ncholecystokinin signaling pathway,receptor related process,0.716\n\"cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase activity\",metabolic process,0.928\ncholestanetetraol 26-dehydrogenase activity,metabolic process,0.928\ncholestanetriol 26-monooxygenase activity,metabolic process,0.932\ncholestenol delta-isomerase activity,metabolic process,0.896\ncholesterol 24-hydroxylase activity,metabolic process,0.932\ncholesterol 25-hydroxylase activity,metabolic process,0.898\ncholesterol 26-hydroxylase activity,metabolic process,0.472\ncholesterol 7-alpha-monooxygenase activity,metabolic process,0.93\ncholesterol O-acyltransferase activity,metabolic process,0.884\ncholesterol biosynthetic process via desmosterol,metabolic process,0.848\ncholesterol biosynthetic process via lathosterol,metabolic process,0.848\ncholesterol catabolic process,metabolic process,0.882\ncholesterol dehydrogenase activity,metabolic process,0.928\ncholesterol efflux,transport,0.538\ncholesterol ester hydrolysis involved in cholesterol transport,metabolic process,0.258\ncholesterol import,transport,0.428\ncholesterol metabolic process,metabolic process,0.868\ncholesterol monooxygenase (side-chain-cleaving) activity,metabolic process,0.924\ncholesterol storage,cellular component organization,0.306\ncholesterol sulfotransferase activity,metabolic process,0.898\ncholesterol transfer activity,cellular component organization,0.22\ncholesterol transport involved in cholesterol storage,transport,0.38\ncholesterol-protein transferase activity,metabolic process,0.48\ncholine O-acetyltransferase activity,metabolic process,0.892\ncholine binding,metabolic process,0.242\ncholine catabolic process,metabolic process,0.724\ncholine dehydrogenase activity,metabolic process,0.908\ncholine kinase activity,metabolic process,0.752\ncholine metabolic process,metabolic process,0.926\ncholine transmembrane transporter activity,transport,0.588\ncholine transport,transport,0.644\ncholine-phosphate cytidylyltransferase activity,metabolic process,0.828\ncholine:sodium symporter activity,metabolic process,0.526\ncholinergic synapse,cellular component organization,0.352\ncholinesterase activity,metabolic process,0.856\ncholoyl-CoA hydrolase activity,metabolic process,0.898\nchondroblast differentiation,morphogenesis/development,0.596\nchondrocyte development involved in endochondral bone morphogenesis,morphogenesis/development,0.866\nchondrocyte differentiation involved in endochondral bone morphogenesis,morphogenesis/development,0.858\nchondrocyte hypertrophy,morphogenesis/development,0.69\nchondrocyte morphogenesis,morphogenesis/development,0.888\nchondrocyte morphogenesis involved in endochondral bone morphogenesis,morphogenesis/development,0.854\nchondroitin 4-sulfotransferase activity,metabolic process,0.898\nchondroitin 6-sulfotransferase activity,metabolic process,0.898\nchondroitin hydrolase activity,metabolic process,0.382\nchondroitin sulfate binding,metabolic process,0.34\nchondroitin sulfate biosynthetic process,metabolic process,0.894\nchondroitin sulfate catabolic process,metabolic process,0.884\nchondroitin sulfate metabolic process,metabolic process,0.948\nchondroitin sulfate proteoglycan binding,metabolic process,0.308\n\"chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process\",protein modification/signaling,0.214\nchondroitin sulfate proteoglycan metabolic process,metabolic process,0.892\nchondroitin sulfotransferase activity,metabolic process,0.89\nchondroitin-glucuronate 5-epimerase activity,metabolic process,0.896\nchorio-allantoic fusion,cell adhesion,0.294\nchoriogonadotropin hormone binding,gene regulation,0.208\nchoriogonadotropin hormone receptor activity,cellular component organization,0.178\nchorion development,morphogenesis/development,0.848\nchorionic trophoblast cell differentiation,morphogenesis/development,0.722\nchorionic trophoblast cell proliferation,cell cycle,0.69\nchromaffin granule,morphogenesis/development,0.21\nchromaffin granule lumen,cellular component organization,0.346\nchromaffin granule membrane,morphogenesis/development,0.208\nchromatin,gene regulation,0.772\nchromatin insulator sequence binding,gene regulation,0.296\nchromatin lock complex,cellular component organization,0.296\nchromatin loop anchoring activity,gene regulation,0.49\nchromatin looping,cellular component organization,0.246\nchromatin remodeling at centromere,cellular component organization,0.65\nchromatin silencing complex,cellular component organization,0.27\nchromatin-protein adaptor activity,protein modification/signaling,0.3\nchromatoid body,cellular component organization,0.33\nchromo shadow domain binding,protein modification/signaling,0.306\nchromocenter,cellular component organization,0.444\nchromosomal region,cell cycle,0.642\nchromosome,gene regulation,0.344\nchromosome attachment to the nuclear envelope,cell cycle,0.606\nchromosome localization to nuclear envelope involved in homologous chromosome segregation,transport,0.562\nchromosome movement towards spindle pole,cell cycle,0.448\nchromosome passenger complex,cell cycle,0.224\nchromosome passenger complex localization to kinetochore,transport,0.244\nchromosome passenger complex localization to spindle midzone,transport,0.238\n\"chromosome, centromeric core domain\",protein modification/signaling,0.258\n\"chromosome, centromeric region\",cell cycle,0.58\n\"chromosome, subtelomeric region\",gene regulation,0.308\n\"chromosome, telomeric region\",cellular component organization,0.31\n\"chromosome, telomeric repeat region\",cell cycle,0.264\nchronic inflammatory response to antigenic stimulus,immune system process,0.5\nchronic inflammatory response to non-antigenic stimulus,immune system process,0.278\nchylomicron,cellular component organization,0.236\nchylomicron assembly,cellular component organization,0.41\nchylomicron binding,protein modification/signaling,0.226\nchylomicron remnant,cellular component organization,0.26\nchylomicron remnant clearance,cellular component organization,0.216\nchylomicron remodeling,metabolic process,0.236\nciliary basal body,cellular component organization,0.5\nciliary basal body organization,cellular component organization,0.798\nciliary basal body-plasma membrane docking,cellular component organization,0.32\nciliary base,cellular component organization,0.266\nciliary body morphogenesis,morphogenesis/development,0.432\nciliary inversin compartment,cellular component organization,0.232\nciliary membrane,cellular component organization,0.516\nciliary neurotrophic factor binding,immune system process,0.176\nciliary neurotrophic factor receptor activity,receptor related process,0.432\nciliary neurotrophic factor receptor binding,receptor related process,0.524\nciliary neurotrophic factor receptor complex,receptor related process,0.26\nciliary neurotrophic factor-mediated signaling pathway,receptor related process,0.574\nciliary plasm,cellular component organization,0.424\nciliary pocket,cellular component organization,0.392\nciliary pocket membrane,cellular component organization,0.378\nciliary receptor clustering involved in smoothened signaling pathway,receptor related process,0.382\nciliary rootlet,cellular component organization,0.28\nciliary tip,cellular component organization,0.312\nciliary transition fiber,cellular component organization,0.274\nciliary transition zone,cellular component organization,0.554\nciliary transition zone assembly,cellular component organization,0.6\ncilium,cellular component organization,0.394\ncilium disassembly,cellular component organization,0.75\ncilium movement,other,0.412\ncilium movement involved in cell motility,other,0.466\ncircadian behavior,neural related process,0.384\ncircadian regulation of translation,gene regulation,0.302\ncircadian sleep/wake cycle,neural related process,0.24\ncircadian sleep/wake cycle process,neural related process,0.378\n\"circadian sleep/wake cycle, REM sleep\",transport,0.148\n\"circadian sleep/wake cycle, non-REM sleep\",cellular component organization,0.218\n\"circadian sleep/wake cycle, sleep\",neural related process,0.196\n\"circadian sleep/wake cycle, wakefulness\",cellular component organization,0.188\ncircadian temperature homeostasis,morphogenesis/development,0.258\ncirculatory system development,morphogenesis/development,0.758\ncis assembly of pre-catalytic spliceosome,cellular component organization,0.432\ncis-Golgi network,ER/endosome/lysosome related process,0.286\ncis-Golgi network membrane,cellular component organization,0.254\ncis-regulatory region sequence-specific DNA binding,gene regulation,0.836\ncis-stilbene-oxide hydrolase activity,metabolic process,0.924\ncis-trans isomerase activity,metabolic process,0.802\ncitrate (Si)-synthase activity,metabolic process,0.862\ncitrate metabolic process,metabolic process,0.902\ncitrate secondary active transmembrane transporter activity,transport,0.69\ncitrate synthase activity,metabolic process,0.898\ncitrate transmembrane transporter activity,transport,0.76\ncitrate transport,transport,0.938\ncitrate-L-glutamate ligase activity,metabolic process,0.752\ncitric acid secretion,metabolic process,0.23\ncitrulline biosynthetic process,metabolic process,0.766\ncitrulline metabolic process,metabolic process,0.986\nclass I DNA-(apurinic or apyrimidinic site) endonuclease activity,metabolic process,0.43\nclass II DNA-(apurinic or apyrimidinic site) endonuclease activity,metabolic process,0.446\nclassical Lewy body,cellular component organization,0.274\nclassical-complement-pathway C3/C5 convertase complex,cellular component organization,0.322\nclathrin adaptor complex,cellular component organization,0.368\nclathrin coat,cellular component organization,0.34\nclathrin coat assembly,cellular component organization,0.76\nclathrin coat disassembly,cellular component organization,0.628\nclathrin coat of coated pit,cellular component organization,0.29\nclathrin coat of endocytic vesicle,cellular component organization,0.21\nclathrin coat of trans-Golgi network vesicle,cellular component organization,0.216\nclathrin complex,cellular component organization,0.48\nclathrin heavy chain binding,metabolic process,0.228\nclathrin light chain binding,metabolic process,0.216\nclathrin vesicle coat,cellular component organization,0.34\nclathrin-coated endocytic vesicle,cellular component organization,0.51\nclathrin-coated endocytic vesicle membrane,cellular component organization,0.676\nclathrin-coated pit,cellular component organization,0.238\nclathrin-coated vesicle,cellular component organization,0.49\nclathrin-coated vesicle cargo loading,transport,0.554\n\"clathrin-coated vesicle cargo loading, AP-3-mediated\",cellular component organization,0.28\nclathrin-coated vesicle membrane,cellular component organization,0.498\nclathrin-dependent endocytosis of virus by host cell,cellular component organization,0.224\nclathrin-dependent extracellular exosome endocytosis,cellular component organization,0.234\nclathrin-dependent synaptic vesicle endocytosis,cellular component organization,0.376\nclathrin-sculpted acetylcholine transport vesicle,cellular component organization,0.216\nclathrin-sculpted acetylcholine transport vesicle membrane,transport,0.196\nclathrin-sculpted gamma-aminobutyric acid transport vesicle,metabolic process,0.232\nclathrin-sculpted gamma-aminobutyric acid transport vesicle membrane,metabolic process,0.25\nclathrin-sculpted glutamate transport vesicle,cellular component organization,0.212\nclathrin-sculpted glutamate transport vesicle membrane,transport,0.21\nclathrin-sculpted monoamine transport vesicle,cellular component organization,0.25\nclathrin-sculpted monoamine transport vesicle membrane,transport,0.208\nclathrin-sculpted vesicle,cellular component organization,0.428\nclathrin-uncoating ATPase activity,metabolic process,0.562\nclearance of foreign intracellular DNA,immune system process,0.37\nclearance of foreign intracellular nucleic acids,immune system process,0.336\ncleavage body,transport,0.202\ncleavage furrow,cellular component organization,0.372\ncleavage furrow formation,cellular component organization,0.396\ncleavage furrow ingression,cellular component organization,0.582\n\"cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)\",gene regulation,0.524\nclimbing fiber,neural related process,0.442\ncloaca development,morphogenesis/development,0.984\ncloacal septation,morphogenesis/development,0.302\nclosure of optic fissure,metabolic process,0.198\nclub cell differentiation,morphogenesis/development,0.734\ncluster of actin-based cell projections,cellular component organization,0.612\nclustering of voltage-gated potassium channels,transport,0.29\nclustering of voltage-gated sodium channels,cellular component organization,0.268\nco-SMAD binding,protein modification/signaling,0.332\nco-receptor binding,receptor related process,0.322\n\"co-transcriptional RNA 3'-end processing, cleavage and polyadenylation pathway\",gene regulation,0.652\n\"co-transcriptional mRNA 3'-end processing, cleavage and polyadenylation pathway\",gene regulation,0.532\nco-translational protein modification,protein modification/signaling,0.752\ncoated membrane,cellular component organization,0.348\ncoated vesicle,cellular component organization,0.49\ncobalamin binding,metabolic process,0.322\ncobalamin metabolic process,metabolic process,0.976\ncobalamin transport,transport,0.718\ncobalt ion binding,metabolic process,0.23\ncobalt ion transmembrane transporter activity,transport,0.612\ncobalt ion transport,transport,0.73\ncocaine binding,metabolic process,0.376\ncocaine metabolic process,metabolic process,0.97\ncochlea morphogenesis,morphogenesis/development,0.542\ncochlear hair cell ribbon synapse,neural related process,0.25\ncochlear nucleus development,morphogenesis/development,0.938\ncoenzyme A binding,metabolic process,0.614\ncoenzyme A biosynthetic process,metabolic process,0.88\ncoenzyme A catabolic process,metabolic process,0.888\ncoenzyme A transmembrane transport,transport,0.596\ncoenzyme A transmembrane transporter activity,transport,0.542\ncoenzyme A transport,transport,0.79\ncohesin complex,protein modification/signaling,0.226\ncohesin loader activity,cellular component organization,0.332\ncohesin loading,cell cycle,0.466\ncold acclimation,morphogenesis/development,0.2\ncold-induced thermogenesis,multicellular organismal process,0.562\ncollagen V binding,metabolic process,0.222\ncollagen anchoring fibril,cellular component organization,0.418\ncollagen beaded filament,cellular component organization,0.45\ncollagen binding involved in cell-matrix adhesion,cell adhesion,0.182\ncollagen biosynthetic process,metabolic process,0.684\ncollagen catabolic process,metabolic process,0.642\ncollagen fibril binding,metabolic process,0.246\ncollagen fibril organization,cellular component organization,0.266\ncollagen network,cellular component organization,0.48\ncollagen receptor activity,receptor related process,0.586\ncollagen sheet,cellular component organization,0.306\ncollagen trimer,cellular component organization,0.456\ncollagen type I trimer,cellular component organization,0.232\ncollagen type II trimer,cellular component organization,0.252\ncollagen type III trimer,cellular component organization,0.248\ncollagen type IV trimer,cellular component organization,0.306\ncollagen type IX trimer,cellular component organization,0.322\ncollagen type V trimer,cellular component organization,0.246\ncollagen type VI trimer,cellular component organization,0.242\ncollagen type VII anchoring fibril,cellular component organization,0.25\ncollagen type VII trimer,metabolic process,0.222\ncollagen type VIII trimer,cellular component organization,0.242\ncollagen type X trimer,cellular component organization,0.244\ncollagen type XI trimer,cellular component organization,0.246\ncollagen type XII trimer,cellular component organization,0.33\ncollagen type XIII trimer,cellular component organization,0.396\ncollagen type XIV trimer,cellular component organization,0.33\ncollagen type XV trimer,cellular component organization,0.352\ncollagen type XVI trimer,cellular component organization,0.254\ncollateral sprouting in absence of injury,neural related process,0.34\ncollateral sprouting of intact axon in response to injury,neural related process,0.434\ncollecting duct development,morphogenesis/development,0.984\ncolon epithelial cell migration,multicellular organismal process,0.314\ncolon smooth muscle contraction,morphogenesis/development,0.164\ncolumnar/cuboidal epithelial cell development,morphogenesis/development,0.918\ncolumnar/cuboidal epithelial cell maturation,morphogenesis/development,0.688\ncomma-shaped body morphogenesis,morphogenesis/development,0.896\ncommissural neuron differentiation in spinal cord,morphogenesis/development,0.468\ncommitment complex,gene regulation,0.58\ncommitment of neuronal cell to specific neuron type in forebrain,neural related process,0.296\ncommon bile duct development,morphogenesis/development,0.94\ncommon myeloid progenitor cell proliferation,cell cycle,0.776\ncompact myelin,cellular component organization,0.344\ncompartment pattern specification,morphogenesis/development,0.362\ncomplement activation,immune system process,0.768\n\"complement activation, alternative pathway\",immune system process,0.456\n\"complement activation, classical pathway\",immune system process,0.464\n\"complement activation, lectin pathway\",immune system process,0.446\ncomplement binding,immune system process,0.3\ncomplement component C1 complex,cellular component organization,0.282\ncomplement component C1q complex,cellular component organization,0.222\ncomplement component C1q complex binding,cellular component organization,0.294\ncomplement component C3a binding,immune system process,0.43\ncomplement component C3a receptor activity,immune system process,0.366\ncomplement component C3b binding,immune system process,0.438\ncomplement component C3b receptor activity,immune system process,0.368\ncomplement component C4b binding,immune system process,0.438\ncomplement component C4b receptor activity,immune system process,0.368\ncomplement component C5a receptor activity,immune system process,0.362\ncomplement component C5a signaling pathway,receptor related process,0.588\ncomplement receptor activity,immune system process,0.394\ncomplement receptor mediated signaling pathway,immune system process,0.616\ncomplement-dependent cytotoxicity,immune system process,0.272\ncomplement-mediated synapse pruning,neural related process,0.232\ncomplex of collagen trimers,cellular component organization,0.482\ncondensed chromosome,cell cycle,0.534\n\"condensed chromosome, centromeric region\",cell cycle,0.576\ncondensed mesenchymal cell proliferation,cell cycle,0.814\ncondensed nuclear chromosome,cell cycle,0.312\ncondensin complex,protein modification/signaling,0.272\nconditioned place preference,cellular component organization,0.168\nconditioned taste aversion,metabolic process,0.234\ncone cell pedicle,cellular component organization,0.222\ncone photoreceptor outer segment,cellular component organization,0.338\ncone photoresponse recovery,immune system process,0.266\ncone retinal bipolar cell differentiation,morphogenesis/development,0.69\nconnecting tubule development,morphogenesis/development,0.988\nconnective tissue growth factor production,immune system process,0.506\nconnective tissue replacement involved in inflammatory response wound healing,cellular component organization,0.148\nconnexin binding,protein modification/signaling,0.254\nconnexin complex,cellular component organization,0.408\nconstitutive protein ectodomain proteolysis,protein modification/signaling,0.268\nconstitutive secretory pathway,cellular component organization,0.41\ncontact inhibition,cell cycle,0.194\ncontractile actin filament bundle,cellular component organization,0.758\ncontractile actin filament bundle assembly,cellular component organization,0.926\ncontractile fiber,cellular component organization,0.702\ncontractile ring,cellular component organization,0.66\ncontractile ring contraction,cell cycle,0.22\nconvergent extension,morphogenesis/development,0.776\nconvergent extension involved in axis elongation,morphogenesis/development,0.84\nconvergent extension involved in gastrulation,morphogenesis/development,0.72\nconvergent extension involved in neural plate elongation,transport,0.36\nconvergent extension involved in organogenesis,morphogenesis/development,0.812\nconvergent extension involved in somitogenesis,morphogenesis/development,0.266\nconversion of methionyl-tRNA to N-formyl-methionyl-tRNA,cellular component organization,0.206\nconversion of seryl-tRNAsec to selenocys-tRNAsec,cellular component organization,0.194\ncopper chaperone activity,transport,0.336\ncopper ion binding,metabolic process,0.186\ncopper ion export,transport,0.438\ncopper ion import,transport,0.44\ncopper ion import across plasma membrane,transport,0.476\ncopper ion transmembrane transport,transport,0.962\ncopper ion transmembrane transporter activity,transport,0.614\ncopper-dependent protein binding,protein modification/signaling,0.41\ncoproporphyrinogen oxidase activity,metabolic process,0.886\ncopulation,metabolic process,0.292\ncore TFIIH complex portion of holo TFIIH complex,gene regulation,0.324\ncore-binding factor complex,gene regulation,0.33\ncoreceptor activity,receptor related process,0.24\ncoreceptor-mediated virion attachment to host cell,viral related process,0.114\ncornea development in camera-type eye,morphogenesis/development,0.942\ncorneocyte desquamation,cellular component organization,0.212\ncorneocyte development,morphogenesis/development,0.99\ncornification,morphogenesis/development,0.21\ncornified envelope assembly,cellular component organization,0.606\ncoronary artery morphogenesis,morphogenesis/development,0.676\ncoronary sinus valve development,morphogenesis/development,0.872\ncoronary sinus valve morphogenesis,morphogenesis/development,0.53\ncoronary vein morphogenesis,morphogenesis/development,0.746\ncorpora quadrigemina development,morphogenesis/development,0.86\ncorpus callosum development,morphogenesis/development,0.832\ncorpus callosum morphogenesis,morphogenesis/development,0.638\ncorrinoid adenosyltransferase activity,metabolic process,0.85\ncortical collecting duct development,morphogenesis/development,0.974\ncortical cytoskeleton,cellular component organization,0.802\ncortical endoplasmic reticulum,cellular component organization,0.338\ncortical granule,cellular component organization,0.358\ncortical granule exocytosis,cellular component organization,0.178\ncortical microtubule,cellular component organization,0.66\ncortical microtubule cytoskeleton,cellular component organization,0.53\ncortical microtubule organization,cellular component organization,0.74\ncortical microtubule plus-end,cellular component organization,0.382\ncorticospinal neuron axon guidance,neural related process,0.424\ncorticospinal neuron axon guidance through spinal cord,neural related process,0.266\ncorticospinal tract morphogenesis,morphogenesis/development,0.288\ncorticosteroid hormone secretion,transport,0.652\ncorticosterone 18-monooxygenase activity,metabolic process,0.922\ncorticosterone secretion,metabolic process,0.17\ncorticotrophin-releasing factor receptor activity,cellular component organization,0.158\ncorticotropin hormone receptor binding,receptor related process,0.496\ncorticotropin hormone secreting cell differentiation,morphogenesis/development,0.692\ncorticotropin receptor activity,cellular component organization,0.17\ncorticotropin secretion,cellular component organization,0.156\ncorticotropin-releasing hormone activity,receptor related process,0.318\ncorticotropin-releasing hormone binding,metabolic process,0.208\ncorticotropin-releasing hormone receptor 1 binding,receptor related process,0.348\ncorticotropin-releasing hormone receptor 2 binding,receptor related process,0.47\ncorticotropin-releasing hormone receptor binding,receptor related process,0.358\ncorticotropin-releasing hormone secretion,stress response,0.166\ncortisol biosynthetic process,metabolic process,0.698\ncortisol dehydrogenase activity,metabolic process,0.934\ncortisol metabolic process,metabolic process,0.93\ncortisol secretion,cellular component organization,0.232\ncostamere,cellular component organization,0.348\ncotranslational protein targeting to membrane,transport,0.66\ncoumarin 7-hydroxylase activity,metabolic process,0.932\ncoumarin catabolic process,metabolic process,0.956\ncoumarin metabolic process,metabolic process,0.972\ncourtship behavior,multicellular organismal process,0.498\ncranial ganglion development,morphogenesis/development,0.96\ncranial nerve formation,morphogenesis/development,0.74\ncranial nerve maturation,morphogenesis/development,0.64\ncranial nerve morphogenesis,morphogenesis/development,0.694\ncranial nerve structural organization,morphogenesis/development,0.542\ncranial skeletal system development,morphogenesis/development,0.952\ncranial suture morphogenesis,morphogenesis/development,0.914\ncraniofacial suture morphogenesis,morphogenesis/development,0.904\ncreatine biosynthetic process,metabolic process,0.668\ncreatine kinase activity,metabolic process,0.792\ncreatine metabolic process,metabolic process,0.968\ncreatine transmembrane transport,transport,0.42\ncreatine transmembrane transporter activity,transport,0.696\ncreatine:sodium symporter activity,metabolic process,0.526\ncreatinine metabolic process,metabolic process,0.852\ncross-receptor inhibition within G protein-coupled receptor heterodimer,receptor related process,0.324\ncrossover junction DNA endonuclease activity,metabolic process,0.422\ncrotonyl-CoA hydratase activity,metabolic process,0.892\ncullin family protein binding,protein modification/signaling,0.478\ncullin-RING ubiquitin ligase complex,protein modification/signaling,0.29\ncumulus cell differentiation,morphogenesis/development,0.534\ncupric ion binding,metabolic process,0.286\ncupric reductase activity,metabolic process,0.928\ncuprous ion binding,metabolic process,0.262\ncuticle development,morphogenesis/development,0.52\ncuticular plate,cellular component organization,0.388\ncyanamide hydratase activity,metabolic process,0.898\ncyanate catabolic process,metabolic process,0.902\ncyanate metabolic process,metabolic process,0.978\ncyanocobalamin reductase (cyanide-eliminating) activity,metabolic process,0.93\ncyclase activator activity,metabolic process,0.628\ncyclase activity,metabolic process,0.832\ncyclase inhibitor activity,metabolic process,0.652\ncyclase regulator activity,metabolic process,0.626\ncyclic ADP-ribose hydrolase,metabolic process,0.8\ncyclic GMP-AMP binding,metabolic process,0.434\ncyclic GMP-AMP synthase activity,metabolic process,0.808\ncyclic nucleotide biosynthetic process,metabolic process,0.978\ncyclic nucleotide catabolic process,metabolic process,0.97\ncyclic nucleotide metabolic process,metabolic process,0.97\ncyclic nucleotide transport,transport,0.804\ncyclic nucleotide-dependent protein kinase activity,protein modification/signaling,0.482\ncyclic purine nucleotide metabolic process,metabolic process,0.934\ncyclic pyranopterin monophosphate synthase activity,metabolic process,0.758\ncyclic-GMP-AMP hydrolase activity,metabolic process,0.86\ncyclic-GMP-AMP transmembrane import across plasma membrane,transport,0.462\ncyclic-GMP-AMP transmembrane transporter activity,cellular component organization,0.282\ncyclic-di-GMP binding,gene regulation,0.268\ncyclic-nucleotide phosphodiesterase activity,metabolic process,0.758\ncyclic-nucleotide-mediated signaling,protein modification/signaling,0.352\ncyclin A1-CDK2 complex,protein modification/signaling,0.422\ncyclin A2-CDK2 complex,protein modification/signaling,0.418\ncyclin B1-CDK1 complex,protein modification/signaling,0.424\ncyclin D1-CDK4 complex,protein modification/signaling,0.416\ncyclin D2-CDK4 complex,protein modification/signaling,0.414\ncyclin D2-CDK6 complex,protein modification/signaling,0.432\ncyclin D3-CDK4 complex,protein modification/signaling,0.422\ncyclin E1-CDK2 complex,protein modification/signaling,0.414\ncyclin E2-CDK2 complex,protein modification/signaling,0.418\ncyclin K-CDK12 complex,protein modification/signaling,0.432\ncyclin K-CDK13 complex,protein modification/signaling,0.434\ncyclin-dependent protein kinase activating kinase activity,metabolic process,0.446\ncyclin-dependent protein kinase activating kinase holoenzyme complex,gene regulation,0.206\ncyclin-dependent protein kinase activity,protein modification/signaling,0.518\ncyclin-dependent protein kinase holoenzyme complex,protein modification/signaling,0.362\ncyclin-dependent protein serine/threonine kinase activator activity,protein modification/signaling,0.408\ncyclin-dependent protein serine/threonine kinase activity,metabolic process,0.424\ncyclin-dependent protein serine/threonine kinase inhibitor activity,protein modification/signaling,0.394\ncyclin/CDK positive transcription elongation factor complex,gene regulation,0.36\ncyclo-ligase activity,metabolic process,0.74\ncyclodextrin metabolic process,metabolic process,0.952\ncyclohydrolase activity,metabolic process,0.716\ncyclooxygenase pathway,metabolic process,0.874\ncyclosporin A binding,metabolic process,0.288\ncystathionine beta-synthase activity,metabolic process,0.9\ncystathionine gamma-lyase activity,metabolic process,0.9\ncysteamine dioxygenase activity,metabolic process,0.896\ncysteine biosynthetic process,metabolic process,0.992\ncysteine biosynthetic process from serine,metabolic process,0.856\ncysteine biosynthetic process via cystathionine,metabolic process,0.872\ncysteine catabolic process,metabolic process,0.994\ncysteine desulfurase activity,metabolic process,0.896\ncysteine dioxygenase activity,metabolic process,0.896\ncysteine synthase activity,metabolic process,0.892\ncysteine transmembrane transport,transport,0.84\ncysteine transmembrane transporter activity,transport,0.71\ncysteine transport,transport,0.936\ncysteine-S-conjugate N-acetyltransferase activity,metabolic process,0.892\ncysteine-S-conjugate beta-lyase activity,metabolic process,0.896\ncysteine-tRNA ligase activity,metabolic process,0.822\ncysteine-type carboxypeptidase activity,metabolic process,0.512\ncysteine-type deubiquitinase activity,protein modification/signaling,0.316\ncysteine-type endopeptidase activator activity,metabolic process,0.252\ncysteine-type endopeptidase activator activity involved in apoptotic process,cell death,0.604\ncysteine-type endopeptidase activity,cell death,0.55\ncysteine-type endopeptidase activity involved in apoptotic process,cell death,0.402\ncysteine-type endopeptidase activity involved in apoptotic signaling pathway,cell death,0.454\ncysteine-type endopeptidase activity involved in execution phase of apoptosis,cell death,0.334\ncysteine-type endopeptidase inhibitor activity,metabolic process,0.55\ncysteine-type endopeptidase inhibitor activity involved in apoptotic process,cell death,0.584\ncysteine-type exopeptidase activity,metabolic process,0.494\ncysteinyl leukotriene receptor activity,metabolic process,0.182\ncysteinyl-tRNA aminoacylation,metabolic process,0.552\ncystine secondary active transmembrane transporter activity,transport,0.654\ncystine:glutamate antiporter activity,metabolic process,0.524\ncytidine catabolic process,metabolic process,0.972\ncytidine deaminase activity,metabolic process,0.866\ncytidine deamination,protein modification/signaling,0.272\ncytidine kinase activity,metabolic process,0.796\ncytidine metabolic process,metabolic process,0.986\ncytidine to uridine editing,gene regulation,0.366\ncytidine transmembrane transporter activity,cellular component organization,0.282\ncytidine transport,transport,0.734\ncytidylate cyclase activity,metabolic process,0.874\ncytidylate kinase activity,metabolic process,0.668\ncytidylyltransferase activity,metabolic process,0.93\ncytochrome c-heme linkage,cellular component organization,0.318\ncytochrome complex,metabolic process,0.554\n\"cytochrome-b5 reductase activity, acting on NAD(P)H\",metabolic process,0.776\ncytokine precursor processing,gene regulation,0.186\ncytokine production involved in inflammatory response,immune system process,0.782\ncytokinesis,cell cycle,0.66\ncytokinetic process,cell cycle,0.554\ncytolysis,cellular component organization,0.326\ncytolysis by host of symbiont cells,cellular component organization,0.23\ncytolysis in another organism,cellular component organization,0.308\ncytolytic granule,immune system process,0.206\ncytolytic granule membrane,cellular component organization,0.252\ncytoophidium,cellular component organization,0.258\ncytoplasm,metabolic process,0.25\ncytoplasm organization,cellular component organization,0.86\ncytoplasm protein quality control,metabolic process,0.744\ncytoplasm protein quality control by the ubiquitin-proteasome system,metabolic process,0.618\ncytoplasmic RNA surveillance,gene regulation,0.604\ncytoplasmic U snRNP body,cellular component organization,0.45\ncytoplasmic actin-based contraction involved in cell motility,cellular component organization,0.268\ncytoplasmic cyclin-dependent protein kinase holoenzyme complex,protein modification/signaling,0.374\ncytoplasmic dynein complex,transport,0.348\ncytoplasmic exosome (RNase complex),gene regulation,0.296\ncytoplasmic microtubule,cellular component organization,0.526\ncytoplasmic microtubule bundle,cellular component organization,0.32\ncytoplasmic microtubule depolymerization,cellular component organization,0.75\ncytoplasmic microtubule organization,cellular component organization,0.78\ncytoplasmic microtubule plus-end,cellular component organization,0.536\ncytoplasmic periphery of the nuclear pore complex,cellular component organization,0.388\ncytoplasmic region,cellular component organization,0.46\ncytoplasmic sequestering of NF-kappaB,gene regulation,0.238\ncytoplasmic side of Golgi membrane,cellular component organization,0.34\ncytoplasmic side of apical plasma membrane,cellular component organization,0.432\ncytoplasmic side of dendritic spine plasma membrane,cellular component organization,0.398\ncytoplasmic side of early endosome membrane,cellular component organization,0.37\ncytoplasmic side of endoplasmic reticulum membrane,cellular component organization,0.544\ncytoplasmic side of endosome membrane,cellular component organization,0.6\ncytoplasmic side of late endosome membrane,cellular component organization,0.37\ncytoplasmic side of lysosomal membrane,cellular component organization,0.37\ncytoplasmic side of mitochondrial outer membrane,cellular component organization,0.434\ncytoplasmic side of nuclear pore,cellular component organization,0.37\ncytoplasmic side of plasma membrane,cellular component organization,0.578\ncytoplasmic side of rough endoplasmic reticulum membrane,cellular component organization,0.29\ncytoplasmic side of trans-Golgi network transport vesicle membrane,cellular component organization,0.278\ncytoplasmic side of transport vesicle membrane,cellular component organization,0.472\ncytoplasmic stress granule,gene regulation,0.172\ncytoplasmic translational elongation,metabolic process,0.398\ncytoplasmic translational termination,cellular component organization,0.266\ncytoplasmic ubiquitin ligase complex,metabolic process,0.418\ncytoplasmic vesicle,ER/endosome/lysosome related process,0.18\ncytoplasmic vesicle lumen,cellular component organization,0.4\ncytoplasmic vesicle membrane,ER/endosome/lysosome related process,0.27\ncytosine C-5 DNA demethylase activity,metabolic process,0.634\ncytosine metabolic process,metabolic process,0.948\ncytoskeletal anchor activity,cellular component organization,0.25\ncytoskeletal calyx,cellular component organization,0.32\ncytoskeletal matrix organization at active zone,cellular component organization,0.526\ncytoskeletal protein-membrane anchor activity,cellular component organization,0.27\n\"cytoskeletal rearrangement involved in phagocytosis, engulfment\",cellular component organization,0.37\ncytoskeletal regulatory protein binding,protein modification/signaling,0.344\ncytoskeleton,cellular component organization,0.464\ncytoskeleton of presynaptic active zone,cellular component organization,0.532\ncytoskeleton organization,cellular component organization,0.756\ncytoskeleton-dependent cytokinesis,cell cycle,0.616\ncytoskeleton-nuclear membrane anchor activity,cellular component organization,0.274\ncytosol,cellular component organization,0.248\ncytosol to ERGIC protein transport,transport,0.318\ncytosol to Golgi apparatus transport,transport,0.876\ncytosol to endoplasmic reticulum transport,transport,0.734\ncytosolic aryl hydrocarbon receptor complex,receptor related process,0.248\ncytosolic calcium signaling involved in initiation of cell movement in glial-mediated radial cell migration,cellular component organization,0.252\ncytosolic ciliogenesis,cellular component organization,0.38\ncytosolic large ribosomal subunit,cellular component organization,0.42\ncytosolic proteasome complex,metabolic process,0.388\ncytosolic region,cellular component organization,0.386\ncytosolic ribosome,cellular component organization,0.276\ncytosolic ribosome assembly,cellular component organization,0.544\ncytosolic small ribosomal subunit,cellular component organization,0.408\ncytosolic tRNA wobble base thiouridylase complex,protein modification/signaling,0.28\ncytotoxic T cell degranulation,immune system process,0.218\ncytotoxic T cell differentiation,immune system process,0.702\ncytotoxic T cell pyroptotic process,cellular component organization,0.204\ndADP biosynthetic process,metabolic process,0.884\ndADP catabolic process,metabolic process,0.884\ndADP metabolic process,metabolic process,1\ndAMP biosynthetic process,metabolic process,1\ndAMP catabolic process,metabolic process,0.886\ndAMP metabolic process,metabolic process,1\ndAMP salvage,cellular component organization,0.206\ndATP binding,metabolic process,0.234\ndATP biosynthetic process,metabolic process,0.996\ndATP catabolic process,metabolic process,0.878\ndATP diphosphatase activity,metabolic process,0.878\ndATP metabolic process,metabolic process,1\ndCMP catabolic process,metabolic process,0.894\ndCMP deaminase activity,metabolic process,0.9\ndCMP kinase activity,metabolic process,0.796\ndCMP metabolic process,metabolic process,1\ndCTP catabolic process,metabolic process,0.882\ndCTP deaminase activity,metabolic process,0.896\ndCTP diphosphatase activity,metabolic process,0.878\ndCTP metabolic process,metabolic process,1\ndGDP biosynthetic process,metabolic process,0.884\ndGDP catabolic process,metabolic process,0.884\ndGDP metabolic process,metabolic process,1\ndGMP catabolic process,metabolic process,0.894\ndGMP metabolic process,metabolic process,1\ndGTP binding,metabolic process,0.242\ndGTP catabolic process,metabolic process,0.882\ndGTP metabolic process,metabolic process,1\ndGTPase activity,metabolic process,0.882\ndIDP phosphatase activity,metabolic process,0.852\ndITP catabolic process,metabolic process,0.858\ndITP diphosphatase activity,metabolic process,0.878\ndITP metabolic process,metabolic process,0.974\ndTDP biosynthetic process,metabolic process,0.884\ndTDP metabolic process,metabolic process,1\n\"dTDP-glucose 4,6-dehydratase activity\",metabolic process,0.9\ndTMP biosynthetic process,metabolic process,0.998\ndTMP catabolic process,metabolic process,0.892\ndTMP metabolic process,metabolic process,1\ndTTP biosynthetic process,metabolic process,0.886\ndTTP diphosphatase activity,metabolic process,0.878\ndTTP metabolic process,metabolic process,1\ndUDP biosynthetic process,metabolic process,0.864\ndUDP metabolic process,metabolic process,1\ndUMP biosynthetic process,metabolic process,0.896\ndUMP catabolic process,metabolic process,0.896\ndUMP metabolic process,metabolic process,1\ndUTP catabolic process,metabolic process,0.896\ndUTP diphosphatase activity,metabolic process,0.878\ndUTP metabolic process,metabolic process,1\ndark adaptation,cellular component organization,0.226\ndaunorubicin metabolic process,metabolic process,0.982\nde novo centriole assembly,cellular component organization,0.58\nde novo centriole assembly involved in multi-ciliated epithelial cell differentiation,cellular component organization,0.336\ndeNEDDylase activity,protein modification/signaling,0.374\ndeSUMOylase activity,protein modification/signaling,0.368\ndeUFMylase activity,protein modification/signaling,0.37\ndeacetylase activity,metabolic process,0.626\ndeactivation of mitotic spindle assembly checkpoint,cell cycle,0.338\ndeadenylation-dependent decapping of nuclear-transcribed mRNA,gene regulation,0.418\ndeadenylation-independent decapping of nuclear-transcribed mRNA,gene regulation,0.732\ndeaminase activity,metabolic process,0.592\ndeaminated base DNA N-glycosylase activity,metabolic process,0.388\ndeaminated glutathione amidase activity,metabolic process,0.9\ndeath domain binding,protein modification/signaling,0.452\ndeath effector domain binding,protein modification/signaling,0.282\ndeath receptor activity,cell death,0.434\ndeath receptor agonist activity,cell death,0.342\ndeath receptor binding,receptor related process,0.44\ndeath-inducing signaling complex,cell death,0.338\ndeath-inducing signaling complex assembly,cellular component organization,0.534\ndecanoate-CoA ligase activity,metabolic process,0.82\ndecaprenyldihydroxybenzoate methyltransferase activity,metabolic process,0.896\ndedifferentiation,morphogenesis/development,0.664\ndefecation,cellular component organization,0.252\ndefense response,immune system process,0.302\ndefense response to fungus,immune system process,0.508\ndefense response to nematode,immune system process,0.486\ndefense response to other organism,stress response,0.266\ndefense response to tumor cell,metabolic process,0.28\ndefinitive erythrocyte differentiation,morphogenesis/development,0.276\ndehydroascorbic acid transmembrane transporter activity,cellular component organization,0.272\ndehydroascorbic acid transport,transport,0.702\ndehydrodolichyl diphosphate synthase activity,metabolic process,0.524\ndehydrodolichyl diphosphate synthase complex,protein modification/signaling,0.272\ndelamination,cell adhesion,0.292\ndelayed rectifier potassium channel activity,metabolic process,0.246\ndelta DNA polymerase complex,cellular component organization,0.222\ndelta(3)-delta(2)-enoyl-CoA isomerase activity,metabolic process,0.896\n\"delta(3,5)-delta(2,4)-dienoyl-CoA isomerase activity\",metabolic process,0.896\ndelta-catenin binding,cellular component organization,0.254\ndelta14-sterol reductase activity,metabolic process,0.934\ndelta24(24-1) sterol reductase activity,metabolic process,0.934\ndelta24-sterol reductase activity,metabolic process,0.934\ndelta4-3-oxosteroid 5beta-reductase activity,metabolic process,0.938\ndelta7-sterol 5(6)-desaturase activity,metabolic process,0.9\ndeltoid tuberosity development,morphogenesis/development,0.95\ndemethylase activity,protein modification/signaling,0.386\ndenatured protein binding,protein modification/signaling,0.34\ndendrite,neural related process,0.51\ndendrite arborization,neural related process,0.488\ndendrite cytoplasm,cellular component organization,0.406\ndendrite development,neural related process,0.686\ndendrite extension,cellular component organization,0.194\ndendrite membrane,cellular component organization,0.31\ndendrite regeneration,morphogenesis/development,0.146\ndendrite self-avoidance,cellular component organization,0.186\ndendrite terminus,cellular component organization,0.45\ndendritic branch,cellular component organization,0.206\ndendritic cell antigen processing and presentation,immune system process,0.718\ndendritic cell apoptotic process,cell death,0.454\ndendritic cell cytokine production,immune system process,0.868\ndendritic cell dendrite assembly,immune system process,0.302\ndendritic cell homeostasis,immune system process,0.278\ndendritic cell migration,immune system process,0.568\ndendritic cell proliferation,immune system process,0.29\ndendritic filopodium,neural related process,0.354\ndendritic growth cone,cellular component organization,0.224\ndendritic microtubule,neural related process,0.324\ndendritic spine cytoplasm,neural related process,0.306\ndendritic spine head,cellular component organization,0.212\ndendritic spine maintenance,neural related process,0.364\ndendritic spine membrane,cellular component organization,0.36\ndendritic spine morphogenesis,morphogenesis/development,0.454\ndendritic spine neck,cellular component organization,0.222\ndendritic spine organization,neural related process,0.662\ndendritic transport,transport,0.868\ndendritic transport of messenger ribonucleoprotein complex,transport,0.876\ndendritic transport of mitochondrion,transport,0.888\ndendritic transport of ribonucleoprotein complex,transport,0.876\ndendritic tree,neural related process,0.48\ndense body,metabolic process,0.298\ndense core granule,cellular component organization,0.448\ndense core granule biogenesis,cellular component organization,0.566\ndense core granule cytoskeletal transport,transport,0.702\ndense core granule exocytosis,transport,0.596\ndense core granule localization,transport,0.616\ndense core granule lumen,cellular component organization,0.564\ndense core granule maturation,cellular component organization,0.188\ndense core granule membrane,cellular component organization,0.62\ndense core granule priming,cellular component organization,0.338\ndense core granule transport,transport,0.81\ndense fibrillar component,gene regulation,0.39\ndentate gyrus development,morphogenesis/development,0.886\ndentate gyrus mossy fiber,cellular component organization,0.226\ndentin mineralization,cellular component organization,0.266\ndentinogenesis,morphogenesis/development,0.522\ndeoxyadenosine catabolic process,metabolic process,0.814\ndeoxyadenosine kinase activity,metabolic process,0.796\ndeoxyadenosine metabolic process,metabolic process,0.974\ndeoxycytidine deaminase activity,metabolic process,0.866\ndeoxycytidine kinase activity,metabolic process,0.892\ndeoxycytidine metabolic process,metabolic process,0.968\ndeoxycytidyl transferase activity,metabolic process,0.412\ndeoxyguanosine catabolic process,metabolic process,0.888\ndeoxyguanosine kinase activity,metabolic process,0.796\ndeoxyguanosine metabolic process,metabolic process,0.994\ndeoxyhypusine monooxygenase activity,metabolic process,0.652\ndeoxyhypusine synthase activity,metabolic process,0.894\ndeoxyinosine catabolic process,metabolic process,0.89\ndeoxyinosine metabolic process,metabolic process,0.992\ndeoxynucleoside kinase activity,metabolic process,0.668\ndeoxynucleoside triphosphate hydrolase activity,metabolic process,0.882\ndeoxynucleotide transmembrane transporter activity,metabolic process,0.21\ndeoxynucleotide transport,transport,0.428\ndeoxyribonuclease I activity,metabolic process,0.346\ndeoxyribonuclease II activity,metabolic process,0.35\ndeoxyribonuclease inhibitor activity,metabolic process,0.24\ndeoxyribonucleoside 5'-monophosphate N-glycosidase activity,metabolic process,0.898\ndeoxyribonucleoside biosynthetic process,metabolic process,0.978\ndeoxyribonucleoside catabolic process,metabolic process,0.986\ndeoxyribonucleoside diphosphate biosynthetic process,metabolic process,1\ndeoxyribonucleoside diphosphate catabolic process,metabolic process,0.992\ndeoxyribonucleoside diphosphate metabolic process,metabolic process,0.996\ndeoxyribonucleoside monophosphate biosynthetic process,metabolic process,1\ndeoxyribonucleoside monophosphate catabolic process,metabolic process,0.996\ndeoxyribonucleoside monophosphate metabolic process,metabolic process,0.998\ndeoxyribonucleoside triphosphate biosynthetic process,metabolic process,0.998\ndeoxyribonucleoside triphosphate catabolic process,metabolic process,0.992\ndeoxyribonucleoside triphosphate metabolic process,metabolic process,0.998\ndeoxyribonucleotide binding,metabolic process,0.562\ndeoxyribonucleotide biosynthetic process,metabolic process,0.998\ndeoxyribonucleotide catabolic process,metabolic process,0.994\ndeoxyribose phosphate catabolic process,metabolic process,0.972\ndeoxyribose-phosphate aldolase activity,metabolic process,0.896\ndeoxyuridine phosphorylase activity,metabolic process,0.85\ndephospho-CoA kinase activity,metabolic process,0.794\ndepurination,cellular component organization,0.226\ndepyrimidination,cellular component organization,0.224\ndermatan sulfate biosynthetic process,metabolic process,0.87\ndermatan sulfate catabolic process,metabolic process,0.886\ndermatan sulfate metabolic process,metabolic process,0.954\ndermatan sulfate proteoglycan biosynthetic process,metabolic process,0.862\n\"dermatan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process\",protein modification/signaling,0.216\ndermatan sulfate proteoglycan metabolic process,metabolic process,0.898\ndermatome development,morphogenesis/development,0.872\ndescending aorta development,morphogenesis/development,0.726\ndescending thin limb development,morphogenesis/development,0.98\ndesensitization of G protein-coupled receptor signaling pathway by arrestin,receptor related process,0.348\ndesmosome,cellular component organization,0.294\ndesmosome assembly,cellular component organization,0.528\ndesmosome disassembly,cellular component organization,0.388\ndesmosome organization,cellular component organization,0.812\ndetection of UV,immune system process,0.294\ndetection of abiotic stimulus,neural related process,0.31\ndetection of bacterial lipopeptide,immune system process,0.382\ndetection of bacterial lipoprotein,immune system process,0.282\ndetection of bacterium,immune system process,0.414\ndetection of biotic stimulus,immune system process,0.47\ndetection of calcium ion,protein modification/signaling,0.234\ndetection of carbohydrate stimulus,immune system process,0.23\ndetection of cell density,immune system process,0.202\ndetection of chemical stimulus,immune system process,0.208\ndetection of chemical stimulus involved in sensory perception,neural related process,0.206\ndetection of chemical stimulus involved in sensory perception of bitter taste,protein modification/signaling,0.21\ndetection of chemical stimulus involved in sensory perception of pain,neural related process,0.2\ndetection of chemical stimulus involved in sensory perception of smell,neural related process,0.184\ndetection of chemical stimulus involved in sensory perception of sour taste,protein modification/signaling,0.21\ndetection of chemical stimulus involved in sensory perception of sweet taste,protein modification/signaling,0.21\ndetection of chemical stimulus involved in sensory perception of taste,immune system process,0.196\ndetection of cold stimulus involved in thermoception,neural related process,0.186\ndetection of diacyl bacterial lipopeptide,immune system process,0.37\ndetection of endogenous stimulus,immune system process,0.252\ndetection of external biotic stimulus,immune system process,0.468\ndetection of external stimulus,neural related process,0.29\ndetection of fungus,immune system process,0.386\ndetection of glucose,protein modification/signaling,0.236\ndetection of gravity,immune system process,0.31\ndetection of hexose stimulus,immune system process,0.232\ndetection of hot stimulus involved in thermoception,protein modification/signaling,0.194\ndetection of hypoxia,immune system process,0.214\ndetection of hypoxic conditions in blood by carotid body chemoreceptor signaling,protein modification/signaling,0.248\ndetection of hypoxic conditions in blood by chemoreceptor signaling,immune system process,0.184\ndetection of light stimulus,immune system process,0.294\ndetection of light stimulus involved in sensory perception,immune system process,0.298\ndetection of light stimulus involved in visual perception,neural related process,0.248\ndetection of lipopolysaccharide,immune system process,0.366\ndetection of lipoteichoic acid,immune system process,0.304\ndetection of mechanical stimulus,neural related process,0.35\ndetection of mechanical stimulus involved in equilibrioception,immune system process,0.258\ndetection of mechanical stimulus involved in sensory perception,neural related process,0.41\ndetection of mechanical stimulus involved in sensory perception of sound,protein modification/signaling,0.222\ndetection of mechanical stimulus involved in sensory perception of touch,neural related process,0.316\ndetection of molecule of bacterial origin,immune system process,0.416\ndetection of molecule of fungal origin,immune system process,0.214\ndetection of monosaccharide stimulus,immune system process,0.23\ndetection of muramyl dipeptide,protein modification/signaling,0.23\ndetection of muscle stretch,protein modification/signaling,0.21\ndetection of nodal flow,protein modification/signaling,0.218\ndetection of other organism,immune system process,0.458\ndetection of oxidative stress,immune system process,0.184\ndetection of oxygen,immune system process,0.266\ndetection of peptidoglycan,immune system process,0.296\ndetection of stimulus,immune system process,0.356\ndetection of stimulus involved in sensory perception,neural related process,0.446\ndetection of stimulus involved in sensory perception of pain,neural related process,0.424\ndetection of temperature stimulus,immune system process,0.274\ndetection of temperature stimulus involved in sensory perception,neural related process,0.298\ndetection of temperature stimulus involved in sensory perception of pain,neural related process,0.404\ndetection of temperature stimulus involved in thermoception,immune system process,0.292\ndetection of triacyl bacterial lipopeptide,immune system process,0.376\ndetection of tumor cell,immune system process,0.436\ndetection of virus,immune system process,0.27\ndetection of visible light,immune system process,0.338\ndetection of wounding,immune system process,0.31\ndetection of yeast,immune system process,0.224\ndetermination of adult lifespan,metabolic process,0.252\ndetermination of affect,morphogenesis/development,0.168\ndetermination of bilateral symmetry,morphogenesis/development,0.524\ndetermination of digestive tract left/right asymmetry,morphogenesis/development,0.432\ndetermination of dorsal identity,morphogenesis/development,0.3\ndetermination of dorsal/ventral asymmetry,cellular component organization,0.192\ndetermination of heart left/right asymmetry,morphogenesis/development,0.61\ndetermination of intestine left/right asymmetry,cellular component organization,0.198\ndetermination of left/right asymmetry in lateral mesoderm,morphogenesis/development,0.17\ndetermination of left/right asymmetry in nervous system,multicellular organismal process,0.39\ndetermination of left/right symmetry,morphogenesis/development,0.476\ndetermination of liver left/right asymmetry,cellular component organization,0.204\ndetermination of pancreatic left/right asymmetry,cellular component organization,0.194\ndetermination of stomach left/right asymmetry,cellular component organization,0.198\ndetermination of ventral identity,morphogenesis/development,0.334\ndetoxification of cadmium ion,transport,0.158\ndetoxification of copper ion,transport,0.166\ndetoxification of hydrogen peroxide,metabolic process,0.378\ndetoxification of inorganic compound,transport,0.16\ndetoxification of mercury ion,transport,0.182\ndetoxification of nitrogen compound,metabolic process,0.4\ndetoxification of zinc ion,transport,0.158\ndeubiquitinase activator activity,metabolic process,0.344\ndeubiquitinase activity,metabolic process,0.342\ndeuterosome,cellular component organization,0.416\ndevelopment of secondary female sexual characteristics,morphogenesis/development,0.95\ndevelopment of secondary male sexual characteristics,morphogenesis/development,0.926\ndevelopment of secondary sexual characteristics,morphogenesis/development,0.912\ndevelopmental pigmentation,morphogenesis/development,0.456\ndevelopmental process,metabolic process,0.186\ndevelopmental process involved in reproduction,morphogenesis/development,0.556\ndextrin catabolic process,metabolic process,0.892\ndiacylglyceride transfer activity,metabolic process,0.234\ndiacylglycerol O-acyltransferase activity,metabolic process,0.89\ndiacylglycerol binding,metabolic process,0.336\ndiacylglycerol biosynthetic process,metabolic process,0.844\ndiacylglycerol catabolic process,metabolic process,0.87\ndiacylglycerol cholinephosphotransferase activity,metabolic process,0.896\ndiacylglycerol diphosphate phosphatase activity,metabolic process,0.852\ndiacylglycerol metabolic process,metabolic process,0.952\ndiadenosine hexaphosphate catabolic process,metabolic process,0.892\ndiadenosine hexaphosphate metabolic process,metabolic process,0.972\ndiadenosine pentaphosphate catabolic process,metabolic process,0.892\ndiadenosine pentaphosphate metabolic process,metabolic process,0.972\ndiadenosine polyphosphate biosynthetic process,metabolic process,0.982\ndiadenosine polyphosphate catabolic process,metabolic process,0.984\ndiadenosine polyphosphate metabolic process,metabolic process,0.986\ndiadenosine tetraphosphate biosynthetic process,metabolic process,0.864\ndiadenosine tetraphosphate metabolic process,metabolic process,0.986\ndiadenosine triphosphate catabolic process,metabolic process,0.846\ndiadenosine triphosphate metabolic process,metabolic process,0.986\ndiamine N-acetyltransferase activity,metabolic process,0.872\ndiamine oxidase activity,metabolic process,0.952\ndiapedesis,immune system process,0.722\ndiaphragm contraction,morphogenesis/development,0.174\ndiaphragm development,morphogenesis/development,0.82\ndibasic protein processing,protein modification/signaling,0.496\ndibenzo-p-dioxin catabolic process,metabolic process,0.854\ndibenzo-p-dioxin metabolic process,metabolic process,0.914\ndicarboxylic acid biosynthetic process,metabolic process,0.986\ndicarboxylic acid catabolic process,metabolic process,0.992\ndicarboxylic acid transmembrane transporter activity,transport,0.814\ndichotomous subdivision of an epithelial terminal unit,morphogenesis/development,0.82\ndichotomous subdivision of terminal units involved in lung branching,morphogenesis/development,0.836\ndichotomous subdivision of terminal units involved in mammary gland duct morphogenesis,cellular component organization,0.216\ndichotomous subdivision of terminal units involved in salivary gland branching,morphogenesis/development,0.23\ndichotomous subdivision of terminal units involved in ureteric bud branching,morphogenesis/development,0.228\ndiencephalon morphogenesis,morphogenesis/development,0.596\ndiet induced thermogenesis,neural related process,0.172\ndigestion,multicellular organismal process,0.506\ndigestive hormone activity,cellular component organization,0.222\ndigestive tract morphogenesis,morphogenesis/development,0.932\ndihydrobiopterin metabolic process,metabolic process,0.922\ndihydroceramidase activity,metabolic process,0.888\ndihydroceramide glucosyltransferase activity,metabolic process,0.892\ndihydroceramide kinase activity,metabolic process,0.798\ndihydrofolate metabolic process,metabolic process,0.972\ndihydrofolate reductase activity,metabolic process,0.934\ndihydrolipoyl dehydrogenase activity,metabolic process,0.676\ndihydrolipoyl dehydrogenase complex,metabolic process,0.456\ndihydrolipoyllysine-residue (2-methylpropanoyl)transferase activity,metabolic process,0.888\ndihydrolipoyllysine-residue acetyltransferase activity,metabolic process,0.894\ndihydrolipoyllysine-residue succinyltransferase activity,metabolic process,0.894\ndihydronicotinamide riboside quinone reductase activity,metabolic process,0.896\ndihydroorotase activity,metabolic process,0.898\ndihydroorotate dehydrogenase (quinone) activity,cellular component organization,0.244\ndihydroorotate dehydrogenase activity,metabolic process,0.944\ndihydropyrimidinase activity,metabolic process,0.9\ndihydropyrimidine dehydrogenase (NADP+) activity,metabolic process,0.934\ndihydrosphingosine-1-phosphate phosphatase activity,metabolic process,0.852\ndihydrotestosterone 17-beta-dehydrogenase activity,metabolic process,0.936\ndiiodophenylpyruvate reductase activity,metabolic process,0.928\ndimeric IgA immunoglobulin complex,cellular component organization,0.296\ndimethylallyl diphosphate biosynthetic process,metabolic process,0.882\ndimethylallyl diphosphate metabolic process,metabolic process,0.914\ndimethylallyltranstransferase activity,metabolic process,0.874\ndimethylargininase activity,metabolic process,0.898\ndimethylglycine dehydrogenase activity,metabolic process,0.896\ndinitrosyl-iron complex binding,metabolic process,0.62\ndinucleotide insertion or deletion binding,gene regulation,0.546\ndinucleotide phosphatase activity,metabolic process,0.906\ndinucleotide repeat insertion binding,gene regulation,0.2\ndiol metabolic process,metabolic process,0.988\ndiolein transacylation activity,metabolic process,0.87\ndioxygenase activity,metabolic process,0.692\ndipeptidase activity,metabolic process,0.56\ndipeptide import across plasma membrane,transport,0.464\ndipeptide transmembrane transport,transport,0.912\ndipeptide transmembrane transporter activity,transport,0.668\ndipeptide transport,transport,0.954\ndipeptidyl-peptidase activity,metabolic process,0.496\ndiphosphate metabolic process,metabolic process,0.868\ndiphosphoinositol polyphosphate catabolic process,metabolic process,0.822\ndiphosphoinositol polyphosphate metabolic process,metabolic process,0.956\ndiphosphoinositol-pentakisphosphate kinase activity,metabolic process,0.796\ndiphosphoinositol-polyphosphate diphosphatase activity,metabolic process,0.85\ndiphosphomevalonate decarboxylase activity,metabolic process,0.734\ndiphosphoric monoester hydrolase activity,metabolic process,0.742\ndiphosphotransferase activity,metabolic process,0.874\ndiphthine methylesterase activity,metabolic process,0.826\ndiphthine synthase activity,metabolic process,0.896\ndiphthine-ammonia ligase activity,metabolic process,0.752\ndirect ossification,multicellular organismal process,0.392\ndirectional guidance of interneurons involved in migration from the subpallium to the cortex,cellular component organization,0.2\ndirectional locomotion,transport,0.366\ndisaccharide binding,protein modification/signaling,0.206\ndisaccharide biosynthetic process,metabolic process,0.978\ndisaccharide catabolic process,metabolic process,0.976\ndisaccharide metabolic process,metabolic process,0.984\ndisaccharide transmembrane transporter activity,transport,0.706\ndisaccharide transport,transport,0.98\ndiscoidal high-density lipoprotein particle,cellular component organization,0.264\ndisordered domain specific binding,protein modification/signaling,0.328\ndisruption of anatomical structure in another organism,morphogenesis/development,0.334\ndisruption of cell in another organism,immune system process,0.204\ndisruption of cell wall in another organism,cellular component organization,0.168\ndisruption of cellular anatomical structure in another organism,cellular component organization,0.402\ndisruption of plasma membrane integrity in another organism,cellular component organization,0.272\ndistal convoluted tubule development,morphogenesis/development,0.974\ndistal dendrite,cellular component organization,0.388\ndistal portion of axoneme,gene regulation,0.23\ndistal stomach smooth muscle contraction,multicellular organismal process,0.616\ndistal tubule morphogenesis,morphogenesis/development,0.91\ndisulfide oxidoreductase activity,metabolic process,0.93\nditerpenoid catabolic process,metabolic process,0.992\ndiuretic hormone activity,receptor related process,0.466\ndivision septum assembly,cellular component organization,0.65\ndodecanoyl-[acyl-carrier-protein] hydrolase activity,metabolic process,0.9\n\"dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase activity\",metabolic process,0.846\n\"dol-P-Man:Man(6)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity\",metabolic process,0.846\n\"dol-P-Man:Man(8)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity\",metabolic process,0.846\ndolichol biosynthetic process,metabolic process,0.888\ndolichol kinase activity,metabolic process,0.85\ndolichol metabolic process,metabolic process,0.98\ndolichol-phosphate-mannose synthase complex,cellular component organization,0.254\ndolichyl diphosphate biosynthetic process,metabolic process,0.884\ndolichyl diphosphate metabolic process,metabolic process,0.878\ndolichyl monophosphate biosynthetic process,metabolic process,0.834\n\"dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase activity\",metabolic process,0.528\n\"dolichyl pyrophosphate Glc2Man9GlcNAc2 alpha-1,2-glucosyltransferase activity\",metabolic process,0.522\n\"dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity\",metabolic process,0.528\n\"dolichyl-P-Man:Man(7)GlcNAc(2)-PP-dolichol alpha-1,6-mannosyltransferase\",metabolic process,0.514\ndolichyl-diphosphooligosaccharide-protein glycotransferase activity,metabolic process,0.598\ndolichyl-phosphate beta-D-mannosyltransferase activity,metabolic process,0.846\ndolichyl-phosphate beta-glucosyltransferase activity,metabolic process,0.846\ndolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity,metabolic process,0.424\ndolichyl-phosphate-mannose-protein mannosyltransferase activity,metabolic process,0.656\ndolichyldiphosphatase activity,metabolic process,0.828\ndopachrome isomerase activity,metabolic process,0.888\ndopamine beta-monooxygenase activity,metabolic process,0.888\ndopamine binding,metabolic process,0.24\ndopamine biosynthetic process,metabolic process,0.96\ndopamine biosynthetic process from tyrosine,metabolic process,0.84\ndopamine catabolic process,metabolic process,0.844\ndopamine metabolic process,metabolic process,0.968\ndopamine neurotransmitter receptor activity,receptor related process,0.432\n\"dopamine neurotransmitter receptor activity, coupled via Gi/Go\",neural related process,0.194\n\"dopamine neurotransmitter receptor activity, coupled via Gs\",neural related process,0.262\ndopamine receptor binding,receptor related process,0.46\ndopamine secretion,transport,0.496\ndopamine transport,transport,0.756\ndopamine uptake,transport,0.664\ndopamine uptake involved in synaptic transmission,neural related process,0.414\ndopamine:sodium symporter activity,metabolic process,0.512\ndopaminergic neuron axon guidance,neural related process,0.426\ndopaminergic neuron differentiation,morphogenesis/development,0.666\ndopaminergic synapse,neural related process,0.31\ndorsal aorta development,morphogenesis/development,0.736\ndorsal aorta morphogenesis,morphogenesis/development,0.62\ndorsal root ganglion development,morphogenesis/development,0.976\ndorsal root ganglion morphogenesis,morphogenesis/development,0.572\ndorsal spinal cord development,morphogenesis/development,0.86\ndorsal spinal cord interneuron anterior axon guidance,neural related process,0.258\ndorsal spinal cord interneuron axon guidance,neural related process,0.404\ndorsal spinal cord interneuron posterior axon guidance,neural related process,0.248\ndorsal/ventral axis specification,multicellular organismal process,0.37\ndorsal/ventral axon guidance,neural related process,0.246\ndorsal/ventral neural tube patterning,morphogenesis/development,0.412\ndorsal/ventral pattern formation,morphogenesis/development,0.526\ndosage compensation by inactivation of X chromosome,gene regulation,0.624\ndosage compensation complex,gene regulation,0.232\ndouble-strand break repair involved in meiotic recombination,cell cycle,0.28\ndouble-strand break repair via alternative nonhomologous end joining,stress response,0.136\ndouble-strand break repair via classical nonhomologous end joining,cellular component organization,0.148\ndouble-strand break repair via single-strand annealing,metabolic process,0.178\ndouble-strand break repair via synthesis-dependent strand annealing,stress response,0.256\ndouble-stranded DNA 3'-5' DNA exonuclease activity,metabolic process,0.386\ndouble-stranded DNA 5'-3' exodeoxyribonuclease activity,metabolic process,0.418\ndouble-stranded DNA binding,gene regulation,0.834\ndouble-stranded DNA endonuclease activity,metabolic process,0.494\ndouble-stranded DNA exodeoxyribonuclease activity,metabolic process,0.424\ndouble-stranded DNA helicase activity,metabolic process,0.614\ndouble-stranded RNA adenosine deaminase activity,metabolic process,0.658\ndouble-stranded RNA-specific ribonuclease activity,metabolic process,0.426\ndouble-stranded methylated DNA binding,transport,0.204\ndouble-stranded telomeric DNA binding,cell cycle,0.206\ndoxorubicin metabolic process,metabolic process,0.876\ndoxorubicin transport,transport,0.736\ndrinking behavior,multicellular organismal process,0.476\ndsRNA transport,transport,0.706\nductus arteriosus closure,morphogenesis/development,0.234\ndynactin binding,protein modification/signaling,0.226\ndynactin complex,cellular component organization,0.628\ndynein axonemal particle,cellular component organization,0.32\ndynein complex,cellular component organization,0.348\ndynein complex binding,cellular component organization,0.272\ndynein heavy chain binding,cellular component organization,0.228\ndynein intermediate chain binding,cellular component organization,0.498\ndynein light chain binding,cellular component organization,0.284\ndynorphin receptor activity,protein modification/signaling,0.294\ndystroglycan binding,cellular component organization,0.326\ndystroglycan complex,cellular component organization,0.25\ndystrophin-associated glycoprotein complex,cellular component organization,0.25\neIF2alpha dephosphorylation in response to endoplasmic reticulum stress,metabolic process,0.196\neNoSc complex,metabolic process,0.324\neRF1 methyltransferase complex,protein modification/signaling,0.44\near development,morphogenesis/development,0.86\near morphogenesis,morphogenesis/development,0.676\nearly endosome lumen,cellular component organization,0.346\nearly endosome membrane,cellular component organization,0.424\nearly endosome to Golgi transport,transport,0.358\nearly endosome to recycling endosome transport,transport,0.338\nearly phagosome,cellular component organization,0.168\nearly phagosome membrane,cellular component organization,0.264\nearly viral transcription,viral related process,0.21\neating behavior,multicellular organismal process,0.332\nectoderm and mesoderm interaction,protein modification/signaling,0.212\nectoderm development,morphogenesis/development,0.978\nectoderm formation,morphogenesis/development,0.27\nectodermal cell differentiation,morphogenesis/development,0.722\nectodermal cell fate commitment,morphogenesis/development,0.24\nectodermal cell fate specification,morphogenesis/development,0.502\nectodermal digestive tract development,morphogenesis/development,0.978\nectodermal digestive tract morphogenesis,morphogenesis/development,0.7\nectodermal placode formation,morphogenesis/development,0.88\nectodermal placode morphogenesis,morphogenesis/development,0.89\nectopic germ cell programmed cell death,cell death,0.362\nectoplasm,cellular component organization,0.406\nefferent axon development in a lateral line nerve,morphogenesis/development,0.45\nefflux transmembrane transporter activity,transport,0.546\negg activation,protein modification/signaling,0.2\negg coat,cellular component organization,0.464\negg coat formation,morphogenesis/development,0.386\neiF2alpha phosphorylation in response to endoplasmic reticulum stress,metabolic process,0.196\nelastic fiber,cellular component organization,0.294\nelastic fiber assembly,cellular component organization,0.38\nelastin biosynthetic process,metabolic process,0.886\nelastin catabolic process,metabolic process,0.83\nelastin metabolic process,metabolic process,0.954\nelectron transfer activity,metabolic process,0.652\nelectron transfer flavoprotein complex,metabolic process,0.37\nelectron transport coupled proton transport,metabolic process,0.238\nelectron-transferring-flavoprotein dehydrogenase activity,metabolic process,0.92\nelongation factor-2 kinase activity,metabolic process,0.702\nelongator holoenzyme complex,cellular component organization,0.244\nelongin complex,gene regulation,0.58\nembryo development,morphogenesis/development,0.814\nembryonic appendage morphogenesis,morphogenesis/development,0.804\nembryonic axis specification,morphogenesis/development,0.352\nembryonic body morphogenesis,morphogenesis/development,0.682\nembryonic brain development,morphogenesis/development,0.962\nembryonic camera-type eye development,morphogenesis/development,0.954\nembryonic camera-type eye formation,morphogenesis/development,0.702\nembryonic camera-type eye morphogenesis,morphogenesis/development,0.788\nembryonic cleavage,metabolic process,0.216\nembryonic cranial skeleton morphogenesis,morphogenesis/development,0.816\nembryonic digestive tract development,morphogenesis/development,0.954\nembryonic digestive tract morphogenesis,morphogenesis/development,0.806\nembryonic digit morphogenesis,morphogenesis/development,0.784\nembryonic ectodermal digestive tract development,morphogenesis/development,0.964\nembryonic ectodermal digestive tract morphogenesis,morphogenesis/development,0.682\nembryonic epithelial tube formation,morphogenesis/development,0.842\nembryonic foregut morphogenesis,morphogenesis/development,0.714\nembryonic forelimb morphogenesis,morphogenesis/development,0.766\nembryonic genitalia morphogenesis,morphogenesis/development,0.748\nembryonic heart tube anterior/posterior pattern specification,morphogenesis/development,0.176\nembryonic heart tube development,morphogenesis/development,0.952\nembryonic heart tube elongation,morphogenesis/development,0.454\nembryonic heart tube formation,morphogenesis/development,0.844\nembryonic heart tube left/right pattern formation,morphogenesis/development,0.324\nembryonic heart tube morphogenesis,morphogenesis/development,0.842\nembryonic hindgut morphogenesis,morphogenesis/development,0.684\nembryonic hindlimb morphogenesis,morphogenesis/development,0.694\nembryonic limb morphogenesis,morphogenesis/development,0.818\nembryonic liver development,morphogenesis/development,0.962\nembryonic lung development,morphogenesis/development,0.964\nembryonic morphogenesis,morphogenesis/development,0.814\nembryonic nail plate morphogenesis,morphogenesis/development,0.748\nembryonic neurocranium morphogenesis,morphogenesis/development,0.67\nembryonic olfactory bulb interneuron precursor migration,transport,0.32\nembryonic pattern specification,morphogenesis/development,0.55\nembryonic placenta development,morphogenesis/development,0.946\nembryonic placenta morphogenesis,morphogenesis/development,0.726\nembryonic process involved in female pregnancy,morphogenesis/development,0.26\nembryonic retina morphogenesis in camera-type eye,morphogenesis/development,0.784\nembryonic skeletal joint development,morphogenesis/development,0.962\nembryonic skeletal joint morphogenesis,morphogenesis/development,0.816\nembryonic skeletal limb joint morphogenesis,morphogenesis/development,0.758\nembryonic skeletal system development,morphogenesis/development,0.936\nembryonic skeletal system morphogenesis,morphogenesis/development,0.882\nembryonic viscerocranium morphogenesis,morphogenesis/development,0.69\nenamel mineralization,morphogenesis/development,0.32\nendocannabinoid signaling pathway,receptor related process,0.53\nendocardial cell differentiation,morphogenesis/development,0.696\nendocardial cell fate commitment,morphogenesis/development,0.686\nendocardial cushion cell development,morphogenesis/development,0.93\nendocardial cushion cell differentiation,morphogenesis/development,0.718\nendocardial cushion cell fate commitment,morphogenesis/development,0.3\nendocardial cushion development,morphogenesis/development,0.908\nendocardial cushion formation,morphogenesis/development,0.77\nendocardial cushion fusion,cell adhesion,0.32\nendocardial cushion morphogenesis,morphogenesis/development,0.912\nendocardial cushion to mesenchymal transition,morphogenesis/development,0.59\nendocardial cushion to mesenchymal transition involved in heart valve formation,cellular component organization,0.356\nendocardium formation,morphogenesis/development,0.564\nendocardium morphogenesis,morphogenesis/development,0.742\nendochitinase activity,metabolic process,0.464\nendochondral bone growth,morphogenesis/development,0.516\nendochondral ossification,morphogenesis/development,0.392\nendocrine pancreas development,morphogenesis/development,0.952\nendocrine process,multicellular organismal process,0.632\nendocrine signaling,immune system process,0.138\nendocytic iron import into cell,transport,0.566\nendocytic vesicle lumen,cellular component organization,0.628\nendocytic vesicle membrane,cellular component organization,0.546\nendocytosis involved in viral entry into host cell,transport,0.688\n\"endodeoxyribonuclease activity, producing 5'-phosphomonoesters\",metabolic process,0.596\nendodeoxyribonuclease complex,metabolic process,0.306\nendoderm formation,morphogenesis/development,0.488\nendodermal cell fate commitment,morphogenesis/development,0.384\nendodermal cell fate determination,morphogenesis/development,0.29\nendodermal cell fate specification,morphogenesis/development,0.55\nendodermal digestive tract morphogenesis,morphogenesis/development,0.728\nendogalactosaminidase activity,metabolic process,0.708\nendogenous lipid antigen binding,metabolic process,0.214\nendolysosome,cellular component organization,0.214\nendolysosome lumen,cellular component organization,0.404\nendolysosome membrane,cellular component organization,0.236\nendomembrane system,cellular component organization,0.166\nendomitotic cell cycle,cell cycle,0.374\n\"endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters\",metabolic process,0.66\n\"endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters\",metabolic process,0.652\nendonuclease complex,metabolic process,0.308\n\"endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)\",gene regulation,0.454\n\"endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)\",gene regulation,0.568\n\"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)\",gene regulation,0.696\n\"endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)\",gene regulation,0.592\n\"endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)\",gene regulation,0.554\nendopeptidase Clp complex,cellular component organization,0.234\nendopeptidase activator activity,metabolic process,0.53\nendopeptidase inhibitor activity,metabolic process,0.614\nendoplasmic reticulum,ER/endosome/lysosome related process,0.206\nendoplasmic reticulum Sec complex,ER/endosome/lysosome related process,0.364\nendoplasmic reticulum chaperone complex,ER/endosome/lysosome related process,0.368\nendoplasmic reticulum localization,transport,0.566\nendoplasmic reticulum mannose trimming,protein modification/signaling,0.494\nendoplasmic reticulum membrane,cellular component organization,0.234\nendoplasmic reticulum membrane fusion,cellular component organization,0.3\nendoplasmic reticulum membrane organization,cellular component organization,0.718\nendoplasmic reticulum palmitoyltransferase complex,metabolic process,0.366\nendoplasmic reticulum polarization,morphogenesis/development,0.204\nendoplasmic reticulum protein-containing complex,ER/endosome/lysosome related process,0.202\nendoplasmic reticulum signal peptide binding,ER/endosome/lysosome related process,0.232\nendoplasmic reticulum stress-induced pre-emptive quality control,protein modification/signaling,0.25\nendoplasmic reticulum subcompartment,ER/endosome/lysosome related process,0.228\nendoplasmic reticulum tubular network,cellular component organization,0.56\nendoplasmic reticulum tubular network formation,cellular component organization,0.546\nendoplasmic reticulum tubular network maintenance,cellular component organization,0.246\nendoplasmic reticulum tubular network membrane,cellular component organization,0.286\nendoplasmic reticulum tubular network membrane organization,cellular component organization,0.636\nendoplasmic reticulum-Golgi intermediate compartment membrane,ER/endosome/lysosome related process,0.376\nendoplasmic reticulum-Golgi intermediate compartment organization,cellular component organization,0.65\nendoplasmic reticulum-autophagosome adaptor activity,cellular component organization,0.236\nendoplasmic reticulum-endosome membrane contact site,cellular component organization,0.328\nendoplasmic reticulum-organelle membrane tether activity,cellular component organization,0.214\nendoplasmic reticulum-plasma membrane contact site,cellular component organization,0.44\nendoplasmic reticulum-plasma membrane tethering,cellular component organization,0.254\nendopolyphosphatase activity,metabolic process,0.65\n\"endoribonuclease activity, cleaving miRNA-paired mRNA\",gene regulation,0.442\n\"endoribonuclease activity, cleaving siRNA-paired mRNA\",gene regulation,0.438\nendoribonuclease complex,gene regulation,0.258\nendoribonuclease inhibitor activity,metabolic process,0.242\nendosomal vesicle fusion,cellular component organization,0.204\nendosome,ER/endosome/lysosome related process,0.444\nendosome fission,metabolic process,0.438\nendosome lumen,cellular component organization,0.604\nendosome membrane,ER/endosome/lysosome related process,0.388\nendosome membrane tubulation,cellular component organization,0.398\nendosome to lysosome transport,ER/endosome/lysosome related process,0.456\nendosome to lysosome transport of low-density lipoprotein particle,transport,0.352\nendosome to lysosome transport via multivesicular body sorting pathway,ER/endosome/lysosome related process,0.504\nendosome to melanosome transport,transport,0.372\nendosome to pigment granule transport,transport,0.84\nendosome to plasma membrane protein transport,transport,0.75\nendosome to plasma membrane transport vesicle,transport,0.27\nendosome transport via multivesicular body sorting pathway,ER/endosome/lysosome related process,0.58\nendothelial cell activation,immune system process,0.482\nendothelial cell activation involved in immune response,immune system process,0.664\nendothelial cell chemotaxis,immune system process,0.18\nendothelial cell chemotaxis to fibroblast growth factor,transport,0.33\nendothelial cell chemotaxis to vascular endothelial growth factor,transport,0.346\nendothelial cell fate commitment,morphogenesis/development,0.67\nendothelial cell fate specification,morphogenesis/development,0.594\nendothelial cell morphogenesis,morphogenesis/development,0.238\nendothelial cell-cell adhesion,cell adhesion,0.362\nendothelial cell-matrix adhesion,cell adhesion,0.352\nendothelial cell-matrix adhesion via fibronectin,gene regulation,0.136\nendothelial differentiation G protein-coupled receptor binding,receptor related process,0.378\nendothelial microparticle,cellular component organization,0.214\nendothelial tip cell fate specification,transport,0.234\nendothelial to hematopoietic transition,morphogenesis/development,0.274\nendothelial tube lumen extension,morphogenesis/development,0.802\nendothelial tube morphogenesis,morphogenesis/development,0.834\nendothelin A receptor binding,receptor related process,0.5\nendothelin B receptor binding,receptor related process,0.466\nendothelin maturation,morphogenesis/development,0.212\nendothelin production,immune system process,0.54\nendothelin receptor activity,cellular component organization,0.246\nendothelin receptor signaling pathway,receptor related process,0.682\nendothelin receptor signaling pathway involved in heart process,receptor related process,0.308\n\"energy coupled proton transmembrane transport, against electrochemical gradient\",transport,0.832\nenergy reserve metabolic process,metabolic process,0.796\nengulfment of apoptotic cell,cell death,0.182\nengulfment of target by autophagosome,cellular component organization,0.358\nenkephalin processing,morphogenesis/development,0.358\nenone reductase activity,metabolic process,0.986\nenoyl-CoA hydratase activity,metabolic process,0.71\n\"enoyl-[acyl-carrier-protein] reductase (NADPH, A-specific) activity\",metabolic process,0.674\nenoyl-[acyl-carrier-protein] reductase activity,metabolic process,0.846\nensheathing process,cellular component organization,0.324\nenteric nervous system development,morphogenesis/development,0.71\nenteric smooth muscle cell differentiation,morphogenesis/development,0.648\nenterobactin binding,metabolic process,0.248\nenterobactin transmembrane transporter activity,transport,0.406\nenterobactin transport,transport,0.704\nenterocyte differentiation,morphogenesis/development,0.648\nenteroendocrine cell differentiation,morphogenesis/development,0.76\nentrainment of circadian clock by photoperiod,cellular component organization,0.22\nentry into host cell by a symbiont-containing vacuole,cellular component organization,0.284\nentry of bacterium into host cell,morphogenesis/development,0.204\nentry of viral genome into host nucleus through nuclear pore complex via importin,viral related process,0.258\nenucleate erythrocyte development,morphogenesis/development,0.53\nenucleate erythrocyte differentiation,morphogenesis/development,0.442\nenucleate erythrocyte maturation,morphogenesis/development,0.484\nenucleation,cellular component organization,0.762\nenvelope,cellular component organization,0.424\nenzyme activator complex,protein modification/signaling,0.262\nenzyme binding,protein modification/signaling,0.372\nenzyme regulator activity,protein modification/signaling,0.358\nenzyme-directed rRNA pseudouridine synthesis,gene regulation,0.336\nenzyme-substrate adaptor activity,metabolic process,0.26\neosinophil activation,immune system process,0.804\neosinophil activation involved in immune response,immune system process,0.594\neosinophil chemotaxis,immune system process,0.556\neosinophil degranulation,protein modification/signaling,0.338\neosinophil differentiation,morphogenesis/development,0.524\neosinophil extravasation,cellular component organization,0.188\neosinophil fate commitment,morphogenesis/development,0.494\neosinophil homeostasis,immune system process,0.338\neosinophil mediated immunity,immune system process,0.602\nephrin receptor activity,receptor related process,0.546\nephrin receptor binding,receptor related process,0.478\nepiblast cell-extraembryonic ectoderm cell signaling involved in anterior/posterior axis specification,morphogenesis/development,0.258\nepiboly involved in gastrulation with mouth forming second,cell cycle,0.25\nepicardium morphogenesis,morphogenesis/development,0.576\nepicardium-derived cardiac fibroblast cell development,morphogenesis/development,0.858\nepicardium-derived cardiac fibroblast cell differentiation,morphogenesis/development,0.508\nepidermal cell division,morphogenesis/development,0.196\nepidermal cell fate specification,morphogenesis/development,0.594\nepidermal growth factor binding,metabolic process,0.184\nepidermal growth factor catabolic process,metabolic process,0.476\nepidermal growth factor receptor activity,receptor related process,0.382\nepidermal growth factor receptor ligand maturation,receptor related process,0.438\nepidermal lamellar body,cellular component organization,0.338\nepidermal lamellar body membrane,cellular component organization,0.348\nepidermis morphogenesis,morphogenesis/development,0.906\nepididymis development,morphogenesis/development,0.982\nepididymosome,cellular component organization,0.332\nepigenetic programing of female pronucleus,cell cycle,0.19\nepigenetic programing of male pronucleus,cell cycle,0.202\nepigenetic programming in the zygotic pronuclei,gene regulation,0.416\nepinephrine binding,metabolic process,0.184\nepinephrine biosynthetic process,metabolic process,0.796\nepinephrine metabolic process,metabolic process,0.946\nepinephrine secretion,transport,0.54\nepinephrine transport,transport,0.906\nepinephrine uptake,transport,0.336\nepithalamus development,morphogenesis/development,0.8\nepithelial cell apoptotic process involved in palatal shelf morphogenesis,cell death,0.634\nepithelial cell differentiation involved in embryonic placenta development,morphogenesis/development,0.596\nepithelial cell differentiation involved in kidney development,morphogenesis/development,0.946\nepithelial cell differentiation involved in mammary gland alveolus development,morphogenesis/development,0.48\nepithelial cell differentiation involved in prostate gland development,morphogenesis/development,0.888\nepithelial cell fate commitment,morphogenesis/development,0.648\nepithelial cell maturation,morphogenesis/development,0.738\nepithelial cell maturation involved in prostate gland development,morphogenesis/development,0.538\nepithelial cell morphogenesis,morphogenesis/development,0.802\nepithelial cell morphogenesis involved in placental branching,morphogenesis/development,0.206\nepithelial cell proliferation involved in lung morphogenesis,cell cycle,0.754\nepithelial cell proliferation involved in mammary gland duct elongation,cell cycle,0.358\nepithelial cell proliferation involved in prostate gland development,cell cycle,0.566\nepithelial cell proliferation involved in prostatic bud elongation,cell cycle,0.274\nepithelial cell proliferation involved in renal tubule morphogenesis,cell cycle,0.584\nepithelial cell proliferation involved in salivary gland morphogenesis,cell cycle,0.76\nepithelial cilium movement involved in determination of left/right asymmetry,transport,0.226\nepithelial cilium movement involved in extracellular fluid movement,transport,0.75\nepithelial fluid transport,transport,0.802\nepithelial structure maintenance,multicellular organismal process,0.632\nepithelial to mesenchymal transition involved in cardiac fibroblast development,cellular component organization,0.322\nepithelial to mesenchymal transition involved in endocardial cushion formation,morphogenesis/development,0.392\nepithelial tube branching involved in lung morphogenesis,morphogenesis/development,0.838\nepithelial tube formation,morphogenesis/development,0.878\nepithelial-mesenchymal cell signaling,morphogenesis/development,0.326\nepithelial-mesenchymal signaling involved in prostate gland development,morphogenesis/development,0.46\nepithelium development,morphogenesis/development,0.76\nepithelium regeneration,morphogenesis/development,0.788\nepoxide hydrolase activity,metabolic process,0.85\nepoxide metabolic process,metabolic process,0.842\nepoxygenase P450 pathway,metabolic process,0.838\nepsilon DNA polymerase complex,gene regulation,0.25\nequatorial microtubule organizing center,cellular component organization,0.218\nequilibrioception,immune system process,0.246\nerror-free postreplication DNA repair,stress response,0.648\nerror-free translesion synthesis,cell cycle,0.214\nerror-prone translesion synthesis,morphogenesis/development,0.224\nerythrocyte apoptotic process,cell death,0.656\nerythrocyte development,morphogenesis/development,0.68\nerythrocyte enucleation,morphogenesis/development,0.256\nerythrocyte maturation,morphogenesis/development,0.67\nerythrophore differentiation,morphogenesis/development,0.678\nerythropoietin receptor activity,receptor related process,0.21\nerythropoietin receptor binding,receptor related process,0.516\nerythropoietin-mediated signaling pathway,receptor related process,0.622\nerythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process,metabolic process,0.988\nerythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process,metabolic process,0.982\nesophagus smooth muscle contraction,cellular component organization,0.218\nestablishment of Golgi localization,transport,0.352\nestablishment of RNA localization to telomere,transport,0.318\nestablishment of Sertoli cell barrier,cellular component organization,0.32\nestablishment of T cell polarity,transport,0.182\nestablishment of anatomical structure orientation,morphogenesis/development,0.386\nestablishment of animal organ orientation,morphogenesis/development,0.252\nestablishment of apical/basal cell polarity,cellular component organization,0.568\nestablishment of bipolar cell polarity,cellular component organization,0.282\nestablishment of bipolar cell polarity involved in cell morphogenesis,morphogenesis/development,0.43\nestablishment of blood-brain barrier,morphogenesis/development,0.542\nestablishment of blood-nerve barrier,metabolic process,0.182\nestablishment of blood-retinal barrier,cellular component organization,0.274\nestablishment of body hair or bristle planar orientation,morphogenesis/development,0.502\nestablishment of body hair planar orientation,morphogenesis/development,0.198\nestablishment of cell polarity involved in ameboidal cell migration,transport,0.36\nestablishment of centrosome localization,transport,0.326\nestablishment of endothelial barrier,morphogenesis/development,0.668\nestablishment of endothelial blood-brain barrier,transport,0.272\nestablishment of endothelial intestinal barrier,morphogenesis/development,0.244\nestablishment of epithelial cell apical/basal polarity,morphogenesis/development,0.54\nestablishment of epithelial cell apical/basal polarity involved in camera-type eye morphogenesis,morphogenesis/development,0.396\nestablishment of epithelial cell polarity,cellular component organization,0.448\nestablishment of glial blood-brain barrier,transport,0.286\nestablishment of integrated proviral latency,viral related process,0.184\nestablishment of left/right asymmetry,multicellular organismal process,0.4\nestablishment of localization,transport,0.29\nestablishment of localization in cell,cellular component organization,0.37\nestablishment of lymphocyte polarity,cellular component organization,0.218\nestablishment of meiotic sister chromatid cohesion,cell cycle,0.354\nestablishment of meiotic spindle localization,cell cycle,0.456\nestablishment of meiotic spindle orientation,cellular component organization,0.294\nestablishment of melanosome localization,transport,0.75\nestablishment of mitochondrion localization,transport,0.584\n\"establishment of mitochondrion localization, microtubule-mediated\",transport,0.702\nestablishment of mitotic sister chromatid cohesion,cell cycle,0.474\nestablishment of mitotic spindle orientation,cell cycle,0.726\nestablishment of monopolar cell polarity,cellular component organization,0.474\nestablishment of natural killer cell polarity,transport,0.184\nestablishment of neuroblast polarity,morphogenesis/development,0.29\nestablishment of pigment granule localization,transport,0.752\nestablishment of planar polarity involved in nephron morphogenesis,morphogenesis/development,0.534\nestablishment of planar polarity involved in neural tube closure,morphogenesis/development,0.296\nestablishment of planar polarity of follicular epithelium,morphogenesis/development,0.244\nestablishment of protein localization,transport,0.498\nestablishment of protein localization to chromatin,transport,0.598\nestablishment of protein localization to chromosome,transport,0.676\nestablishment of protein localization to endoplasmic reticulum,ER/endosome/lysosome related process,0.464\nestablishment of protein localization to endoplasmic reticulum membrane,ER/endosome/lysosome related process,0.308\nestablishment of protein localization to extracellular region,transport,0.592\nestablishment of protein localization to juxtaparanode region of axon,transport,0.32\nestablishment of protein localization to mitochondrial membrane,transport,0.462\nestablishment of protein localization to mitochondrial membrane involved in mitochondrial fission,transport,0.382\nestablishment of protein localization to mitochondrion,transport,0.634\nestablishment of protein localization to organelle,transport,0.644\nestablishment of protein localization to peroxisome,transport,0.438\nestablishment of protein localization to plasma membrane,transport,0.752\nestablishment of protein localization to postsynaptic membrane,transport,0.66\nestablishment of protein localization to telomere,transport,0.322\nestablishment of protein-containing complex localization to telomere,transport,0.33\nestablishment of spindle orientation,cell cycle,0.668\nestablishment of synaptic specificity at neuromuscular junction,neural related process,0.274\nestablishment of viral latency,viral related process,0.364\nestablishment or maintenance of actin cytoskeleton polarity,morphogenesis/development,0.324\nestablishment or maintenance of cell polarity regulating cell shape,morphogenesis/development,0.502\nestablishment or maintenance of cytoskeleton polarity,cellular component organization,0.628\nestablishment or maintenance of microtubule cytoskeleton polarity,cellular component organization,0.642\nestablishment or maintenance of monopolar cell polarity,cellular component organization,0.52\nestablishment or maintenance of neuroblast polarity,cellular component organization,0.272\nestablishment or maintenance of polarity of embryonic epithelium,cellular component organization,0.29\nestablishment or maintenance of polarity of follicular epithelium,cellular component organization,0.346\nestablishment or maintenance of transmembrane electrochemical gradient,transport,0.672\nestradiol 17-beta-dehydrogenase [NAD(P)] activity,metabolic process,0.948\nestradiol binding,metabolic process,0.244\nestradiol secretion,cellular component organization,0.204\nestrogen 16-alpha-hydroxylase activity,metabolic process,0.882\nestrogen 2-hydroxylase activity,metabolic process,0.876\nestrogen binding,metabolic process,0.246\nestrogen biosynthetic process,metabolic process,0.816\nestrogen catabolic process,metabolic process,0.81\nestrogen metabolic process,metabolic process,0.908\nestrogen response element binding,gene regulation,0.502\nestrone sulfotransferase activity,metabolic process,0.898\nestrous cycle,cellular component organization,0.158\nethanol binding,metabolic process,0.294\nethanol catabolic process,metabolic process,0.88\nethanol oxidation,metabolic process,0.244\nethanolamine kinase activity,metabolic process,0.796\nethanolamine metabolic process,metabolic process,0.976\nethanolamine transmembrane transporter activity,cellular component organization,0.35\nethanolamine transport,transport,0.672\nethanolamine-containing compound metabolic process,metabolic process,0.92\nethanolamine-phosphate cytidylyltransferase activity,metabolic process,0.828\nethanolamine-phosphate phospho-lyase activity,metabolic process,0.852\nethanolaminephosphotransferase activity,metabolic process,0.896\nether catabolic process,metabolic process,0.978\nether hydrolase activity,metabolic process,0.736\nether lipid biosynthetic process,metabolic process,0.968\nether lipid metabolic process,metabolic process,0.948\nether metabolic process,metabolic process,0.966\nethylene metabolic process,metabolic process,0.95\neuchromatin,gene regulation,0.184\neukaryotic 43S preinitiation complex,cellular component organization,0.504\neukaryotic 48S preinitiation complex,cellular component organization,0.376\neukaryotic 80S initiation complex,cellular component organization,0.51\neukaryotic initiation factor 4E binding,metabolic process,0.222\neukaryotic initiation factor 4G binding,gene regulation,0.194\neukaryotic initiation factor eIF2 binding,protein modification/signaling,0.238\neukaryotic translation elongation factor 1 complex,cellular component organization,0.268\neukaryotic translation initiation factor 2 complex,gene regulation,0.282\neukaryotic translation initiation factor 2 complex assembly,cellular component organization,0.622\neukaryotic translation initiation factor 2B complex,cellular component organization,0.214\neukaryotic translation initiation factor 2alpha kinase activity,metabolic process,0.57\neukaryotic translation initiation factor 3 complex,gene regulation,0.266\n\"eukaryotic translation initiation factor 3 complex, eIF3e\",cellular component organization,0.252\n\"eukaryotic translation initiation factor 3 complex, eIF3m\",cellular component organization,0.254\neukaryotic translation initiation factor 4F complex,cellular component organization,0.308\neukaryotic translation initiation factor 4F complex assembly,cellular component organization,0.614\nevoked neurotransmitter secretion,metabolic process,0.16\nexcitatory chemical synaptic transmission,neural related process,0.358\nexcitatory extracellular ligand-gated monoatomic ion channel activity,transport,0.434\nexcitatory postsynaptic potential,neural related process,0.69\nexcitatory synapse assembly,neural related process,0.39\nexcitatory synapse pruning,cellular component organization,0.466\nexcretion,multicellular organismal process,0.354\nexecution phase of necroptosis,cell death,0.296\nexit from host cell,viral related process,0.444\nexit from mitosis,cell cycle,0.66\nexo-alpha-(2->3)-sialidase activity,metabolic process,0.472\nexo-alpha-(2->6)-sialidase activity,metabolic process,0.472\nexo-alpha-(2->8)-sialidase activity,metabolic process,0.472\nexo-alpha-sialidase activity,metabolic process,0.736\nexocrine pancreas development,morphogenesis/development,0.94\nexocrine system development,morphogenesis/development,0.772\nexocyst,cellular component organization,0.508\nexocyst assembly,cellular component organization,0.574\nexocyst localization,transport,0.47\nexocytic insertion of neurotransmitter receptor to postsynaptic membrane,neural related process,0.268\nexocytic process,cellular component organization,0.316\nexocytic vesicle,transport,0.304\nexocytic vesicle membrane,cellular component organization,0.406\nexogenous lipid antigen binding,metabolic process,0.262\nexogenous protein binding,protein modification/signaling,0.294\nexomer complex,cellular component organization,0.274\nexon-exon junction complex,gene regulation,0.53\nexon-exon junction complex binding,gene regulation,0.478\nexon-exon junction complex disassembly,cellular component organization,0.56\nexon-exon junction subcomplex mago-y14,gene regulation,0.304\nexonuclease activity,cell cycle,0.644\nexonucleolytic catabolism of deadenylated mRNA,metabolic process,0.722\n\"exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)\",gene regulation,0.618\nexopolyphosphatase activity,metabolic process,0.852\nexoribonuclease II activity,metabolic process,0.542\nexoribonuclease complex,gene regulation,0.47\nexosomal secretion,morphogenesis/development,0.318\nexosome (RNase complex),gene regulation,0.296\nexploration behavior,multicellular organismal process,0.302\nexport from cell,transport,0.608\nextension of a leading process involved in cell motility in cerebral cortex radial glia guided migration,transport,0.182\nexternal encapsulating structure,cellular component organization,0.452\nexternal genitalia morphogenesis,morphogenesis/development,0.676\nexternal side of apical plasma membrane,cellular component organization,0.378\nextracellular exosome,cellular component organization,0.24\nextracellular exosome assembly,cellular component organization,0.58\nextracellular ligand-gated monoatomic ion channel activity,transport,0.406\nextracellular matrix,cellular component organization,0.408\nextracellular matrix assembly,cellular component organization,0.788\nextracellular matrix constituent conferring elasticity,cellular component organization,0.374\n\"extracellular matrix constituent, lubricant activity\",cellular component organization,0.338\nextracellular matrix of synaptic cleft,neural related process,0.224\nextracellular matrix protein binding,protein modification/signaling,0.306\nextracellular matrix structural constituent,cellular component organization,0.306\nextracellular matrix structural constituent conferring compression resistance,cellular component organization,0.334\nextracellular matrix structural constituent conferring tensile strength,cellular component organization,0.308\nextracellular matrix-cell signaling,protein modification/signaling,0.19\nextracellular matrix-dependent thymocyte migration,immune system process,0.602\nextracellular membrane-bounded organelle,cellular component organization,0.274\nextracellular negative regulation of signal transduction,protein modification/signaling,0.376\nextracellular organelle,cellular component organization,0.274\nextracellular polysaccharide biosynthetic process,metabolic process,0.894\nextracellular polysaccharide metabolic process,metabolic process,0.904\nextracellular region,cellular component organization,0.114\nextracellular regulation of signal transduction,protein modification/signaling,0.482\nextracellular space,cellular component organization,0.112\nextracellular transport,transport,0.724\nextracellular vesicle,cellular component organization,0.258\nextracellularly ATP-gated monoatomic cation channel activity,cellular component organization,0.406\nextracellularly glutamate-gated chloride channel activity,cellular component organization,0.4\nextracellularly glutamate-gated ion channel activity,transport,0.536\nextracellularly glycine-gated chloride channel activity,cellular component organization,0.4\nextracellularly glycine-gated ion channel activity,transport,0.542\nextraction of mislocalized protein from ER membrane,ER/endosome/lysosome related process,0.32\nextraction of mislocalized protein from membrane,transport,0.482\nextraction of mislocalized protein from mitochondrial outer membrane,cellular component organization,0.37\nextraembryonic membrane development,morphogenesis/development,0.952\nextraocular skeletal muscle development,morphogenesis/development,0.898\nextrathymic T cell differentiation,immune system process,0.362\nextrathymic T cell selection,immune system process,0.52\nextrinsic component of cytoplasmic side of plasma membrane,cellular component organization,0.438\nextrinsic component of dense core granule membrane,cellular component organization,0.606\nextrinsic component of endoplasmic reticulum membrane,cellular component organization,0.34\nextrinsic component of endosome membrane,cellular component organization,0.658\nextrinsic component of external side of plasma membrane,cellular component organization,0.596\nextrinsic component of mitochondrial inner membrane,cellular component organization,0.674\nextrinsic component of neuronal dense core vesicle membrane,cellular component organization,0.342\nextrinsic component of omegasome membrane,cellular component organization,0.408\nextrinsic component of phagophore assembly site membrane,cellular component organization,0.49\nextrinsic component of plasma membrane,cellular component organization,0.578\nextrinsic component of postsynaptic density membrane,cellular component organization,0.396\nextrinsic component of postsynaptic early endosome membrane,cellular component organization,0.398\nextrinsic component of postsynaptic endosome membrane,cellular component organization,0.64\nextrinsic component of postsynaptic membrane,cellular component organization,0.57\nextrinsic component of postsynaptic specialization membrane,cellular component organization,0.576\nextrinsic component of presynaptic endocytic zone membrane,cellular component organization,0.394\nextrinsic component of presynaptic membrane,cellular component organization,0.566\nextrinsic component of synaptic membrane,cellular component organization,0.572\nextrinsic component of synaptic vesicle membrane,cellular component organization,0.41\neye blink reflex,immune system process,0.254\neye morphogenesis,morphogenesis/development,0.764\neye photoreceptor cell development,morphogenesis/development,0.476\neye photoreceptor cell differentiation,morphogenesis/development,0.642\neye photoreceptor cell fate commitment,morphogenesis/development,0.47\neye pigment biosynthetic process,metabolic process,0.766\neye pigment granule organization,cellular component organization,0.704\neye pigment metabolic process,metabolic process,0.812\neye pigmentation,morphogenesis/development,0.384\nface morphogenesis,morphogenesis/development,0.766\nfacial nerve development,morphogenesis/development,0.81\nfacial nerve morphogenesis,morphogenesis/development,0.588\nfacial nerve structural organization,morphogenesis/development,0.318\nfacial nucleus development,morphogenesis/development,0.966\nfacioacoustic ganglion development,morphogenesis/development,0.96\nfarnesol catabolic process,metabolic process,0.896\nfarnesol dehydrogenase activity,metabolic process,0.934\nfarnesol metabolic process,metabolic process,1\nfarnesyl diphosphate biosynthetic process,metabolic process,0.992\n\"farnesyl diphosphate biosynthetic process, mevalonate pathway\",metabolic process,0.258\nfarnesyl diphosphate catabolic process,metabolic process,0.884\nfarnesyl diphosphate metabolic process,metabolic process,0.974\nfarnesyl-diphosphate farnesyltransferase activity,metabolic process,0.874\nfarnesylated protein binding,protein modification/signaling,0.296\nfarnesylcysteine lyase activity,metabolic process,0.9\nfarnesyltranstransferase activity,metabolic process,0.888\nfascia adherens,cellular component organization,0.196\nfasciculation of motor neuron axon,neural related process,0.366\nfasciculation of sensory neuron axon,neural related process,0.372\n\"fast, calcium ion-dependent exocytosis of neurotransmitter\",neural related process,0.272\nfast-twitch skeletal muscle fiber contraction,morphogenesis/development,0.264\nfat cell apoptotic process,cell death,0.222\nfat cell proliferation,cell cycle,0.812\nfat pad development,morphogenesis/development,0.742\nfat-soluble vitamin biosynthetic process,metabolic process,0.944\nfat-soluble vitamin catabolic process,metabolic process,0.952\nfat-soluble vitamin metabolic process,metabolic process,0.944\nfatty acid alpha-hydroxylase activity,metabolic process,0.574\nfatty acid alpha-oxidation,metabolic process,0.452\nfatty acid amide hydrolase activity,metabolic process,0.612\nfatty acid beta-oxidation multienzyme complex,metabolic process,0.744\nfatty acid beta-oxidation using acyl-CoA dehydrogenase,metabolic process,0.458\nfatty acid binding,metabolic process,0.44\nfatty acid catabolic process,metabolic process,0.98\nfatty acid derivative binding,metabolic process,0.352\nfatty acid derivative biosynthetic process,metabolic process,0.956\nfatty acid elongase activity,metabolic process,0.74\nfatty acid elongase complex,metabolic process,0.306\nfatty acid elongation,metabolic process,0.814\n\"fatty acid elongation, monounsaturated fatty acid\",metabolic process,0.386\n\"fatty acid elongation, polyunsaturated fatty acid\",metabolic process,0.364\n\"fatty acid elongation, saturated fatty acid\",metabolic process,0.374\n\"fatty acid elongation, unsaturated fatty acid\",metabolic process,0.806\nfatty acid homeostasis,other,0.418\nfatty acid in-chain hydroxylase activity,metabolic process,0.904\nfatty acid ligase activity,metabolic process,0.716\nfatty acid omega-hydroxylase activity,metabolic process,0.914\nfatty acid omega-oxidation,metabolic process,0.536\nfatty acid oxidation,metabolic process,0.826\nfatty acid peroxidase activity,metabolic process,0.9\nfatty acid primary amide biosynthetic process,metabolic process,0.888\nfatty acid primary amide metabolic process,metabolic process,0.934\nfatty acid synthase activity,metabolic process,0.932\nfatty acid transmembrane transport,transport,0.86\nfatty acid transmembrane transporter activity,transport,0.714\nfatty acid transport,transport,0.954\nfatty alcohol metabolic process,metabolic process,0.978\nfatty-acyl-CoA biosynthetic process,metabolic process,0.99\nfatty-acyl-CoA catabolic process,metabolic process,0.99\nfatty-acyl-CoA synthase activity,metabolic process,0.956\nfatty-acyl-CoA transport,transport,0.844\nfear response,multicellular organismal process,0.264\nfemale courtship behavior,cellular component organization,0.224\nfemale genitalia development,morphogenesis/development,0.954\nfemale genitalia morphogenesis,morphogenesis/development,0.898\nfemale germ cell nucleus,cellular component organization,0.432\nfemale gonad morphogenesis,morphogenesis/development,0.44\nfemale mating behavior,multicellular organismal process,0.486\nfemale meiosis I,cell cycle,0.356\nfemale meiosis II,cell cycle,0.21\nfemale meiosis chromosome segregation,cell cycle,0.584\nfemale meiosis chromosome separation,cellular component organization,0.214\nfemale meiosis sister chromatid cohesion,cellular component organization,0.226\nfemale pronucleus,cellular component organization,0.29\nfemale pronucleus assembly,cellular component organization,0.396\nfemale sex determination,morphogenesis/development,0.486\nfemale somatic sex determination,cellular component organization,0.2\nfermentation,metabolic process,0.5\nferredoxin-NAD(P) reductase activity,metabolic process,0.788\nferredoxin-NADP+ reductase activity,metabolic process,0.95\nferric iron binding,metabolic process,0.222\nferric-chelate reductase (NADPH) activity,metabolic process,0.934\nferric-chelate reductase activity,metabolic process,0.924\nferritin complex,cellular component organization,0.184\nferritin receptor activity,cellular component organization,0.202\nferrochelatase activity,metabolic process,0.864\nferroptosis,cell death,0.366\nferrous iron binding,metabolic process,0.256\nferrous iron transmembrane transporter activity,transport,0.598\nferroxidase activity,metabolic process,0.892\nfertilization,cell cycle,0.156\nfever generation,morphogenesis/development,0.26\nfibrillar collagen trimer,cellular component organization,0.334\nfibrinogen binding,cellular component organization,0.168\nfibrinogen complex,cellular component organization,0.334\nfibroblast activation,multicellular organismal process,0.314\nfibroblast growth factor production,immune system process,0.488\nfibroblast growth factor receptor activity,receptor related process,0.364\nfibroblast growth factor receptor apoptotic signaling pathway,cell death,0.41\nfibroblast growth factor receptor binding,receptor related process,0.528\nfibroblast growth factor receptor signaling pathway involved in hemopoiesis,receptor related process,0.502\nfibroblast growth factor receptor signaling pathway involved in mammary gland specification,receptor related process,0.42\nfibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow cell,cell death,0.536\nfibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,receptor related process,0.742\nfibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development,morphogenesis/development,0.54\nfibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow,receptor related process,0.428\nfibroblast growth factor receptor signaling pathway involved in ureteric bud formation,receptor related process,0.488\nfibronectin binding,cell adhesion,0.124\nfibronectin fibril organization,cellular component organization,0.674\nfibronectin-dependent thymocyte migration,morphogenesis/development,0.384\nfibrous ring of heart morphogenesis,morphogenesis/development,0.584\nficolin-1-rich granule membrane,metabolic process,0.188\nfilamentous actin,cellular component organization,0.32\nfilamentous growth,multicellular organismal process,0.258\nfilamentous growth of a population of unicellular organisms,immune system process,0.236\nfilamin binding,cellular component organization,0.264\nfilopodium assembly,cellular component organization,0.772\nfilopodium membrane,cellular component organization,0.382\nfilopodium tip,cellular component organization,0.252\nfiltration diaphragm,cellular component organization,0.29\nfiltration diaphragm assembly,cellular component organization,0.674\nfirst spliceosomal transesterification activity,metabolic process,0.464\nflagellated sperm motility,transport,0.282\nflap endonuclease activity,metabolic process,0.4\nflap-structured DNA binding,gene regulation,0.6\nflavin adenine dinucleotide biosynthetic process,metabolic process,0.984\nflavin adenine dinucleotide catabolic process,metabolic process,0.876\nflavin adenine dinucleotide metabolic process,metabolic process,0.99\nflavin-containing compound biosynthetic process,metabolic process,0.974\nflavin-containing compound catabolic process,metabolic process,0.96\nflavin-containing compound metabolic process,metabolic process,0.974\nflavin-dependent sulfhydryl oxidase activity,metabolic process,0.624\nflavone metabolic process,metabolic process,0.968\nflavonoid 3'-monooxygenase activity,metabolic process,0.932\nflavonoid binding,metabolic process,0.28\nflavonoid catabolic process,metabolic process,0.96\nflavonoid glucuronidation,metabolic process,0.308\nflavonoid metabolic process,metabolic process,0.974\nflavonol 3-sulfotransferase activity,metabolic process,0.9\nflippase activity,transport,0.422\nfloor plate development,morphogenesis/development,0.808\nfloor plate formation,morphogenesis/development,0.26\nfloor plate morphogenesis,morphogenesis/development,0.74\nfloppase activity,transport,0.418\nflotillin complex,cellular component organization,0.3\nfocal adhesion,cell adhesion,0.466\nfocal adhesion assembly,cellular component organization,0.436\nfocal adhesion disassembly,cellular component organization,0.434\nfolate import across plasma membrane,transport,0.456\nfolate import into mitochondrion,metabolic process,0.246\nfolate reductase activity,metabolic process,0.934\nfolate transmembrane transport,transport,0.76\nfolate:monoatomic anion antiporter activity,metabolic process,0.508\nfolic acid binding,metabolic process,0.366\nfolic acid catabolic process,metabolic process,0.894\nfolic acid metabolic process,metabolic process,0.972\nfolic acid receptor activity,metabolic process,0.222\nfolic acid transmembrane transporter activity,transport,0.728\nfolic acid transport,transport,0.93\nfolic acid-containing compound biosynthetic process,metabolic process,0.962\nfolic acid-containing compound catabolic process,metabolic process,0.952\nfolic acid:proton symporter activity,metabolic process,0.468\nfollicle-stimulating hormone activity,receptor related process,0.472\nfollicle-stimulating hormone complex,cellular component organization,0.266\nfollicle-stimulating hormone receptor activity,cellular component organization,0.174\nfollicle-stimulating hormone secretion,metabolic process,0.212\nfollicle-stimulating hormone signaling pathway,receptor related process,0.662\nfollicular B cell differentiation,morphogenesis/development,0.402\nfollicular dendritic cell activation,immune system process,0.416\nfollicular dendritic cell differentiation,morphogenesis/development,0.46\nforamen ovale closure,multicellular organismal process,0.184\nforebrain anterior/posterior pattern specification,morphogenesis/development,0.26\nforebrain astrocyte development,morphogenesis/development,0.354\nforebrain astrocyte differentiation,morphogenesis/development,0.542\nforebrain cell migration,neural related process,0.266\nforebrain dorsal/ventral pattern formation,morphogenesis/development,0.406\nforebrain generation of neurons,morphogenesis/development,0.304\nforebrain morphogenesis,morphogenesis/development,0.604\nforebrain neuroblast division,cell cycle,0.25\nforebrain neuron development,morphogenesis/development,0.544\nforebrain neuron differentiation,morphogenesis/development,0.502\nforebrain neuron fate commitment,morphogenesis/development,0.498\nforebrain radial glial cell differentiation,morphogenesis/development,0.384\nforebrain regionalization,morphogenesis/development,0.378\nforebrain ventricular zone progenitor cell division,cell cycle,0.398\nforebrain-midbrain boundary formation,morphogenesis/development,0.488\nforegut morphogenesis,morphogenesis/development,0.776\nforegut regionalization,multicellular organismal process,0.428\nforelimb morphogenesis,morphogenesis/development,0.7\nforked DNA-dependent helicase activity,cell cycle,0.236\nformaldehyde biosynthetic process,metabolic process,0.888\nformaldehyde catabolic process,metabolic process,0.888\nformaldehyde dehydrogenase activity,metabolic process,0.826\nformaldehyde metabolic process,metabolic process,0.944\nformamide metabolic process,metabolic process,0.944\nformate metabolic process,metabolic process,0.968\nformate transmembrane transporter activity,transport,0.664\nformate transport,transport,0.878\nformate-tetrahydrofolate ligase activity,metabolic process,0.69\nformation of anatomical boundary,morphogenesis/development,0.838\nformation of animal organ boundary,morphogenesis/development,0.732\nformation of extrachromosomal circular DNA,cell cycle,0.396\nformation of quadruple SL/U4/U5/U6 snRNP,gene regulation,0.474\nformation of radial glial scaffolds,morphogenesis/development,0.356\nformation of structure involved in a symbiotic process,morphogenesis/development,0.546\nformimidoyltetrahydrofolate cyclodeaminase activity,metabolic process,0.896\nformin-nucleated actin cable assembly,cellular component organization,0.716\nformin-nucleated actin cable organization,cellular component organization,0.932\nformylglycine-generating oxidase activity,metabolic process,0.898\nformyltetrahydrofolate dehydrogenase activity,metabolic process,0.932\nfour-way junction DNA binding,gene regulation,0.578\nfour-way junction helicase activity,cell cycle,0.24\nfourth ventricle development,morphogenesis/development,0.964\nfractalkine production,immune system process,0.572\nfree ubiquitin chain polymerization,protein modification/signaling,0.364\nfrizzled binding,receptor related process,0.376\nfrontal suture morphogenesis,morphogenesis/development,0.554\nfructokinase activity,metabolic process,0.79\nfructosamine catabolic process,metabolic process,0.96\nfructosamine metabolic process,metabolic process,0.96\n\"fructose 1,6-bisphosphate 1-phosphatase activity\",metabolic process,0.852\n\"fructose 1,6-bisphosphate metabolic process\",metabolic process,0.854\n\"fructose 2,6-bisphosphate metabolic process\",metabolic process,0.772\nfructose 6-phosphate aldolase activity,metabolic process,0.896\nfructose 6-phosphate metabolic process,metabolic process,0.942\nfructose binding,metabolic process,0.268\nfructose biosynthetic process,metabolic process,0.892\nfructose catabolic process,metabolic process,0.984\nfructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate,metabolic process,0.77\nfructose import across plasma membrane,transport,0.462\nfructose metabolic process,metabolic process,0.976\nfructose transmembrane transport,transport,0.97\nfructose transmembrane transporter activity,transport,0.584\nfructose-1-phosphatase activity,metabolic process,0.9\nfructose-1-phosphate aldolase activity,metabolic process,0.798\n\"fructose-2,6-bisphosphate 2-phosphatase activity\",metabolic process,0.848\nfructose-6-phosphate binding,metabolic process,0.288\nfructose-bisphosphate aldolase activity,metabolic process,0.844\nfructose:sodium symporter activity,metabolic process,0.526\nfructoselysine metabolic process,metabolic process,0.988\nfucokinase activity,metabolic process,0.796\nfucose binding,metabolic process,0.246\nfucose catabolic process,metabolic process,0.986\nfucose metabolic process,metabolic process,0.99\nfucose transmembrane transport,transport,0.314\nfucose transmembrane transporter activity,transport,0.7\nfucose-1-phosphate guanylyltransferase activity,metabolic process,0.874\nfucosidase activity,metabolic process,0.648\nfucosylation,protein modification/signaling,0.3\nfucosyltransferase activity,metabolic process,0.868\nfumarate hydratase activity,metabolic process,0.9\nfumarate metabolic process,metabolic process,0.964\nfumarate reductase (menaquinone),metabolic process,0.904\nfumarate reductase complex,cellular component organization,0.376\nfumarate transmembrane transporter activity,transport,0.732\nfumarate transport,transport,0.728\nfumarylacetoacetase activity,metabolic process,0.9\nfumarylpyruvate hydrolase activity,metabolic process,0.9\nfungiform papilla development,morphogenesis/development,0.884\nfungiform papilla formation,morphogenesis/development,0.63\nfungiform papilla morphogenesis,morphogenesis/development,0.798\nfused antrum stage,cellular component organization,0.204\nfusion of sperm to egg plasma membrane involved in single fertilization,cellular component organization,0.274\nfusion of virus membrane with host endosome membrane,viral related process,0.31\nfusion of virus membrane with host plasma membrane,cellular component organization,0.562\nfutile creatine cycle,cell cycle,0.208\ngalactitol metabolic process,metabolic process,0.992\ngalactokinase activity,metabolic process,0.796\ngalactolipid biosynthetic process,metabolic process,0.964\ngalactolipid catabolic process,metabolic process,0.966\ngalactolipid metabolic process,metabolic process,0.96\ngalactose 3-O-sulfotransferase activity,metabolic process,0.822\ngalactose binding,cellular component organization,0.244\ngalactose catabolic process,metabolic process,0.986\ngalactose catabolic process via UDP-galactose,metabolic process,0.852\ngalactose metabolic process,metabolic process,0.958\ngalactose transmembrane transport,transport,0.85\ngalactose transmembrane transporter activity,transport,0.628\ngalactose:proton symporter activity,metabolic process,0.526\ngalactose:sodium symporter activity,metabolic process,0.524\ngalactosidase activity,metabolic process,0.672\ngalactoside 2-alpha-L-fucosyltransferase activity,metabolic process,0.888\ngalactoside binding,metabolic process,0.332\ngalactosylceramidase activity,metabolic process,0.888\ngalactosylceramide biosynthetic process,metabolic process,0.852\ngalactosylceramide catabolic process,metabolic process,0.87\ngalactosylceramide metabolic process,metabolic process,0.958\ngalactosylceramide sulfotransferase activity,metabolic process,0.898\ngalactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity,metabolic process,0.896\ngalactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity,metabolic process,0.896\ngalactosyltransferase activity,metabolic process,0.94\ngalactosylxylosylprotein 3-beta-galactosyltransferase activity,metabolic process,0.896\ngalanin receptor activity,cellular component organization,0.17\ngalanin receptor binding,receptor related process,0.472\ngalanin-activated signaling pathway,receptor related process,0.47\ngalectin complex,protein modification/signaling,0.28\ngallbladder development,morphogenesis/development,0.862\ngamete generation,morphogenesis/development,0.312\ngamma DNA polymerase complex,cellular component organization,0.226\ngamma-aminobutyric acid biosynthetic process,metabolic process,0.8\ngamma-aminobutyric acid catabolic process,metabolic process,0.792\ngamma-aminobutyric acid import,transport,0.414\ngamma-aminobutyric acid metabolic process,metabolic process,0.994\ngamma-aminobutyric acid receptor clustering,transport,0.21\ngamma-aminobutyric acid reuptake,neural related process,0.33\ngamma-aminobutyric acid secretion,transport,0.616\n\"gamma-aminobutyric acid secretion, neurotransmission\",metabolic process,0.234\ngamma-aminobutyric acid signaling pathway,receptor related process,0.35\ngamma-aminobutyric acid transmembrane transporter activity,transport,0.766\ngamma-aminobutyric acid transport,transport,0.908\ngamma-aminobutyric acid:proton antiporter activity,metabolic process,0.524\ngamma-aminobutyric acid:proton symporter activity,metabolic process,0.524\ngamma-aminobutyric acid:sodium:chloride symporter activity,metabolic process,0.524\ngamma-butyrobetaine dioxygenase activity,metabolic process,0.896\ngamma-catenin binding,cellular component organization,0.238\ngamma-catenin-TCF7L2 complex,gene regulation,0.386\ngamma-delta T cell activation,immune system process,0.808\ngamma-delta T cell differentiation,immune system process,0.72\ngamma-delta T cell receptor complex,receptor related process,0.18\ngamma-delta intraepithelial T cell differentiation,immune system process,0.76\ngamma-glutamyl carboxylase activity,metabolic process,0.892\ngamma-glutamyl-peptidase activity,metabolic process,0.496\ngamma-glutamylaminecyclotransferase activity,metabolic process,0.896\ngamma-glutamylcyclotransferase activity,metabolic process,0.898\ngamma-secretase complex,gene regulation,0.214\ngamma-tubulin binding,cellular component organization,0.328\ngamma-tubulin complex,transport,0.266\ngamma-tubulin complex localization,transport,0.366\ngamma-tubulin ring complex,cellular component organization,0.366\ngamma-tubulin small complex,cellular component organization,0.318\nganglion development,morphogenesis/development,0.936\nganglion morphogenesis,morphogenesis/development,0.912\nganglion mother cell fate determination,morphogenesis/development,0.286\nganglioside GM1 binding,metabolic process,0.244\nganglioside GM1 transport to membrane,transport,0.386\nganglioside GM2 binding,metabolic process,0.244\nganglioside GM3 binding,metabolic process,0.244\nganglioside GP1c binding,metabolic process,0.244\nganglioside GT1b binding,metabolic process,0.236\nganglioside binding,metabolic process,0.29\nganglioside biosynthetic process,metabolic process,0.952\nganglioside biosynthetic process via lactosylceramide,metabolic process,0.82\nganglioside catabolic process,metabolic process,0.828\nganglioside galactosyltransferase activity,metabolic process,0.896\nganglioside metabolic process,metabolic process,0.962\ngap junction,protein modification/signaling,0.254\ngap junction assembly,cellular component organization,0.262\ngap junction channel activity,transport,0.498\ngap junction channel activity involved in AV node cell-bundle of His cell electrical coupling,transport,0.22\ngap junction channel activity involved in Purkinje myocyte-ventricular cardiac muscle cell electrical coupling,transport,0.22\ngap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling,transport,0.222\ngap junction channel activity involved in atrial cardiac muscle cell-AV node cell electrical coupling,transport,0.222\ngap junction channel activity involved in bundle of His cell-Purkinje myocyte electrical coupling,transport,0.222\ngap junction channel activity involved in cardiac conduction electrical coupling,transport,0.428\ngap junction channel activity involved in cell communication by electrical coupling,transport,0.378\ngap junction hemi-channel activity,transport,0.33\ngap junction-mediated intercellular transport,transport,0.214\ngas transport,transport,0.986\ngastric acid secretion,transport,0.432\ngastric emptying,cellular component organization,0.22\ngastric inhibitory peptide receptor activity,cellular component organization,0.2\ngastric inhibitory peptide signaling pathway,receptor related process,0.666\ngastric inhibitory polypeptide receptor binding,receptor related process,0.498\ngastric motility,multicellular organismal process,0.482\ngastric mucosal blood circulation,immune system process,0.204\ngastrin receptor activity,receptor related process,0.184\ngastrin-induced gastric acid secretion,receptor related process,0.338\ngastro-intestinal system smooth muscle contraction,multicellular organismal process,0.622\ngastrulation with mouth forming second,morphogenesis/development,0.334\ngated channel activity,transport,0.42\ngene conversion,gene regulation,0.396\ngene expression,metabolic process,0.55\ngene expression involved in extracellular matrix organization,gene regulation,0.542\ngeneral adaptation syndrome,metabolic process,0.298\n\"general adaptation syndrome, behavioral process\",immune system process,0.234\ngeneration of catalytic spliceosome for first transesterification step,metabolic process,0.518\ngeneration of catalytic spliceosome for second transesterification step,gene regulation,0.454\ngeneration of neurons,neural related process,0.322\ngeneration of ovulation cycle rhythm,morphogenesis/development,0.316\ngenitalia development,morphogenesis/development,0.946\ngenomic imprinting,gene regulation,0.362\ngentamycin metabolic process,metabolic process,0.988\ngephyrin clustering involved in postsynaptic density assembly,cellular component organization,0.41\ngeranyl diphosphate biosynthetic process,metabolic process,0.858\ngeranyl diphosphate metabolic process,metabolic process,0.974\ngeranylgeranyl diphosphate biosynthetic process,metabolic process,0.858\ngeranylgeranyl diphosphate catabolic process,metabolic process,0.882\ngeranylgeranyl diphosphate metabolic process,metabolic process,0.988\ngeranylgeranyl reductase activity,metabolic process,0.528\ngeranyltranstransferase activity,metabolic process,0.844\ngerm cell development,morphogenesis/development,0.726\ngerm cell migration,morphogenesis/development,0.19\ngerm cell nucleus,cellular component organization,0.312\ngerm cell proliferation,cell cycle,0.552\ngerm plasm,morphogenesis/development,0.272\ngerm-line sex determination,morphogenesis/development,0.56\ngerm-line stem cell division,cell cycle,0.344\ngerm-line stem cell population maintenance,morphogenesis/development,0.472\ngerminal center B cell differentiation,morphogenesis/development,0.308\ngerminal vesicle,morphogenesis/development,0.22\n\"germline cell cycle switching, mitotic to meiotic cell cycle\",cell cycle,0.486\ngermline stem cell asymmetric division,cell cycle,0.346\nghrelin receptor binding,receptor related process,0.494\nghrelin secretion,metabolic process,0.238\ngibberellic acid mediated signaling pathway,receptor related process,0.332\ngibberellin mediated signaling pathway,receptor related process,0.332\nglandular epithelial cell development,morphogenesis/development,0.912\nglandular epithelial cell maturation,morphogenesis/development,0.684\nglial cell fate commitment,morphogenesis/development,0.65\nglial cell fate determination,morphogenesis/development,0.344\nglial cell fate specification,morphogenesis/development,0.564\nglial cell migration,immune system process,0.256\nglial cell projection,cellular component organization,0.474\nglial cell projection elongation,cellular component organization,0.374\nglial cell-derived neurotrophic factor production,neural related process,0.248\nglial cell-derived neurotrophic factor receptor activity,receptor related process,0.228\nglial cell-derived neurotrophic factor receptor binding,receptor related process,0.53\nglial cell-derived neurotrophic factor receptor signaling pathway,receptor related process,0.736\nglial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,receptor related process,0.476\nglial cell-neuron signaling,neural related process,0.244\nglial cytoplasmic inclusion,protein modification/signaling,0.238\nglial limiting end-foot,cellular component organization,0.3\nglobal gene silencing by mRNA cleavage,gene regulation,0.286\nglobal genome nucleotide-excision repair,gene regulation,0.198\ngloboside alpha-N-acetylgalactosaminyltransferase activity,metabolic process,0.896\ngloboside biosynthetic process,metabolic process,0.936\ngloboside biosynthetic process via lactosylceramide,metabolic process,0.824\ngloboside metabolic process,metabolic process,0.92\nglobus pallidus development,morphogenesis/development,0.672\nglomerular basement membrane development,morphogenesis/development,0.668\nglomerular capillary formation,morphogenesis/development,0.868\nglomerular endothelium development,morphogenesis/development,0.976\nglomerular endothelium fenestra,cellular component organization,0.286\nglomerular epithelial cell development,morphogenesis/development,0.928\nglomerular epithelial cell differentiation,morphogenesis/development,0.868\nglomerular epithelium development,morphogenesis/development,0.892\nglomerular filtration,cellular component organization,0.348\nglomerular mesangial cell development,morphogenesis/development,0.946\nglomerular mesangial cell differentiation,morphogenesis/development,0.926\nglomerular mesangial cell proliferation,cell cycle,0.846\nglomerular parietal epithelial cell development,morphogenesis/development,0.864\nglomerular parietal epithelial cell differentiation,morphogenesis/development,0.772\nglomerulus morphogenesis,morphogenesis/development,0.912\nglomerulus vasculature morphogenesis,morphogenesis/development,0.898\nglossopharyngeal nerve development,cellular component organization,0.35\nglossopharyngeal nerve morphogenesis,morphogenesis/development,0.562\nglucagon family peptide binding,metabolic process,0.246\nglucagon processing,morphogenesis/development,0.38\nglucagon receptor activity,cellular component organization,0.278\nglucagon receptor binding,receptor related process,0.502\nglucagon secretion,cellular component organization,0.18\nglucagon-like peptide 1 receptor activity,cellular component organization,0.184\n\"glucan 1,3-alpha-glucosidase activity\",metabolic process,0.542\n\"glucan 1,4-alpha-glucosidase activity\",metabolic process,0.456\nglucan biosynthetic process,metabolic process,0.954\nglucan catabolic process,metabolic process,0.96\nglucocorticoid biosynthetic process,metabolic process,0.962\nglucocorticoid catabolic process,metabolic process,0.888\nglucocorticoid mediated signaling pathway,protein modification/signaling,0.266\nglucocorticoid metabolic process,metabolic process,0.954\nglucocorticoid secretion,transport,0.626\nglucokinase activity,metabolic process,0.79\ngluconeogenesis,metabolic process,0.274\ngluconokinase activity,metabolic process,0.796\ngluconolactonase activity,metabolic process,0.898\nglucosamine 6-phosphate N-acetyltransferase activity,metabolic process,0.892\nglucosamine catabolic process,metabolic process,0.864\nglucosamine kinase activity,metabolic process,0.752\nglucosamine metabolic process,metabolic process,0.966\nglucosamine-6-phosphate deaminase activity,metabolic process,0.9\nglucosamine-containing compound biosynthetic process,metabolic process,0.98\nglucosamine-containing compound catabolic process,metabolic process,0.974\nglucosamine-containing compound metabolic process,metabolic process,0.966\nglucosaminyl-phosphatidylinositol O-acyltransferase activity,metabolic process,0.898\nglucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity,metabolic process,0.896\nglucose 1-dehydrogenase (NAD+) activity,metabolic process,0.928\nglucose 1-dehydrogenase (NADP+) activity,metabolic process,0.934\nglucose 1-dehydrogenase [NAD(P)] activity,metabolic process,0.934\nglucose 1-phosphate metabolic process,metabolic process,0.89\nglucose 6-phosphate metabolic process,metabolic process,0.948\nglucose 6-phosphate:inorganic phosphate antiporter activity,metabolic process,0.494\nglucose binding,metabolic process,0.376\nglucose catabolic process,metabolic process,0.986\nglucose catabolic process to lactate,metabolic process,0.968\nglucose catabolic process to lactate via pyruvate,metabolic process,0.818\nglucose catabolic process to pyruvate,metabolic process,0.97\nglucose dehydrogenase activity,metabolic process,0.978\nglucose import,transport,0.8\nglucose import across plasma membrane,transport,0.464\nglucose import in response to insulin stimulus,transport,0.33\nglucose mediated signaling pathway,morphogenesis/development,0.344\nglucose transmembrane transporter activity,transport,0.61\nglucose uniporter activity,metabolic process,0.526\n\"glucose-1,6-bisphosphate synthase activity\",metabolic process,0.85\nglucose-6-phosphatase activity,metabolic process,0.848\nglucose-6-phosphate dehydrogenase activity,metabolic process,0.934\nglucose-6-phosphate isomerase activity,metabolic process,0.896\nglucose-6-phosphate transmembrane transporter activity,transport,0.61\nglucose-6-phosphate transport,transport,0.67\nglucose:proton symporter activity,transport,0.552\nglucose:sodium symporter activity,transport,0.512\nglucosidase II complex,cellular component organization,0.278\nglucosidase activity,metabolic process,0.684\nglucoside transmembrane transporter activity,transport,0.636\nglucoside transport,transport,0.936\nglucosylceramidase activity,metabolic process,0.888\nglucosylceramide biosynthetic process,metabolic process,0.836\nglucosylceramide catabolic process,metabolic process,0.862\nglucosylceramide metabolic process,metabolic process,0.96\nglucuronate catabolic process,metabolic process,0.984\nglucuronate catabolic process to xylulose 5-phosphate,metabolic process,0.872\nglucuronate transmembrane transport,transport,0.816\nglucuronate transmembrane transporter activity,transport,0.662\nglucuronate-2-sulfatase activity,metabolic process,0.504\nglucuronolactone reductase activity,metabolic process,0.934\nglucuronoside catabolic process,metabolic process,0.848\nglucuronoside metabolic process,metabolic process,0.974\nglucuronoside transmembrane transporter activity,transport,0.606\nglucuronoside transport,transport,0.688\nglucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity,metabolic process,0.896\nglucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity,metabolic process,0.888\nglucuronosyltransferase activity,metabolic process,0.92\nglucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity,metabolic process,0.896\nglucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity,metabolic process,0.896\nglutamate 5-kinase activity,metabolic process,0.796\nglutamate binding,metabolic process,0.308\nglutamate biosynthetic process,metabolic process,0.98\nglutamate catabolic process,metabolic process,0.994\nglutamate catabolic process to 2-oxoglutarate,metabolic process,0.868\nglutamate catabolic process to aspartate,metabolic process,0.868\nglutamate catabolic process via 2-oxoglutarate,metabolic process,0.874\nglutamate decarboxylase activity,metabolic process,0.896\nglutamate decarboxylation to succinate,metabolic process,0.864\nglutamate dehydrogenase (NAD+) activity,metabolic process,0.93\nglutamate dehydrogenase (NADP+) activity,metabolic process,0.932\nglutamate dehydrogenase [NAD(P)+] activity,metabolic process,0.972\nglutamate formimidoyltransferase activity,metabolic process,0.896\nglutamate metabolic process,metabolic process,0.98\nglutamate receptor binding,receptor related process,0.414\nglutamate receptor clustering,transport,0.372\nglutamate receptor signaling pathway,receptor related process,0.626\nglutamate reuptake,neural related process,0.368\nglutamate secretion,transport,0.56\n\"glutamate secretion, neurotransmission\",morphogenesis/development,0.218\nglutamate-5-semialdehyde dehydrogenase activity,metabolic process,0.884\nglutamate-cysteine ligase activity,metabolic process,0.74\nglutamate-cysteine ligase catalytic subunit binding,metabolic process,0.35\nglutamate-cysteine ligase complex,metabolic process,0.388\nglutamate-gated calcium ion channel activity,cellular component organization,0.304\nglutamate-tRNA ligase activity,metabolic process,0.822\nglutamate-tRNA(Gln) ligase activity,metabolic process,0.822\nglutamate:sodium symporter activity,transport,0.572\nglutamatergic neuron differentiation,morphogenesis/development,0.752\nglutamic-type peptidase activity,metabolic process,0.456\nglutaminase activity,metabolic process,0.9\nglutamine N-acyltransferase activity,metabolic process,0.894\nglutamine biosynthetic process,metabolic process,0.996\nglutamine catabolic process,metabolic process,0.992\nglutamine family amino acid biosynthetic process,metabolic process,0.998\nglutamine family amino acid catabolic process,metabolic process,0.986\nglutamine family amino acid metabolic process,metabolic process,0.996\nglutamine secretion,cellular component organization,0.236\nglutamine synthetase activity,metabolic process,0.752\nglutamine transport,transport,0.956\nglutamine-fructose-6-phosphate transaminase (isomerizing) activity,metabolic process,0.896\nglutamine-phenylpyruvate transaminase activity,metabolic process,0.896\nglutamine-tRNA ligase activity,metabolic process,0.822\nglutaminyl-peptide cyclotransferase activity,metabolic process,0.896\nglutaminyl-tRNA aminoacylation,metabolic process,0.578\nglutaminyl-tRNA synthase (glutamine-hydrolyzing) activity,metabolic process,0.752\nglutaminyl-tRNAGln biosynthesis via transamidation,metabolic process,0.232\nglutamyl-tRNA aminoacylation,metabolic process,0.562\nglutamyl-tRNA(Gln) amidotransferase complex,cellular component organization,0.34\nglutaryl-CoA dehydrogenase activity,metabolic process,0.378\nglutaryl-CoA hydrolase activity,metabolic process,0.898\nglutathione binding,metabolic process,0.35\nglutathione biosynthetic process,metabolic process,0.772\nglutathione catabolic process,metabolic process,0.784\nglutathione deglycation,metabolic process,0.256\nglutathione dehydrogenase (ascorbate) activity,metabolic process,0.898\nglutathione derivative biosynthetic process,metabolic process,0.978\nglutathione derivative metabolic process,metabolic process,0.962\nglutathione disulfide oxidoreductase activity,metabolic process,0.942\nglutathione hydrolase activity,metabolic process,0.9\nglutathione import into mitochondrion,cellular component organization,0.204\nglutathione specific gamma-glutamylcyclotransferase activity,metabolic process,0.896\nglutathione synthase activity,metabolic process,0.752\nglutathione transmembrane transport,transport,0.892\nglutathione transmembrane transporter activity,cellular component organization,0.268\nglutathione transport,transport,0.98\nglutathione-dependent sulfide quinone oxidoreductase activity,metabolic process,0.892\nglutathione-disulfide reductase (NADP) activity,metabolic process,0.934\nglyceraldehyde oxidoreductase activity,metabolic process,0.9\nglyceraldehyde-3-phosphate biosynthetic process,metabolic process,0.826\nglyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity,metabolic process,0.888\nglyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity,metabolic process,0.926\nglyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity,metabolic process,0.876\nglyceraldehyde-3-phosphate metabolic process,metabolic process,0.98\nglycerate dehydrogenase activity,metabolic process,0.928\nglycerate kinase activity,metabolic process,0.796\nglycerol biosynthetic process,metabolic process,0.97\nglycerol biosynthetic process from pyruvate,metabolic process,0.848\nglycerol catabolic process,metabolic process,0.968\nglycerol channel activity,cellular component organization,0.184\nglycerol dehydrogenase [NAD(P)+] activity,metabolic process,0.98\nglycerol dehydrogenase [NADP+] activity,metabolic process,0.934\nglycerol ether biosynthetic process,metabolic process,0.97\nglycerol ether catabolic process,metabolic process,0.94\nglycerol ether metabolic process,metabolic process,0.962\nglycerol kinase activity,metabolic process,0.796\nglycerol metabolic process,metabolic process,0.964\nglycerol transmembrane transport,transport,0.4\nglycerol transmembrane transporter activity,transport,0.606\nglycerol-1-phosphatase activity,metabolic process,0.852\nglycerol-3-phosphatase activity,metabolic process,0.84\nglycerol-3-phosphate O-acyltransferase activity,metabolic process,0.886\nglycerol-3-phosphate biosynthetic process,metabolic process,0.886\nglycerol-3-phosphate catabolic process,metabolic process,0.886\nglycerol-3-phosphate dehydrogenase (quinone) activity,metabolic process,0.85\nglycerol-3-phosphate dehydrogenase [NAD(P)+] activity,metabolic process,0.884\nglycerol-3-phosphate dehydrogenase complex,metabolic process,0.4\nglycerol-3-phosphate metabolic process,metabolic process,0.982\nglycerolipid biosynthetic process,metabolic process,0.946\nglycerolipid catabolic process,metabolic process,0.978\nglycerolipid metabolic process,metabolic process,0.928\nglycerone kinase activity,metabolic process,0.752\nglycerone-phosphate O-acyltransferase activity,metabolic process,0.846\nglycerophosphate shuttle,metabolic process,0.288\nglycerophosphocholine cholinephosphodiesterase activity,metabolic process,0.852\nglycerophosphocholine phosphodiesterase activity,metabolic process,0.9\nglycerophosphodiester phosphodiesterase activity,metabolic process,0.9\nglycerophosphoinositol glycerophosphodiesterase activity,metabolic process,0.9\nglycerophosphoinositol inositolphosphodiesterase activity,metabolic process,0.9\nglycerophospholipid biosynthetic process,metabolic process,0.99\nglycerophospholipid flippase activity,transport,0.424\nglyceryl-ether monooxygenase activity,metabolic process,0.9\nglycine C-acetyltransferase activity,metabolic process,0.892\nglycine N-acyltransferase activity,metabolic process,0.894\nglycine N-benzoyltransferase activity,metabolic process,0.894\nglycine N-choloyltransferase activity,metabolic process,0.894\nglycine N-methyltransferase activity,metabolic process,0.896\nglycine amidinotransferase activity,metabolic process,0.896\nglycine betaine biosynthetic process,metabolic process,0.984\nglycine betaine biosynthetic process from choline,metabolic process,0.9\nglycine betaine metabolic process,metabolic process,0.964\nglycine betaine transport,transport,0.724\nglycine binding,metabolic process,0.32\nglycine biosynthetic process,metabolic process,0.998\nglycine biosynthetic process from serine,metabolic process,0.862\n\"glycine biosynthetic process, by transamination of glyoxylate\",metabolic process,0.89\nglycine catabolic process,metabolic process,0.932\nglycine cleavage complex,cellular component organization,0.404\nglycine decarboxylation via glycine cleavage system,metabolic process,0.894\nglycine dehydrogenase (decarboxylating) activity,metabolic process,0.896\nglycine hydroxymethyltransferase activity,metabolic process,0.9\nglycine import across plasma membrane,transport,0.458\nglycine import into mitochondrion,cellular component organization,0.194\nglycine metabolic process,metabolic process,0.994\nglycine receptor clustering,transport,0.224\nglycine transmembrane transporter activity,transport,0.768\nglycine transport,transport,0.948\nglycine-gated chloride channel complex,cellular component organization,0.266\nglycine-gated chloride ion channel activity,cellular component organization,0.32\nglycine-tRNA ligase activity,metabolic process,0.822\nglycine:2-oxoglutarate aminotransferase activity,metabolic process,0.896\nglycine:proton antiporter activity,metabolic process,0.524\nglycine:sodium symporter activity,metabolic process,0.514\nglycinergic synapse,neural related process,0.304\nglycocalyx,cellular component organization,0.404\nglycogen (starch) synthase activity,metabolic process,0.894\nglycogen binding,metabolic process,0.25\nglycogen biosynthetic process,metabolic process,0.816\nglycogen catabolic process,metabolic process,0.84\nglycogen cell differentiation involved in embryonic placenta development,morphogenesis/development,0.736\nglycogen debranching enzyme activity,metabolic process,0.536\nglycogen granule,metabolic process,0.314\nglycogen metabolic process,metabolic process,0.964\nglycogen phosphorylase activity,metabolic process,0.85\n\"glycogen synthase activity, transferring glucose-1-phosphate\",metabolic process,0.838\nglycogenin glucosyltransferase activity,metabolic process,0.896\nglycolate biosynthetic process,metabolic process,0.958\nglycolate catabolic process,metabolic process,0.894\nglycolate metabolic process,metabolic process,0.99\nglycolipid binding,metabolic process,0.348\nglycolipid catabolic process,metabolic process,0.962\nglycolipid floppase activity,metabolic process,0.306\nglycolipid mannosyltransferase activity,metabolic process,0.83\nglycolipid metabolic process,metabolic process,0.962\nglycolipid transfer activity,transport,0.292\nglycolipid translocation,cellular component organization,0.314\nglycolipid transport,transport,0.93\nglycolysis from storage polysaccharide through glucose-1-phosphate,metabolic process,0.762\nglycolytic fermentation,metabolic process,0.594\nglycolytic process from galactose,metabolic process,0.748\nglycolytic process through fructose-6-phosphate,metabolic process,0.97\nglycolytic process through glucose-1-phosphate,metabolic process,0.954\nglycophagy,cellular component organization,0.254\nglycoprotein 6-alpha-L-fucosyltransferase activity,metabolic process,0.894\nglycoprotein Ib-IX-V complex,receptor related process,0.35\nglycoprotein biosynthetic process,metabolic process,0.874\nglycoprotein complex,cellular component organization,0.28\n\"glycoprotein endo-alpha-1,2-mannosidase activity\",cellular component organization,0.346\nglycoprotein transport,transport,0.658\nglycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity,metabolic process,0.462\nglycosaminoglycan binding,other,0.278\nglycosaminoglycan catabolic process,metabolic process,0.962\nglycosaminoglycan metabolic process,metabolic process,0.954\nglycoside catabolic process,metabolic process,0.976\nglycoside transport,transport,0.958\nglycosphingolipid binding,metabolic process,0.254\nglycosphingolipid biosynthetic process,metabolic process,0.968\nglycosphingolipid catabolic process,metabolic process,0.976\nglycosphingolipid metabolic process,metabolic process,0.972\nglycosyl compound biosynthetic process,metabolic process,0.982\nglycosyl compound catabolic process,metabolic process,0.976\nglycosylated region protein binding,protein modification/signaling,0.346\nglycosylation,metabolic process,0.248\nglycosylceramidase activity,metabolic process,0.9\nglycosylceramide biosynthetic process,metabolic process,0.958\nglycosylceramide catabolic process,metabolic process,0.962\nglycosylceramide flippase activity,metabolic process,0.36\nglycosylceramide metabolic process,metabolic process,0.96\nglycosylphosphatidylinositol phospholipase D activity,metabolic process,0.9\nglycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex,metabolic process,0.248\nglycosylphosphatidylinositol-mannosyltransferase I complex,metabolic process,0.258\nglycosyltransferase activity,metabolic process,0.682\nglycyl-tRNA aminoacylation,metabolic process,0.572\nglycylpeptide N-tetradecanoyltransferase activity,metabolic process,0.894\nglyoxal catabolic process,metabolic process,0.848\nglyoxal metabolic process,metabolic process,0.882\nglyoxalase (glycolic acid-forming) activity,metabolic process,0.846\nglyoxalase III activity,metabolic process,0.9\nglyoxylate catabolic process,metabolic process,0.902\nglyoxylate cycle,metabolic process,0.224\nglyoxylate metabolic process,metabolic process,0.972\nglyoxylate oxidase activity,metabolic process,0.9\nglyoxylate reductase (NADP+) activity,metabolic process,0.934\nglyoxylate reductase activity,metabolic process,0.98\ngonad morphogenesis,morphogenesis/development,0.886\ngonadal mesoderm development,morphogenesis/development,0.92\ngonadotrophin-releasing hormone neuronal migration to the hypothalamus,transport,0.288\ngonadotropin hormone-releasing hormone activity,receptor related process,0.358\ngonadotropin secretion,transport,0.524\ngonadotropin-releasing hormone receptor activity,cellular component organization,0.144\ngonadotropin-releasing hormone receptor binding,receptor related process,0.498\ngranular component,cellular component organization,0.328\ngranular vesicle,cellular component organization,0.538\ngranulocyte activation,immune system process,0.76\ngranulocyte colony-stimulating factor binding,metabolic process,0.218\ngranulocyte colony-stimulating factor production,immune system process,0.678\ngranulocyte colony-stimulating factor receptor binding,receptor related process,0.526\ngranulocyte colony-stimulating factor signaling pathway,receptor related process,0.546\ngranulocyte macrophage colony-stimulating factor production,immune system process,0.606\ngranulocyte macrophage colony-stimulating factor receptor binding,receptor related process,0.504\ngranulocyte macrophage colony-stimulating factor receptor complex,receptor related process,0.37\ngranulocyte-macrophage colony-stimulating factor signaling pathway,receptor related process,0.498\ngranuloma formation,immune system process,0.302\ngranulosa cell apoptotic process,cell death,0.24\ngranulosa cell differentiation,morphogenesis/development,0.754\ngranulosa cell proliferation,cell cycle,0.742\ngranzyme A production,immune system process,0.608\ngranzyme B localization to T cell secretory granule,transport,0.274\ngranzyme B production,immune system process,0.688\ngranzyme-mediated apoptotic signaling pathway,cell death,0.586\ngranzyme-mediated programmed cell death signaling pathway,cell death,0.382\ngrooming behavior,neural related process,0.306\ngroup II metabotropic glutamate receptor activity,receptor related process,0.33\ngroup III metabotropic glutamate receptor activity,receptor related process,0.394\ngrowing cell tip,cellular component organization,0.392\ngrowth cone,cellular component organization,0.422\ngrowth cone filopodium,neural related process,0.222\ngrowth cone leading edge,cellular component organization,0.398\ngrowth cone membrane,cellular component organization,0.368\ngrowth factor complex,protein modification/signaling,0.224\ngrowth factor dependent regulation of skeletal muscle satellite cell proliferation,cell cycle,0.202\ngrowth hormone receptor activity,receptor related process,0.228\ngrowth hormone receptor binding,receptor related process,0.534\ngrowth hormone receptor complex,receptor related process,0.46\ngrowth hormone receptor signaling pathway,receptor related process,0.742\ngrowth hormone receptor signaling pathway via JAK-STAT,receptor related process,0.264\ngrowth hormone secretagogue receptor activity,cellular component organization,0.178\ngrowth hormone secretion,multicellular organismal process,0.174\ngrowth hormone-releasing hormone activity,metabolic process,0.214\ngrowth hormone-releasing hormone receptor activity,cellular component organization,0.164\ngrowth hormone-releasing hormone receptor binding,receptor related process,0.526\ngrowth involved in heart morphogenesis,morphogenesis/development,0.632\ngrowth of unicellular organism as a thread of attached cells,cell cycle,0.29\ngrowth plate cartilage axis specification,cellular component organization,0.178\ngrowth plate cartilage chondrocyte development,morphogenesis/development,0.674\ngrowth plate cartilage chondrocyte differentiation,morphogenesis/development,0.634\ngrowth plate cartilage chondrocyte growth,morphogenesis/development,0.738\ngrowth plate cartilage chondrocyte morphogenesis,morphogenesis/development,0.534\ngrowth plate cartilage chondrocyte proliferation,cell cycle,0.69\ngrowth plate cartilage morphogenesis,morphogenesis/development,0.89\nguanidinoacetate N-methyltransferase activity,metabolic process,0.896\nguanidinobutyrase activity,metabolic process,0.9\nguanidinopropionase activity,metabolic process,0.9\nguanine biosynthetic process,metabolic process,0.874\nguanine catabolic process,metabolic process,0.64\nguanine deaminase activity,metabolic process,0.9\nguanine deglycation,metabolic process,0.716\n\"guanine deglycation, glyoxal removal\",metabolic process,0.23\n\"guanine deglycation, methylglyoxal removal\",metabolic process,0.23\nguanine metabolic process,metabolic process,0.9\nguanine nucleotide transmembrane transport,transport,0.74\nguanine nucleotide transmembrane transporter activity,transport,0.67\nguanine nucleotide transport,transport,0.916\nguanine phosphoribosyltransferase activity,metabolic process,0.86\nguanine salvage,morphogenesis/development,0.224\nguanine transmembrane transport,transport,0.77\nguanine transmembrane transporter activity,transport,0.674\nguanine transport,transport,0.938\nguanine/thymine mispair binding,gene regulation,0.212\nguanosine metabolic process,metabolic process,0.992\nguanosine phosphorylase activity,metabolic process,0.846\n\"guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity\",metabolic process,0.878\n\"guanosine-5'-triphosphate,3'-diphosphate diphosphatase activity\",metabolic process,0.852\nguanosine-containing compound metabolic process,metabolic process,0.99\nguanyl deoxyribonucleotide binding,metabolic process,0.572\nguanyl nucleotide binding,protein modification/signaling,0.366\nguanyl ribonucleotide binding,metabolic process,0.344\nguanyl-nucleotide exchange factor adaptor activity,protein modification/signaling,0.238\nguanyl-nucleotide exchange factor complex,cellular component organization,0.234\nguanylate cyclase activator activity,metabolic process,0.486\nguanylate cyclase activity,metabolic process,0.858\n\"guanylate cyclase complex, soluble\",cellular component organization,0.402\nguanylate cyclase inhibitor activity,metabolic process,0.272\nguanylate cyclase regulator activity,metabolic process,0.472\nguanylate kinase activity,metabolic process,0.766\nguanylate kinase-associated protein clustering,neural related process,0.284\nguanylyltransferase activity,metabolic process,0.618\nhabenula development,morphogenesis/development,0.78\nhabituation,neural related process,0.254\nhair cell differentiation,morphogenesis/development,0.778\nhair cycle phase,cellular component organization,0.172\nhair follicle cell proliferation,cell cycle,0.8\nhair follicle maturation,morphogenesis/development,0.574\nhair follicle placode formation,morphogenesis/development,0.552\nhalogenase activity,metabolic process,0.864\nhalogenated hydrocarbon metabolic process,metabolic process,0.946\nhaloperoxidase activity,metabolic process,0.928\nhaptoglobin binding,metabolic process,0.244\nhaptoglobin-hemoglobin complex,protein modification/signaling,0.266\nhard palate development,morphogenesis/development,0.838\nhard palate morphogenesis,morphogenesis/development,0.596\nhatching,multicellular organismal process,0.45\nhead morphogenesis,morphogenesis/development,0.752\nheart field specification,morphogenesis/development,0.38\nheart growth,morphogenesis/development,0.414\nheart induction,morphogenesis/development,0.3\nheart looping,morphogenesis/development,0.56\nheart trabecula formation,morphogenesis/development,0.306\nheart trabecula morphogenesis,morphogenesis/development,0.832\nheart valve formation,morphogenesis/development,0.872\nheart valve morphogenesis,morphogenesis/development,0.92\nheat acclimation,immune system process,0.324\nheat generation,multicellular organismal process,0.546\nhedgehog family protein binding,protein modification/signaling,0.388\nhedgehog receptor activity,protein modification/signaling,0.274\nhelper T cell diapedesis,immune system process,0.728\nhelper T cell enhancement of adaptive immune response,immune system process,0.826\nhelper T cell extravasation,immune system process,0.736\nhemangioblast cell differentiation,morphogenesis/development,0.526\nhematopoietic stem cell differentiation,morphogenesis/development,0.684\nhematopoietic stem cell homeostasis,cell cycle,0.264\nhematopoietic stem cell migration,immune system process,0.486\nhematopoietic stem cell migration to bone marrow,immune system process,0.366\nhematopoietic stem cell proliferation,cell cycle,0.364\nheme A biosynthetic process,metabolic process,0.886\nheme a metabolic process,metabolic process,0.97\nheme binding,metabolic process,0.296\nheme biosynthetic process,metabolic process,0.956\nheme catabolic process,metabolic process,0.958\nheme export,transport,0.422\nheme metabolic process,metabolic process,0.986\nheme oxidation,metabolic process,0.878\nheme oxygenase (decyclizing) activity,metabolic process,0.918\nheme transmembrane transport,transport,0.814\nheme transmembrane transporter activity,transport,0.642\nheme transport,transport,0.944\nhemi-methylated DNA-binding,transport,0.202\nhemidesmosome,cellular component organization,0.358\nhemidesmosome assembly,cellular component organization,0.296\nhemocyte differentiation,morphogenesis/development,0.47\nhemoglobin alpha binding,metabolic process,0.234\nhemoglobin binding,protein modification/signaling,0.506\nhemoglobin biosynthetic process,metabolic process,0.732\nhemoglobin complex,metabolic process,0.324\nhemoglobin metabolic process,metabolic process,0.914\nhemopoiesis,immune system process,0.526\nheparan sulfate 2-O-sulfotransferase activity,metabolic process,0.84\nheparan sulfate 6-O-sulfotransferase activity,metabolic process,0.82\nheparan sulfate N-acetylglucosaminyltransferase activity,metabolic process,0.89\nheparan sulfate N-deacetylase activity,metabolic process,0.9\nheparan sulfate binding,metabolic process,0.228\nheparan sulfate proteoglycan binding,metabolic process,0.25\nheparan sulfate proteoglycan biosynthetic process,metabolic process,0.794\n\"heparan sulfate proteoglycan biosynthetic process, enzymatic modification\",cellular component organization,0.216\n\"heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process\",metabolic process,0.762\nheparan sulfate proteoglycan catabolic process,metabolic process,0.824\nheparan sulfate proteoglycan metabolic process,metabolic process,0.852\nheparan sulfate sulfotransferase activity,metabolic process,0.888\nheparan-alpha-glucosaminide N-acetyltransferase activity,metabolic process,0.892\nheparanase activity,metabolic process,0.5\nheparin binding,cellular component organization,0.17\nheparin biosynthetic process,metabolic process,0.854\nheparin catabolic process,metabolic process,0.85\nheparin metabolic process,metabolic process,0.924\nheparosan-N-sulfate-glucuronate 5-epimerase activity,metabolic process,0.896\nhepatic immune response,immune system process,0.424\nhepatic stellate cell activation,immune system process,0.182\nhepatic stellate cell contraction,cellular component organization,0.352\nhepatic stellate cell migration,transport,0.184\nhepatic stellate cell proliferation,cell cycle,0.558\nhepatoblast differentiation,morphogenesis/development,0.752\nhepatocyte cell migration,cellular component organization,0.156\nhepatocyte dedifferentiation,morphogenesis/development,0.536\nhepatocyte growth factor binding,metabolic process,0.186\nhepatocyte growth factor production,immune system process,0.51\nhepatocyte growth factor receptor activity,receptor related process,0.386\nhepatocyte growth factor receptor binding,receptor related process,0.554\nhepatocyte growth factor receptor signaling pathway,receptor related process,0.584\nhepatocyte homeostasis,cell cycle,0.242\nhepoxilin A3 synthase activity,metabolic process,0.896\nhepoxilin biosynthetic process,metabolic process,0.764\nhepoxilin metabolic process,metabolic process,0.924\nhepoxilin-epoxide hydrolase activity,metabolic process,0.88\nheterochromatin,gene regulation,0.292\nheterochromatin boundary formation,cellular component organization,0.23\nheterochromatin organization,gene regulation,0.424\nheterocycle biosynthetic process,metabolic process,0.876\nheterocycle metabolic process,metabolic process,0.806\nheterocyclic compound binding,metabolic process,0.61\nheteroduplex DNA loop binding,cell cycle,0.22\nheteromeric SMAD protein complex,gene regulation,0.39\nheterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,cell adhesion,0.33\nheterotrimeric G-protein binding,metabolic process,0.236\nheterotrimeric G-protein complex,receptor related process,0.246\nheterotrimeric G-protein complex assembly,cellular component organization,0.648\nhexadecanal metabolic process,metabolic process,0.906\nhexameric IgM immunoglobulin complex,immune system process,0.216\nhexaprenyldihydroxybenzoate methyltransferase activity,metabolic process,0.896\nhexitol catabolic process,metabolic process,0.988\nhexitol dehydrogenase activity,metabolic process,0.942\nhexitol metabolic process,metabolic process,0.994\nhexokinase activity,metabolic process,0.734\nhexosaminidase activity,metabolic process,0.672\nhexose biosynthetic process,metabolic process,0.984\nhexose catabolic process,metabolic process,0.988\nhexose import across plasma membrane,transport,0.926\nhexose mediated signaling,receptor related process,0.318\nhexose metabolic process,metabolic process,0.992\nhexose phosphate transmembrane transporter activity,transport,0.588\nhexose phosphate transport,transport,0.928\nhexose transmembrane transporter activity,transport,0.706\nhexose uniporter activity,transport,0.55\nhexose-phosphate:inorganic phosphate antiporter activity,transport,0.458\nhexose:proton symporter activity,transport,0.5\nhexuronate transmembrane transport,transport,0.76\nhigh voltage-gated calcium channel activity,transport,0.214\nhigh-affinity IgE receptor activity,immune system process,0.296\nhigh-affinity IgG receptor activity,immune system process,0.298\nhigh-affinity L-arginine transmembrane transporter activity,transport,0.352\nhigh-affinity L-glutamate transmembrane transporter activity,transport,0.36\nhigh-affinity basic amino acid transmembrane transporter activity,transport,0.716\nhigh-affinity inorganic phosphate:sodium symporter activity,metabolic process,0.388\nhigh-affinity lysine transmembrane transporter activity,transport,0.352\nhigh-affinity sodium:dicarboxylate symporter activity,metabolic process,0.388\nhigh-density lipoprotein particle,cellular component organization,0.212\nhigh-density lipoprotein particle assembly,cellular component organization,0.416\nhigh-density lipoprotein particle binding,metabolic process,0.288\nhigh-density lipoprotein particle clearance,cellular component organization,0.25\nhigh-density lipoprotein particle receptor activity,cellular component organization,0.192\nhigh-density lipoprotein particle receptor binding,receptor related process,0.5\nhigh-density lipoprotein particle remodeling,cellular component organization,0.444\nhindbrain development,morphogenesis/development,0.736\nhindbrain formation,morphogenesis/development,0.408\nhindbrain maturation,morphogenesis/development,0.498\nhindbrain morphogenesis,morphogenesis/development,0.678\nhindbrain radial glia guided cell migration,transport,0.236\nhindbrain structural organization,morphogenesis/development,0.368\nhindbrain tangential cell migration,neural related process,0.256\nhindgut contraction,cellular component organization,0.16\nhindgut development,morphogenesis/development,0.98\nhindgut morphogenesis,morphogenesis/development,0.744\nhinge region between urothelial plaques of apical plasma membrane,cellular component organization,0.4\nhippocampal mossy fiber,cellular component organization,0.398\nhippocampal mossy fiber expansion,neural related process,0.286\nhippocampal mossy fiber to CA3 synapse,neural related process,0.274\nhippocampal neuron apoptotic process,cell death,0.224\nhippocampus development,morphogenesis/development,0.728\nhistamine N-methyltransferase activity,metabolic process,0.896\nhistamine biosynthetic process,metabolic process,0.724\nhistamine catabolic process,metabolic process,0.716\nhistamine metabolic process,metabolic process,0.934\nhistamine oxidase activity,metabolic process,0.9\nhistamine production involved in inflammatory response,immune system process,0.554\nhistamine receptor activity,metabolic process,0.346\nhistamine secretion,transport,0.462\nhistamine secretion by mast cell,immune system process,0.342\nhistamine secretion involved in inflammatory response,transport,0.486\nhistamine secretion mediated by IgE immunoglobulin,immune system process,0.25\nhistamine secretion mediated by immunoglobulin,immune system process,0.384\nhistamine transport,transport,0.776\nhistamine uptake,transport,0.264\nhistidine ammonia-lyase activity,metabolic process,0.896\nhistidine biosynthetic process,metabolic process,0.904\nhistidine catabolic process,metabolic process,0.994\nhistidine catabolic process to glutamate and formamide,metabolic process,0.868\nhistidine catabolic process to glutamate and formate,metabolic process,0.862\nhistidine decarboxylase activity,metabolic process,0.896\nhistidine metabolic process,metabolic process,0.974\nhistidine transport,transport,0.946\nhistidine-tRNA ligase activity,metabolic process,0.822\nhistidyl-tRNA aminoacylation,metabolic process,0.558\nhistone H2A K63-linked deubiquitination,protein modification/signaling,0.546\nhistone H2A K63-linked ubiquitination,protein modification/signaling,0.278\nhistone H2A acetylation,gene regulation,0.488\nhistone H2A acetyltransferase activity,metabolic process,0.56\nhistone H2A deubiquitinase activity,protein modification/signaling,0.364\nhistone H2A kinase activity,metabolic process,0.39\nhistone H2A methyltransferase activity,metabolic process,0.51\nhistone H2A monoubiquitination,protein modification/signaling,0.582\nhistone H2A ubiquitin ligase activity,metabolic process,0.494\nhistone H2A-K119 monoubiquitination,gene regulation,0.3\nhistone H2A-K15 ubiquitination,gene regulation,0.3\nhistone H2AK119 ubiquitin ligase activity,metabolic process,0.49\nhistone H2AK15 ubiquitin ligase activity,metabolic process,0.494\nhistone H2AK5 acetyltransferase activity,metabolic process,0.782\nhistone H2AQ104 methyltransferase activity,metabolic process,0.786\nhistone H2AR3 methyltransferase activity,metabolic process,0.63\nhistone H2AS1 kinase activity,metabolic process,0.554\nhistone H2AT120 kinase activity,metabolic process,0.564\nhistone H2AX kinase activity,metabolic process,0.382\nhistone H2AXY142 kinase activity,metabolic process,0.56\nhistone H2AXY142 phosphatase activity,metabolic process,0.684\nhistone H2B C-terminal K residue ubiquitin ligase activity,metabolic process,0.478\nhistone H2B acetyltransferase activity,metabolic process,0.546\nhistone H2B conserved C-terminal lysine ubiquitination,protein modification/signaling,0.244\nhistone H2B deubiquitinase activity,protein modification/signaling,0.39\nhistone H2B kinase activity,metabolic process,0.384\nhistone H2B ubiquitin ligase activity,metabolic process,0.494\nhistone H2B ubiquitination,protein modification/signaling,0.632\nhistone H2BS36 kinase activity,metabolic process,0.56\nhistone H3 acetylation,protein modification/signaling,0.606\nhistone H3 acetyltransferase activity,metabolic process,0.43\nhistone H3 arginine deiminase activity,metabolic process,0.588\nhistone H3 deacetylation,protein modification/signaling,0.598\nhistone H3 demethylase activity,protein modification/signaling,0.48\nhistone H3 kinase activity,gene regulation,0.382\nhistone H3 methyltransferase activity,metabolic process,0.512\nhistone H3-K14 acetylation,gene regulation,0.464\nhistone H3-K14 acetyltransferase complex,metabolic process,0.312\nhistone H3-K27 demethylation,gene regulation,0.408\nhistone H3-K27 methylation,gene regulation,0.612\nhistone H3-K27 trimethylation,gene regulation,0.542\nhistone H3-K36 dimethylation,gene regulation,0.518\nhistone H3-K36 trimethylation,gene regulation,0.542\nhistone H3-K4 acetylation,gene regulation,0.49\nhistone H3-K4 demethylation,gene regulation,0.526\nhistone H3-K79 methylation,gene regulation,0.52\nhistone H3-K9 acetylation,gene regulation,0.53\nhistone H3-K9 demethylation,gene regulation,0.392\nhistone H3-K9 dimethylation,gene regulation,0.504\nhistone H3-K9 methylation,gene regulation,0.64\nhistone H3-K9 modification,protein modification/signaling,0.47\nhistone H3-K9 trimethylation,gene regulation,0.518\nhistone H3-R2 demethylation,gene regulation,0.38\nhistone H3-R26 methylation,gene regulation,0.484\nhistone H3K deacetylase activity,metabolic process,0.476\nhistone H3K122 acetyltransferase activity,metabolic process,0.766\nhistone H3K14 acetyltransferase activity,metabolic process,0.704\nhistone H3K14 deacetylase activity,metabolic process,0.452\nhistone H3K18 acetyltransferase activity,metabolic process,0.778\nhistone H3K23 acetyltransferase activity,metabolic process,0.778\nhistone H3K27 dimethyltransferase activity,metabolic process,0.622\nhistone H3K27 methyltransferase activity,metabolic process,0.482\nhistone H3K27 trimethyltransferase activity,metabolic process,0.616\nhistone H3K27me2/H3K27me3 demethylase activity,metabolic process,0.51\nhistone H3K36 demethylase activity,metabolic process,0.478\nhistone H3K36 dimethyltransferase activity,metabolic process,0.614\nhistone H3K36 methyltransferase activity,metabolic process,0.492\nhistone H3K36 trimethyltransferase activity,metabolic process,0.618\nhistone H3K36me/H3K36me2 demethylase activity,metabolic process,0.516\nhistone H3K36me2/H3K36me3 demethylase activity,metabolic process,0.524\nhistone H3K4 acetyltransferase activity,metabolic process,0.778\nhistone H3K4 demethylase activity,protein modification/signaling,0.424\nhistone H3K4 dimethyltransferase activity,metabolic process,0.622\nhistone H3K4 methyltransferase activity,metabolic process,0.472\nhistone H3K4 monomethyltransferase activity,metabolic process,0.616\nhistone H3K4 trimethyltransferase activity,metabolic process,0.612\nhistone H3K4me/H3K4me2/H3K4me3 demethylase activity,metabolic process,0.524\nhistone H3K56 methyltransferase activity,metabolic process,0.508\nhistone H3K79 methyltransferase activity,metabolic process,0.48\nhistone H3K79 trimethyltransferase activity,metabolic process,0.532\nhistone H3K9 acetyltransferase activity,metabolic process,0.76\nhistone H3K9 deacetylase activity,metabolic process,0.45\nhistone H3K9 demethylase activity,protein modification/signaling,0.52\nhistone H3K9 methyltransferase activity,metabolic process,0.472\nhistone H3K9 monomethyltransferase activity,metabolic process,0.618\nhistone H3K9 trimethyltransferase activity,metabolic process,0.614\nhistone H3K9me/H3K9me2 demethylase activity,metabolic process,0.52\nhistone H3K9me2 methyltransferase activity,metabolic process,0.616\nhistone H3K9me2/H3K9me3 demethylase activity,metabolic process,0.516\nhistone H3R17 arginine deiminase activity,metabolic process,0.79\nhistone H3R17 methyltransferase activity,metabolic process,0.638\nhistone H3R2 arginine deiminase activity,metabolic process,0.79\nhistone H3R2 demethylase activity,metabolic process,0.522\nhistone H3R2 methyltransferase activity,metabolic process,0.63\nhistone H3R26 arginine deiminase activity,metabolic process,0.79\nhistone H3R8 arginine deiminase activity,metabolic process,0.79\nhistone H3R8 methyltransferase activity,metabolic process,0.634\nhistone H3S10 kinase activity,metabolic process,0.536\nhistone H3S28 kinase activity,metabolic process,0.514\nhistone H3T11 kinase activity,metabolic process,0.53\nhistone H3T3 kinase activity,metabolic process,0.546\nhistone H3T45 kinase activity,metabolic process,0.538\nhistone H3T6 kinase activity,metabolic process,0.536\nhistone H3Y41 kinase activity,metabolic process,0.494\nhistone H4 acetyltransferase activity,metabolic process,0.36\nhistone H4 deacetylation,protein modification/signaling,0.592\nhistone H4 demethylase activity,metabolic process,0.424\nhistone H4 methyltransferase activity,metabolic process,0.506\nhistone H4-K12 acetylation,gene regulation,0.49\nhistone H4-K16 deacetylation,gene regulation,0.39\nhistone H4-K20 dimethylation,gene regulation,0.504\nhistone H4-K20 methylation,gene regulation,0.608\nhistone H4-K5 acetylation,gene regulation,0.64\nhistone H4-K8 acetylation,gene regulation,0.64\nhistone H4-R3 demethylation,gene regulation,0.38\nhistone H4-R3 methylation,gene regulation,0.476\nhistone H4K deacetylase activity,metabolic process,0.478\nhistone H4K12 acetyltransferase activity,metabolic process,0.712\nhistone H4K12 methyltransferase activity,metabolic process,0.508\nhistone H4K16 acetyltransferase activity,metabolic process,0.654\nhistone H4K16 deacetylase activity,metabolic process,0.436\nhistone H4K20 demethylase activity,metabolic process,0.51\nhistone H4K20 methyltransferase activity,metabolic process,0.478\nhistone H4K20 monomethyltransferase activity,metabolic process,0.628\nhistone H4K20 trimethyltransferase activity,metabolic process,0.496\nhistone H4K20me methyltransferase activity,metabolic process,0.672\nhistone H4K5 acetyltransferase activity,metabolic process,0.706\nhistone H4K8 acetyltransferase activity,metabolic process,0.706\nhistone H4R3 demethylase activity,metabolic process,0.522\nhistone H4R3 methyltransferase activity,metabolic process,0.616\nhistone acetylation,gene regulation,0.504\nhistone acetyltransferase regulator activity,gene regulation,0.254\nhistone arginine N-methyltransferase activity,metabolic process,0.894\nhistone arginine deiminase activity,metabolic process,0.592\nhistone arginine methylation,protein modification/signaling,0.506\nhistone butyryltransferase activity,metabolic process,0.824\nhistone chaperone activity,protein modification/signaling,0.318\nhistone crotonyltransferase activity,metabolic process,0.824\nhistone deacetylase activity,metabolic process,0.37\nhistone deacetylase complex,gene regulation,0.422\nhistone deacetylase inhibitor activity,protein modification/signaling,0.272\nhistone deacetylase regulator activity,metabolic process,0.324\nhistone deacetylation,protein modification/signaling,0.708\nhistone decrotonylase activity,metabolic process,0.606\nhistone demethylase activity,protein modification/signaling,0.642\nhistone demethylation,gene regulation,0.512\nhistone deubiquitinase activity,protein modification/signaling,0.418\nhistone deubiquitination,protein modification/signaling,0.756\nhistone dopaminyltransferase activity,metabolic process,0.892\nhistone glutamine methylation,gene regulation,0.35\nhistone glutaryltransferase activity,metabolic process,0.836\nhistone lactyltransferase activity,metabolic process,0.872\nhistone locus body,gene regulation,0.534\nhistone lysine methylation,gene regulation,0.826\nhistone mRNA catabolic process,metabolic process,0.598\nhistone mRNA metabolic process,metabolic process,0.568\nhistone mRNA stem-loop binding complex,gene regulation,0.208\nhistone methyltransferase activity,metabolic process,0.522\nhistone methyltransferase binding,metabolic process,0.302\nhistone methyltransferase inhibitor activity,metabolic process,0.252\nhistone monoubiquitination,protein modification/signaling,0.668\nhistone octamer slider activity,cell cycle,0.386\nhistone phosphatase activity,metabolic process,0.522\nhistone pre-mRNA 3'end processing complex,gene regulation,0.328\nhistone pre-mRNA DCP binding,immune system process,0.23\nhistone pre-mRNA stem-loop binding,gene regulation,0.21\nhistone reader activity,gene regulation,0.39\nhistone serotonyltransferase activity,metabolic process,0.892\nhistone succinylation,gene regulation,0.338\nhistone succinyltransferase activity,metabolic process,0.836\nhistone ubiquitin ligase activity,metabolic process,0.47\nhistone-dependent DNA binding,gene regulation,0.25\nholo-[acyl-carrier-protein] synthase activity,metabolic process,0.62\nholocytochrome-c synthase activity,metabolic process,0.896\nhomeostasis of number of cells within a tissue,multicellular organismal process,0.34\nhomeostasis of number of retina cells,cell cycle,0.25\nhomeostatic process,other,0.262\nhomocarnosine synthase activity,metabolic process,0.814\nhomocysteine catabolic process,metabolic process,0.874\nhomocysteine desulfhydrase activity,metabolic process,0.9\n\"homogentisate 1,2-dioxygenase activity\",metabolic process,0.896\nhomogentisate catabolic process,metabolic process,0.892\nhomogentisate metabolic process,metabolic process,0.962\nhomoiothermy,morphogenesis/development,0.24\nhomologous chromosome movement towards spindle pole in meiosis I anaphase,transport,0.35\nhomologous chromosome pairing at meiosis,cellular component organization,0.302\nhomologous chromosome segregation,cell cycle,0.598\nhomomeric SMAD protein complex,protein modification/signaling,0.27\nhomoserine metabolic process,metabolic process,0.99\nhormonal regulation of the force of heart contraction,morphogenesis/development,0.182\nhormone activity,metabolic process,0.19\nhormone binding,receptor related process,0.176\nhormone biosynthetic process,metabolic process,0.828\nhormone catabolic process,metabolic process,0.794\nhormone receptor binding,receptor related process,0.438\nhormone-mediated apoptotic signaling pathway,cell death,0.508\nhormone-sensitive lipase activity,metabolic process,0.894\nhost cell,cellular component organization,0.296\nhost cell surface binding,receptor related process,0.316\nhost cell surface receptor binding,receptor related process,0.408\nhost cellular component,cellular component organization,0.496\nhost-mediated regulation of intestinal microbiota composition,cell cycle,0.252\nhumoral immune response mediated by circulating immunoglobulin,immune system process,0.622\nhyaloid vascular plexus regression,morphogenesis/development,0.542\nhyaluranon cable,cellular component organization,0.294\nhyaluranon cable assembly,cellular component organization,0.334\nhyaluronan biosynthetic process,metabolic process,0.882\nhyaluronan catabolic process,metabolic process,0.872\nhyaluronan metabolic process,metabolic process,0.962\nhyaluronan synthase activity,metabolic process,0.892\nhyaluronic acid binding,metabolic process,0.316\nhyaluronoglucuronidase activity,metabolic process,0.476\nhyalurononglucosaminidase activity,metabolic process,0.466\nhydro-lyase activity,metabolic process,0.81\nhydrocarbon catabolic process,metabolic process,0.976\nhydrocarbon metabolic process,metabolic process,0.988\nhydrogen peroxide biosynthetic process,metabolic process,0.724\nhydrogen peroxide catabolic process,metabolic process,0.87\nhydrogen peroxide metabolic process,metabolic process,0.632\nhydrogen peroxide transmembrane transport,transport,0.266\nhydrogen peroxide-mediated programmed cell death,cell death,0.656\nhydrogen sulfide biosynthetic process,metabolic process,0.856\nhydrogen sulfide metabolic process,metabolic process,0.892\nhydrolase activity,metabolic process,0.42\n\"hydrolase activity, acting on acid anhydrides, in sulfonyl-containing anhydrides\",metabolic process,0.764\n\"hydrolase activity, acting on acid carbon-carbon bonds\",metabolic process,0.72\n\"hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances\",metabolic process,0.77\n\"hydrolase activity, acting on acid phosphorus-nitrogen bonds\",metabolic process,0.598\n\"hydrolase activity, acting on acid sulfur-nitrogen bonds\",metabolic process,0.756\n\"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds\",metabolic process,0.632\n\"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides\",metabolic process,0.756\n\"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines\",metabolic process,0.646\n\"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides\",metabolic process,0.634\n\"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines\",metabolic process,0.712\n\"hydrolase activity, acting on carbon-sulfur bonds\",metabolic process,0.748\n\"hydrolase activity, acting on ether bonds\",metabolic process,0.664\n\"hydrolase activity, acting on glycosyl bonds\",metabolic process,0.556\n\"hydrolase activity, hydrolyzing N-glycosyl compounds\",metabolic process,0.53\n\"hydrolase activity, hydrolyzing O-glycosyl compounds\",metabolic process,0.696\nhydroperoxy icosatetraenoate dehydratase activity,metabolic process,0.256\nhydroperoxy icosatetraenoate isomerase activity,cellular component organization,0.244\nhydroxyacid-oxoacid transhydrogenase activity,metabolic process,0.896\nhydroxyacylglutathione hydrolase activity,metabolic process,0.898\nhydroxyapatite binding,cellular component organization,0.258\nhydroxylysine biosynthetic process,metabolic process,0.912\nhydroxylysine kinase activity,metabolic process,0.896\nhydroxylysine metabolic process,metabolic process,0.994\nhydroxymethylbilane synthase activity,metabolic process,0.9\nhydroxymethylglutaryl-CoA hydrolase activity,metabolic process,0.898\nhydroxymethylglutaryl-CoA lyase activity,metabolic process,0.894\nhydroxymethylglutaryl-CoA reductase (NADPH) activity,metabolic process,0.932\nhydroxymethylglutaryl-CoA synthase activity,metabolic process,0.894\nhydroxyphenylpyruvate reductase activity,metabolic process,0.928\nhydroxyproline transport,transport,0.73\nhydroxypyruvate isomerase activity,metabolic process,0.896\nhydroxypyruvate reductase activity,metabolic process,0.934\nhyperosmotic salinity response,stress response,0.636\nhypersensitivity,immune system process,0.83\nhypochlorous acid biosynthetic process,metabolic process,0.806\nhypochlorous acid metabolic process,metabolic process,0.886\nhypoglossal nerve development,morphogenesis/development,0.958\nhypoglossal nerve morphogenesis,morphogenesis/development,0.722\nhypoglossal nucleus development,morphogenesis/development,0.976\nhypoglycin A gamma-glutamyl transpeptidase activity,metabolic process,0.896\nhypophysis morphogenesis,morphogenesis/development,0.722\nhypotaurine dehydrogenase activity,metabolic process,0.932\nhypothalamic tangential migration using cell-axon interactions,neural related process,0.296\nhypothalamus cell differentiation,morphogenesis/development,0.6\nhypothalamus cell migration,transport,0.25\nhypothalamus development,morphogenesis/development,0.708\nhypothalamus gonadotrophin-releasing hormone neuron development,morphogenesis/development,0.614\nhypothalamus gonadotrophin-releasing hormone neuron differentiation,morphogenesis/development,0.526\nhypotonic salinity response,stress response,0.56\nhypoxanthine biosynthetic process,metabolic process,0.972\nhypoxanthine catabolic process,metabolic process,0.862\nhypoxanthine dehydrogenase activity,metabolic process,0.908\nhypoxanthine metabolic process,metabolic process,0.986\nhypoxanthine oxidase activity,metabolic process,0.874\nhypoxanthine phosphoribosyltransferase activity,metabolic process,0.86\nhypoxanthine salvage,metabolic process,0.23\nhypoxanthine transport,transport,0.734\nhypoxia-inducible factor-1alpha signaling pathway,gene regulation,0.236\nicosanoid binding,metabolic process,0.414\nicosanoid biosynthetic process,metabolic process,0.852\nicosanoid catabolic process,metabolic process,0.952\nicosanoid metabolic process,metabolic process,0.682\nicosanoid receptor activity,receptor related process,0.59\nicosanoid secretion,transport,0.728\nicosanoid transmembrane transporter activity,transport,0.672\nicosanoid transport,transport,0.944\nicosatetraenoic acid binding,metabolic process,0.504\niduronate-2-sulfatase activity,metabolic process,0.564\nimidazole-containing compound catabolic process,metabolic process,0.95\nimidazole-containing compound metabolic process,metabolic process,0.938\nimidazolonepropionase activity,metabolic process,0.904\nimitative learning,multicellular organismal process,0.428\nimmature B cell differentiation,immune system process,0.72\nimmature T cell proliferation,immune system process,0.826\nimmature T cell proliferation in thymus,immune system process,0.372\nimmune complex clearance,immune system process,0.614\nimmune complex clearance by erythrocytes,immune system process,0.432\nimmune complex clearance by monocytes and macrophages,immune system process,0.57\nimmune complex formation,immune system process,0.404\nimmune receptor activity,immune system process,0.65\nimmune response,immune system process,0.512\nimmune response in brain or nervous system,immune system process,0.476\nimmune response in gut-associated lymphoid tissue,immune system process,0.726\nimmune response in nasopharyngeal-associated lymphoid tissue,immune system process,0.726\nimmune response to tumor cell,immune system process,0.788\nimmune response-inhibiting cell surface receptor signaling pathway,immune system process,0.7\nimmune response-inhibiting signal transduction,immune system process,0.718\nimmune response-regulating cell surface receptor signaling pathway involved in phagocytosis,immune system process,0.794\nimmune system process,immune system process,0.384\nimmunoglobulin V(D)J recombination,immune system process,0.61\nimmunoglobulin binding,metabolic process,0.2\nimmunoglobulin complex,cellular component organization,0.252\n\"immunoglobulin complex, circulating\",cellular component organization,0.414\nimmunoglobulin heavy chain V-D-J recombination,immune system process,0.364\nimmunoglobulin mediated immune response,immune system process,0.926\nimmunoglobulin production,immune system process,0.796\nimmunoglobulin production in mucosal tissue,cellular component organization,0.218\nimmunoglobulin production involved in immunoglobulin-mediated immune response,immune system process,0.754\nimmunoglobulin receptor activity,receptor related process,0.418\nimmunoglobulin receptor binding,receptor related process,0.456\nimmunoglobulin transcytosis in epithelial cells,transport,0.45\nimmunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor,immune system process,0.42\nimmunological memory formation process,immune system process,0.664\nimmunological memory process,immune system process,0.688\nimmunological synapse,immune system process,0.276\nimmunological synapse formation,immune system process,0.228\nimportin-alpha family protein binding,gene regulation,0.218\ninactive sex chromosome,cellular component organization,0.202\ninclusion body assembly,cellular component organization,0.812\nindanol dehydrogenase activity,metabolic process,0.934\nindolalkylamine biosynthetic process,metabolic process,0.952\nindolalkylamine metabolic process,metabolic process,0.938\nindole metabolic process,metabolic process,0.964\nindole-containing compound biosynthetic process,metabolic process,0.972\nindole-containing compound catabolic process,metabolic process,0.962\nindole-containing compound metabolic process,metabolic process,0.97\nindoleacetic acid metabolic process,metabolic process,0.982\n\"indoleamine 2,3-dioxygenase activity\",metabolic process,0.704\ninduced systemic resistance,immune system process,0.198\ninduction of bacterial agglutination,cellular component organization,0.174\ninduction of negative chemotaxis,transport,0.294\ninduction of positive chemotaxis,immune system process,0.258\ninduction of programmed cell death,cell death,0.392\ninduction of synaptic plasticity by chemical substance,metabolic process,0.29\ninductive cell-cell signaling,morphogenesis/development,0.274\ninferior colliculus development,morphogenesis/development,0.872\ninferior endocardial cushion morphogenesis,morphogenesis/development,0.604\ninflammasome-mediated signaling pathway,immune system process,0.236\ninflammatory response to wounding,metabolic process,0.408\ningression involved in gastrulation with mouth forming second,cellular component organization,0.196\ninhibin A complex,cellular component organization,0.434\ninhibin B complex,cellular component organization,0.45\ninhibin binding,metabolic process,0.238\ninhibin complex,cellular component organization,0.378\ninhibin-betaglycan-ActRII complex,receptor related process,0.332\ninhibition of cysteine-type endopeptidase activity,gene regulation,0.366\ninhibition of cysteine-type endopeptidase activity involved in apoptotic process,cell death,0.65\ninhibition of neuroepithelial cell differentiation,morphogenesis/development,0.78\ninhibition of non-skeletal tissue mineralization,cellular component organization,0.226\ninhibitory G protein-coupled receptor phosphorylation,receptor related process,0.312\ninhibitory MHC class I receptor activity,immune system process,0.46\ninhibitory MHC class Ib receptor activity,immune system process,0.362\ninhibitory chemical synaptic transmission,neural related process,0.33\ninhibitory extracellular ligand-gated monoatomic ion channel activity,transport,0.414\ninhibitory synapse,neural related process,0.482\ninhibitory synapse assembly,cellular component organization,0.488\ninitiation of movement involved in cerebral cortex radial glia guided migration,morphogenesis/development,0.216\ninitiation of neural tube closure,morphogenesis/development,0.166\ninitiation of primordial ovarian follicle growth,cell cycle,0.176\ninitiator methionyl aminopeptidase activity,metabolic process,0.486\ninnate immune response,immune system process,0.474\ninnate immune response in mucosa,immune system process,0.562\ninner acrosomal membrane,cellular component organization,0.298\ninner cell mass cell differentiation,morphogenesis/development,0.73\ninner cell mass cell fate commitment,morphogenesis/development,0.242\ninner cell mass cellular morphogenesis,morphogenesis/development,0.31\ninner dense plaque of desmosome,cellular component organization,0.432\ninner dynein arm,cellular component organization,0.398\ninner dynein arm assembly,cellular component organization,0.638\ninner ear auditory receptor cell differentiation,morphogenesis/development,0.622\ninner ear development,morphogenesis/development,0.848\ninner ear morphogenesis,morphogenesis/development,0.72\ninner ear receptor cell development,morphogenesis/development,0.742\ninner ear receptor cell differentiation,morphogenesis/development,0.64\ninner ear receptor cell fate commitment,morphogenesis/development,0.472\ninner ear receptor cell stereocilium organization,cellular component organization,0.658\ninner kinetochore,protein modification/signaling,0.22\ninner medullary collecting duct development,morphogenesis/development,0.994\ninner mitochondrial membrane protein complex,metabolic process,0.466\ninorganic anion import across plasma membrane,transport,0.908\ninorganic anion transmembrane transport,transport,0.918\ninorganic anion transmembrane transporter activity,transport,0.7\ninorganic cation import across plasma membrane,transport,0.916\ninorganic cation transmembrane transport,transport,0.812\ninorganic cation transmembrane transporter activity,transport,0.666\ninorganic diphosphate phosphatase activity,metabolic process,0.828\ninorganic diphosphate transmembrane transporter activity,cellular component organization,0.27\ninorganic diphosphate transport,transport,0.722\ninorganic ion homeostasis,other,0.554\ninorganic ion import across plasma membrane,transport,0.898\ninorganic ion transmembrane transport,transport,0.76\ninorganic molecular entity transmembrane transporter activity,transport,0.652\ninorganic phosphate transmembrane transporter activity,transport,0.628\ninorganic triphosphate phosphatase activity,metabolic process,0.812\ninosine biosynthetic process,metabolic process,0.938\ninosine catabolic process,metabolic process,0.854\ninosine metabolic process,metabolic process,0.96\ninosine transport,transport,0.72\n\"inositol 1,3,4,5 tetrakisphosphate binding\",metabolic process,0.24\n\"inositol 1,4,5 trisphosphate binding\",metabolic process,0.22\n\"inositol 1,4,5-trisphosphate receptor activity involved in regulation of postsynaptic cytosolic calcium levels\",receptor related process,0.308\n\"inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity\",transport,0.408\ninositol 5-diphosphate pentakisphosphate 5-kinase activity,metabolic process,0.796\ninositol biosynthetic process,metabolic process,0.818\ninositol bisdiphosphate tetrakisphosphate diphosphatase activity,metabolic process,0.85\ninositol bisphosphate phosphatase activity,metabolic process,0.76\ninositol catabolic process,metabolic process,0.826\ninositol diphosphate pentakisphosphate diphosphatase activity,metabolic process,0.848\ninositol diphosphate tetrakisphosphate diphosphatase activity,metabolic process,0.85\ninositol diphosphate tetrakisphosphate kinase activity,metabolic process,0.778\ninositol heptakisphosphate kinase activity,metabolic process,0.698\ninositol hexakisphosphate 1-kinase activity,metabolic process,0.796\ninositol hexakisphosphate 2-phosphatase activity,metabolic process,0.852\ninositol hexakisphosphate 3-kinase activity,metabolic process,0.796\ninositol hexakisphosphate 5-kinase activity,metabolic process,0.796\ninositol hexakisphosphate 6-kinase activity,metabolic process,0.796\ninositol hexakisphosphate binding,metabolic process,0.242\ninositol hexakisphosphate kinase activity,metabolic process,0.684\ninositol metabolic process,metabolic process,0.95\ninositol monophosphate 1-phosphatase activity,metabolic process,0.846\ninositol monophosphate 3-phosphatase activity,metabolic process,0.846\ninositol monophosphate 4-phosphatase activity,metabolic process,0.846\ninositol monophosphate phosphatase activity,metabolic process,0.782\ninositol oxygenase activity,metabolic process,0.9\ninositol pentakisphosphate 2-kinase activity,metabolic process,0.796\ninositol pentakisphosphate phosphatase activity,metabolic process,0.764\ninositol phosphate biosynthetic process,metabolic process,0.98\ninositol phosphate catabolic process,metabolic process,0.98\ninositol phosphate metabolic process,metabolic process,0.974\ninositol tetrakisphosphate 1-kinase activity,metabolic process,0.796\ninositol tetrakisphosphate 3-kinase activity,metabolic process,0.796\ninositol tetrakisphosphate 5-kinase activity,metabolic process,0.796\ninositol tetrakisphosphate 6-kinase activity,metabolic process,0.796\ninositol tetrakisphosphate kinase activity,metabolic process,0.732\ninositol tetrakisphosphate phosphatase activity,metabolic process,0.692\ninositol trisphosphate biosynthetic process,metabolic process,0.834\ninositol trisphosphate kinase activity,metabolic process,0.732\ninositol trisphosphate metabolic process,metabolic process,0.96\ninositol trisphosphate phosphatase activity,metabolic process,0.582\n\"inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity\",metabolic process,0.834\n\"inositol-1,3,4,5,6-pentakisphosphate kinase activity\",metabolic process,0.796\n\"inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity\",metabolic process,0.804\n\"inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity\",metabolic process,0.792\n\"inositol-1,3,4-trisphosphate 1-phosphatase activity\",metabolic process,0.834\n\"inositol-1,3,4-trisphosphate 4-phosphatase activity\",metabolic process,0.834\n\"inositol-1,3,4-trisphosphate 5-kinase activity\",metabolic process,0.796\n\"inositol-1,3,4-trisphosphate 6-kinase activity\",metabolic process,0.796\n\"inositol-1,4,5-trisphosphate 3-kinase activity\",metabolic process,0.796\n\"inositol-1,4,5-trisphosphate 5-phosphatase activity\",metabolic process,0.786\n\"inositol-1,4,5-trisphosphate 6-kinase activity\",metabolic process,0.796\n\"inositol-1,4-bisphosphate 1-phosphatase activity\",metabolic process,0.852\n\"inositol-3,4-bisphosphate 4-phosphatase activity\",metabolic process,0.832\n\"inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity\",metabolic process,0.852\ninositol-3-phosphate synthase activity,metabolic process,0.834\n\"inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity\",metabolic process,0.852\ninositol-hexakisphosphate phosphatase activity,metabolic process,0.798\ninositol-polyphosphate 5-phosphatase activity,metabolic process,0.758\ninsecticide metabolic process,metabolic process,0.888\ninsemination,metabolic process,0.198\ninsulin binding,metabolic process,0.264\ninsulin catabolic process,metabolic process,0.872\ninsulin metabolic process,metabolic process,0.892\ninsulin processing,morphogenesis/development,0.266\ninsulin receptor activity,receptor related process,0.338\ninsulin receptor binding,receptor related process,0.524\ninsulin receptor complex,receptor related process,0.334\ninsulin receptor internalization,transport,0.56\ninsulin receptor recycling,receptor related process,0.236\ninsulin receptor substrate binding,receptor related process,0.364\ninsulin secretion,transport,0.654\ninsulin secretion involved in cellular response to glucose stimulus,immune system process,0.182\ninsulin-like growth factor II binding,response to stimulus,0.274\ninsulin-like growth factor binary complex,protein modification/signaling,0.206\ninsulin-like growth factor binding,response to stimulus,0.184\ninsulin-like growth factor binding protein complex,protein modification/signaling,0.25\ninsulin-like growth factor receptor activity,receptor related process,0.382\ninsulin-like growth factor receptor binding,receptor related process,0.518\ninsulin-like growth factor ternary complex,cellular component organization,0.214\ninsulin-responsive compartment,cellular component organization,0.196\nintegrator complex,gene regulation,0.438\nintegrin activation,cellular component organization,0.33\nintegrin alpha1-beta1 complex,cellular component organization,0.42\nintegrin alpha10-beta1 complex,cellular component organization,0.418\nintegrin alpha11-beta1 complex,cellular component organization,0.418\nintegrin alpha2-beta1 complex,cellular component organization,0.406\nintegrin alpha3-beta1 complex,cellular component organization,0.412\nintegrin alpha4-beta1 complex,cellular component organization,0.41\nintegrin alpha4-beta7 complex,cellular component organization,0.422\nintegrin alpha5-beta1 complex,cellular component organization,0.394\nintegrin alpha6-beta4 complex,cellular component organization,0.41\nintegrin alpha7-beta1 complex,cellular component organization,0.418\nintegrin alpha8-beta1 complex,cellular component organization,0.416\nintegrin alphaIIb-beta3 complex,cellular component organization,0.422\nintegrin alphaL-beta2 complex,cellular component organization,0.414\nintegrin alphaM-beta2 complex,cellular component organization,0.408\nintegrin alphaX-beta2 complex,cellular component organization,0.414\nintegrin alphav-beta3 complex,cellular component organization,0.372\nintegrin alphav-beta5 complex,cellular component organization,0.4\nintegrin alphav-beta6 complex,cellular component organization,0.388\nintegrin alphav-beta8 complex,cellular component organization,0.398\nintegrin binding involved in cell-matrix adhesion,cell adhesion,0.212\nintegrin biosynthetic process,metabolic process,0.842\nintegrin complex,receptor related process,0.306\nintein-mediated protein splicing,protein modification/signaling,0.486\ninter-Golgi cisterna vesicle-mediated transport,transport,0.386\ninter-male aggressive behavior,cellular component organization,0.244\nintercellular bridge,cellular component organization,0.254\nintercellular bridge organization,cellular component organization,0.718\nintercellular canaliculus,cellular component organization,0.204\nintercellular transport,transport,0.842\ninterchromatin granule,gene regulation,0.312\ninterferon binding,immune system process,0.43\ninterferon receptor activity,receptor related process,0.402\ninterkinetic nuclear migration,transport,0.196\ninterleukin-1 alpha production,immune system process,0.56\ninterleukin-1 binding,receptor related process,0.352\ninterleukin-1 receptor activity,immune system process,0.418\ninterleukin-1 receptor antagonist activity,receptor related process,0.432\ninterleukin-1 receptor binding,receptor related process,0.446\ninterleukin-1 type I receptor antagonist activity,receptor related process,0.5\ninterleukin-1 type II receptor antagonist activity,receptor related process,0.5\n\"interleukin-1, type I receptor binding\",receptor related process,0.502\n\"interleukin-1, type I, activating receptor activity\",protein modification/signaling,0.33\n\"interleukin-1, type II receptor binding\",receptor related process,0.512\n\"interleukin-1, type II, blocking receptor activity\",receptor related process,0.338\ninterleukin-10 binding,metabolic process,0.244\ninterleukin-10 receptor activity,receptor related process,0.218\ninterleukin-10 receptor binding,receptor related process,0.516\ninterleukin-10-mediated signaling pathway,receptor related process,0.59\ninterleukin-11 binding,metabolic process,0.236\ninterleukin-11 receptor activity,receptor related process,0.21\ninterleukin-11 receptor binding,receptor related process,0.524\ninterleukin-11-mediated signaling pathway,receptor related process,0.542\ninterleukin-12 alpha subunit binding,gene regulation,0.206\ninterleukin-12 beta subunit binding,metabolic process,0.214\ninterleukin-12 binding,protein modification/signaling,0.3\ninterleukin-12 complex,immune system process,0.312\ninterleukin-12 receptor activity,receptor related process,0.202\ninterleukin-12 receptor binding,receptor related process,0.468\ninterleukin-12 receptor complex,receptor related process,0.334\ninterleukin-12-mediated signaling pathway,receptor related process,0.498\ninterleukin-13 receptor binding,receptor related process,0.522\ninterleukin-13 receptor complex,receptor related process,0.4\ninterleukin-13-mediated signaling pathway,receptor related process,0.584\ninterleukin-15 production,immune system process,0.572\ninterleukin-15 receptor activity,receptor related process,0.212\ninterleukin-15 receptor binding,receptor related process,0.516\ninterleukin-15-mediated signaling pathway,receptor related process,0.52\ninterleukin-16 binding,metabolic process,0.244\ninterleukin-16 production,immune system process,0.568\ninterleukin-16 receptor activity,receptor related process,0.214\ninterleukin-17 binding,immune system process,0.312\ninterleukin-17 receptor activity,immune system process,0.422\ninterleukin-17-mediated signaling pathway,receptor related process,0.544\ninterleukin-17A production,immune system process,0.558\ninterleukin-17A-mediated signaling pathway,receptor related process,0.576\ninterleukin-17E receptor binding,receptor related process,0.524\ninterleukin-18 binding,metabolic process,0.242\ninterleukin-18 production,immune system process,0.612\ninterleukin-18 receptor activity,receptor related process,0.208\ninterleukin-18 receptor binding,receptor related process,0.504\ninterleukin-18 receptor complex,cellular component organization,0.25\ninterleukin-18-mediated signaling pathway,receptor related process,0.536\ninterleukin-2 binding,metabolic process,0.236\ninterleukin-2 receptor activity,receptor related process,0.208\ninterleukin-2 receptor binding,receptor related process,0.496\ninterleukin-2 receptor complex,cellular component organization,0.252\ninterleukin-2-mediated signaling pathway,receptor related process,0.514\ninterleukin-20 binding,metabolic process,0.236\ninterleukin-20 receptor binding,receptor related process,0.508\ninterleukin-21 production,immune system process,0.562\ninterleukin-21 receptor activity,receptor related process,0.214\ninterleukin-21-mediated signaling pathway,receptor related process,0.606\ninterleukin-22 binding,metabolic process,0.244\ninterleukin-22 receptor activity,receptor related process,0.214\ninterleukin-22 receptor binding,receptor related process,0.508\ninterleukin-22-mediated signaling pathway,receptor related process,0.626\ninterleukin-23 binding,metabolic process,0.218\ninterleukin-23 complex,immune system process,0.328\ninterleukin-23 production,immune system process,0.658\ninterleukin-23 receptor activity,receptor related process,0.2\ninterleukin-23 receptor binding,receptor related process,0.468\ninterleukin-23 receptor complex,receptor related process,0.334\ninterleukin-23-mediated signaling pathway,receptor related process,0.562\ninterleukin-27 binding,metabolic process,0.242\ninterleukin-27 receptor activity,receptor related process,0.212\ninterleukin-27 receptor binding,receptor related process,0.508\ninterleukin-27-mediated signaling pathway,immune system process,0.552\ninterleukin-28 receptor binding,receptor related process,0.514\ninterleukin-28 receptor complex,receptor related process,0.384\ninterleukin-3 production,immune system process,0.614\ninterleukin-3 receptor activity,receptor related process,0.214\ninterleukin-3 receptor binding,receptor related process,0.52\ninterleukin-3-mediated signaling pathway,receptor related process,0.576\ninterleukin-33 binding,metabolic process,0.232\ninterleukin-33 production,immune system process,0.556\ninterleukin-33 receptor activity,receptor related process,0.208\ninterleukin-33 receptor binding,receptor related process,0.49\ninterleukin-33-mediated signaling pathway,receptor related process,0.582\ninterleukin-34-mediated signaling pathway,receptor related process,0.592\ninterleukin-35-mediated signaling pathway,immune system process,0.514\ninterleukin-4 receptor activity,receptor related process,0.21\ninterleukin-4 receptor binding,receptor related process,0.52\ninterleukin-4-dependent isotype switching to IgE isotypes,immune system process,0.222\ninterleukin-4-mediated signaling pathway,receptor related process,0.506\ninterleukin-5 receptor activity,receptor related process,0.214\ninterleukin-5 receptor binding,receptor related process,0.526\ninterleukin-5 receptor complex,receptor related process,0.362\ninterleukin-5-mediated signaling pathway,receptor related process,0.58\ninterleukin-6 binding,metabolic process,0.236\ninterleukin-6 receptor activity,receptor related process,0.21\ninterleukin-6 receptor binding,receptor related process,0.478\ninterleukin-6 receptor complex,receptor related process,0.27\ninterleukin-7 receptor activity,receptor related process,0.212\ninterleukin-7 receptor binding,receptor related process,0.516\ninterleukin-7-mediated signaling pathway,receptor related process,0.59\ninterleukin-8 binding,metabolic process,0.242\ninterleukin-8 receptor activity,receptor related process,0.214\ninterleukin-8 receptor binding,immune system process,0.382\ninterleukin-8-mediated signaling pathway,receptor related process,0.604\ninterleukin-9 binding,metabolic process,0.244\ninterleukin-9 receptor activity,receptor related process,0.214\ninterleukin-9 receptor binding,receptor related process,0.524\ninterleukin-9-mediated signaling pathway,receptor related process,0.542\nintermediate filament,cellular component organization,0.35\nintermediate filament binding,cellular component organization,0.296\nintermediate filament bundle assembly,cellular component organization,0.78\nintermediate filament cytoskeleton,cellular component organization,0.474\nintermediate filament depolymerization,cellular component organization,0.494\nintermediate filament polymerization,cellular component organization,0.466\nintermediate filament polymerization or depolymerization,cellular component organization,0.872\nintermediate filament-based process,cellular component organization,0.398\nintermediate mesoderm development,morphogenesis/development,0.982\nintermediate mesoderm formation,morphogenesis/development,0.482\nintermediate mesoderm morphogenesis,morphogenesis/development,0.766\nintermediate mesodermal cell differentiation,morphogenesis/development,0.688\nintermediate-density lipoprotein particle,receptor related process,0.414\nintermediate-density lipoprotein particle clearance,cellular component organization,0.264\nintermediate-density lipoprotein particle remodeling,protein modification/signaling,0.27\nintermembrane lipid transfer,transport,0.422\nintermembrane sphingolipid transfer,cellular component organization,0.232\nintermicrovillar adhesion,cell adhesion,0.276\ninternal peptidyl-lysine acetylation,protein modification/signaling,0.596\ninternal protein amino acid acetylation,protein modification/signaling,0.626\ninterneuron axon guidance,neural related process,0.404\ninterneuron migration,neural related process,0.39\ninterneuron migration from the subpallium to the cortex,transport,0.236\ninternode region of axon,cellular component organization,0.23\ninterphase microtubule organizing center,cellular component organization,0.332\ninterphotoreceptor matrix,cellular component organization,0.198\ninterstitial matrix,cellular component organization,0.224\nintestinal D-glucose absorption,cellular component organization,0.29\nintestinal absorption,transport,0.428\nintestinal cholesterol absorption,metabolic process,0.208\nintestinal epithelial cell maturation,morphogenesis/development,0.61\nintestinal epithelial cell migration,multicellular organismal process,0.314\nintestinal epithelial structure maintenance,morphogenesis/development,0.276\nintestinal folate absorption,cellular component organization,0.2\nintestinal hexose absorption,transport,0.47\nintestinal lipid absorption,transport,0.51\nintestinal lipid catabolic process,metabolic process,0.858\nintestinal motility,multicellular organismal process,0.474\nintestinal phytosterol absorption,morphogenesis/development,0.212\nintestinal stem cell homeostasis,cell cycle,0.248\nintestine smooth muscle contraction,cellular component organization,0.156\nintracellular amino acid homeostasis,other,0.372\nintracellular anatomical structure,metabolic process,0.356\nintracellular bile acid receptor signaling pathway,receptor related process,0.508\nintracellular cAMP-activated cation channel activity,transport,0.486\nintracellular cAMP-activated cation channel activity involved in regulation of presynaptic membrane potential,cellular component organization,0.396\nintracellular cGMP-activated cation channel activity,cellular component organization,0.342\nintracellular calcium activated chloride channel activity,metabolic process,0.242\nintracellular calcium ion homeostasis,other,0.65\nintracellular canaliculus,cellular component organization,0.324\nintracellular chemical homeostasis,other,0.652\nintracellular chloride channel activity,transport,0.508\nintracellular chloride ion homeostasis,other,0.464\nintracellular copper ion homeostasis,other,0.54\nintracellular cyclic nucleotide activated cation channel complex,cellular component organization,0.238\nintracellular distribution of mitochondria,cellular component organization,0.246\nintracellular estrogen receptor signaling pathway,receptor related process,0.59\nintracellular ferritin complex,cellular component organization,0.346\nintracellular glucose homeostasis,metabolic process,0.232\nintracellular glutamate homeostasis,other,0.382\nintracellular ligand-gated monoatomic ion channel activity,transport,0.416\nintracellular mRNA localization,transport,0.334\nintracellular magnesium ion homeostasis,other,0.432\nintracellular manganese ion homeostasis,other,0.442\nintracellular membrane-bounded organelle,metabolic process,0.322\nintracellular monoatomic anion homeostasis,other,0.464\nintracellular monoatomic cation homeostasis,other,0.688\nintracellular monoatomic ion homeostasis,other,0.696\nintracellular nitric oxide homeostasis,other,0.366\nintracellular nitrogen homeostasis,other,0.342\nintracellular non-membrane-bounded organelle,cellular component organization,0.324\nintracellular organelle,metabolic process,0.346\nintracellular organelle lumen,metabolic process,0.212\nintracellular oxygen homeostasis,other,0.366\nintracellular pH elevation,other,0.272\nintracellular pH reduction,other,0.312\nintracellular phosphate ion homeostasis,other,0.47\n\"intracellular phosphatidylinositol-3,5-bisphosphate-sensitive monatomic cation channel activity\",cellular component organization,0.34\nintracellular potassium ion homeostasis,other,0.576\nintracellular sequestering of iron ion,cellular component organization,0.236\nintracellular signal transduction,protein modification/signaling,0.274\nintracellular sphingolipid homeostasis,other,0.39\nintracellular transport,transport,0.602\nintracellular transport of viral protein in host cell,transport,0.386\nintracellular transport of virus,transport,0.442\nintracellular triglyceride homeostasis,other,0.378\nintracellular vesicle,ER/endosome/lysosome related process,0.222\nintracellular water homeostasis,other,0.392\nintracellular zinc ion homeostasis,other,0.452\nintracellularly ATP-gated chloride channel activity,cellular component organization,0.434\nintracellularly ATP-gated ion channel activity,transport,0.524\nintraciliary anterograde transport,transport,0.398\nintraciliary retrograde transport,transport,0.388\nintraciliary transport involved in cilium assembly,cellular component organization,0.36\nintraciliary transport particle,cellular component organization,0.288\nintraciliary transport particle A,cellular component organization,0.242\nintraciliary transport particle A binding,metabolic process,0.184\nintraciliary transport particle B,cellular component organization,0.256\nintraciliary transport particle B binding,transport,0.186\nintrahepatic bile duct development,morphogenesis/development,0.842\nintralumenal vesicle formation,cellular component organization,0.254\nintramanchette transport,cellular component organization,0.31\nintramembrane lipid transporter activity,transport,0.484\nintramembranous ossification,multicellular organismal process,0.402\nintramolecular lyase activity,metabolic process,0.812\nintramolecular oxidoreductase activity,metabolic process,0.804\n\"intramolecular oxidoreductase activity, interconverting aldoses and ketoses\",metabolic process,0.826\n\"intramolecular oxidoreductase activity, interconverting keto- and enol-groups\",metabolic process,0.818\n\"intramolecular oxidoreductase activity, transposing C=C bonds\",metabolic process,0.82\n\"intramolecular oxidoreductase activity, transposing S-S bonds\",metabolic process,0.67\nintramolecular transferase activity,metabolic process,0.888\nintrinsic apoptotic signaling pathway in response to hydrogen peroxide,cell death,0.404\nintrinsic apoptotic signaling pathway in response to hypoxia,cell death,0.556\nintrinsic apoptotic signaling pathway in response to nitrosative stress,cell death,0.302\nintrinsic apoptotic signaling pathway in response to osmotic stress,cell death,0.478\nintrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,cell death,0.604\nintronic transcription regulatory region sequence-specific DNA binding,gene regulation,0.728\nintussusceptive angiogenesis,morphogenesis/development,0.234\ninvoluntary skeletal muscle contraction,multicellular organismal process,0.618\ninward rectifier potassium channel activity,transport,0.554\ninward rectifier potassium channel complex,transport,0.28\ninward rectifier potassium channel inhibitor activity,metabolic process,0.27\ninward rectifying potassium channel,receptor related process,0.342\niodide peroxidase activity,metabolic process,0.9\niodide transmembrane transport,transport,0.272\niodide transmembrane transporter activity,transport,0.64\niodide transport,transport,0.98\niodotyrosine deiodinase activity,metabolic process,0.602\nion binding,other,0.286\nion channel inhibitor activity,metabolic process,0.356\n\"ion channel modulating, G protein-coupled receptor signaling pathway\",receptor related process,0.642\nion channel regulator activity,transport,0.2\nionotropic glutamate receptor activity,metabolic process,0.23\nionotropic glutamate receptor binding,receptor related process,0.354\nionotropic glutamate receptor complex,cellular component organization,0.236\nionotropic glutamate receptor signaling pathway,receptor related process,0.58\niris morphogenesis,morphogenesis/development,0.728\niron chaperone activity,transport,0.282\niron import into cell,transport,0.764\niron import into the mitochondrion,transport,0.196\niron incorporation into metallo-sulfur cluster,protein modification/signaling,0.3\niron ion binding,metabolic process,0.22\niron ion export across plasma membrane,transport,0.484\niron ion import across plasma membrane,transport,0.802\niron ion sequestering activity,transport,0.238\niron ion transmembrane transporter activity,transport,0.614\niron-responsive element binding,protein modification/signaling,0.31\niron-sulfur cluster assembly complex,cellular component organization,0.396\niron-sulfur cluster binding,metabolic process,0.778\niron-sulfur cluster export from the mitochondrion,transport,0.376\niron-sulfur cluster transmembrane transport,transport,0.874\nislet amyloid polypeptide processing,morphogenesis/development,0.392\nisoamylase complex,metabolic process,0.302\nisobutyryl-CoA:FAD oxidoreductase activity,metabolic process,0.896\nisocitrate dehydrogenase (NAD+) activity,metabolic process,0.928\nisocitrate dehydrogenase (NADP+) activity,metabolic process,0.932\nisocitrate dehydrogenase [NAD(P)+] activity,metabolic process,0.98\nisocitrate dehydrogenase complex (NAD+),metabolic process,0.54\nisocitrate metabolic process,metabolic process,0.746\nisoleucine biosynthetic process,metabolic process,0.996\nisoleucine catabolic process,metabolic process,0.898\nisoleucine metabolic process,metabolic process,0.994\nisoleucine transmembrane transport,transport,0.85\nisoleucine transport,transport,0.954\nisoleucine-tRNA ligase activity,metabolic process,0.822\nisoleucyl-tRNA aminoacylation,metabolic process,0.552\nisopentenyl diphosphate biosynthetic process,metabolic process,0.992\n\"isopentenyl diphosphate biosynthetic process, mevalonate pathway\",metabolic process,0.988\nisopentenyl diphosphate metabolic process,metabolic process,0.966\nisopentenyl-diphosphate delta-isomerase activity,metabolic process,0.874\nisopeptide cross-linking,protein modification/signaling,0.512\nisopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine,cellular component organization,0.246\nisoprenoid binding,metabolic process,0.294\nisoprenoid biosynthetic process via mevalonate,metabolic process,0.976\nisoprenoid catabolic process,metabolic process,0.994\nisoprenoid diphosphate phosphatase activity,metabolic process,0.536\nisoprenoid transport,transport,0.926\nisoquinoline alkaloid metabolic process,metabolic process,0.942\nisotype switching,immune system process,0.756\nisotype switching to IgA isotypes,immune system process,0.216\nisotype switching to IgE isotypes,immune system process,0.656\nisotype switching to IgG isotypes,immune system process,0.422\nisoursodeoxycholate 7-beta-dehydrogenase (NAD+) activity,metabolic process,0.928\nisovaleryl-CoA dehydrogenase activity,metabolic process,0.92\nitaconyl-CoA hydratase activity,metabolic process,0.9\njump response,multicellular organismal process,0.334\njunctional membrane complex,cellular component organization,0.41\njunctional sarcoplasmic reticulum membrane,cellular component organization,0.338\njuxtaglomerular apparatus development,morphogenesis/development,0.976\njuxtaparanode region of axon,neural related process,0.314\nkainate selective glutamate receptor activity,receptor related process,0.344\nkainate selective glutamate receptor complex,cellular component organization,0.28\nkappa-type opioid receptor binding,receptor related process,0.488\nkaryogamy,cellular component organization,0.782\nkatanin complex,cellular component organization,0.316\nkeratan sulfate biosynthetic process,metabolic process,0.862\nkeratan sulfate catabolic process,metabolic process,0.858\nkeratan sulfate metabolic process,metabolic process,0.962\nkeratan sulfotransferase activity,metabolic process,0.898\nkeratin filament,cellular component organization,0.188\nkeratin filament binding,metabolic process,0.188\nkeratinization,morphogenesis/development,0.232\nkeratinocyte activation,immune system process,0.168\nkeratinocyte apoptotic process,cell death,0.578\nkeratinocyte development,morphogenesis/development,0.988\nkeratinocyte migration,transport,0.358\nkeratohyalin granule,cellular component organization,0.298\nketohexokinase activity,metabolic process,0.796\nketone biosynthetic process,metabolic process,0.98\nketone body biosynthetic process,metabolic process,0.978\nketone body catabolic process,metabolic process,0.962\nketone body metabolic process,metabolic process,0.946\nketoreductase activity,metabolic process,0.844\nketosteroid monooxygenase activity,metabolic process,0.936\nkidney field specification,multicellular organismal process,0.402\nkidney interstitial fibroblast differentiation,morphogenesis/development,0.924\nkidney mesenchymal cell proliferation,cell cycle,0.828\nkidney mesenchyme morphogenesis,morphogenesis/development,0.878\nkidney morphogenesis,morphogenesis/development,0.854\nkidney rudiment formation,morphogenesis/development,0.768\nkidney smooth muscle cell differentiation,morphogenesis/development,0.658\nkidney smooth muscle tissue development,morphogenesis/development,0.984\nkidney vasculature morphogenesis,morphogenesis/development,0.918\nkilling by host of symbiont cells,immune system process,0.412\nkilling of cells of another organism,immune system process,0.272\nkinase activator activity,protein modification/signaling,0.726\nkinesin I complex,cellular component organization,0.372\nkinesin II complex,cellular component organization,0.352\nkinesin binding,cellular component organization,0.248\nkinesin complex,gene regulation,0.244\nkinetochore,cell cycle,0.628\nkinetochore adaptor activity,protein modification/signaling,0.278\nkinetochore assembly,cellular component organization,0.524\nkinetochore binding,cellular component organization,0.248\nkinetochore microtubule,cellular component organization,0.41\nkinin cascade,metabolic process,0.272\nkininogen binding,protein modification/signaling,0.424\nkinociliary basal body,gene regulation,0.216\nkinocilium,receptor related process,0.286\nkisspeptin receptor binding,receptor related process,0.502\nkringle domain binding,protein modification/signaling,0.25\nkynurenic acid biosynthetic process,metabolic process,0.882\nkynurenic acid metabolic process,metabolic process,0.978\nkynureninase activity,metabolic process,0.898\nkynurenine 3-monooxygenase activity,metabolic process,0.934\nkynurenine aminotransferase activity,metabolic process,0.878\nkynurenine metabolic process,metabolic process,0.984\nkynurenine-glyoxylate transaminase activity,metabolic process,0.896\nkynurenine-oxoglutarate transaminase activity,metabolic process,0.896\nlabyrinthine layer blood vessel development,morphogenesis/development,0.976\nlabyrinthine layer development,morphogenesis/development,0.854\nlacrimal gland development,morphogenesis/development,0.982\nlactam catabolic process,metabolic process,0.91\nlactam metabolic process,metabolic process,0.932\nlactase activity,metabolic process,0.9\nlactate biosynthetic process,metabolic process,0.952\nlactate biosynthetic process from pyruvate,metabolic process,0.984\nlactate catabolic process,metabolic process,0.978\nlactate dehydrogenase activity,metabolic process,0.93\nlactate metabolic process,metabolic process,0.984\nlactate oxidation,metabolic process,0.856\nlactate transmembrane transport,transport,0.734\nlactate transmembrane transporter activity,transport,0.648\nlactate transport,transport,0.93\nlactate:proton symporter activity,metabolic process,0.522\nlactone biosynthetic process,metabolic process,0.972\nlactone metabolic process,metabolic process,0.972\nlactonohydrolase activity,metabolic process,0.654\nlactoperoxidase activity,metabolic process,0.9\nlactose binding,metabolic process,0.278\nlactose biosynthetic process,metabolic process,0.89\nlactose catabolic process,metabolic process,0.974\nlactose metabolic process,metabolic process,0.97\nlactose synthase activity,metabolic process,0.886\n\"lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity\",metabolic process,0.896\nlactosylceramide 4-alpha-galactosyltransferase activity,metabolic process,0.896\n\"lactosylceramide alpha-2,3-sialyltransferase activity\",metabolic process,0.894\nlactosylceramide biosynthetic process,metabolic process,0.884\nlactosylceramide metabolic process,metabolic process,0.944\nlactoylglutathione lyase activity,metabolic process,0.896\nlagging strand elongation,cell cycle,0.552\nlambdoid suture morphogenesis,morphogenesis/development,0.45\nlamellar body,cellular component organization,0.484\nlamellar body membrane,cellular component organization,0.528\nlamellipodium assembly,cellular component organization,0.888\nlamellipodium assembly involved in ameboidal cell migration,cellular component organization,0.6\nlamellipodium membrane,cellular component organization,0.384\nlamellipodium morphogenesis,morphogenesis/development,0.31\nlamin binding,protein modification/signaling,0.274\nlamin filament,protein modification/signaling,0.314\nlaminin complex,cellular component organization,0.452\nlaminin receptor activity,cellular component organization,0.25\nlaminin-1 binding,cellular component organization,0.192\nlaminin-1 complex,cellular component organization,0.368\nlaminin-10 complex,cellular component organization,0.37\nlaminin-11 complex,cellular component organization,0.37\nlaminin-2 complex,cellular component organization,0.372\nlaminin-3 complex,cellular component organization,0.372\nlaminin-5 complex,cellular component organization,0.374\nlaminin-8 complex,cellular component organization,0.372\nlanosterol synthase activity,metabolic process,0.862\nlarge conductance calcium-activated potassium channel activity,transport,0.22\nlarge intestinal transit,cellular component organization,0.26\nlarge ribosomal subunit,cellular component organization,0.488\nlarge ribosomal subunit rRNA binding,gene regulation,0.712\nlarynx development,morphogenesis/development,0.774\nlarynx morphogenesis,morphogenesis/development,0.272\nlate endosomal microautophagy,protein modification/signaling,0.21\nlate endosome lumen,cellular component organization,0.638\nlate endosome membrane,cellular component organization,0.512\nlate endosome to Golgi transport,transport,0.35\nlate endosome to lysosome transport,transport,0.492\nlate endosome to lysosome transport via multivesicular body sorting pathway,transport,0.314\nlate endosome to vacuole transport via multivesicular body sorting pathway,transport,0.48\nlate recombination nodule,cellular component organization,0.278\nlate viral transcription,gene regulation,0.286\nlatent virus replication,cellular component organization,0.182\nlateral attachment of mitotic spindle microtubules to kinetochore,cell cycle,0.346\nlateral cell cortex,cellular component organization,0.302\nlateral element,metabolic process,0.196\nlateral element assembly,cellular component organization,0.284\nlateral ganglionic eminence cell proliferation,cell cycle,0.796\nlateral geniculate nucleus development,morphogenesis/development,0.742\nlateral inhibition,morphogenesis/development,0.464\nlateral line development,morphogenesis/development,0.916\nlateral line nerve development,morphogenesis/development,0.936\nlateral line system development,morphogenesis/development,0.866\nlateral loop,cellular component organization,0.274\nlateral mesoderm development,morphogenesis/development,0.98\nlateral mesoderm formation,morphogenesis/development,0.42\nlateral mesoderm morphogenesis,morphogenesis/development,0.752\nlateral mesodermal cell differentiation,morphogenesis/development,0.698\nlateral mesodermal cell fate commitment,morphogenesis/development,0.216\nlateral mesodermal cell fate specification,morphogenesis/development,0.526\nlateral motor column neuron migration,neural related process,0.266\nlateral part of cell,cellular component organization,0.408\nlateral semicircular canal development,morphogenesis/development,0.498\nlateral sprouting from an epithelium,morphogenesis/development,0.906\nlateral sprouting involved in lung morphogenesis,morphogenesis/development,0.242\nlateral sprouting involved in mammary gland duct morphogenesis,morphogenesis/development,0.26\nlateral ventricle development,morphogenesis/development,0.934\nlateral wall of outer hair cell,cellular component organization,0.358\nlatrotoxin receptor activity,receptor related process,0.208\nlauric acid metabolic process,metabolic process,0.878\nlayer formation in cerebral cortex,morphogenesis/development,0.356\nlead ion binding,metabolic process,0.23\nlead ion transmembrane transporter activity,cellular component organization,0.25\nlead ion transport,transport,0.73\nleading edge cell differentiation,morphogenesis/development,0.902\nleading edge membrane,cellular component organization,0.512\nleading edge of lamellipodium,cellular component organization,0.31\nleading strand elongation,cell cycle,0.606\nleak channel activity,transport,0.524\nlearned vocalization behavior,cellular component organization,0.202\nlearned vocalization behavior or vocal learning,multicellular organismal process,0.438\nlecithin:11-cis retinol acyltransferase activity,metabolic process,0.696\nleft lung development,morphogenesis/development,0.896\nleft lung morphogenesis,morphogenesis/development,0.758\nleft ventricular cardiac muscle tissue morphogenesis,morphogenesis/development,0.894\nleft-handed Z-DNA binding,metabolic process,0.242\nleft/right axis specification,morphogenesis/development,0.386\nleft/right pattern formation,morphogenesis/development,0.572\nlens epithelial cell proliferation,cell cycle,0.78\nlens fiber cell apoptotic process,morphogenesis/development,0.254\nlens fiber cell development,morphogenesis/development,0.946\nlens fiber cell morphogenesis,morphogenesis/development,0.71\nlens induction in camera-type eye,morphogenesis/development,0.226\nlens morphogenesis in camera-type eye,morphogenesis/development,0.82\nlens placode formation,morphogenesis/development,0.872\nlens placode formation involved in camera-type eye formation,morphogenesis/development,0.28\nleptin receptor activity,receptor related process,0.2\nleptin receptor binding,receptor related process,0.512\nleptin-mediated signaling pathway,receptor related process,0.6\nleptomycin B binding,metabolic process,0.244\nleucine binding,metabolic process,0.312\nleucine biosynthetic process,metabolic process,0.996\nleucine catabolic process,metabolic process,0.992\nleucine import across plasma membrane,transport,0.856\nleucine metabolic process,metabolic process,0.994\nleucine transport,transport,0.956\nleucine zipper domain binding,protein modification/signaling,0.322\nleucine-tRNA ligase activity,metabolic process,0.822\nleucyl-tRNA aminoacylation,metabolic process,0.562\nleukemia inhibitory factor receptor activity,receptor related process,0.23\nleukemia inhibitory factor receptor binding,receptor related process,0.526\nleukemia inhibitory factor signaling pathway,receptor related process,0.666\nleukocyte activation,immune system process,0.836\nleukocyte adhesion to arterial endothelial cell,immune system process,0.382\nleukocyte adhesive activation,immune system process,0.342\nleukocyte aggregation,immune system process,0.35\nleukocyte chemotaxis involved in inflammatory response,immune system process,0.614\nleukocyte migration involved in immune response,immune system process,0.776\nleukocyte migration involved in inflammatory response,immune system process,0.774\nleukotriene A4 biosynthetic process,metabolic process,0.876\nleukotriene A4 metabolic process,metabolic process,0.976\nleukotriene B4 12-hydroxy dehydrogenase activity,metabolic process,0.934\nleukotriene B4 catabolic process,metabolic process,0.894\nleukotriene B4 metabolic process,metabolic process,0.932\nleukotriene B4 receptor activity,cellular component organization,0.182\nleukotriene C4 gamma-glutamyl transferase activity,metabolic process,0.866\nleukotriene D4 biosynthetic process,metabolic process,0.886\nleukotriene D4 catabolic process,metabolic process,0.888\nleukotriene D4 metabolic process,metabolic process,0.966\nleukotriene biosynthetic process,metabolic process,0.814\nleukotriene catabolic process,metabolic process,0.928\nleukotriene production involved in inflammatory response,immune system process,0.558\nleukotriene receptor activity,receptor related process,0.504\nleukotriene signaling pathway,receptor related process,0.662\nleukotriene transport,transport,0.926\nleukotriene-A4 hydrolase activity,metabolic process,0.838\nleukotriene-B4 20-monooxygenase activity,metabolic process,0.922\nleukotriene-C(4) hydrolase,metabolic process,0.9\nleukotriene-C4 synthase activity,metabolic process,0.912\nligamentous ossification,cellular component organization,0.19\nligand-gated calcium channel activity,transport,0.448\nligand-gated channel activity,transport,0.382\nligand-gated ion channel signaling pathway,receptor related process,0.458\nligand-gated monoatomic anion channel activity,transport,0.472\nligand-gated monoatomic cation channel activity,transport,0.444\nligand-gated monoatomic ion channel activity,transport,0.45\nligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential,cellular component organization,0.26\nligand-gated sodium channel activity,transport,0.406\nligase activity,metabolic process,0.698\n\"ligase activity, forming carbon-carbon bonds\",metabolic process,0.682\n\"ligase activity, forming carbon-oxygen bonds\",metabolic process,0.622\n\"ligase activity, forming carbon-sulfur bonds\",metabolic process,0.708\n\"ligase activity, forming phosphoric ester bonds\",metabolic process,0.508\nligase regulator activity,metabolic process,0.438\nlight absorption,cellular component organization,0.238\nlight adaption,cellular component organization,0.246\nlimb bud formation,morphogenesis/development,0.338\nlimb epidermis development,morphogenesis/development,0.976\nlimb joint morphogenesis,morphogenesis/development,0.79\nlimbic system development,morphogenesis/development,0.686\nlimonene monooxygenase activity,metabolic process,0.894\nlinear malto-oligosaccharide phosphorylase activity,metabolic process,0.898\nlinear polyubiquitin binding,metabolic process,0.266\nlinear vestibuloocular reflex,receptor related process,0.348\nlinoleate 13S-lipoxygenase activity,metabolic process,0.876\nlinoleate 9S-lipoxygenase activity,metabolic process,0.892\nlinoleic acid binding,metabolic process,0.334\nlinoleic acid epoxygenase activity,metabolic process,0.89\nlinoleic acid metabolic process,metabolic process,0.826\nlinoleoyl-CoA desaturase activity,metabolic process,0.86\nlipase activator activity,metabolic process,0.516\nlipase activity,metabolic process,0.65\nlipase binding,metabolic process,0.23\nlipid antigen binding,metabolic process,0.23\nlipid biosynthetic process,metabolic process,0.916\nlipid catabolic process,metabolic process,0.938\nlipid digestion,cellular component organization,0.206\nlipid droplet disassembly,cellular component organization,0.49\nlipid droplet formation,cellular component organization,0.616\nlipid droplet fusion,cellular component organization,0.236\nlipid glycosylation,protein modification/signaling,0.2\nlipid hydroperoxide transport,transport,0.736\nlipid hydroxylation,metabolic process,0.41\nlipid import into cell,transport,0.862\nlipid kinase activity,metabolic process,0.612\nlipid metabolic process,metabolic process,0.81\nlipid modification,metabolic process,0.56\nlipid modification by small protein conjugation,metabolic process,0.364\nlipid oxidation,metabolic process,0.664\nlipid phosphatase activity,metabolic process,0.756\nlipid sensor activity,metabolic process,0.318\nlipid transfer activity,transport,0.362\nlipid translocation,transport,0.458\nlipid transport across blood-brain barrier,transport,0.356\nlipid transport involved in lipid storage,transport,0.792\nlipid transporter activity,transport,0.824\nlipid tube,protein modification/signaling,0.28\nlipid tube assembly,cellular component organization,0.85\nlipid tube assembly involved in organelle fusion,cellular component organization,0.568\nlipid ubiquitination,metabolic process,0.266\nlipoamidase activity,metabolic process,0.406\nlipoate biosynthetic process,metabolic process,0.904\nlipoate metabolic process,metabolic process,0.976\nlipoate synthase activity,metabolic process,0.642\nlipoic acid binding,metabolic process,0.366\nlipopeptide binding,metabolic process,0.302\nlipophagy,cellular component organization,0.244\nlipopolysaccharide binding,immune system process,0.19\nlipopolysaccharide catabolic process,metabolic process,0.558\nlipopolysaccharide immune receptor activity,immune system process,0.44\nlipopolysaccharide metabolic process,metabolic process,0.824\nlipopolysaccharide receptor complex,immune system process,0.346\nlipopolysaccharide transport,transport,0.482\nlipoprotein catabolic process,metabolic process,0.926\nlipoprotein lipase activator activity,metabolic process,0.376\nlipoprotein lipase activity,metabolic process,0.824\nlipoprotein lipid oxidation,metabolic process,0.344\nlipoprotein localization,transport,0.558\nlipoprotein localization to membrane,transport,0.602\nlipoprotein modification,metabolic process,0.756\nlipoprotein oxidation,protein modification/signaling,0.532\nlipoprotein particle,cellular component organization,0.232\nlipoprotein particle binding,protein modification/signaling,0.272\nlipoprotein particle mediated signaling,protein modification/signaling,0.314\nlipoprotein particle receptor activity,receptor related process,0.32\nlipoprotein transport,transport,0.666\nliposaccharide metabolic process,metabolic process,0.874\nlipoteichoic acid binding,metabolic process,0.244\nlipoteichoic acid immune receptor activity,immune system process,0.476\nlipoxin A4 biosynthetic process,metabolic process,0.888\nlipoxin A4 metabolic process,metabolic process,0.966\nlipoxin B4 biosynthetic process,metabolic process,0.888\nlipoxin B4 metabolic process,metabolic process,0.966\nlipoxin biosynthetic process,metabolic process,0.886\nlipoxin metabolic process,metabolic process,0.848\nlipoxygenase pathway,metabolic process,0.938\nlipoyl(octanoyl) transferase activity,metabolic process,0.896\nlipoyltransferase activity,metabolic process,0.64\nlithium ion binding,metabolic process,0.236\nlithium ion transport,transport,0.996\nlithium:proton antiporter activity,metabolic process,0.524\nlithocholic acid binding,metabolic process,0.318\nlithocholic acid receptor activity,protein modification/signaling,0.208\nlncRNA binding,gene regulation,0.54\nlncRNA catabolic process,metabolic process,0.89\nlncRNA transcription,gene regulation,0.226\nlncRNA-mediated post-transcriptional gene silencing,gene regulation,0.268\nlobar bronchus development,morphogenesis/development,0.866\nlobar bronchus epithelium development,morphogenesis/development,0.874\nlocalization,cellular component organization,0.304\nlocalization of cell,transport,0.492\nlocomotion,other,0.46\nlocomotion involved in locomotory behavior,transport,0.168\nlocomotor rhythm,morphogenesis/development,0.166\nlocomotory behavior,neural related process,0.516\nlocomotory exploration behavior,neural related process,0.15\nlocus ceruleus development,morphogenesis/development,0.862\nlong-chain acyl-CoA hydrolase activity,metabolic process,0.882\nlong-chain fatty acid binding,metabolic process,0.39\nlong-chain fatty acid biosynthetic process,metabolic process,0.974\nlong-chain fatty acid catabolic process,metabolic process,0.982\nlong-chain fatty acid import across plasma membrane,transport,0.448\nlong-chain fatty acid import into cell,transport,0.822\nlong-chain fatty acid import into peroxisome,transport,0.35\nlong-chain fatty acid omega-1 hydroxylase activity,metabolic process,0.932\nlong-chain fatty acid omega-hydroxylase activity,metabolic process,0.896\nlong-chain fatty acid transport,transport,0.956\nlong-chain fatty acid transporter activity,transport,0.604\nlong-chain fatty acid-CoA ligase activity,metabolic process,0.9\nlong-chain fatty acyl-CoA binding,metabolic process,0.438\nlong-chain fatty-acyl-CoA biosynthetic process,metabolic process,0.906\nlong-chain fatty-acyl-CoA catabolic process,metabolic process,0.9\nlong-chain fatty-acyl-CoA metabolic process,metabolic process,0.994\nlong-chain-3-hydroxyacyl-CoA dehydrogenase activity,metabolic process,0.834\nlong-chain-acyl-CoA dehydrogenase activity,metabolic process,0.922\nlong-chain-alcohol O-fatty-acyltransferase activity,metabolic process,0.888\nlong-chain-alcohol oxidase activity,metabolic process,0.9\nlong-chain-aldehyde dehydrogenase activity,metabolic process,0.914\nlong-chain-fatty-acyl-CoA reductase activity,metabolic process,0.936\nlong-day photoperiodism,response to stimulus,0.766\nlong-term memory,gene regulation,0.354\nlong-term synaptic depression,neural related process,0.43\nlong-term synaptic potentiation,neural related process,0.558\nlongitudinal sarcoplasmic reticulum,cellular component organization,0.234\nloop of Henle development,morphogenesis/development,0.986\nlow voltage-gated calcium channel activity,transport,0.21\nlow-affinity IgE receptor activity,immune system process,0.292\nlow-affinity IgG receptor activity,immune system process,0.31\nlow-affinity glucose:sodium symporter activity,metabolic process,0.388\nlow-affinity phosphate transmembrane transporter activity,transport,0.328\nlow-affinity sodium:dicarboxylate symporter activity,metabolic process,0.388\nlow-density lipoprotein particle,transport,0.174\nlow-density lipoprotein particle binding,metabolic process,0.214\nlow-density lipoprotein particle clearance,multicellular organismal process,0.236\nlow-density lipoprotein particle mediated signaling,protein modification/signaling,0.258\nlow-density lipoprotein particle receptor activity,cellular component organization,0.206\nlow-density lipoprotein particle receptor catabolic process,metabolic process,0.586\nlow-density lipoprotein particle remodeling,metabolic process,0.286\nlow-density lipoprotein receptor particle metabolic process,metabolic process,0.86\nlumenal side of endoplasmic reticulum membrane,cellular component organization,0.446\nlumenal side of lysosomal membrane,cellular component organization,0.344\nlumenal side of membrane,cellular component organization,0.47\nlung cell differentiation,morphogenesis/development,0.86\nlung ciliated cell differentiation,morphogenesis/development,0.64\nlung connective tissue development,morphogenesis/development,0.894\nlung development,morphogenesis/development,0.94\nlung epithelial cell differentiation,morphogenesis/development,0.91\nlung epithelium development,morphogenesis/development,0.89\nlung field specification,morphogenesis/development,0.362\nlung goblet cell differentiation,morphogenesis/development,0.694\nlung growth,morphogenesis/development,0.314\nlung induction,morphogenesis/development,0.282\nlung lobe development,morphogenesis/development,0.908\nlung lobe morphogenesis,morphogenesis/development,0.824\nlung neuroendocrine cell differentiation,morphogenesis/development,0.718\nlung pattern specification process,morphogenesis/development,0.51\nlung proximal/distal axis specification,cellular component organization,0.192\nlung saccule development,morphogenesis/development,0.73\nlung secretory cell differentiation,morphogenesis/development,0.912\nlung smooth muscle development,morphogenesis/development,0.994\nlung vasculature development,morphogenesis/development,0.872\nlung-associated mesenchyme development,morphogenesis/development,0.944\nlutein catabolic process,metabolic process,0.896\nlutein metabolic process,metabolic process,0.982\nluteinization,morphogenesis/development,0.328\nluteinizing hormone receptor activity,cellular component organization,0.186\nluteinizing hormone secretion,metabolic process,0.2\nluteinizing hormone signaling pathway,receptor related process,0.704\nluteolysis,morphogenesis/development,0.292\nlycopene catabolic process,metabolic process,0.89\nlycopene metabolic process,metabolic process,0.994\nlymph circulation,cellular component organization,0.242\nlymph node development,morphogenesis/development,0.688\nlymphangiogenesis,morphogenesis/development,0.44\nlymphatic endothelial cell differentiation,morphogenesis/development,0.55\nlymphatic endothelial cell fate commitment,morphogenesis/development,0.316\nlymphatic endothelial cell migration,transport,0.168\nlymphocyte adhesion to endothelial cell of high endothelial venule,receptor related process,0.202\nlymphocyte aggregation,immune system process,0.366\nlymphocyte anergy,immune system process,0.698\nlymphocyte chemotaxis across high endothelial venule,immune system process,0.816\nlymphocyte migration into lymph node,immune system process,0.272\nlymphocyte migration into lymphoid organs,immune system process,0.696\nlymphoid lineage cell migration,morphogenesis/development,0.152\nlymphoid lineage cell migration into thymus,morphogenesis/development,0.338\nlymphotoxin A production,metabolic process,0.798\n\"lysine N-acetyltransferase activity, acting on acetyl phosphate as donor\",metabolic process,0.792\nlysine N-methyltransferase activity,metabolic process,0.808\nlysine biosynthetic process,metabolic process,0.99\nlysine biosynthetic process via aminoadipic acid,metabolic process,0.988\nlysine catabolic process,metabolic process,0.988\nlysine metabolic process,metabolic process,0.99\nlysine transport,transport,0.96\nlysine-acetylated histone binding,protein modification/signaling,0.3\nlysine-tRNA ligase activity,metabolic process,0.822\nlysobisphosphatidic acid metabolic process,metabolic process,0.952\nlysophosphatidic acid binding,receptor related process,0.374\nlysophosphatidic acid phosphatase activity,metabolic process,0.856\nlysophosphatidic acid receptor activity,protein modification/signaling,0.212\nlysophosphatidylcholine flippase activity,metabolic process,0.334\nlysophosphatidylethanolamine acyltransferase activity,metabolic process,0.622\nlysophospholipase activity,metabolic process,0.906\nlysophospholipid translocation,cellular component organization,0.246\nlysophospholipid transport,transport,0.928\nlysophospholipid:sodium symporter activity,transport,0.414\nlysosomal HOPS complex,cellular component organization,0.412\nlysosomal lumen,cellular component organization,0.58\nlysosomal lumen acidification,ER/endosome/lysosome related process,0.544\nlysosomal lumen pH elevation,other,0.164\nlysosomal membrane,cellular component organization,0.688\nlysosomal membrane organization,cellular component organization,0.904\nlysosomal proton-transporting V-type ATPase complex,cellular component organization,0.402\nlysosome,cellular component organization,0.3\nlysosome localization,transport,0.386\nlysozyme activity,metabolic process,0.55\nlysyl-tRNA aminoacylation,metabolic process,0.566\nlytic vacuole,cellular component organization,0.326\nlytic vacuole membrane,cellular component organization,0.674\nlytic vacuole organization,cellular component organization,0.482\nm-AAA complex,cellular component organization,0.342\nmCRD-mediated mRNA stability complex,gene regulation,0.352\nmRNA (2'-O-methyladenosine-N6-)-methyltransferase activity,metabolic process,0.894\nmRNA (N6-adenosine)-methyltransferase activity,metabolic process,0.868\nmRNA (adenine-N1-)-methyltransferase activity,metabolic process,0.798\nmRNA (cytidine-5-)-methyltransferase activity,metabolic process,0.806\nmRNA (nucleoside-2'-O-)-methyltransferase activity,metabolic process,0.898\nmRNA 3'-UTR binding,gene regulation,0.784\nmRNA 3'-end processing by stem-loop binding and cleavage,gene regulation,0.282\nmRNA 3'-splice site recognition,cellular component organization,0.854\nmRNA 5'-diphosphatase activity,metabolic process,0.48\nmRNA 5'-phosphatase activity,metabolic process,0.406\nmRNA 5'-splice site recognition,cellular component organization,0.854\nmRNA CDS binding,gene regulation,0.398\nmRNA N-acetyltransferase activity,metabolic process,0.69\nmRNA N1-methyladenosine dioxygenase activity,metabolic process,0.504\nmRNA N6-methyladenosine dioxygenase activity,metabolic process,0.508\nmRNA alternative polyadenylation,morphogenesis/development,0.248\nmRNA base-pairing translational repressor activity,gene regulation,0.378\nmRNA branch site recognition,cellular component organization,0.498\nmRNA cap binding,gene regulation,0.316\nmRNA cap binding complex,gene regulation,0.3\nmRNA cap binding complex binding,gene regulation,0.304\nmRNA cap methyltransferase complex,gene regulation,0.45\n\"mRNA cis splicing, via spliceosome\",gene regulation,0.548\nmRNA cleavage and polyadenylation specificity factor complex,gene regulation,0.234\nmRNA cleavage factor complex,gene regulation,0.306\nmRNA cleavage stimulating factor complex,gene regulation,0.294\nmRNA destabilization,gene regulation,0.504\nmRNA dihydrouridine synthase activity,metabolic process,0.934\nmRNA editing complex,gene regulation,0.434\nmRNA export from nucleus in response to heat stress,transport,0.3\nmRNA guanylyltransferase activity,metabolic process,0.688\nmRNA localization resulting in post-transcriptional regulation of gene expression,gene regulation,0.288\nmRNA methyltransferase activity,metabolic process,0.614\nmRNA modification,gene regulation,0.762\nmRNA polyadenylation,gene regulation,0.43\nmRNA pseudouridine synthesis,gene regulation,0.26\nmRNA regulatory element binding translation repressor activity,gene regulation,0.394\nmRNA splice site recognition,cellular component organization,0.854\n\"mRNA splicing, via endonucleolytic cleavage and ligation\",gene regulation,0.628\nmRNA stabilization,gene regulation,0.63\n\"mRNA trans splicing, SL addition\",gene regulation,0.52\n\"mRNA trans splicing, via spliceosome\",gene regulation,0.692\nmRNA transcription by RNA polymerase II,gene regulation,0.58\nmRNA transport,transport,0.972\nmacrolide binding,metabolic process,0.28\nmacromolecule biosynthetic process,metabolic process,0.78\nmacromolecule catabolic process,metabolic process,0.658\nmacromolecule deacylation,protein modification/signaling,0.476\nmacromolecule depalmitoylation,protein modification/signaling,0.366\nmacromolecule glycosylation,protein modification/signaling,0.332\nmacromolecule metabolic process,metabolic process,0.648\nmacromolecule modification,protein modification/signaling,0.356\nmacromolecule transmembrane transporter activity,transport,0.596\nmacrophage antigen processing and presentation,immune system process,0.382\nmacrophage apoptotic process,cell death,0.58\nmacrophage colony-stimulating factor production,immune system process,0.61\nmacrophage colony-stimulating factor receptor activity,receptor related process,0.358\nmacrophage colony-stimulating factor receptor binding,receptor related process,0.498\nmacrophage colony-stimulating factor signaling pathway,receptor related process,0.492\nmacrophage fusion,metabolic process,0.14\nmacrophage homeostasis,immune system process,0.328\nmacrophage inflammatory protein-1 alpha production,immune system process,0.556\nmacrophage migration inhibitory factor binding,immune system process,0.216\nmacrophage migration inhibitory factor receptor complex,protein modification/signaling,0.242\nmacrophage migration inhibitory factor signaling pathway,receptor related process,0.552\nmacrophage proliferation,cell cycle,0.494\nmacrophage tolerance induction,morphogenesis/development,0.184\nmacropinocytic cup,cellular component organization,0.326\nmacropinocytosis,transport,0.802\nmacropinosome,cellular component organization,0.24\nmacula densa development,morphogenesis/development,0.976\nmagnesium ion homeostasis,other,0.71\nmagnesium ion transmembrane transporter activity,transport,0.636\nmagnesium:sodium antiporter activity,metabolic process,0.894\nmaintenance of DNA repeat elements,cell cycle,0.362\nmaintenance of ER location,transport,0.284\nmaintenance of Golgi location,morphogenesis/development,0.18\nmaintenance of animal organ identity,morphogenesis/development,0.598\nmaintenance of apical/basal cell polarity,cellular component organization,0.356\nmaintenance of blood vessel diameter homeostasis by renin-angiotensin,multicellular organismal process,0.214\nmaintenance of cell polarity,cellular component organization,0.37\nmaintenance of centrosome location,morphogenesis/development,0.192\nmaintenance of ciliary planar beating movement pattern,transport,0.21\nmaintenance of epithelial cell apical/basal polarity,cellular component organization,0.288\nmaintenance of granzyme B location in T cell secretory granule,cellular component organization,0.208\nmaintenance of lens transparency,morphogenesis/development,0.214\nmaintenance of mitochondrion location,cellular component organization,0.188\nmaintenance of mitotic sister chromatid cohesion,cell cycle,0.704\n\"maintenance of mitotic sister chromatid cohesion, centromeric\",cell cycle,0.398\n\"maintenance of mitotic sister chromatid cohesion, telomeric\",cell cycle,0.398\nmaintenance of nucleus location,transport,0.338\nmaintenance of postsynaptic density structure,cellular component organization,0.342\nmaintenance of postsynaptic specialization structure,cellular component organization,0.646\nmaintenance of presynaptic active zone structure,cellular component organization,0.276\nmaintenance of protease location in T cell secretory granule,transport,0.254\nmaintenance of protease location in mast cell secretory granule,morphogenesis/development,0.218\nmaintenance of protein location in T cell secretory granule,transport,0.258\nmaintenance of protein location in cell,cellular component organization,0.532\nmaintenance of protein location in extracellular region,transport,0.282\nmaintenance of protein location in mast cell secretory granule,transport,0.256\nmaintenance of protein location in membrane,cellular component organization,0.35\nmaintenance of protein location in mitochondrion,protein modification/signaling,0.212\nmaintenance of protein location in plasma membrane,cellular component organization,0.334\nmaintenance of rDNA,cell cycle,0.428\nmaintenance of sister chromatid cohesion,cell cycle,0.748\nmaintenance of transcriptional fidelity during transcription elongation,gene regulation,0.756\nmaintenance of transcriptional fidelity during transcription elongation by RNA polymerase II,gene regulation,0.58\nmaintenance of translational fidelity,protein modification/signaling,0.288\nmaintenance of unfolded protein,protein modification/signaling,0.282\nmaintenance of unfolded protein involved in ERAD pathway,ER/endosome/lysosome related process,0.368\nmalate dehydrogenase (NADP+) activity,metabolic process,0.934\nmalate dehydrogenase (decarboxylating) (NAD+) activity,metabolic process,0.926\nmalate dehydrogenase (decarboxylating) (NADP+) activity,metabolic process,0.932\nmalate dehydrogenase activity,metabolic process,0.834\nmalate metabolic process,metabolic process,0.658\nmalate synthase activity,metabolic process,0.896\nmalate transmembrane transport,transport,0.854\nmalate transmembrane transporter activity,transport,0.612\nmalate transport,transport,0.966\nmalate-aspartate shuttle,metabolic process,0.25\nmale anatomical structure morphogenesis,morphogenesis/development,0.882\nmale courtship behavior,multicellular organismal process,0.434\nmale gamete generation,morphogenesis/development,0.286\nmale genitalia morphogenesis,morphogenesis/development,0.884\nmale germ cell nucleus,cell cycle,0.346\nmale germ cell proliferation,cell cycle,0.792\nmale germ-line sex determination,morphogenesis/development,0.22\nmale germ-line stem cell asymmetric division,cell cycle,0.242\nmale germ-line stem cell population maintenance,cell cycle,0.238\nmale mating behavior,multicellular organismal process,0.484\nmale meiosis I,morphogenesis/development,0.33\nmale meiosis chromosome segregation,cell cycle,0.556\nmale meiosis chromosome separation,cellular component organization,0.222\nmale meiosis cytokinesis,cell cycle,0.444\nmale meiotic nuclear division,cell cycle,0.644\nmale pronucleus,cellular component organization,0.264\nmale pronucleus assembly,cellular component organization,0.212\nmale sex determination,morphogenesis/development,0.554\nmale somatic sex determination,cellular component organization,0.208\nmaleylacetoacetate isomerase activity,metabolic process,0.896\nmalic enzyme activity,metabolic process,0.748\nmalonate catabolic process,metabolic process,0.86\nmalonate-semialdehyde dehydrogenase (acetylating) activity,metabolic process,0.93\nmalonyl-CoA biosynthetic process,metabolic process,0.884\nmalonyl-CoA catabolic process,metabolic process,0.904\nmalonyl-CoA decarboxylase activity,metabolic process,0.896\nmalonyl-CoA metabolic process,metabolic process,1\nmalonyl-CoA synthetase activity,metabolic process,0.834\nmalonyltransferase activity,metabolic process,0.932\nmaltose alpha-glucosidase activity,metabolic process,0.9\nmaltose catabolic process,metabolic process,0.878\nmaltose metabolic process,metabolic process,0.974\nmammalian oogenesis stage,multicellular organismal process,0.36\nmammary duct terminal end bud growth,cellular component organization,0.196\nmammary gland alveolus development,morphogenesis/development,0.85\nmammary gland branching involved in pregnancy,morphogenesis/development,0.56\nmammary gland branching involved in thelarche,morphogenesis/development,0.548\nmammary gland bud formation,morphogenesis/development,0.324\nmammary gland bud morphogenesis,morphogenesis/development,0.84\nmammary gland epithelial cell differentiation,morphogenesis/development,0.846\nmammary gland epithelial cell proliferation,cell cycle,0.676\nmammary gland fat development,morphogenesis/development,0.868\nmammary gland formation,morphogenesis/development,0.872\nmammary gland involution,morphogenesis/development,0.236\nmammary gland lobule development,morphogenesis/development,0.786\nmammary gland specification,morphogenesis/development,0.314\nmammary placode formation,morphogenesis/development,0.638\nmammary stem cell proliferation,cell cycle,0.486\nmammillary axonal complex development,morphogenesis/development,0.658\nmammillary body development,morphogenesis/development,0.846\nmammillothalamic axonal tract development,morphogenesis/development,0.722\nmanchette,cellular component organization,0.314\nmanchette assembly,cellular component organization,0.588\nmanchette disassembly,cellular component organization,0.442\nmanganese ion binding,protein modification/signaling,0.214\nmanganese ion export across plasma membrane,transport,0.488\nmanganese ion homeostasis,other,0.776\nmanganese ion transmembrane transport,transport,0.896\nmanganese ion transmembrane transporter activity,transport,0.612\nmanganese ion transport,transport,0.984\nmannan binding,metabolic process,0.244\nmannitol transmembrane transport,transport,0.392\nmannokinase activity,metabolic process,0.798\nmannoprotein biosynthetic process,metabolic process,0.93\nmannoprotein metabolic process,metabolic process,0.962\nmannosamine metabolic process,metabolic process,0.924\nmannose binding,metabolic process,0.274\nmannose metabolic process,metabolic process,0.972\nmannose to fructose-6-phosphate metabolic process,metabolic process,0.842\nmannose transmembrane transport,transport,0.374\nmannose transmembrane transporter activity,transport,0.632\nmannose trimming involved in glycoprotein ERAD pathway,protein modification/signaling,0.444\nmannose-1-phosphate guanylyltransferase (GTP) activity,metabolic process,0.874\nmannose-6-phosphate isomerase activity,metabolic process,0.896\nmannose-ethanolamine phosphotransferase activity,metabolic process,0.768\nmannose:sodium symporter activity,metabolic process,0.526\nmannosidase activity,metabolic process,0.668\nmannosyl-glycoprotein endo-beta-N-acetylglucosaminidase activity,metabolic process,0.366\n\"mannosyl-oligosaccharide 1,2-alpha-mannosidase activity\",metabolic process,0.442\n\"mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity\",metabolic process,0.48\nmannosyl-oligosaccharide mannosidase activity,metabolic process,0.696\nmannosylation,protein modification/signaling,0.374\nmannosyltransferase complex,metabolic process,0.458\nmarginal zone B cell differentiation,morphogenesis/development,0.332\nmast cell activation,immune system process,0.8\nmast cell activation involved in immune response,immune system process,0.624\nmast cell apoptotic process,cell death,0.556\nmast cell chemotaxis,immune system process,0.442\nmast cell cytokine production,immune system process,0.394\nmast cell degranulation,immune system process,0.286\nmast cell differentiation,morphogenesis/development,0.652\nmast cell granule,cellular component organization,0.39\nmast cell homeostasis,immune system process,0.426\nmast cell mediated immunity,immune system process,0.86\nmast cell migration,immune system process,0.706\nmast cell proliferation,cell cycle,0.402\nmast cell secretagogue receptor activity,metabolic process,0.458\nmast cell secretory granule organization,cellular component organization,0.608\nmastication,cellular component organization,0.24\nmaternal aggressive behavior,cellular component organization,0.244\n\"maternal determination of anterior/posterior axis, embryo\",gene regulation,0.26\nmaternal process involved in parturition,morphogenesis/development,0.184\nmaternal-to-zygotic transition of gene expression,morphogenesis/development,0.368\nmating,cellular component organization,0.198\nmating behavior,multicellular organismal process,0.366\nmating plug formation,metabolic process,0.23\nmatrilin complex,cellular component organization,0.462\nmatrix metallopeptidase secretion,protein modification/signaling,0.362\nmatrix side of mitochondrial inner membrane,cellular component organization,0.382\nmaturation of 5S rRNA,gene regulation,0.624\n\"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)\",gene regulation,0.772\nmature B cell apoptotic process,cell death,0.456\nmature B cell differentiation,immune system process,0.822\nmature chylomicron,transport,0.168\nmature conventional dendritic cell differentiation,morphogenesis/development,0.332\nmature natural killer cell chemotaxis,morphogenesis/development,0.244\nmechanoreceptor differentiation,morphogenesis/development,0.588\nmechanosensitive monoatomic cation channel activity,transport,0.522\nmechanosensitive monoatomic ion channel activity,transport,0.476\nmechanosensitived potassium channel activity,metabolic process,0.222\nmechanosensory behavior,multicellular organismal process,0.39\nmechanosensory lateral line system development,morphogenesis/development,0.768\nmedial motor column neuron differentiation,morphogenesis/development,0.464\nmediator complex assembly,gene regulation,0.472\nmediator complex binding,gene regulation,0.576\nmediolateral intercalation,morphogenesis/development,0.264\nmedium-chain acyl-CoA hydrolase activity,metabolic process,0.836\nmedium-chain fatty acid biosynthetic process,metabolic process,0.906\nmedium-chain fatty acid catabolic process,metabolic process,0.904\nmedium-chain fatty acid metabolic process,metabolic process,0.976\nmedium-chain fatty acid omega-hydroxylase activity,metabolic process,0.934\nmedium-chain fatty acid transport,transport,0.706\nmedium-chain fatty acid-CoA ligase activity,metabolic process,0.87\nmedium-chain fatty-acyl-CoA catabolic process,metabolic process,0.9\nmedium-chain fatty-acyl-CoA metabolic process,metabolic process,0.98\nmedium-chain-acyl-CoA dehydrogenase activity,metabolic process,0.918\nmedium-chain-aldehyde dehydrogenase activity,metabolic process,0.906\nmedulla oblongata development,morphogenesis/development,0.872\nmedullary reticular formation development,morphogenesis/development,0.958\nmegakaryocyte development,morphogenesis/development,0.836\nmegakaryocyte differentiation,morphogenesis/development,0.552\nmegasporocyte nucleus,cellular component organization,0.506\nmeiosis II,cell cycle,0.664\nmeiosis II cell cycle process,cell cycle,0.762\nmeiotic DNA double-strand break formation,cell cycle,0.396\nmeiotic DNA double-strand break formation involved in reciprocal meiotic recombination,cell cycle,0.39\nmeiotic DNA double-strand break processing,cell cycle,0.41\nmeiotic DNA double-strand break processing involved in reciprocal meiotic recombination,morphogenesis/development,0.244\nmeiotic DNA integrity checkpoint signaling,cell cycle,0.608\nmeiotic DNA recombinase assembly,cell cycle,0.424\nmeiotic DNA repair synthesis,cell cycle,0.366\nmeiotic attachment of telomere to nuclear envelope,morphogenesis/development,0.278\nmeiotic cell cycle checkpoint signaling,cell cycle,0.718\nmeiotic cell cycle process involved in oocyte maturation,morphogenesis/development,0.31\nmeiotic chromosome condensation,cellular component organization,0.3\nmeiotic chromosome movement towards spindle pole,cell cycle,0.432\nmeiotic chromosome separation,cell cycle,0.786\nmeiotic cohesin complex,cellular component organization,0.35\nmeiotic cytokinesis,cell cycle,0.674\nmeiotic gene conversion,cell cycle,0.194\nmeiotic joint molecule formation,cell cycle,0.238\nmeiotic metaphase I homologous chromosome alignment,cellular component organization,0.252\nmeiotic metaphase chromosome alignment,cell cycle,0.488\nmeiotic mismatch repair,stress response,0.404\nmeiotic nuclear membrane microtubule tethering complex,cellular component organization,0.43\nmeiotic recombination checkpoint signaling,protein modification/signaling,0.194\nmeiotic sister chromatid cohesion,cell cycle,0.616\nmeiotic sister chromatid cohesion involved in meiosis I,morphogenesis/development,0.228\n\"meiotic sister chromatid cohesion, centromeric\",cellular component organization,0.188\nmeiotic spindle,cell cycle,0.304\nmeiotic spindle assembly,cell cycle,0.632\nmeiotic spindle assembly checkpoint signaling,cell cycle,0.674\nmeiotic spindle checkpoint signaling,cell cycle,0.686\nmeiotic spindle elongation,cell cycle,0.226\nmeiotic spindle midzone,cellular component organization,0.248\nmeiotic spindle midzone assembly,cellular component organization,0.232\nmeiotic spindle pole,cellular component organization,0.214\nmeiotic strand invasion,cell cycle,0.38\nmeiotic strand invasion involved in reciprocal meiotic recombination,cell cycle,0.398\nmeiotic telomere clustering,cell cycle,0.498\nmeiotic telomere tethering at nuclear periphery,cell cycle,0.196\nmelanin biosynthetic process,metabolic process,0.856\nmelanin biosynthetic process from tyrosine,metabolic process,0.836\nmelanin metabolic process,metabolic process,0.848\nmelanin-concentrating hormone activity,receptor related process,0.438\nmelanin-concentrating hormone receptor activity,cellular component organization,0.166\nmelanin-concentrating hormone receptor binding,receptor related process,0.478\nmelanocortin receptor activity,receptor related process,0.606\nmelanocortin receptor binding,receptor related process,0.452\nmelanocyte adhesion,cell adhesion,0.27\nmelanocyte apoptotic process,cellular component organization,0.34\nmelanocyte differentiation,morphogenesis/development,0.876\nmelanocyte migration,multicellular organismal process,0.268\nmelanocyte proliferation,cell cycle,0.732\nmelanocyte-stimulating hormone receptor activity,cellular component organization,0.176\nmelanosome,cellular component organization,0.274\nmelanosome assembly,cellular component organization,0.584\nmelanosome localization,transport,0.628\nmelanosome membrane,cellular component organization,0.242\nmelanosome organization,cellular component organization,0.848\nmelatonin binding,metabolic process,0.244\nmelatonin biosynthetic process,metabolic process,0.872\nmelatonin metabolic process,metabolic process,0.958\nmelatonin receptor activity,cellular component organization,0.172\nmembrane,cellular component organization,0.156\nmembrane assembly,cellular component organization,0.676\nmembrane attack complex,cellular component organization,0.336\nmembrane bending,cellular component organization,0.816\nmembrane biogenesis,cellular component organization,0.684\nmembrane bone morphogenesis,morphogenesis/development,0.816\nmembrane coat,cellular component organization,0.292\nmembrane curvature sensor activity,protein modification/signaling,0.318\nmembrane depolarization,transport,0.228\nmembrane depolarization during AV node cell action potential,transport,0.224\nmembrane depolarization during Purkinje myocyte cell action potential,cellular component organization,0.226\nmembrane depolarization during SA node cell action potential,transport,0.23\nmembrane depolarization during action potential,transport,0.25\nmembrane depolarization during atrial cardiac muscle cell action potential,transport,0.224\nmembrane depolarization during bundle of His cell action potential,transport,0.224\nmembrane depolarization during cardiac muscle cell action potential,transport,0.222\nmembrane destabilizing activity,cellular component organization,0.268\nmembrane disassembly,cellular component organization,0.834\nmembrane fusion involved in viral entry into host cell,viral related process,0.362\nmembrane hyperpolarization,cellular component organization,0.254\nmembrane insertase activity,cellular component organization,0.274\nmembrane invagination,cellular component organization,0.67\nmembrane lipid biosynthetic process,metabolic process,0.954\nmembrane microdomain,cellular component organization,0.59\nmembrane potential driven uniporter activity,transport,0.564\nmembrane protein complex,metabolic process,0.138\nmembrane protein dislocase activity,metabolic process,0.286\nmembrane protein ectodomain proteolysis,metabolic process,0.596\nmembrane protein intracellular domain proteolysis,metabolic process,0.36\n\"membrane protein proteolysis involved in retrograde protein transport, ER to cytosol\",cellular component organization,0.212\nmembrane raft assembly,cellular component organization,0.912\nmembrane raft distribution,cellular component organization,0.606\nmembrane raft localization,transport,0.486\nmembrane raft polarization,cellular component organization,0.574\nmembrane repolarization,transport,0.336\nmembrane repolarization during SA node cell action potential,transport,0.218\nmembrane repolarization during action potential,transport,0.372\nmembrane repolarization during atrial cardiac muscle cell action potential,transport,0.366\nmembrane repolarization during bundle of His cell action potential,transport,0.374\nmembrane repolarization during cardiac muscle cell action potential,transport,0.348\nmembrane repolarization during ventricular cardiac muscle cell action potential,transport,0.382\nmembrane to membrane docking,cellular component organization,0.314\nmembrane tubulation,cellular component organization,0.806\nmembrane-bounded organelle,metabolic process,0.348\nmembrane-enclosed lumen,metabolic process,0.204\nmembranous septum morphogenesis,morphogenesis/development,0.48\nmemory B cell differentiation,morphogenesis/development,0.386\nmemory T cell activation,immune system process,0.302\nmemory T cell differentiation,immune system process,0.504\nmemory T cell extravasation,morphogenesis/development,0.288\nmemory T cell proliferation,cell cycle,0.488\nmenaquinone biosynthetic process,metabolic process,0.688\nmenaquinone catabolic process,metabolic process,0.694\nmenaquinone metabolic process,metabolic process,0.872\nmeprin A complex,cellular component organization,0.228\nmercury ion binding,metabolic process,0.254\nmercury ion transport,transport,0.73\nmesangial cell development,morphogenesis/development,0.946\nmesangial cell differentiation,morphogenesis/development,0.922\nmesangial cell-matrix adhesion,cell adhesion,0.244\nmesaxon,cellular component organization,0.374\nmesenchymal cell apoptotic process,cell death,0.606\nmesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis,cell death,0.594\nmesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,cell death,0.598\nmesenchymal cell apoptotic process involved in metanephros development,cell death,0.796\nmesenchymal cell apoptotic process involved in nephron morphogenesis,cell death,0.772\nmesenchymal cell development,morphogenesis/development,0.582\nmesenchymal cell differentiation involved in bone development,morphogenesis/development,0.84\nmesenchymal cell differentiation involved in kidney development,morphogenesis/development,0.848\nmesenchymal cell differentiation involved in lung development,morphogenesis/development,0.674\nmesenchymal cell differentiation involved in renal system development,morphogenesis/development,0.854\nmesenchymal cell proliferation,cell cycle,0.698\nmesenchymal cell proliferation involved in lung development,cell cycle,0.554\nmesenchymal cell proliferation involved in prostate gland development,cell cycle,0.58\nmesenchymal cell proliferation involved in ureter development,cell cycle,0.698\nmesenchymal cell proliferation involved in ureteric bud development,cell cycle,0.708\nmesenchymal smoothened signaling pathway involved in prostate gland development,morphogenesis/development,0.366\nmesenchymal stem cell differentiation,morphogenesis/development,0.912\nmesenchymal stem cell maintenance involved in mesonephric nephron morphogenesis,cell cycle,0.352\nmesenchymal stem cell maintenance involved in metanephric nephron morphogenesis,cell cycle,0.348\nmesenchymal stem cell maintenance involved in nephron morphogenesis,morphogenesis/development,0.634\nmesenchymal stem cell migration,transport,0.182\nmesenchymal stem cell proliferation,cell cycle,0.772\nmesenchymal to epithelial transition,morphogenesis/development,0.626\nmesenchymal to epithelial transition involved in metanephric renal vesicle formation,cellular component organization,0.286\nmesenchymal to epithelial transition involved in metanephros morphogenesis,morphogenesis/development,0.658\nmesenchymal to epithelial transition involved in renal vesicle formation,morphogenesis/development,0.564\nmesenchymal-epithelial cell signaling,morphogenesis/development,0.328\nmesenchymal-epithelial cell signaling involved in lung development,morphogenesis/development,0.188\nmesenchymal-epithelial cell signaling involved in prostate gland development,morphogenesis/development,0.358\nmesenchyme development,morphogenesis/development,0.888\nmesenchyme migration,multicellular organismal process,0.33\nmesendoderm development,morphogenesis/development,0.988\nmesendoderm migration,transport,0.364\nmesoderm migration involved in gastrulation,morphogenesis/development,0.196\nmesoderm morphogenesis,morphogenesis/development,0.948\nmesoderm structural organization,morphogenesis/development,0.654\nmesodermal cell fate commitment,morphogenesis/development,0.71\nmesodermal cell fate determination,morphogenesis/development,0.69\nmesodermal cell fate specification,morphogenesis/development,0.65\nmesodermal cell migration,morphogenesis/development,0.212\nmesodermal to mesenchymal transition involved in gastrulation,cellular component organization,0.326\nmesodermal-endodermal cell signaling,protein modification/signaling,0.174\nmesonephric duct development,morphogenesis/development,0.976\nmesonephric duct formation,morphogenesis/development,0.582\nmesonephric duct morphogenesis,morphogenesis/development,0.906\nmesonephric epithelium development,morphogenesis/development,0.984\nmesonephric nephron development,morphogenesis/development,0.986\nmesonephric nephron morphogenesis,morphogenesis/development,0.722\nmesonephric tubule development,morphogenesis/development,0.96\nmesonephric tubule formation,morphogenesis/development,0.838\nmesonephric tubule morphogenesis,morphogenesis/development,0.918\nmesonephros development,morphogenesis/development,0.944\nmesonephros morphogenesis,morphogenesis/development,0.734\nmessenger ribonucleoprotein complex,gene regulation,0.578\nmessenger ribonucleoprotein complex assembly,cellular component organization,0.42\nmetabolic process,metabolic process,0.664\nmetabolite repair,metabolic process,0.56\nmetal cation:monoatomic cation antiporter activity,transport,0.53\nmetal cation:proton antiporter activity,transport,0.526\nmetal chelating activity,cellular component organization,0.28\nmetal incorporation into metallo-molybdopterin complex,protein modification/signaling,0.618\nmetal incorporation into metallo-sulfur cluster,protein modification/signaling,0.674\nmetal ion binding,other,0.224\nmetal ion sensor activity,metabolic process,0.302\nmetal ion sequestering activity,transport,0.27\nmetal ion transmembrane transporter activity,transport,0.666\nmetal ion transport,transport,0.768\nmetal-dependent deubiquitinase activity,protein modification/signaling,0.386\nmetallo-sulfur cluster assembly,cellular component organization,0.834\nmetalloaminopeptidase activity,metabolic process,0.462\nmetallocarboxypeptidase activity,metabolic process,0.544\nmetallodipeptidase activity,metabolic process,0.496\nmetalloendopeptidase activity,metabolic process,0.48\nmetalloendopeptidase activity involved in amyloid precursor protein catabolic process,metabolic process,0.27\nmetalloexopeptidase activity,metabolic process,0.456\nmetallopeptidase activity,metabolic process,0.434\nmetanephric DCT cell differentiation,morphogenesis/development,0.862\nmetanephric S-shaped body morphogenesis,morphogenesis/development,0.538\nmetanephric ascending thin limb development,morphogenesis/development,0.932\nmetanephric cap development,morphogenesis/development,0.692\nmetanephric cap mesenchymal cell proliferation involved in metanephros development,cell cycle,0.8\nmetanephric cap morphogenesis,morphogenesis/development,0.676\nmetanephric capsule development,morphogenesis/development,0.986\nmetanephric capsule formation,morphogenesis/development,0.59\nmetanephric capsule morphogenesis,morphogenesis/development,0.726\nmetanephric capsule specification,cellular component organization,0.324\nmetanephric comma-shaped body morphogenesis,morphogenesis/development,0.622\nmetanephric connecting tubule development,morphogenesis/development,0.988\nmetanephric cortex development,morphogenesis/development,0.968\nmetanephric cortical collecting duct development,morphogenesis/development,0.976\nmetanephric descending thin limb development,morphogenesis/development,0.978\nmetanephric distal convoluted tubule development,morphogenesis/development,0.966\nmetanephric distal tubule development,morphogenesis/development,0.98\nmetanephric distal tubule morphogenesis,morphogenesis/development,0.722\nmetanephric epithelium development,morphogenesis/development,0.964\nmetanephric glomerular basement membrane development,morphogenesis/development,0.952\nmetanephric glomerular capillary formation,morphogenesis/development,0.384\nmetanephric glomerular epithelial cell development,morphogenesis/development,0.926\nmetanephric glomerular epithelial cell differentiation,morphogenesis/development,0.89\nmetanephric glomerular epithelium development,morphogenesis/development,0.878\nmetanephric glomerular mesangial cell development,morphogenesis/development,0.974\nmetanephric glomerular mesangial cell differentiation,morphogenesis/development,0.846\nmetanephric glomerular mesangial cell proliferation involved in metanephros development,cell cycle,0.856\nmetanephric glomerular mesangium development,morphogenesis/development,0.926\nmetanephric glomerulus morphogenesis,morphogenesis/development,0.728\nmetanephric glomerulus vasculature development,morphogenesis/development,0.862\nmetanephric glomerulus vasculature morphogenesis,morphogenesis/development,0.684\nmetanephric interstitial fibroblast development,morphogenesis/development,0.994\nmetanephric interstitial fibroblast differentiation,morphogenesis/development,0.844\nmetanephric juxtaglomerular apparatus development,morphogenesis/development,0.926\nmetanephric loop of Henle development,morphogenesis/development,0.98\nmetanephric macula densa development,morphogenesis/development,0.964\nmetanephric mesangial cell differentiation,morphogenesis/development,0.926\nmetanephric mesenchymal cell differentiation,morphogenesis/development,0.862\nmetanephric mesenchymal cell migration,morphogenesis/development,0.194\nmetanephric mesenchymal cell proliferation involved in metanephros development,cell cycle,0.752\nmetanephric mesenchyme development,morphogenesis/development,0.95\nmetanephric mesenchyme morphogenesis,morphogenesis/development,0.87\nmetanephric nephron development,morphogenesis/development,0.98\nmetanephric nephron epithelium development,morphogenesis/development,0.964\nmetanephric nephron morphogenesis,morphogenesis/development,0.82\nmetanephric nephron tubule development,morphogenesis/development,0.942\nmetanephric nephron tubule epithelial cell differentiation,morphogenesis/development,0.866\nmetanephric nephron tubule formation,morphogenesis/development,0.636\nmetanephric nephron tubule morphogenesis,morphogenesis/development,0.906\nmetanephric part of ureteric bud development,morphogenesis/development,0.332\nmetanephric podocyte development,morphogenesis/development,0.964\nmetanephric podocyte differentiation,morphogenesis/development,0.704\nmetanephric proximal convoluted tubule development,morphogenesis/development,0.99\nmetanephric proximal convoluted tubule segment 2 development,morphogenesis/development,0.978\nmetanephric proximal straight tubule development,morphogenesis/development,0.978\nmetanephric proximal tubule development,morphogenesis/development,0.984\nmetanephric renal vesicle formation,morphogenesis/development,0.582\nmetanephric renal vesicle morphogenesis,morphogenesis/development,0.742\nmetanephric smooth muscle tissue development,morphogenesis/development,0.988\nmetanephric thick ascending limb development,morphogenesis/development,0.914\nmetanephric tubule development,morphogenesis/development,0.944\nmetanephric tubule formation,morphogenesis/development,0.876\nmetanephric tubule morphogenesis,morphogenesis/development,0.9\nmetanephros morphogenesis,morphogenesis/development,0.852\nmetaphase chromosome alignment,cell cycle,0.832\nmetaphase/anaphase transition of meiosis I,morphogenesis/development,0.294\nmetaphase/anaphase transition of meiotic cell cycle,cell cycle,0.752\nmetencephalon development,morphogenesis/development,0.816\nmethanethiol oxidase activity,metabolic process,0.9\nmethenyltetrahydrofolate cyclohydrolase activity,metabolic process,0.904\nmethione N-acyltransferase activity,metabolic process,0.9\nmethionine adenosyltransferase activity,metabolic process,0.786\nmethionine adenosyltransferase complex,metabolic process,0.328\nmethionine adenosyltransferase regulator activity,metabolic process,0.232\nmethionine catabolic process,metabolic process,0.988\nmethionine metabolic process,metabolic process,0.998\nmethionine synthase activity,metabolic process,0.896\nmethionine transmembrane transporter activity,transport,0.712\nmethionine transport,transport,0.952\nmethionine-glyoxylate transaminase activity,metabolic process,0.896\nmethionine-tRNA ligase activity,metabolic process,0.822\nmethionyl-tRNA aminoacylation,metabolic process,0.572\nmethionyl-tRNA formyltransferase activity,metabolic process,0.9\nmethotrexate transmembrane transporter activity,metabolic process,0.304\nmethotrexate transport,transport,0.716\nmethyl-CpG binding,metabolic process,0.224\nmethyl-CpNpG binding,metabolic process,0.242\nmethyl-branched fatty acid metabolic process,metabolic process,0.952\nmethyl/ethyl malonyl-CoA decarboxylase activity,metabolic process,0.896\nmethylammonium channel activity,cellular component organization,0.208\nmethylammonium transmembrane transport,transport,0.264\nmethylammonium transmembrane transporter activity,transport,0.778\nmethylammonium transport,transport,0.942\nmethylarsonate reductase activity,metabolic process,0.906\nmethylarsonite methyltransferase activity,metabolic process,0.896\nmethylated histone binding,protein modification/signaling,0.558\nmethylated-DNA-[protein]-cysteine S-methyltransferase activity,metabolic process,0.574\nmethylation,metabolic process,0.346\nmethylation-dependent protein binding,protein modification/signaling,0.64\nmethylbutanoate-CoA ligase activity,metabolic process,0.82\nmethylcrotonoyl-CoA carboxylase activity,metabolic process,0.752\nmethylcrotonoyl-CoA carboxylase complex,metabolic process,0.316\nmethylcytosine dioxygenase activity,metabolic process,0.892\nmethylenetetrahydrofolate dehydrogenase (NAD+) activity,metabolic process,0.93\nmethylenetetrahydrofolate dehydrogenase (NADP+) activity,metabolic process,0.938\nmethylenetetrahydrofolate dehydrogenase [NAD(P)+] activity,metabolic process,0.984\nmethylenetetrahydrofolate reductase (NAD(P)H) activity,metabolic process,0.988\nmethylenetetrahydrofolate reductase NADPH activity,metabolic process,0.934\nmethylglutaconyl-CoA hydratase activity,metabolic process,0.9\nmethylglyoxal biosynthetic process,metabolic process,0.904\nmethylglyoxal catabolic process,metabolic process,0.98\nmethylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione,metabolic process,0.83\nmethylglyoxal catabolic process to lactate,metabolic process,0.99\nmethylglyoxal metabolic process,metabolic process,0.932\n\"methylglyoxal reductase (NADPH-dependent, acetol producing)\",metabolic process,0.934\nmethylglyoxal synthase activity,metabolic process,0.846\nmethylguanosine-cap decapping,gene regulation,0.752\n\"methylmalonate-semialdehyde dehydrogenase (acylating, NAD) activity\",metabolic process,0.644\nmethylmalonyl-CoA epimerase activity,metabolic process,0.896\nmethylmalonyl-CoA mutase activity,metabolic process,0.896\nmethylosome,cellular component organization,0.254\nmethylputrescine oxidase activity,metabolic process,0.9\nmethylthioribulose 1-phosphate dehydratase activity,metabolic process,0.852\nmethylthiotransferase activity,metabolic process,0.7\nmethyltransferase activity,metabolic process,0.688\nmethyltransferase complex,gene regulation,0.658\nmethylumbelliferyl-acetate deacetylase activity,metabolic process,0.886\nmevalonate kinase activity,metabolic process,0.796\nmevalonate transmembrane transporter activity,metabolic process,0.302\nmevalonate transport,transport,0.728\nmiRNA catabolic process,metabolic process,0.738\nmiRNA inhibitor activity via base-pairing,gene regulation,0.272\nmiRNA transport,transport,0.848\nmiRNA-mediated gene silencing by inhibition of translation,gene regulation,0.398\nmiRNA-mediated gene silencing by mRNA destabilization,gene regulation,0.482\nmiRNA-mediated post-transcriptional gene silencing,gene regulation,0.528\nmicrobody,cellular component organization,0.498\nmicrobody lumen,cellular component organization,0.622\nmicrobody membrane,cellular component organization,0.704\nmicrofibril,cellular component organization,0.368\nmicrofibril assembly,cellular component organization,0.5\nmicrofibril binding,gene regulation,0.236\nmicrofilament motor activity,transport,0.3\nmicroglia development,morphogenesis/development,0.494\nmicroglia differentiation,morphogenesis/development,0.374\nmicroglial cell activation involved in immune response,immune system process,0.582\nmicroglial cell mediated cytotoxicity,transport,0.194\nmicroglial cell migration,transport,0.17\nmicroglial cell proliferation,cell cycle,0.464\nmicroprocessor complex,cellular component organization,0.23\nmicrospike,cellular component organization,0.356\nmicrospike assembly,cellular component organization,0.398\nmicrotubule anchoring,cellular component organization,0.638\nmicrotubule anchoring at centrosome,cellular component organization,0.208\nmicrotubule anchoring at microtubule organizing center,cellular component organization,0.622\nmicrotubule associated complex,cellular component organization,0.324\nmicrotubule binding,cellular component organization,0.592\nmicrotubule bundle,cellular component organization,0.572\nmicrotubule bundle formation,cellular component organization,0.648\nmicrotubule cytoskeleton,cellular component organization,0.37\nmicrotubule cytoskeleton organization involved in establishment of planar polarity,cellular component organization,0.71\nmicrotubule depolymerization,cellular component organization,0.658\nmicrotubule end,cellular component organization,0.506\nmicrotubule lateral binding,metabolic process,0.212\nmicrotubule minus-end,cellular component organization,0.538\nmicrotubule minus-end binding,cellular component organization,0.286\nmicrotubule motor activity,cellular component organization,0.248\nmicrotubule nucleation by interphase microtubule organizing center,morphogenesis/development,0.278\nmicrotubule nucleation by microtubule organizing center,cellular component organization,0.706\nmicrotubule nucleator activity,cellular component organization,0.286\nmicrotubule organizing center,cellular component organization,0.334\nmicrotubule organizing center attachment site,cellular component organization,0.222\nmicrotubule organizing center localization,transport,0.424\nmicrotubule plus end polymerase,metabolic process,0.838\nmicrotubule plus-end,cellular component organization,0.576\nmicrotubule plus-end directed mitotic chromosome migration,cell cycle,0.312\nmicrotubule polymerization or depolymerization,cellular component organization,0.738\nmicrotubule severing,cellular component organization,0.28\nmicrotubule severing ATPase activity,metabolic process,0.668\nmicrotubule sliding,transport,0.328\nmicrotubule stabilizing activity,cellular component organization,0.368\nmicrotubule-based movement,transport,0.31\nmicrotubule-based peroxisome localization,transport,0.188\nmicrotubule-based process,cellular component organization,0.488\nmicrotubule-based protein transport,transport,0.546\nmicrotubule-based transport,transport,0.534\nmicrotubule-dependent intracellular transport of viral material,transport,0.504\nmicrotubule-dependent intracellular transport of viral material towards nucleus,transport,0.352\nmicrovesicle,cellular component organization,0.648\nmicrovillar actin bundle assembly,cellular component organization,0.536\nmicrovillus membrane,cellular component organization,0.606\nmicturition,morphogenesis/development,0.194\nmidbody,cell cycle,0.402\nmidbody abscission,cell cycle,0.388\nmidbrain development,morphogenesis/development,0.822\nmidbrain dopaminergic neuron differentiation,morphogenesis/development,0.588\nmidbrain morphogenesis,morphogenesis/development,0.576\nmidbrain-hindbrain boundary development,morphogenesis/development,0.98\nmidbrain-hindbrain boundary initiation,morphogenesis/development,0.304\nmidbrain-hindbrain boundary maturation,morphogenesis/development,0.54\nmidbrain-hindbrain boundary maturation during brain development,morphogenesis/development,0.564\nmidbrain-hindbrain boundary morphogenesis,morphogenesis/development,0.684\nmiddle ear morphogenesis,morphogenesis/development,0.638\nmidgut development,morphogenesis/development,0.962\nmigracytosis,transport,0.726\nmigrasome,cellular component organization,0.262\nmineralocorticoid biosynthetic process,metabolic process,0.952\nmineralocorticoid metabolic process,metabolic process,0.976\nmineralocorticoid receptor signaling pathway,receptor related process,0.622\nmineralocorticoid secretion,transport,0.634\nmini excitatory postsynaptic potential,neural related process,0.264\nminor groove of adenine-thymine-rich DNA binding,protein modification/signaling,0.248\nminus-end directed microfilament motor activity,cellular component organization,0.358\nminus-end-directed organelle transport along microtubule,transport,0.802\nmisfolded protein transport,transport,0.756\nmismatch base pair DNA N-glycosylase activity,metabolic process,0.514\nmismatch repair complex,cellular component organization,0.25\nmismatch repair complex binding,metabolic process,0.208\nmismatch repair involved in maintenance of fidelity involved in DNA-dependent DNA replication,stress response,0.624\nmismatched DNA binding,gene regulation,0.508\nmitochondria-associated endoplasmic reticulum membrane,cellular component organization,0.47\nmitochondria-nucleus signaling pathway,receptor related process,0.224\nmitochondrial ADP transmembrane transport,cellular component organization,0.33\nmitochondrial ATP transmembrane transport,cellular component organization,0.314\nmitochondrial ATP-gated potassium channel activity,cellular component organization,0.338\nmitochondrial ATP-gated potassium channel complex,cellular component organization,0.4\nmitochondrial DNA catabolic process,metabolic process,0.796\nmitochondrial DNA metabolic process,metabolic process,0.548\nmitochondrial DNA repair,cellular component organization,0.258\nmitochondrial DNA-directed RNA polymerase complex,gene regulation,0.56\nmitochondrial FAD transmembrane transport,cellular component organization,0.312\nmitochondrial L-ornithine transmembrane transport,cellular component organization,0.312\nmitochondrial NAD transmembrane transport,cellular component organization,0.298\nmitochondrial RNA 3'-end processing,gene regulation,0.76\nmitochondrial RNA 5'-end processing,gene regulation,0.758\nmitochondrial RNA catabolic process,metabolic process,0.74\nmitochondrial RNA modification,gene regulation,0.696\nmitochondrial RNA processing,gene regulation,0.72\nmitochondrial RNA surveillance,gene regulation,0.612\nmitochondrial S-adenosyl-L-methionine transmembrane transport,cellular component organization,0.312\nmitochondrial alanyl-tRNA aminoacylation,metabolic process,0.392\nmitochondrial alpha-ketoglutarate dehydrogenase complex,metabolic process,0.498\nmitochondrial alpha-ketoglutarate transmembrane transport,cellular component organization,0.312\nmitochondrial asparaginyl-tRNA aminoacylation,metabolic process,0.392\nmitochondrial calcium ion homeostasis,other,0.48\nmitochondrial calcium ion transmembrane transport,transport,0.902\nmitochondrial citrate transmembrane transport,transport,0.364\nmitochondrial coenzyme A transmembrane transport,cellular component organization,0.306\nmitochondrial crista,metabolic process,0.314\nmitochondrial crista junction,cellular component organization,0.44\nmitochondrial cytochrome c oxidase assembly,cellular component organization,0.716\nmitochondrial degradosome,cellular component organization,0.246\nmitochondrial depolarization,cellular component organization,0.198\nmitochondrial double-strand break repair,stress response,0.696\nmitochondrial double-strand break repair via homologous recombination,cell cycle,0.21\n\"mitochondrial electron transport, succinate to ubiquinone\",metabolic process,0.768\nmitochondrial endopeptidase Clp complex,cellular component organization,0.36\nmitochondrial envelope,metabolic process,0.464\nmitochondrial fatty acid beta-oxidation multienzyme complex,metabolic process,0.29\nmitochondrial fission,cellular component organization,0.234\nmitochondrial fragmentation involved in apoptotic process,cell death,0.582\nmitochondrial glycyl-tRNA aminoacylation,metabolic process,0.394\nmitochondrial inner membrane,metabolic process,0.656\nmitochondrial inner membrane peptidase complex,cellular component organization,0.476\nmitochondrial intermembrane space,cellular component organization,0.29\nmitochondrial intermembrane space protein transporter complex,cellular component organization,0.334\nmitochondrial iron-sulfur cluster assembly complex,protein modification/signaling,0.28\nmitochondrial isocitrate dehydrogenase complex (NAD+),cellular component organization,0.346\nmitochondrial large ribosomal subunit,cellular component organization,0.472\nmitochondrial large ribosomal subunit assembly,cellular component organization,0.7\nmitochondrial large ribosomal subunit binding,cellular component organization,0.246\nmitochondrial mRNA catabolic process,metabolic process,0.746\nmitochondrial mRNA polyadenylation,gene regulation,0.442\nmitochondrial mRNA processing,gene regulation,0.762\nmitochondrial mRNA surveillance,gene regulation,0.458\nmitochondrial magnesium ion transmembrane transport,transport,0.906\nmitochondrial manganese ion transmembrane transport,transport,0.29\nmitochondrial matrix,metabolic process,0.486\nmitochondrial membrane,metabolic process,0.412\nmitochondrial membrane fission,cellular component organization,0.408\nmitochondrial ncRNA surveillance,gene regulation,0.452\nmitochondrial nucleoid,cell cycle,0.236\nmitochondrial nucleoid organization,cellular component organization,0.618\nmitochondrial outer membrane,cellular component organization,0.348\nmitochondrial outer membrane permeabilization,cell death,0.538\nmitochondrial outer membrane permeabilization involved in programmed cell death,cell death,0.394\nmitochondrial outer membrane translocase complex,cellular component organization,0.384\nmitochondrial oxoglutarate dehydrogenase complex,cellular component organization,0.43\nmitochondrial permeability transition pore complex,cellular component organization,0.414\nmitochondrial phosphate ion transmembrane transport,transport,0.28\nmitochondrial potassium ion transmembrane transport,transport,0.29\nmitochondrial processing peptidase complex,cellular component organization,0.224\nmitochondrial prohibitin complex,cellular component organization,0.398\nmitochondrial promoter sequence-specific DNA binding,gene regulation,0.258\nmitochondrial protein catabolic process,metabolic process,0.488\nmitochondrial protein processing,protein modification/signaling,0.426\nmitochondrial protein-containing complex,metabolic process,0.422\nmitochondrial proton-transporting ATP synthase complex,cellular component organization,0.404\nmitochondrial proton-transporting ATP synthase complex assembly,cellular component organization,0.558\nmitochondrial proton-transporting ATP synthase complex binding,metabolic process,0.264\n\"mitochondrial proton-transporting ATP synthase complex, catalytic sector F(1)\",cellular component organization,0.434\n\"mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)\",cellular component organization,0.456\n\"mitochondrial proton-transporting ATP synthase, catalytic core\",metabolic process,0.396\n\"mitochondrial proton-transporting ATP synthase, stator stalk\",metabolic process,0.394\nmitochondrial pyruvate dehydrogenase complex,metabolic process,0.37\nmitochondrial pyruvate transmembrane transport,cellular component organization,0.316\nmitochondrial respirasome,metabolic process,0.608\nmitochondrial respirasome assembly,cellular component organization,0.558\nmitochondrial respiratory chain complex I,metabolic process,0.53\nmitochondrial respiratory chain complex II assembly,cellular component organization,0.73\n\"mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)\",cellular component organization,0.378\nmitochondrial respiratory chain complex III,cellular component organization,0.41\nmitochondrial respiratory chain complex III assembly,cellular component organization,0.71\nmitochondrial respiratory chain complex IV,cellular component organization,0.364\nmitochondrial ribonuclease P complex,gene regulation,0.332\nmitochondrial ribosomal large subunit rRNA binding,gene regulation,0.502\nmitochondrial ribosome,cellular component organization,0.238\nmitochondrial ribosome assembly,cellular component organization,0.556\nmitochondrial ribosome binding,cellular component organization,0.208\nmitochondrial seryl-tRNA aminoacylation,metabolic process,0.39\nmitochondrial small ribosomal subunit,cellular component organization,0.434\nmitochondrial tRNA 3'-end processing,gene regulation,0.21\nmitochondrial tRNA 5'-end processing,gene regulation,0.228\nmitochondrial tRNA methylation,gene regulation,0.234\nmitochondrial tRNA modification,gene regulation,0.656\nmitochondrial tRNA processing,gene regulation,0.734\nmitochondrial tRNA pseudouridine synthesis,cellular component organization,0.254\nmitochondrial threonyl-tRNA aminoacylation,metabolic process,0.392\nmitochondrial transcription,gene regulation,0.454\nmitochondrial transcription factor activity,gene regulation,0.538\nmitochondrial translational elongation,protein modification/signaling,0.408\nmitochondrial translational initiation,gene regulation,0.278\nmitochondrial translational termination,cellular component organization,0.246\nmitochondrial tricarboxylic acid cycle enzyme complex,metabolic process,0.51\nmitochondrial tricarboxylic acid transmembrane transport,transport,0.82\nmitochondrial tryptophanyl-tRNA aminoacylation,metabolic process,0.394\nmitochondrial tyrosyl-tRNA aminoacylation,metabolic process,0.37\nmitochondrial unfolded protein response,protein modification/signaling,0.27\nmitochondrion,metabolic process,0.436\nmitochondrion distribution,cellular component organization,0.552\nmitochondrion localization,transport,0.604\nmitochondrion migration along actin filament,transport,0.318\nmitochondrion targeting sequence binding,protein modification/signaling,0.208\nmitochondrion to lysosome transport,cellular component organization,0.204\nmitochondrion transport along microtubule,transport,0.818\nmitochondrion-derived vesicle,cellular component organization,0.292\nmitochondrion-derived vesicle mediated transport,transport,0.726\nmitochondrion-endoplasmic reticulum membrane tethering,cellular component organization,0.308\nmitocytosis,cellular component organization,0.188\nmitogen-activated protein kinase kinase binding,protein modification/signaling,0.58\nmitogen-activated protein kinase kinase kinase binding,protein modification/signaling,0.652\nmitogen-activated protein kinase p38 binding,protein modification/signaling,0.472\nmitotic DNA damage checkpoint signaling,cell cycle,0.724\nmitotic DNA replication,cell cycle,0.77\nmitotic DNA replication checkpoint signaling,cell cycle,0.368\nmitotic DNA replication initiation,cell cycle,0.508\nmitotic DNA replication maintenance of fidelity,cell cycle,0.652\nmitotic DNA replication preinitiation complex assembly,cell cycle,0.4\nmitotic DNA replication termination,cell cycle,0.474\nmitotic DNA-templated DNA replication,cell cycle,0.486\nmitotic actomyosin contractile ring assembly,cellular component organization,0.316\nmitotic actomyosin contractile ring assembly actin filament organization,cell cycle,0.484\nmitotic cell cycle process,cell cycle,0.836\n\"mitotic cell cycle, embryonic\",cell cycle,0.622\nmitotic centrosome separation,cell cycle,0.318\nmitotic checkpoint complex,cell cycle,0.3\nmitotic chromosome movement towards spindle pole,transport,0.352\nmitotic cleavage furrow formation,cell cycle,0.294\nmitotic cleavage furrow ingression,cell cycle,0.372\nmitotic cohesin complex,cellular component organization,0.392\nmitotic cohesin loading,cell cycle,0.506\nmitotic cytokinesis checkpoint signaling,cell cycle,0.398\nmitotic cytokinetic process,cell cycle,0.484\nmitotic intra-S DNA damage checkpoint signaling,cell cycle,0.46\nmitotic metaphase chromosome alignment,cell cycle,0.698\nmitotic nuclear membrane disassembly,cellular component organization,0.458\nmitotic nuclear membrane organization,cellular component organization,0.5\nmitotic nuclear membrane reassembly,cell cycle,0.344\nmitotic recombination,cell cycle,0.58\nmitotic recombination-dependent replication fork processing,protein modification/signaling,0.202\nmitotic sister chromatid biorientation,cell cycle,0.348\n\"mitotic sister chromatid cohesion, centromeric\",cellular component organization,0.196\n\"mitotic sister chromatid cohesion, telomeric\",cellular component organization,0.194\nmitotic spindle,cell cycle,0.39\nmitotic spindle assembly checkpoint MAD1-MAD2 complex,cellular component organization,0.248\nmitotic spindle astral microtubule,cell cycle,0.28\nmitotic spindle astral microtubule end,cellular component organization,0.27\nmitotic spindle disassembly,cell cycle,0.342\nmitotic spindle elongation,cell cycle,0.628\nmitotic spindle microtubule,cellular component organization,0.434\nmitotic spindle microtubule depolymerization,cell cycle,0.218\nmitotic spindle midzone,cellular component organization,0.236\nmitotic spindle midzone assembly,cell cycle,0.402\nmitotic spindle pole,cell cycle,0.324\nmitotic telomere maintenance via semi-conservative replication,cell cycle,0.352\nmitral valve formation,morphogenesis/development,0.702\nmitral valve morphogenesis,morphogenesis/development,0.614\nmodification of dendritic spine,cellular component organization,0.254\nmodification of postsynaptic actin cytoskeleton,cellular component organization,0.29\nmodification of synaptic structure,neural related process,0.61\nmodified amino acid transmembrane transporter activity,transport,0.78\nmodified amino acid transport,transport,0.97\nmodulation by host of RNA binding by virus,gene regulation,0.418\nmodulation by host of symbiont catalytic activity,metabolic process,0.246\nmodulation by host of symbiont transcription,gene regulation,0.23\nmodulation by host of viral RNA genome replication,viral related process,0.364\nmodulation by host of viral RNA-binding transcription factor activity,viral related process,0.272\nmodulation by host of viral catalytic activity,viral related process,0.356\nmodulation by host of viral exo-alpha-sialidase activity,metabolic process,0.304\nmodulation by host of viral glycoprotein metabolic process,viral related process,0.424\nmodulation by host of viral molecular function,viral related process,0.404\nmodulation by host of viral transcription,viral related process,0.508\nmodulation by symbiont of host cellular process,cell death,0.206\nmodulation by symbiont of host process,immune system process,0.146\nmodulation by virus of host autophagy,viral related process,0.272\nmodulation by virus of host cellular process,gene regulation,0.196\nmodulation by virus of host process,metabolic process,0.22\nmodulation of inhibitory postsynaptic potential,neural related process,0.432\nmodulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration,cellular component organization,0.53\nmodulation of process of another organism,protein modification/signaling,0.128\nmolecular carrier activity,transport,0.24\nmolecular condensate scaffold activity,gene regulation,0.234\nmolecular function activator activity,protein modification/signaling,0.176\nmolecular function regulator activity,protein modification/signaling,0.202\nmolecular sequestering activity,transport,0.186\nmolecular tag activity,protein modification/signaling,0.34\nmolecular template activity,metabolic process,0.182\nmolecular_function,metabolic process,0.39\nmolybdate ion transmembrane transporter activity,transport,0.606\nmolybdate ion transport,transport,0.934\nmolybdenum cofactor sulfurtransferase activity,metabolic process,0.9\nmolybdenum incorporation into molybdenum-molybdopterin complex,protein modification/signaling,0.598\nmolybdenum ion binding,metabolic process,0.234\nmolybdopterin adenylyltransferase activity,metabolic process,0.768\nmolybdopterin cofactor binding,metabolic process,0.512\nmolybdopterin cofactor biosynthetic process,metabolic process,0.958\nmolybdopterin cofactor metabolic process,metabolic process,0.962\nmolybdopterin molybdotransferase activity,metabolic process,0.842\nmolybdopterin synthase activity,metabolic process,0.518\nmolybdopterin synthase complex,cellular component organization,0.366\nmolybdopterin-synthase adenylyltransferase activity,metabolic process,0.768\nmolybdopterin-synthase sulfurtransferase activity,metabolic process,0.842\nmono-ADP-D-ribose binding,metabolic process,0.244\nmono-olein transacylation activity,metabolic process,0.87\nmonoacylglycerol biosynthetic process,metabolic process,0.902\nmonoacylglycerol catabolic process,metabolic process,0.884\nmonoacylglycerol metabolic process,metabolic process,0.98\nmonoamine oxidase activity,metabolic process,0.896\nmonoamine transmembrane transporter activity,transport,0.614\nmonoamine transport,transport,0.674\nmonoamine:proton antiporter activity,metabolic process,0.522\nmonoatomic anion channel activity,transport,0.636\nmonoatomic anion homeostasis,other,0.712\nmonoatomic anion transmembrane transporter activity,transport,0.806\nmonoatomic anion transport,transport,0.966\nmonoatomic anion:monoatomic cation symporter activity,transport,0.58\nmonoatomic anion:sodium symporter activity,transport,0.538\nmonoatomic cation channel activity,transport,0.594\nmonoatomic cation efflux transmembrane transporter activity,transport,0.62\nmonoatomic cation homeostasis,other,0.578\nmonoatomic cation transmembrane transport,transport,0.736\nmonoatomic cation transmembrane transporter activity,transport,0.732\nmonoatomic cation transport,transport,0.802\nmonoatomic cation:bicarbonate symporter activity,transport,0.534\nmonoatomic ion antiporter activity involved in regulation of postsynaptic membrane potential,cellular component organization,0.262\nmonoatomic ion channel activity,transport,0.71\nmonoatomic ion channel complex,transport,0.398\nmonoatomic ion homeostasis,other,0.756\nmonoatomic ion transmembrane transport,transport,0.704\nmonoatomic ion transmembrane transporter activity,transport,0.772\nmonoatomic ion transport,transport,0.778\nmonocarboxylate:sodium symporter activity,transport,0.566\nmonocarboxylic acid binding,metabolic process,0.458\nmonocarboxylic acid transmembrane transporter activity,transport,0.73\nmonocyte activation,immune system process,0.746\nmonocyte activation involved in immune response,immune system process,0.546\nmonocyte aggregation,metabolic process,0.196\nmonocyte chemotactic protein-1 production,immune system process,0.702\nmonocyte extravasation,cellular component organization,0.162\nmonocyte homeostasis,immune system process,0.338\nmonocyte proliferation,cell cycle,0.406\nmonomeric IgA immunoglobulin complex,cellular component organization,0.262\nmonosaccharide transmembrane transporter activity,transport,0.72\nmonoterpenoid metabolic process,metabolic process,0.998\nmonoubiquitinated histone H2A deubiquitination,protein modification/signaling,0.46\nmonoubiquitinated histone deubiquitination,protein modification/signaling,0.796\nmonounsaturated fatty acid catabolic process,metabolic process,0.88\nmonounsaturated fatty acid metabolic process,metabolic process,0.98\nmorphine receptor activity,protein modification/signaling,0.218\nmorphogen activity,morphogenesis/development,0.192\nmorphogenesis of an endothelium,morphogenesis/development,0.838\nmorphogenesis of an epithelial bud,morphogenesis/development,0.79\nmorphogenesis of an epithelial sheet,morphogenesis/development,0.778\nmorphogenesis of follicular epithelium,morphogenesis/development,0.696\nmossy fiber rosette,cellular component organization,0.208\nmotile cilium,cellular component organization,0.37\nmotile cilium assembly,cellular component organization,0.836\nmotilin receptor binding,receptor related process,0.502\nmotor behavior,multicellular organismal process,0.402\nmotor learning,morphogenesis/development,0.24\nmotor neuron apoptotic process,cell death,0.456\nmotor neuron migration,neural related process,0.33\nmu-type opioid receptor binding,receptor related process,0.49\nmucin granule,cellular component organization,0.23\nmucociliary clearance,immune system process,0.156\nmucosa-associated lymphoid tissue development,morphogenesis/development,0.828\nmucus layer,cellular component organization,0.344\nmucus secretion,immune system process,0.312\nmulti-ciliated epithelial cell differentiation,morphogenesis/development,0.666\nmulti-eIF complex,gene regulation,0.244\nmulti-layer follicle stage,cellular component organization,0.208\nmulti-pass translocon complex,ER/endosome/lysosome related process,0.312\nmulti-pass transmembrane protein insertion into ER membrane,ER/endosome/lysosome related process,0.274\nmulticellular organism development,morphogenesis/development,0.256\nmulticellular organism reproduction,morphogenesis/development,0.342\nmulticellular organismal locomotion,multicellular organismal process,0.252\nmulticellular organismal movement,multicellular organismal process,0.332\nmulticellular organismal process,metabolic process,0.192\nmulticellular organismal reproductive process,morphogenesis/development,0.364\nmulticellular organismal response to stress,response to stimulus,0.414\nmulticellular organismal-level chemical homeostasis,multicellular organismal process,0.388\nmulticellular organismal-level homeostasis,multicellular organismal process,0.448\nmulticellular organismal-level iron ion homeostasis,multicellular organismal process,0.25\nmulticellular organismal-level water homeostasis,multicellular organismal process,0.42\nmultimeric ribonuclease P complex,gene regulation,0.486\nmultimerin complex,cellular component organization,0.286\nmultinuclear osteoclast differentiation,morphogenesis/development,0.598\nmultiple spine synapse organization,cellular component organization,0.844\n\"multiple spine synapse organization, single dendrite\",cellular component organization,0.62\nmultivesicular body,cellular component organization,0.266\nmultivesicular body assembly,cellular component organization,0.612\nmultivesicular body lumen,cellular component organization,0.354\nmultivesicular body membrane,metabolic process,0.256\nmultivesicular body organization,cellular component organization,0.798\nmultivesicular body sorting pathway,transport,0.54\n\"multivesicular body, internal vesicle\",cellular component organization,0.19\n\"multivesicular body, internal vesicle lumen\",cellular component organization,0.316\nmultivesicular body-lysosome fusion,cellular component organization,0.438\nmuramyl dipeptide binding,cellular component organization,0.204\nmuscle adaptation,multicellular organismal process,0.572\nmuscle alpha-actinin binding,transport,0.22\nmuscle atrophy,multicellular organismal process,0.418\nmuscle attachment,morphogenesis/development,0.51\nmuscle cell cellular homeostasis,morphogenesis/development,0.268\nmuscle cell development,morphogenesis/development,0.836\nmuscle cell fate commitment,morphogenesis/development,0.698\nmuscle cell fate determination,morphogenesis/development,0.668\nmuscle cell fate specification,morphogenesis/development,0.574\nmuscle cell projection,morphogenesis/development,0.288\nmuscle cell projection membrane,cellular component organization,0.4\nmuscle filament sliding,cellular component organization,0.362\nmuscle hyperplasia,multicellular organismal process,0.466\nmuscle hypertrophy in response to stress,multicellular organismal process,0.436\nmuscle myosin complex,cellular component organization,0.3\nmuscle organ morphogenesis,morphogenesis/development,0.878\nmuscle tendon junction,cellular component organization,0.254\nmuscle thin filament tropomyosin,cellular component organization,0.49\nmuscle tissue morphogenesis,morphogenesis/development,0.842\nmuscular septum morphogenesis,morphogenesis/development,0.366\nmusculoskeletal movement,multicellular organismal process,0.344\n\"musculoskeletal movement, spinal reflex action\",immune system process,0.224\nmycophenolic acid acyl-glucuronide esterase activity,metabolic process,0.904\nmycotoxin catabolic process,metabolic process,0.926\nmycotoxin metabolic process,metabolic process,0.946\nmyelin assembly,morphogenesis/development,0.4\nmyelin sheath,neural related process,0.51\nmyelin sheath abaxonal region,cellular component organization,0.24\nmyelin sheath adaxonal region,cellular component organization,0.21\nmyelination in peripheral nervous system,neural related process,0.518\nmyeloid cell apoptotic process,cell death,0.77\nmyeloid dendritic cell activation involved in immune response,immune system process,0.816\nmyeloid dendritic cell antigen processing and presentation,immune system process,0.386\nmyeloid dendritic cell chemotaxis,immune system process,0.678\nmyeloid dendritic cell cytokine production,immune system process,0.596\nmyeloid progenitor cell differentiation,immune system process,0.378\nmyo-inositol import across plasma membrane,transport,0.466\nmyo-inositol transmembrane transporter activity,transport,0.626\nmyo-inositol transport,transport,0.938\n\"myo-inositol-1,2,3,4,6-heptakisphosphate 5-kinase activity\",metabolic process,0.796\nmyo-inositol:proton symporter activity,metabolic process,0.526\nmyo-inositol:sodium symporter activity,metabolic process,0.522\nmyoblast development,morphogenesis/development,0.982\nmyoblast differentiation involved in skeletal muscle regeneration,morphogenesis/development,0.642\nmyoblast fate commitment,morphogenesis/development,0.666\nmyoblast fate determination,morphogenesis/development,0.704\nmyoblast fate specification,morphogenesis/development,0.612\nmyoblast fusion involved in skeletal muscle regeneration,morphogenesis/development,0.224\nmyoblast migration,multicellular organismal process,0.28\nmyoblast migration involved in skeletal muscle regeneration,morphogenesis/development,0.246\nmyofibril assembly,cellular component organization,0.566\nmyofibroblast cell apoptotic process,cell death,0.224\nmyofibroblast contraction,cellular component organization,0.374\nmyofibroblast differentiation,morphogenesis/development,0.422\nmyofilament,cellular component organization,0.554\nmyosin I binding,protein modification/signaling,0.356\nmyosin II binding,protein modification/signaling,0.34\nmyosin II complex,cellular component organization,0.532\nmyosin II filament,cellular component organization,0.328\nmyosin II filament disassembly,cellular component organization,0.356\nmyosin II filament organization,cellular component organization,0.884\nmyosin II head/neck binding,metabolic process,0.23\nmyosin II heavy chain binding,protein modification/signaling,0.376\nmyosin V complex,transport,0.398\nmyosin VI binding,cellular component organization,0.306\nmyosin VI light chain binding,cellular component organization,0.262\nmyosin VII complex,cellular component organization,0.29\nmyosin complex,cellular component organization,0.322\nmyosin filament,cellular component organization,0.636\nmyosin filament assembly,cellular component organization,0.898\nmyosin filament disassembly,cellular component organization,0.788\nmyosin filament organization,cellular component organization,0.882\nmyosin head/neck binding,protein modification/signaling,0.408\nmyosin heavy chain binding,protein modification/signaling,0.346\nmyosin light chain binding,protein modification/signaling,0.364\nmyosin light chain kinase activity,metabolic process,0.748\nmyosin phosphatase activity,metabolic process,0.64\nmyosin phosphatase regulator activity,metabolic process,0.246\nmyosin tail binding,protein modification/signaling,0.4\nmyosin-light-chain-phosphatase activity,metabolic process,0.82\nmyotome development,morphogenesis/development,0.88\nmyotube cell development,morphogenesis/development,0.79\nmyotube cell development involved in skeletal muscle regeneration,morphogenesis/development,0.516\nmyotube differentiation involved in skeletal muscle regeneration,morphogenesis/development,0.658\nmyristoyl-CoA hydrolase activity,metabolic process,0.908\nmyristoyl-[acyl-carrier-protein] hydrolase activity,metabolic process,0.9\nmyristoyltransferase activity,metabolic process,0.942\nnBAF complex,gene regulation,0.268\nnail development,morphogenesis/development,0.97\nnaphthalene catabolic process,metabolic process,0.89\nnarrow pore channel activity,transport,0.558\nnascent polypeptide-associated complex,protein modification/signaling,0.222\nnatriuretic peptide receptor activity,receptor related process,0.212\nnatural killer cell activation involved in immune response,immune system process,0.868\nnatural killer cell apoptotic process,cell death,0.472\nnatural killer cell chemotaxis,immune system process,0.718\nnatural killer cell cytokine production,immune system process,0.648\nnatural killer cell degranulation,immune system process,0.202\nnatural killer cell differentiation involved in immune response,immune system process,0.502\nnatural killer cell inhibitory signaling pathway,immune system process,0.624\nnatural killer cell lectin-like receptor binding,receptor related process,0.384\nnatural killer cell mediated cytotoxicity directed against tumor cell target,immune system process,0.414\nnatural killer cell mediated immune response to tumor cell,immune system process,0.886\nnatural killer cell proliferation,immune system process,0.87\nnatural killer cell tolerance induction,immune system process,0.314\nncRNA 5'-end processing,gene regulation,0.884\nncRNA catabolic process,metabolic process,0.72\nncRNA deadenylation,cellular component organization,0.224\nncRNA export from nucleus,transport,0.826\nncRNA transcription,gene regulation,0.62\nnecroptotic signaling pathway,cell death,0.462\nnegative T cell selection,immune system process,0.586\nnegative cofactor 2 complex,gene regulation,0.48\nnegative regulation by host of symbiont catalytic activity,metabolic process,0.27\nnegative regulation by host of viral exo-alpha-sialidase activity,metabolic process,0.276\nnegative regulation by host of viral genome replication,viral related process,0.408\nnegative regulation by host of viral glycoprotein metabolic process,viral related process,0.306\nnegative regulation by host of viral process,viral related process,0.666\nnegative regulation by host of viral transcription,viral related process,0.456\nnegative regulation by virus of viral protein levels in host cell,viral related process,0.218\nnegative regulation of 3'-UTR-mediated mRNA stabilization,gene regulation,0.206\nnegative regulation of AIM2 inflammasome complex assembly,cellular component organization,0.34\nnegative regulation of ATF6-mediated unfolded protein response,protein modification/signaling,0.298\nnegative regulation of ATP biosynthetic process,metabolic process,0.538\nnegative regulation of ATP citrate synthase activity,metabolic process,0.16\nnegative regulation of ATP metabolic process,metabolic process,0.58\nnegative regulation of ATP-dependent activity,metabolic process,0.258\nnegative regulation of ATPase-coupled calcium transmembrane transporter activity,transport,0.21\nnegative regulation of Arp2/3 complex-mediated actin nucleation,protein modification/signaling,0.262\nnegative regulation of B cell apoptotic process,immune system process,0.51\nnegative regulation of B cell differentiation,immune system process,0.796\nnegative regulation of B cell mediated immunity,immune system process,0.94\nnegative regulation of B cell proliferation,immune system process,0.246\nnegative regulation of B cell receptor signaling pathway,receptor related process,0.33\nnegative regulation of BMP signaling pathway,receptor related process,0.51\nnegative regulation of CD4 production,metabolic process,0.738\n\"negative regulation of CD4-positive, alpha-beta T cell activation\",immune system process,0.974\n\"negative regulation of CD4-positive, alpha-beta T cell costimulation\",cell cycle,0.12\n\"negative regulation of CD4-positive, alpha-beta T cell differentiation\",immune system process,0.96\n\"negative regulation of CD4-positive, alpha-beta T cell proliferation\",immune system process,0.388\nnegative regulation of CD40 signaling pathway,protein modification/signaling,0.256\n\"negative regulation of CD8-positive, alpha-beta T cell activation\",immune system process,0.878\n\"negative regulation of CD8-positive, alpha-beta T cell differentiation\",immune system process,0.368\n\"negative regulation of CD8-positive, alpha-beta T cell proliferation\",cell cycle,0.21\nnegative regulation of CREB transcription factor activity,gene regulation,0.214\nnegative regulation of D-amino-acid oxidase activity,immune system process,0.136\nnegative regulation of DNA catabolic process,metabolic process,0.346\nnegative regulation of DNA damage checkpoint,cell cycle,0.654\n\"negative regulation of DNA damage response, signal transduction by p53 class mediator\",protein modification/signaling,0.3\nnegative regulation of DNA demethylation,cell cycle,0.212\nnegative regulation of DNA duplex unwinding,cellular component organization,0.476\nnegative regulation of DNA endoreduplication,cell cycle,0.228\nnegative regulation of DNA helicase activity,cell cycle,0.272\nnegative regulation of DNA ligase activity,cell cycle,0.22\nnegative regulation of DNA ligation,cell cycle,0.412\nnegative regulation of DNA methylation,cell cycle,0.224\nnegative regulation of DNA methylation-dependent heterochromatin formation,morphogenesis/development,0.2\nnegative regulation of DNA recombination,cell cycle,0.488\nnegative regulation of DNA recombination at telomere,cell cycle,0.424\nnegative regulation of DNA repair,stress response,0.72\nnegative regulation of DNA-templated DNA replication,cell cycle,0.68\nnegative regulation of DNA-templated transcription initiation,gene regulation,0.842\n\"negative regulation of DNA-templated transcription, elongation\",gene regulation,0.828\nnegative regulation of ER-associated ubiquitin-dependent protein catabolic process,protein modification/signaling,0.266\nnegative regulation of ERAD pathway,ER/endosome/lysosome related process,0.296\nnegative regulation of ERBB4 signaling pathway,protein modification/signaling,0.302\nnegative regulation of Fas signaling pathway,protein modification/signaling,0.294\nnegative regulation of FasL production,metabolic process,0.736\nnegative regulation of Fc-gamma receptor signaling pathway involved in phagocytosis,receptor related process,0.318\nnegative regulation of G protein-coupled receptor internalization,receptor related process,0.286\nnegative regulation of G0 to G1 transition,cell cycle,0.312\nnegative regulation of G1 to G0 transition,cell cycle,0.154\nnegative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter,cell cycle,0.368\nnegative regulation of GTP binding,gene regulation,0.164\nnegative regulation of GTP cyclohydrolase I activity,metabolic process,0.334\nnegative regulation of Golgi to plasma membrane protein transport,cellular component organization,0.258\nnegative regulation of I-kappaB phosphorylation,protein modification/signaling,0.174\nnegative regulation of IP-10 production,immune system process,0.558\nnegative regulation of IRE1-mediated unfolded protein response,protein modification/signaling,0.302\nnegative regulation of JNK cascade,protein modification/signaling,0.432\nnegative regulation of JUN kinase activity,protein modification/signaling,0.238\nnegative regulation of Kit signaling pathway,protein modification/signaling,0.294\nnegative regulation of L-glutamate import across plasma membrane,transport,0.716\nnegative regulation of Lewy body formation,morphogenesis/development,0.234\nnegative regulation of MDA-5 signaling pathway,protein modification/signaling,0.304\nnegative regulation of MHC class I biosynthetic process,metabolic process,0.732\nnegative regulation of MHC class II biosynthetic process,metabolic process,0.668\nnegative regulation of MyD88-dependent toll-like receptor signaling pathway,immune system process,0.33\nnegative regulation of MyD88-independent toll-like receptor signaling pathway,immune system process,0.33\nnegative regulation of N-terminal protein palmitoylation,protein modification/signaling,0.512\nnegative regulation of NAD(P)H oxidase activity,metabolic process,0.36\nnegative regulation of NK T cell activation,immune system process,0.894\nnegative regulation of NK T cell proliferation,immune system process,0.244\nnegative regulation of NLRP3 inflammasome complex assembly,cellular component organization,0.302\nnegative regulation of NMDA glutamate receptor activity,receptor related process,0.302\nnegative regulation of Notch signaling pathway,protein modification/signaling,0.464\nnegative regulation of Notch signaling pathway involved in somitogenesis,protein modification/signaling,0.256\nnegative regulation of PERK-mediated unfolded protein response,protein modification/signaling,0.308\nnegative regulation of RIG-I signaling pathway,protein modification/signaling,0.294\nnegative regulation of RNA binding,gene regulation,0.576\nnegative regulation of RNA biosynthetic process,gene regulation,0.662\nnegative regulation of RNA catabolic process,gene regulation,0.642\nnegative regulation of RNA export from nucleus,transport,0.736\nnegative regulation of RNA metabolic process,gene regulation,0.5\nnegative regulation of RNA polymerase II regulatory region sequence-specific DNA binding,gene regulation,0.474\nnegative regulation of RNA polymerase II transcription preinitiation complex assembly,gene regulation,0.464\nnegative regulation of RNA-dependent RNA polymerase activity,gene regulation,0.39\nnegative regulation of Rac protein signal transduction,protein modification/signaling,0.614\nnegative regulation of Rho guanyl-nucleotide exchange factor activity,protein modification/signaling,0.142\nnegative regulation of Rho-dependent protein serine/threonine kinase activity,protein modification/signaling,0.43\nnegative regulation of SCF-dependent proteasomal ubiquitin-dependent catabolic process,metabolic process,0.614\nnegative regulation of SMAD protein signal transduction,protein modification/signaling,0.458\nnegative regulation of SNARE complex assembly,cellular component organization,0.396\nnegative regulation of SREBP signaling pathway,receptor related process,0.312\nnegative regulation of Schwann cell migration,cell cycle,0.206\nnegative regulation of Schwann cell proliferation,neural related process,0.314\nnegative regulation of Schwann cell proliferation involved in axon regeneration,cell cycle,0.214\nnegative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,immune system process,0.22\nnegative regulation of T cell costimulation,immune system process,0.808\nnegative regulation of T cell differentiation in thymus,immune system process,0.814\nnegative regulation of T cell extravasation,immune system process,0.802\nnegative regulation of T cell mediated cytotoxicity,immune system process,0.91\nnegative regulation of T cell mediated immune response to tumor cell,immune system process,0.87\nnegative regulation of T cell migration,immune system process,0.838\nnegative regulation of T-helper 1 cell activation,immune system process,0.224\nnegative regulation of T-helper 1 cell differentiation,morphogenesis/development,0.214\nnegative regulation of T-helper 1 type immune response,immune system process,0.932\nnegative regulation of T-helper 17 cell differentiation,immune system process,0.902\nnegative regulation of T-helper 17 cell lineage commitment,immune system process,0.19\nnegative regulation of T-helper 17 type immune response,immune system process,0.83\nnegative regulation of T-helper 2 cell cytokine production,immune system process,0.484\nnegative regulation of T-helper 2 cell differentiation,morphogenesis/development,0.234\nnegative regulation of T-helper cell differentiation,immune system process,0.934\nnegative regulation of TOR signaling,protein modification/signaling,0.486\nnegative regulation of TORC1 signaling,protein modification/signaling,0.266\nnegative regulation of TORC2 signaling,protein modification/signaling,0.28\nnegative regulation of TRAIL-activated apoptotic signaling pathway,cell death,0.254\nnegative regulation of Toll signaling pathway,protein modification/signaling,0.3\nnegative regulation of UDP-glucose catabolic process,metabolic process,0.734\nnegative regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly,cellular component organization,0.33\nnegative regulation of Wnt protein secretion,protein modification/signaling,0.29\nnegative regulation of Wnt signaling pathway involved in digestive tract morphogenesis,protein modification/signaling,0.27\nnegative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,protein modification/signaling,0.258\nnegative regulation of Wnt signaling pathway involved in heart development,morphogenesis/development,0.364\nnegative regulation of Wnt-Frizzled-LRP5/6 complex assembly,cellular component organization,0.328\nnegative regulation of acetylcholine-gated cation channel activity,protein modification/signaling,0.14\nnegative regulation of acrosome reaction,metabolic process,0.47\nnegative regulation of actin binding,protein modification/signaling,0.324\nnegative regulation of actin filament binding,cellular component organization,0.208\nnegative regulation of actin filament bundle assembly,cellular component organization,0.866\nnegative regulation of actin filament depolymerization,cellular component organization,0.928\nnegative regulation of actin filament polymerization,cellular component organization,0.928\nnegative regulation of actin filament severing,cellular component organization,0.284\nnegative regulation of actin nucleation,cellular component organization,0.742\nnegative regulation of action potential,neural related process,0.406\n\"negative regulation of activated CD8-positive, alpha-beta T cell apoptotic process\",cell death,0.258\nnegative regulation of activated T cell proliferation,immune system process,0.384\nnegative regulation of activation of Janus kinase activity,protein modification/signaling,0.258\nnegative regulation of activation of membrane attack complex,cellular component organization,0.398\nnegative regulation of activation-induced cell death of T cells,immune system process,0.306\nnegative regulation of activin receptor signaling pathway,receptor related process,0.712\nnegative regulation of acute inflammatory response,immune system process,0.684\nnegative regulation of acute inflammatory response to antigenic stimulus,immune system process,0.87\nnegative regulation of adaptive immune memory response,immune system process,0.386\nnegative regulation of adenosine receptor signaling pathway,receptor related process,0.438\nnegative regulation of adenylate cyclase activity,immune system process,0.18\nnegative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway,receptor related process,0.836\nnegative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway,receptor related process,0.76\nnegative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,receptor related process,0.308\nnegative regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process,receptor related process,0.31\nnegative regulation of adherens junction organization,morphogenesis/development,0.174\nnegative regulation of adiponectin secretion,morphogenesis/development,0.118\nnegative regulation of adipose tissue development,morphogenesis/development,0.15\nnegative regulation of alcohol biosynthetic process,metabolic process,0.72\nnegative regulation of aldosterone biosynthetic process,metabolic process,0.712\nnegative regulation of aldosterone metabolic process,metabolic process,0.88\nnegative regulation of alkaline phosphatase activity,metabolic process,0.578\n\"negative regulation of all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity\",metabolic process,0.172\nnegative regulation of alpha-beta T cell proliferation,immune system process,0.908\nnegative regulation of amacrine cell differentiation,morphogenesis/development,0.21\nnegative regulation of amine catabolic process,metabolic process,0.854\nnegative regulation of amine metabolic process,metabolic process,0.904\nnegative regulation of amine transport,transport,0.792\nnegative regulation of amino acid biosynthetic process,metabolic process,0.602\nnegative regulation of amino acid transport,transport,0.836\nnegative regulation of amniotic stem cell differentiation,morphogenesis/development,0.23\nnegative regulation of amyloid fibril formation,morphogenesis/development,0.198\nnegative regulation of amyloid precursor protein biosynthetic process,metabolic process,0.614\nnegative regulation of amyloid precursor protein catabolic process,metabolic process,0.554\nnegative regulation of amyloid-beta clearance,immune system process,0.132\nnegative regulation of amyloid-beta formation,morphogenesis/development,0.186\nnegative regulation of androgen biosynthetic process,metabolic process,0.244\nnegative regulation of androgen receptor signaling pathway,receptor related process,0.364\nnegative regulation of anion channel activity,transport,0.69\nnegative regulation of anion transmembrane transport,transport,0.77\nnegative regulation of anoikis,cell death,0.262\nnegative regulation of anti-Mullerian hormone signaling pathway,protein modification/signaling,0.294\nnegative regulation of antibacterial peptide production,immune system process,0.62\nnegative regulation of antibody-dependent cellular cytotoxicity,immune system process,0.34\nnegative regulation of antifungal innate immune response,immune system process,0.396\nnegative regulation of antigen processing and presentation,immune system process,0.682\nnegative regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I,immune system process,0.138\nnegative regulation of antigen processing and presentation of peptide antigen,immune system process,0.572\nnegative regulation of antigen processing and presentation of peptide antigen via MHC class I,immune system process,0.59\nnegative regulation of antigen processing and presentation of peptide antigen via MHC class II,immune system process,0.546\nnegative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,immune system process,0.596\nnegative regulation of antimicrobial humoral response,immune system process,0.798\nnegative regulation of antimicrobial peptide production,immune system process,0.63\nnegative regulation of apolipoprotein binding,gene regulation,0.17\nnegative regulation of apoptotic DNA fragmentation,cell death,0.266\nnegative regulation of apoptotic cell clearance,transport,0.346\nnegative regulation of apoptotic process in bone marrow cell,cell death,0.762\nnegative regulation of apoptotic process involved in development,cell death,0.4\nnegative regulation of apoptotic process involved in metanephric collecting duct development,cell death,0.268\nnegative regulation of apoptotic process involved in metanephric nephron tubule development,cell death,0.268\nnegative regulation of apoptotic process involved in morphogenesis,morphogenesis/development,0.412\nnegative regulation of apoptotic process involved in outflow tract morphogenesis,cell death,0.602\nnegative regulation of appetite,immune system process,0.456\nnegative regulation of appetite by leptin-mediated signaling pathway,receptor related process,0.562\nnegative regulation of arachidonic acid secretion,metabolic process,0.216\nnegative regulation of arginine catabolic process,metabolic process,0.24\nnegative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,protein modification/signaling,0.274\nnegative regulation of aspartic-type peptidase activity,metabolic process,0.444\nnegative regulation of astrocyte activation,protein modification/signaling,0.134\nnegative regulation of astrocyte differentiation,morphogenesis/development,0.372\nnegative regulation of asymmetric cell division,cell cycle,0.318\nnegative regulation of autophagic cell death,cell death,0.218\nnegative regulation of autophagosome assembly,cellular component organization,0.318\nnegative regulation of autophagosome maturation,morphogenesis/development,0.174\nnegative regulation of autophagy of mitochondrion,metabolic process,0.486\nnegative regulation of axon extension involved in axon guidance,neural related process,0.164\nnegative regulation of axon extension involved in regeneration,immune system process,0.118\nnegative regulation of axon guidance,neural related process,0.3\nnegative regulation of axon regeneration,neural related process,0.496\nnegative regulation of barbed-end actin filament capping,cellular component organization,0.31\nnegative regulation of behavior,multicellular organismal process,0.314\nnegative regulation of beta-catenin-TCF complex assembly,cellular component organization,0.318\nnegative regulation of beta-galactosidase activity,immune system process,0.132\nnegative regulation of bicellular tight junction assembly,cellular component organization,0.282\nnegative regulation of bile acid biosynthetic process,metabolic process,0.74\nnegative regulation of bile acid metabolic process,metabolic process,0.752\nnegative regulation of bile acid secretion,metabolic process,0.162\nnegative regulation of binding of sperm to zona pellucida,gene regulation,0.162\nnegative regulation of biological process,metabolic process,0.256\nnegative regulation of biomineral tissue development,morphogenesis/development,0.684\nnegative regulation of biosynthetic process,metabolic process,0.842\nnegative regulation of blood circulation,multicellular organismal process,0.702\nnegative regulation of blood vessel endothelial cell differentiation,morphogenesis/development,0.566\nnegative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,cell cycle,0.226\nnegative regulation of blood vessel morphogenesis,morphogenesis/development,0.944\nnegative regulation of blood vessel remodeling,morphogenesis/development,0.696\nnegative regulation of blood-brain barrier permeability,metabolic process,0.246\nnegative regulation of bone development,morphogenesis/development,0.194\nnegative regulation of bone mineralization,morphogenesis/development,0.596\nnegative regulation of bone mineralization involved in bone maturation,morphogenesis/development,0.208\nnegative regulation of bone remodeling,multicellular organismal process,0.584\nnegative regulation of bone resorption,morphogenesis/development,0.19\nnegative regulation of bone trabecula formation,morphogenesis/development,0.298\nnegative regulation of brain-derived neurotrophic factor receptor signaling pathway,receptor related process,0.86\nnegative regulation of branching involved in lung morphogenesis,morphogenesis/development,0.778\nnegative regulation of branching involved in ureteric bud morphogenesis,morphogenesis/development,0.58\nnegative regulation of branching morphogenesis of a nerve,morphogenesis/development,0.2\nnegative regulation of brown fat cell differentiation,morphogenesis/development,0.226\nnegative regulation of cAMP-dependent protein kinase activity,protein modification/signaling,0.466\nnegative regulation of cAMP-mediated signaling,protein modification/signaling,0.31\nnegative regulation of cGAS/STING signaling pathway,protein modification/signaling,0.3\nnegative regulation of cGMP-mediated signaling,protein modification/signaling,0.308\nnegative regulation of calcidiol 1-monooxygenase activity,metabolic process,0.638\nnegative regulation of calcineurin-NFAT signaling cascade,protein modification/signaling,0.276\nnegative regulation of calcineurin-mediated signaling,protein modification/signaling,0.488\nnegative regulation of calcium import into the mitochondrion,transport,0.122\nnegative regulation of calcium ion binding,gene regulation,0.13\nnegative regulation of calcium ion export across plasma membrane,cellular component organization,0.172\nnegative regulation of calcium ion import,transport,0.402\nnegative regulation of calcium ion import across plasma membrane,transport,0.204\nnegative regulation of calcium ion import into sarcoplasmic reticulum,transport,0.134\nnegative regulation of calcium ion transmembrane transport,transport,0.788\nnegative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,transport,0.226\nnegative regulation of calcium ion transmembrane transporter activity,transport,0.662\nnegative regulation of calcium ion transport,transport,0.892\nnegative regulation of calcium ion transport into cytosol,transport,0.626\nnegative regulation of calcium ion-dependent exocytosis,transport,0.482\nnegative regulation of calcium-dependent ATPase activity,metabolic process,0.146\nnegative regulation of calcium-dependent cell-cell adhesion,cell adhesion,0.26\nnegative regulation of calcium-independent cell-cell adhesion,cell adhesion,0.254\nnegative regulation of calcium-mediated signaling,protein modification/signaling,0.498\nnegative regulation of calcium:sodium antiporter activity,immune system process,0.13\nnegative regulation of canonical NF-kappaB signal transduction,immune system process,0.262\nnegative regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,protein modification/signaling,0.226\nnegative regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation,protein modification/signaling,0.262\nnegative regulation of canonical Wnt signaling pathway involved in heart development,morphogenesis/development,0.324\nnegative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation,protein modification/signaling,0.29\nnegative regulation of canonical Wnt signaling pathway involved in osteoblast differentiation,protein modification/signaling,0.228\nnegative regulation of cardiac cell fate specification,morphogenesis/development,0.592\nnegative regulation of cardiac chamber formation,morphogenesis/development,0.57\nnegative regulation of cardiac conduction,immune system process,0.116\nnegative regulation of cardiac epithelial to mesenchymal transition,morphogenesis/development,0.494\nnegative regulation of cardiac muscle adaptation,multicellular organismal process,0.392\nnegative regulation of cardiac muscle cell apoptotic process,cell death,0.818\nnegative regulation of cardiac muscle cell contraction,multicellular organismal process,0.404\nnegative regulation of cardiac muscle cell differentiation,morphogenesis/development,0.56\nnegative regulation of cardiac muscle cell myoblast differentiation,morphogenesis/development,0.224\nnegative regulation of cardiac muscle cell proliferation,cell cycle,0.214\nnegative regulation of cardiac muscle contraction,multicellular organismal process,0.692\nnegative regulation of cardiac muscle hypertrophy in response to stress,immune system process,0.15\nnegative regulation of cardiac muscle tissue development,morphogenesis/development,0.196\nnegative regulation of cardiac muscle tissue growth,morphogenesis/development,0.57\nnegative regulation of cardiac muscle tissue regeneration,cell cycle,0.16\nnegative regulation of cardiac myofibril assembly,cellular component organization,0.282\nnegative regulation of cardiac vascular smooth muscle cell differentiation,morphogenesis/development,0.236\nnegative regulation of cardioblast cell fate specification,morphogenesis/development,0.466\nnegative regulation of cardioblast differentiation,morphogenesis/development,0.652\nnegative regulation of cardiocyte differentiation,morphogenesis/development,0.64\nnegative regulation of cargo loading into COPII-coated vesicle,immune system process,0.124\nnegative regulation of cartilage development,morphogenesis/development,0.942\nnegative regulation of catecholamine metabolic process,metabolic process,0.798\nnegative regulation of catecholamine secretion,transport,0.626\nnegative regulation of catecholamine uptake involved in synaptic transmission,transport,0.53\nnegative regulation of cation channel activity,transport,0.65\nnegative regulation of cation transmembrane transport,transport,0.672\nnegative regulation of caveolin-mediated endocytosis,immune system process,0.136\nnegative regulation of cell adhesion involved in sprouting angiogenesis,cell adhesion,0.222\nnegative regulation of cell adhesion involved in substrate-bound cell migration,morphogenesis/development,0.25\nnegative regulation of cell adhesion mediated by integrin,cell adhesion,0.538\nnegative regulation of cell adhesion molecule production,cell adhesion,0.268\nnegative regulation of cell chemotaxis to fibroblast growth factor,immune system process,0.3\nnegative regulation of cell communication,protein modification/signaling,0.214\nnegative regulation of cell communication by electrical coupling,protein modification/signaling,0.238\nnegative regulation of cell communication by electrical coupling involved in cardiac conduction,morphogenesis/development,0.116\nnegative regulation of cell cycle checkpoint,cell cycle,0.63\nnegative regulation of cell differentiation involved in embryonic placenta development,morphogenesis/development,0.634\nnegative regulation of cell differentiation involved in phenotypic switching,morphogenesis/development,0.726\nnegative regulation of cell fate commitment,morphogenesis/development,0.312\nnegative regulation of cell fate determination,morphogenesis/development,0.66\nnegative regulation of cell fate specification,morphogenesis/development,0.532\nnegative regulation of cell growth involved in cardiac muscle cell development,morphogenesis/development,0.7\nnegative regulation of cell growth involved in contact inhibition,morphogenesis/development,0.184\nnegative regulation of cell junction assembly,cellular component organization,0.636\nnegative regulation of cell maturation,morphogenesis/development,0.63\nnegative regulation of cell migration involved in sprouting angiogenesis,multicellular organismal process,0.396\nnegative regulation of cell motility involved in cerebral cortex radial glia guided migration,protein modification/signaling,0.164\nnegative regulation of cell proliferation in midbrain,cell cycle,0.23\nnegative regulation of cell proliferation involved in contact inhibition,cell cycle,0.226\nnegative regulation of cell proliferation involved in heart morphogenesis,cell cycle,0.594\nnegative regulation of cell proliferation involved in heart valve morphogenesis,cell cycle,0.196\nnegative regulation of cell proliferation involved in kidney development,cell cycle,0.694\nnegative regulation of cell proliferation involved in mesonephros development,cell cycle,0.722\nnegative regulation of cell size,cellular component organization,0.196\nnegative regulation of cell volume,cellular component organization,0.196\nnegative regulation of cell-cell adhesion mediated by cadherin,cell adhesion,0.318\nnegative regulation of cell-cell adhesion mediated by integrin,immune system process,0.268\nnegative regulation of cell-substrate junction organization,cellular component organization,0.758\nnegative regulation of cellular amino acid metabolic process,metabolic process,0.89\nnegative regulation of cellular catabolic process,metabolic process,0.73\nnegative regulation of cellular extravasation,immune system process,0.834\nnegative regulation of cellular glucuronidation,cellular component organization,0.14\nnegative regulation of cellular organofluorine metabolic process,metabolic process,0.61\nnegative regulation of cellular organohalogen metabolic process,metabolic process,0.734\nnegative regulation of cellular pH reduction,other,0.224\nnegative regulation of cellular process,metabolic process,0.244\nnegative regulation of cellular respiration,metabolic process,0.634\nnegative regulation of cellular response to hepatocyte growth factor stimulus,immune system process,0.268\nnegative regulation of cellular response to hypoxia,stress response,0.348\nnegative regulation of cellular response to insulin stimulus,immune system process,0.262\nnegative regulation of cellular response to oxidative stress,stress response,0.454\nnegative regulation of cellular response to testosterone stimulus,immune system process,0.298\nnegative regulation of cellular response to transforming growth factor beta stimulus,immune system process,0.286\nnegative regulation of cellular response to vascular endothelial growth factor stimulus,immune system process,0.242\nnegative regulation of cellular senescence,cell cycle,0.118\nnegative regulation of centriole elongation,metabolic process,0.126\nnegative regulation of centriole replication,cell cycle,0.118\nnegative regulation of centriole-centriole cohesion,cell cycle,0.158\nnegative regulation of centrosome cycle,cell cycle,0.532\nnegative regulation of centrosome duplication,cell cycle,0.518\nnegative regulation of ceramide biosynthetic process,metabolic process,0.33\nnegative regulation of cerebellar granule cell precursor proliferation,cell cycle,0.184\nnegative regulation of chaperone-mediated autophagy,metabolic process,0.144\nnegative regulation of chaperone-mediated protein folding,protein modification/signaling,0.34\nnegative regulation of chemokine (C-C motif) ligand 4 production,immune system process,0.464\nnegative regulation of chemokine (C-C motif) ligand 5 production,immune system process,0.496\nnegative regulation of chemokine (C-X-C motif) ligand 2 production,immune system process,0.508\nnegative regulation of chemokine (C-X-C motif) ligand 9 production,immune system process,0.464\nnegative regulation of chemokine-mediated signaling pathway,receptor related process,0.42\nnegative regulation of chloride transport,transport,0.638\nnegative regulation of cholangiocyte apoptotic process,cell death,0.292\nnegative regulation of cholangiocyte proliferation,cell cycle,0.18\nnegative regulation of cholesterol biosynthetic process,metabolic process,0.742\nnegative regulation of cholesterol efflux,transport,0.418\nnegative regulation of cholesterol import,transport,0.498\nnegative regulation of cholesterol metabolic process,metabolic process,0.946\nnegative regulation of cholesterol storage,cellular component organization,0.292\nnegative regulation of cholesterol transport,transport,0.916\nnegative regulation of cholesterol transporter activity,transport,0.176\nnegative regulation of chondrocyte development,morphogenesis/development,0.78\nnegative regulation of chondrocyte differentiation,morphogenesis/development,0.744\nnegative regulation of chondrocyte proliferation,cell cycle,0.72\nnegative regulation of chorionic trophoblast cell proliferation,cell cycle,0.22\nnegative regulation of chromatin binding,gene regulation,0.47\nnegative regulation of chromatin organization,cellular component organization,0.544\nnegative regulation of chromosome condensation,cellular component organization,0.49\nnegative regulation of chronic inflammatory response,immune system process,0.594\nnegative regulation of chronic inflammatory response to antigenic stimulus,immune system process,0.494\nnegative regulation of cilium assembly,cellular component organization,0.78\nnegative regulation of cilium movement,transport,0.268\nnegative regulation of cilium-dependent cell motility,cell cycle,0.232\nnegative regulation of circadian rhythm,cell cycle,0.216\n\"negative regulation of circadian sleep/wake cycle, REM sleep\",cellular component organization,0.18\n\"negative regulation of circadian sleep/wake cycle, non-REM sleep\",cellular component organization,0.184\n\"negative regulation of circadian sleep/wake cycle, sleep\",multicellular organismal process,0.37\nnegative regulation of citrulline biosynthetic process,metabolic process,0.25\nnegative regulation of clathrin-dependent endocytosis,immune system process,0.134\nnegative regulation of collagen binding,gene regulation,0.168\nnegative regulation of collagen biosynthetic process,metabolic process,0.612\nnegative regulation of collagen catabolic process,metabolic process,0.718\nnegative regulation of collagen fibril organization,morphogenesis/development,0.154\nnegative regulation of collateral sprouting,neural related process,0.55\nnegative regulation of collateral sprouting in absence of injury,morphogenesis/development,0.146\nnegative regulation of collateral sprouting of intact axon in response to injury,morphogenesis/development,0.124\nnegative regulation of complement activation,immune system process,0.756\n\"negative regulation of complement activation, alternative pathway\",immune system process,0.75\n\"negative regulation of complement activation, classical pathway\",immune system process,0.822\n\"negative regulation of complement activation, lectin pathway\",immune system process,0.808\nnegative regulation of complement-dependent cytotoxicity,immune system process,0.17\nnegative regulation of connective tissue growth factor production,immune system process,0.402\nnegative regulation of connective tissue replacement,multicellular organismal process,0.604\nnegative regulation of connective tissue replacement involved in inflammatory response wound healing,immune system process,0.156\nnegative regulation of constitutive secretory pathway,metabolic process,0.172\nnegative regulation of convergent extension involved in axis elongation,morphogenesis/development,0.768\nnegative regulation of core promoter binding,gene regulation,0.184\nnegative regulation of corticosteroid hormone secretion,transport,0.52\nnegative regulation of corticosterone secretion,immune system process,0.126\nnegative regulation of corticotropin secretion,cellular component organization,0.126\nnegative regulation of corticotropin-releasing hormone receptor activity,receptor related process,0.314\nnegative regulation of cortisol biosynthetic process,metabolic process,0.242\nnegative regulation of cortisol secretion,cellular component organization,0.122\nnegative regulation of creatine transmembrane transporter activity,transport,0.222\nnegative regulation of cyclase activity,metabolic process,0.55\nnegative regulation of cyclic-nucleotide phosphodiesterase activity,metabolic process,0.666\nnegative regulation of cyclin-dependent protein serine/threonine kinase activity,protein modification/signaling,0.426\nnegative regulation of cystathionine beta-synthase activity,immune system process,0.134\nnegative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,cell death,0.626\nnegative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,cell death,0.47\nnegative regulation of cytokine activity,receptor related process,0.412\nnegative regulation of cytokine production involved in immune response,immune system process,0.898\nnegative regulation of cytokine production involved in inflammatory response,immune system process,0.568\nnegative regulation of cytokinesis,cell cycle,0.764\nnegative regulation of cytoplasmic mRNA processing body assembly,cellular component organization,0.36\nnegative regulation of cytoplasmic translation,gene regulation,0.704\nnegative regulation of cytoplasmic translational elongation,gene regulation,0.694\nnegative regulation of cytoplasmic translational initiation,gene regulation,0.722\nnegative regulation of cytoplasmic transport,transport,0.602\nnegative regulation of cytoskeleton organization,cellular component organization,0.81\nnegative regulation of cytosolic calcium ion concentration,transport,0.2\nnegative regulation of cytotoxic T cell degranulation,immune system process,0.244\nnegative regulation of cytotoxic T cell differentiation,morphogenesis/development,0.226\nnegative regulation of deadenylation-dependent decapping of nuclear-transcribed mRNA,gene regulation,0.25\nnegative regulation of death-inducing signaling complex assembly,cellular component organization,0.252\nnegative regulation of defecation,transport,0.322\nnegative regulation of defense response to bacterium,immune system process,0.464\nnegative regulation of defense response to virus,viral related process,0.372\nnegative regulation of defense response to virus by host,immune system process,0.268\nnegative regulation of delayed rectifier potassium channel activity,immune system process,0.116\nnegative regulation of dendrite development,morphogenesis/development,0.15\nnegative regulation of dendrite extension,metabolic process,0.118\nnegative regulation of dendrite morphogenesis,morphogenesis/development,0.166\nnegative regulation of dendritic cell antigen processing and presentation,immune system process,0.646\nnegative regulation of dendritic cell apoptotic process,cell death,0.738\nnegative regulation of dendritic cell chemotaxis,immune system process,0.762\nnegative regulation of dendritic cell cytokine production,immune system process,0.856\nnegative regulation of dendritic cell dendrite assembly,cellular component organization,0.29\nnegative regulation of dendritic cell differentiation,morphogenesis/development,0.206\nnegative regulation of dendritic spine development,morphogenesis/development,0.862\nnegative regulation of dendritic spine maintenance,cellular component organization,0.126\nnegative regulation of dendritic spine morphogenesis,morphogenesis/development,0.62\nnegative regulation of dense core granule biogenesis,cellular component organization,0.26\nnegative regulation of deoxyribonuclease activity,cell cycle,0.266\nnegative regulation of dermatome development,morphogenesis/development,0.806\nnegative regulation of determination of dorsal identity,immune system process,0.128\nnegative regulation of developmental pigmentation,morphogenesis/development,0.562\nnegative regulation of digestive system process,multicellular organismal process,0.34\nnegative regulation of dopamine metabolic process,metabolic process,0.842\nnegative regulation of dopamine receptor signaling pathway,receptor related process,0.768\nnegative regulation of dopamine secretion,immune system process,0.122\nnegative regulation of dopamine uptake involved in synaptic transmission,transport,0.532\nnegative regulation of dopaminergic neuron differentiation,morphogenesis/development,0.598\nnegative regulation of double-strand break repair,stress response,0.734\nnegative regulation of double-strand break repair via nonhomologous end joining,stress response,0.144\nnegative regulation of double-strand break repair via single-strand annealing,stress response,0.14\nnegative regulation of double-stranded telomeric DNA binding,cell cycle,0.212\nnegative regulation of early endosome to late endosome transport,transport,0.16\nnegative regulation of eating behavior,multicellular organismal process,0.528\nnegative regulation of ectoderm development,morphogenesis/development,0.146\nnegative regulation of ectodermal cell fate specification,morphogenesis/development,0.178\nnegative regulation of elastin biosynthetic process,metabolic process,0.74\nnegative regulation of elastin catabolic process,metabolic process,0.728\nnegative regulation of electron transfer activity,metabolic process,0.552\nnegative regulation of embryonic development,morphogenesis/development,0.626\nnegative regulation of endocytic recycling,transport,0.59\nnegative regulation of endocytosis,transport,0.308\nnegative regulation of endodeoxyribonuclease activity,metabolic process,0.268\nnegative regulation of endodermal cell differentiation,morphogenesis/development,0.77\nnegative regulation of endodermal cell fate specification,morphogenesis/development,0.22\nnegative regulation of endoplasmic reticulum calcium ion concentration,ER/endosome/lysosome related process,0.286\nnegative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation,ER/endosome/lysosome related process,0.182\nnegative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway,cell death,0.278\nnegative regulation of endoplasmic reticulum unfolded protein response,stress response,0.48\nnegative regulation of endoribonuclease activity,metabolic process,0.354\nnegative regulation of endosome organization,cellular component organization,0.64\nnegative regulation of endothelial cell chemotaxis,multicellular organismal process,0.304\nnegative regulation of endothelial cell chemotaxis to fibroblast growth factor,immune system process,0.128\nnegative regulation of endothelial cell development,morphogenesis/development,0.596\nnegative regulation of endothelial cell differentiation,morphogenesis/development,0.672\nnegative regulation of endothelial cell-matrix adhesion via fibronectin,cell adhesion,0.17\nnegative regulation of entry of bacterium into host cell,viral related process,0.162\nnegative regulation of eosinophil activation,immune system process,0.198\nnegative regulation of eosinophil degranulation,immune system process,0.234\nnegative regulation of eosinophil extravasation,immune system process,0.144\nnegative regulation of eosinophil migration,immune system process,0.794\nnegative regulation of epidermal cell differentiation,morphogenesis/development,0.756\nnegative regulation of epidermal growth factor-activated receptor activity,receptor related process,0.304\nnegative regulation of epidermis development,morphogenesis/development,0.776\nnegative regulation of epinephrine secretion,immune system process,0.124\nnegative regulation of epithelial cell differentiation involved in kidney development,morphogenesis/development,0.696\nnegative regulation of epithelial cell proliferation involved in lung morphogenesis,cell cycle,0.196\nnegative regulation of epithelial cell proliferation involved in prostate gland development,morphogenesis/development,0.418\nnegative regulation of epithelial to mesenchymal transition,morphogenesis/development,0.51\nnegative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,morphogenesis/development,0.242\nnegative regulation of epithelium regeneration,immune system process,0.118\nnegative regulation of erythrocyte apoptotic process,cell death,0.746\nnegative regulation of erythrocyte differentiation,morphogenesis/development,0.236\nnegative regulation of establishment of RNA localization to telomere,transport,0.36\nnegative regulation of establishment of Sertoli cell barrier,transport,0.146\nnegative regulation of establishment of T cell polarity,cellular component organization,0.148\nnegative regulation of establishment of blood-brain barrier,morphogenesis/development,0.228\nnegative regulation of establishment of endothelial barrier,transport,0.142\nnegative regulation of establishment of protein localization,transport,0.482\nnegative regulation of establishment of protein localization to mitochondrion,transport,0.364\nnegative regulation of establishment of protein localization to telomere,transport,0.348\nnegative regulation of establishment of protein-containing complex localization to telomere,transport,0.35\nnegative regulation of excitatory postsynaptic potential,neural related process,0.504\nnegative regulation of excitatory synapse assembly,cellular component organization,0.266\nnegative regulation of execution phase of apoptosis,cell death,0.852\nnegative regulation of exit from mitosis,cell cycle,0.838\nnegative regulation of exo-alpha-sialidase activity,immune system process,0.128\nnegative regulation of exocytosis,transport,0.426\nnegative regulation of exonuclease activity,metabolic process,0.282\nnegative regulation of exosomal secretion,metabolic process,0.118\nnegative regulation of extracellular matrix assembly,cellular component organization,0.796\nnegative regulation of extracellular matrix constituent secretion,morphogenesis/development,0.154\nnegative regulation of extracellular matrix disassembly,cellular component organization,0.206\nnegative regulation of extracellular matrix organization,cellular component organization,0.78\nnegative regulation of eye pigmentation,morphogenesis/development,0.394\nnegative regulation of fat cell proliferation,cell cycle,0.748\nnegative regulation of fatty acid beta-oxidation,metabolic process,0.798\nnegative regulation of fatty acid beta-oxidation using acyl-CoA dehydrogenase,metabolic process,0.258\nnegative regulation of fatty acid biosynthetic process,metabolic process,0.934\nnegative regulation of fatty acid metabolic process,metabolic process,0.946\nnegative regulation of fatty acid oxidation,metabolic process,0.734\nnegative regulation of fatty acid transport,transport,0.674\nnegative regulation of feeding behavior,multicellular organismal process,0.53\nnegative regulation of female gonad development,morphogenesis/development,0.604\nnegative regulation of female receptivity,multicellular organismal process,0.54\nnegative regulation of fermentation,metabolic process,0.53\nnegative regulation of ferroptosis,immune system process,0.14\nnegative regulation of fertilization,cell cycle,0.176\nnegative regulation of fibrinolysis,multicellular organismal process,0.228\nnegative regulation of fibroblast apoptotic process,cell death,0.72\nnegative regulation of fibroblast growth factor production,immune system process,0.464\nnegative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,receptor related process,0.328\nnegative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,receptor related process,0.32\nnegative regulation of fibroblast migration,multicellular organismal process,0.31\nnegative regulation of fibroblast proliferation,cell cycle,0.778\nnegative regulation of filopodium assembly,cellular component organization,0.296\nnegative regulation of flagellated sperm motility,gene regulation,0.152\nnegative regulation of focal adhesion assembly,cellular component organization,0.224\nnegative regulation of follicle-stimulating hormone secretion,immune system process,0.122\nnegative regulation of forebrain neuron differentiation,neural related process,0.192\nnegative regulation of formation of translation preinitiation complex,morphogenesis/development,0.21\nnegative regulation of fusion of virus membrane with host plasma membrane,cellular component organization,0.218\nnegative regulation of gamma-aminobutyric acid secretion,metabolic process,0.224\nnegative regulation of gap junction assembly,cellular component organization,0.292\nnegative regulation of gastric acid secretion,transport,0.342\nnegative regulation of gastrin-induced gastric acid secretion,metabolic process,0.23\nnegative regulation of gene expression via CpG island methylation,gene regulation,0.458\nnegative regulation of gene silencing by regulatory ncRNA,gene regulation,0.554\nnegative regulation of germ cell proliferation,cell cycle,0.382\nnegative regulation of germinal center formation,immune system process,0.284\nnegative regulation of glial cell apoptotic process,cell death,0.824\nnegative regulation of glial cell differentiation,neural related process,0.396\nnegative regulation of glial cell migration,cell cycle,0.192\nnegative regulation of glial cell proliferation,neural related process,0.37\nnegative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,receptor related process,0.318\nnegative regulation of gliogenesis,neural related process,0.462\nnegative regulation of glomerular filtration,multicellular organismal process,0.204\nnegative regulation of glomerular mesangial cell proliferation,cell cycle,0.69\nnegative regulation of glomerulus development,morphogenesis/development,0.838\nnegative regulation of glucagon secretion,immune system process,0.134\nnegative regulation of glucocorticoid biosynthetic process,metabolic process,0.866\nnegative regulation of glucocorticoid metabolic process,metabolic process,0.908\nnegative regulation of glucocorticoid receptor signaling pathway,receptor related process,0.372\nnegative regulation of glucocorticoid secretion,transport,0.518\nnegative regulation of glucokinase activity,metabolic process,0.46\nnegative regulation of gluconeogenesis,immune system process,0.124\nnegative regulation of glucose catabolic process to lactate via pyruvate,metabolic process,0.234\nnegative regulation of glucose import,cellular component organization,0.168\nnegative regulation of glucose transmembrane transport,transport,0.902\nnegative regulation of glucosylceramide biosynthetic process,metabolic process,0.716\nnegative regulation of glucuronosyltransferase activity,immune system process,0.13\nnegative regulation of glutamate metabolic process,metabolic process,0.676\nnegative regulation of glutamate receptor signaling pathway,receptor related process,0.772\nnegative regulation of glutamate secretion,transport,0.62\nnegative regulation of glutamatergic neuron differentiation,neural related process,0.204\nnegative regulation of glutamine transport,transport,0.658\nnegative regulation of glycine import across plasma membrane,transport,0.118\nnegative regulation of glycogen (starch) synthase activity,metabolic process,0.17\nnegative regulation of glycogen biosynthetic process,metabolic process,0.732\nnegative regulation of glycogen catabolic process,metabolic process,0.728\nnegative regulation of glycogen metabolic process,metabolic process,0.884\n\"negative regulation of glycogen synthase activity, transferring glucose-1-phosphate\",metabolic process,0.238\nnegative regulation of glycolytic process,metabolic process,0.664\nnegative regulation of glycolytic process through fructose-6-phosphate,protein modification/signaling,0.132\nnegative regulation of glycoprotein biosynthetic process,metabolic process,0.676\nnegative regulation of glycoprotein metabolic process,metabolic process,0.61\nnegative regulation of gonad development,morphogenesis/development,0.606\nnegative regulation of gonadotropin secretion,transport,0.348\nnegative regulation of granulocyte chemotaxis,immune system process,0.77\nnegative regulation of granulocyte colony-stimulating factor production,immune system process,0.524\nnegative regulation of granulocyte differentiation,immune system process,0.718\nnegative regulation of granulocyte macrophage colony-stimulating factor production,immune system process,0.454\nnegative regulation of growth hormone receptor signaling pathway,receptor related process,0.482\nnegative regulation of growth hormone secretion,morphogenesis/development,0.172\nnegative regulation of growth rate,morphogenesis/development,0.194\nnegative regulation of guanyl-nucleotide exchange factor activity,metabolic process,0.46\nnegative regulation of guanylate cyclase activity,immune system process,0.148\nnegative regulation of hair cycle,gene regulation,0.128\nnegative regulation of hair follicle development,morphogenesis/development,0.628\nnegative regulation of hair follicle maturation,morphogenesis/development,0.616\nnegative regulation of hair follicle placode formation,morphogenesis/development,0.588\nnegative regulation of heart contraction,multicellular organismal process,0.68\nnegative regulation of heart growth,morphogenesis/development,0.518\nnegative regulation of heart induction,morphogenesis/development,0.71\nnegative regulation of heart induction by canonical Wnt signaling pathway,protein modification/signaling,0.272\nnegative regulation of heart looping,immune system process,0.126\nnegative regulation of heart rate,multicellular organismal process,0.716\nnegative regulation of heart rate involved in baroreceptor response to increased systemic arterial blood pressure,multicellular organismal process,0.224\nnegative regulation of heat generation,multicellular organismal process,0.542\nnegative regulation of helicase activity,cell cycle,0.364\nnegative regulation of hematopoietic stem cell differentiation,morphogenesis/development,0.234\nnegative regulation of hematopoietic stem cell proliferation,cell cycle,0.234\nnegative regulation of hemocyte differentiation,immune system process,0.462\nnegative regulation of hemoglobin biosynthetic process,metabolic process,0.664\nnegative regulation of hepatic stellate cell activation,immune system process,0.118\nnegative regulation of hepatocyte apoptotic process,cell death,0.298\nnegative regulation of hepatocyte differentiation,morphogenesis/development,0.206\nnegative regulation of hepatocyte growth factor production,immune system process,0.408\nnegative regulation of hepatocyte growth factor receptor signaling pathway,receptor related process,0.378\nnegative regulation of hepatocyte proliferation,immune system process,0.146\nnegative regulation of heterochromatin formation,gene regulation,0.576\nnegative regulation of heterochromatin organization,cellular component organization,0.588\nnegative regulation of heterotypic cell-cell adhesion,cell adhesion,0.462\nnegative regulation of hexokinase activity,metabolic process,0.376\nnegative regulation of hh target transcription factor activity,gene regulation,0.25\nnegative regulation of high voltage-gated calcium channel activity,protein modification/signaling,0.158\nnegative regulation of high-density lipoprotein particle clearance,cellular component organization,0.192\nnegative regulation of hippo signaling,protein modification/signaling,0.324\nnegative regulation of hippocampal neuron apoptotic process,cell death,0.416\nnegative regulation of histone H2A K63-linked ubiquitination,protein modification/signaling,0.178\nnegative regulation of histone H3-K27 methylation,gene regulation,0.588\nnegative regulation of histone H3-K27 trimethylation,protein modification/signaling,0.128\nnegative regulation of histone H3-K4 methylation,gene regulation,0.27\nnegative regulation of histone H3-K9 methylation,gene regulation,0.668\nnegative regulation of histone H3-K9 trimethylation,protein modification/signaling,0.124\nnegative regulation of histone H4 acetylation,gene regulation,0.36\nnegative regulation of histone acetylation,gene regulation,0.54\nnegative regulation of histone deacetylation,protein modification/signaling,0.462\nnegative regulation of histone ubiquitination,protein modification/signaling,0.624\nnegative regulation of homotypic cell-cell adhesion,cell adhesion,0.486\nnegative regulation of hormone biosynthetic process,metabolic process,0.888\nnegative regulation of hormone metabolic process,metabolic process,0.902\nnegative regulation of hormone secretion,transport,0.454\nnegative regulation of humoral immune response,immune system process,0.844\nnegative regulation of humoral immune response mediated by circulating immunoglobulin,immune system process,0.884\nnegative regulation of hyaluronan biosynthetic process,metabolic process,0.24\nnegative regulation of hydrogen peroxide biosynthetic process,metabolic process,0.622\nnegative regulation of hydrogen peroxide catabolic process,metabolic process,0.244\nnegative regulation of hydrogen peroxide metabolic process,metabolic process,0.694\nnegative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway,cell death,0.266\nnegative regulation of hydrogen peroxide-mediated programmed cell death,cell death,0.534\nnegative regulation of hypersensitivity,immune system process,0.866\nnegative regulation of hypoxia-induced intrinsic apoptotic signaling pathway,cell death,0.258\nnegative regulation of hypoxia-inducible factor-1alpha signaling pathway,protein modification/signaling,0.31\nnegative regulation of icosanoid secretion,transport,0.734\nnegative regulation of immature T cell proliferation,immune system process,0.806\nnegative regulation of immature T cell proliferation in thymus,immune system process,0.27\nnegative regulation of immune response to tumor cell,immune system process,0.81\nnegative regulation of immunoglobulin mediated immune response,immune system process,0.916\nnegative regulation of immunoglobulin production,immune system process,0.652\nnegative regulation of immunological synapse formation,morphogenesis/development,0.214\nnegative regulation of inflammasome-mediated signaling pathway,protein modification/signaling,0.276\nnegative regulation of inflammatory response to antigenic stimulus,immune system process,0.894\nnegative regulation of inflammatory response to wounding,immune system process,0.278\nnegative regulation of inhibitory synapse assembly,cellular component organization,0.286\nnegative regulation of inner ear auditory receptor cell differentiation,morphogenesis/development,0.552\nnegative regulation of inner ear receptor cell differentiation,morphogenesis/development,0.544\nnegative regulation of inositol phosphate biosynthetic process,metabolic process,0.88\nnegative regulation of insulin receptor signaling pathway,receptor related process,0.622\nnegative regulation of insulin secretion,transport,0.506\nnegative regulation of insulin secretion involved in cellular response to glucose stimulus,morphogenesis/development,0.15\nnegative regulation of insulin-like growth factor receptor signaling pathway,receptor related process,0.372\nnegative regulation of integrin activation,immune system process,0.282\nnegative regulation of integrin biosynthetic process,metabolic process,0.698\nnegative regulation of integrin-mediated signaling pathway,protein modification/signaling,0.306\nnegative regulation of interferon-alpha production,immune system process,0.554\nnegative regulation of interferon-beta production,immune system process,0.492\nnegative regulation of interleukin-1 alpha production,immune system process,0.492\nnegative regulation of interleukin-1-mediated signaling pathway,protein modification/signaling,0.308\nnegative regulation of interleukin-10 production,immune system process,0.632\nnegative regulation of interleukin-12 production,immune system process,0.56\nnegative regulation of interleukin-13 production,immune system process,0.486\nnegative regulation of interleukin-17 production,immune system process,0.878\nnegative regulation of interleukin-18 production,immune system process,0.506\nnegative regulation of interleukin-18-mediated signaling pathway,protein modification/signaling,0.318\nnegative regulation of interleukin-2-mediated signaling pathway,protein modification/signaling,0.29\nnegative regulation of interleukin-23 production,immune system process,0.52\nnegative regulation of interleukin-3 production,immune system process,0.554\nnegative regulation of interleukin-4 production,immune system process,0.512\nnegative regulation of interleukin-4-mediated signaling pathway,protein modification/signaling,0.29\nnegative regulation of interleukin-5 production,immune system process,0.586\nnegative regulation of interleukin-6 production,immune system process,0.764\nnegative regulation of interleukin-6-mediated signaling pathway,protein modification/signaling,0.27\nnegative regulation of intestinal absorption,transport,0.332\nnegative regulation of intestinal cholesterol absorption,multicellular organismal process,0.196\nnegative regulation of intestinal lipid absorption,transport,0.436\nnegative regulation of intestinal phytosterol absorption,transport,0.308\nnegative regulation of intracellular calcium activated chloride channel activity,immune system process,0.132\nnegative regulation of intracellular cholesterol transport,transport,0.774\nnegative regulation of intracellular estrogen receptor signaling pathway,receptor related process,0.372\nnegative regulation of intracellular lipid transport,transport,0.788\nnegative regulation of intracellular steroid hormone receptor signaling pathway,receptor related process,0.832\nnegative regulation of intracellular sterol transport,transport,0.788\nnegative regulation of intracellular transport of viral material,viral related process,0.172\nnegative regulation of intralumenal vesicle formation,morphogenesis/development,0.216\nnegative regulation of intrinsic apoptotic signaling pathway by p53 class mediator,cell death,0.8\nnegative regulation of intrinsic apoptotic signaling pathway in response to DNA damage,cell death,0.808\nnegative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,cell death,0.294\nnegative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide,cell death,0.576\nnegative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,cell death,0.692\nnegative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,cell death,0.582\nnegative regulation of inward rectifier potassium channel activity,protein modification/signaling,0.126\nnegative regulation of ion transmembrane transporter activity,transport,0.598\nnegative regulation of iron ion import across plasma membrane,transport,0.208\nnegative regulation of iron ion transmembrane transport,transport,0.92\nnegative regulation of iron ion transport,transport,0.946\nnegative regulation of isoprenoid metabolic process,metabolic process,0.904\nnegative regulation of isotype switching,immune system process,0.736\nnegative regulation of isotype switching to IgA isotypes,immune system process,0.134\nnegative regulation of isotype switching to IgE isotypes,immune system process,0.212\nnegative regulation of keratinocyte apoptotic process,cell death,0.75\nnegative regulation of keratinocyte differentiation,morphogenesis/development,0.354\nnegative regulation of keratinocyte migration,immune system process,0.13\nnegative regulation of keratinocyte proliferation,cell cycle,0.654\nnegative regulation of kidney development,morphogenesis/development,0.888\nnegative regulation of kidney smooth muscle cell differentiation,morphogenesis/development,0.214\nnegative regulation of lamellipodium assembly,morphogenesis/development,0.296\nnegative regulation of lamellipodium morphogenesis,morphogenesis/development,0.182\nnegative regulation of lamellipodium organization,cellular component organization,0.616\nnegative regulation of large conductance calcium-activated potassium channel activity,immune system process,0.136\nnegative regulation of late endosome to lysosome transport,transport,0.158\nnegative regulation of lens fiber cell differentiation,morphogenesis/development,0.208\nnegative regulation of leucine import,transport,0.79\nnegative regulation of leucine import across plasma membrane,transport,0.734\nnegative regulation of leucine-tRNA ligase activity,metabolic process,0.146\nnegative regulation of leukocyte adhesion to arterial endothelial cell,immune system process,0.266\nnegative regulation of leukocyte adhesion to vascular endothelial cell,immune system process,0.42\nnegative regulation of leukocyte chemotaxis,immune system process,0.874\nnegative regulation of leukocyte degranulation,immune system process,0.706\nnegative regulation of leukocyte tethering or rolling,immune system process,0.298\nnegative regulation of ligase activity,metabolic process,0.598\nnegative regulation of lipase activity,metabolic process,0.558\nnegative regulation of lipid binding,gene regulation,0.154\nnegative regulation of lipid catabolic process,metabolic process,0.902\nnegative regulation of lipid kinase activity,protein modification/signaling,0.434\nnegative regulation of lipid metabolic process,metabolic process,0.906\nnegative regulation of lipid transporter activity,transport,0.582\nnegative regulation of lipopolysaccharide-mediated signaling pathway,protein modification/signaling,0.3\nnegative regulation of lipoprotein lipase activity,metabolic process,0.384\nnegative regulation of lipoprotein lipid oxidation,metabolic process,0.268\nnegative regulation of lipoprotein metabolic process,metabolic process,0.774\nnegative regulation of lipoprotein oxidation,metabolic process,0.394\nnegative regulation of lipoprotein particle clearance,multicellular organismal process,0.62\nnegative regulation of lncRNA transcription,protein modification/signaling,0.134\nnegative regulation of locomotion involved in locomotory behavior,transport,0.178\nnegative regulation of long-chain fatty acid import across plasma membrane,transport,0.51\nnegative regulation of long-chain fatty acid import into cell,transport,0.704\nnegative regulation of long-term synaptic depression,neural related process,0.162\nnegative regulation of long-term synaptic potentiation,neural related process,0.24\nnegative regulation of low-density lipoprotein particle clearance,multicellular organismal process,0.194\nnegative regulation of low-density lipoprotein particle receptor binding,receptor related process,0.416\nnegative regulation of low-density lipoprotein particle receptor catabolic process,metabolic process,0.618\nnegative regulation of low-density lipoprotein receptor activity,receptor related process,0.284\nnegative regulation of lung blood pressure,morphogenesis/development,0.206\nnegative regulation of lung ciliated cell differentiation,morphogenesis/development,0.218\nnegative regulation of luteinizing hormone secretion,immune system process,0.136\nnegative regulation of lyase activity,metabolic process,0.588\nnegative regulation of lymphangiogenesis,morphogenesis/development,0.194\nnegative regulation of lymphocyte chemotaxis,immune system process,0.872\nnegative regulation of lymphocyte migration,immune system process,0.864\nnegative regulation of lymphoid progenitor cell differentiation,morphogenesis/development,0.634\nnegative regulation of lysosomal protein catabolic process,metabolic process,0.324\nnegative regulation of lysosome organization,morphogenesis/development,0.15\nnegative regulation of mRNA 3'-end processing,gene regulation,0.664\nnegative regulation of mRNA binding,gene regulation,0.576\nnegative regulation of mRNA catabolic process,gene regulation,0.76\nnegative regulation of mRNA modification,gene regulation,0.266\nnegative regulation of mRNA polyadenylation,gene regulation,0.212\n\"negative regulation of mRNA splicing, via spliceosome\",gene regulation,0.936\nnegative regulation of macroautophagy,metabolic process,0.484\nnegative regulation of macromolecule metabolic process,metabolic process,0.77\nnegative regulation of macrophage antigen processing and presentation,immune system process,0.344\nnegative regulation of macrophage apoptotic process,cell death,0.684\nnegative regulation of macrophage chemotaxis,immune system process,0.388\nnegative regulation of macrophage colony-stimulating factor production,immune system process,0.8\nnegative regulation of macrophage colony-stimulating factor signaling pathway,protein modification/signaling,0.256\nnegative regulation of macrophage cytokine production,immune system process,0.694\nnegative regulation of macrophage differentiation,immune system process,0.72\nnegative regulation of macrophage inflammatory protein 1 alpha production,immune system process,0.408\nnegative regulation of macrophage migration,immune system process,0.838\nnegative regulation of macrophage proliferation,immune system process,0.198\nnegative regulation of macropinocytosis,metabolic process,0.132\nnegative regulation of maintenance of mitotic sister chromatid cohesion,cell cycle,0.69\n\"negative regulation of maintenance of mitotic sister chromatid cohesion, centromeric\",cell cycle,0.24\n\"negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric\",cell cycle,0.282\nnegative regulation of maintenance of sister chromatid cohesion,cell cycle,0.698\nnegative regulation of male germ cell proliferation,cell cycle,0.218\nnegative regulation of male gonad development,morphogenesis/development,0.166\nnegative regulation of mammary gland epithelial cell proliferation,cell cycle,0.2\nnegative regulation of mast cell activation,immune system process,0.8\nnegative regulation of mast cell activation involved in immune response,immune system process,0.436\nnegative regulation of mast cell apoptotic process,cell death,0.636\nnegative regulation of mast cell chemotaxis,immune system process,0.31\nnegative regulation of mast cell cytokine production,immune system process,0.484\nnegative regulation of mast cell degranulation,immune system process,0.262\nnegative regulation of mast cell differentiation,morphogenesis/development,0.642\nnegative regulation of mast cell proliferation,immune system process,0.282\nnegative regulation of matrix metallopeptidase secretion,immune system process,0.122\nnegative regulation of mature B cell apoptotic process,cell death,0.55\nnegative regulation of mechanoreceptor differentiation,morphogenesis/development,0.58\nnegative regulation of megakaryocyte differentiation,morphogenesis/development,0.224\nnegative regulation of meiotic cell cycle,cell cycle,0.706\nnegative regulation of meiotic cell cycle phase transition,cell cycle,0.782\nnegative regulation of meiotic chromosome separation,cell cycle,0.696\nnegative regulation of meiotic nuclear division,cell cycle,0.62\nnegative regulation of melanin biosynthetic process,metabolic process,0.724\nnegative regulation of membrane depolarization,cellular component organization,0.176\nnegative regulation of membrane depolarization during cardiac muscle cell action potential,cell cycle,0.176\nnegative regulation of membrane hyperpolarization,cellular component organization,0.204\nnegative regulation of membrane invagination,cellular component organization,0.654\nnegative regulation of membrane permeability,cellular component organization,0.2\nnegative regulation of membrane potential,transport,0.29\nnegative regulation of membrane protein ectodomain proteolysis,protein modification/signaling,0.234\nnegative regulation of membrane repolarization during cardiac muscle cell action potential,cell cycle,0.17\nnegative regulation of membrane repolarization during ventricular cardiac muscle cell action potential,cell cycle,0.168\nnegative regulation of membrane tubulation,cellular component organization,0.248\nnegative regulation of memory T cell differentiation,morphogenesis/development,0.212\nnegative regulation of mesenchymal cell apoptotic process,cell death,0.686\nnegative regulation of mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis,cell death,0.75\nnegative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,cell death,0.75\nnegative regulation of mesenchymal cell apoptotic process involved in metanephros development,cell death,0.592\nnegative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis,cell death,0.418\nnegative regulation of mesenchymal cell proliferation,cell cycle,0.686\nnegative regulation of mesenchymal cell proliferation involved in lung development,cell cycle,0.204\nnegative regulation of mesenchymal cell proliferation involved in ureter development,morphogenesis/development,0.466\nnegative regulation of mesenchymal stem cell differentiation,morphogenesis/development,0.77\nnegative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,cellular component organization,0.262\nnegative regulation of mesoderm development,morphogenesis/development,0.648\nnegative regulation of mesodermal cell differentiation,morphogenesis/development,0.768\nnegative regulation of mesodermal cell fate specification,morphogenesis/development,0.742\nnegative regulation of mesonephros development,morphogenesis/development,0.842\nnegative regulation of metabolic process,metabolic process,0.766\nnegative regulation of metalloendopeptidase activity,metabolic process,0.432\nnegative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process,protein modification/signaling,0.28\nnegative regulation of metallopeptidase activity,metabolic process,0.354\nnegative regulation of metanephric S-shaped body morphogenesis,morphogenesis/development,0.3\nnegative regulation of metanephric comma-shaped body morphogenesis,morphogenesis/development,0.3\nnegative regulation of metanephric glomerular mesangial cell proliferation,cell cycle,0.206\nnegative regulation of metanephric mesenchymal cell migration,morphogenesis/development,0.15\nnegative regulation of metanephric nephron tubule epithelial cell differentiation,morphogenesis/development,0.26\nnegative regulation of metanephros development,morphogenesis/development,0.874\nnegative regulation of metaphase/anaphase transition of meiotic cell cycle,cell cycle,0.724\nnegative regulation of miRNA catabolic process,metabolic process,0.23\nnegative regulation of miRNA metabolic process,gene regulation,0.468\nnegative regulation of miRNA processing,gene regulation,0.696\nnegative regulation of miRNA transcription,gene regulation,0.422\nnegative regulation of miRNA-mediated gene silencing,gene regulation,0.56\nnegative regulation of microglial cell activation,immune system process,0.172\nnegative regulation of microglial cell mediated cytotoxicity,cell cycle,0.15\nnegative regulation of microglial cell migration,cell cycle,0.146\nnegative regulation of microtubule binding,protein modification/signaling,0.382\nnegative regulation of microtubule depolymerization,cellular component organization,0.622\nnegative regulation of microtubule nucleation,cellular component organization,0.134\nnegative regulation of microtubule polymerization,cellular component organization,0.756\nnegative regulation of microtubule polymerization or depolymerization,cellular component organization,0.642\nnegative regulation of microvillus assembly,cellular component organization,0.29\nnegative regulation of mini excitatory postsynaptic potential,neural related process,0.258\nnegative regulation of mitochondrial ATP synthesis coupled electron transport,metabolic process,0.424\nnegative regulation of mitochondrial DNA metabolic process,cell cycle,0.46\nnegative regulation of mitochondrial DNA replication,cell cycle,0.204\nnegative regulation of mitochondrial RNA catabolic process,metabolic process,0.656\nnegative regulation of mitochondrial calcium ion concentration,other,0.286\nnegative regulation of mitochondrial depolarization,cellular component organization,0.152\n\"negative regulation of mitochondrial electron transport, NADH to ubiquinone\",metabolic process,0.18\nnegative regulation of mitochondrial fission,cellular component organization,0.182\nnegative regulation of mitochondrial fusion,cellular component organization,0.148\nnegative regulation of mitochondrial membrane permeability involved in apoptotic process,cell death,0.568\nnegative regulation of mitochondrial membrane potential,transport,0.248\nnegative regulation of mitochondrial translation,gene regulation,0.56\nnegative regulation of mitophagy,cellular component organization,0.128\nnegative regulation of mitophagy in response to mitochondrial depolarization,immune system process,0.15\nnegative regulation of mitotic DNA damage checkpoint,cell cycle,0.384\nnegative regulation of mitotic cell cycle DNA replication,cell cycle,0.648\n\"negative regulation of mitotic cell cycle, embryonic\",cell cycle,0.686\nnegative regulation of mitotic centrosome separation,immune system process,0.13\nnegative regulation of mitotic chromosome condensation,cell cycle,0.292\nnegative regulation of mitotic recombination,cell cycle,0.496\nnegative regulation of mitotic spindle assembly checkpoint signaling,cell cycle,0.69\nnegative regulation of molecular function,protein modification/signaling,0.364\nnegative regulation of monoatomic anion transport,transport,0.69\nnegative regulation of monoatomic ion transmembrane transport,transport,0.834\nnegative regulation of monoatomic ion transport,transport,0.796\nnegative regulation of monocyte activation,immune system process,0.222\nnegative regulation of monocyte chemotactic protein-1 production,immune system process,0.494\nnegative regulation of monocyte chemotaxis,protein modification/signaling,0.172\nnegative regulation of monocyte differentiation,morphogenesis/development,0.212\nnegative regulation of monocyte extravasation,immune system process,0.134\nnegative regulation of mononuclear cell migration,immune system process,0.782\nnegative regulation of monooxygenase activity,metabolic process,0.68\nnegative regulation of morphogenesis of an epithelium,morphogenesis/development,0.862\nnegative regulation of mucus secretion,immune system process,0.288\nnegative regulation of multicellular organism growth,multicellular organismal process,0.18\nnegative regulation of multicellular organismal process,morphogenesis/development,0.24\nnegative regulation of muscle adaptation,multicellular organismal process,0.496\nnegative regulation of muscle cell apoptotic process,cell death,0.824\nnegative regulation of muscle contraction,multicellular organismal process,0.72\nnegative regulation of muscle hyperplasia,multicellular organismal process,0.128\nnegative regulation of muscle hypertrophy,multicellular organismal process,0.698\nnegative regulation of muscle organ development,morphogenesis/development,0.65\nnegative regulation of muscle tissue development,morphogenesis/development,0.598\nnegative regulation of myelination,morphogenesis/development,0.196\nnegative regulation of myeloid cell apoptotic process,cell death,0.686\nnegative regulation of myeloid dendritic cell activation,immune system process,0.23\nnegative regulation of myeloid leukocyte mediated immunity,immune system process,0.916\nnegative regulation of myeloid progenitor cell differentiation,morphogenesis/development,0.208\nnegative regulation of myoblast differentiation,morphogenesis/development,0.822\nnegative regulation of myoblast fusion,immune system process,0.134\nnegative regulation of myoblast proliferation,cell cycle,0.686\nnegative regulation of myofibroblast differentiation,morphogenesis/development,0.19\nnegative regulation of myosin-light-chain-phosphatase activity,immune system process,0.15\nnegative regulation of myotube differentiation,morphogenesis/development,0.826\nnegative regulation of natural killer cell activation,immune system process,0.892\nnegative regulation of natural killer cell chemotaxis,immune system process,0.158\nnegative regulation of natural killer cell cytokine production,immune system process,0.584\nnegative regulation of natural killer cell degranulation,immune system process,0.216\nnegative regulation of natural killer cell differentiation,immune system process,0.786\nnegative regulation of natural killer cell differentiation involved in immune response,immune system process,0.382\nnegative regulation of natural killer cell mediated cytotoxicity,immune system process,0.952\nnegative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,immune system process,0.344\nnegative regulation of natural killer cell mediated immune response to tumor cell,immune system process,0.91\nnegative regulation of natural killer cell mediated immunity,immune system process,0.974\nnegative regulation of necroptotic process,cell death,0.636\nnegative regulation of negative chemotaxis,immune system process,0.504\nnegative regulation of nephron tubule epithelial cell differentiation,morphogenesis/development,0.656\nnegative regulation of nervous system process,neural related process,0.296\nnegative regulation of neural crest formation,morphogenesis/development,0.674\nnegative regulation of neural precursor cell proliferation,cell cycle,0.638\nnegative regulation of neuroblast migration,immune system process,0.134\nnegative regulation of neuroblast proliferation,cell cycle,0.162\nnegative regulation of neurofibrillary tangle assembly,cellular component organization,0.292\nnegative regulation of neuroinflammatory response,immune system process,0.636\nnegative regulation of neuron differentiation,morphogenesis/development,0.53\nnegative regulation of neuron maturation,morphogenesis/development,0.608\nnegative regulation of neuron migration,neural related process,0.236\nnegative regulation of neuron projection arborization,morphogenesis/development,0.558\nnegative regulation of neuron projection regeneration,neural related process,0.44\nnegative regulation of neuron remodeling,neural related process,0.218\nnegative regulation of neuronal action potential,neural related process,0.236\nnegative regulation of neurotransmitter secretion,transport,0.43\nnegative regulation of neurotransmitter transport,transport,0.728\nnegative regulation of neurotransmitter uptake,transport,0.54\nnegative regulation of neurotrophin TRK receptor signaling pathway,receptor related process,0.332\nnegative regulation of neurotrophin production,multicellular organismal process,0.412\nnegative regulation of neutrophil activation,immune system process,0.172\nnegative regulation of neutrophil apoptotic process,cell death,0.626\nnegative regulation of neutrophil chemotaxis,immune system process,0.4\nnegative regulation of neutrophil degranulation,immune system process,0.194\nnegative regulation of neutrophil differentiation,morphogenesis/development,0.218\nnegative regulation of neutrophil migration,immune system process,0.822\nnegative regulation of nitric oxide biosynthetic process,metabolic process,0.772\nnegative regulation of nitric oxide mediated signal transduction,protein modification/signaling,0.35\nnegative regulation of nitric-oxide synthase activity,metabolic process,0.362\nnegative regulation of nitric-oxide synthase biosynthetic process,metabolic process,0.762\nnegative regulation of nitrogen compound metabolic process,metabolic process,0.624\nnegative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway,cell death,0.23\nnegative regulation of nodal signaling pathway,protein modification/signaling,0.276\nnegative regulation of non-canonical NF-kappaB signal transduction,protein modification/signaling,0.242\nnegative regulation of non-canonical Wnt signaling pathway,protein modification/signaling,0.396\nnegative regulation of non-membrane spanning protein tyrosine kinase activity,protein modification/signaling,0.49\nnegative regulation of non-motile cilium assembly,cellular component organization,0.304\nnegative regulation of norepinephrine secretion,protein modification/signaling,0.158\nnegative regulation of norepinephrine uptake,transport,0.68\nnegative regulation of nuclear cell cycle DNA replication,cell cycle,0.652\n\"negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay\",gene regulation,0.69\n\"negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay\",metabolic process,0.22\nnegative regulation of nuclear-transcribed mRNA poly(A) tail shortening,gene regulation,0.286\nnegative regulation of nuclease activity,metabolic process,0.342\nnegative regulation of nucleobase-containing compound metabolic process,metabolic process,0.392\nnegative regulation of nucleobase-containing compound transport,transport,0.868\nnegative regulation of nucleoside transport,transport,0.842\nnegative regulation of nucleotide biosynthetic process,metabolic process,0.844\nnegative regulation of nucleotide metabolic process,metabolic process,0.87\nnegative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway,immune system process,0.314\nnegative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,immune system process,0.374\nnegative regulation of nucleotide-binding oligomerization domain containing signaling pathway,immune system process,0.882\nnegative regulation of odontogenesis,morphogenesis/development,0.84\nnegative regulation of odontogenesis of dentin-containing tooth,morphogenesis/development,0.33\nnegative regulation of oligodendrocyte apoptotic process,cell death,0.31\nnegative regulation of oligodendrocyte differentiation,morphogenesis/development,0.284\nnegative regulation of oligodendrocyte progenitor proliferation,cellular component organization,0.146\nnegative regulation of oocyte development,morphogenesis/development,0.69\nnegative regulation of oocyte maturation,morphogenesis/development,0.59\nnegative regulation of organ growth,morphogenesis/development,0.46\nnegative regulation of organic acid transport,transport,0.898\nnegative regulation of ossification,morphogenesis/development,0.46\nnegative regulation of osteoblast differentiation,morphogenesis/development,0.386\nnegative regulation of osteoblast proliferation,cell cycle,0.154\nnegative regulation of osteoclast development,morphogenesis/development,0.148\nnegative regulation of osteoclast differentiation,immune system process,0.736\nnegative regulation of osteoclast proliferation,cell cycle,0.612\nnegative regulation of outer hair cell apoptotic process,cell death,0.266\nnegative regulation of ovarian follicle development,morphogenesis/development,0.164\nnegative regulation of ovulation,morphogenesis/development,0.22\nnegative regulation of oxidative phosphorylation,metabolic process,0.608\nnegative regulation of oxidative phosphorylation uncoupler activity,metabolic process,0.244\nnegative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,cell death,0.818\nnegative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,cell death,0.6\nnegative regulation of oxidoreductase activity,metabolic process,0.75\nnegative regulation of p38MAPK cascade,immune system process,0.152\nnegative regulation of pancreatic A cell differentiation,morphogenesis/development,0.218\nnegative regulation of pancreatic juice secretion,protein modification/signaling,0.144\nnegative regulation of pancreatic stellate cell proliferation,cell cycle,0.208\nnegative regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,immune system process,0.156\nnegative regulation of penile erection,multicellular organismal process,0.216\nnegative regulation of pentose-phosphate shunt,immune system process,0.12\nnegative regulation of peptide hormone secretion,transport,0.556\nnegative regulation of peptide secretion,transport,0.486\nnegative regulation of peptidyl-cysteine S-nitrosylation,immune system process,0.126\nnegative regulation of peptidyl-lysine acetylation,protein modification/signaling,0.688\nnegative regulation of peptidyl-lysine crotonylation,protein modification/signaling,0.44\nnegative regulation of peptidyl-serine dephosphorylation,immune system process,0.128\nnegative regulation of peptidyl-serine phosphorylation,protein modification/signaling,0.62\nnegative regulation of peptidyl-serine phosphorylation of STAT protein,protein modification/signaling,0.542\nnegative regulation of peptidyl-tyrosine autophosphorylation,protein modification/signaling,0.138\nnegative regulation of peroxisome proliferator activated receptor signaling pathway,receptor related process,0.356\nnegative regulation of phagocytosis,transport,0.242\n\"negative regulation of phagocytosis, engulfment\",cellular component organization,0.298\nnegative regulation of phenotypic switching,cell cycle,0.22\nnegative regulation of phosphatase activity,metabolic process,0.454\nnegative regulation of phosphatidate phosphatase activity,immune system process,0.136\nnegative regulation of phosphatidylcholine biosynthetic process,metabolic process,0.274\nnegative regulation of phosphatidylcholine catabolic process,metabolic process,0.77\nnegative regulation of phosphatidylcholine metabolic process,metabolic process,0.64\nnegative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction,protein modification/signaling,0.434\nnegative regulation of phosphatidylinositol biosynthetic process,metabolic process,0.878\n\"negative regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity\",immune system process,0.13\nnegative regulation of phospholipase A2 activity,immune system process,0.154\nnegative regulation of phospholipase C activity,immune system process,0.128\nnegative regulation of phospholipase C-activating G protein-coupled receptor signaling pathway,receptor related process,0.838\nnegative regulation of phospholipase activity,metabolic process,0.536\nnegative regulation of phospholipid biosynthetic process,metabolic process,0.916\nnegative regulation of phospholipid metabolic process,metabolic process,0.732\nnegative regulation of phosphoprotein phosphatase activity,protein modification/signaling,0.564\nnegative regulation of photoreceptor cell differentiation,morphogenesis/development,0.534\nnegative regulation of pinocytosis,transport,0.394\nnegative regulation of planar cell polarity pathway involved in axis elongation,morphogenesis/development,0.17\nnegative regulation of plasma cell differentiation,morphogenesis/development,0.216\nnegative regulation of plasma lipoprotein oxidation,metabolic process,0.2\nnegative regulation of plasma membrane bounded cell projection assembly,cellular component organization,0.754\nnegative regulation of plasmacytoid dendritic cell cytokine production,immune system process,0.566\nnegative regulation of plasminogen activation,protein modification/signaling,0.148\nnegative regulation of platelet activation,multicellular organismal process,0.298\nnegative regulation of platelet aggregation,cell adhesion,0.178\nnegative regulation of platelet-derived growth factor receptor signaling pathway,receptor related process,0.866\nnegative regulation of platelet-derived growth factor receptor-alpha signaling pathway,protein modification/signaling,0.266\nnegative regulation of platelet-derived growth factor receptor-beta signaling pathway,protein modification/signaling,0.256\nnegative regulation of polyamine transmembrane transport,transport,0.222\nnegative regulation of polynucleotide adenylyltransferase activity,immune system process,0.136\nnegative regulation of positive chemotaxis,immune system process,0.534\nnegative regulation of positive thymic T cell selection,cell cycle,0.124\nnegative regulation of post-transcriptional gene silencing,gene regulation,0.604\nnegative regulation of post-transcriptional gene silencing by regulatory ncRNA,gene regulation,0.616\nnegative regulation of post-translational protein modification,protein modification/signaling,0.714\nnegative regulation of postsynaptic density organization,cellular component organization,0.652\nnegative regulation of potassium ion export across plasma membrane,cellular component organization,0.188\nnegative regulation of potassium ion transmembrane transport,transport,0.832\nnegative regulation of potassium ion transmembrane transporter activity,transport,0.682\nnegative regulation of potassium ion transport,transport,0.922\nnegative regulation of pre-miRNA processing,morphogenesis/development,0.148\nnegative regulation of presynapse assembly,cellular component organization,0.278\nnegative regulation of primary amine oxidase activity,metabolic process,0.512\nnegative regulation of primary miRNA processing,gene regulation,0.166\nnegative regulation of pro-B cell differentiation,morphogenesis/development,0.246\nnegative regulation of production of molecular mediator of immune response,immune system process,0.792\nnegative regulation of programmed necrotic cell death,cell death,0.636\nnegative regulation of prostaglandin biosynthetic process,metabolic process,0.716\nnegative regulation of prostaglandin secretion,cellular component organization,0.118\nnegative regulation of prostatic bud formation,morphogenesis/development,0.418\nnegative regulation of proteasomal protein catabolic process,metabolic process,0.742\nnegative regulation of proteasomal ubiquitin-dependent protein catabolic process,metabolic process,0.658\nnegative regulation of protection from non-homologous end joining at telomere,cell cycle,0.12\nnegative regulation of protein ADP-ribosylation,protein modification/signaling,0.412\nnegative regulation of protein K48-linked deubiquitination,protein modification/signaling,0.328\nnegative regulation of protein K48-linked ubiquitination,protein modification/signaling,0.566\nnegative regulation of protein K63-linked ubiquitination,protein modification/signaling,0.784\nnegative regulation of protein autophosphorylation,protein modification/signaling,0.68\nnegative regulation of protein autoubiquitination,protein modification/signaling,0.356\nnegative regulation of protein catabolic process in the vacuole,metabolic process,0.638\nnegative regulation of protein dephosphorylation,protein modification/signaling,0.492\nnegative regulation of protein deubiquitination,protein modification/signaling,0.782\nnegative regulation of protein exit from endoplasmic reticulum,ER/endosome/lysosome related process,0.49\nnegative regulation of protein export from nucleus,transport,0.342\nnegative regulation of protein folding,protein modification/signaling,0.238\nnegative regulation of protein glutathionylation,protein modification/signaling,0.444\nnegative regulation of protein glycosylation,protein modification/signaling,0.422\nnegative regulation of protein homodimerization activity,protein modification/signaling,0.466\nnegative regulation of protein homooligomerization,cellular component organization,0.744\nnegative regulation of protein import into nucleus,protein modification/signaling,0.248\nnegative regulation of protein kinase C signaling,metabolic process,0.338\nnegative regulation of protein kinase activity by regulation of protein phosphorylation,protein modification/signaling,0.586\nnegative regulation of protein lipidation,protein modification/signaling,0.358\nnegative regulation of protein localization to cell cortex,transport,0.298\nnegative regulation of protein localization to cell leading edge,transport,0.246\nnegative regulation of protein localization to cell periphery,cellular component organization,0.514\nnegative regulation of protein localization to cell surface,transport,0.258\nnegative regulation of protein localization to centrosome,transport,0.26\nnegative regulation of protein localization to chromatin,transport,0.304\n\"negative regulation of protein localization to chromosome, telomeric region\",transport,0.352\nnegative regulation of protein localization to ciliary membrane,transport,0.268\nnegative regulation of protein localization to cilium,cellular component organization,0.364\nnegative regulation of protein localization to endoplasmic reticulum,transport,0.224\nnegative regulation of protein localization to endosome,transport,0.258\nnegative regulation of protein localization to lysosome,protein modification/signaling,0.254\nnegative regulation of protein localization to microtubule,protein modification/signaling,0.248\nnegative regulation of protein localization to nucleolus,transport,0.278\nnegative regulation of protein localization to nucleus,transport,0.48\nnegative regulation of protein localization to plasma membrane,cellular component organization,0.412\nnegative regulation of protein maturation,protein modification/signaling,0.474\nnegative regulation of protein modification by small protein conjugation or removal,protein modification/signaling,0.84\nnegative regulation of protein neddylation,protein modification/signaling,0.402\nnegative regulation of protein oligomerization,cellular component organization,0.746\nnegative regulation of protein polyubiquitination,protein modification/signaling,0.774\nnegative regulation of protein processing,protein modification/signaling,0.47\nnegative regulation of protein processing involved in protein targeting to mitochondrion,protein modification/signaling,0.356\nnegative regulation of protein refolding,protein modification/signaling,0.31\nnegative regulation of protein secretion,transport,0.642\nnegative regulation of protein serine/threonine kinase activity,protein modification/signaling,0.756\nnegative regulation of protein serine/threonine phosphatase activity,protein modification/signaling,0.386\nnegative regulation of protein sumoylation,protein modification/signaling,0.666\nnegative regulation of protein targeting to membrane,transport,0.546\nnegative regulation of protein targeting to mitochondrion,transport,0.618\nnegative regulation of protein transport,transport,0.818\nnegative regulation of protein tyrosine phosphatase activity,protein modification/signaling,0.424\nnegative regulation of protein-containing complex disassembly,cellular component organization,0.852\nnegative regulation of proteoglycan biosynthetic process,metabolic process,0.75\nnegative regulation of purine nucleotide biosynthetic process,metabolic process,0.568\nnegative regulation of purine nucleotide metabolic process,metabolic process,0.678\nnegative regulation of quinolinate biosynthetic process,metabolic process,0.262\nnegative regulation of rDNA heterochromatin formation,morphogenesis/development,0.238\nnegative regulation of rRNA processing,immune system process,0.136\nnegative regulation of reactive oxygen species biosynthetic process,metabolic process,0.424\nnegative regulation of receptor binding,receptor related process,0.226\nnegative regulation of receptor catabolic process,metabolic process,0.532\nnegative regulation of receptor clustering,cellular component organization,0.326\nnegative regulation of receptor internalization,receptor related process,0.318\nnegative regulation of receptor recycling,immune system process,0.278\nnegative regulation of receptor-mediated endocytosis,transport,0.298\nnegative regulation of receptor-mediated endocytosis involved in cholesterol transport,transport,0.166\nnegative regulation of regulated secretory pathway,transport,0.374\nnegative regulation of regulatory T cell differentiation,immune system process,0.836\nnegative regulation of relaxation of cardiac muscle,multicellular organismal process,0.134\nnegative regulation of relaxation of muscle,multicellular organismal process,0.622\nnegative regulation of relaxation of smooth muscle,multicellular organismal process,0.636\nnegative regulation of release of sequestered calcium ion into cytosol,transport,0.678\nnegative regulation of renal albumin absorption,immune system process,0.128\nnegative regulation of renal phosphate excretion,metabolic process,0.15\nnegative regulation of renal sodium excretion,multicellular organismal process,0.32\nnegative regulation of renin secretion into blood stream,multicellular organismal process,0.186\nnegative regulation of reproductive process,cell cycle,0.182\nnegative regulation of respiratory burst,immune system process,0.408\nnegative regulation of respiratory burst involved in inflammatory response,immune system process,0.452\nnegative regulation of respiratory gaseous exchange,immune system process,0.12\nnegative regulation of response to extracellular stimulus,immune system process,0.366\nnegative regulation of response to food,immune system process,0.46\nnegative regulation of response to nutrient levels,immune system process,0.238\nnegative regulation of response to oxidative stress,stress response,0.53\nnegative regulation of response to reactive oxygen species,stress response,0.496\nnegative regulation of response to stimulus,response to stimulus,0.2\nnegative regulation of response to tumor cell,immune system process,0.67\nnegative regulation of response to type II interferon,immune system process,0.46\nnegative regulation of retinal cell programmed cell death,morphogenesis/development,0.37\nnegative regulation of retinal ganglion cell axon guidance,neural related process,0.236\nnegative regulation of retinoic acid biosynthetic process,metabolic process,0.36\nnegative regulation of retinoic acid receptor signaling pathway,receptor related process,0.314\n\"negative regulation of retrograde protein transport, ER to cytosol\",protein modification/signaling,0.238\nnegative regulation of retrograde trans-synaptic signaling by neuropeptide,protein modification/signaling,0.298\n\"negative regulation of retrograde transport, endosome to Golgi\",transport,0.158\nnegative regulation of ribonuclease activity,gene regulation,0.438\nnegative regulation of ribosome biogenesis,cellular component organization,0.688\nnegative regulation of ripoptosome assembly involved in necroptotic process,cell death,0.442\nnegative regulation of ruffle assembly,cellular component organization,0.294\nnegative regulation of ryanodine-sensitive calcium-release channel activity,cellular component organization,0.228\nnegative regulation of saliva secretion,metabolic process,0.118\nnegative regulation of sarcomere organization,cellular component organization,0.408\nnegative regulation of satellite cell differentiation,morphogenesis/development,0.21\nnegative regulation of sebum secreting cell proliferation,cell cycle,0.24\nnegative regulation of secondary metabolite biosynthetic process,metabolic process,0.558\nnegative regulation of secretion by cell,transport,0.604\nnegative regulation of secretion of lysosomal enzymes,metabolic process,0.16\nnegative regulation of selenocysteine incorporation,immune system process,0.122\nnegative regulation of selenocysteine insertion sequence binding,gene regulation,0.212\nnegative regulation of sensory perception of pain,immune system process,0.122\nnegative regulation of sequestering of triglyceride,cellular component organization,0.238\nnegative regulation of serine C-palmitoyltransferase activity,immune system process,0.128\nnegative regulation of serine-type endopeptidase activity,immune system process,0.16\nnegative regulation of serine-type peptidase activity,metabolic process,0.318\nnegative regulation of serotonin secretion,immune system process,0.134\nnegative regulation of serotonin uptake,transport,0.628\nnegative regulation of shelterin complex assembly,cellular component organization,0.34\nnegative regulation of short-term neuronal synaptic plasticity,neural related process,0.432\nnegative regulation of short-term synaptic potentiation,neural related process,0.172\nnegative regulation of signal transduction,protein modification/signaling,0.27\nnegative regulation of signal transduction by p53 class mediator,protein modification/signaling,0.426\nnegative regulation of signaling,protein modification/signaling,0.276\nnegative regulation of signaling receptor activity,receptor related process,0.626\nnegative regulation of single strand break repair,stress response,0.528\nnegative regulation of single stranded viral RNA replication via double stranded DNA intermediate,viral related process,0.324\nnegative regulation of single-species biofilm formation,cellular component organization,0.198\nnegative regulation of single-species biofilm formation in or on host organism,morphogenesis/development,0.25\nnegative regulation of sister chromatid cohesion,cell cycle,0.566\nnegative regulation of skeletal muscle acetylcholine-gated channel clustering,cell cycle,0.118\nnegative regulation of skeletal muscle cell differentiation,morphogenesis/development,0.814\nnegative regulation of skeletal muscle cell proliferation,cell cycle,0.75\nnegative regulation of skeletal muscle hypertrophy,cell cycle,0.126\nnegative regulation of skeletal muscle satellite cell proliferation,cell cycle,0.682\nnegative regulation of skeletal muscle tissue development,morphogenesis/development,0.564\nnegative regulation of skeletal muscle tissue growth,immune system process,0.116\nnegative regulation of skeletal muscle tissue regeneration,morphogenesis/development,0.334\nnegative regulation of smooth muscle cell apoptotic process,cell death,0.834\nnegative regulation of smooth muscle cell chemotaxis,cell cycle,0.156\nnegative regulation of smooth muscle cell differentiation,morphogenesis/development,0.726\nnegative regulation of smooth muscle cell migration,multicellular organismal process,0.34\nnegative regulation of smooth muscle cell-matrix adhesion,cell adhesion,0.174\nnegative regulation of smoothened signaling pathway,receptor related process,0.482\nnegative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,protein modification/signaling,0.252\nnegative regulation of smoothened signaling pathway involved in ventral spinal cord patterning,protein modification/signaling,0.198\nnegative regulation of snRNA transcription by RNA polymerase II,gene regulation,0.5\nnegative regulation of sodium ion transmembrane transport,transport,0.84\nnegative regulation of sodium ion transmembrane transporter activity,transport,0.704\nnegative regulation of sodium-dependent phosphate transport,transport,0.154\nnegative regulation of sodium:proton antiporter activity,metabolic process,0.58\nnegative regulation of somatic stem cell population maintenance,morphogenesis/development,0.578\nnegative regulation of somatostatin secretion,morphogenesis/development,0.142\nnegative regulation of sperm capacitation,immune system process,0.13\nnegative regulation of sphingolipid biosynthetic process,metabolic process,0.718\nnegative regulation of spindle checkpoint,cell cycle,0.738\nnegative regulation of spontaneous neurotransmitter secretion,protein modification/signaling,0.114\nnegative regulation of sprouting angiogenesis,morphogenesis/development,0.762\nnegative regulation of sprouting of injured axon,neural related process,0.418\nnegative regulation of stem cell proliferation,cell cycle,0.734\nnegative regulation of steroid biosynthetic process,metabolic process,0.912\nnegative regulation of steroid hormone biosynthetic process,metabolic process,0.868\nnegative regulation of steroid hormone secretion,transport,0.512\nnegative regulation of steroid metabolic process,metabolic process,0.928\nnegative regulation of sterol biosynthetic process,metabolic process,0.576\nnegative regulation of sterol transport,transport,0.912\nnegative regulation of stomach neuroendocrine cell differentiation,morphogenesis/development,0.284\nnegative regulation of store-operated calcium channel activity,immune system process,0.136\nnegative regulation of stress fiber assembly,cellular component organization,0.314\nnegative regulation of stress granule assembly,cellular component organization,0.412\nnegative regulation of stress-activated MAPK cascade,protein modification/signaling,0.452\nnegative regulation of stress-activated protein kinase signaling cascade,protein modification/signaling,0.434\nnegative regulation of striated muscle cell apoptotic process,cell death,0.796\nnegative regulation of striated muscle contraction,multicellular organismal process,0.638\nnegative regulation of striated muscle tissue development,morphogenesis/development,0.61\nnegative regulation of superoxide anion generation,morphogenesis/development,0.178\nnegative regulation of supramolecular fiber organization,cellular component organization,0.86\nnegative regulation of synapse assembly,neural related process,0.302\nnegative regulation of synapse maturation,morphogenesis/development,0.174\nnegative regulation of synapse organization,cellular component organization,0.582\nnegative regulation of synaptic plasticity,neural related process,0.328\n\"negative regulation of synaptic transmission, GABAergic\",neural related process,0.458\n\"negative regulation of synaptic transmission, cholinergic\",neural related process,0.59\n\"negative regulation of synaptic transmission, dopaminergic\",neural related process,0.468\nnegative regulation of synaptic vesicle clustering,neural related process,0.176\nnegative regulation of synaptic vesicle exocytosis,transport,0.318\nnegative regulation of synaptic vesicle recycling,transport,0.464\nnegative regulation of syncytium formation by plasma membrane fusion,cellular component organization,0.424\nnegative regulation of systemic arterial blood pressure,multicellular organismal process,0.458\nnegative regulation of t-circle formation,morphogenesis/development,0.208\nnegative regulation of tRNA catabolic process,gene regulation,0.476\nnegative regulation of tRNA metabolic process,gene regulation,0.448\nnegative regulation of tau-protein kinase activity,protein modification/signaling,0.216\nnegative regulation of telomerase RNA reverse transcriptase activity,gene regulation,0.336\nnegative regulation of telomerase activity,metabolic process,0.3\nnegative regulation of telomere capping,cell cycle,0.5\nnegative regulation of telomere maintenance,cell cycle,0.632\nnegative regulation of telomere maintenance in response to DNA damage,stress response,0.408\nnegative regulation of telomere maintenance via recombination,cellular component organization,0.132\nnegative regulation of telomere maintenance via semi-conservative replication,cell cycle,0.222\nnegative regulation of telomere maintenance via telomerase,cell cycle,0.192\nnegative regulation of telomere maintenance via telomere lengthening,cell cycle,0.526\nnegative regulation of telomere single strand break repair,immune system process,0.114\nnegative regulation of telomeric D-loop disassembly,cellular component organization,0.172\nnegative regulation of telomeric DNA binding,gene regulation,0.242\nnegative regulation of telomeric loop disassembly,cell cycle,0.39\nnegative regulation of termination of DNA-templated transcription,gene regulation,0.73\nnegative regulation of termination of RNA polymerase II transcription,gene regulation,0.746\n\"negative regulation of termination of RNA polymerase II transcription, poly(A)-coupled\",gene regulation,0.502\nnegative regulation of testicular blood vessel morphogenesis,morphogenesis/development,0.27\nnegative regulation of testosterone biosynthetic process,metabolic process,0.262\nnegative regulation of the force of heart contraction,cellular component organization,0.192\nnegative regulation of the force of heart contraction by chemical signal,multicellular organismal process,0.594\nnegative regulation of thioredoxin peroxidase activity by peptidyl-threonine phosphorylation,metabolic process,0.234\nnegative regulation of thrombin-activated receptor signaling pathway,receptor related process,0.404\nnegative regulation of thymocyte apoptotic process,cell death,0.602\nnegative regulation of thyroid gland epithelial cell proliferation,cell cycle,0.248\nnegative regulation of timing of anagen,morphogenesis/development,0.178\nnegative regulation of timing of catagen,morphogenesis/development,0.18\nnegative regulation of tolerance induction,immune system process,0.634\nnegative regulation of toll-like receptor 2 signaling pathway,immune system process,0.38\nnegative regulation of toll-like receptor 3 signaling pathway,immune system process,0.356\nnegative regulation of toll-like receptor 4 signaling pathway,immune system process,0.352\nnegative regulation of toll-like receptor 5 signaling pathway,immune system process,0.35\nnegative regulation of toll-like receptor 7 signaling pathway,immune system process,0.336\nnegative regulation of toll-like receptor 9 signaling pathway,immune system process,0.352\nnegative regulation of toll-like receptor signaling pathway,immune system process,0.872\nnegative regulation of tooth mineralization,morphogenesis/development,0.628\nnegative regulation of transcription by RNA polymerase I,gene regulation,0.842\nnegative regulation of transcription by RNA polymerase III,gene regulation,0.844\nnegative regulation of transcription by competitive promoter binding,gene regulation,0.22\nnegative regulation of transcription by glucose,gene regulation,0.866\nnegative regulation of transcription by transcription factor localization,gene regulation,0.208\nnegative regulation of transcription elongation by RNA polymerase II,gene regulation,0.57\nnegative regulation of transcription from RNA polymerase II promoter by glucose,gene regulation,0.474\nnegative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,gene regulation,0.33\nnegative regulation of transcription from RNA polymerase II promoter in response to hypoxia,gene regulation,0.386\nnegative regulation of transcription from RNA polymerase II promoter in response to stress,stress response,0.534\nnegative regulation of transcription initiation by RNA polymerase II,gene regulation,0.82\nnegative regulation of transcription of nucleolar large rRNA by RNA polymerase I,gene regulation,0.53\nnegative regulation of transcription regulatory region DNA binding,gene regulation,0.58\nnegative regulation of transformation of host cell by virus,viral related process,0.234\nnegative regulation of transforming growth factor beta activation,immune system process,0.696\nnegative regulation of transforming growth factor beta receptor signaling pathway,receptor related process,0.686\nnegative regulation of transforming growth factor beta1 production,immune system process,0.85\nnegative regulation of transforming growth factor beta2 production,immune system process,0.828\nnegative regulation of transforming growth factor beta3 production,immune system process,0.83\nnegative regulation of translation in response to endoplasmic reticulum stress,gene regulation,0.438\nnegative regulation of translation in response to oxidative stress,metabolic process,0.178\nnegative regulation of translation in response to stress,stress response,0.47\nnegative regulation of translational elongation,gene regulation,0.71\nnegative regulation of translational frameshifting,immune system process,0.13\nnegative regulation of translational initiation by iron,metabolic process,0.158\nnegative regulation of translational initiation in response to stress,stress response,0.474\nnegative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,receptor related process,0.654\nnegative regulation of transmission of nerve impulse,neural related process,0.548\nnegative regulation of transporter activity,transport,0.568\nnegative regulation of triglyceride biosynthetic process,metabolic process,0.71\nnegative regulation of triglyceride catabolic process,metabolic process,0.722\nnegative regulation of triglyceride metabolic process,metabolic process,0.916\nnegative regulation of trophoblast cell migration,morphogenesis/development,0.17\nnegative regulation of tubulin deacetylation,protein modification/signaling,0.564\nnegative regulation of tumor necrosis factor (ligand) superfamily member 11 production,immune system process,0.424\nnegative regulation of tumor necrosis factor production,immune system process,0.79\nnegative regulation of tumor necrosis factor superfamily cytokine production,immune system process,0.882\nnegative regulation of tumor necrosis factor-mediated signaling pathway,receptor related process,0.356\nnegative regulation of type 2 immune response,immune system process,0.896\nnegative regulation of type B pancreatic cell apoptotic process,cell death,0.712\nnegative regulation of type B pancreatic cell development,morphogenesis/development,0.188\nnegative regulation of type B pancreatic cell proliferation,cell cycle,0.244\nnegative regulation of type I hypersensitivity,immune system process,0.426\nnegative regulation of type II hypersensitivity,immune system process,0.914\nnegative regulation of type II interferon-mediated signaling pathway,protein modification/signaling,0.282\nnegative regulation of type III interferon production,immune system process,0.58\nnegative regulation of type IIa hypersensitivity,immune system process,0.908\nnegative regulation of type IV hypersensitivity,immune system process,0.466\nnegative regulation of ubiquitin protein ligase activity,protein modification/signaling,0.43\nnegative regulation of ubiquitin-dependent protein catabolic process,metabolic process,0.742\nnegative regulation of ubiquitin-specific protease activity,metabolic process,0.156\nnegative regulation of ureter smooth muscle cell differentiation,morphogenesis/development,0.21\nnegative regulation of urine volume,multicellular organismal process,0.544\nnegative regulation of uterine smooth muscle contraction,multicellular organismal process,0.156\nnegative regulation of vacuolar transport,transport,0.592\nnegative regulation of vascular associated smooth muscle cell apoptotic process,cell death,0.252\nnegative regulation of vascular associated smooth muscle cell differentiation,morphogenesis/development,0.706\nnegative regulation of vascular associated smooth muscle cell differentiation involved in phenotypic switching,cell cycle,0.206\nnegative regulation of vascular associated smooth muscle cell migration,cell cycle,0.296\nnegative regulation of vascular associated smooth muscle contraction,multicellular organismal process,0.566\nnegative regulation of vascular endothelial cell proliferation,cell cycle,0.294\nnegative regulation of vascular endothelial growth factor production,immune system process,0.35\nnegative regulation of vascular endothelial growth factor receptor signaling pathway,receptor related process,0.368\nnegative regulation of vascular endothelial growth factor signaling pathway,protein modification/signaling,0.26\nnegative regulation of vascular permeability,multicellular organismal process,0.774\nnegative regulation of vascular wound healing,morphogenesis/development,0.26\nnegative regulation of vasculature development involved in avascular cornea development in camera-type eye,metabolic process,0.192\nnegative regulation of vasculogenesis,immune system process,0.13\nnegative regulation of vasoconstriction,multicellular organismal process,0.518\nnegative regulation of ventricular cardiac muscle cell action potential,cell cycle,0.17\nnegative regulation of very-low-density lipoprotein particle clearance,cellular component organization,0.182\nnegative regulation of very-low-density lipoprotein particle remodeling,protein modification/signaling,0.304\nnegative regulation of vesicle fusion,cellular component organization,0.434\nnegative regulation of viral transcription,viral related process,0.392\nnegative regulation of vitamin D biosynthetic process,metabolic process,0.858\nnegative regulation of vitamin D receptor signaling pathway,receptor related process,0.356\nnegative regulation of vitamin metabolic process,metabolic process,0.928\nnegative regulation of voltage-gated calcium channel activity,transport,0.674\nnegative regulation of voltage-gated potassium channel activity,transport,0.628\nnegative regulation of voltage-gated sodium channel activity,immune system process,0.136\n\"negative regulation of wound healing, spreading of epidermal cells\",cellular component organization,0.16\nnegative regulation of zinc ion transmembrane import,transport,0.132\nnegative regulation of zinc ion transmembrane transport,transport,0.866\nnegative regulation of zinc ion transport,transport,0.932\nnegative stranded viral RNA replication,gene regulation,0.286\nnegative thymic T cell selection,immune system process,0.236\nnephric duct development,morphogenesis/development,0.96\nnephric duct elongation,cellular component organization,0.23\nnephric duct formation,morphogenesis/development,0.848\nnephric duct morphogenesis,morphogenesis/development,0.892\nnephrogenic mesenchyme development,morphogenesis/development,0.854\nnephrogenic mesenchyme morphogenesis,morphogenesis/development,0.672\nnephron epithelium development,morphogenesis/development,0.978\nnephron epithelium morphogenesis,morphogenesis/development,0.916\nnephron morphogenesis,morphogenesis/development,0.94\nnephron tubule development,morphogenesis/development,0.962\nnephron tubule epithelial cell differentiation,morphogenesis/development,0.928\nnephron tubule formation,morphogenesis/development,0.862\nnephron tubule morphogenesis,morphogenesis/development,0.916\nnerve growth factor binding,metabolic process,0.18\nnerve growth factor production,neural related process,0.266\nnerve growth factor receptor activity,neural related process,0.288\nnerve growth factor receptor binding,receptor related process,0.548\nnerve growth factor signaling pathway,receptor related process,0.534\nnerve maturation,morphogenesis/development,0.712\nnervous system development,neural related process,0.314\nnervous system process,neural related process,0.594\nnervous system process involved in regulation of systemic arterial blood pressure,multicellular organismal process,0.516\nnetrin receptor activity,receptor related process,0.546\nnetrin receptor activity involved in chemorepulsion,transport,0.33\nnetrin receptor binding,receptor related process,0.5\nnetrin-activated signaling pathway,receptor related process,0.466\nnetwork-forming collagen trimer,cellular component organization,0.33\nneural crest cell fate commitment,morphogenesis/development,0.306\nneural crest cell fate specification,morphogenesis/development,0.554\nneural crest cell migration involved in autonomic nervous system development,morphogenesis/development,0.256\nneural crest cell migration involved in heart formation,morphogenesis/development,0.256\nneural crest formation,morphogenesis/development,0.412\nneural fold bending,morphogenesis/development,0.232\nneural fold elevation formation,morphogenesis/development,0.268\nneural fold formation,morphogenesis/development,0.386\nneural plate anterior/posterior regionalization,cellular component organization,0.262\nneural plate axis specification,morphogenesis/development,0.188\nneural plate development,morphogenesis/development,0.832\nneural plate elongation,cellular component organization,0.206\nneural plate mediolateral regionalization,cellular component organization,0.262\nneural plate morphogenesis,morphogenesis/development,0.59\nneural plate pattern specification,morphogenesis/development,0.49\nneural plate regionalization,multicellular organismal process,0.43\nneural precursor cell proliferation,cell cycle,0.468\nneural retina development,morphogenesis/development,0.776\nneural tissue regeneration,cellular component organization,0.22\nneural tube formation,morphogenesis/development,0.654\nneural tube patterning,morphogenesis/development,0.332\nneuregulin binding,response to stimulus,0.326\nneuregulin receptor activity,receptor related process,0.248\nneurexin clustering involved in presynaptic membrane assembly,cellular component organization,0.264\nneurexin family protein binding,neural related process,0.24\nneuroblast delamination,morphogenesis/development,0.218\nneuroblast differentiation,morphogenesis/development,0.92\nneuroblast division,cell cycle,0.286\nneuroblast division in subventricular zone,morphogenesis/development,0.238\nneuroblast fate commitment,morphogenesis/development,0.644\nneuroblast fate determination,morphogenesis/development,0.296\nneuroblast migration,morphogenesis/development,0.218\nneuroblast proliferation,cell cycle,0.314\nneuroendocrine cell differentiation,morphogenesis/development,0.692\nneuroepithelial cell differentiation,morphogenesis/development,0.81\nneurofibrillary tangle,protein modification/signaling,0.232\nneurofibrillary tangle assembly,cellular component organization,0.614\nneurofilament,neural related process,0.344\nneurofilament bundle assembly,cellular component organization,0.596\nneurofilament cytoskeleton,cellular component organization,0.278\nneurofilament cytoskeleton organization,cellular component organization,0.688\nneurogenesis,morphogenesis/development,0.318\nneurohypophyseal hormone activity,cellular component organization,0.196\nneurohypophysis development,morphogenesis/development,0.764\nneurokinin receptor binding,receptor related process,0.422\nneuroligin clustering involved in postsynaptic membrane assembly,neural related process,0.264\nneuroligin family protein binding,neural related process,0.258\nneuromast development,morphogenesis/development,0.886\nneuromast hair cell development,morphogenesis/development,0.786\nneuromast hair cell differentiation,morphogenesis/development,0.664\nneuromedin B receptor binding,receptor related process,0.496\nneuromedin U binding,stress response,0.158\nneuromedin U receptor activity,cellular component organization,0.17\nneuromedin U receptor binding,receptor related process,0.442\nneuromuscular junction development,cellular component organization,0.67\n\"neuromuscular junction development, skeletal muscle fiber\",cellular component organization,0.692\nneuromuscular process controlling balance,neural related process,0.264\nneuromuscular process controlling posture,morphogenesis/development,0.446\nneuromuscular synaptic transmission,neural related process,0.574\nneuron development,neural related process,0.62\nneuron differentiation,neural related process,0.39\nneuron fate commitment,morphogenesis/development,0.598\nneuron fate determination,morphogenesis/development,0.526\nneuron fate specification,morphogenesis/development,0.486\nneuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,cell death,0.288\nneuron intrinsic apoptotic signaling pathway in response to hydrogen peroxide,cell death,0.324\nneuron intrinsic apoptotic signaling pathway in response to oxidative stress,cell death,0.46\nneuron maturation,morphogenesis/development,0.562\nneuron projection,neural related process,0.492\nneuron projection branch point,cellular component organization,0.384\nneuron projection cytoplasm,cellular component organization,0.38\nneuron projection extension involved in neuron projection guidance,morphogenesis/development,0.44\nneuron projection fasciculation,cellular component organization,0.398\nneuron projection maintenance,neural related process,0.358\nneuron projection morphogenesis,neural related process,0.718\nneuron projection regeneration,neural related process,0.498\nneuron projection retraction,neural related process,0.366\nneuron projection terminus,neural related process,0.562\nneuron remodeling,neural related process,0.342\nneuron spine,neural related process,0.804\nneuron-glial cell signaling,neural related process,0.258\nneuron-neuron synaptic transmission,neural related process,0.41\nneuronal action potential,neural related process,0.486\nneuronal action potential propagation,neural related process,0.226\nneuronal cell body,neural related process,0.53\nneuronal cell body membrane,neural related process,0.466\nneuronal dense core vesicle,neural related process,0.506\nneuronal dense core vesicle exocytosis,transport,0.55\nneuronal dense core vesicle lumen,neural related process,0.286\nneuronal dense core vesicle membrane,neural related process,0.29\nneuronal ion channel clustering,cellular component organization,0.508\nneuronal ribonucleoprotein granule,cellular component organization,0.2\nneuronal signal transduction,neural related process,0.228\nneuronal stem cell division,neural related process,0.314\nneuronal stem cell population maintenance,morphogenesis/development,0.292\nneuronal-glial interaction involved in cerebral cortex radial glia guided migration,neural related process,0.272\nneuronal-glial interaction involved in hindbrain glial-mediated radial cell migration,neural related process,0.266\nneuropeptide Y receptor activity,receptor related process,0.616\nneuropeptide Y receptor binding,receptor related process,0.464\nneuropeptide activity,receptor related process,0.29\nneuropeptide catabolic process,metabolic process,0.836\nneuropeptide hormone activity,neural related process,0.196\nneuropeptide processing,protein modification/signaling,0.216\nneuropeptide receptor activity,receptor related process,0.586\nneuropeptide signaling pathway,receptor related process,0.648\nneuropilin binding,metabolic process,0.202\nneuropilin signaling pathway,receptor related process,0.648\n\"neurotensin receptor activity, non-G protein-coupled\",protein modification/signaling,0.23\nneurotransmitter loading into synaptic vesicle,transport,0.68\nneurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration,neural related process,0.316\nneurotransmitter receptor activity involved in regulation of postsynaptic membrane potential,neural related process,0.512\nneurotransmitter receptor complex,neural related process,0.276\nneurotransmitter receptor cycle,transport,0.434\nneurotransmitter receptor diffusion trapping,transport,0.298\nneurotransmitter receptor internalization,transport,0.524\nneurotransmitter receptor localization to postsynaptic specialization membrane,neural related process,0.23\nneurotransmitter receptor regulator activity,receptor related process,0.308\nneurotransmitter receptor transport,transport,0.632\nneurotransmitter receptor transport postsynaptic membrane to endosome,neural related process,0.248\nneurotransmitter receptor transport to plasma membrane,transport,0.676\nneurotransmitter receptor transport to postsynaptic membrane,transport,0.642\n\"neurotransmitter receptor transport, endosome to plasma membrane\",transport,0.672\n\"neurotransmitter receptor transport, endosome to postsynaptic membrane\",transport,0.392\n\"neurotransmitter receptor transport, postsynaptic endosome to lysosome\",transport,0.312\nneurotransmitter reuptake,neural related process,0.442\nneurotransmitter secretion,neural related process,0.414\nneurotransmitter secretion involved in regulation of skeletal muscle contraction,neural related process,0.376\nneurotransmitter transmembrane transporter activity,transport,0.528\nneurotransmitter-gated ion channel clustering,transport,0.338\nneurotransmitter:sodium symporter activity,metabolic process,0.524\nneurotrophin TRK receptor binding,receptor related process,0.466\nneurotrophin TRK receptor signaling pathway,receptor related process,0.564\nneurotrophin TRKA receptor binding,receptor related process,0.544\nneurotrophin TRKB receptor binding,receptor related process,0.524\nneurotrophin TRKC receptor binding,receptor related process,0.524\nneurotrophin binding,protein modification/signaling,0.28\nneurotrophin p75 receptor binding,receptor related process,0.52\nneurotrophin production,multicellular organismal process,0.3\nneurotrophin receptor activity,receptor related process,0.514\nneurotrophin receptor binding,receptor related process,0.518\nneutral L-amino acid secondary active transmembrane transporter activity,transport,0.696\nneutral L-amino acid transmembrane transporter activity,transport,0.902\nneutral L-amino acid:sodium symporter activity,transport,0.586\nneutral L-amino acid:sodium:chloride symporter activity,metabolic process,0.526\n\"neutral amino acid, sodium:proton antiporter activity\",metabolic process,0.516\nneutral lipid biosynthetic process,metabolic process,0.97\nneutral lipid catabolic process,metabolic process,0.984\nneutral lipid metabolic process,metabolic process,0.944\nneutral sphingomyelin phosphodiesterase activity,metabolic process,0.798\n\"neutral, basic amino acid:sodium:chloride symporter activity\",metabolic process,0.516\nneutrophil activation,immune system process,0.798\nneutrophil activation involved in immune response,immune system process,0.584\nneutrophil aggregation,metabolic process,0.206\nneutrophil apoptotic process,cell death,0.44\nneutrophil clearance,cellular component organization,0.188\nneutrophil degranulation,immune system process,0.18\nneutrophil differentiation,morphogenesis/development,0.434\nneutrophil extravasation,cellular component organization,0.17\nneutrophil mediated cytotoxicity,immune system process,0.776\nneutrophil-mediated killing of bacterium,immune system process,0.806\nneutrophil-mediated killing of fungus,immune system process,0.252\nneutrophil-mediated killing of gram-negative bacterium,immune system process,0.236\nneutrophil-mediated killing of gram-positive bacterium,immune system process,0.202\nneutrophil-mediated killing of symbiont cell,immune system process,0.784\nnew growing cell tip,cell cycle,0.202\nnickel cation binding,metabolic process,0.242\nnickel cation transmembrane transport,transport,0.962\nnickel cation transmembrane transporter activity,transport,0.61\nnickel cation transport,transport,0.978\nnicotinamide N-methyltransferase activity,metabolic process,0.896\nnicotinamide metabolic process,metabolic process,0.95\nnicotinamide phosphoribosyltransferase activity,metabolic process,0.874\nnicotinamide riboside catabolic process,metabolic process,0.776\nnicotinamide riboside metabolic process,metabolic process,0.946\nnicotinamide-nucleotide adenylyltransferase activity,metabolic process,0.832\nnicotinate phosphoribosyltransferase activity,metabolic process,0.874\nnicotinate transmembrane transporter activity,cellular component organization,0.264\nnicotinate transport,transport,0.736\nnicotinate-nucleotide adenylyltransferase activity,metabolic process,0.802\nnicotinate-nucleotide diphosphorylase (carboxylating) activity,metabolic process,0.874\nnicotinic acid receptor activity,metabolic process,0.208\nnipple development,morphogenesis/development,0.856\nnipple morphogenesis,morphogenesis/development,0.448\nnitrate import,transport,0.866\nnitrate metabolic process,metabolic process,0.936\nnitrate reductase activity,metabolic process,0.838\nnitrate transmembrane transport,transport,0.954\nnitrate transmembrane transporter activity,transport,0.638\nnitric oxide binding,metabolic process,0.308\nnitric oxide mediated signal transduction,protein modification/signaling,0.3\nnitric oxide production involved in inflammatory response,immune system process,0.566\nnitric oxide storage,protein modification/signaling,0.196\nnitric oxide transmembrane transporter activity,metabolic process,0.364\nnitric oxide transport,transport,0.674\nnitric oxide-cGMP-mediated signaling pathway,protein modification/signaling,0.278\nnitric-oxide synthase activity,metabolic process,0.932\nnitric-oxide synthase binding,metabolic process,0.264\nnitric-oxide synthase complex,metabolic process,0.414\nnitric-oxide synthase inhibitor activity,metabolic process,0.396\nnitric-oxide synthase regulator activity,metabolic process,0.454\nnitrite reductase (NO-forming) activity,metabolic process,0.926\nnitrite reductase activity,metabolic process,0.808\nnitrite transport,transport,0.724\nnitrobenzene metabolic process,metabolic process,0.952\nnitrogen catabolite activation of transcription,gene regulation,0.492\nnitrogen catabolite activation of transcription from RNA polymerase II promoter,gene regulation,0.616\nnitrogen catabolite regulation of transcription,gene regulation,0.48\nnitrogen catabolite regulation of transcription from RNA polymerase II promoter,gene regulation,0.488\nnitrogen compound metabolic process,metabolic process,0.686\nnitrogen cycle metabolic process,metabolic process,0.37\nnitrogen utilization,immune system process,0.18\nnitroglycerin reductase activity,metabolic process,0.508\nnociceptin receptor activity,cellular component organization,0.196\nnodal binding,protein modification/signaling,0.336\nnodal signaling pathway,receptor related process,0.49\nnode of Ranvier,neural related process,0.266\nnon-canonical NF-kappaB signal transduction,immune system process,0.37\nnon-canonical Wnt signaling pathway involved in heart development,receptor related process,0.326\nnon-canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,receptor related process,0.346\nnon-canonical Wnt signaling pathway via JNK cascade,receptor related process,0.44\nnon-canonical inflammasome complex,cellular component organization,0.36\nnon-canonical inflammasome complex assembly,cellular component organization,0.694\nnon-lytic viral release,viral related process,0.496\nnon-membrane spanning protein tyrosine phosphatase activity,metabolic process,0.514\nnon-membrane-bounded organelle,cellular component organization,0.318\nnon-motile cilium,cellular component organization,0.484\nnon-replicative DNA transposition,cellular component organization,0.236\nnon-ribosomal peptide synthetase activity,metabolic process,0.528\n\"non-sequence-specific DNA binding, bending\",cell cycle,0.21\nnonassociative learning,neural related process,0.32\nnonfunctional rRNA decay,metabolic process,0.24\nnonhomologous end joining complex,metabolic process,0.208\nnor-spermidine metabolic process,metabolic process,0.958\nnoradrenergic neuron development,morphogenesis/development,0.626\nnoradrenergic neuron differentiation,morphogenesis/development,0.728\nnoradrenergic neuron fate commitment,morphogenesis/development,0.536\nnorepinephrine binding,metabolic process,0.246\nnorepinephrine biosynthetic process,metabolic process,0.712\nnorepinephrine metabolic process,metabolic process,0.884\nnorepinephrine secretion,transport,0.528\nnorepinephrine transport,transport,0.744\nnorepinephrine uptake,neural related process,0.316\nnorepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure,multicellular organismal process,0.188\nnorepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure,multicellular organismal process,0.206\nnorepinephrine:sodium symporter activity,metabolic process,0.512\nnorspermine:oxygen oxidoreductase activity,metabolic process,0.902\nnose development,morphogenesis/development,0.888\nnose morphogenesis,morphogenesis/development,0.568\nnotochord cell development,morphogenesis/development,0.972\nnotochord cell differentiation,morphogenesis/development,0.752\nnotochord development,morphogenesis/development,0.958\nnotochord formation,morphogenesis/development,0.288\nnotochord morphogenesis,morphogenesis/development,0.704\nnotochord regression,morphogenesis/development,0.542\nnpBAF complex,gene regulation,0.228\nnuclear DNA replication termination,cell cycle,0.652\nnuclear DNA-directed RNA polymerase complex,gene regulation,0.496\nnuclear RNA export factor complex,transport,0.284\nnuclear RNA surveillance,gene regulation,0.606\nnuclear RNA-directed RNA polymerase complex,gene regulation,0.42\nnuclear aryl hydrocarbon receptor complex,receptor related process,0.37\nnuclear body organization,cellular component organization,0.882\nnuclear cap binding complex,gene regulation,0.424\nnuclear cell cycle DNA replication initiation,cell cycle,0.698\nnuclear chromosome,cell cycle,0.404\nnuclear cyclin-dependent protein kinase holoenzyme complex,protein modification/signaling,0.372\nnuclear envelope budding,cellular component organization,0.452\nnuclear envelope lumen,cellular component organization,0.24\nnuclear estrogen receptor activity,receptor related process,0.582\nnuclear estrogen receptor binding,receptor related process,0.444\nnuclear exosome (RNase complex),gene regulation,0.308\nnuclear export signal receptor activity,transport,0.3\nnuclear fragmentation involved in apoptotic nuclear change,cell death,0.35\nnuclear glucocorticoid receptor activity,receptor related process,0.58\nnuclear histone mRNA catabolic process,metabolic process,0.596\nnuclear import signal receptor activity,transport,0.348\nnuclear inner membrane,cellular component organization,0.256\nnuclear inner membrane organization,cellular component organization,0.746\nnuclear lamina,cellular component organization,0.334\nnuclear localization sequence binding,transport,0.256\nnuclear lumen,cell cycle,0.19\nnuclear mRNA surveillance,gene regulation,0.616\nnuclear mRNA surveillance of mRNA 3'-end processing,cellular component organization,0.18\nnuclear matrix,cellular component organization,0.294\nnuclear matrix anchoring at nuclear membrane,cellular component organization,0.302\nnuclear matrix organization,cellular component organization,0.936\nnuclear membrane microtubule tethering complex,cellular component organization,0.386\nnuclear membrane organization,cellular component organization,0.818\nnuclear membrane protein complex,cellular component organization,0.396\nnuclear membrane reassembly,cellular component organization,0.728\nnuclear microtubule,cellular component organization,0.282\nnuclear migration along microfilament,transport,0.398\nnuclear migration along microtubule,transport,0.718\nnuclear mineralocorticoid receptor binding,receptor related process,0.504\nnuclear ncRNA surveillance,gene regulation,0.588\nnuclear origin of replication recognition complex,cellular component organization,0.316\nnuclear outer membrane,cellular component organization,0.274\nnuclear outer membrane-endoplasmic reticulum membrane network,ER/endosome/lysosome related process,0.24\nnuclear periphery,cellular component organization,0.332\nnuclear polyadenylation-dependent CUT catabolic process,metabolic process,0.638\nnuclear polyadenylation-dependent antisense transcript catabolic process,metabolic process,0.618\nnuclear polyadenylation-dependent mRNA catabolic process,metabolic process,0.554\nnuclear polyadenylation-dependent ncRNA catabolic process,metabolic process,0.72\nnuclear polyadenylation-dependent rRNA catabolic process,metabolic process,0.464\nnuclear polyadenylation-dependent snRNA catabolic process,metabolic process,0.602\nnuclear polyadenylation-dependent snoRNA catabolic process,metabolic process,0.61\nnuclear polyadenylation-dependent tRNA catabolic process,metabolic process,0.61\nnuclear pore central transport channel,transport,0.248\nnuclear pore complex assembly,cellular component organization,0.874\nnuclear pore cytoplasmic filaments,cellular component organization,0.586\nnuclear pore inner ring,cellular component organization,0.532\nnuclear pore localization,transport,0.276\nnuclear pore outer ring,cellular component organization,0.514\nnuclear pore transmembrane ring,cellular component organization,0.512\nnuclear pre-replicative complex,cellular component organization,0.312\nnuclear progesterone receptor binding,receptor related process,0.532\nnuclear proteasome complex,cellular component organization,0.232\nnuclear protein quality control by the ubiquitin-proteasome system,metabolic process,0.502\nnuclear protein-containing complex,gene regulation,0.33\nnuclear receptor activity,gene regulation,0.704\nnuclear receptor corepressor activity,gene regulation,0.366\nnuclear replication fork,cellular component organization,0.216\nnuclear replisome,cell cycle,0.232\nnuclear retinoic acid receptor binding,gene regulation,0.408\nnuclear speck organization,cellular component organization,0.6\nnuclear stress granule,cellular component organization,0.2\nnuclear telomere cap complex,cellular component organization,0.224\nnuclear ubiquitin ligase complex,metabolic process,0.366\nnuclear vitamin D receptor binding,receptor related process,0.386\n\"nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay\",metabolic process,0.596\n\"nuclear-transcribed mRNA catabolic process, RNase MRP-dependent\",metabolic process,0.234\n\"nuclear-transcribed mRNA catabolic process, deadenylation-independent decay\",gene regulation,0.36\n\"nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'\",metabolic process,0.674\n\"nuclear-transcribed mRNA catabolic process, no-go decay\",metabolic process,0.754\n\"nuclear-transcribed mRNA catabolic process, non-stop decay\",metabolic process,0.766\nnuclease inhibitor activity,metabolic process,0.444\nnucleate erythrocyte differentiation,morphogenesis/development,0.432\nnucleic acid metabolic process,metabolic process,0.564\nnucleic acid phosphodiester bond hydrolysis,metabolic process,0.24\nnucleic acid transmembrane transporter activity,transport,0.5\nnucleic acid-protein covalent cross-linking,protein modification/signaling,0.616\nnucleobase binding,metabolic process,0.446\nnucleobase catabolic process,metabolic process,0.946\nnucleobase transmembrane transporter activity,transport,0.492\nnucleobase transport,transport,0.856\nnucleobase-containing compound kinase activity,metabolic process,0.59\nnucleobase-containing compound metabolic process,metabolic process,0.722\nnucleobase-containing compound transmembrane transporter activity,transport,0.66\nnucleobase-containing small molecule biosynthetic process,metabolic process,0.958\nnucleobase-containing small molecule catabolic process,metabolic process,0.964\nnucleobase-containing small molecule interconversion,metabolic process,0.864\nnucleobase-containing small molecule metabolic process,metabolic process,0.98\nnucleobase:monoatomic cation symporter activity,transport,0.546\nnucleocytoplasmic transport complex,transport,0.298\nnucleoid,cellular component organization,0.346\nnucleoid organization,cellular component organization,0.81\nnucleokinesis involved in cell motility in cerebral cortex radial glia guided migration,cellular component organization,0.232\nnucleolar chromatin,cellular component organization,0.344\nnucleolar chromatin organization,morphogenesis/development,0.346\nnucleolar exosome (RNase complex),gene regulation,0.294\nnucleolar large rRNA transcription by RNA polymerase I,gene regulation,0.562\nnucleolar ribonuclease P complex,gene regulation,0.31\nnucleologenesis,cellular component organization,0.536\nnucleolus,cellular component organization,0.188\nnucleolus organizer region,gene regulation,0.41\nnucleophagy,metabolic process,0.434\nnucleoplasm,gene regulation,0.206\nnucleoplasmic reticulum,protein modification/signaling,0.206\nnucleoside binding,metabolic process,0.492\nnucleoside biosynthetic process,metabolic process,0.984\nnucleoside bisphosphate biosynthetic process,metabolic process,0.994\nnucleoside bisphosphate catabolic process,metabolic process,0.99\nnucleoside bisphosphate metabolic process,metabolic process,0.99\nnucleoside catabolic process,metabolic process,0.988\nnucleoside diphosphate catabolic process,metabolic process,0.992\nnucleoside diphosphate kinase activity,metabolic process,0.768\nnucleoside diphosphate phosphatase activity,metabolic process,0.852\nnucleoside import across plasma membrane,transport,0.45\nnucleoside kinase activity,metabolic process,0.7\nnucleoside monophosphate kinase activity,metabolic process,0.678\nnucleoside monophosphate phosphorylation,metabolic process,0.734\nnucleoside phosphate binding,other,0.484\nnucleoside phosphotransferase activity,metabolic process,0.882\nnucleoside salvage,metabolic process,0.744\nnucleoside transmembrane transport,transport,0.79\nnucleoside transmembrane transporter activity,transport,0.62\nnucleoside transport,transport,0.882\nnucleoside triphosphate adenylate kinase activity,metabolic process,0.82\nnucleoside triphosphate catabolic process,metabolic process,0.992\nnucleoside triphosphate diphosphatase activity,metabolic process,0.812\nnucleoside:sodium symporter activity,transport,0.452\nnucleosomal DNA binding,gene regulation,0.318\nnucleosome,gene regulation,0.33\nnucleosome disassembly,cellular component organization,0.308\nnucleotidase activity,metabolic process,0.8\nnucleotide binding,other,0.484\nnucleotide metabolic process,metabolic process,0.994\nnucleotide receptor activity,receptor related process,0.488\nnucleotide salvage,metabolic process,0.776\nnucleotide transmembrane transport,transport,0.826\nnucleotide transmembrane transporter activity,transport,0.658\nnucleotide transport,transport,0.76\nnucleotide-activated protein kinase complex,protein modification/signaling,0.448\nnucleotide-binding oligomerization domain containing 1 signaling pathway,immune system process,0.55\nnucleotide-excision repair complex,cellular component organization,0.242\nnucleotide-excision repair factor 1 complex,cellular component organization,0.276\nnucleotide-excision repair factor 2 complex,protein modification/signaling,0.236\nnucleotide-excision repair factor 3 complex,protein modification/signaling,0.202\nnucleotide-excision repair involved in interstrand cross-link repair,metabolic process,0.216\n\"nucleotide-excision repair, DNA damage recognition\",cellular component organization,0.576\n\"nucleotide-excision repair, DNA duplex unwinding\",transport,0.218\n\"nucleotide-excision repair, DNA gap filling\",cell cycle,0.234\n\"nucleotide-excision repair, preincision complex assembly\",cellular component organization,0.488\nnucleotide-sugar biosynthetic process,metabolic process,0.958\nnucleotide-sugar catabolic process,metabolic process,0.97\nnucleotide-sugar transmembrane transport,transport,0.876\nnucleotide-sugar transmembrane transporter activity,transport,0.608\nnucleus,metabolic process,0.252\nnucleus accumbens development,morphogenesis/development,0.768\nnucleus localization,transport,0.556\nnucleus-vacuole junction,cellular component organization,0.366\nobservational learning,multicellular organismal process,0.454\noctanoyltransferase activity,metabolic process,0.942\noctopamine biosynthetic process,metabolic process,0.862\noctopamine metabolic process,metabolic process,0.98\noculomotor nerve development,morphogenesis/development,0.808\noculomotor nerve formation,morphogenesis/development,0.332\noculomotor nerve morphogenesis,morphogenesis/development,0.492\nodontoblast differentiation,morphogenesis/development,0.65\nodontogenesis of dentin-containing tooth,morphogenesis/development,0.9\nodorant binding,metabolic process,0.258\noleate transmembrane transporter activity,cellular component organization,0.264\nolefin metabolic process,metabolic process,0.958\nolefinic compound biosynthetic process,metabolic process,0.98\nolefinic compound catabolic process,metabolic process,0.97\noleic acid binding,metabolic process,0.342\noleoyl-CoA ligase activity,metabolic process,0.84\noleoyl-[acyl-carrier-protein] hydrolase activity,metabolic process,0.9\nolfactory behavior,multicellular organismal process,0.52\nolfactory bulb axon guidance,neural related process,0.464\nolfactory bulb development,morphogenesis/development,0.656\nolfactory bulb interneuron development,morphogenesis/development,0.638\nolfactory bulb interneuron differentiation,morphogenesis/development,0.472\nolfactory bulb mitral cell layer development,morphogenesis/development,0.734\nolfactory cortex development,morphogenesis/development,0.804\nolfactory learning,morphogenesis/development,0.23\nolfactory lobe development,morphogenesis/development,0.822\nolfactory nerve development,morphogenesis/development,0.912\nolfactory nerve formation,morphogenesis/development,0.41\nolfactory nerve maturation,morphogenesis/development,0.502\nolfactory nerve morphogenesis,morphogenesis/development,0.706\nolfactory nerve structural organization,morphogenesis/development,0.38\nolfactory pit development,morphogenesis/development,0.852\nolfactory placode development,morphogenesis/development,0.844\nolfactory placode formation,morphogenesis/development,0.356\nolfactory placode morphogenesis,morphogenesis/development,0.76\nolfactory receptor activity,receptor related process,0.572\nolfactory receptor binding,receptor related process,0.502\n\"oligo-1,6-glucosidase activity\",metabolic process,0.51\noligodendrocyte apoptotic process,cell death,0.562\noligodendrocyte cell fate commitment,morphogenesis/development,0.57\noligodendrocyte cell fate specification,morphogenesis/development,0.544\noligodendrocyte development,morphogenesis/development,0.37\noligodendrocyte differentiation,morphogenesis/development,0.468\noligodendrocyte progenitor proliferation,cell cycle,0.62\noligonucleotidase activity,metabolic process,0.69\noligopeptidase activity,metabolic process,0.488\noligopeptide binding,protein modification/signaling,0.228\noligopeptide import across plasma membrane,transport,0.894\noligopeptide transmembrane transport,transport,0.742\noligopeptide transmembrane transporter activity,transport,0.616\noligoribonucleotidase activity,metabolic process,0.486\noligosaccharide binding,metabolic process,0.236\noligosaccharide biosynthetic process,metabolic process,0.974\noligosaccharide catabolic process,metabolic process,0.972\noligosaccharide transmembrane transporter activity,transport,0.7\noligosaccharide transport,transport,0.956\noligosaccharide-lipid intermediate biosynthetic process,metabolic process,0.96\noligosaccharyl transferase activity,metabolic process,0.892\noligosaccharyltransferase I complex,cellular component organization,0.302\noligosaccharyltransferase III complex,cellular component organization,0.348\noligosaccharyltransferase complex,cellular component organization,0.236\noligosaccharyltransferase complex binding,metabolic process,0.236\nomega peptidase activity,metabolic process,0.562\nomega-6 fatty acid desaturase activity,metabolic process,0.59\nomega-amidase activity,metabolic process,0.904\nomega-hydroxyceramide biosynthetic process,metabolic process,0.892\nomega-hydroxyceramide transacylase activity,metabolic process,0.896\nomega-hydroxydecanoate dehydrogenase activity,metabolic process,0.928\nomega-hydroxylase P450 pathway,metabolic process,0.842\nomegasome,cellular component organization,0.412\nomegasome membrane,cellular component organization,0.352\noncogene-induced cell senescence,stress response,0.134\noncostatin-M receptor activity,receptor related process,0.214\noncostatin-M receptor binding,receptor related process,0.524\noncostatin-M receptor complex,immune system process,0.326\noncostatin-M-mediated signaling pathway,receptor related process,0.638\none-carbon compound transport,transport,0.904\noocyte anterior/posterior axis specification,cellular component organization,0.206\noocyte axis specification,morphogenesis/development,0.442\noocyte construction,morphogenesis/development,0.254\noocyte growth,morphogenesis/development,0.456\nooplasm,cellular component organization,0.26\nopen rectifier potassium channel activity,transport,0.268\noperant conditioning,neural related process,0.232\nopioid growth factor receptor activity,receptor related process,0.434\nopioid peptide activity,metabolic process,0.224\nopioid receptor binding,receptor related process,0.466\nopsin binding,cellular component organization,0.262\nopsin transport,transport,0.562\nopsonin binding,immune system process,0.346\nopsonin receptor activity,receptor related process,0.368\nopsonization,cellular component organization,0.262\noptic chiasma development,morphogenesis/development,0.854\noptic cup formation involved in camera-type eye development,morphogenesis/development,0.618\noptic cup morphogenesis involved in camera-type eye development,morphogenesis/development,0.318\noptic cup structural organization,morphogenesis/development,0.408\noptic nerve development,morphogenesis/development,0.662\noptic nerve formation,morphogenesis/development,0.388\noptic nerve morphogenesis,morphogenesis/development,0.514\noptic nerve structural organization,morphogenesis/development,0.334\noptic vesicle morphogenesis,morphogenesis/development,0.628\noptokinetic behavior,multicellular organismal process,0.304\norbitofrontal cortex development,morphogenesis/development,0.842\norcinol O-methyltransferase activity,metabolic process,0.896\norexigenic neuropeptide QRFP receptor binding,receptor related process,0.502\norexin receptor activity,cellular component organization,0.17\norexin receptor binding,receptor related process,0.454\norgan induction,morphogenesis/development,0.794\norgan or tissue specific immune response,immune system process,0.788\norganellar large ribosomal subunit,cellular component organization,0.53\norganellar ribosome,cellular component organization,0.574\norganellar small ribosomal subunit,cellular component organization,0.524\norganelle,metabolic process,0.362\norganelle disassembly,cellular component organization,0.518\norganelle envelope,cellular component organization,0.426\norganelle envelope lumen,cellular component organization,0.542\norganelle inner membrane,metabolic process,0.452\norganelle localization by membrane tethering,cellular component organization,0.272\norganelle lumen,metabolic process,0.21\norganelle membrane,cellular component organization,0.198\norganelle membrane contact site,cellular component organization,0.534\norganelle membrane fusion,cellular component organization,0.798\norganelle organization,cellular component organization,0.6\norganelle subcompartment,ER/endosome/lysosome related process,0.368\norganelle transport along microtubule,transport,0.742\norganic acid binding,metabolic process,0.462\norganic acid metabolic process,metabolic process,0.974\norganic acid transport,transport,0.914\norganic acid:sodium symporter activity,transport,0.582\norganic cation transmembrane transporter activity,transport,0.624\norganic cation transport,transport,0.81\norganic cyclic compound catabolic process,metabolic process,0.916\norganic cyclic compound metabolic process,metabolic process,0.816\norganic heteropentacyclic compound catabolic process,metabolic process,0.96\norganic heteropentacyclic compound metabolic process,metabolic process,0.978\norganic hydroxy compound catabolic process,metabolic process,0.96\norganic hydroxy compound transmembrane transporter activity,transport,0.664\norganic substance biosynthetic process,metabolic process,0.856\norganic substance catabolic process,metabolic process,0.806\norganic substance metabolic process,metabolic process,0.7\norganic substance transport,transport,0.686\norganism emergence from protective structure,morphogenesis/development,0.552\norganonitrogen compound biosynthetic process,metabolic process,0.766\norganonitrogen compound metabolic process,metabolic process,0.598\norganophosphate biosynthetic process,metabolic process,0.974\norganophosphate ester transmembrane transporter activity,transport,0.672\norganophosphate ester transport,transport,0.872\norganophosphate metabolic process,metabolic process,0.952\norganophosphate:inorganic phosphate antiporter activity,transport,0.494\norigin recognition complex,cellular component organization,0.292\nornithine biosynthetic process,metabolic process,0.644\nornithine carbamoyltransferase activity,metabolic process,0.846\nornithine catabolic process,metabolic process,0.972\nornithine decarboxylase activator activity,metabolic process,0.24\nornithine decarboxylase activity,metabolic process,0.896\nornithine decarboxylase inhibitor activity,metabolic process,0.266\nornithine decarboxylase regulator activity,metabolic process,0.42\nornithine metabolic process,metabolic process,0.966\nornithine transport,transport,0.96\norotate phosphoribosyltransferase activity,metabolic process,0.874\norotidine-5'-phosphate decarboxylase activity,metabolic process,0.896\northogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis,morphogenesis/development,0.244\nosmolarity-sensing monoatomic cation channel activity,metabolic process,0.182\nosmosensor activity,receptor related process,0.398\nosmosensory signaling pathway,stress response,0.262\nossification involved in bone maturation,morphogenesis/development,0.654\nossification involved in bone remodeling,morphogenesis/development,0.232\nosteoblast fate commitment,morphogenesis/development,0.26\nosteoclast development,morphogenesis/development,0.822\nosteoclast fusion,cellular component organization,0.348\nosteoclast maturation,morphogenesis/development,0.576\nosteoclast proliferation,cell cycle,0.654\nother organism cell membrane,cellular component organization,0.298\nother organism part,cellular component organization,0.574\notic placode development,morphogenesis/development,0.992\notic placode formation,morphogenesis/development,0.614\notic vesicle development,morphogenesis/development,0.976\notic vesicle formation,morphogenesis/development,0.436\notic vesicle morphogenesis,morphogenesis/development,0.786\notolith development,morphogenesis/development,0.984\notolith formation,morphogenesis/development,0.374\notolith mineralization,morphogenesis/development,0.698\notolith mineralization completed early in development,morphogenesis/development,0.268\notolith morphogenesis,morphogenesis/development,0.73\nouter acrosomal membrane,metabolic process,0.446\nouter dense fiber,protein modification/signaling,0.432\nouter dense plaque of desmosome,cellular component organization,0.404\nouter dynein arm,cellular component organization,0.328\nouter dynein arm assembly,cellular component organization,0.64\nouter dynein arm docking complex,cellular component organization,0.254\nouter ear morphogenesis,morphogenesis/development,0.554\nouter hair cell apoptotic process,cell death,0.226\nouter kinetochore,cell cycle,0.374\nouter medullary collecting duct development,morphogenesis/development,0.988\nouter membrane,cellular component organization,0.656\nouter mitochondrial membrane organization,cellular component organization,0.948\nouter mitochondrial membrane protein complex,cellular component organization,0.424\noutward rectifier potassium channel activity,transport,0.55\novarian cumulus expansion,cellular component organization,0.174\novarian follicle atresia,cell death,0.416\novarian follicle development,morphogenesis/development,0.966\novarian follicle rupture,cellular component organization,0.224\noviduct development,morphogenesis/development,0.99\noviduct epithelium development,morphogenesis/development,0.928\novulation from ovarian follicle,cellular component organization,0.216\noxalate metabolic process,metabolic process,0.964\noxalate transmembrane transporter activity,transport,0.722\noxalate transport,transport,0.902\noxalic acid secretion,metabolic process,0.228\noxaloacetate decarboxylase activity,metabolic process,0.896\noxaloacetate metabolic process,metabolic process,0.954\noxaloacetate transmembrane transporter activity,transport,0.768\noxaloacetate transport,transport,0.984\noxaloacetate(2-) transmembrane transport,transport,0.878\noxidation-dependent protein catabolic process,metabolic process,0.662\noxidative DNA demethylase activity,metabolic process,0.682\noxidative RNA demethylase activity,metabolic process,0.63\noxidative RNA demethylation,gene regulation,0.614\noxidative phosphorylation uncoupler activity,transport,0.328\noxidative single-stranded DNA demethylation,metabolic process,0.46\noxidative single-stranded RNA demethylation,metabolic process,0.472\noxidative stress-induced premature senescence,metabolic process,0.168\noxidised low-density lipoprotein particle clearance,cellular component organization,0.264\noxidised low-density lipoprotein particle receptor activity,cellular component organization,0.21\noxidized DNA binding,gene regulation,0.464\noxidized base lesion DNA N-glycosylase activity,metabolic process,0.566\noxidized purine DNA binding,gene regulation,0.472\noxidized purine nucleobase lesion DNA N-glycosylase activity,metabolic process,0.556\noxidized pyrimidine DNA binding,metabolic process,0.268\noxidized pyrimidine nucleobase lesion DNA N-glycosylase activity,metabolic process,0.55\n\"oxidoreductase activity, acting on CH or CH2 groups\",metabolic process,0.926\n\"oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor\",metabolic process,0.976\n\"oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor\",metabolic process,0.966\n\"oxidoreductase activity, acting on CH or CH2 groups, oxygen as acceptor\",metabolic process,0.952\n\"oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor\",metabolic process,0.892\n\"oxidoreductase activity, acting on NAD(P)H\",metabolic process,0.904\n\"oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor\",metabolic process,0.958\n\"oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor\",metabolic process,0.816\n\"oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor\",metabolic process,0.94\n\"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor\",metabolic process,0.9\n\"oxidoreductase activity, acting on X-H and Y-H to form an X-Y bond\",metabolic process,0.902\n\"oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor\",metabolic process,0.964\n\"oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor\",metabolic process,0.962\n\"oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor\",metabolic process,0.948\n\"oxidoreductase activity, acting on diphenols and related substances as donors\",metabolic process,0.852\n\"oxidoreductase activity, acting on iron-sulfur proteins as donors\",metabolic process,0.764\n\"oxidoreductase activity, acting on iron-sulfur proteins as donors, NAD or NADP as acceptor\",metabolic process,0.768\n\"oxidoreductase activity, acting on metal ions\",metabolic process,0.728\n\"oxidoreductase activity, acting on metal ions, NAD or NADP as acceptor\",metabolic process,0.852\n\"oxidoreductase activity, acting on metal ions, oxygen as acceptor\",metabolic process,0.724\n\"oxidoreductase activity, acting on other nitrogenous compounds as donors\",metabolic process,0.91\n\"oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor\",metabolic process,0.934\n\"oxidoreductase activity, acting on other nitrogenous compounds as donors, oxygen as acceptor\",metabolic process,0.926\n\"oxidoreductase activity, acting on other nitrogenous compounds as donors, with NAD or NADP as acceptor\",metabolic process,0.952\n\"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen\",metabolic process,0.9\n\"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen\",metabolic process,0.872\n\"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen\",metabolic process,0.912\n\"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen\",metabolic process,0.958\n\"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen\",metabolic process,0.814\n\"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen\",metabolic process,0.862\n\"oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water\",metabolic process,0.914\n\"oxidoreductase activity, acting on peroxide as acceptor\",metabolic process,0.922\n\"oxidoreductase activity, acting on phosphorus or arsenic in donors\",metabolic process,0.874\n\"oxidoreductase activity, acting on phosphorus or arsenic in donors, disulfide as acceptor\",metabolic process,0.914\n\"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen\",metabolic process,0.914\n\"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen\",metabolic process,0.9\n\"oxidoreductase activity, acting on superoxide radicals as acceptor\",metabolic process,0.932\n\"oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor\",metabolic process,0.968\n\"oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor\",metabolic process,0.952\n\"oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor\",metabolic process,0.962\n\"oxidoreductase activity, acting on the CH-NH group of donors\",metabolic process,0.956\n\"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor\",metabolic process,0.986\n\"oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor\",metabolic process,0.962\n\"oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor\",metabolic process,0.966\n\"oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor\",metabolic process,0.936\n\"oxidoreductase activity, acting on the CH-NH2 group of donors\",metabolic process,0.916\n\"oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor\",metabolic process,0.984\n\"oxidoreductase activity, acting on the CH-NH2 group of donors, disulfide as acceptor\",metabolic process,0.952\n\"oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor\",metabolic process,0.892\n\"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor\",metabolic process,0.946\n\"oxidoreductase activity, acting on the CH-OH group of donors, cytochrome as acceptor\",metabolic process,0.954\n\"oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor\",metabolic process,0.95\n\"oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor\",metabolic process,0.962\n\"oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor\",metabolic process,0.962\n\"oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor\",metabolic process,0.958\noxidoreductase complex,metabolic process,0.666\noxidoreduction-driven active transmembrane transporter activity,metabolic process,0.45\noxidosqualene cyclase activity,metabolic process,0.874\noxo-acid-lyase activity,metabolic process,0.824\noxoglutarate dehydrogenase (NAD+) activity,metabolic process,0.908\noxoglutarate dehydrogenase (succinyl-transferring) activity,metabolic process,0.896\noxoglutarate dehydrogenase [NAD(P)+] activity,metabolic process,0.97\noxoglutarate dehydrogenase complex,metabolic process,0.508\noxoglutarate:malate antiporter activity,metabolic process,0.526\noxygen binding,metabolic process,0.382\noxygen carrier activity,metabolic process,0.284\noxygen metabolic process,metabolic process,0.824\noxygen sensor activity,metabolic process,0.254\noxygen transport,transport,0.722\noxygen-dependent protoporphyrinogen oxidase activity,metabolic process,0.896\noxylipin biosynthetic process,metabolic process,0.874\noxylipin metabolic process,metabolic process,0.924\noxysterol 7-alpha-hydroxylase activity,metabolic process,0.93\noxysterol binding,metabolic process,0.338\noxytocin production,immune system process,0.428\noxytocin receptor activity,cellular component organization,0.162\noxytocin receptor binding,receptor related process,0.502\npH elevation,other,0.194\npH reduction,morphogenesis/development,0.192\npH-gated chloride channel activity,metabolic process,0.216\npICln-Sm protein complex,protein modification/signaling,0.3\npallium cell proliferation in forebrain,cell cycle,0.804\npallium development,morphogenesis/development,0.826\npalmitic acid biosynthetic process,metabolic process,0.902\npalmitic acid metabolic process,metabolic process,0.984\npalmitoleoyltransferase activity,metabolic process,0.692\npalmitoleyl hydrolase activity,metabolic process,0.842\npalmitoyl hydrolase activity,metabolic process,0.778\npalmitoyl-(protein) hydrolase activity,metabolic process,0.702\npalmitoyl-CoA 9-desaturase activity,metabolic process,0.904\npalmitoyl-CoA hydrolase activity,metabolic process,0.9\npalmitoyl-CoA ligase activity,metabolic process,0.838\npalmitoyl-CoA oxidase activity,metabolic process,0.892\npalmitoyl-[acyl-carrier-protein] hydrolase activity,metabolic process,0.9\npalmitoyltransferase activity,metabolic process,0.928\npalmitoyltransferase complex,metabolic process,0.296\npancreas morphogenesis,morphogenesis/development,0.812\npancreatic A cell development,morphogenesis/development,0.946\npancreatic A cell differentiation,morphogenesis/development,0.68\npancreatic A cell fate commitment,morphogenesis/development,0.292\npancreatic D cell differentiation,morphogenesis/development,0.728\npancreatic PP cell differentiation,morphogenesis/development,0.724\npancreatic PP cell fate commitment,morphogenesis/development,0.308\npancreatic epsilon cell differentiation,morphogenesis/development,0.7\npancreatic juice secretion,metabolic process,0.452\npancreatic polypeptide receptor activity,cellular component organization,0.174\npancreatic stellate cell proliferation,cell cycle,0.73\npantetheine hydrolase activity,metabolic process,0.898\npantetheine-phosphate adenylyltransferase activity,metabolic process,0.82\npantothenate kinase activity,metabolic process,0.792\npantothenate metabolic process,metabolic process,0.964\npantothenate transmembrane transport,transport,0.702\npantothenate transmembrane transporter activity,transport,0.39\nparacrine signaling,protein modification/signaling,0.146\nparaferritin complex,cellular component organization,0.206\nparallel actin filament bundle assembly,cellular component organization,0.93\nparallel fiber,cellular component organization,0.202\nparallel fiber to Purkinje cell synapse,neural related process,0.224\nparamesonephric duct development,morphogenesis/development,0.976\nparanodal junction,neural related process,0.282\nparanodal junction assembly,morphogenesis/development,0.262\nparanodal junction maintenance,neural related process,0.254\nparanode region of axon,neural related process,0.242\nparaspeckles,cellular component organization,0.23\nparasympathetic nervous system development,morphogenesis/development,0.734\nparathyroid gland development,morphogenesis/development,0.982\nparathyroid hormone receptor activity,cellular component organization,0.178\nparathyroid hormone receptor binding,receptor related process,0.48\nparathyroid hormone secretion,cellular component organization,0.19\nparaxial mesoderm development,morphogenesis/development,0.98\nparaxial mesoderm formation,morphogenesis/development,0.492\nparaxial mesoderm morphogenesis,morphogenesis/development,0.792\nparaxial mesoderm structural organization,morphogenesis/development,0.376\nparaxial mesodermal cell differentiation,morphogenesis/development,0.67\nparaxial mesodermal cell fate commitment,morphogenesis/development,0.212\nparental behavior,multicellular organismal process,0.454\nparkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,metabolic process,0.26\nparturition,metabolic process,0.174\npassive transmembrane transporter activity,transport,0.598\npatched binding,receptor related process,0.33\npatched ligand maturation,protein modification/signaling,0.484\npattern recognition receptor activity,immune system process,0.422\npattern specification involved in kidney development,morphogenesis/development,0.662\npattern specification involved in mesonephros development,morphogenesis/development,0.658\npattern specification involved in metanephros development,morphogenesis/development,0.652\npattern specification involved in pronephros development,morphogenesis/development,0.648\npenetration of cumulus oophorus,metabolic process,0.308\npenetration of zona pellucida,metabolic process,0.292\npenile erection,multicellular organismal process,0.176\npentacyclic triterpenoid metabolic process,metabolic process,0.988\npentameric IgM immunoglobulin complex,immune system process,0.216\npentitol catabolic process,metabolic process,0.988\npentitol metabolic process,metabolic process,0.994\npentitol phosphate metabolic process,metabolic process,0.914\npentose biosynthetic process,metabolic process,0.994\npentose catabolic process,metabolic process,0.988\npentose metabolic process,metabolic process,0.992\npentose transmembrane transport,transport,0.844\npentose transmembrane transporter activity,transport,0.696\npentose-phosphate shunt,metabolic process,0.698\n\"pentose-phosphate shunt, non-oxidative branch\",metabolic process,0.678\n\"pentose-phosphate shunt, oxidative branch\",metabolic process,0.414\npentosyltransferase activity,metabolic process,0.778\npeptidase activator activity,metabolic process,0.392\npeptidase activator activity involved in apoptotic process,cell death,0.54\npeptidase activity,cell death,0.484\npeptidase inhibitor activity,metabolic process,0.676\npeptidase inhibitor complex,cellular component organization,0.24\npeptidase regulator activity,metabolic process,0.654\npeptide 2-hydroxyisobutyryltransferase activity,metabolic process,0.842\npeptide N-acetyltransferase activity,protein modification/signaling,0.386\npeptide N-succinyltransferase activity,metabolic process,0.676\npeptide YY receptor activity,cellular component organization,0.17\npeptide alpha-N-acetyltransferase activity,metabolic process,0.708\npeptide amidation,metabolic process,0.54\npeptide antigen assembly with MHC class I protein complex,immune system process,0.282\npeptide antigen assembly with MHC class II protein complex,immune system process,0.304\npeptide antigen assembly with MHC protein complex,cellular component organization,0.62\npeptide antigen binding,immune system process,0.346\npeptide antigen stabilization,cellular component organization,0.26\npeptide antigen transport,transport,0.568\npeptide binding,protein modification/signaling,0.37\npeptide butyryltransferase activity,metabolic process,0.79\npeptide catabolic process,metabolic process,0.934\npeptide cross-linking,protein modification/signaling,0.648\npeptide cross-linking via chondroitin 4-sulfate glycosaminoglycan,cellular component organization,0.202\npeptide crotonyltransferase activity,metabolic process,0.79\npeptide deformylase activity,metabolic process,0.782\npeptide dopaminyltransferase activity,metabolic process,0.828\npeptide glutaryltransferase activity,metabolic process,0.81\npeptide histaminyltransferase activity,metabolic process,0.892\npeptide hormone binding,metabolic process,0.196\npeptide hormone receptor binding,receptor related process,0.436\npeptide hormone secretion,transport,0.776\npeptide lactyltransferase activity,metabolic process,0.814\npeptide modification,metabolic process,0.422\npeptide noradrenalinyltransferase activity,metabolic process,0.892\npeptide receptor activity,receptor related process,0.518\npeptide secretion,transport,0.722\npeptide serotonyltransferase activity,metabolic process,0.828\npeptide stabilization,metabolic process,0.41\npeptide transmembrane transporter activity,transport,0.686\npeptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity,metabolic process,0.798\npeptide-O-fucosyltransferase activity,metabolic process,0.482\npeptide-glutamate-alpha-N-acetyltransferase activity,metabolic process,0.876\npeptide-methionine (R)-S-oxide reductase activity,metabolic process,0.782\npeptide-methionine (S)-S-oxide reductase activity,metabolic process,0.782\npeptide-serine-alpha-N-acetyltransferase activity,metabolic process,0.876\npeptide:proton symporter activity,transport,0.42\npeptidoglycan binding,cellular component organization,0.182\npeptidoglycan catabolic process,metabolic process,0.768\npeptidoglycan glycosyltransferase activity,metabolic process,0.874\npeptidoglycan immune receptor activity,immune system process,0.344\npeptidoglycan metabolic process,metabolic process,0.926\npeptidoglycan muralytic activity,metabolic process,0.504\npeptidoglycan transmembrane transporter activity,transport,0.612\npeptidoglycan transport,transport,0.928\npeptidyl-L-cysteine S-palmitoylation,metabolic process,0.28\npeptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine,protein modification/signaling,0.612\npeptidyl-alanine modification,protein modification/signaling,0.608\npeptidyl-amino acid modification,protein modification/signaling,0.712\npeptidyl-arginine 3-dioxygenase activity,metabolic process,0.68\npeptidyl-arginine N-methylation,protein modification/signaling,0.684\npeptidyl-arginine deglycation,protein modification/signaling,0.502\npeptidyl-arginine hydroxylation,protein modification/signaling,0.596\n\"peptidyl-arginine methylation, to asymmetrical-dimethyl arginine\",cellular component organization,0.23\n\"peptidyl-arginine methylation, to symmetrical-dimethyl arginine\",cellular component organization,0.23\npeptidyl-arginine modification,protein modification/signaling,0.714\npeptidyl-arginine omega-N-methylation,protein modification/signaling,0.7\npeptidyl-aspartic acid 3-dioxygenase activity,metabolic process,0.634\npeptidyl-aspartic acid autophosphorylation,protein modification/signaling,0.56\npeptidyl-aspartic acid hydroxylation,protein modification/signaling,0.658\npeptidyl-aspartic acid modification,protein modification/signaling,0.57\npeptidyl-aspartic acid phosphorylation,protein modification/signaling,0.72\npeptidyl-cysteine S-nitrosylase activity,metabolic process,0.53\npeptidyl-cysteine S-nitrosylation,protein modification/signaling,0.7\npeptidyl-cysteine S-trans-nitrosylation,metabolic process,0.476\npeptidyl-cysteine deglycation,protein modification/signaling,0.502\npeptidyl-cysteine methylation,cellular component organization,0.232\npeptidyl-cysteine oxidation,metabolic process,0.452\npeptidyl-dipeptidase activity,metabolic process,0.494\npeptidyl-dipeptidase inhibitor activity,metabolic process,0.29\npeptidyl-glutamate ADP-deribosylation,protein modification/signaling,0.226\npeptidyl-glutamic acid carboxylation,metabolic process,0.398\npeptidyl-glutamic acid modification,protein modification/signaling,0.678\npeptidyl-glutamine methylation,protein modification/signaling,0.672\npeptidyl-glutamine modification,protein modification/signaling,0.602\npeptidyl-glycine modification,protein modification/signaling,0.594\npeptidyl-histidine dephosphorylation,protein modification/signaling,0.354\npeptidyl-histidine dioxygenase activity,metabolic process,0.882\npeptidyl-histidine methylation,protein modification/signaling,0.726\n\"peptidyl-histidine methylation, to form tele-methylhistidine\",metabolic process,0.234\npeptidyl-histidine modification,protein modification/signaling,0.63\npeptidyl-histidine phosphorylation,metabolic process,0.25\npeptidyl-lysine 3-dioxygenase activity,metabolic process,0.638\npeptidyl-lysine 4-dioxygenase activity,metabolic process,0.638\npeptidyl-lysine 5-dioxygenase activity,metabolic process,0.628\npeptidyl-lysine N6-acetylation,protein modification/signaling,0.372\npeptidyl-lysine N6-myristoyltransferase activity,metabolic process,0.592\npeptidyl-lysine acetylation,protein modification/signaling,0.69\npeptidyl-lysine acetyltransferase activity,metabolic process,0.826\npeptidyl-lysine butyrylation,protein modification/signaling,0.456\npeptidyl-lysine crotonylation,protein modification/signaling,0.456\npeptidyl-lysine deacetylation,protein modification/signaling,0.53\npeptidyl-lysine deglycation,protein modification/signaling,0.504\npeptidyl-lysine demalonylation,protein modification/signaling,0.576\npeptidyl-lysine desuccinylation,protein modification/signaling,0.568\npeptidyl-lysine dimethylation,protein modification/signaling,0.718\npeptidyl-lysine glutarylation,protein modification/signaling,0.456\npeptidyl-lysine hydroxylation,protein modification/signaling,0.666\npeptidyl-lysine hydroxylation to 5-hydroxy-L-lysine,metabolic process,0.244\npeptidyl-lysine methylation,gene regulation,0.494\npeptidyl-lysine modification to peptidyl-hypusine,cellular component organization,0.206\npeptidyl-lysine monomethylation,cellular component organization,0.226\npeptidyl-lysine oxidation,protein modification/signaling,0.354\npeptidyl-lysine propionylation,cellular component organization,0.232\npeptidyl-methionine modification,protein modification/signaling,0.624\npeptidyl-proline 3-dioxygenase activity,metabolic process,0.732\npeptidyl-proline 4-dioxygenase activity,metabolic process,0.732\npeptidyl-proline dioxygenase activity,metabolic process,0.666\npeptidyl-proline hydroxylation to 3-hydroxy-L-proline,metabolic process,0.23\npeptidyl-proline hydroxylation to 4-hydroxy-L-proline,metabolic process,0.236\npeptidyl-proline modification,protein modification/signaling,0.6\npeptidyl-prolyl cis-trans isomerase activity,metabolic process,0.624\n\"peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase\",metabolic process,0.912\npeptidyl-pyrromethane cofactor linkage,protein modification/signaling,0.322\npeptidyl-serine ADP-deribosylation,protein modification/signaling,0.226\npeptidyl-serine autophosphorylation,protein modification/signaling,0.77\npeptidyl-serine dephosphorylation,protein modification/signaling,0.512\npeptidyl-serine octanoylation,protein modification/signaling,0.354\npeptidyl-serine trans-autophosphorylation,protein modification/signaling,0.466\npeptidyl-threonine autophosphorylation,protein modification/signaling,0.602\npeptidyl-tryptophan modification,protein modification/signaling,0.598\npeptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity,protein modification/signaling,0.436\npeptidyl-tyrosine sulfation,protein modification/signaling,0.244\npeptidylamidoglycolate lyase activity,metabolic process,0.894\npeptidylglycine monooxygenase activity,metabolic process,0.9\npeptidyltransferase activity,metabolic process,0.89\nperforant pathway to dendrate granule cell synapse,neural related process,0.384\npericardium development,morphogenesis/development,0.984\npericardium morphogenesis,morphogenesis/development,0.776\npericellular basket,cellular component organization,0.17\npericentric heterochromatin,cellular component organization,0.25\npericentric heterochromatin formation,gene regulation,0.7\npericentriolar material,cellular component organization,0.266\nperichondral bone morphogenesis,morphogenesis/development,0.386\nperichromatin fibrils,gene regulation,0.442\npericiliary membrane compartment,cellular component organization,0.328\npericyte cell differentiation,morphogenesis/development,0.872\nperineuronal net,neural related process,0.422\nperinuclear endoplasmic reticulum,cellular component organization,0.298\nperinuclear endoplasmic reticulum lumen,cellular component organization,0.288\nperinuclear endoplasmic reticulum membrane,cellular component organization,0.298\nperinuclear region of cytoplasm,cellular component organization,0.26\nperinuclear theca,cellular component organization,0.266\nperinucleolar chromocenter,cellular component organization,0.242\nperinucleolar compartment,gene regulation,0.56\nperipheral B cell selection,immune system process,0.436\nperipheral B cell tolerance induction,immune system process,0.794\nperipheral T cell tolerance induction,immune system process,0.86\nperipheral nervous system axon ensheathment,neural related process,0.548\nperipheral nervous system axon regeneration,neural related process,0.21\nperipheral nervous system myelin formation,cellular component organization,0.242\nperipheral nervous system myelin maintenance,morphogenesis/development,0.302\nperipheral nervous system neuron axonogenesis,neural related process,0.406\nperipheral nervous system neuron development,morphogenesis/development,0.424\nperipheral nervous system neuron differentiation,morphogenesis/development,0.534\nperipheral region of growth cone,neural related process,0.22\nperipheral tolerance induction,immune system process,0.756\nperistalsis,multicellular organismal process,0.512\nperisynaptic extracellular matrix,cellular component organization,0.444\nperisynaptic space,cellular component organization,0.218\nperivitelline space,cellular component organization,0.426\nperoxidase activity,metabolic process,0.946\nperoxidase inhibitor activity,metabolic process,0.28\nperoxiredoxin activity,metabolic process,0.922\nperoxisomal importomer complex,cellular component organization,0.332\nperoxisomal matrix,cellular component organization,0.512\nperoxisomal membrane,cellular component organization,0.704\nperoxisomal membrane transport,transport,0.882\nperoxisomal transport,transport,0.704\nperoxisome,cellular component organization,0.32\nperoxisome fission,morphogenesis/development,0.212\nperoxisome localization,transport,0.412\nperoxisome matrix targeting signal-1 binding,receptor related process,0.208\nperoxisome matrix targeting signal-2 binding,receptor related process,0.208\nperoxisome membrane biogenesis,cellular component organization,0.414\nperoxisome membrane class-1 targeting sequence binding,protein modification/signaling,0.238\nperoxisome membrane targeting sequence binding,protein modification/signaling,0.232\nperoxisome organization,cellular component organization,0.762\nperoxisome proliferator activated receptor binding,receptor related process,0.49\nperoxisome proliferator activated receptor signaling pathway,receptor related process,0.338\nperoxisome targeting sequence binding,protein modification/signaling,0.232\nperoxisome transport along microtubule,transport,0.334\nperoxynitrite isomerase activity,metabolic process,0.896\npexophagy,cellular component organization,0.264\nphagocytic cup,cellular component organization,0.296\nphagocytic vesicle,cellular component organization,0.438\nphagocytic vesicle lumen,cellular component organization,0.642\n\"phagocytosis, engulfment\",cellular component organization,0.384\n\"phagocytosis, recognition\",immune system process,0.358\nphagolysosome,cellular component organization,0.488\nphagolysosome assembly,cellular component organization,0.66\nphagolysosome assembly involved in apoptotic cell clearance,cell death,0.218\nphagolysosome membrane,cellular component organization,0.218\nphagophore assembly site membrane,cellular component organization,0.566\nphagosome acidification,cellular component organization,0.22\nphagosome maturation,cellular component organization,0.654\nphagosome maturation involved in apoptotic cell clearance,cellular component organization,0.356\nphagosome-lysosome docking,transport,0.346\nphagosome-lysosome fusion,cellular component organization,0.746\nphagosome-lysosome fusion involved in apoptotic cell clearance,cell death,0.212\npharyngeal arch artery morphogenesis,morphogenesis/development,0.742\npharynx development,morphogenesis/development,0.852\nphasic smooth muscle contraction,multicellular organismal process,0.65\n\"phenanthrene 9,10-monooxygenase activity\",metabolic process,0.936\n\"phenanthrene-9,10-epoxide hydrolase activity\",metabolic process,0.846\nphenanthrene-epoxide hydrolase activity,metabolic process,0.846\nphenethylamine:oxygen oxidoreductase (deaminating) activity,metabolic process,0.898\nphenol-containing compound biosynthetic process,metabolic process,0.894\nphenol-containing compound catabolic process,metabolic process,0.888\nphenol-containing compound metabolic process,metabolic process,0.872\nphenotypic switching,multicellular organismal process,0.164\nphenylacetaldehyde dehydrogenase activity,metabolic process,0.93\nphenylacetate catabolic process,metabolic process,0.896\nphenylalanine 4-monooxygenase activity,metabolic process,0.898\nphenylalanine transport,transport,0.938\nphenylalanine-tRNA ligase activity,metabolic process,0.822\nphenylalanine-tRNA ligase complex,metabolic process,0.39\nphenylalanyl-tRNA aminoacylation,metabolic process,0.554\nphenylethanolamine N-methyltransferase activity,metabolic process,0.896\nphenylpropanoid catabolic process,metabolic process,0.958\nphenylpropanoid metabolic process,metabolic process,0.982\nphenylpyruvate tautomerase activity,metabolic process,0.888\npheromone receptor activity,receptor related process,0.522\nphlorizin hydrolase activity,metabolic process,0.9\nphosphagen biosynthetic process,metabolic process,0.966\nphosphagen metabolic process,metabolic process,0.964\nphosphatase activator activity,protein modification/signaling,0.492\nphosphatase complex,protein modification/signaling,0.354\nphosphatase inhibitor activity,protein modification/signaling,0.43\nphosphate ion binding,metabolic process,0.228\nphosphate ion transmembrane transport,transport,0.854\nphosphate ion transmembrane transporter activity,transport,0.622\nphosphate ion uniporter activity,metabolic process,0.274\nphosphate-containing compound metabolic process,metabolic process,0.584\nphosphate:proton symporter activity,metabolic process,0.526\nphosphatidate cytidylyltransferase activity,metabolic process,0.874\nphosphatidate phosphatase activity,metabolic process,0.85\nphosphatidic acid binding,metabolic process,0.38\nphosphatidic acid biosynthetic process,metabolic process,0.878\nphosphatidic acid transfer activity,metabolic process,0.32\nphosphatidyl phospholipase B activity,metabolic process,0.904\nphosphatidyl-N-dimethylethanolamine N-methyltransferase activity,metabolic process,0.896\nphosphatidyl-N-methylethanolamine N-methyltransferase activity,metabolic process,0.896\nphosphatidylcholine flippase activity,metabolic process,0.326\nphosphatidylcholine floppase activity,metabolic process,0.332\nphosphatidylcholine metabolic process,metabolic process,0.924\nphosphatidylcholine phospholipase C activity,metabolic process,0.876\nphosphatidylcholine transfer activity,cellular component organization,0.23\nphosphatidylcholine transporter activity,transport,0.746\nphosphatidylcholine-retinol O-acyltransferase activity,metabolic process,0.896\nphosphatidylcholine-sterol O-acyltransferase activator activity,metabolic process,0.282\nphosphatidylcholine-sterol O-acyltransferase activity,metabolic process,0.888\nphosphatidylethanolamine N-methyltransferase activity,metabolic process,0.896\nphosphatidylethanolamine acyl-chain remodeling,metabolic process,0.812\nphosphatidylethanolamine binding,metabolic process,0.426\nphosphatidylethanolamine biosynthetic process,metabolic process,0.994\nphosphatidylethanolamine catabolic process,metabolic process,0.916\nphosphatidylethanolamine flippase activity,metabolic process,0.332\nphosphatidylethanolamine metabolic process,metabolic process,0.836\nphosphatidylethanolamine transfer activity,cellular component organization,0.254\nphosphatidylglycerol acyl-chain remodeling,metabolic process,0.774\nphosphatidylglycerol binding,protein modification/signaling,0.228\nphosphatidylglycerol biosynthetic process,metabolic process,0.99\nphosphatidylglycerol catabolic process,metabolic process,0.892\nphosphatidylglycerol metabolic process,metabolic process,0.922\nphosphatidylglycerol transfer activity,metabolic process,0.234\nphosphatidylglycerophosphatase activity,metabolic process,0.852\nphosphatidylinositol 3-kinase binding,protein modification/signaling,0.436\nphosphatidylinositol 3-kinase catalytic subunit binding,metabolic process,0.362\nphosphatidylinositol 3-kinase complex,metabolic process,0.282\n\"phosphatidylinositol 3-kinase complex, class I\",metabolic process,0.282\n\"phosphatidylinositol 3-kinase complex, class IA\",protein modification/signaling,0.456\n\"phosphatidylinositol 3-kinase complex, class IB\",gene regulation,0.24\n\"phosphatidylinositol 3-kinase complex, class III\",metabolic process,0.276\n\"phosphatidylinositol 3-kinase complex, class III, type I\",cellular component organization,0.314\n\"phosphatidylinositol 3-kinase complex, class III, type II\",cellular component organization,0.256\nphosphatidylinositol 3-kinase regulatory subunit binding,metabolic process,0.288\nphosphatidylinositol 3-kinase/protein kinase B signal transduction,protein modification/signaling,0.278\nphosphatidylinositol 5-phosphate metabolic process,metabolic process,0.964\nphosphatidylinositol N-acetylglucosaminyltransferase activity,metabolic process,0.896\nphosphatidylinositol acyl-chain remodeling,metabolic process,0.744\nphosphatidylinositol bisphosphate phosphatase activity,metabolic process,0.602\nphosphatidylinositol catabolic process,metabolic process,0.988\nphosphatidylinositol deacylase activity,metabolic process,0.896\nphosphatidylinositol dephosphorylation,metabolic process,0.32\nphosphatidylinositol kinase activity,metabolic process,0.662\nphosphatidylinositol metabolic process,metabolic process,0.982\nphosphatidylinositol phosphate 4-phosphatase activity,metabolic process,0.562\nphosphatidylinositol phosphate 5-phosphatase activity,metabolic process,0.476\nphosphatidylinositol phosphate binding,protein modification/signaling,0.822\nphosphatidylinositol phosphate phosphatase activity,protein modification/signaling,0.504\nphosphatidylinositol phospholipase C activity,metabolic process,0.836\nphosphatidylinositol transfer activity,cellular component organization,0.232\nphosphatidylinositol trisphosphate phosphatase activity,metabolic process,0.62\n\"phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity\",metabolic process,0.792\n\"phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity\",metabolic process,0.252\n\"phosphatidylinositol-3,4,5-trisphosphate binding\",protein modification/signaling,0.472\n\"phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity\",metabolic process,0.804\n\"phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity\",metabolic process,0.852\n\"phosphatidylinositol-3,4-bisphosphate binding\",protein modification/signaling,0.406\n\"phosphatidylinositol-3,4-bisphosphate phosphatase activity\",metabolic process,0.786\n\"phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity\",metabolic process,0.854\n\"phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity\",metabolic process,0.884\n\"phosphatidylinositol-3,5-bisphosphate binding\",protein modification/signaling,0.448\n\"phosphatidylinositol-3,5-bisphosphate phosphatase activity\",metabolic process,0.774\nphosphatidylinositol-3-phosphate biosynthetic process,metabolic process,0.8\nphosphatidylinositol-3-phosphate phosphatase activity,metabolic process,0.846\n\"phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity\",metabolic process,0.832\n\"phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity\",metabolic process,0.762\n\"phosphatidylinositol-4,5-bisphosphate binding\",protein modification/signaling,0.65\n\"phosphatidylinositol-4,5-bisphosphate phosphatase activity\",metabolic process,0.644\nphosphatidylinositol-4-phosphate binding,protein modification/signaling,0.444\nphosphatidylinositol-4-phosphate phosphatase activity,metabolic process,0.842\nphosphatidylinositol-5-phosphate binding,protein modification/signaling,0.478\nphosphatidylserine 1-acylhydrolase activity,metabolic process,0.902\nphosphatidylserine acyl-chain remodeling,metabolic process,0.778\nphosphatidylserine biosynthetic process,metabolic process,0.912\nphosphatidylserine catabolic process,metabolic process,0.914\nphosphatidylserine decarboxylase activity,metabolic process,0.896\nphosphatidylserine exposure on apoptotic cell surface,cell death,0.51\nphosphatidylserine exposure on blood platelet,multicellular organismal process,0.176\nphosphatidylserine flippase activity,metabolic process,0.328\nphosphatidylserine floppase activity,metabolic process,0.33\nphosphatidylserine transfer activity,cellular component organization,0.256\nphosphatidyltransferase activity,metabolic process,0.854\nphosphoacetylglucosamine mutase activity,metabolic process,0.896\nphosphoamidase activity,metabolic process,0.85\nphosphoanandamide dephosphorylation,protein modification/signaling,0.314\nphosphocholine phosphatase activity,metabolic process,0.848\nphosphocreatine biosynthetic process,metabolic process,0.888\nphosphocreatine metabolic process,metabolic process,0.958\nphosphodiesterase I activity,metabolic process,0.492\n\"phosphodiesterase activity, acting on 3'-phosphoglycolate-terminated DNA strands\",metabolic process,0.432\nphosphodiesterase decapping endonuclease activity,gene regulation,0.322\nphosphoenolpyruvate carboxykinase (GTP) activity,metabolic process,0.886\nphosphoenolpyruvate carboxykinase activity,metabolic process,0.672\nphosphoethanolamine phosphatase activity,metabolic process,0.85\nphosphofructokinase activity,metabolic process,0.722\nphosphoglucomutase activity,metabolic process,0.88\nphosphogluconate dehydrogenase (decarboxylating) activity,metabolic process,0.934\nphosphoglycerate dehydrogenase activity,metabolic process,0.928\nphosphoglycerate kinase activity,metabolic process,0.754\nphosphoglycerate mutase activity,metabolic process,0.898\nphosphoglycolate phosphatase activity,metabolic process,0.852\nphospholipase A1 activity,metabolic process,0.892\nphospholipase A2 activator activity,metabolic process,0.36\nphospholipase A2 activity,metabolic process,0.798\nphospholipase A2 inhibitor activity,metabolic process,0.3\nphospholipase C activity,metabolic process,0.804\nphospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway,receptor related process,0.546\nphospholipase C-activating G protein-coupled glutamate receptor signaling pathway,receptor related process,0.604\nphospholipase C-activating G protein-coupled receptor signaling pathway,receptor related process,0.458\nphospholipase C-activating adrenergic receptor signaling pathway,receptor related process,0.642\nphospholipase C-activating angiotensin-activated signaling pathway,receptor related process,0.762\nphospholipase C-activating dopamine receptor signaling pathway,receptor related process,0.572\nphospholipase C-activating serotonin receptor signaling pathway,receptor related process,0.606\nphospholipase C-inhibiting G protein-coupled receptor signaling pathway,receptor related process,0.392\nphospholipase D activity,metabolic process,0.842\nphospholipase D-activating G protein-coupled receptor signaling pathway,receptor related process,0.35\nphospholipase activator activity,metabolic process,0.55\nphospholipase activity,metabolic process,0.7\nphospholipase binding,metabolic process,0.216\nphospholipid catabolic process,metabolic process,0.992\nphospholipid dephosphorylation,metabolic process,0.456\nphospholipid efflux,transport,0.462\nphospholipid homeostasis,other,0.454\nphospholipid scramblase activity,metabolic process,0.346\nphospholipid transfer activity,transport,0.39\nphospholipid transfer to membrane,cellular component organization,0.376\nphospholipid translocation,transport,0.52\nphospholipid transport,transport,0.896\nphospholipid-hydroperoxide glutathione peroxidase activity,metabolic process,0.908\nphospholipid-translocating ATPase complex,transport,0.222\nphosphomannomutase activity,metabolic process,0.896\nphosphomevalonate kinase activity,metabolic process,0.794\nphosphopantetheine binding,metabolic process,0.28\nphosphopantetheine-dependent carrier activity,metabolic process,0.382\nphosphopantothenate--cysteine ligase activity,metabolic process,0.854\nphosphopantothenoylcysteine decarboxylase activity,metabolic process,0.896\nphosphopantothenoylcysteine decarboxylase complex,cellular component organization,0.248\nphosphopentomutase activity,metabolic process,0.896\nphosphopyruvate hydratase activity,metabolic process,0.898\nphosphopyruvate hydratase complex,metabolic process,0.412\nphosphorelay signal transduction system,protein modification/signaling,0.38\nphosphoribosylamine-glycine ligase activity,metabolic process,0.752\nphosphoribosylaminoimidazole carboxylase activity,metabolic process,0.896\nphosphoribosylaminoimidazolecarboxamide formyltransferase activity,metabolic process,0.896\nphosphoribosylaminoimidazolesuccinocarboxamide synthase activity,metabolic process,0.752\nphosphoribosylformylglycinamidine cyclo-ligase activity,metabolic process,0.752\nphosphoribosylformylglycinamidine synthase activity,metabolic process,0.762\nphosphoribosylglycinamide formyltransferase activity,metabolic process,0.896\nphosphoric diester hydrolase activity,metabolic process,0.472\nphosphorus metabolic process,metabolic process,0.56\nphosphorus-oxygen lyase activity,metabolic process,0.716\nphosphorylase kinase activity,metabolic process,0.782\nphosphorylase kinase complex,metabolic process,0.396\nphosphorylase kinase regulator activity,metabolic process,0.338\nphosphorylated histone binding,protein modification/signaling,0.26\nphosphorylation,protein modification/signaling,0.552\nphosphorylation-dependent protein binding,protein modification/signaling,0.69\nphosphoserine residue binding,protein modification/signaling,0.428\nphosphothreonine residue binding,protein modification/signaling,0.442\n\"phosphotransferase activity, carboxyl group as acceptor\",metabolic process,0.714\n\"phosphotransferase activity, for other substituted phosphate groups\",metabolic process,0.888\n\"phosphotransferase activity, nitrogenous group as acceptor\",metabolic process,0.676\n\"phosphotransferase activity, paired acceptors\",metabolic process,0.872\n\"phosphotransferase activity, phosphate group as acceptor\",metabolic process,0.726\nphosphotyrosine residue binding,protein modification/signaling,0.52\nphotoperiodism,response to stimulus,0.664\nphotoreceptor activity,receptor related process,0.388\nphotoreceptor cell cilium,cellular component organization,0.232\nphotoreceptor cell development,morphogenesis/development,0.598\nphotoreceptor cell differentiation,morphogenesis/development,0.576\nphotoreceptor cell fate commitment,morphogenesis/development,0.49\nphotoreceptor cell maintenance,morphogenesis/development,0.232\nphotoreceptor cell morphogenesis,morphogenesis/development,0.706\nphotoreceptor cell outer segment organization,cellular component organization,0.6\nphotoreceptor connecting cilium,cellular component organization,0.262\nphotoreceptor disc membrane,cellular component organization,0.58\nphotoreceptor distal connecting cilium,cellular component organization,0.254\nphotoreceptor inner segment,cellular component organization,0.366\nphotoreceptor inner segment membrane,cellular component organization,0.48\nphotoreceptor outer segment,cellular component organization,0.544\nphotoreceptor outer segment membrane,cellular component organization,0.368\nphotoreceptor ribbon synapse,neural related process,0.256\nphototransduction,protein modification/signaling,0.238\n\"phototransduction, UV\",metabolic process,0.356\n\"phototransduction, visible light\",metabolic process,0.252\nphthalate metabolic process,metabolic process,0.888\nphylloquinone catabolic process,metabolic process,0.872\nphylloquinone metabolic process,metabolic process,0.954\nphysiological cardiac muscle hypertrophy,morphogenesis/development,0.462\nphysiological muscle hypertrophy,multicellular organismal process,0.63\nphytanate-CoA ligase activity,metabolic process,0.822\nphytanic acid metabolic process,metabolic process,0.85\nphytanoyl-CoA dioxygenase activity,metabolic process,0.896\nphytoalexin metabolic process,metabolic process,0.908\nphytoceramidase activity,metabolic process,0.912\nphytol metabolic process,metabolic process,0.972\nphytosphingosine biosynthetic process,metabolic process,0.866\nphytosphingosine metabolic process,metabolic process,0.944\nphytosteroid biosynthetic process,metabolic process,0.956\nphytosteroid metabolic process,metabolic process,0.96\npi-body,metabolic process,0.254\npiP-body,protein modification/signaling,0.26\npiRNA binding,gene regulation,0.454\npiRNA processing,gene regulation,0.682\npiRNA transcription,gene regulation,0.358\npiRNA-mediated retrotransposon silencing by heterochromatin formation,cellular component organization,0.35\npicolinic acid biosynthetic process,metabolic process,0.87\npicolinic acid metabolic process,metabolic process,0.958\npiecemeal microautophagy of the nucleus,cellular component organization,0.268\npigment accumulation,immune system process,0.32\npigment biosynthetic process,metabolic process,0.928\npigment catabolic process,metabolic process,0.928\npigment cell development,morphogenesis/development,0.97\npigment cell differentiation,morphogenesis/development,0.79\npigment granule aggregation in cell center,transport,0.44\npigment granule localization,transport,0.622\npigment granule maturation,morphogenesis/development,0.506\npigment granule membrane,cellular component organization,0.704\npigment granule organization,cellular component organization,0.896\npigment granule transport,transport,0.908\npigment metabolic process involved in developmental pigmentation,metabolic process,0.644\npigment metabolic process involved in pigmentation,metabolic process,0.626\npilomotor reflex,cellular component organization,0.208\npinceau fiber,cellular component organization,0.17\npinosome,cellular component organization,0.572\npituitary adenylate cyclase activating polypeptide activity,immune system process,0.272\npituitary gland development,morphogenesis/development,0.75\npituitary gonadotropin complex,morphogenesis/development,0.188\nplacenta blood vessel development,morphogenesis/development,0.984\nplacental growth factor receptor activity,receptor related process,0.39\nplanar cell polarity pathway involved in axis elongation,receptor related process,0.384\nplanar cell polarity pathway involved in axon guidance,protein modification/signaling,0.2\nplanar cell polarity pathway involved in cardiac muscle tissue morphogenesis,receptor related process,0.398\nplanar cell polarity pathway involved in cardiac right atrium morphogenesis,receptor related process,0.408\nplanar cell polarity pathway involved in gastrula mediolateral intercalation,receptor related process,0.416\nplanar cell polarity pathway involved in heart morphogenesis,morphogenesis/development,0.354\nplanar cell polarity pathway involved in midbrain dopaminergic neuron differentiation,neural related process,0.256\nplanar cell polarity pathway involved in neural tube closure,receptor related process,0.342\nplanar cell polarity pathway involved in outflow tract morphogenesis,receptor related process,0.408\nplanar cell polarity pathway involved in pericardium morphogenesis,receptor related process,0.408\nplanar cell polarity pathway involved in ventricular septum morphogenesis,receptor related process,0.408\nplanar dichotomous subdivision of terminal units involved in lung branching morphogenesis,morphogenesis/development,0.244\nplasma cell differentiation,morphogenesis/development,0.412\nplasma kallikrein-kinin cascade,immune system process,0.298\nplasma lipoprotein particle,cellular component organization,0.236\nplasma lipoprotein particle assembly,cellular component organization,0.71\nplasma lipoprotein particle organization,cellular component organization,0.584\nplasma lipoprotein particle oxidation,metabolic process,0.28\nplasma lipoprotein particle remodeling,cellular component organization,0.428\nplasma membrane,cellular component organization,0.116\nplasma membrane ATP synthesis coupled electron transport,metabolic process,0.35\nplasma membrane bounded cell projection,cellular component organization,0.304\nplasma membrane bounded cell projection cytoplasm,cellular component organization,0.412\nplasma membrane bounded cell projection morphogenesis,neural related process,0.636\nplasma membrane bounded cell projection organization,cellular component organization,0.452\nplasma membrane copper ion transport,transport,0.95\nplasma membrane fusion,cellular component organization,0.756\nplasma membrane invagination,cellular component organization,0.618\nplasma membrane lactate transport,transport,0.86\nplasma membrane phospholipid scrambling,transport,0.468\nplasma membrane protein complex,receptor related process,0.244\nplasma membrane proton-transporting V-type ATPase complex,cellular component organization,0.458\nplasma membrane raft,cellular component organization,0.484\nplasma membrane raft assembly,cellular component organization,0.95\nplasma membrane raft distribution,cellular component organization,0.616\nplasma membrane raft localization,cellular component organization,0.542\nplasma membrane raft organization,cellular component organization,0.97\nplasma membrane raft polarization,cellular component organization,0.376\nplasma membrane region,cellular component organization,0.38\nplasma membrane selenite transport,transport,0.424\nplasma membrane to endosome transport,transport,0.624\nplasmacytoid dendritic cell activation,immune system process,0.682\nplasmacytoid dendritic cell antigen processing and presentation,immune system process,0.36\nplasmacytoid dendritic cell cytokine production,immune system process,0.564\nplasmacytoid dendritic cell differentiation,immune system process,0.596\nplasmalogen synthase activity,metabolic process,0.898\nplasmanylethanolamine desaturase activity,metabolic process,0.546\nplatelet activating factor biosynthetic process,metabolic process,0.664\nplatelet activating factor catabolic process,metabolic process,0.842\nplatelet activating factor metabolic process,metabolic process,0.912\nplatelet activating factor receptor activity,cellular component organization,0.148\nplatelet aggregation,cell adhesion,0.22\nplatelet alpha granule lumen,cellular component organization,0.232\nplatelet alpha granule membrane,cellular component organization,0.242\nplatelet alpha granule organization,cellular component organization,0.636\nplatelet degranulation,immune system process,0.238\nplatelet dense granule,cellular component organization,0.252\nplatelet dense granule lumen,cellular component organization,0.364\nplatelet dense granule membrane,metabolic process,0.268\nplatelet dense granule organization,cellular component organization,0.598\nplatelet dense tubular network,cellular component organization,0.228\nplatelet dense tubular network membrane,cellular component organization,0.266\nplatelet maturation,morphogenesis/development,0.5\nplatelet-activating factor acetyltransferase activity,metabolic process,0.896\nplatelet-derived growth factor alpha-receptor activity,cellular component organization,0.14\nplatelet-derived growth factor beta-receptor activity,cellular component organization,0.144\nplatelet-derived growth factor binding,metabolic process,0.18\nplatelet-derived growth factor complex,receptor related process,0.306\nplatelet-derived growth factor production,immune system process,0.492\nplatelet-derived growth factor receptor activity,receptor related process,0.592\nplatelet-derived growth factor receptor-alpha signaling pathway,receptor related process,0.832\nplus-end directed microfilament motor activity,cellular component organization,0.364\nplus-end kinesin complex,cellular component organization,0.314\nplus-end specific microtubule depolymerization,cellular component organization,0.232\nplus-end-directed organelle transport along microtubule,transport,0.816\nplus-end-directed vesicle transport along microtubule,transport,0.66\npodocyte apoptotic process,cell death,0.22\npodocyte cell migration,morphogenesis/development,0.284\npodocyte development,morphogenesis/development,0.936\npodocyte differentiation,morphogenesis/development,0.902\npodocyte foot,cellular component organization,0.234\npodosome assembly,cellular component organization,0.562\npodosome ring,cellular component organization,0.314\npointed-end actin filament capping,cellular component organization,0.35\npolar body extrusion after meiotic divisions,cell cycle,0.232\npolar microtubule,cellular component organization,0.464\npolarity specification of anterior/posterior axis,cellular component organization,0.204\npolarity specification of proximal/distal axis,cellular component organization,0.204\npolarized secretion of basement membrane proteins in epithelium,cellular component organization,0.426\npole plasm,cellular component organization,0.45\npole plasm assembly,cellular component organization,0.212\npolkadots,receptor related process,0.312\npoly(A) RNA polymerase activity,metabolic process,0.568\npoly(A) binding,gene regulation,0.614\npoly(A)+ mRNA export from nucleus,transport,0.36\npoly(A)-specific ribonuclease activity,metabolic process,0.424\npoly(ADP-ribose) glycohydrolase activity,metabolic process,0.504\npoly(C) RNA binding,gene regulation,0.524\npoly(G) binding,gene regulation,0.558\npoly(U) RNA binding,gene regulation,0.572\n\"poly(U)-specific exoribonuclease activity, producing 3' uridine cyclic phosphate ends\",metabolic process,0.482\npoly-ADP-D-ribose binding,metabolic process,0.246\npoly-ADP-D-ribose modification-dependent protein binding,protein modification/signaling,0.46\npoly-N-acetyllactosamine biosynthetic process,metabolic process,0.866\npoly-N-acetyllactosamine metabolic process,metabolic process,0.956\npoly-purine tract binding,gene regulation,0.758\npoly-pyrimidine tract binding,gene regulation,0.76\npolyadenylation-dependent RNA catabolic process,metabolic process,0.738\npolyadenylation-dependent mRNA catabolic process,metabolic process,0.584\npolyadenylation-dependent ncRNA catabolic process,metabolic process,0.708\npolyadenylation-dependent snoRNA 3'-end processing,gene regulation,0.274\npolyamine acetylation,metabolic process,0.382\npolyamine binding,metabolic process,0.314\npolyamine biosynthetic process,metabolic process,0.988\npolyamine catabolic process,metabolic process,0.976\npolyamine deacetylation,protein modification/signaling,0.48\npolyamine metabolic process,metabolic process,0.97\npolyamine oxidase activity,metabolic process,0.904\npolyamine transmembrane transport,transport,0.736\npolyamine transmembrane transporter activity,transport,0.652\npolyamine transport,transport,0.906\npolyamine:proton antiporter activity,metabolic process,0.526\npolychlorinated biphenyl binding,metabolic process,0.338\npolycystin complex,cellular component organization,0.414\npolyketide metabolic process,metabolic process,0.908\npolymeric IgA immunoglobulin complex,cellular component organization,0.296\npolymeric cytoskeletal fiber,cellular component organization,0.698\npolymeric immunoglobulin receptor activity,immune system process,0.292\npolynucleotide 3'-phosphatase activity,metabolic process,0.712\npolynucleotide 5'-hydroxyl-kinase activity,metabolic process,0.628\npolynucleotide 5'-phosphatase activity,metabolic process,0.852\npolyol biosynthetic process,metabolic process,0.984\npolyol catabolic process,metabolic process,0.982\npolyol transmembrane transport,transport,0.884\npolyol transmembrane transporter activity,transport,0.646\npolypeptide N-acetylgalactosaminyltransferase activity,metabolic process,0.688\npolyphosphate metabolic process,metabolic process,0.976\npolyprenol biosynthetic process,metabolic process,0.988\npolyprenol catabolic process,metabolic process,0.99\npolyprenol metabolic process,metabolic process,0.994\npolyprenol reductase activity,metabolic process,0.934\npolyprenyltransferase activity,metabolic process,0.886\npolyribonucleotide nucleotidyltransferase activity,metabolic process,0.824\npolysaccharide binding,metabolic process,0.212\npolysaccharide biosynthetic process,metabolic process,0.934\npolysaccharide catabolic process,metabolic process,0.936\npolysaccharide digestion,cellular component organization,0.234\npolysaccharide localization,transport,0.49\npolysaccharide transport,transport,0.974\npolysomal ribosome,gene regulation,0.288\npolysome,gene regulation,0.344\npolysome binding,metabolic process,0.246\npolyspecific organic cation:proton antiporter activity,metabolic process,0.498\npolytene chromosome,cell cycle,0.21\npolyubiquitinated misfolded protein transport,transport,0.35\npolyubiquitinated protein transport,transport,0.756\npolyuridylation-dependent mRNA catabolic process,metabolic process,0.57\npons development,morphogenesis/development,0.87\npons maturation,morphogenesis/development,0.44\npore complex,cellular component organization,0.36\npore-forming activity,cellular component organization,0.232\nporin activity,transport,0.654\nporphobilinogen synthase activity,metabolic process,0.9\nporphyrin-containing compound biosynthetic process,metabolic process,0.972\nporphyrin-containing compound catabolic process,metabolic process,0.954\npositive T cell selection,immune system process,0.576\npositive regulation by host of viral genome replication,viral related process,0.44\npositive regulation by symbiont of entry into host,viral related process,0.314\npositive regulation by virus of viral protein levels in host cell,protein modification/signaling,0.21\npositive regulation of 3'-UTR-mediated mRNA stabilization,gene regulation,0.25\npositive regulation of AIM2 inflammasome complex assembly,cellular component organization,0.352\npositive regulation of AMPA glutamate receptor clustering,receptor related process,0.302\npositive regulation of AMPA receptor activity,receptor related process,0.282\npositive regulation of ARF protein signal transduction,protein modification/signaling,0.552\npositive regulation of ATF6-mediated unfolded protein response,protein modification/signaling,0.332\npositive regulation of ATP metabolic process,metabolic process,0.604\npositive regulation of ATPase-coupled calcium transmembrane transporter activity,transport,0.192\npositive regulation of Arp2/3 complex-mediated actin nucleation,cellular component organization,0.174\npositive regulation of B cell activation,immune system process,0.95\npositive regulation of B cell apoptotic process,cell death,0.478\npositive regulation of B cell chemotaxis,immune system process,0.228\npositive regulation of B cell differentiation,immune system process,0.82\npositive regulation of B cell mediated immunity,immune system process,0.968\npositive regulation of B cell proliferation,immune system process,0.426\npositive regulation of B cell receptor signaling pathway,receptor related process,0.366\npositive regulation of B cell tolerance induction,immune system process,0.562\npositive regulation of C-C chemokine receptor CCR7 signaling pathway,receptor related process,0.338\npositive regulation of CAMKK-AMPK signaling cascade,protein modification/signaling,0.296\npositive regulation of CD24 production,metabolic process,0.278\n\"positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation\",immune system process,0.854\n\"positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response\",immune system process,0.426\n\"positive regulation of CD4-positive, alpha-beta T cell costimulation\",immune system process,0.238\n\"positive regulation of CD4-positive, alpha-beta T cell proliferation\",immune system process,0.372\npositive regulation of CD40 signaling pathway,protein modification/signaling,0.284\n\"positive regulation of CD8-positive, alpha-beta T cell activation\",immune system process,0.91\n\"positive regulation of CD8-positive, alpha-beta T cell differentiation\",immune system process,0.424\n\"positive regulation of CD8-positive, alpha-beta T cell extravasation\",immune system process,0.808\n\"positive regulation of CD8-positive, alpha-beta T cell proliferation\",immune system process,0.356\n\"positive regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation\",immune system process,0.174\npositive regulation of CD80 production,metabolic process,0.252\npositive regulation of CD86 production,metabolic process,0.252\npositive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity,cell cycle,0.138\npositive regulation of CREB transcription factor activity,gene regulation,0.206\npositive regulation of CoA-transferase activity,protein modification/signaling,0.132\npositive regulation of DNA catabolic process,metabolic process,0.328\npositive regulation of DNA damage checkpoint,cell cycle,0.628\n\"positive regulation of DNA damage response, signal transduction by p53 class mediator\",protein modification/signaling,0.334\n\"positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator\",protein modification/signaling,0.288\npositive regulation of DNA demethylation,cell cycle,0.224\npositive regulation of DNA duplex unwinding,cellular component organization,0.494\npositive regulation of DNA endoreduplication,cell cycle,0.224\npositive regulation of DNA helicase activity,cell cycle,0.31\npositive regulation of DNA ligase activity,cell cycle,0.264\npositive regulation of DNA ligation,cell cycle,0.436\npositive regulation of DNA methylation,cell cycle,0.252\npositive regulation of DNA methylation-dependent heterochromatin formation,morphogenesis/development,0.186\npositive regulation of DNA primase activity,cell cycle,0.388\npositive regulation of DNA strand elongation,cell cycle,0.268\npositive regulation of DNA topoisomerase (ATP-hydrolyzing) activity,cell cycle,0.258\npositive regulation of DNA-templated DNA replication,cell cycle,0.652\npositive regulation of DNA-templated DNA replication initiation,cell cycle,0.52\npositive regulation of DNA-templated transcription,gene regulation,0.602\npositive regulation of ER to Golgi vesicle-mediated transport,transport,0.174\npositive regulation of ER-associated ubiquitin-dependent protein catabolic process,protein modification/signaling,0.27\npositive regulation of ERAD pathway,ER/endosome/lysosome related process,0.37\npositive regulation of ERBB3 signaling pathway,protein modification/signaling,0.314\npositive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling,protein modification/signaling,0.29\npositive regulation of ERK5 cascade,protein modification/signaling,0.372\npositive regulation of Fc receptor mediated stimulatory signaling pathway,immune system process,0.694\npositive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis,receptor related process,0.3\npositive regulation of G protein-coupled receptor internalization,receptor related process,0.296\npositive regulation of G0 to G1 transition,cell cycle,0.294\npositive regulation of G2/MI transition of meiotic cell cycle,cell cycle,0.398\npositive regulation of GTP binding,gene regulation,0.202\npositive regulation of GTPase activity,protein modification/signaling,0.416\npositive regulation of Golgi lumen acidification,morphogenesis/development,0.132\npositive regulation of Golgi to plasma membrane protein transport,cellular component organization,0.232\npositive regulation of I-kappaB phosphorylation,protein modification/signaling,0.186\npositive regulation of IP-10 production,immune system process,0.454\npositive regulation of IRE1-mediated unfolded protein response,protein modification/signaling,0.312\npositive regulation of JUN kinase activity,protein modification/signaling,0.282\npositive regulation of L-dopa biosynthetic process,metabolic process,0.296\npositive regulation of L-dopa decarboxylase activity,metabolic process,0.162\npositive regulation of L-glutamate import across plasma membrane,transport,0.742\npositive regulation of L-glutamine import across plasma membrane,cell cycle,0.126\npositive regulation of L-proline import across plasma membrane,transport,0.198\npositive regulation of Lys63-specific deubiquitinase activity,metabolic process,0.23\npositive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway,receptor related process,0.47\npositive regulation of MDA-5 signaling pathway,protein modification/signaling,0.292\npositive regulation of MHC class I biosynthetic process,metabolic process,0.7\npositive regulation of MHC class II biosynthetic process,metabolic process,0.59\npositive regulation of N-terminal peptidyl-lysine acetylation,protein modification/signaling,0.148\npositive regulation of NAD(P)H oxidase activity,metabolic process,0.366\npositive regulation of NAD+ ADP-ribosyltransferase activity,metabolic process,0.134\npositive regulation of NK T cell activation,immune system process,0.91\npositive regulation of NK T cell differentiation,immune system process,0.24\npositive regulation of NK T cell proliferation,immune system process,0.322\npositive regulation of NLRP3 inflammasome complex assembly,immune system process,0.3\npositive regulation of NMDA glutamate receptor activity,receptor related process,0.274\npositive regulation of Notch signaling pathway involved in heart induction,receptor related process,0.478\npositive regulation of P-type sodium:potassium-exchanging transporter activity,cell cycle,0.15\npositive regulation of PERK-mediated unfolded protein response,protein modification/signaling,0.32\npositive regulation of RNA binding,gene regulation,0.636\npositive regulation of RNA biosynthetic process,gene regulation,0.536\npositive regulation of RNA export from nucleus,transport,0.738\npositive regulation of RNA polymerase II regulatory region sequence-specific DNA binding,gene regulation,0.416\npositive regulation of RNA polymerase II transcription preinitiation complex assembly,gene regulation,0.464\npositive regulation of RNA splicing,gene regulation,0.926\npositive regulation of Rac protein signal transduction,protein modification/signaling,0.626\npositive regulation of Ras protein signal transduction,protein modification/signaling,0.614\npositive regulation of Rho guanyl-nucleotide exchange factor activity,protein modification/signaling,0.138\npositive regulation of Rho protein signal transduction,protein modification/signaling,0.614\npositive regulation of SNARE complex assembly,cellular component organization,0.386\npositive regulation of SREBP signaling pathway,receptor related process,0.322\npositive regulation of SUMO transferase activity,metabolic process,0.158\npositive regulation of Schwann cell chemotaxis,cell cycle,0.166\npositive regulation of Schwann cell differentiation,morphogenesis/development,0.226\npositive regulation of Schwann cell migration,morphogenesis/development,0.194\npositive regulation of Schwann cell proliferation,neural related process,0.322\npositive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,receptor related process,0.2\npositive regulation of T cell anergy,immune system process,0.376\npositive regulation of T cell chemotaxis,immune system process,0.478\npositive regulation of T cell costimulation,immune system process,0.884\npositive regulation of T cell differentiation in thymus,immune system process,0.84\npositive regulation of T cell extravasation,immune system process,0.804\npositive regulation of T cell mediated cytotoxicity,immune system process,0.962\npositive regulation of T cell mediated cytotoxicity directed against tumor cell target,immune system process,0.23\npositive regulation of T cell mediated immune response to tumor cell,immune system process,0.876\npositive regulation of T cell receptor signaling pathway,receptor related process,0.34\npositive regulation of T cell tolerance induction,immune system process,0.628\npositive regulation of T-helper 1 cell cytokine production,immune system process,0.582\npositive regulation of T-helper 1 cell differentiation,morphogenesis/development,0.224\npositive regulation of T-helper 1 type immune response,immune system process,0.956\npositive regulation of T-helper 17 cell differentiation,immune system process,0.886\npositive regulation of T-helper 17 cell lineage commitment,immune system process,0.262\npositive regulation of T-helper 17 type immune response,immune system process,0.82\npositive regulation of T-helper 2 cell activation,cell cycle,0.148\npositive regulation of T-helper 2 cell cytokine production,immune system process,0.592\npositive regulation of T-helper 2 cell differentiation,immune system process,0.284\npositive regulation of TOR signaling,protein modification/signaling,0.48\npositive regulation of TORC1 signaling,protein modification/signaling,0.3\npositive regulation of TORC2 signaling,protein modification/signaling,0.286\npositive regulation of TRAIL production,immune system process,0.51\npositive regulation of TRAIL-activated apoptotic signaling pathway,protein modification/signaling,0.272\npositive regulation of Wnt protein secretion,protein modification/signaling,0.312\n\"positive regulation of Wnt signaling pathway, calcium modulating pathway\",protein modification/signaling,0.452\n\"positive regulation of Wnt signaling pathway, planar cell polarity pathway\",protein modification/signaling,0.314\npositive regulation of Wnt-mediated midbrain dopaminergic neuron differentiation,protein modification/signaling,0.238\npositive regulation of abscisic acid-activated signaling pathway,protein modification/signaling,0.296\n\"positive regulation of acetylcholine secretion, neurotransmission\",protein modification/signaling,0.124\npositive regulation of aconitate hydratase activity,cell cycle,0.138\npositive regulation of acrosomal vesicle exocytosis,protein modification/signaling,0.136\npositive regulation of acrosome reaction,metabolic process,0.458\npositive regulation of actin binding,protein modification/signaling,0.322\npositive regulation of actin filament binding,cellular component organization,0.216\npositive regulation of actin filament bundle assembly,cellular component organization,0.892\npositive regulation of actin filament depolymerization,cellular component organization,0.842\npositive regulation of actin filament severing,cellular component organization,0.284\npositive regulation of actin filament-based movement,cellular component organization,0.24\npositive regulation of action potential,neural related process,0.366\n\"positive regulation of activated CD8-positive, alpha-beta T cell apoptotic process\",cell death,0.23\npositive regulation of activated T cell autonomous cell death,cell death,0.466\npositive regulation of activated T cell proliferation,immune system process,0.418\npositive regulation of activation of Janus kinase activity,protein modification/signaling,0.716\npositive regulation of activation of membrane attack complex,cellular component organization,0.396\npositive regulation of activin receptor signaling pathway,receptor related process,0.698\npositive regulation of acute inflammatory response to antigenic stimulus,immune system process,0.918\npositive regulation of acute inflammatory response to non-antigenic stimulus,immune system process,0.492\npositive regulation of acylglycerol transport,transport,0.646\npositive regulation of adaptive immune memory response,immune system process,0.372\npositive regulation of adenosine receptor signaling pathway,receptor related process,0.432\npositive regulation of adenylate cyclase activity,metabolic process,0.444\npositive regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway,receptor related process,0.782\npositive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway,receptor related process,0.692\npositive regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway,receptor related process,0.344\npositive regulation of adenylate cyclase-inhibiting opioid receptor signaling pathway,receptor related process,0.358\npositive regulation of adherens junction organization,morphogenesis/development,0.162\npositive regulation of adiponectin secretion,morphogenesis/development,0.126\npositive regulation of adipose tissue development,morphogenesis/development,0.16\npositive regulation of aggrephagy,cell cycle,0.132\npositive regulation of alcohol biosynthetic process,metabolic process,0.728\npositive regulation of aldosterone biosynthetic process,metabolic process,0.714\npositive regulation of aldosterone metabolic process,metabolic process,0.906\npositive regulation of aldosterone secretion,protein modification/signaling,0.14\npositive regulation of alkaline phosphatase activity,metabolic process,0.582\npositive regulation of amacrine cell differentiation,morphogenesis/development,0.218\npositive regulation of amine metabolic process,metabolic process,0.904\npositive regulation of amine transport,transport,0.584\npositive regulation of amino acid biosynthetic process,metabolic process,0.622\npositive regulation of amino acid metabolic process,metabolic process,0.902\npositive regulation of amino acid transport,transport,0.77\npositive regulation of amino acid uptake involved in synaptic transmission,transport,0.556\npositive regulation of ammonia assimilation cycle,protein modification/signaling,0.122\npositive regulation of amyloid fibril formation,morphogenesis/development,0.206\npositive regulation of amyloid precursor protein biosynthetic process,metabolic process,0.642\npositive regulation of amyloid precursor protein catabolic process,metabolic process,0.596\npositive regulation of amyloid-beta clearance,immune system process,0.138\npositive regulation of amyloid-beta formation,morphogenesis/development,0.238\npositive regulation of anaphase-promoting complex-dependent catabolic process,metabolic process,0.234\npositive regulation of androgen receptor activity,receptor related process,0.292\npositive regulation of androgen secretion,protein modification/signaling,0.128\npositive regulation of anion channel activity,transport,0.702\npositive regulation of anion transmembrane transport,transport,0.796\npositive regulation of anoikis,immune system process,0.116\npositive regulation of anterior head development,morphogenesis/development,0.198\npositive regulation of anterograde axonal transport of mitochondrion,transport,0.378\npositive regulation of anterograde dense core granule transport,transport,0.162\npositive regulation of anterograde synaptic vesicle transport,neural related process,0.194\npositive regulation of antibacterial peptide biosynthetic process,immune system process,0.508\npositive regulation of antibacterial peptide production,immune system process,0.638\npositive regulation of antibody-dependent cellular cytotoxicity,immune system process,0.424\npositive regulation of antifungal innate immune response,immune system process,0.374\npositive regulation of antigen processing and presentation,immune system process,0.706\npositive regulation of antigen processing and presentation of peptide antigen,immune system process,0.582\npositive regulation of antigen processing and presentation of peptide antigen via MHC class II,immune system process,0.312\npositive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,immune system process,0.61\npositive regulation of antigen receptor-mediated signaling pathway,immune system process,0.698\npositive regulation of antimicrobial humoral response,immune system process,0.856\npositive regulation of antimicrobial peptide biosynthetic process,immune system process,0.546\npositive regulation of antimicrobial peptide production,immune system process,0.664\npositive regulation of antral ovarian follicle growth,protein modification/signaling,0.136\npositive regulation of aorta morphogenesis,morphogenesis/development,0.216\npositive regulation of aortic smooth muscle cell differentiation,morphogenesis/development,0.194\npositive regulation of apoptotic DNA fragmentation,cell death,0.236\npositive regulation of apoptotic cell clearance,transport,0.376\npositive regulation of apoptotic process involved in development,cell death,0.412\npositive regulation of apoptotic process involved in mammary gland involution,cell death,0.76\npositive regulation of apoptotic process involved in morphogenesis,cell death,0.41\npositive regulation of appetite,immune system process,0.232\npositive regulation of arachidonic acid secretion,morphogenesis/development,0.14\npositive regulation of arginase activity,protein modification/signaling,0.134\npositive regulation of artery morphogenesis,morphogenesis/development,0.764\npositive regulation of aspartate secretion,cell cycle,0.13\npositive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,protein modification/signaling,0.29\npositive regulation of aspartic-type peptidase activity,metabolic process,0.458\npositive regulation of astrocyte activation,protein modification/signaling,0.138\npositive regulation of astrocyte chemotaxis,immune system process,0.198\npositive regulation of astrocyte differentiation,morphogenesis/development,0.38\npositive regulation of atrial cardiac muscle cell action potential,cell cycle,0.176\npositive regulation of attachment of mitotic spindle microtubules to kinetochore,cell cycle,0.756\npositive regulation of attachment of spindle microtubules to kinetochore,cell cycle,0.93\npositive regulation of autophagic cell death,cell death,0.192\npositive regulation of autophagosome assembly,cellular component organization,0.324\npositive regulation of autophagosome maturation,morphogenesis/development,0.186\npositive regulation of axo-dendritic protein transport,protein modification/signaling,0.28\npositive regulation of axon extension,neural related process,0.618\npositive regulation of axon extension involved in axon guidance,neural related process,0.18\npositive regulation of axon guidance,neural related process,0.3\npositive regulation of axon regeneration,neural related process,0.412\npositive regulation of base-excision repair,cell cycle,0.124\npositive regulation of basement membrane assembly involved in embryonic body morphogenesis,cellular component organization,0.362\npositive regulation of behavior,neural related process,0.28\npositive regulation of behavioral fear response,immune system process,0.142\npositive regulation of beta-galactosidase activity,cell cycle,0.15\npositive regulation of bicellular tight junction assembly,cellular component organization,0.296\npositive regulation of bile acid biosynthetic process,metabolic process,0.748\npositive regulation of bile acid metabolic process,metabolic process,0.764\npositive regulation of bile acid secretion,metabolic process,0.162\npositive regulation of biological process,metabolic process,0.33\npositive regulation of biosynthetic process,metabolic process,0.784\npositive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria,immune system process,0.2\npositive regulation of bleb assembly,cellular component organization,0.288\npositive regulation of blood coagulation,immune system process,0.32\npositive regulation of blood microparticle formation,cellular component organization,0.384\npositive regulation of blood pressure,multicellular organismal process,0.414\npositive regulation of blood pressure by epinephrine-norepinephrine,multicellular organismal process,0.22\npositive regulation of blood vessel branching,multicellular organismal process,0.186\npositive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,multicellular organismal process,0.224\npositive regulation of blood vessel remodeling,morphogenesis/development,0.698\npositive regulation of blood-brain barrier permeability,metabolic process,0.242\npositive regulation of bone development,morphogenesis/development,0.224\npositive regulation of bone mineralization,morphogenesis/development,0.754\npositive regulation of bone mineralization involved in bone maturation,morphogenesis/development,0.214\npositive regulation of bone resorption,morphogenesis/development,0.172\npositive regulation of brain-derived neurotrophic factor receptor signaling pathway,receptor related process,0.83\npositive regulation of branching involved in lung morphogenesis,morphogenesis/development,0.778\npositive regulation of branching involved in ureteric bud morphogenesis,morphogenesis/development,0.638\npositive regulation of branching morphogenesis of a nerve,morphogenesis/development,0.218\npositive regulation of brown fat cell differentiation,morphogenesis/development,0.738\npositive regulation of cAMP-dependent protein kinase activity,protein modification/signaling,0.474\npositive regulation of cAMP-mediated signaling,protein modification/signaling,0.328\npositive regulation of cGMP-mediated signaling,protein modification/signaling,0.296\npositive regulation of calcidiol 1-monooxygenase activity,metabolic process,0.636\npositive regulation of calcineurin-NFAT signaling cascade,protein modification/signaling,0.264\npositive regulation of calcineurin-mediated signaling,protein modification/signaling,0.46\npositive regulation of calcium ion import,transport,0.396\npositive regulation of calcium ion import across plasma membrane,transport,0.214\npositive regulation of calcium ion import into sarcoplasmic reticulum,transport,0.138\npositive regulation of calcium ion transmembrane transport,transport,0.81\npositive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,transport,0.222\npositive regulation of calcium ion transmembrane transporter activity,transport,0.66\npositive regulation of calcium ion transport into cytosol,transport,0.606\npositive regulation of calcium ion-dependent exocytosis,transport,0.536\npositive regulation of calcium ion-dependent exocytosis of neurotransmitter,cell cycle,0.128\npositive regulation of calcium-dependent ATPase activity,cell cycle,0.152\npositive regulation of calcium-dependent cell-cell adhesion,cell adhesion,0.244\npositive regulation of calcium-independent cell-cell adhesion,cell adhesion,0.24\npositive regulation of calcium-mediated signaling,protein modification/signaling,0.322\npositive regulation of calcium:sodium antiporter activity,cell cycle,0.134\npositive regulation of canonical NF-kappaB signal transduction,immune system process,0.376\npositive regulation of canonical Wnt signaling pathway,protein modification/signaling,0.352\npositive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,protein modification/signaling,0.232\npositive regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation,protein modification/signaling,0.292\npositive regulation of canonical Wnt signaling pathway involved in heart development,morphogenesis/development,0.312\npositive regulation of cap-dependent translational initiation,metabolic process,0.124\npositive regulation of cap-independent translational initiation,metabolic process,0.124\npositive regulation of cardiac conduction,cell cycle,0.122\npositive regulation of cardiac endothelial to mesenchymal transition,multicellular organismal process,0.11\npositive regulation of cardiac epithelial to mesenchymal transition,morphogenesis/development,0.596\npositive regulation of cardiac muscle adaptation,multicellular organismal process,0.366\npositive regulation of cardiac muscle cell apoptotic process,cell death,0.782\npositive regulation of cardiac muscle cell contraction,multicellular organismal process,0.438\npositive regulation of cardiac muscle cell differentiation,morphogenesis/development,0.672\npositive regulation of cardiac muscle cell proliferation,morphogenesis/development,0.348\npositive regulation of cardiac muscle contraction,multicellular organismal process,0.232\npositive regulation of cardiac muscle fiber development,morphogenesis/development,0.248\npositive regulation of cardiac muscle hypertrophy in response to stress,immune system process,0.13\npositive regulation of cardiac muscle myoblast proliferation,cell cycle,0.18\npositive regulation of cardiac muscle tissue development,morphogenesis/development,0.152\npositive regulation of cardiac muscle tissue growth,morphogenesis/development,0.642\npositive regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis,morphogenesis/development,0.344\npositive regulation of cardiac vascular smooth muscle cell differentiation,morphogenesis/development,0.21\npositive regulation of cardiac ventricle development,morphogenesis/development,0.174\npositive regulation of cardioblast differentiation,morphogenesis/development,0.664\npositive regulation of cardioblast proliferation,cell cycle,0.202\npositive regulation of cardiocyte differentiation,morphogenesis/development,0.654\npositive regulation of cardiolipin metabolic process,metabolic process,0.186\npositive regulation of catalase activity,cell cycle,0.148\npositive regulation of catalytic activity,metabolic process,0.51\npositive regulation of catecholamine metabolic process,metabolic process,0.802\npositive regulation of catecholamine secretion,transport,0.648\npositive regulation of catecholamine uptake involved in synaptic transmission,transport,0.52\npositive regulation of cation channel activity,transport,0.632\npositive regulation of cation transmembrane transport,transport,0.702\npositive regulation of caveolin-mediated endocytosis,protein modification/signaling,0.128\npositive regulation of cell adhesion mediated by integrin,cell adhesion,0.556\npositive regulation of cell adhesion molecule production,cell adhesion,0.23\npositive regulation of cell chemotaxis to fibroblast growth factor,immune system process,0.294\npositive regulation of cell communication,protein modification/signaling,0.336\npositive regulation of cell communication by chemical coupling,protein modification/signaling,0.276\npositive regulation of cell communication by electrical coupling,protein modification/signaling,0.226\npositive regulation of cell communication by electrical coupling involved in cardiac conduction,morphogenesis/development,0.128\npositive regulation of cell differentiation involved in phenotypic switching,morphogenesis/development,0.75\npositive regulation of cell fate commitment,morphogenesis/development,0.312\npositive regulation of cell fate determination,morphogenesis/development,0.538\npositive regulation of cell fate specification,morphogenesis/development,0.662\npositive regulation of cell growth involved in cardiac muscle cell development,morphogenesis/development,0.698\npositive regulation of cell maturation,morphogenesis/development,0.486\npositive regulation of cell migration by vascular endothelial growth factor signaling pathway,receptor related process,0.534\npositive regulation of cell morphogenesis,morphogenesis/development,0.676\npositive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway,receptor related process,0.492\npositive regulation of cell proliferation in bone marrow,cell cycle,0.222\npositive regulation of cell proliferation in midbrain,cell cycle,0.25\npositive regulation of cell proliferation involved in heart morphogenesis,cell cycle,0.586\npositive regulation of cell proliferation involved in heart valve morphogenesis,cell cycle,0.214\npositive regulation of cell proliferation involved in kidney development,cell cycle,0.788\npositive regulation of cell proliferation involved in outflow tract morphogenesis,morphogenesis/development,0.31\npositive regulation of cell size,cellular component organization,0.186\npositive regulation of cell volume,cellular component organization,0.196\npositive regulation of cell-cell adhesion mediated by cadherin,cell adhesion,0.264\npositive regulation of cell-cell adhesion mediated by integrin,cell adhesion,0.278\npositive regulation of cell-substrate junction organization,cellular component organization,0.774\npositive regulation of cellular component organization,cellular component organization,0.578\npositive regulation of cellular defense response,immune system process,0.192\npositive regulation of cellular extravasation,immune system process,0.844\npositive regulation of cellular glucuronidation,cellular component organization,0.13\npositive regulation of cellular metabolic process,metabolic process,0.744\npositive regulation of cellular pH reduction,other,0.22\npositive regulation of cellular process,metabolic process,0.308\npositive regulation of cellular respiration,metabolic process,0.648\npositive regulation of cellular response to drug,immune system process,0.146\npositive regulation of cellular response to heat,immune system process,0.144\npositive regulation of cellular response to hepatocyte growth factor stimulus,immune system process,0.282\npositive regulation of cellular response to hypoxia,immune system process,0.144\npositive regulation of cellular response to insulin stimulus,immune system process,0.306\npositive regulation of cellular response to macrophage colony-stimulating factor stimulus,immune system process,0.376\npositive regulation of cellular response to oxidative stress,metabolic process,0.182\npositive regulation of cellular senescence,immune system process,0.126\npositive regulation of central B cell tolerance induction,immune system process,0.574\npositive regulation of central tolerance induction,immune system process,0.532\npositive regulation of centriole elongation,cell cycle,0.146\npositive regulation of centriole replication,cell cycle,0.542\npositive regulation of centrosome duplication,morphogenesis/development,0.3\npositive regulation of ceramide biosynthetic process,metabolic process,0.348\npositive regulation of cerebellar granule cell precursor proliferation,morphogenesis/development,0.25\npositive regulation of chaperone-mediated autophagy,cell cycle,0.13\npositive regulation of chaperone-mediated protein complex assembly,cellular component organization,0.608\npositive regulation of chemokine (C-C motif) ligand 1 production,immune system process,0.452\npositive regulation of chemokine (C-C motif) ligand 20 production,immune system process,0.38\npositive regulation of chemokine (C-C motif) ligand 5 production,immune system process,0.466\npositive regulation of chemokine (C-X-C motif) ligand 1 production,immune system process,0.478\npositive regulation of chemokine (C-X-C motif) ligand 2 production,immune system process,0.53\npositive regulation of chemokine-mediated signaling pathway,receptor related process,0.422\npositive regulation of cholangiocyte proliferation,cell cycle,0.206\npositive regulation of cholesterol biosynthetic process,metabolic process,0.724\npositive regulation of cholesterol metabolic process,metabolic process,0.96\npositive regulation of cholesterol storage,cellular component organization,0.304\npositive regulation of cholesterol transport,transport,0.924\npositive regulation of choline O-acetyltransferase activity,cell cycle,0.144\npositive regulation of chondrocyte development,morphogenesis/development,0.708\npositive regulation of chondrocyte differentiation,morphogenesis/development,0.766\npositive regulation of chondrocyte hypertrophy,protein modification/signaling,0.134\npositive regulation of chondrocyte proliferation,cell cycle,0.704\npositive regulation of chorionic trophoblast cell proliferation,cell cycle,0.23\npositive regulation of chromatin organization,cellular component organization,0.406\npositive regulation of chromosome condensation,cellular component organization,0.486\npositive regulation of chromosome organization,cell cycle,0.612\npositive regulation of chronic inflammatory response,immune system process,0.596\npositive regulation of chronic inflammatory response to antigenic stimulus,immune system process,0.5\npositive regulation of chronic inflammatory response to non-antigenic stimulus,immune system process,0.49\npositive regulation of chylomicron remnant clearance,cellular component organization,0.196\npositive regulation of cilium assembly,cellular component organization,0.766\npositive regulation of cilium movement,transport,0.268\npositive regulation of cilium-dependent cell motility,cell cycle,0.242\npositive regulation of circadian rhythm,cell cycle,0.222\n\"positive regulation of circadian sleep/wake cycle, REM sleep\",transport,0.184\n\"positive regulation of circadian sleep/wake cycle, non-REM sleep\",transport,0.18\n\"positive regulation of circadian sleep/wake cycle, sleep\",multicellular organismal process,0.35\n\"positive regulation of circadian sleep/wake cycle, wakefulness\",cell cycle,0.246\npositive regulation of clathrin coat assembly,cellular component organization,0.274\npositive regulation of clathrin-dependent endocytosis,immune system process,0.124\npositive regulation of coagulation,multicellular organismal process,0.568\npositive regulation of cobalamin metabolic process,metabolic process,0.156\npositive regulation of collagen binding,gene regulation,0.172\npositive regulation of collagen biosynthetic process,metabolic process,0.598\npositive regulation of collagen catabolic process,metabolic process,0.714\npositive regulation of collagen fibril organization,morphogenesis/development,0.16\npositive regulation of collagen metabolic process,metabolic process,0.872\npositive regulation of collateral sprouting,neural related process,0.518\npositive regulation of collateral sprouting in absence of injury,morphogenesis/development,0.174\npositive regulation of colon smooth muscle contraction,cell cycle,0.168\npositive regulation of complement activation,immune system process,0.716\n\"positive regulation of complement activation, classical pathway\",immune system process,0.804\npositive regulation of complement-dependent cytotoxicity,cell cycle,0.136\npositive regulation of connective tissue growth factor production,immune system process,0.386\npositive regulation of connective tissue replacement,multicellular organismal process,0.606\npositive regulation of constitutive secretory pathway,metabolic process,0.158\npositive regulation of convergent extension involved in gastrulation,morphogenesis/development,0.782\npositive regulation of core promoter binding,gene regulation,0.188\npositive regulation of corticosteroid hormone secretion,transport,0.526\npositive regulation of corticotropin secretion,cell cycle,0.132\npositive regulation of corticotropin-releasing hormone secretion,cell cycle,0.128\npositive regulation of cortisol biosynthetic process,metabolic process,0.276\npositive regulation of cortisol secretion,cell cycle,0.134\npositive regulation of cristae formation,morphogenesis/development,0.222\npositive regulation of cyclase activity,metabolic process,0.482\npositive regulation of cyclic nucleotide-gated ion channel activity,cell cycle,0.13\npositive regulation of cyclic-nucleotide phosphodiesterase activity,metabolic process,0.574\npositive regulation of cyclin-dependent protein kinase activity,protein modification/signaling,0.542\npositive regulation of cyclin-dependent protein serine/threonine kinase activity,protein modification/signaling,0.516\npositive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,cell death,0.326\npositive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,cell death,0.436\npositive regulation of cytochrome-c oxidase activity,cell cycle,0.146\npositive regulation of cytokine activity,morphogenesis/development,0.228\npositive regulation of cytoplasmic mRNA processing body assembly,cellular component organization,0.41\npositive regulation of cytoplasmic translation,gene regulation,0.266\npositive regulation of cytoplasmic translational initiation,gene regulation,0.732\npositive regulation of cytoplasmic transport,transport,0.59\npositive regulation of cytoskeleton organization,cellular component organization,0.856\npositive regulation of cytosolic calcium ion concentration,transport,0.154\npositive regulation of cytosolic calcium ion concentration involved in egg activation,other,0.146\npositive regulation of cytotoxic T cell differentiation,morphogenesis/development,0.252\npositive regulation of dUTP diphosphatase activity,cell cycle,0.144\npositive regulation of deacetylase activity,metabolic process,0.56\npositive regulation of deadenylation-independent decapping of nuclear-transcribed mRNA,gene regulation,0.244\npositive regulation of defense response to bacterium,immune system process,0.496\npositive regulation of delayed rectifier potassium channel activity,cell cycle,0.134\npositive regulation of dendrite extension,protein modification/signaling,0.152\npositive regulation of dendrite morphogenesis,neural related process,0.5\npositive regulation of dendritic cell antigen processing and presentation,immune system process,0.662\npositive regulation of dendritic cell apoptotic process,cell death,0.648\npositive regulation of dendritic cell chemotaxis,immune system process,0.764\npositive regulation of dendritic cell cytokine production,immune system process,0.884\npositive regulation of dendritic cell dendrite assembly,cellular component organization,0.282\npositive regulation of dendritic cell differentiation,morphogenesis/development,0.2\npositive regulation of dendritic spine development,morphogenesis/development,0.64\npositive regulation of dendritic spine maintenance,cell cycle,0.118\npositive regulation of dendritic spine morphogenesis,morphogenesis/development,0.588\npositive regulation of dense core granule biogenesis,cellular component organization,0.246\npositive regulation of dense core granule exocytosis,metabolic process,0.13\npositive regulation of dense core granule transport,transport,0.666\npositive regulation of deoxyribonuclease activity,cell cycle,0.29\npositive regulation of dermatome development,morphogenesis/development,0.804\npositive regulation of detection of glucose,metabolic process,0.12\npositive regulation of determination of dorsal identity,morphogenesis/development,0.2\npositive regulation of developmental pigmentation,morphogenesis/development,0.532\npositive regulation of developmental process,morphogenesis/development,0.488\npositive regulation of diacylglycerol kinase activity,protein modification/signaling,0.232\npositive regulation of digestive system process,multicellular organismal process,0.308\npositive regulation of dipeptide transmembrane transport,transport,0.22\npositive regulation of dipeptide transport,transport,0.712\npositive regulation of dopamine biosynthetic process,metabolic process,0.296\npositive regulation of dopamine metabolic process,metabolic process,0.854\npositive regulation of dopamine receptor signaling pathway,receptor related process,0.744\npositive regulation of dopamine secretion,neural related process,0.144\npositive regulation of dopamine uptake involved in synaptic transmission,transport,0.374\npositive regulation of dopaminergic neuron differentiation,morphogenesis/development,0.59\npositive regulation of double-strand break repair,stress response,0.834\npositive regulation of double-strand break repair via nonhomologous end joining,stress response,0.154\npositive regulation of early endosome to late endosome transport,transport,0.148\npositive regulation of early endosome to recycling endosome transport,transport,0.154\npositive regulation of eating behavior,multicellular organismal process,0.504\npositive regulation of electron transfer activity,metabolic process,0.564\npositive regulation of embryonic development,morphogenesis/development,0.654\npositive regulation of enamel mineralization,immune system process,0.128\npositive regulation of endocardial cushion to mesenchymal transition,morphogenesis/development,0.566\npositive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation,morphogenesis/development,0.236\npositive regulation of endocytic recycling,transport,0.59\npositive regulation of endodeoxyribonuclease activity,metabolic process,0.244\npositive regulation of endodermal cell differentiation,morphogenesis/development,0.232\npositive regulation of endoplasmic reticulum calcium ion concentration,ER/endosome/lysosome related process,0.254\npositive regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation,ER/endosome/lysosome related process,0.192\npositive regulation of endoplasmic reticulum tubular network organization,ER/endosome/lysosome related process,0.2\npositive regulation of endoplasmic reticulum unfolded protein response,stress response,0.402\npositive regulation of endoribonuclease activity,protein modification/signaling,0.138\npositive regulation of endosome organization,cellular component organization,0.658\npositive regulation of endosome to plasma membrane protein transport,cellular component organization,0.236\npositive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway,receptor related process,0.474\npositive regulation of endothelial cell chemotaxis to fibroblast growth factor,cell cycle,0.128\npositive regulation of endothelial cell development,morphogenesis/development,0.624\npositive regulation of endothelial cell differentiation,morphogenesis/development,0.702\npositive regulation of endothelial cell-matrix adhesion via fibronectin,cell adhesion,0.154\npositive regulation of endothelial tube morphogenesis,morphogenesis/development,0.198\npositive regulation of endothelin production,immune system process,0.41\npositive regulation of engulfment of apoptotic cell,cell death,0.244\npositive regulation of eosinophil activation,cell cycle,0.136\npositive regulation of eosinophil chemotaxis,immune system process,0.154\npositive regulation of eosinophil degranulation,immune system process,0.218\npositive regulation of eosinophil differentiation,morphogenesis/development,0.234\npositive regulation of eosinophil migration,immune system process,0.832\npositive regulation of ephrin receptor signaling pathway,receptor related process,0.358\npositive regulation of epidermal cell differentiation,morphogenesis/development,0.766\npositive regulation of epidermal growth factor-activated receptor activity,receptor related process,0.358\npositive regulation of epidermis development,morphogenesis/development,0.714\npositive regulation of epinephrine secretion,protein modification/signaling,0.13\npositive regulation of epithelial cell apoptotic process,cell death,0.636\npositive regulation of epithelial cell differentiation,morphogenesis/development,0.774\npositive regulation of epithelial cell differentiation involved in kidney development,morphogenesis/development,0.684\npositive regulation of epithelial cell proliferation involved in lung morphogenesis,cell cycle,0.68\npositive regulation of epithelial cell proliferation involved in prostate gland development,morphogenesis/development,0.46\npositive regulation of epithelial cell proliferation involved in wound healing,morphogenesis/development,0.202\npositive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,morphogenesis/development,0.252\npositive regulation of epithelial tube formation,morphogenesis/development,0.814\npositive regulation of error-prone translesion synthesis,cell cycle,0.136\npositive regulation of erythrocyte enucleation,protein modification/signaling,0.128\npositive regulation of establishment of T cell polarity,transport,0.144\npositive regulation of establishment of endothelial barrier,transport,0.146\npositive regulation of establishment of protein localization,transport,0.51\npositive regulation of establishment of protein localization to telomere,transport,0.386\npositive regulation of establishment or maintenance of cell polarity regulating cell shape,morphogenesis/development,0.458\npositive regulation of estradiol secretion,protein modification/signaling,0.126\npositive regulation of eukaryotic translation initiation factor 4F complex assembly,cellular component organization,0.298\npositive regulation of excitatory synapse assembly,cellular component organization,0.256\npositive regulation of execution phase of apoptosis,cell death,0.518\npositive regulation of exit from mitosis,cell cycle,0.254\npositive regulation of exosomal secretion,morphogenesis/development,0.15\npositive regulation of extracellular exosome assembly,cellular component organization,0.3\npositive regulation of extracellular matrix assembly,cellular component organization,0.774\npositive regulation of extracellular matrix constituent secretion,metabolic process,0.14\npositive regulation of extracellular matrix disassembly,cellular component organization,0.352\npositive regulation of extrinsic apoptotic signaling pathway in absence of ligand,cell death,0.61\npositive regulation of eye pigmentation,morphogenesis/development,0.38\npositive regulation of fast-twitch skeletal muscle fiber contraction,multicellular organismal process,0.126\npositive regulation of fat cell apoptotic process,cell death,0.24\npositive regulation of fat cell proliferation,cell cycle,0.742\npositive regulation of fatty acid beta-oxidation,metabolic process,0.702\npositive regulation of fatty acid biosynthetic process,metabolic process,0.938\npositive regulation of fatty acid oxidation,metabolic process,0.754\npositive regulation of fatty acid transport,transport,0.822\npositive regulation of fear response,multicellular organismal process,0.314\npositive regulation of feeding behavior,multicellular organismal process,0.502\npositive regulation of female gonad development,morphogenesis/development,0.594\npositive regulation of female receptivity,multicellular organismal process,0.532\npositive regulation of ferroptosis,protein modification/signaling,0.132\npositive regulation of ferrous iron binding,gene regulation,0.162\npositive regulation of fertilization,cell cycle,0.138\npositive regulation of fever generation,immune system process,0.49\npositive regulation of fever generation by positive regulation of prostaglandin secretion,morphogenesis/development,0.196\npositive regulation of fibrinolysis,multicellular organismal process,0.18\npositive regulation of fibroblast apoptotic process,cell death,0.744\npositive regulation of fibroblast growth factor production,immune system process,0.456\npositive regulation of fibroblast growth factor receptor signaling pathway,receptor related process,0.776\npositive regulation of fibroblast migration,multicellular organismal process,0.336\npositive regulation of fibronectin-dependent thymocyte migration,immune system process,0.13\npositive regulation of filamentous growth,multicellular organismal process,0.274\npositive regulation of filamentous growth of a population of unicellular organisms,immune system process,0.268\npositive regulation of flagellated sperm motility,cell cycle,0.234\npositive regulation of flagellated sperm motility involved in capacitation,morphogenesis/development,0.196\npositive regulation of focal adhesion assembly,cellular component organization,0.216\npositive regulation of focal adhesion disassembly,cellular component organization,0.36\npositive regulation of follicle-stimulating hormone secretion,protein modification/signaling,0.122\npositive regulation of forebrain neuron differentiation,neural related process,0.2\npositive regulation of fractalkine production,immune system process,0.454\npositive regulation of free ubiquitin chain polymerization,protein modification/signaling,0.16\n\"positive regulation of fructose 1,6-bisphosphate 1-phosphatase activity\",metabolic process,0.58\n\"positive regulation of fructose 1,6-bisphosphate metabolic process\",metabolic process,0.746\npositive regulation of gamma-aminobutyric acid secretion,metabolic process,0.222\npositive regulation of gamma-delta T cell activation,immune system process,0.864\npositive regulation of gamma-delta T cell differentiation,morphogenesis/development,0.258\npositive regulation of gap junction assembly,cellular component organization,0.282\npositive regulation of gastric mucosal blood circulation,multicellular organismal process,0.2\npositive regulation of gastro-intestinal system smooth muscle contraction,multicellular organismal process,0.616\npositive regulation of gastrulation,morphogenesis/development,0.156\npositive regulation of gene expression via CpG island demethylation,gene regulation,0.456\npositive regulation of germ cell proliferation,cell cycle,0.368\npositive regulation of germinal center formation,immune system process,0.27\npositive regulation of glial cell apoptotic process,cell death,0.85\npositive regulation of glial cell differentiation,neural related process,0.536\npositive regulation of glial cell migration,immune system process,0.27\npositive regulation of glial cell-derived neurotrophic factor production,immune system process,0.368\npositive regulation of glomerular filtration,multicellular organismal process,0.186\npositive regulation of glomerular mesangial cell proliferation,cell cycle,0.764\npositive regulation of glomerular metanephric mesangial cell proliferation,cell cycle,0.22\npositive regulation of glucagon secretion,immune system process,0.13\npositive regulation of glucocorticoid biosynthetic process,metabolic process,0.872\npositive regulation of glucocorticoid metabolic process,metabolic process,0.918\npositive regulation of glucocorticoid receptor signaling pathway,receptor related process,0.36\npositive regulation of glucocorticoid secretion,transport,0.512\npositive regulation of glucokinase activity,metabolic process,0.484\npositive regulation of gluconeogenesis,protein modification/signaling,0.142\npositive regulation of glucose catabolic process to lactate via pyruvate,metabolic process,0.236\npositive regulation of glucose import,transport,0.168\npositive regulation of glucose mediated signaling pathway,protein modification/signaling,0.31\npositive regulation of glucose metabolic process,metabolic process,0.912\npositive regulation of glucose transmembrane transport,transport,0.888\npositive regulation of glucosylceramide catabolic process,metabolic process,0.234\npositive regulation of glutamate metabolic process,metabolic process,0.692\npositive regulation of glutamate neurotransmitter secretion in response to membrane depolarization,cellular component organization,0.16\npositive regulation of glutamate receptor signaling pathway,receptor related process,0.35\npositive regulation of glutamate secretion,transport,0.63\n\"positive regulation of glutamate secretion, neurotransmission\",transport,0.39\npositive regulation of glutamate uptake involved in transmission of nerve impulse,transport,0.344\npositive regulation of glutamate-cysteine ligase activity,metabolic process,0.178\npositive regulation of glutamatergic neuron differentiation,neural related process,0.218\npositive regulation of glutamine transport,transport,0.704\npositive regulation of glutathione biosynthetic process,metabolic process,0.27\npositive regulation of glutathione peroxidase activity,protein modification/signaling,0.15\npositive regulation of glycogen (starch) synthase activity,metabolic process,0.16\npositive regulation of glycogen biosynthetic process,metabolic process,0.738\npositive regulation of glycogen catabolic process,metabolic process,0.732\npositive regulation of glycolytic process,metabolic process,0.692\npositive regulation of glycoprotein biosynthetic process,metabolic process,0.688\npositive regulation of glycoprotein biosynthetic process involved in immunological synapse formation,metabolic process,0.256\npositive regulation of gonad development,morphogenesis/development,0.612\npositive regulation of gonadotropin secretion,transport,0.352\npositive regulation of granulocyte chemotaxis,immune system process,0.914\npositive regulation of granulocyte colony-stimulating factor production,immune system process,0.44\npositive regulation of granulocyte differentiation,immune system process,0.704\npositive regulation of granulocyte macrophage colony-stimulating factor production,immune system process,0.58\npositive regulation of granulosa cell proliferation,cell cycle,0.264\npositive regulation of granzyme A production,immune system process,0.488\npositive regulation of granzyme B production,immune system process,0.524\npositive regulation of growth factor dependent skeletal muscle satellite cell proliferation,cell cycle,0.236\npositive regulation of growth hormone receptor signaling pathway,receptor related process,0.474\npositive regulation of growth hormone secretion,morphogenesis/development,0.152\npositive regulation of growth of unicellular organism as a thread of attached cells,cell cycle,0.314\npositive regulation of growth rate,morphogenesis/development,0.196\npositive regulation of guanyl-nucleotide exchange factor activity,metabolic process,0.454\npositive regulation of guanylate cyclase activity,immune system process,0.13\npositive regulation of hair cycle,cell cycle,0.152\npositive regulation of hair follicle cell proliferation,cell cycle,0.194\npositive regulation of hair follicle development,morphogenesis/development,0.63\npositive regulation of hair follicle maturation,morphogenesis/development,0.652\npositive regulation of heart growth,morphogenesis/development,0.586\npositive regulation of heart induction,morphogenesis/development,0.706\npositive regulation of heart induction by negative regulation of canonical Wnt signaling pathway,receptor related process,0.328\npositive regulation of heart rate by epinephrine,multicellular organismal process,0.518\npositive regulation of heart rate by epinephrine-norepinephrine,multicellular organismal process,0.522\npositive regulation of heart rate involved in baroreceptor response to decreased systemic arterial blood pressure,multicellular organismal process,0.206\npositive regulation of heat generation,multicellular organismal process,0.52\npositive regulation of helicase activity,metabolic process,0.466\npositive regulation of hematopoietic progenitor cell differentiation,morphogenesis/development,0.674\npositive regulation of hematopoietic stem cell differentiation,morphogenesis/development,0.282\npositive regulation of hematopoietic stem cell migration,immune system process,0.204\npositive regulation of hematopoietic stem cell proliferation,cell cycle,0.236\npositive regulation of heme biosynthetic process,metabolic process,0.712\npositive regulation of hemoglobin biosynthetic process,metabolic process,0.656\npositive regulation of hemostasis,multicellular organismal process,0.382\npositive regulation of heparan sulfate binding,gene regulation,0.168\npositive regulation of heparan sulfate proteoglycan binding,gene regulation,0.168\npositive regulation of heparan sulfate proteoglycan biosynthetic process,metabolic process,0.754\npositive regulation of hepatic stellate cell activation,cell cycle,0.142\npositive regulation of hepatic stellate cell contraction,morphogenesis/development,0.126\npositive regulation of hepatic stellate cell migration,morphogenesis/development,0.15\npositive regulation of hepatic stellate cell proliferation,cell cycle,0.272\npositive regulation of hepatocyte apoptotic process,cell death,0.268\npositive regulation of hepatocyte differentiation,morphogenesis/development,0.264\npositive regulation of hepatocyte growth factor receptor signaling pathway,receptor related process,0.38\npositive regulation of hepatocyte proliferation,immune system process,0.166\npositive regulation of heterochromatin organization,cellular component organization,0.428\npositive regulation of heterotypic cell-cell adhesion,cell adhesion,0.496\npositive regulation of hexokinase activity,protein modification/signaling,0.398\npositive regulation of hh target transcription factor activity,gene regulation,0.252\npositive regulation of high voltage-gated calcium channel activity,cell cycle,0.13\npositive regulation of high-density lipoprotein particle assembly,cellular component organization,0.446\npositive regulation of high-density lipoprotein particle clearance,multicellular organismal process,0.184\npositive regulation of hippo signaling,protein modification/signaling,0.338\npositive regulation of hippocampal neuron apoptotic process,cell death,0.38\npositive regulation of histamine secretion by mast cell,cell cycle,0.152\npositive regulation of histone H3-K4 methylation,gene regulation,0.368\npositive regulation of histone H3-K9 acetylation,gene regulation,0.158\npositive regulation of histone H3-K9 dimethylation,protein modification/signaling,0.144\npositive regulation of histone H3-K9 methylation,gene regulation,0.61\npositive regulation of histone H3-K9 trimethylation,protein modification/signaling,0.142\npositive regulation of histone H4 acetylation,gene regulation,0.558\npositive regulation of histone H4-K16 acetylation,gene regulation,0.166\npositive regulation of histone H4-K20 methylation,gene regulation,0.27\npositive regulation of histone deacetylase activity,morphogenesis/development,0.13\npositive regulation of histone deacetylation,protein modification/signaling,0.58\npositive regulation of histone methylation,gene regulation,0.76\npositive regulation of homophilic cell adhesion,cell adhesion,0.19\npositive regulation of hormone biosynthetic process,metabolic process,0.884\npositive regulation of hormone metabolic process,metabolic process,0.886\npositive regulation of humoral immune response,immune system process,0.838\npositive regulation of humoral immune response mediated by circulating immunoglobulin,immune system process,0.856\npositive regulation of hyaluranon cable assembly,cellular component organization,0.274\npositive regulation of hyaluronan biosynthetic process,metabolic process,0.25\npositive regulation of hydrogen peroxide biosynthetic process,metabolic process,0.634\npositive regulation of hydrogen peroxide catabolic process,metabolic process,0.264\npositive regulation of hydrogen peroxide metabolic process,metabolic process,0.704\npositive regulation of hydrogen peroxide-mediated programmed cell death,cell death,0.536\npositive regulation of hydrogen sulfide biosynthetic process,metabolic process,0.256\npositive regulation of hypersensitivity,immune system process,0.908\npositive regulation of hypoxia-inducible factor-1alpha signaling pathway,protein modification/signaling,0.33\npositive regulation of immature T cell proliferation,immune system process,0.834\npositive regulation of immature T cell proliferation in thymus,immune system process,0.404\npositive regulation of immune complex clearance by monocytes and macrophages,immune system process,0.41\npositive regulation of immune response to tumor cell,immune system process,0.798\npositive regulation of immune system process,immune system process,0.63\npositive regulation of immunoglobulin mediated immune response,immune system process,0.958\npositive regulation of immunoglobulin production,immune system process,0.756\npositive regulation of immunoglobulin production in mucosal tissue,immune system process,0.484\npositive regulation of immunological synapse formation,morphogenesis/development,0.23\npositive regulation of inclusion body assembly,cellular component organization,0.9\npositive regulation of inflammasome-mediated signaling pathway,immune system process,0.366\npositive regulation of inflammatory response to antigenic stimulus,immune system process,0.922\npositive regulation of inflammatory response to wounding,immune system process,0.176\npositive regulation of inhibitory G protein-coupled receptor phosphorylation,receptor related process,0.298\npositive regulation of inhibitory postsynaptic potential,neural related process,0.534\npositive regulation of inhibitory synapse assembly,cellular component organization,0.278\npositive regulation of inner ear auditory receptor cell differentiation,morphogenesis/development,0.258\npositive regulation of inner ear receptor cell differentiation,morphogenesis/development,0.54\npositive regulation of inorganic anion transmembrane transport,transport,0.734\n\"positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity\",morphogenesis/development,0.14\npositive regulation of inositol phosphate biosynthetic process,metabolic process,0.888\npositive regulation of inositol trisphosphate biosynthetic process,metabolic process,0.704\npositive regulation of inositol-polyphosphate 5-phosphatase activity,metabolic process,0.614\npositive regulation of insulin receptor signaling pathway,receptor related process,0.556\npositive regulation of insulin secretion,transport,0.638\npositive regulation of insulin secretion involved in cellular response to glucose stimulus,immune system process,0.128\npositive regulation of insulin-like growth factor receptor signaling pathway,receptor related process,0.392\npositive regulation of integrin activation,cellular component organization,0.508\npositive regulation of integrin activation by cell surface receptor linked signal transduction,receptor related process,0.26\npositive regulation of integrin biosynthetic process,metabolic process,0.694\npositive regulation of interleukin-1 alpha production,immune system process,0.446\npositive regulation of interleukin-1-mediated signaling pathway,protein modification/signaling,0.342\npositive regulation of interleukin-13 production,immune system process,0.742\npositive regulation of interleukin-15 production,immune system process,0.452\npositive regulation of interleukin-16 production,immune system process,0.46\npositive regulation of interleukin-17-mediated signaling pathway,protein modification/signaling,0.298\npositive regulation of interleukin-17A production,immune system process,0.434\npositive regulation of interleukin-18 production,immune system process,0.502\npositive regulation of interleukin-18-mediated signaling pathway,protein modification/signaling,0.342\npositive regulation of interleukin-21 production,immune system process,0.454\npositive regulation of interleukin-23 production,immune system process,0.554\npositive regulation of interleukin-3 production,immune system process,0.45\npositive regulation of interleukin-33 production,immune system process,0.422\npositive regulation of interleukin-4-dependent isotype switching to IgE isotypes,immune system process,0.222\npositive regulation of interleukin-4-mediated signaling pathway,protein modification/signaling,0.32\npositive regulation of interleukin-5 production,immune system process,0.55\npositive regulation of interleukin-6-mediated signaling pathway,protein modification/signaling,0.274\npositive regulation of intermediate filament depolymerization,cellular component organization,0.188\npositive regulation of intestinal absorption,transport,0.338\npositive regulation of intestinal cholesterol absorption,multicellular organismal process,0.182\npositive regulation of intestinal epithelial structure maintenance,morphogenesis/development,0.252\npositive regulation of intestinal lipid absorption,transport,0.44\npositive regulation of intracellular cholesterol transport,transport,0.772\npositive regulation of intracellular estrogen receptor signaling pathway,receptor related process,0.354\npositive regulation of intracellular lipid transport,transport,0.788\npositive regulation of intracellular mRNA localization,transport,0.342\npositive regulation of intracellular steroid hormone receptor signaling pathway,receptor related process,0.78\npositive regulation of intracellular sterol transport,transport,0.788\npositive regulation of intracellular transport of viral material,viral related process,0.148\npositive regulation of intrinsic apoptotic signaling pathway by p53 class mediator,cell death,0.728\npositive regulation of intrinsic apoptotic signaling pathway in response to DNA damage,cell death,0.706\npositive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,protein modification/signaling,0.24\npositive regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,cell death,0.682\npositive regulation of inward rectifier potassium channel activity,transport,0.706\npositive regulation of ion transmembrane transporter activity,transport,0.566\npositive regulation of iron ion import across plasma membrane,transport,0.224\npositive regulation of iron ion transmembrane transport,transport,0.912\npositive regulation of iron ion transport,transport,0.926\npositive regulation of iron-sulfur cluster assembly,cellular component organization,0.548\npositive regulation of isomerase activity,metabolic process,0.434\npositive regulation of isoprenoid metabolic process,metabolic process,0.908\npositive regulation of isotype switching,immune system process,0.742\npositive regulation of isotype switching to IgA isotypes,protein modification/signaling,0.126\npositive regulation of isotype switching to IgE isotypes,immune system process,0.722\npositive regulation of isotype switching to IgG isotypes,immune system process,0.238\npositive regulation of keratinocyte apoptotic process,cell death,0.708\npositive regulation of keratinocyte differentiation,morphogenesis/development,0.314\npositive regulation of keratinocyte migration,morphogenesis/development,0.132\npositive regulation of keratinocyte proliferation,cell cycle,0.604\npositive regulation of kidney smooth muscle cell differentiation,morphogenesis/development,0.228\npositive regulation of killing of cells of another organism,cell death,0.346\npositive regulation of lactation,morphogenesis/development,0.368\npositive regulation of lamellipodium assembly,cellular component organization,0.342\npositive regulation of lamellipodium morphogenesis,morphogenesis/development,0.22\npositive regulation of lamellipodium organization,cellular component organization,0.77\npositive regulation of large conductance calcium-activated potassium channel activity,cell cycle,0.154\npositive regulation of late endosome to lysosome transport,transport,0.154\npositive regulation of lateral attachment of mitotic spindle microtubules to kinetochore,cell cycle,0.404\npositive regulation of lateral motor column neuron migration,neural related process,0.256\npositive regulation of lens epithelial cell proliferation,cell cycle,0.224\npositive regulation of lens fiber cell differentiation,morphogenesis/development,0.23\npositive regulation of leucine import across plasma membrane,transport,0.198\npositive regulation of leukocyte adhesion to arterial endothelial cell,immune system process,0.284\npositive regulation of leukocyte degranulation,immune system process,0.692\npositive regulation of leukocyte tethering or rolling,immune system process,0.382\npositive regulation of leukotriene production involved in inflammatory response,immune system process,0.362\npositive regulation of ligase activity,metabolic process,0.554\npositive regulation of lipase activity,metabolic process,0.722\npositive regulation of lipid catabolic process,metabolic process,0.898\npositive regulation of lipid kinase activity,protein modification/signaling,0.556\npositive regulation of lipid metabolic process,metabolic process,0.908\npositive regulation of lipid transport across blood-brain barrier,transport,0.196\npositive regulation of lipid transporter activity,transport,0.59\npositive regulation of lipophagy,morphogenesis/development,0.148\npositive regulation of lipopolysaccharide-mediated signaling pathway,protein modification/signaling,0.258\npositive regulation of lipoprotein lipase activity,metabolic process,0.346\npositive regulation of lipoprotein metabolic process,metabolic process,0.786\npositive regulation of lipoprotein particle clearance,multicellular organismal process,0.612\npositive regulation of locomotion involved in locomotory behavior,transport,0.19\npositive regulation of long-chain fatty acid import across plasma membrane,transport,0.51\npositive regulation of long-chain fatty acid import into cell,transport,0.732\npositive regulation of long-term neuronal synaptic plasticity,neural related process,0.46\npositive regulation of long-term synaptic depression,neural related process,0.174\npositive regulation of long-term synaptic potentiation,neural related process,0.296\npositive regulation of low-density lipoprotein particle clearance,cell cycle,0.132\npositive regulation of low-density lipoprotein particle receptor binding,receptor related process,0.408\npositive regulation of low-density lipoprotein particle receptor catabolic process,metabolic process,0.622\npositive regulation of low-density lipoprotein receptor activity,receptor related process,0.292\npositive regulation of lung ciliated cell differentiation,morphogenesis/development,0.228\npositive regulation of lung goblet cell differentiation,morphogenesis/development,0.232\npositive regulation of luteinizing hormone secretion,protein modification/signaling,0.126\npositive regulation of lyase activity,metabolic process,0.544\npositive regulation of lymphangiogenesis,morphogenesis/development,0.15\npositive regulation of lymphocyte anergy,immune system process,0.694\npositive regulation of lymphocyte apoptotic process,immune system process,0.61\npositive regulation of lymphoid progenitor cell differentiation,morphogenesis/development,0.72\npositive regulation of lymphotoxin A production,immune system process,0.458\npositive regulation of lysosomal membrane permeability,cellular component organization,0.208\npositive regulation of lysosomal protein catabolic process,metabolic process,0.306\npositive regulation of lysosome organization,morphogenesis/development,0.162\npositive regulation of mRNA 3'-end processing,gene regulation,0.714\npositive regulation of mRNA binding,gene regulation,0.622\npositive regulation of mRNA cap binding,gene regulation,0.288\npositive regulation of mRNA metabolic process,gene regulation,0.674\npositive regulation of macromolecule biosynthetic process,metabolic process,0.63\npositive regulation of macromolecule metabolic process,metabolic process,0.716\npositive regulation of macrophage apoptotic process,cell death,0.684\npositive regulation of macrophage chemotaxis,immune system process,0.538\npositive regulation of macrophage colony-stimulating factor production,immune system process,0.778\npositive regulation of macrophage colony-stimulating factor signaling pathway,protein modification/signaling,0.268\npositive regulation of macrophage derived foam cell differentiation,morphogenesis/development,0.694\npositive regulation of macrophage differentiation,immune system process,0.734\npositive regulation of macrophage fusion,immune system process,0.186\npositive regulation of macrophage inflammatory protein 1 alpha production,immune system process,0.366\npositive regulation of macrophage migration inhibitory factor signaling pathway,protein modification/signaling,0.288\npositive regulation of macrophage proliferation,cell cycle,0.18\npositive regulation of macrophage tolerance induction,morphogenesis/development,0.172\npositive regulation of macropinocytosis,cell cycle,0.13\npositive regulation of maintenance of mitotic sister chromatid cohesion,cell cycle,0.692\npositive regulation of maintenance of sister chromatid cohesion,cell cycle,0.692\npositive regulation of male germ cell proliferation,cell cycle,0.224\npositive regulation of male gonad development,morphogenesis/development,0.252\npositive regulation of male mating behavior,multicellular organismal process,0.49\npositive regulation of mammary gland epithelial cell proliferation,cell cycle,0.184\npositive regulation of mammary stem cell proliferation,cell cycle,0.23\npositive regulation of mast cell activation,immune system process,0.73\npositive regulation of mast cell activation by Fc-epsilon receptor signaling pathway,receptor related process,0.276\npositive regulation of mast cell activation involved in immune response,immune system process,0.4\npositive regulation of mast cell apoptotic process,cell death,0.618\npositive regulation of mast cell chemotaxis,immune system process,0.344\npositive regulation of mast cell cytokine production,immune system process,0.468\npositive regulation of mast cell degranulation,immune system process,0.606\npositive regulation of mast cell differentiation,morphogenesis/development,0.632\npositive regulation of mast cell proliferation,immune system process,0.284\npositive regulation of maternal process involved in parturition,cell cycle,0.128\npositive regulation of matrix metallopeptidase secretion,immune system process,0.176\npositive regulation of mechanoreceptor differentiation,morphogenesis/development,0.556\npositive regulation of mediator complex assembly,cellular component organization,0.34\npositive regulation of megakaryocyte differentiation,morphogenesis/development,0.256\npositive regulation of meiosis I,cell cycle,0.296\npositive regulation of meiotic DNA double-strand break formation,cell cycle,0.502\npositive regulation of meiotic cell cycle phase transition,cell cycle,0.806\npositive regulation of meiotic chromosome separation,cell cycle,0.708\npositive regulation of meiotic nuclear division,cell cycle,0.646\npositive regulation of melanin biosynthetic process,metabolic process,0.738\npositive regulation of melanocyte differentiation,morphogenesis/development,0.754\npositive regulation of melanosome transport,transport,0.162\npositive regulation of membrane depolarization,cellular component organization,0.188\npositive regulation of membrane depolarization during cardiac muscle cell action potential,cellular component organization,0.182\npositive regulation of membrane invagination,cellular component organization,0.618\npositive regulation of membrane permeability,transport,0.432\npositive regulation of membrane potential,transport,0.306\npositive regulation of membrane protein ectodomain proteolysis,protein modification/signaling,0.248\npositive regulation of membrane repolarization during cardiac muscle cell action potential,cellular component organization,0.154\npositive regulation of membrane repolarization during ventricular cardiac muscle cell action potential,cellular component organization,0.16\npositive regulation of membrane tubulation,cellular component organization,0.25\npositive regulation of memory T cell activation,immune system process,0.136\npositive regulation of memory T cell differentiation,immune system process,0.444\npositive regulation of mesenchymal cell apoptotic process,cell death,0.76\npositive regulation of mesenchymal cell proliferation involved in ureter development,morphogenesis/development,0.21\npositive regulation of mesenchymal stem cell differentiation,morphogenesis/development,0.792\npositive regulation of mesenchymal stem cell migration,cell cycle,0.192\npositive regulation of mesenchymal stem cell proliferation,cell cycle,0.252\npositive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,cellular component organization,0.284\npositive regulation of mesoderm development,morphogenesis/development,0.632\npositive regulation of mesodermal cell differentiation,morphogenesis/development,0.778\npositive regulation of mesodermal cell fate specification,morphogenesis/development,0.728\npositive regulation of metabolic process,metabolic process,0.73\npositive regulation of metalloendopeptidase activity,metabolic process,0.426\npositive regulation of metallopeptidase activity,metabolic process,0.338\npositive regulation of metanephric DCT cell differentiation,morphogenesis/development,0.254\npositive regulation of metanephric cap mesenchymal cell proliferation,cell cycle,0.718\npositive regulation of metanephric glomerulus development,morphogenesis/development,0.772\npositive regulation of metanephric mesenchymal cell migration,cell cycle,0.15\npositive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway,protein modification/signaling,0.238\npositive regulation of metanephric podocyte development,morphogenesis/development,0.204\npositive regulation of metanephric ureteric bud development,morphogenesis/development,0.186\npositive regulation of metanephros development,morphogenesis/development,0.902\npositive regulation of metaphase/anaphase transition of cell cycle,cell cycle,0.874\npositive regulation of metaphase/anaphase transition of meiosis I,cell cycle,0.226\npositive regulation of metaphase/anaphase transition of meiotic cell cycle,cell cycle,0.758\npositive regulation of miRNA catabolic process,metabolic process,0.236\npositive regulation of miRNA processing,gene regulation,0.688\npositive regulation of miRNA-mediated gene silencing,gene regulation,0.57\npositive regulation of microglia differentiation,morphogenesis/development,0.636\npositive regulation of microglial cell activation,cell cycle,0.164\npositive regulation of microglial cell mediated cytotoxicity,cell cycle,0.144\npositive regulation of microglial cell migration,immune system process,0.194\npositive regulation of microtubule binding,protein modification/signaling,0.376\npositive regulation of microtubule depolymerization,cellular component organization,0.152\npositive regulation of microtubule nucleation,cellular component organization,0.64\npositive regulation of microtubule plus-end binding,cellular component organization,0.152\npositive regulation of microtubule polymerization,cellular component organization,0.744\npositive regulation of microtubule polymerization or depolymerization,cellular component organization,0.658\npositive regulation of midbrain dopaminergic neuron differentiation,morphogenesis/development,0.578\npositive regulation of mineralocorticoid secretion,transport,0.504\npositive regulation of mini excitatory postsynaptic potential,neural related process,0.254\npositive regulation of mismatch repair,immune system process,0.14\npositive regulation of mitochondrial ATP synthesis coupled electron transport,metabolic process,0.16\npositive regulation of mitochondrial DNA metabolic process,cell cycle,0.402\npositive regulation of mitochondrial DNA replication,cell cycle,0.216\npositive regulation of mitochondrial RNA catabolic process,metabolic process,0.664\npositive regulation of mitochondrial depolarization,cellular component organization,0.164\n\"positive regulation of mitochondrial electron transport, NADH to ubiquinone\",metabolic process,0.2\npositive regulation of mitochondrial fission,cellular component organization,0.186\npositive regulation of mitochondrial fusion,morphogenesis/development,0.152\npositive regulation of mitochondrial membrane permeability,transport,0.46\npositive regulation of mitochondrial membrane permeability involved in apoptotic process,cell death,0.478\npositive regulation of mitochondrial membrane potential,transport,0.27\npositive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,cell death,0.45\npositive regulation of mitochondrial transcription,gene regulation,0.194\npositive regulation of mitophagy,metabolic process,0.534\npositive regulation of mitophagy in response to mitochondrial depolarization,stress response,0.648\npositive regulation of mitotic DNA damage checkpoint,cell cycle,0.404\npositive regulation of mitotic cell cycle spindle assembly checkpoint,cell cycle,0.898\n\"positive regulation of mitotic cell cycle, embryonic\",cell cycle,0.694\npositive regulation of mitotic centrosome separation,cell cycle,0.12\npositive regulation of mitotic cytokinesis,cell cycle,0.912\npositive regulation of mitotic cytokinetic process,cell cycle,0.53\npositive regulation of mitotic metaphase/anaphase transition,cell cycle,0.792\npositive regulation of mitotic recombination,cell cycle,0.502\npositive regulation of mitotic sister chromatid segregation,cell cycle,0.702\npositive regulation of mitotic spindle elongation,cell cycle,0.728\npositive regulation of molecular function,metabolic process,0.36\npositive regulation of monoatomic anion transport,transport,0.734\npositive regulation of monoatomic ion transmembrane transport,transport,0.816\npositive regulation of monocyte aggregation,cellular component organization,0.118\npositive regulation of monocyte chemotactic protein-1 production,immune system process,0.622\npositive regulation of monocyte chemotaxis,immune system process,0.298\npositive regulation of monocyte differentiation,morphogenesis/development,0.228\npositive regulation of monocyte extravasation,immune system process,0.19\npositive regulation of motile cilium assembly,cellular component organization,0.282\npositive regulation of motor neuron apoptotic process,cell death,0.674\npositive regulation of motor neuron migration,neural related process,0.256\npositive regulation of mucus secretion,immune system process,0.27\npositive regulation of multicellular organismal process,morphogenesis/development,0.238\npositive regulation of muscle adaptation,multicellular organismal process,0.458\npositive regulation of muscle atrophy,protein modification/signaling,0.114\npositive regulation of muscle cell apoptotic process,cell death,0.822\npositive regulation of muscle cell differentiation,morphogenesis/development,0.858\npositive regulation of muscle hypertrophy,multicellular organismal process,0.714\npositive regulation of muscle organ development,morphogenesis/development,0.586\npositive regulation of muscle tissue development,morphogenesis/development,0.608\npositive regulation of myelination,morphogenesis/development,0.192\npositive regulation of myeloid cell apoptotic process,cell death,0.73\npositive regulation of myeloid dendritic cell activation,morphogenesis/development,0.146\npositive regulation of myeloid dendritic cell chemotaxis,immune system process,0.14\npositive regulation of myeloid dendritic cell cytokine production,immune system process,0.594\npositive regulation of myoblast differentiation,morphogenesis/development,0.786\npositive regulation of myoblast fusion,morphogenesis/development,0.136\npositive regulation of myoblast proliferation,cell cycle,0.644\npositive regulation of myofibroblast contraction,cell cycle,0.134\npositive regulation of myofibroblast differentiation,morphogenesis/development,0.206\npositive regulation of myosin light chain kinase activity,protein modification/signaling,0.244\npositive regulation of myosin-light-chain-phosphatase activity,protein modification/signaling,0.156\npositive regulation of myotome development,morphogenesis/development,0.156\npositive regulation of myotube differentiation,morphogenesis/development,0.838\npositive regulation of natural killer cell chemotaxis,immune system process,0.294\npositive regulation of natural killer cell cytokine production,immune system process,0.658\npositive regulation of natural killer cell degranulation,immune system process,0.25\npositive regulation of natural killer cell differentiation,immune system process,0.794\npositive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,immune system process,0.284\npositive regulation of natural killer cell mediated immune response to tumor cell,immune system process,0.932\npositive regulation of natural killer cell mediated immunity,immune system process,0.982\npositive regulation of natural killer cell proliferation,immune system process,0.866\npositive regulation of necroptotic process,cell death,0.578\npositive regulation of negative chemotaxis,immune system process,0.534\npositive regulation of nephron tubule epithelial cell differentiation,morphogenesis/development,0.266\npositive regulation of nervous system process,neural related process,0.396\npositive regulation of neural precursor cell proliferation,cell cycle,0.54\npositive regulation of neuroblast proliferation,morphogenesis/development,0.316\npositive regulation of neuroepithelial cell differentiation,morphogenesis/development,0.648\npositive regulation of neurofibrillary tangle assembly,cellular component organization,0.294\npositive regulation of neuroinflammatory response,immune system process,0.674\npositive regulation of neuromuscular junction development,cellular component organization,0.612\npositive regulation of neuromuscular synaptic transmission,neural related process,0.296\npositive regulation of neuron differentiation,morphogenesis/development,0.524\npositive regulation of neuron maturation,morphogenesis/development,0.61\npositive regulation of neuron migration,neural related process,0.318\npositive regulation of neuron projection arborization,morphogenesis/development,0.51\npositive regulation of neuron projection regeneration,neural related process,0.386\npositive regulation of neuronal action potential,neural related process,0.254\npositive regulation of neurotransmitter secretion,transport,0.368\npositive regulation of neurotransmitter uptake,transport,0.522\npositive regulation of neurotrophin TRK receptor signaling pathway,receptor related process,0.344\npositive regulation of neurotrophin production,immune system process,0.44\npositive regulation of neutrophil activation,cell cycle,0.14\npositive regulation of neutrophil apoptotic process,cell death,0.596\npositive regulation of neutrophil chemotaxis,immune system process,0.626\npositive regulation of neutrophil degranulation,immune system process,0.21\npositive regulation of neutrophil differentiation,morphogenesis/development,0.234\npositive regulation of neutrophil extravasation,immune system process,0.158\npositive regulation of neutrophil mediated cytotoxicity,immune system process,0.804\npositive regulation of neutrophil mediated killing of bacterium,immune system process,0.722\npositive regulation of neutrophil mediated killing of fungus,immune system process,0.252\npositive regulation of neutrophil mediated killing of gram-negative bacterium,immune system process,0.278\npositive regulation of neutrophil mediated killing of symbiont cell,immune system process,0.718\npositive regulation of neutrophil migration,immune system process,0.922\npositive regulation of nitric oxide mediated signal transduction,protein modification/signaling,0.358\npositive regulation of nitric-oxide synthase activity,metabolic process,0.358\npositive regulation of nitric-oxide synthase biosynthetic process,metabolic process,0.774\npositive regulation of nitrogen utilization,immune system process,0.422\npositive regulation of non-canonical NF-kappaB signal transduction,immune system process,0.582\npositive regulation of non-canonical Wnt signaling pathway,protein modification/signaling,0.558\npositive regulation of non-canonical Wnt signaling pathway via JNK cascade,protein modification/signaling,0.298\npositive regulation of non-membrane spanning protein tyrosine kinase activity,protein modification/signaling,0.514\npositive regulation of non-motile cilium assembly,cellular component organization,0.3\npositive regulation of norepinephrine secretion,protein modification/signaling,0.148\npositive regulation of norepinephrine uptake,transport,0.394\npositive regulation of nuclear cell cycle DNA replication,cell cycle,0.73\npositive regulation of nuclear division,cell cycle,0.538\n\"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay\",gene regulation,0.708\npositive regulation of nuclease activity,metabolic process,0.376\npositive regulation of nucleobase-containing compound metabolic process,metabolic process,0.676\npositive regulation of nucleobase-containing compound transport,transport,0.87\npositive regulation of nucleoside transport,transport,0.828\npositive regulation of nucleotide biosynthetic process,metabolic process,0.828\npositive regulation of nucleotide metabolic process,metabolic process,0.864\npositive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway,immune system process,0.326\npositive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,immune system process,0.352\npositive regulation of nucleotide-binding oligomerization domain containing signaling pathway,immune system process,0.874\npositive regulation of odontoblast differentiation,morphogenesis/development,0.218\npositive regulation of odontogenesis,morphogenesis/development,0.81\npositive regulation of odontogenesis of dentin-containing tooth,morphogenesis/development,0.796\npositive regulation of oligodendrocyte apoptotic process,cell death,0.272\npositive regulation of oligodendrocyte differentiation,morphogenesis/development,0.212\npositive regulation of oligodendrocyte progenitor proliferation,cell cycle,0.146\npositive regulation of oligopeptide transport,transport,0.662\npositive regulation of oocyte development,morphogenesis/development,0.694\npositive regulation of oocyte maturation,morphogenesis/development,0.208\npositive regulation of opioid receptor signaling pathway,receptor related process,0.782\npositive regulation of opsonization,cell cycle,0.124\npositive regulation of optic nerve formation,morphogenesis/development,0.254\npositive regulation of organ growth,morphogenesis/development,0.608\npositive regulation of organic acid transport,transport,0.882\npositive regulation of ossification,morphogenesis/development,0.598\npositive regulation of osteoblast proliferation,morphogenesis/development,0.188\npositive regulation of osteoclast development,morphogenesis/development,0.164\npositive regulation of osteoclast differentiation,immune system process,0.7\npositive regulation of osteoclast proliferation,cell cycle,0.616\npositive regulation of otic vesicle morphogenesis,morphogenesis/development,0.21\npositive regulation of ovarian follicle development,morphogenesis/development,0.18\npositive regulation of ovulation,morphogenesis/development,0.254\npositive regulation of oxidative phosphorylation,metabolic process,0.34\npositive regulation of oxidative phosphorylation uncoupler activity,metabolic process,0.266\npositive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,cell death,0.776\npositive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,cell death,0.248\npositive regulation of oxygen metabolic process,metabolic process,0.166\npositive regulation of oxytocin production,immune system process,0.416\npositive regulation of p38MAPK cascade,protein modification/signaling,0.196\npositive regulation of pancreatic juice secretion,protein modification/signaling,0.134\npositive regulation of pancreatic stellate cell proliferation,cell cycle,0.212\npositive regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,immune system process,0.134\npositive regulation of penile erection,multicellular organismal process,0.212\npositive regulation of pentose-phosphate shunt,cell cycle,0.132\npositive regulation of peptide hormone secretion,transport,0.712\npositive regulation of peptide secretion,transport,0.59\npositive regulation of peptidyl-cysteine S-nitrosylation,protein modification/signaling,0.142\npositive regulation of peptidyl-serine dephosphorylation,protein modification/signaling,0.118\npositive regulation of peptidyl-serine phosphorylation,protein modification/signaling,0.73\npositive regulation of peptidyl-serine phosphorylation of STAT protein,protein modification/signaling,0.532\npositive regulation of peptidyl-threonine phosphorylation,protein modification/signaling,0.274\npositive regulation of peptidyl-tyrosine autophosphorylation,morphogenesis/development,0.146\npositive regulation of peripheral T cell tolerance induction,immune system process,0.886\npositive regulation of peripheral tolerance induction,immune system process,0.708\npositive regulation of peroxidase activity,metabolic process,0.432\npositive regulation of peroxisome proliferator activated receptor signaling pathway,receptor related process,0.346\n\"positive regulation of phagocytosis, engulfment\",transport,0.278\npositive regulation of phagosome maturation,morphogenesis/development,0.176\npositive regulation of phosphate transmembrane transport,transport,0.202\npositive regulation of phosphatidic acid biosynthetic process,metabolic process,0.36\npositive regulation of phosphatidylcholine biosynthetic process,metabolic process,0.272\npositive regulation of phosphatidylcholine metabolic process,metabolic process,0.574\npositive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction,protein modification/signaling,0.354\npositive regulation of phosphatidylinositol biosynthetic process,metabolic process,0.884\npositive regulation of phosphatidylserine exposure on apoptotic cell surface,cell death,0.248\npositive regulation of phospholipase A2 activity,metabolic process,0.748\npositive regulation of phospholipase C activity,metabolic process,0.646\npositive regulation of phospholipase C-activating G protein-coupled receptor signaling pathway,receptor related process,0.356\npositive regulation of phospholipid biosynthetic process,metabolic process,0.908\npositive regulation of phospholipid catabolic process,metabolic process,0.896\npositive regulation of phospholipid efflux,cell cycle,0.124\npositive regulation of phospholipid metabolic process,metabolic process,0.77\npositive regulation of phospholipid scramblase activity,cell cycle,0.146\npositive regulation of phospholipid translocation,cellular component organization,0.434\npositive regulation of phospholipid transport,transport,0.612\npositive regulation of phosphoprotein phosphatase activity,protein modification/signaling,0.662\npositive regulation of phosphorus metabolic process,metabolic process,0.618\npositive regulation of piRNA transcription,protein modification/signaling,0.124\npositive regulation of pigment cell differentiation,morphogenesis/development,0.726\npositive regulation of pinocytosis,transport,0.43\npositive regulation of plasma cell differentiation,morphogenesis/development,0.232\npositive regulation of plasma membrane bounded cell projection assembly,cellular component organization,0.852\npositive regulation of plasma membrane repair,cellular component organization,0.228\npositive regulation of plasminogen activation,protein modification/signaling,0.146\npositive regulation of platelet activation,morphogenesis/development,0.298\npositive regulation of platelet aggregation,cell adhesion,0.2\npositive regulation of platelet formation,morphogenesis/development,0.274\npositive regulation of platelet-derived growth factor production,immune system process,0.462\npositive regulation of platelet-derived growth factor receptor signaling pathway,receptor related process,0.872\npositive regulation of platelet-derived growth factor receptor-beta signaling pathway,protein modification/signaling,0.28\npositive regulation of podocyte apoptotic process,cell death,0.242\npositive regulation of podosome assembly,cellular component organization,0.434\npositive regulation of polarized epithelial cell differentiation,morphogenesis/development,0.24\npositive regulation of polyamine transmembrane transport,transport,0.218\npositive regulation of polynucleotide adenylyltransferase activity,cell cycle,0.148\npositive regulation of polysome binding,gene regulation,0.198\npositive regulation of post-transcriptional gene silencing,gene regulation,0.632\npositive regulation of post-transcriptional gene silencing by RNA,gene regulation,0.628\npositive regulation of post-translational protein modification,protein modification/signaling,0.744\npositive regulation of postsynaptic membrane organization,cellular component organization,0.614\npositive regulation of potassium ion export across plasma membrane,transport,0.17\npositive regulation of potassium ion import across plasma membrane,transport,0.234\npositive regulation of potassium ion transmembrane transport,transport,0.83\npositive regulation of potassium ion transmembrane transporter activity,transport,0.674\npositive regulation of potassium ion transport,transport,0.886\npositive regulation of pre-miRNA processing,morphogenesis/development,0.168\npositive regulation of presynapse assembly,cellular component organization,0.716\npositive regulation of presynaptic active zone assembly,cellular component organization,0.266\npositive regulation of presynaptic membrane organization,cellular component organization,0.188\npositive regulation of primary miRNA processing,morphogenesis/development,0.23\npositive regulation of pro-B cell differentiation,morphogenesis/development,0.236\npositive regulation of pro-T cell differentiation,morphogenesis/development,0.236\npositive regulation of progesterone biosynthetic process,metabolic process,0.25\npositive regulation of progesterone secretion,protein modification/signaling,0.13\npositive regulation of programmed necrotic cell death,cell death,0.538\npositive regulation of prolactin secretion,cell cycle,0.13\npositive regulation of proline import across plasma membrane,transport,0.75\npositive regulation of prostaglandin biosynthetic process,metabolic process,0.902\npositive regulation of prostaglandin secretion,transport,0.612\npositive regulation of prostaglandin secretion involved in immune response,immune system process,0.38\npositive regulation of prostaglandin-E synthase activity,immune system process,0.152\npositive regulation of prostaglandin-endoperoxide synthase activity,metabolic process,0.594\npositive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia,metabolic process,0.264\npositive regulation of protein K48-linked ubiquitination,protein modification/signaling,0.434\npositive regulation of protein K63-linked deubiquitination,protein modification/signaling,0.656\npositive regulation of protein K63-linked ubiquitination,protein modification/signaling,0.806\npositive regulation of protein O-linked glycosylation,protein modification/signaling,0.378\npositive regulation of protein acetylation,protein modification/signaling,0.676\npositive regulation of protein autophosphorylation,protein modification/signaling,0.692\npositive regulation of protein autoubiquitination,protein modification/signaling,0.412\npositive regulation of protein catabolic process in the vacuole,metabolic process,0.646\npositive regulation of protein dephosphorylation,protein modification/signaling,0.528\npositive regulation of protein depolymerization,cellular component organization,0.746\npositive regulation of protein deubiquitination,protein modification/signaling,0.678\npositive regulation of protein folding,protein modification/signaling,0.258\npositive regulation of protein geranylgeranylation,protein modification/signaling,0.404\npositive regulation of protein glycosylation,protein modification/signaling,0.4\npositive regulation of protein homooligomerization,cellular component organization,0.736\npositive regulation of protein import,protein modification/signaling,0.346\npositive regulation of protein import into nucleus,transport,0.254\npositive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,cell death,0.51\npositive regulation of protein insertion into mitochondrial outer membrane,cellular component organization,0.3\npositive regulation of protein kinase A signaling,protein modification/signaling,0.374\npositive regulation of protein kinase C activity,protein modification/signaling,0.45\npositive regulation of protein kinase C signaling,metabolic process,0.32\npositive regulation of protein kinase D signaling,protein modification/signaling,0.524\npositive regulation of protein linear polyubiquitination,protein modification/signaling,0.408\npositive regulation of protein lipidation,protein modification/signaling,0.362\npositive regulation of protein localization to Cajal body,transport,0.352\npositive regulation of protein localization to actin cortical patch,transport,0.268\npositive regulation of protein localization to basolateral plasma membrane,transport,0.28\npositive regulation of protein localization to cell cortex,transport,0.292\npositive regulation of protein localization to cell surface,transport,0.286\npositive regulation of protein localization to cell-cell junction,transport,0.336\npositive regulation of protein localization to centrosome,transport,0.286\npositive regulation of protein localization to chromatin,transport,0.336\n\"positive regulation of protein localization to chromosome, telomeric region\",transport,0.384\npositive regulation of protein localization to ciliary membrane,transport,0.3\npositive regulation of protein localization to cilium,transport,0.392\npositive regulation of protein localization to early endosome,transport,0.234\npositive regulation of protein localization to endoplasmic reticulum,transport,0.242\npositive regulation of protein localization to endosome,transport,0.264\npositive regulation of protein localization to kinetochore,transport,0.322\npositive regulation of protein localization to lysosome,protein modification/signaling,0.282\npositive regulation of protein localization to nucleolus,transport,0.35\npositive regulation of protein localization to phagocytic vesicle,transport,0.29\npositive regulation of protein localization to presynapse,transport,0.278\npositive regulation of protein localization to spindle pole body,transport,0.282\npositive regulation of protein localization to synapse,transport,0.28\npositive regulation of protein maturation,protein modification/signaling,0.434\npositive regulation of protein monoubiquitination,protein modification/signaling,0.396\npositive regulation of protein neddylation,protein modification/signaling,0.416\npositive regulation of protein oligomerization,cellular component organization,0.724\npositive regulation of protein oxidation,protein modification/signaling,0.352\npositive regulation of protein polymerization,cellular component organization,0.82\npositive regulation of protein polyubiquitination,protein modification/signaling,0.806\npositive regulation of protein processing,protein modification/signaling,0.428\npositive regulation of protein processing in phagocytic vesicle,protein modification/signaling,0.318\npositive regulation of protein serine/threonine phosphatase activity,protein modification/signaling,0.412\npositive regulation of protein sumoylation,protein modification/signaling,0.37\npositive regulation of protein targeting to membrane,transport,0.446\npositive regulation of protein targeting to mitochondrion,transport,0.658\npositive regulation of protein transport,transport,0.806\npositive regulation of protein tyrosine phosphatase activity,protein modification/signaling,0.434\npositive regulation of protein-glutamine gamma-glutamyltransferase activity,protein modification/signaling,0.134\npositive regulation of proteoglycan biosynthetic process,metabolic process,0.772\npositive regulation of proteolysis involved in protein catabolic process,metabolic process,0.944\n\"positive regulation of proton-transporting ATP synthase activity, rotational mechanism\",metabolic process,0.16\npositive regulation of pseudohyphal growth,cellular component organization,0.324\npositive regulation of pseudohyphal growth by positive regulation of transcription from RNA polymerase II promoter,gene regulation,0.496\npositive regulation of pseudopodium assembly,cellular component organization,0.292\npositive regulation of purine nucleotide biosynthetic process,metabolic process,0.594\npositive regulation of purine nucleotide metabolic process,metabolic process,0.698\npositive regulation of pyloric antrum smooth muscle contraction,multicellular organismal process,0.15\npositive regulation of pyroptosis,protein modification/signaling,0.136\npositive regulation of pyrroline-5-carboxylate reductase activity,metabolic process,0.168\npositive regulation of pyruvate dehydrogenase activity,protein modification/signaling,0.146\npositive regulation of rRNA processing,immune system process,0.12\npositive regulation of reactive oxygen species biosynthetic process,metabolic process,0.434\npositive regulation of receptor binding,receptor related process,0.224\npositive regulation of receptor catabolic process,metabolic process,0.536\npositive regulation of receptor clustering,transport,0.32\npositive regulation of receptor localization to synapse,transport,0.222\npositive regulation of receptor recycling,immune system process,0.284\npositive regulation of receptor-mediated endocytosis,receptor related process,0.41\npositive regulation of receptor-mediated endocytosis involved in cholesterol transport,transport,0.176\npositive regulation of reciprocal meiotic recombination,cell cycle,0.508\npositive regulation of regulated secretory pathway,transport,0.514\npositive regulation of regulation of vascular associated smooth muscle cell membrane depolarization,cellular component organization,0.204\npositive regulation of relaxation of cardiac muscle,multicellular organismal process,0.15\npositive regulation of relaxation of muscle,multicellular organismal process,0.636\npositive regulation of relaxation of smooth muscle,multicellular organismal process,0.63\npositive regulation of release of sequestered calcium ion into cytosol,transport,0.726\npositive regulation of renal albumin absorption,protein modification/signaling,0.138\npositive regulation of renal sodium excretion,multicellular organismal process,0.332\npositive regulation of renal water transport,transport,0.164\npositive regulation of renin secretion into blood stream,multicellular organismal process,0.164\npositive regulation of reproductive process,cell cycle,0.2\npositive regulation of respiratory burst,immune system process,0.478\npositive regulation of respiratory burst involved in inflammatory response,immune system process,0.476\npositive regulation of respiratory gaseous exchange,cell cycle,0.134\npositive regulation of response to drug,immune system process,0.376\npositive regulation of response to extracellular stimulus,immune system process,0.402\npositive regulation of response to food,immune system process,0.51\npositive regulation of response to macrophage colony-stimulating factor,immune system process,0.548\npositive regulation of response to nutrient levels,immune system process,0.252\npositive regulation of response to oxidative stress,stress response,0.516\npositive regulation of response to stimulus,immune system process,0.156\npositive regulation of response to tumor cell,immune system process,0.678\npositive regulation of response to type II interferon,immune system process,0.442\npositive regulation of retinal ganglion cell axon guidance,neural related process,0.166\npositive regulation of retinoic acid biosynthetic process,metabolic process,0.358\npositive regulation of retinoic acid receptor signaling pathway,receptor related process,0.322\npositive regulation of retrograde axon cargo transport,transport,0.706\npositive regulation of retrograde dense core granule transport,transport,0.164\n\"positive regulation of retrograde protein transport, ER to cytosol\",protein modification/signaling,0.238\n\"positive regulation of retrograde transport, endosome to Golgi\",transport,0.152\npositive regulation of reverse cholesterol transport,transport,0.162\npositive regulation of ribonucleoprotein complex localization,transport,0.376\npositive regulation of ribosomal small subunit export from nucleus,cellular component organization,0.202\npositive regulation of ribosomal subunit export from nucleus,transport,0.624\npositive regulation of ribosome biogenesis,cellular component organization,0.65\npositive regulation of ruffle assembly,cellular component organization,0.312\npositive regulation of ryanodine-sensitive calcium-release channel activity,cellular component organization,0.224\npositive regulation of saliva secretion,protein modification/signaling,0.116\npositive regulation of sarcomere organization,cellular component organization,0.39\npositive regulation of satellite cell activation involved in skeletal muscle regeneration,cell cycle,0.228\npositive regulation of sclerotome development,morphogenesis/development,0.806\npositive regulation of secondary heart field cardioblast proliferation,morphogenesis/development,0.228\npositive regulation of secondary metabolite biosynthetic process,metabolic process,0.58\npositive regulation of secretion,transport,0.722\npositive regulation of secretion of lysosomal enzymes,metabolic process,0.152\npositive regulation of secretory granule organization,morphogenesis/development,0.162\npositive regulation of semaphorin-plexin signaling pathway,receptor related process,0.436\npositive regulation of semaphorin-plexin signaling pathway involved in outflow tract morphogenesis,protein modification/signaling,0.256\npositive regulation of sensory perception of pain,cell cycle,0.136\npositive regulation of sequestering of calcium ion,cellular component organization,0.222\npositive regulation of sequestering of triglyceride,cellular component organization,0.226\npositive regulation of serine C-palmitoyltransferase activity,cell cycle,0.138\npositive regulation of serine-type endopeptidase activity,cell cycle,0.144\npositive regulation of serine-type peptidase activity,metabolic process,0.322\npositive regulation of serotonin secretion,protein modification/signaling,0.128\npositive regulation of shelterin complex assembly,cellular component organization,0.342\npositive regulation of signal transduction,protein modification/signaling,0.408\npositive regulation of signaling,protein modification/signaling,0.396\npositive regulation of single strand break repair,stress response,0.514\npositive regulation of single stranded viral RNA replication via double stranded DNA intermediate,protein modification/signaling,0.134\npositive regulation of single-stranded telomeric DNA binding,cell cycle,0.198\npositive regulation of sister chromatid cohesion,cell cycle,0.558\npositive regulation of skeletal muscle acetylcholine-gated channel clustering,cell cycle,0.152\npositive regulation of skeletal muscle cell differentiation,morphogenesis/development,0.83\npositive regulation of skeletal muscle cell proliferation,cell cycle,0.73\npositive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion,protein modification/signaling,0.194\npositive regulation of skeletal muscle fiber development,morphogenesis/development,0.306\npositive regulation of skeletal muscle fiber differentiation,morphogenesis/development,0.764\npositive regulation of skeletal muscle hypertrophy,cell cycle,0.152\npositive regulation of skeletal muscle satellite cell proliferation,cell cycle,0.672\npositive regulation of skeletal muscle tissue development,morphogenesis/development,0.638\npositive regulation of skeletal muscle tissue growth,morphogenesis/development,0.172\npositive regulation of skeletal muscle tissue regeneration,morphogenesis/development,0.414\npositive regulation of small GTPase mediated signal transduction,protein modification/signaling,0.606\npositive regulation of small intestinal transit,morphogenesis/development,0.136\npositive regulation of small intestine smooth muscle contraction,cell cycle,0.156\npositive regulation of small molecule metabolic process,metabolic process,0.8\npositive regulation of smooth muscle cell chemotaxis,cell cycle,0.17\npositive regulation of smooth muscle cell differentiation,morphogenesis/development,0.718\npositive regulation of smooth muscle cell migration,multicellular organismal process,0.454\npositive regulation of smooth muscle cell-matrix adhesion,cell adhesion,0.15\npositive regulation of smooth muscle contraction,multicellular organismal process,0.796\npositive regulation of smoothened signaling pathway,receptor related process,0.408\npositive regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,protein modification/signaling,0.274\npositive regulation of snRNA transcription by RNA polymerase II,gene regulation,0.518\npositive regulation of sodium ion export across plasma membrane,cellular component organization,0.176\npositive regulation of sodium ion transmembrane transport,transport,0.874\npositive regulation of sodium ion transmembrane transporter activity,transport,0.738\npositive regulation of sodium-dependent phosphate transport,transport,0.15\npositive regulation of sodium:proton antiporter activity,metabolic process,0.542\npositive regulation of somatic stem cell division,cell cycle,0.198\npositive regulation of somatic stem cell population maintenance,morphogenesis/development,0.532\npositive regulation of somatostatin secretion,morphogenesis/development,0.14\npositive regulation of spermidine biosynthetic process,metabolic process,0.264\npositive regulation of sphingolipid biosynthetic process,metabolic process,0.716\npositive regulation of sphingolipid mediated signaling pathway,protein modification/signaling,0.298\npositive regulation of sphingomyelin catabolic process,metabolic process,0.234\npositive regulation of spindle assembly,cell cycle,0.642\npositive regulation of spindle checkpoint,cell cycle,0.91\npositive regulation of spontaneous neurotransmitter secretion,cell cycle,0.124\npositive regulation of stem cell differentiation,morphogenesis/development,0.772\npositive regulation of stem cell proliferation,cell cycle,0.668\npositive regulation of steroid biosynthetic process,metabolic process,0.928\npositive regulation of steroid hormone biosynthetic process,metabolic process,0.886\npositive regulation of steroid hormone secretion,transport,0.544\npositive regulation of sterol biosynthetic process,metabolic process,0.592\npositive regulation of sterol transport,transport,0.922\npositive regulation of store-operated calcium channel activity,transport,0.694\npositive regulation of strand invasion,cell cycle,0.184\npositive regulation of stress fiber assembly,cellular component organization,0.318\npositive regulation of stress granule assembly,cellular component organization,0.394\npositive regulation of striated muscle cell apoptotic process,cell death,0.762\npositive regulation of striated muscle contraction,multicellular organismal process,0.706\npositive regulation of striated muscle tissue development,morphogenesis/development,0.564\npositive regulation of substrate adhesion-dependent cell spreading,protein modification/signaling,0.124\n\"positive regulation of substrate-dependent cell migration, cell attachment to substrate\",cell cycle,0.16\npositive regulation of succinate dehydrogenase activity,protein modification/signaling,0.136\npositive regulation of sulfur metabolic process,metabolic process,0.852\npositive regulation of superoxide dismutase activity,metabolic process,0.176\npositive regulation of synapse maturation,cellular component organization,0.34\npositive regulation of synapse pruning,cell cycle,0.122\npositive regulation of synapse structural plasticity,morphogenesis/development,0.18\npositive regulation of synaptic assembly at neuromuscular junction,cellular component organization,0.28\npositive regulation of synaptic plasticity,neural related process,0.286\npositive regulation of synaptic plasticity by chemical substance,neural related process,0.294\n\"positive regulation of synaptic transmission, GABAergic\",neural related process,0.532\n\"positive regulation of synaptic transmission, cholinergic\",neural related process,0.588\n\"positive regulation of synaptic transmission, dopaminergic\",neural related process,0.484\n\"positive regulation of synaptic transmission, glutamatergic\",neural related process,0.75\n\"positive regulation of synaptic transmission, glycinergic\",neural related process,0.586\npositive regulation of synaptic vesicle clustering,neural related process,0.306\npositive regulation of synaptic vesicle endocytosis,neural related process,0.234\npositive regulation of synaptic vesicle exocytosis,transport,0.324\npositive regulation of synaptic vesicle fusion to presynaptic active zone membrane,cellular component organization,0.372\npositive regulation of synaptic vesicle membrane organization,cellular component organization,0.62\npositive regulation of synaptic vesicle priming,cellular component organization,0.256\npositive regulation of synaptic vesicle recycling,transport,0.482\npositive regulation of synaptic vesicle transport,transport,0.548\npositive regulation of synoviocyte proliferation,cell cycle,0.19\npositive regulation of systemic arterial blood pressure,multicellular organismal process,0.252\npositive regulation of t-SNARE clustering,neural related process,0.132\npositive regulation of t-circle formation,morphogenesis/development,0.212\npositive regulation of tau-protein kinase activity,protein modification/signaling,0.224\npositive regulation of telomerase RNA reverse transcriptase activity,gene regulation,0.346\npositive regulation of telomerase catalytic core complex assembly,cellular component organization,0.28\npositive regulation of telomere maintenance,cell cycle,0.726\npositive regulation of telomere maintenance in response to DNA damage,stress response,0.414\npositive regulation of telomere maintenance via telomere lengthening,cell cycle,0.558\npositive regulation of telomeric DNA binding,gene regulation,0.252\npositive regulation of telomeric loop disassembly,cell cycle,0.352\npositive regulation of tendon cell differentiation,morphogenesis/development,0.238\npositive regulation of termination of DNA-templated transcription,gene regulation,0.742\npositive regulation of termination of RNA polymerase II transcription,gene regulation,0.766\n\"positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled\",gene regulation,0.51\npositive regulation of testosterone secretion,protein modification/signaling,0.13\npositive regulation of tetrapyrrole biosynthetic process,metabolic process,0.528\npositive regulation of tetrapyrrole metabolic process,metabolic process,0.674\npositive regulation of the force of heart contraction,cellular component organization,0.176\npositive regulation of the force of heart contraction by chemical signal,multicellular organismal process,0.634\npositive regulation of the force of heart contraction by epinephrine-norepinephrine,multicellular organismal process,0.57\npositive regulation of thymocyte apoptotic process,cell death,0.668\npositive regulation of thymocyte migration,immune system process,0.878\npositive regulation of thyroid hormone generation,morphogenesis/development,0.166\npositive regulation of thyroid hormone mediated signaling pathway,protein modification/signaling,0.32\npositive regulation of tight junction disassembly,cellular component organization,0.168\npositive regulation of timing of anagen,morphogenesis/development,0.218\npositive regulation of timing of catagen,morphogenesis/development,0.28\npositive regulation of tissue remodeling,multicellular organismal process,0.488\npositive regulation of tolerance induction,immune system process,0.742\npositive regulation of tolerance induction dependent upon immune response,immune system process,0.694\npositive regulation of tolerance induction to self antigen,immune system process,0.3\npositive regulation of tolerance induction to tumor cell,immune system process,0.692\npositive regulation of toll-like receptor 2 signaling pathway,immune system process,0.368\npositive regulation of toll-like receptor 3 signaling pathway,immune system process,0.406\npositive regulation of toll-like receptor 4 signaling pathway,immune system process,0.45\npositive regulation of toll-like receptor 7 signaling pathway,immune system process,0.386\npositive regulation of toll-like receptor 8 signaling pathway,immune system process,0.346\npositive regulation of toll-like receptor 9 signaling pathway,immune system process,0.886\npositive regulation of toll-like receptor signaling pathway,immune system process,0.884\npositive regulation of tongue muscle cell differentiation,morphogenesis/development,0.254\npositive regulation of tooth mineralization,morphogenesis/development,0.63\npositive regulation of transcription by RNA polymerase II,gene regulation,0.53\npositive regulation of transcription by galactose,gene regulation,0.474\npositive regulation of transcription by glucose,gene regulation,0.482\npositive regulation of transcription by transcription factor localization,transport,0.226\npositive regulation of transcription from RNA polymerase II promoter by galactose,gene regulation,0.57\npositive regulation of transcription from RNA polymerase II promoter by glucose,gene regulation,0.568\npositive regulation of transcription from RNA polymerase II promoter in response to acidic pH,gene regulation,0.386\npositive regulation of transcription from RNA polymerase II promoter in response to hypoxia,gene regulation,0.362\npositive regulation of transcription from RNA polymerase II promoter in response to oxidative stress,stress response,0.406\npositive regulation of transcription from RNA polymerase II promoter in response to stress,stress response,0.634\npositive regulation of transcription of Notch receptor target,gene regulation,0.264\npositive regulation of transcription of nucleolar large rRNA by RNA polymerase I,gene regulation,0.528\npositive regulation of transcription regulatory region DNA binding,gene regulation,0.53\npositive regulation of transcytosis,cell cycle,0.134\npositive regulation of transdifferentiation,cell cycle,0.146\npositive regulation of transferrin receptor binding,receptor related process,0.408\npositive regulation of transformation of host cell by virus,viral related process,0.216\npositive regulation of transforming growth factor beta activation,immune system process,0.68\npositive regulation of transforming growth factor beta1 activation,cell cycle,0.138\npositive regulation of transforming growth factor beta1 production,immune system process,0.854\npositive regulation of transforming growth factor beta2 production,immune system process,0.798\npositive regulation of transforming growth factor beta3 production,immune system process,0.802\npositive regulation of translation in response to endoplasmic reticulum stress,gene regulation,0.422\npositive regulation of translation in response to stress,stress response,0.49\npositive regulation of translation initiation in response to endoplasmic reticulum stress,ER/endosome/lysosome related process,0.18\npositive regulation of translational elongation,gene regulation,0.702\npositive regulation of translational fidelity,morphogenesis/development,0.206\npositive regulation of translational initiation by iron,metabolic process,0.146\npositive regulation of translational initiation in response to starvation,immune system process,0.126\npositive regulation of translational initiation in response to stress,stress response,0.432\npositive regulation of translational termination,protein modification/signaling,0.13\npositive regulation of transmembrane transport,transport,0.826\npositive regulation of transmission of nerve impulse,neural related process,0.586\npositive regulation of transport across blood-brain barrier,transport,0.422\npositive regulation of transporter activity,transport,0.564\npositive regulation of triglyceride biosynthetic process,metabolic process,0.72\npositive regulation of triglyceride catabolic process,metabolic process,0.726\npositive regulation of triglyceride lipase activity,metabolic process,0.62\npositive regulation of triglyceride metabolic process,metabolic process,0.932\npositive regulation of triglyceride transport,transport,0.158\npositive regulation of trophectodermal cell proliferation,cell cycle,0.266\npositive regulation of trophoblast cell migration,morphogenesis/development,0.172\npositive regulation of tubulin deacetylation,protein modification/signaling,0.75\npositive regulation of tumor necrosis factor (ligand) superfamily member 11 production,immune system process,0.41\npositive regulation of tumor necrosis factor-mediated signaling pathway,protein modification/signaling,0.272\npositive regulation of type B pancreatic cell apoptotic process,cell death,0.688\npositive regulation of type B pancreatic cell development,morphogenesis/development,0.196\npositive regulation of type B pancreatic cell proliferation,cell cycle,0.27\npositive regulation of type I hypersensitivity,immune system process,0.454\npositive regulation of type II hypersensitivity,immune system process,0.934\npositive regulation of type II interferon-mediated signaling pathway,protein modification/signaling,0.278\npositive regulation of type III hypersensitivity,immune system process,0.45\npositive regulation of type III interferon production,immune system process,0.6\npositive regulation of type IIa hypersensitivity,immune system process,0.936\npositive regulation of type IV hypersensitivity,immune system process,0.438\npositive regulation of tyrosinase activity,metabolic process,0.27\npositive regulation of tyrosine 3-monooxygenase activity,protein modification/signaling,0.18\npositive regulation of ubiquitin-dependent endocytosis,immune system process,0.13\npositive regulation of ubiquitin-specific protease activity,protein modification/signaling,0.144\npositive regulation of unsaturated fatty acid biosynthetic process,metabolic process,0.718\npositive regulation of ureter smooth muscle cell differentiation,morphogenesis/development,0.224\npositive regulation of ureteric bud formation,morphogenesis/development,0.598\npositive regulation of urine volume,multicellular organismal process,0.53\npositive regulation of urothelial cell proliferation,cell cycle,0.214\npositive regulation of uterine smooth muscle contraction,multicellular organismal process,0.18\npositive regulation of uterine smooth muscle relaxation,multicellular organismal process,0.626\npositive regulation of vacuolar transport,transport,0.614\npositive regulation of vascular associated smooth muscle cell apoptotic process,cell death,0.246\npositive regulation of vascular associated smooth muscle cell dedifferentiation,cell cycle,0.218\npositive regulation of vascular associated smooth muscle cell differentiation,morphogenesis/development,0.712\npositive regulation of vascular associated smooth muscle cell differentiation involved in phenotypic switching,cell cycle,0.196\npositive regulation of vascular associated smooth muscle contraction,multicellular organismal process,0.552\npositive regulation of vascular endothelial cell proliferation,cell cycle,0.316\npositive regulation of vascular endothelial growth factor receptor signaling pathway,receptor related process,0.396\npositive regulation of vascular endothelial growth factor signaling pathway,protein modification/signaling,0.2\npositive regulation of vascular wound healing,morphogenesis/development,0.274\npositive regulation of vasculogenesis,protein modification/signaling,0.182\npositive regulation of vasoconstriction,multicellular organismal process,0.596\npositive regulation of very-low-density lipoprotein particle remodeling,protein modification/signaling,0.306\npositive regulation of vesicle docking,protein modification/signaling,0.128\npositive regulation of vesicle fusion,cellular component organization,0.416\npositive regulation of vesicle transport along microtubule,transport,0.636\npositive regulation of viral budding via host ESCRT complex,viral related process,0.272\npositive regulation of viral entry into host cell,viral related process,0.586\npositive regulation of viral transcription,gene regulation,0.182\npositive regulation of viral translation,viral related process,0.146\npositive regulation of vitamin D 24-hydroxylase activity,protein modification/signaling,0.16\npositive regulation of vitamin D biosynthetic process,metabolic process,0.724\npositive regulation of vitamin D receptor signaling pathway,receptor related process,0.38\npositive regulation of vitamin metabolic process,metabolic process,0.926\npositive regulation of voltage-gated calcium channel activity,transport,0.7\npositive regulation of voltage-gated chloride channel activity,cell cycle,0.146\npositive regulation of voltage-gated potassium channel activity,transport,0.638\npositive regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,cell cycle,0.168\npositive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,cell cycle,0.158\npositive regulation of white fat cell proliferation,cell cycle,0.194\n\"positive regulation of wound healing, spreading of epidermal cells\",morphogenesis/development,0.17\npositive regulation of xenophagy,immune system process,0.226\npositive thymic T cell selection,cell death,0.298\npost-anal tail morphogenesis,morphogenesis/development,0.456\npost-chaperonin tubulin folding pathway,cellular component organization,0.348\npost-embryonic animal morphogenesis,morphogenesis/development,0.662\npost-embryonic appendage morphogenesis,morphogenesis/development,0.88\npost-embryonic camera-type eye development,morphogenesis/development,0.952\npost-embryonic camera-type eye morphogenesis,morphogenesis/development,0.718\npost-embryonic digestive tract morphogenesis,morphogenesis/development,0.674\npost-embryonic eye morphogenesis,morphogenesis/development,0.882\npost-embryonic forelimb morphogenesis,morphogenesis/development,0.71\npost-embryonic hemopoiesis,morphogenesis/development,0.808\npost-embryonic hindlimb morphogenesis,morphogenesis/development,0.734\npost-embryonic limb morphogenesis,morphogenesis/development,0.918\npost-embryonic retina morphogenesis in camera-type eye,morphogenesis/development,0.756\npost-fertilization epigenetic regulation of gene expression,gene regulation,0.532\npost-mRNA release spliceosomal complex,gene regulation,0.296\npost-spliceosomal complex,gene regulation,0.294\npost-transcriptional gene silencing,gene regulation,0.66\npost-transcriptional regulation of gene expression,gene regulation,0.492\npost-transcriptional tethering of RNA polymerase II gene DNA at nuclear periphery,gene regulation,0.608\npost-translational protein acetylation,protein modification/signaling,0.364\n\"post-translational protein targeting to membrane, translocation\",cellular component organization,0.29\nposterior compartment specification,morphogenesis/development,0.216\nposterior lateral line development,morphogenesis/development,0.924\nposterior lateral line neuromast development,morphogenesis/development,0.798\nposterior lateral line neuromast hair cell development,morphogenesis/development,0.868\nposterior lateral line neuromast hair cell differentiation,morphogenesis/development,0.392\nposterior lateral line system development,morphogenesis/development,0.764\nposterior mesonephric tubule development,morphogenesis/development,0.838\nposterior midgut development,morphogenesis/development,0.986\npostganglionic parasympathetic fiber development,morphogenesis/development,0.764\npostnatal olfactory bulb interneuron migration,morphogenesis/development,0.184\npostsynapse assembly,neural related process,0.49\npostsynapse to nucleus signaling pathway,protein modification/signaling,0.252\npostsynaptic Golgi apparatus,cellular component organization,0.274\npostsynaptic actin cytoskeleton,cellular component organization,0.622\npostsynaptic actin cytoskeleton organization,cellular component organization,0.74\npostsynaptic cytoskeleton,cellular component organization,0.626\npostsynaptic cytosol,cellular component organization,0.19\npostsynaptic dense core vesicle exocytosis,cellular component organization,0.194\npostsynaptic density,neural related process,0.442\npostsynaptic density assembly,cellular component organization,0.454\npostsynaptic density membrane,neural related process,0.508\npostsynaptic density organization,cellular component organization,0.688\npostsynaptic density protein 95 clustering,neural related process,0.388\n\"postsynaptic density, intracellular component\",cellular component organization,0.278\npostsynaptic early endosome,receptor related process,0.322\npostsynaptic early endosome membrane,cellular component organization,0.248\npostsynaptic endocytic zone,protein modification/signaling,0.306\npostsynaptic endocytic zone cytoplasmic component,cellular component organization,0.394\npostsynaptic endocytic zone membrane,cellular component organization,0.344\npostsynaptic endocytosis,transport,0.55\npostsynaptic endosome,cellular component organization,0.578\npostsynaptic endosome membrane,cellular component organization,0.704\npostsynaptic intermediate filament cytoskeleton,cellular component organization,0.312\npostsynaptic intermediate filament cytoskeleton organization,cellular component organization,0.714\npostsynaptic membrane assembly,cellular component organization,0.436\npostsynaptic membrane organization,cellular component organization,0.612\npostsynaptic neurotransmitter receptor activity,neural related process,0.698\npostsynaptic neurotransmitter receptor cycle,neural related process,0.296\npostsynaptic neurotransmitter receptor diffusion trapping,cellular component organization,0.294\npostsynaptic recycling endosome,neural related process,0.252\npostsynaptic recycling endosome membrane,cellular component organization,0.248\npostsynaptic signal transduction,receptor related process,0.306\npostsynaptic specialization,neural related process,0.504\npostsynaptic specialization assembly,cellular component organization,0.704\npostsynaptic specialization membrane,neural related process,0.534\npostsynaptic specialization of symmetric synapse,cellular component organization,0.252\npostsynaptic specialization organization,cellular component organization,0.71\n\"postsynaptic specialization, intracellular component\",cellular component organization,0.45\npostsynaptic spectrin-associated cytoskeleton,cellular component organization,0.214\n\"potassium channel activating, G protein-coupled receptor signaling pathway\",receptor related process,0.442\npotassium channel activator activity,receptor related process,0.34\npotassium channel activity,transport,0.516\npotassium channel complex,transport,0.316\npotassium channel inhibitor activity,metabolic process,0.418\npotassium channel regulator activity,metabolic process,0.348\npotassium ion binding,metabolic process,0.236\npotassium ion export across plasma membrane,transport,0.512\npotassium ion leak channel activity,transport,0.324\npotassium ion transmembrane transport,transport,0.878\npotassium ion transmembrane transporter activity,transport,0.674\npotassium ion transport,transport,0.862\npotassium ion-transporting ATPase complex,metabolic process,0.288\npotassium:chloride symporter activity,transport,0.524\npotassium:proton antiporter activity,metabolic process,0.51\npotassium:proton exchanging ATPase complex,gene regulation,0.208\npotassium:sodium symporter activity,transport,0.516\npre-B cell allelic exclusion,immune system process,0.346\npre-B cell differentiation,morphogenesis/development,0.37\npre-mRNA 3'-splice site binding,gene regulation,0.246\npre-mRNA 5'-splice site binding,gene regulation,0.244\npre-mRNA binding,gene regulation,0.632\npre-mRNA branch point binding,gene regulation,0.238\npre-mRNA catabolic process,metabolic process,0.732\npre-mRNA intronic pyrimidine-rich binding,gene regulation,0.566\npre-miRNA binding,gene regulation,0.736\npre-miRNA export from nucleus,gene regulation,0.278\npre-miRNA processing,gene regulation,0.78\npre-replicative complex,cellular component organization,0.236\npre-snoRNP complex,gene regulation,0.388\npreantral ovarian follicle growth,morphogenesis/development,0.304\npreassembly of GPI anchor in ER membrane,cellular component organization,0.41\nprechordal plate formation,morphogenesis/development,0.384\nprefoldin complex,gene regulation,0.362\npreganglionic parasympathetic fiber development,morphogenesis/development,0.888\nprenylated protein catabolic process,metabolic process,0.72\nprenylated protein tyrosine phosphatase activity,metabolic process,0.778\nprenylation,metabolic process,0.368\nprenylcysteine catabolic process,metabolic process,0.826\nprenylcysteine metabolic process,metabolic process,0.914\nprenylcysteine oxidase activity,metabolic process,0.878\nprenyltransferase activity,metabolic process,0.774\npreprotein binding,protein modification/signaling,0.308\nprepulse inhibition,neural related process,0.296\npreribosome,cellular component organization,0.486\npreribosome binding,metabolic process,0.248\n\"preribosome, large subunit precursor\",cellular component organization,0.372\n\"preribosome, small subunit precursor\",cellular component organization,0.392\nprespliceosome,gene regulation,0.322\npressure natriuresis,multicellular organismal process,0.644\npresynapse,neural related process,0.632\npresynapse to nucleus signaling pathway,protein modification/signaling,0.256\npresynaptic actin cytoskeleton organization,cellular component organization,0.734\npresynaptic active zone,neural related process,0.53\npresynaptic active zone assembly,cellular component organization,0.404\npresynaptic active zone cytoplasmic component,neural related process,0.278\npresynaptic active zone membrane,neural related process,0.344\npresynaptic active zone organization,cellular component organization,0.79\npresynaptic cytoskeleton,cellular component organization,0.61\npresynaptic cytoskeleton organization,cellular component organization,0.924\npresynaptic cytosol,metabolic process,0.19\npresynaptic dense core vesicle exocytosis,transport,0.474\npresynaptic endocytic zone,cellular component organization,0.32\npresynaptic endocytic zone membrane,cellular component organization,0.248\npresynaptic endocytosis,transport,0.434\npresynaptic endosome,cellular component organization,0.228\npresynaptic intermediate filament cytoskeleton,cellular component organization,0.306\npresynaptic membrane assembly,cellular component organization,0.4\npresynaptic membrane organization,cellular component organization,0.602\npresynaptic modulation of chemical synaptic transmission,neural related process,0.454\npresynaptic signal transduction,protein modification/signaling,0.278\nprevention of polyspermy,morphogenesis/development,0.192\nprimary adaptive immune response,immune system process,0.726\nprimary adaptive immune response involving T cells and B cells,immune system process,0.608\nprimary alcohol biosynthetic process,metabolic process,0.976\nprimary alcohol catabolic process,metabolic process,0.982\nprimary amine oxidase activity,metabolic process,0.892\nprimary amino compound biosynthetic process,metabolic process,0.96\nprimary amino compound metabolic process,metabolic process,0.97\nprimary dendrite,neural related process,0.362\nprimary follicle stage,cellular component organization,0.232\nprimary heart field specification,morphogenesis/development,0.212\nprimary lung bud formation,morphogenesis/development,0.32\nprimary lysosome,cellular component organization,0.444\nprimary metabolic process,metabolic process,0.648\nprimary miRNA binding,gene regulation,0.506\nprimary miRNA processing,gene regulation,0.364\nprimary neural tube formation,morphogenesis/development,0.518\nprimary ovarian follicle growth,morphogenesis/development,0.376\nprimary palate development,morphogenesis/development,0.926\nprimary piRNA processing,gene regulation,0.25\nprimary prostatic bud elongation,morphogenesis/development,0.274\nprimary sex determination,morphogenesis/development,0.492\n\"primary sex determination, germ-line\",morphogenesis/development,0.428\nprimary ureteric bud growth,morphogenesis/development,0.192\nprimitive erythrocyte differentiation,morphogenesis/development,0.288\nprimitive hemopoiesis,morphogenesis/development,0.426\nprimitive streak formation,morphogenesis/development,0.662\nprincipal sensory nucleus of trigeminal nerve development,morphogenesis/development,0.968\npristanate-CoA ligase activity,metabolic process,0.822\npristanoyl-CoA oxidase activity,metabolic process,0.894\npro-T cell differentiation,immune system process,0.426\nproacrosomal vesicle fusion,cellular component organization,0.294\nprocentriole,morphogenesis/development,0.272\nprocentriole replication complex,protein modification/signaling,0.308\nprocess utilizing autophagic mechanism,metabolic process,0.276\nprocollagen galactosyltransferase activity,metabolic process,0.896\nprocollagen glucosyltransferase activity,metabolic process,0.896\nprocollagen-lysine 5-dioxygenase activity,metabolic process,0.896\nprocollagen-proline 3-dioxygenase activity,metabolic process,0.898\nprocollagen-proline 4-dioxygenase activity,metabolic process,0.894\nprocollagen-proline 4-dioxygenase complex,metabolic process,0.234\nprocollagen-proline dioxygenase activity,metabolic process,0.734\nproepicardium cell migration involved in pericardium morphogenesis,morphogenesis/development,0.234\nproepicardium development,morphogenesis/development,0.744\nprofilin binding,protein modification/signaling,0.31\nprogesterone 21-hydroxylase activity,metabolic process,0.924\nprogesterone biosynthetic process,metabolic process,0.846\nprogesterone receptor signaling pathway,receptor related process,0.582\nprogesterone secretion,cellular component organization,0.234\nprogrammed cell death,cell death,0.906\nprogrammed cell death in response to reactive oxygen species,cell death,0.562\nprogrammed cell death induced by symbiont,immune system process,0.28\nprolactin receptor activity,receptor related process,0.21\nprolactin receptor binding,receptor related process,0.526\nprolactin secreting cell differentiation,morphogenesis/development,0.698\nprolactin secretion,metabolic process,0.26\nprolactin signaling pathway,receptor related process,0.598\nprolactin-releasing peptide receptor binding,receptor related process,0.498\nproline biosynthetic process,metabolic process,0.992\nproline catabolic process,metabolic process,0.988\nproline catabolic process to glutamate,metabolic process,0.868\nproline dehydrogenase activity,metabolic process,0.902\nproline dipeptidase activity,metabolic process,0.872\nproline import across plasma membrane,transport,0.882\nproline metabolic process,metabolic process,0.992\nproline transmembrane transport,transport,0.914\nproline transport,transport,0.96\nproline-tRNA ligase activity,metabolic process,0.822\nproline:proton symporter activity,metabolic process,0.514\nproline:sodium symporter activity,metabolic process,0.524\nprolyl-tRNA aminoacylation,metabolic process,0.574\nprominosome,morphogenesis/development,0.168\npromoter clearance during DNA-templated transcription,gene regulation,0.698\npromoter-enhancer loop anchoring activity,cellular component organization,0.274\npronephric duct development,morphogenesis/development,0.992\npronephric duct morphogenesis,morphogenesis/development,0.734\npronephric field specification,morphogenesis/development,0.23\npronephric nephron development,morphogenesis/development,0.986\npronephric nephron morphogenesis,morphogenesis/development,0.724\npronephric nephron tubule development,morphogenesis/development,0.976\npronephric nephron tubule morphogenesis,morphogenesis/development,0.892\npronephros development,morphogenesis/development,0.93\npronephros morphogenesis,morphogenesis/development,0.806\npronuclear fusion,cellular component organization,0.238\npronucleus,cellular component organization,0.582\n\"propane-1,3-diamine oxidase activity\",metabolic process,0.9\npropanoate transmembrane transport,transport,0.728\npropanoyl-CoA C-acyltransferase activity,metabolic process,0.892\npropionate CoA-transferase activity,metabolic process,0.894\npropionate biosynthetic process,metabolic process,0.896\npropionate catabolic process,metabolic process,0.982\npropionate metabolic process,metabolic process,0.972\n\"propionate metabolic process, methylmalonyl pathway\",metabolic process,0.852\npropionate transmembrane transporter activity,transport,0.718\npropionate-CoA ligase activity,metabolic process,0.836\npropionyl-CoA C2-trimethyltridecanoyltransferase activity,metabolic process,0.892\npropionyl-CoA biosynthetic process,metabolic process,0.89\npropionyl-CoA carboxylase activity,metabolic process,0.752\npropionyl-CoA catabolic process,metabolic process,0.892\npropionyl-CoA metabolic process,metabolic process,0.998\nproprioception,multicellular organismal process,0.344\nproprioception involved in equilibrioception,transport,0.234\npropylene metabolic process,metabolic process,0.866\nprosaposin receptor activity,immune system process,0.212\nprostacyclin receptor activity,cellular component organization,0.188\nprostaglandin D receptor activity,cellular component organization,0.188\nprostaglandin D2 11-ketoreductase activity,metabolic process,0.936\nprostaglandin E receptor activity,cellular component organization,0.184\nprostaglandin F receptor activity,cellular component organization,0.188\nprostaglandin H2 endoperoxidase reductase activity,metabolic process,0.93\nprostaglandin J receptor activity,cellular component organization,0.174\nprostaglandin biosynthetic process,metabolic process,0.978\nprostaglandin catabolic process,metabolic process,0.862\nprostaglandin metabolic process,metabolic process,0.976\nprostaglandin receptor activity,receptor related process,0.594\nprostaglandin secretion,transport,0.576\nprostaglandin secretion involved in immune response,immune system process,0.296\nprostaglandin transmembrane transporter activity,metabolic process,0.294\nprostaglandin-D synthase activity,metabolic process,0.896\nprostaglandin-E synthase activity,metabolic process,0.89\nprostaglandin-E2 9-reductase activity,metabolic process,0.934\nprostaglandin-F synthase activity,metabolic process,0.936\nprostaglandin-I synthase activity,metabolic process,0.896\nprostaglandin-endoperoxide synthase activity,metabolic process,0.884\nprostanoid biosynthetic process,metabolic process,0.958\nprostanoid catabolic process,metabolic process,0.962\nprostanoid receptor activity,receptor related process,0.506\nprostanoid receptor binding,receptor related process,0.46\nprostate epithelial cord arborization involved in prostate glandular acinus morphogenesis,morphogenesis/development,0.53\nprostate epithelial cord elongation,morphogenesis/development,0.568\nprostate field specification,morphogenesis/development,0.324\nprostate gland morphogenetic growth,morphogenesis/development,0.626\nprostate gland stromal morphogenesis,morphogenesis/development,0.432\nprostate glandular acinus development,morphogenesis/development,0.904\nprostate glandular acinus morphogenesis,morphogenesis/development,0.646\nprostate induction,morphogenesis/development,0.272\nprostatic bud formation,morphogenesis/development,0.48\nprosthetic group binding,protein modification/signaling,0.31\nprosthetic group metabolic process,metabolic process,0.87\nprotease inhibitor complex,cellular component organization,0.25\nprotease localization to T cell secretory granule,transport,0.632\nprotease localization to mast cell secretory granule,transport,0.272\nproteasomal ubiquitin-independent protein catabolic process,metabolic process,0.686\nproteasome activator complex,gene regulation,0.24\nproteasome core complex assembly,cellular component organization,0.446\nproteasome core complex binding,metabolic process,0.234\n\"proteasome core complex, alpha-subunit complex\",cellular component organization,0.404\n\"proteasome core complex, beta-subunit complex\",cellular component organization,0.402\nproteasome localization,transport,0.218\nproteasome regulatory particle assembly,cellular component organization,0.458\nproteasome regulatory particle binding,metabolic process,0.24\n\"proteasome regulatory particle, base subcomplex\",metabolic process,0.382\n\"proteasome regulatory particle, lid subcomplex\",metabolic process,0.374\nproteasome storage granule,cellular component organization,0.286\nproteasome-activating activity,metabolic process,0.62\nprotection from natural killer cell mediated cytotoxicity,immune system process,0.488\nprotection from non-homologous end joining at telomere,cellular component organization,0.242\nprotein ADP-ribosyltransferase-substrate adaptor activity,protein modification/signaling,0.316\nprotein C inhibitor-KLK3 complex,protein modification/signaling,0.268\nprotein C inhibitor-PLAT complex,protein modification/signaling,0.282\nprotein C inhibitor-PLAU complex,protein modification/signaling,0.278\nprotein C inhibitor-TMPRSS11E complex,protein modification/signaling,0.248\nprotein C inhibitor-TMPRSS7 complex,protein modification/signaling,0.248\nprotein C inhibitor-coagulation factor V complex,protein modification/signaling,0.25\nprotein C inhibitor-coagulation factor XI complex,protein modification/signaling,0.25\nprotein C inhibitor-coagulation factor Xa complex,protein modification/signaling,0.25\nprotein C inhibitor-plasma kallikrein complex,cellular component organization,0.276\nprotein C inhibitor-thrombin complex,protein modification/signaling,0.274\nprotein C-linked glycosylation,protein modification/signaling,0.776\nprotein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan,metabolic process,0.308\nprotein C-linked glycosylation via tryptophan,protein modification/signaling,0.794\nprotein C-terminal S-isoprenylcysteine carboxyl O-methyltransferase activity,metabolic process,0.626\nprotein C-terminal carboxyl O-methyltransferase activity,metabolic process,0.576\nprotein C-terminal leucine carboxyl O-methyltransferase activity,metabolic process,0.5\nprotein C-terminal methylesterase activity,metabolic process,0.622\nprotein K11-linked deubiquitination,protein modification/signaling,0.704\nprotein K27-linked deubiquitination,protein modification/signaling,0.7\nprotein K27-linked ubiquitination,protein modification/signaling,0.64\nprotein K29-linked deubiquitination,protein modification/signaling,0.692\nprotein K29-linked ubiquitination,protein modification/signaling,0.666\nprotein K33-linked deubiquitination,protein modification/signaling,0.704\nprotein K33-linked ubiquitination,protein modification/signaling,0.616\nprotein K48-linked deubiquitination,protein modification/signaling,0.618\nprotein K6-linked deubiquitination,protein modification/signaling,0.69\nprotein K6-linked ubiquitination,protein modification/signaling,0.552\nprotein K63-linked deubiquitination,protein modification/signaling,0.716\nprotein K69-linked ufmylation,protein modification/signaling,0.6\nprotein N-acetylglucosaminyltransferase activity,metabolic process,0.596\nprotein N-acetylglucosaminyltransferase complex,metabolic process,0.366\nprotein N-linked glycosylation via arginine,protein modification/signaling,0.332\nprotein O-GlcNAcylation via threonine,protein modification/signaling,0.288\nprotein O-acetylglucosaminyltransferase activity,metabolic process,0.62\nprotein O-linked fucosylation,protein modification/signaling,0.386\nprotein O-linked glycosylation via serine,protein modification/signaling,0.728\nprotein O-linked glycosylation via threonine,protein modification/signaling,0.776\nprotein O-linked mannosylation,protein modification/signaling,0.378\nprotein acetyltransferase complex,gene regulation,0.526\nprotein activation cascade,metabolic process,0.386\nprotein adenylylation,protein modification/signaling,0.75\nprotein adenylylhydrolase activity,metabolic process,0.486\nprotein aggregate center assembly,protein modification/signaling,0.434\nprotein alkylation,protein modification/signaling,0.574\n\"protein alpha-1,2-demannosylation\",protein modification/signaling,0.414\nprotein antigen binding,protein modification/signaling,0.346\nprotein arginylation,protein modification/signaling,0.41\nprotein auto-ADP-ribosylation,protein modification/signaling,0.534\nprotein autosumoylation,protein modification/signaling,0.57\nprotein binding,metabolic process,0.34\nprotein branching point deglutamylation,protein modification/signaling,0.328\nprotein carboxyl O-methyltransferase activity,metabolic process,0.57\nprotein carboxylation,protein modification/signaling,0.718\nprotein catabolic process,metabolic process,0.848\nprotein catabolic process at postsynapse,metabolic process,0.738\nprotein catabolic process at synapse,metabolic process,0.888\nprotein complex involved in cell-cell adhesion,cell adhesion,0.36\nprotein complex involved in cell-matrix adhesion,cell adhesion,0.346\nprotein de-2-hydroxyisobutyrylase activity,metabolic process,0.87\nprotein de-ADP-ribosylation,protein modification/signaling,0.744\nprotein deacylation,protein modification/signaling,0.848\nprotein deadenylylation,protein modification/signaling,0.478\nprotein dealkylation,protein modification/signaling,0.772\nprotein deamination,protein modification/signaling,0.808\nprotein decanoylation,protein modification/signaling,0.724\nprotein decrotonylase activity,metabolic process,0.768\nprotein deglutamylation,protein modification/signaling,0.79\nprotein deglutarylation,protein modification/signaling,0.77\nprotein deglutathionylation,protein modification/signaling,0.476\nprotein deglycase activity,protein modification/signaling,0.412\nprotein deglycation,protein modification/signaling,0.736\n\"protein deglycation, glyoxal removal\",protein modification/signaling,0.524\n\"protein deglycation, methylglyoxal removal\",protein modification/signaling,0.524\nprotein deglycosylation involved in glycoprotein catabolic process,metabolic process,0.558\nprotein delipidation,protein modification/signaling,0.318\nprotein demalonylation,protein modification/signaling,0.776\nprotein demannosylation,protein modification/signaling,0.55\nprotein denucleotidylation,protein modification/signaling,0.794\nprotein depalmitoleylation,metabolic process,0.368\nprotein depalmitoylation,protein modification/signaling,0.256\nprotein depolymerization,cellular component organization,0.86\nprotein depropionylation,protein modification/signaling,0.58\nprotein desuccinylation,protein modification/signaling,0.774\nprotein desumoylation,protein modification/signaling,0.394\nprotein deubiquitination,protein modification/signaling,0.728\nprotein deubiquitination involved in ubiquitin-dependent protein catabolic process,protein modification/signaling,0.392\nprotein dimerization activity,protein modification/signaling,0.482\nprotein disulfide isomerase activity,metabolic process,0.362\nprotein farnesylation,protein modification/signaling,0.65\nprotein farnesyltransferase activity,metabolic process,0.684\nprotein farnesyltransferase complex,protein modification/signaling,0.362\nprotein folding chaperone,protein modification/signaling,0.488\nprotein folding chaperone complex,cellular component organization,0.296\nprotein geranylgeranylation,protein modification/signaling,0.65\nprotein geranylgeranyltransferase activity,metabolic process,0.512\nprotein glutathionylation,protein modification/signaling,0.406\nprotein glycosylation,protein modification/signaling,0.74\nprotein heterooligomerization,cellular component organization,0.768\nprotein heterotrimerization,cellular component organization,0.51\nprotein hexamerization,cellular component organization,0.512\nprotein histidine kinase activity,metabolic process,0.418\nprotein histidine phosphatase activity,metabolic process,0.602\nprotein histidyl modification to diphthamide,cellular component organization,0.192\nprotein homooligomerization,cellular component organization,0.77\nprotein homotrimerization,cellular component organization,0.498\nprotein hydroxylation,protein modification/signaling,0.538\nprotein import,transport,0.798\nprotein import into mitochondrial intermembrane space,cellular component organization,0.378\nprotein import into mitochondrial matrix,cellular component organization,0.3\nprotein import into peroxisome matrix,receptor related process,0.28\n\"protein import into peroxisome matrix, docking\",cellular component organization,0.286\n\"protein import into peroxisome matrix, receptor recycling\",receptor related process,0.276\n\"protein import into peroxisome matrix, substrate release\",cellular component organization,0.298\n\"protein import into peroxisome matrix, translocation\",cellular component organization,0.228\nprotein import into peroxisome membrane,protein modification/signaling,0.312\nprotein insertion into ER membrane by stop-transfer membrane-anchor sequence,ER/endosome/lysosome related process,0.32\nprotein insertion into membrane,transport,0.436\nprotein insertion into membrane from inner side,transport,0.518\nprotein insertion into mitochondrial inner membrane,cellular component organization,0.42\nprotein insertion into mitochondrial inner membrane from matrix,cellular component organization,0.326\nprotein insertion into mitochondrial membrane,transport,0.44\nprotein insertion into mitochondrial membrane involved in apoptotic signaling pathway,cell death,0.428\nprotein insertion into plasma membrane,transport,0.49\nprotein kinase 5 complex,protein modification/signaling,0.372\nprotein kinase A binding,protein modification/signaling,0.55\nprotein kinase A catalytic subunit binding,protein modification/signaling,0.336\nprotein kinase A regulatory subunit binding,protein modification/signaling,0.374\nprotein kinase A signaling,metabolic process,0.356\nprotein kinase B binding,protein modification/signaling,0.426\nprotein kinase C deactivation,protein modification/signaling,0.422\nprotein kinase C inhibitor activity,protein modification/signaling,0.532\nprotein kinase C signaling,metabolic process,0.35\nprotein kinase C-activating G protein-coupled receptor signaling pathway,receptor related process,0.342\nprotein kinase CK2 complex,protein modification/signaling,0.448\nprotein kinase D signaling,metabolic process,0.38\nprotein kinase inhibitor activity,protein modification/signaling,0.772\nprotein linear deubiquitination,protein modification/signaling,0.534\nprotein linear polyubiquitination,protein modification/signaling,0.48\nprotein lipidation involved in autophagosome assembly,cellular component organization,0.434\nprotein lipoylation,cellular component organization,0.238\nprotein localization,transport,0.354\nprotein localization involved in establishment of planar polarity,transport,0.336\nprotein localization to CENP-A containing chromatin,transport,0.214\nprotein localization to Cajal body,transport,0.338\nprotein localization to ERGIC,transport,0.288\nprotein localization to Golgi apparatus,transport,0.604\nprotein localization to Golgi membrane,transport,0.382\nprotein localization to M-band,cellular component organization,0.26\nprotein localization to P-body,transport,0.24\nprotein localization to T cell secretory granule,transport,0.63\nprotein localization to T-tubule,cellular component organization,0.28\nprotein localization to actin cortical patch,cellular component organization,0.28\nprotein localization to actin cytoskeleton,transport,0.558\nprotein localization to adherens junction,transport,0.248\nprotein localization to astral microtubule,transport,0.336\nprotein localization to axon,transport,0.564\nprotein localization to basolateral plasma membrane,cellular component organization,0.3\nprotein localization to bicellular tight junction,transport,0.336\nprotein localization to cell leading edge,transport,0.316\nprotein localization to chromatin,transport,0.568\n\"protein localization to chromosome, telomeric region\",transport,0.6\nprotein localization to ciliary inversin compartment,transport,0.342\nprotein localization to ciliary membrane,transport,0.61\nprotein localization to ciliary transition zone,transport,0.592\nprotein localization to cytoplasmic microtubule,transport,0.626\nprotein localization to cytoplasmic microtubule plus-end,transport,0.278\nprotein localization to cytoplasmic stress granule,transport,0.282\nprotein localization to cytosolic proteasome complex,transport,0.48\nprotein localization to cytosolic proteasome complex involved in ERAD pathway,ER/endosome/lysosome related process,0.262\nprotein localization to early endosome,transport,0.402\nprotein localization to endoplasmic reticulum exit site,ER/endosome/lysosome related process,0.398\nprotein localization to endoplasmic reticulum tubular network,transport,0.454\nprotein localization to extracellular region,transport,0.61\nprotein localization to heterochromatin,transport,0.502\nprotein localization to juxtaparanode region of axon,transport,0.61\nprotein localization to kinetochore,cell cycle,0.346\nprotein localization to kinetochore involved in kinetochore assembly,cellular component organization,0.286\nprotein localization to lipid droplet,transport,0.32\nprotein localization to mast cell secretory granule,transport,0.624\nprotein localization to meiotic spindle,transport,0.532\nprotein localization to meiotic spindle midzone,transport,0.292\nprotein localization to membrane,cellular component organization,0.478\nprotein localization to membrane raft,transport,0.654\nprotein localization to microtubule,cellular component organization,0.42\nprotein localization to microtubule end,transport,0.598\nprotein localization to microtubule organizing center,transport,0.52\nprotein localization to microtubule plus-end,transport,0.602\nprotein localization to microvillus,transport,0.64\nprotein localization to mitochondrion,transport,0.588\nprotein localization to mitotic spindle,transport,0.518\nprotein localization to motile cilium,transport,0.306\nprotein localization to myelin sheath abaxonal region,transport,0.228\nprotein localization to non-motile cilium,transport,0.562\nprotein localization to nuclear body,transport,0.6\nprotein localization to nuclear inner membrane,transport,0.362\nprotein localization to nuclear pore,transport,0.262\nprotein localization to nucleoplasm,transport,0.582\nprotein localization to organelle,transport,0.422\nprotein localization to paranode region of axon,transport,0.436\nprotein localization to pericentric heterochromatin,transport,0.26\nprotein localization to pericentriolar material,transport,0.344\nprotein localization to perinuclear region of cytoplasm,transport,0.326\nprotein localization to peroxisome,cellular component organization,0.434\nprotein localization to phagocytic vesicle,transport,0.334\nprotein localization to photoreceptor connecting cilium,transport,0.342\nprotein localization to photoreceptor outer segment,transport,0.336\nprotein localization to plasma membrane raft,transport,0.676\nprotein localization to postsynapse,cellular component organization,0.298\nprotein localization to postsynaptic membrane,transport,0.456\nprotein localization to postsynaptic specialization membrane,transport,0.372\nprotein localization to presynapse,transport,0.572\nprotein localization to secretory granule,transport,0.632\nprotein localization to site of double-strand break,transport,0.188\nprotein localization to somatodendritic compartment,transport,0.332\nprotein localization to spindle microtubule,transport,0.566\nprotein localization to spindle pole body,transport,0.462\nprotein localization to synapse,cellular component organization,0.446\nprotein localization to tricellular tight junction,transport,0.332\nprotein localization to vacuolar membrane,transport,0.652\nprotein lysine deacetylase activity,metabolic process,0.526\nprotein mannosylation,protein modification/signaling,0.638\nprotein maturation by [2Fe-2S] cluster transfer,protein modification/signaling,0.324\nprotein maturation by [4Fe-4S] cluster transfer,protein modification/signaling,0.324\nprotein maturation by copper ion transfer,protein modification/signaling,0.28\nprotein maturation by protein folding,cellular component organization,0.388\nprotein metabolic process,metabolic process,0.584\nprotein methylesterase activity,metabolic process,0.592\nprotein methyltransferase activity,metabolic process,0.478\nprotein modification by small protein conjugation or removal,protein modification/signaling,0.922\nprotein modification process,protein modification/signaling,0.478\nprotein myristoylation,protein modification/signaling,0.756\nprotein nitrosylation,protein modification/signaling,0.692\nprotein nucleotidylation,protein modification/signaling,0.764\nprotein octanoylation,protein modification/signaling,0.724\nprotein oxidation,protein modification/signaling,0.772\nprotein palmitoleylation,protein modification/signaling,0.69\nprotein palmitoylation,protein modification/signaling,0.75\nprotein phosphatase 1 binding,protein modification/signaling,0.368\nprotein phosphatase 2A binding,protein modification/signaling,0.396\nprotein phosphatase 2B binding,protein modification/signaling,0.376\nprotein phosphatase 4 complex,protein modification/signaling,0.312\nprotein phosphatase activator activity,protein modification/signaling,0.558\nprotein phosphatase binding,protein modification/signaling,0.724\nprotein phosphatase inhibitor activity,protein modification/signaling,0.536\nprotein phosphatase regulator activity,protein modification/signaling,0.634\nprotein phosphatase type 1 complex,protein modification/signaling,0.316\nprotein phosphatase type 2A complex,metabolic process,0.222\nprotein phosphorylated amino acid binding,protein modification/signaling,0.692\nprotein phosphorylation,protein modification/signaling,0.686\nprotein poly-ADP-ribosylation,protein modification/signaling,0.338\nprotein polyglutamylation,metabolic process,0.404\nprotein polyglycylation,metabolic process,0.38\nprotein polymerization,cellular component organization,0.808\nprotein polyufmylation,protein modification/signaling,0.764\nprotein prenylation,protein modification/signaling,0.66\nprotein prenyltransferase activity,metabolic process,0.52\nprotein processing in phagocytic vesicle,protein modification/signaling,0.418\nprotein processing involved in protein targeting to mitochondrion,protein modification/signaling,0.28\nprotein propionyltransferase activity,metabolic process,0.682\nprotein quality control for misfolded or incompletely synthesized proteins,metabolic process,0.716\nprotein repair,protein modification/signaling,0.504\nprotein retention in ER lumen,transport,0.202\nprotein retention in Golgi apparatus,transport,0.32\nprotein secretion by platelet,protein modification/signaling,0.31\nprotein sequestering activity,transport,0.186\nprotein serine kinase activity (using GTP as donor),metabolic process,0.886\nprotein serine/threonine kinase binding,protein modification/signaling,0.452\nprotein serine/threonine kinase inhibitor activity,protein modification/signaling,0.61\nprotein serine/threonine phosphatase activity,protein modification/signaling,0.582\nprotein serine/threonine phosphatase complex,protein modification/signaling,0.492\nprotein serine/threonine phosphatase inhibitor activity,metabolic process,0.472\nprotein sialylation,protein modification/signaling,0.28\nprotein side chain deglutamylation,protein modification/signaling,0.48\nprotein splicing,protein modification/signaling,0.478\nprotein stearoylation,protein modification/signaling,0.408\nprotein succinylation,protein modification/signaling,0.738\nprotein sulfation,protein modification/signaling,0.692\nprotein sulfhydration,protein modification/signaling,0.746\nprotein tag activity,protein modification/signaling,0.336\nprotein targeting to ER,transport,0.476\nprotein targeting to Golgi apparatus,protein modification/signaling,0.404\nprotein targeting to lysosome involved in chaperone-mediated autophagy,receptor related process,0.34\nprotein targeting to peroxisome,transport,0.572\nprotein targeting to vacuole involved in autophagy,transport,0.614\nprotein tetramerization,cellular component organization,0.792\nprotein to membrane docking,cellular component organization,0.27\nprotein trans-autophosphorylation,protein modification/signaling,0.728\nprotein transmembrane import into intracellular organelle,transport,0.836\nprotein transmembrane transport,transport,0.662\nprotein transmembrane transporter activity,transport,0.556\nprotein transport,transport,0.736\nprotein transport along microtubule,transport,0.766\nprotein transport from ciliary membrane to plasma membrane,transport,0.37\nprotein transport into membrane raft,transport,0.596\nprotein transport into plasma membrane raft,transport,0.374\nprotein transport out of membrane raft,transport,0.584\nprotein transport within extracellular region,transport,0.56\nprotein transport within lipid bilayer,transport,0.624\nprotein transporter activity,transport,0.406\nprotein trimerization,cellular component organization,0.738\nprotein tyrosine kinase collagen receptor activity,metabolic process,0.278\nprotein tyrosine kinase inhibitor activity,protein modification/signaling,0.554\nprotein tyrosine phosphatase activator activity,protein modification/signaling,0.402\nprotein tyrosine/threonine phosphatase activity,metabolic process,0.452\nprotein ubiquitination,protein modification/signaling,0.898\nprotein ufmylation,protein modification/signaling,0.754\nprotein unfolding,protein modification/signaling,0.388\nprotein urmylation,protein modification/signaling,0.474\nprotein xylosyltransferase activity,metabolic process,0.474\nprotein-(glutamine-N5) methyltransferase activity,metabolic process,0.882\nprotein-DNA complex organization,cell cycle,0.506\nprotein-DNA complex remodeling,cellular component organization,0.638\nprotein-DNA covalent cross-linking,protein modification/signaling,0.5\nprotein-DNA covalent cross-linking repair,protein modification/signaling,0.386\nprotein-FAD linkage,protein modification/signaling,0.714\nprotein-L-histidine N-pros-methyltransferase activity,metabolic process,0.896\nprotein-L-histidine N-tele-methyltransferase activity,metabolic process,0.896\nprotein-L-isoaspartate (D-aspartate) O-methyltransferase activity,metabolic process,0.626\nprotein-N-terminal asparagine amidohydrolase activity,metabolic process,0.622\nprotein-N-terminal glutamine amidohydrolase activity,metabolic process,0.632\nprotein-RNA adaptor activity,gene regulation,0.354\nprotein-RNA complex assembly,cellular component organization,0.512\nprotein-RNA complex disassembly,cellular component organization,0.748\nprotein-arginine N-methyltransferase activity,metabolic process,0.554\nprotein-arginine deiminase activity,metabolic process,0.648\nprotein-arginine omega-N asymmetric methyltransferase activity,metabolic process,0.454\nprotein-arginine omega-N monomethyltransferase activity,metabolic process,0.742\nprotein-arginine omega-N symmetric methyltransferase activity,metabolic process,0.458\nprotein-containing complex,metabolic process,0.19\nprotein-containing complex assembly,cellular component organization,0.364\nprotein-containing complex assembly involved in synapse maturation,cellular component organization,0.556\nprotein-containing complex binding,cellular component organization,0.21\nprotein-containing complex destabilizing activity,protein modification/signaling,0.264\nprotein-containing complex localization to centriolar satellite,transport,0.388\nprotein-containing complex organization,cellular component organization,0.358\nprotein-containing complex remodeling,cellular component organization,0.648\nprotein-containing complex stabilizing activity,metabolic process,0.182\nprotein-cysteine S-acyltransferase activity,metabolic process,0.662\nprotein-cysteine S-myristoyltransferase activity,metabolic process,0.676\nprotein-cysteine S-palmitoyltransferase activity,metabolic process,0.716\nprotein-cysteine S-stearoyltransferase activity,metabolic process,0.71\nprotein-cysteine methyltransferase activity,metabolic process,0.888\nprotein-disulfide reductase (glutathione) activity,metabolic process,0.896\nprotein-disulfide reductase activity,metabolic process,0.686\nprotein-fructosamine 3-kinase activity,metabolic process,0.796\nprotein-glucosylgalactosylhydroxylysine glucosidase activity,metabolic process,0.55\nprotein-glutamate O-methyltransferase activity,metabolic process,0.606\nprotein-glutamic acid ligase activity,metabolic process,0.508\nprotein-glutamine N-methyltransferase activity,metabolic process,0.594\nprotein-glutamine gamma-glutamyltransferase activity,metabolic process,0.736\nprotein-glutamine glutaminase activity,metabolic process,0.636\nprotein-glutaryllysine deglutarylase activity,metabolic process,0.862\nprotein-glycine ligase activity,metabolic process,0.578\n\"protein-glycine ligase activity, initiating\",metabolic process,0.4\nprotein-heme linkage,protein modification/signaling,0.63\nprotein-hormone receptor activity,receptor related process,0.56\nprotein-lipid complex,metabolic process,0.246\nprotein-lipid complex assembly,cellular component organization,0.898\nprotein-lipid complex binding,protein modification/signaling,0.22\nprotein-lipid complex organization,cellular component organization,0.784\nprotein-lipid complex remodeling,cellular component organization,0.656\nprotein-lysine 6-oxidase activity,metabolic process,0.894\nprotein-lysine N-methyltransferase activity,metabolic process,0.464\nprotein-malonyllysine demalonylase activity,metabolic process,0.558\nprotein-membrane adaptor activity,cellular component organization,0.256\nprotein-phosphatidylethanolamide deconjugating activity,metabolic process,0.61\nprotein-propionyllysine depropionylase activity,metabolic process,0.56\nprotein-pyridoxal-5-phosphate linkage,protein modification/signaling,0.668\nprotein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine,metabolic process,0.204\nprotein-ribulosamine 3-kinase activity,metabolic process,0.796\nprotein-succinyllysine desuccinylase activity,metabolic process,0.92\nprotein-tetrapyrrole linkage,protein modification/signaling,0.724\nprotein-transporting ATPase activity,transport,0.422\nprotein-tyrosine sulfotransferase activity,metabolic process,0.594\nproteinase activated receptor binding,receptor related process,0.454\nproteinase-activated receptor activity,receptor related process,0.5\nproteoglycan catabolic process,metabolic process,0.96\nproteoglycan sulfotransferase activity,metabolic process,0.804\nproteolysis,metabolic process,0.652\nprotoheme IX farnesyltransferase activity,metabolic process,0.878\nproton channel activity,transport,0.522\nproton transmembrane transporter activity,transport,0.654\nproton-dependent oligopeptide secondary active transmembrane transporter activity,transport,0.494\n\"proton-transporting ATP synthase activity, rotational mechanism\",metabolic process,0.47\nproton-transporting ATP synthase complex,transport,0.23\nproton-transporting ATP synthase complex assembly,cellular component organization,0.94\n\"proton-transporting ATP synthase complex, catalytic core F(1)\",cellular component organization,0.408\n\"proton-transporting ATP synthase complex, coupling factor F(o)\",cellular component organization,0.432\n\"proton-transporting ATP synthase, catalytic core\",metabolic process,0.308\n\"proton-transporting ATP synthase, stator stalk\",metabolic process,0.302\n\"proton-transporting ATPase activity, rotational mechanism\",metabolic process,0.436\nproton-transporting V-type ATPase complex,transport,0.236\nproton-transporting V-type ATPase complex assembly,cellular component organization,0.932\n\"proton-transporting V-type ATPase, V0 domain\",cellular component organization,0.384\n\"proton-transporting V-type ATPase, V1 domain\",metabolic process,0.332\nproton-transporting two-sector ATPase complex,transport,0.3\n\"proton-transporting two-sector ATPase complex, catalytic domain\",cellular component organization,0.36\n\"proton-transporting two-sector ATPase complex, proton-transporting domain\",cellular component organization,0.27\nprotoporphyrinogen IX biosynthetic process,metabolic process,0.97\nprotoporphyrinogen oxidase activity,metabolic process,0.922\nproximal convoluted tubule development,morphogenesis/development,0.986\nproximal convoluted tubule segment 2 development,morphogenesis/development,0.986\nproximal dendrite,cellular component organization,0.388\nproximal neuron projection,neural related process,0.438\nproximal portion of axoneme,cellular component organization,0.244\nproximal straight tubule development,morphogenesis/development,0.98\nproximal tubule development,morphogenesis/development,0.988\nproximal tubule morphogenesis,morphogenesis/development,0.902\nproximal/distal axis specification,multicellular organismal process,0.432\nproximal/distal pattern formation,morphogenesis/development,0.514\nproximal/distal pattern formation involved in metanephric nephron development,morphogenesis/development,0.308\nproximal/distal pattern formation involved in nephron development,morphogenesis/development,0.432\npseudohyphal growth,immune system process,0.226\npseudophosphatase activity,protein modification/signaling,0.37\npseudopodium,transport,0.184\npseudopodium assembly,cellular component organization,0.796\npseudopodium membrane,cellular component organization,0.406\npseudopodium organization,cellular component organization,0.8\npseudouridine 5'-phosphatase activity,metabolic process,0.852\npsychomotor behavior,transport,0.156\npteridine-containing compound catabolic process,metabolic process,0.966\npteridine-containing compound metabolic process,metabolic process,0.984\npulmonary artery endothelial tube morphogenesis,morphogenesis/development,0.798\npulmonary artery morphogenesis,morphogenesis/development,0.754\npulmonary myocardium development,morphogenesis/development,0.856\npulmonary valve formation,morphogenesis/development,0.672\npulmonary valve morphogenesis,morphogenesis/development,0.664\npulmonary vein morphogenesis,morphogenesis/development,0.69\npumilio-response element binding,gene regulation,0.578\npurine deoxyribonucleoside catabolic process,metabolic process,0.98\npurine deoxyribonucleoside diphosphate biosynthetic process,metabolic process,0.998\npurine deoxyribonucleoside diphosphate catabolic process,metabolic process,0.992\npurine deoxyribonucleoside diphosphate metabolic process,metabolic process,0.996\npurine deoxyribonucleoside metabolic process,metabolic process,0.992\npurine deoxyribonucleoside monophosphate biosynthetic process,metabolic process,0.998\npurine deoxyribonucleoside monophosphate catabolic process,metabolic process,0.994\npurine deoxyribonucleoside monophosphate metabolic process,metabolic process,0.998\npurine deoxyribonucleoside triphosphate biosynthetic process,metabolic process,0.998\npurine deoxyribonucleoside triphosphate catabolic process,metabolic process,0.992\npurine deoxyribonucleoside triphosphate metabolic process,metabolic process,0.998\npurine deoxyribonucleotide binding,metabolic process,0.574\npurine deoxyribonucleotide biosynthetic process,metabolic process,0.998\npurine deoxyribonucleotide catabolic process,metabolic process,0.992\npurine deoxyribonucleotide salvage,metabolic process,0.818\npurine nucleobase binding,metabolic process,0.426\npurine nucleobase biosynthetic process,metabolic process,0.936\npurine nucleobase catabolic process,metabolic process,0.942\npurine nucleobase salvage,metabolic process,0.654\npurine nucleobase transmembrane transport,transport,0.768\npurine nucleobase transmembrane transporter activity,transport,0.528\npurine nucleobase transport,transport,0.888\npurine nucleoside binding,metabolic process,0.448\npurine nucleoside biosynthetic process,metabolic process,0.982\npurine nucleoside bisphosphate biosynthetic process,metabolic process,0.996\npurine nucleoside bisphosphate catabolic process,metabolic process,0.99\npurine nucleoside bisphosphate metabolic process,metabolic process,0.994\npurine nucleoside catabolic process,metabolic process,0.984\npurine nucleoside diphosphate biosynthetic process,metabolic process,0.998\npurine nucleoside diphosphate catabolic process,metabolic process,0.992\npurine nucleoside diphosphate metabolic process,metabolic process,0.998\npurine nucleoside metabolic process,metabolic process,0.996\npurine nucleoside monophosphate biosynthetic process,metabolic process,0.998\npurine nucleoside monophosphate catabolic process,metabolic process,0.994\npurine nucleoside monophosphate metabolic process,metabolic process,1\npurine nucleoside transmembrane transport,transport,0.27\npurine nucleoside transmembrane transporter activity,transport,0.6\npurine nucleoside triphosphate catabolic process,metabolic process,0.992\npurine nucleotide catabolic process,metabolic process,0.988\npurine nucleotide import into lysosome,transport,0.292\npurine nucleotide salvage,metabolic process,0.812\npurine nucleotide transmembrane transporter activity,transport,0.712\npurine nucleotide transport,transport,0.79\npurine nucleotide uniporter activity,metabolic process,0.278\npurine nucleotide-sugar transmembrane transport,transport,0.712\npurine nucleotide-sugar transmembrane transporter activity,transport,0.62\npurine phosphoribosyltransferase activity,metabolic process,0.894\npurine ribonucleoside biosynthetic process,metabolic process,0.978\npurine ribonucleoside bisphosphate biosynthetic process,metabolic process,0.994\npurine ribonucleoside bisphosphate metabolic process,metabolic process,0.99\npurine ribonucleoside catabolic process,metabolic process,0.98\npurine ribonucleoside diphosphate biosynthetic process,metabolic process,0.996\npurine ribonucleoside diphosphate catabolic process,metabolic process,0.992\npurine ribonucleoside diphosphate metabolic process,metabolic process,0.996\npurine ribonucleoside metabolic process,metabolic process,0.992\npurine ribonucleoside monophosphate biosynthetic process,metabolic process,0.996\npurine ribonucleoside monophosphate catabolic process,metabolic process,0.992\npurine ribonucleoside monophosphate metabolic process,metabolic process,0.996\npurine ribonucleoside salvage,metabolic process,0.74\npurine ribonucleoside triphosphate binding,other,0.398\npurine ribonucleoside triphosphate catabolic process,metabolic process,0.992\npurine ribonucleotide binding,other,0.468\npurine ribonucleotide catabolic process,metabolic process,0.98\npurine ribonucleotide salvage,metabolic process,0.814\npurine ribonucleotide transport,transport,0.858\npurine-containing compound catabolic process,metabolic process,0.982\npurine-containing compound salvage,metabolic process,0.562\npurine-containing compound transmembrane transport,transport,0.68\npurine-nucleoside phosphorylase activity,metabolic process,0.838\npurine-rich negative regulatory element binding,gene regulation,0.442\npurine-specific mismatch base pair DNA N-glycosylase activity,metabolic process,0.712\npurine-specific nucleoside:sodium symporter activity,metabolic process,0.526\npurinergic nucleotide receptor activity,receptor related process,0.572\npurinergic nucleotide receptor signaling pathway,receptor related process,0.792\nputamen development,morphogenesis/development,0.728\nputrescine acetylation,gene regulation,0.286\nputrescine binding,metabolic process,0.298\nputrescine biosynthetic process,metabolic process,0.992\nputrescine biosynthetic process from arginine,metabolic process,0.968\n\"putrescine biosynthetic process from arginine, using agmatinase\",metabolic process,0.82\nputrescine biosynthetic process from ornithine,metabolic process,0.866\nputrescine catabolic process,metabolic process,0.894\nputrescine metabolic process,metabolic process,0.942\nputrescine transmembrane transporter activity,transport,0.69\nputrescine transport,transport,0.7\npyloric antrum smooth muscle contraction,morphogenesis/development,0.172\npyramidal neuron development,morphogenesis/development,0.684\npyramidal neuron differentiation,morphogenesis/development,0.56\npyramidal neuron migration to cerebral cortex,neural related process,0.256\npyridine N-methyltransferase activity,metabolic process,0.896\npyridine nucleoside catabolic process,metabolic process,0.978\npyridine nucleoside metabolic process,metabolic process,0.988\npyridine nucleotide catabolic process,metabolic process,0.994\npyridine nucleotide salvage,metabolic process,0.802\npyridine-containing compound catabolic process,metabolic process,0.984\npyridoxal 5'-phosphate salvage,metabolic process,0.768\npyridoxal binding,metabolic process,0.27\npyridoxal kinase activity,metabolic process,0.796\npyridoxal phosphatase activity,metabolic process,0.85\npyridoxal phosphate binding,metabolic process,0.438\npyridoxal phosphate biosynthetic process,metabolic process,0.974\npyridoxal phosphate catabolic process,metabolic process,0.804\npyridoxal phosphate metabolic process,metabolic process,0.97\npyridoxamine phosphate oxidase activity,metabolic process,0.9\npyridoxine biosynthetic process,metabolic process,0.856\npyridoxine metabolic process,metabolic process,0.96\npyrimidine deoxyribonucleoside biosynthetic process,metabolic process,0.978\npyrimidine deoxyribonucleoside catabolic process,metabolic process,0.984\npyrimidine deoxyribonucleoside diphosphate biosynthetic process,metabolic process,1\npyrimidine deoxyribonucleoside diphosphate metabolic process,metabolic process,0.996\npyrimidine deoxyribonucleoside metabolic process,metabolic process,0.992\npyrimidine deoxyribonucleoside monophosphate biosynthetic process,metabolic process,1\npyrimidine deoxyribonucleoside monophosphate catabolic process,metabolic process,0.994\npyrimidine deoxyribonucleoside monophosphate metabolic process,metabolic process,0.996\npyrimidine deoxyribonucleoside triphosphate biosynthetic process,metabolic process,1\npyrimidine deoxyribonucleoside triphosphate catabolic process,metabolic process,0.992\npyrimidine deoxyribonucleoside triphosphate metabolic process,metabolic process,0.996\npyrimidine deoxyribonucleotide binding,metabolic process,0.35\npyrimidine deoxyribonucleotide biosynthetic process,metabolic process,0.996\npyrimidine deoxyribonucleotide catabolic process,metabolic process,0.994\npyrimidine deoxyribonucleotide metabolic process,metabolic process,0.998\npyrimidine dimer repair,stress response,0.668\npyrimidine dimer repair by nucleotide-excision repair,cell cycle,0.216\npyrimidine nucleobase binding,metabolic process,0.406\npyrimidine nucleobase biosynthetic process,metabolic process,0.98\npyrimidine nucleobase catabolic process,metabolic process,0.988\npyrimidine nucleobase metabolic process,metabolic process,0.994\npyrimidine nucleobase transmembrane transport,transport,0.738\npyrimidine nucleobase transmembrane transporter activity,transport,0.544\npyrimidine nucleobase transport,transport,0.9\npyrimidine nucleoside biosynthetic process,metabolic process,0.978\npyrimidine nucleoside catabolic process,metabolic process,0.98\npyrimidine nucleoside diphosphate biosynthetic process,metabolic process,1\npyrimidine nucleoside diphosphate catabolic process,metabolic process,0.992\npyrimidine nucleoside diphosphate metabolic process,metabolic process,0.996\npyrimidine nucleoside metabolic process,metabolic process,0.996\npyrimidine nucleoside monophosphate catabolic process,metabolic process,0.994\npyrimidine nucleoside monophosphate metabolic process,metabolic process,0.996\npyrimidine nucleoside salvage,metabolic process,0.734\npyrimidine nucleoside transmembrane transporter activity,transport,0.612\npyrimidine nucleoside transport,transport,0.894\npyrimidine nucleoside triphosphate catabolic process,metabolic process,0.992\npyrimidine nucleotide binding,metabolic process,0.46\npyrimidine nucleotide biosynthetic process,metabolic process,1\npyrimidine nucleotide catabolic process,metabolic process,0.994\npyrimidine nucleotide import into mitochondrion,cellular component organization,0.292\npyrimidine nucleotide salvage,metabolic process,0.804\npyrimidine nucleotide transmembrane transporter activity,metabolic process,0.29\npyrimidine nucleotide transport,transport,0.81\npyrimidine nucleotide-sugar transmembrane transport,transport,0.694\npyrimidine nucleotide-sugar transmembrane transporter activity,transport,0.644\npyrimidine ribonucleoside catabolic process,metabolic process,0.976\npyrimidine ribonucleoside diphosphate biosynthetic process,metabolic process,1\npyrimidine ribonucleoside diphosphate catabolic process,metabolic process,0.992\npyrimidine ribonucleoside diphosphate metabolic process,metabolic process,0.994\npyrimidine ribonucleoside metabolic process,metabolic process,0.986\npyrimidine ribonucleoside monophosphate catabolic process,metabolic process,0.994\npyrimidine ribonucleoside monophosphate metabolic process,metabolic process,0.994\npyrimidine ribonucleoside triphosphate biosynthetic process,metabolic process,1\npyrimidine ribonucleoside triphosphate catabolic process,metabolic process,0.992\npyrimidine ribonucleoside triphosphate metabolic process,metabolic process,0.998\npyrimidine ribonucleotide binding,metabolic process,0.562\npyrimidine ribonucleotide biosynthetic process,metabolic process,0.998\npyrimidine ribonucleotide catabolic process,metabolic process,0.994\npyrimidine ribonucleotide metabolic process,metabolic process,1\npyrimidine ribonucleotide salvage,metabolic process,0.846\npyrimidine- and adenosine-specific:sodium symporter activity,metabolic process,0.544\npyrimidine-containing compound biosynthetic process,metabolic process,0.986\npyrimidine-containing compound salvage,metabolic process,0.488\npyrimidine-containing compound transmembrane transport,transport,0.736\npyrimidine-nucleoside phosphorylase activity,metabolic process,0.854\npyrimidine-specific mismatch base pair DNA N-glycosylase activity,metabolic process,0.55\npyroglutamyl-peptidase activity,metabolic process,0.406\npyrophosphatase activity,metabolic process,0.808\npyroptosis,cell death,0.662\npyroptosome complex assembly,cellular component organization,0.682\npyrroline-5-carboxylate reductase activity,metabolic process,0.934\npyruvate biosynthetic process,metabolic process,0.986\npyruvate carboxylase activity,metabolic process,0.752\npyruvate catabolic process,metabolic process,0.982\npyruvate dehydrogenase (NAD+) activity,metabolic process,0.91\npyruvate dehydrogenase (acetyl-transferring) activity,metabolic process,0.896\npyruvate dehydrogenase (acetyl-transferring) kinase activity,metabolic process,0.756\npyruvate dehydrogenase (lipoamide) phosphatase complex,cellular component organization,0.364\npyruvate dehydrogenase [NAD(P)+] activity,metabolic process,0.97\npyruvate dehydrogenase activity,metabolic process,0.838\npyruvate dehydrogenase complex,metabolic process,0.49\npyruvate family amino acid catabolic process,metabolic process,0.986\npyruvate family amino acid metabolic process,metabolic process,0.984\npyruvate kinase activity,metabolic process,0.794\npyruvate oxidation,metabolic process,0.89\npyruvate secondary active transmembrane transporter activity,transport,0.452\npyruvate transmembrane transport,transport,0.892\npyruvate transmembrane transporter activity,transport,0.76\npyruvate transport,transport,0.984\nquaternary ammonium group transmembrane transporter activity,transport,0.582\nquaternary ammonium group transport,transport,0.844\n\"quercetin 2,3-dioxygenase activity\",metabolic process,0.896\nquercetin catabolic process,metabolic process,0.89\nquercetin metabolic process,metabolic process,0.972\nquinine 3-monooxygenase activity,metabolic process,0.932\nquinolinate biosynthetic process,metabolic process,0.908\nquinolinate catabolic process,metabolic process,0.88\nquinolinate metabolic process,metabolic process,0.992\nquinone binding,metabolic process,0.512\nquinone biosynthetic process,metabolic process,0.988\nquinone catabolic process,metabolic process,0.964\nquinone cofactor methyltransferase activity,metabolic process,0.868\nrDNA binding,gene regulation,0.672\nrDNA heterochromatin,cellular component organization,0.24\nrDNA heterochromatin formation,cellular component organization,0.236\nrRNA (adenine) methyltransferase activity,metabolic process,0.67\n\"rRNA (adenine-N6,N6-)-dimethyltransferase activity\",metabolic process,0.614\nrRNA (adenine-N6-)-methyltransferase activity,metabolic process,0.672\nrRNA (cytosine) methyltransferase activity,metabolic process,0.67\nrRNA (cytosine-C5-)-methyltransferase activity,metabolic process,0.416\nrRNA (cytosine-N4-)-methyltransferase activity,metabolic process,0.894\nrRNA (guanine) methyltransferase activity,metabolic process,0.674\nrRNA (guanine-N7)-methylation,metabolic process,0.296\nrRNA (guanosine-2'-O-)-methyltransferase activity,metabolic process,0.864\nrRNA (pseudouridine) methyltransferase activity,metabolic process,0.628\nrRNA (uridine) methyltransferase activity,metabolic process,0.67\nrRNA (uridine-2'-O-)-methyltransferase activity,metabolic process,0.864\nrRNA (uridine-C5-)-methyltransferase activity,metabolic process,0.864\nrRNA (uridine-N3-)-methyltransferase activity,metabolic process,0.864\nrRNA 2'-O-methylation,gene regulation,0.608\nrRNA 3'-end processing,gene regulation,0.75\nrRNA 5'-end processing,gene regulation,0.796\nrRNA acetylation,gene regulation,0.642\nrRNA acetylation involved in maturation of SSU-rRNA,morphogenesis/development,0.18\nrRNA base methylation,gene regulation,0.604\nrRNA catabolic process,metabolic process,0.762\nrRNA cytidine N-acetyltransferase activity,metabolic process,0.812\nrRNA export from nucleus,transport,0.332\nrRNA import into mitochondrion,metabolic process,0.236\nrRNA methylation,gene regulation,0.686\nrRNA methyltransferase activity,metabolic process,0.622\nrRNA primary transcript binding,gene regulation,0.578\nrRNA pseudouridine synthesis,gene regulation,0.608\nrRNA transport,transport,0.916\n\"racemase activity, acting on amino acids and derivatives\",metabolic process,0.74\nracemase and epimerase activity,metabolic process,0.862\n\"racemase and epimerase activity, acting on amino acids and derivatives\",metabolic process,0.868\n\"racemase and epimerase activity, acting on carbohydrates and derivatives\",metabolic process,0.876\nradial glia guided migration of Purkinje cell,morphogenesis/development,0.288\nradial glia guided migration of cerebellar granule cell,morphogenesis/development,0.246\nradial glia-guided pyramidal neuron migration,neural related process,0.34\nradial glial cell differentiation,morphogenesis/development,0.656\nradial pattern formation,multicellular organismal process,0.394\nradial spoke,cellular component organization,0.328\nradial spoke assembly,cellular component organization,0.694\nradial spoke head,cellular component organization,0.26\nradial spoke stalk,protein modification/signaling,0.282\nraffinose alpha-galactosidase activity,metabolic process,0.9\nrandom inactivation of X chromosome,gene regulation,0.294\nre-entry into mitotic cell cycle,cell cycle,0.688\nreactive gliosis,immune system process,0.182\nreactive oxygen species biosynthetic process,metabolic process,0.748\nreceptor antagonist activity,receptor related process,0.33\nreceptor clustering,cellular component organization,0.194\nreceptor complex,receptor related process,0.364\nreceptor decoy activity,receptor related process,0.382\nreceptor diffusion trapping,transport,0.322\nreceptor guanylyl cyclase signaling pathway,receptor related process,0.582\nreceptor internalization,receptor related process,0.314\nreceptor internalization involved in canonical Wnt signaling pathway,receptor related process,0.396\nreceptor localization to non-motile cilium,receptor related process,0.278\nreceptor localization to synapse,neural related process,0.474\nreceptor recycling,metabolic process,0.236\nreceptor serine/threonine kinase binding,receptor related process,0.348\nreceptor signaling protein tyrosine kinase activator activity,receptor related process,0.456\nreceptor signaling protein tyrosine kinase inhibitor activity,protein modification/signaling,0.422\nreceptor transactivation,receptor related process,0.394\nreceptor tyrosine kinase binding,protein modification/signaling,0.514\nreceptor tyrosine kinase-like orphan receptor binding,receptor related process,0.5\nreceptor-mediated endocytosis involved in cholesterol transport,transport,0.192\nreceptor-mediated endocytosis of virus by host cell,transport,0.646\nreceptor-mediated virion attachment to host cell,cell adhesion,0.188\nreceptor-receptor interaction,cellular component organization,0.25\nreciprocal homologous recombination,cell cycle,0.612\nreciprocal meiotic recombination,cell cycle,0.24\nrecognition of apoptotic cell,protein modification/signaling,0.36\nrecombinase activator activity,metabolic process,0.242\nrecombination hotspot binding,gene regulation,0.232\nrecombination nodule,cellular component organization,0.434\nrecombinational interstrand cross-link repair,cell cycle,0.186\nrecruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex,gene regulation,0.502\nrecruitment of mRNA capping enzyme to RNA polymerase II holoenzyme complex,gene regulation,0.442\nrecycling endosome,ER/endosome/lysosome related process,0.31\nrecycling endosome lumen,cellular component organization,0.356\nrecycling endosome to Golgi transport,transport,0.356\nreduction of food intake in response to dietary excess,cellular component organization,0.232\nreductive iron assimilation,transport,0.256\nreelin complex,receptor related process,0.276\nreelin receptor activity,receptor related process,0.2\nreelin-mediated signaling pathway,receptor related process,0.542\nreflex,immune system process,0.304\nregionalization,morphogenesis/development,0.822\nregulation by virus of viral protein levels in host cell,viral related process,0.426\nregulation of 'de novo' NAD biosynthetic process from tryptophan,metabolic process,0.582\nregulation of 3'-UTR-mediated mRNA stabilization,gene regulation,0.728\nregulation of AIM2 inflammasome complex assembly,cellular component organization,0.774\nregulation of AMPA glutamate receptor clustering,transport,0.35\nregulation of AMPA receptor activity,receptor related process,0.318\nregulation of ARF protein signal transduction,protein modification/signaling,0.652\nregulation of ATF6-mediated unfolded protein response,protein modification/signaling,0.448\nregulation of ATP biosynthetic process,metabolic process,0.528\nregulation of ATP citrate synthase activity,metabolic process,0.482\nregulation of ATP metabolic process,metabolic process,0.574\nregulation of ATP:ADP antiporter activity,transport,0.662\nregulation of ATPase-coupled calcium transmembrane transporter activity,transport,0.684\nregulation of AV node cell action potential,neural related process,0.154\nregulation of Arp2/3 complex-mediated actin nucleation,cellular component organization,0.658\nregulation of B cell activation,immune system process,0.94\nregulation of B cell antigen processing and presentation,immune system process,0.872\nregulation of B cell apoptotic process,immune system process,0.444\nregulation of B cell chemotaxis,immune system process,0.886\nregulation of B cell cytokine production,immune system process,0.904\nregulation of B cell differentiation,immune system process,0.812\nregulation of B cell mediated immunity,immune system process,0.97\nregulation of B cell receptor signaling pathway,immune system process,0.62\nregulation of B cell tolerance induction,immune system process,0.604\nregulation of BMP signaling pathway,receptor related process,0.468\nregulation of C-C chemokine receptor CCR7 signaling pathway,receptor related process,0.662\nregulation of CAMKK-AMPK signaling cascade,protein modification/signaling,0.534\nregulation of CD24 production,metabolic process,0.352\nregulation of CD4 production,metabolic process,0.74\n\"regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation\",immune system process,0.84\n\"regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response\",immune system process,0.824\n\"regulation of CD4-positive, alpha-beta T cell costimulation\",immune system process,0.794\n\"regulation of CD4-positive, alpha-beta T cell proliferation\",immune system process,0.892\nregulation of CD40 signaling pathway,receptor related process,0.434\n\"regulation of CD8-positive, alpha-beta T cell activation\",immune system process,0.866\n\"regulation of CD8-positive, alpha-beta T cell differentiation\",immune system process,0.844\n\"regulation of CD8-positive, alpha-beta T cell extravasation\",immune system process,0.802\n\"regulation of CD8-positive, alpha-beta T cell proliferation\",immune system process,0.828\n\"regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation\",immune system process,0.776\nregulation of CD80 production,metabolic process,0.344\nregulation of CD86 production,metabolic process,0.346\nregulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity,metabolic process,0.45\nregulation of COPII vesicle coating,cellular component organization,0.234\nregulation of Cdc42 protein signal transduction,protein modification/signaling,0.546\nregulation of CoA-transferase activity,metabolic process,0.456\nregulation of D-amino-acid oxidase activity,metabolic process,0.482\nregulation of D-erythro-sphingosine kinase activity,metabolic process,0.384\nregulation of DNA catabolic process,metabolic process,0.374\n\"regulation of DNA damage response, signal transduction by p53 class mediator\",stress response,0.348\n\"regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator\",protein modification/signaling,0.326\nregulation of DNA double-strand break processing,cell cycle,0.226\nregulation of DNA duplex unwinding,cell cycle,0.344\nregulation of DNA endoreduplication,cell cycle,0.626\nregulation of DNA helicase activity,cell cycle,0.352\nregulation of DNA ligase activity,cell cycle,0.322\nregulation of DNA ligation,cell cycle,0.372\nregulation of DNA methylation-dependent heterochromatin formation,gene regulation,0.696\nregulation of DNA primase activity,cell cycle,0.354\nregulation of DNA recombination,cell cycle,0.548\nregulation of DNA recombination at telomere,cell cycle,0.358\nregulation of DNA replication origin binding,cell cycle,0.264\nregulation of DNA stability,cellular component organization,0.21\nregulation of DNA strand resection involved in replication fork processing,cell cycle,0.436\nregulation of DNA topoisomerase (ATP-hydrolyzing) activity,metabolic process,0.386\nregulation of ER to Golgi vesicle-mediated transport,transport,0.528\nregulation of ER-associated ubiquitin-dependent protein catabolic process,ER/endosome/lysosome related process,0.318\nregulation of ERBB3 signaling pathway,receptor related process,0.478\nregulation of ERK5 cascade,protein modification/signaling,0.464\nregulation of Fas signaling pathway,receptor related process,0.454\nregulation of FasL production,metabolic process,0.74\nregulation of Fc-gamma receptor signaling pathway involved in phagocytosis,immune system process,0.61\nregulation of G protein-coupled receptor internalization,receptor related process,0.492\nregulation of G1 to G0 transition,cell cycle,0.634\nregulation of G2/MI transition of meiotic cell cycle,cell cycle,0.756\nregulation of GABA-A receptor activity,receptor related process,0.568\nregulation of GTP binding,gene regulation,0.206\nregulation of GTP cyclohydrolase I activity,metabolic process,0.654\nregulation of Golgi inheritance,cell cycle,0.198\nregulation of Golgi lumen acidification,cellular component organization,0.18\nregulation of Golgi organization,cellular component organization,0.506\nregulation of Golgi to plasma membrane protein transport,transport,0.65\nregulation of I-kappaB phosphorylation,protein modification/signaling,0.586\nregulation of IP-10 production,immune system process,0.736\nregulation of Kit signaling pathway,receptor related process,0.418\nregulation of L-dopa biosynthetic process,metabolic process,0.624\nregulation of L-dopa decarboxylase activity,metabolic process,0.444\nregulation of L-glutamate import across plasma membrane,transport,0.736\nregulation of L-glutamine import across plasma membrane,transport,0.752\nregulation of L-proline import across plasma membrane,transport,0.738\nregulation of Lewy body formation,cellular component organization,0.712\nregulation of MAPK export from nucleus,transport,0.326\nregulation of MDA-5 signaling pathway,immune system process,0.77\nregulation of MHC class I biosynthetic process,metabolic process,0.688\nregulation of MyD88-dependent toll-like receptor signaling pathway,immune system process,0.87\nregulation of MyD88-independent toll-like receptor signaling pathway,immune system process,0.858\nregulation of N-terminal peptidyl-lysine acetylation,protein modification/signaling,0.436\nregulation of N-terminal protein palmitoylation,protein modification/signaling,0.47\nregulation of NAD metabolic process,metabolic process,0.566\nregulation of NAD(P)H oxidase activity,metabolic process,0.696\nregulation of NAD+ ADP-ribosyltransferase activity,metabolic process,0.456\nregulation of NADP metabolic process,metabolic process,0.484\nregulation of NK T cell activation,immune system process,0.852\nregulation of NK T cell differentiation,immune system process,0.764\nregulation of NK T cell proliferation,immune system process,0.828\nregulation of NLRP3 inflammasome complex assembly,cellular component organization,0.61\nregulation of NMDA receptor activity,transport,0.322\nregulation of Notch signaling pathway involved in heart induction,receptor related process,0.534\nregulation of Notch signaling pathway involved in somitogenesis,receptor related process,0.436\nregulation of P-type sodium:potassium-exchanging transporter activity,transport,0.736\nregulation of PERK-mediated unfolded protein response,protein modification/signaling,0.394\nregulation of Purkinje myocyte action potential,gene regulation,0.152\nregulation of RNA export from nucleus,transport,0.776\nregulation of RNA polymerase II regulatory region sequence-specific DNA binding,gene regulation,0.576\nregulation of RNA polymerase II transcription preinitiation complex assembly,gene regulation,0.774\nregulation of RNA stability,gene regulation,0.576\nregulation of RNA-dependent RNA polymerase activity,gene regulation,0.34\nregulation of Rab protein signal transduction,protein modification/signaling,0.548\nregulation of Rac protein signal transduction,protein modification/signaling,0.674\nregulation of Ral protein signal transduction,protein modification/signaling,0.548\nregulation of Rap protein signal transduction,protein modification/signaling,0.542\nregulation of Rho guanyl-nucleotide exchange factor activity,protein modification/signaling,0.136\nregulation of Rho-dependent protein serine/threonine kinase activity,protein modification/signaling,0.726\nregulation of SA node cell action potential,gene regulation,0.15\nregulation of SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,metabolic process,0.802\nregulation of SNARE complex assembly,cellular component organization,0.732\nregulation of SREBP signaling pathway,receptor related process,0.326\nregulation of SUMO transferase activity,protein modification/signaling,0.632\nregulation of Schwann cell chemotaxis,immune system process,0.304\nregulation of Schwann cell differentiation,morphogenesis/development,0.734\nregulation of Schwann cell migration,morphogenesis/development,0.208\nregulation of Schwann cell proliferation,cell cycle,0.68\nregulation of Schwann cell proliferation involved in axon regeneration,cell cycle,0.71\nregulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,immune system process,0.814\nregulation of T cell anergy,immune system process,0.734\nregulation of T cell antigen processing and presentation,immune system process,0.866\nregulation of T cell chemotaxis,immune system process,0.92\nregulation of T cell costimulation,immune system process,0.816\nregulation of T cell extravasation,immune system process,0.794\nregulation of T cell homeostatic proliferation,immune system process,0.76\nregulation of T cell mediated cytotoxicity directed against tumor cell target,immune system process,0.856\nregulation of T cell mediated immune response to tumor cell,immune system process,0.848\nregulation of T cell receptor signaling pathway,immune system process,0.796\nregulation of T cell tolerance induction,immune system process,0.682\nregulation of T-helper 1 cell activation,immune system process,0.796\nregulation of T-helper 1 cell cytokine production,immune system process,0.928\nregulation of T-helper 1 cell differentiation,immune system process,0.86\nregulation of T-helper 17 cell differentiation,immune system process,0.92\nregulation of T-helper 17 cell lineage commitment,immune system process,0.842\nregulation of T-helper 2 cell activation,immune system process,0.762\nregulation of T-helper 2 cell cytokine production,immune system process,0.954\nregulation of T-helper 2 cell differentiation,immune system process,0.884\nregulation of TOR signaling,protein modification/signaling,0.542\nregulation of TORC1 signaling,protein modification/signaling,0.548\nregulation of TORC2 signaling,protein modification/signaling,0.518\nregulation of TRAIL production,immune system process,0.758\nregulation of TRAIL-activated apoptotic signaling pathway,cell death,0.564\nregulation of Toll signaling pathway,receptor related process,0.464\nregulation of UDP-glucose catabolic process,metabolic process,0.852\nregulation of VCP-NPL4-UFD1 AAA ATPase complex assembly,cellular component organization,0.74\nregulation of Wnt protein secretion,transport,0.55\nregulation of Wnt signaling pathway,protein modification/signaling,0.67\nregulation of Wnt signaling pathway involved in digestive tract morphogenesis,protein modification/signaling,0.4\nregulation of Wnt signaling pathway involved in dorsal/ventral axis specification,protein modification/signaling,0.446\nregulation of Wnt signaling pathway involved in heart development,protein modification/signaling,0.282\n\"regulation of Wnt signaling pathway, calcium modulating pathway\",receptor related process,0.486\n\"regulation of Wnt signaling pathway, planar cell polarity pathway\",morphogenesis/development,0.298\nregulation of Wnt-Frizzled-LRP5/6 complex assembly,cellular component organization,0.736\nregulation of Wnt-mediated midbrain dopaminergic neuron differentiation,morphogenesis/development,0.27\nregulation of abscisic acid-activated signaling pathway,protein modification/signaling,0.338\nregulation of acetyl-CoA biosynthetic process from pyruvate,metabolic process,0.732\nregulation of acetylcholine metabolic process,metabolic process,0.668\n\"regulation of acetylcholine secretion, neurotransmission\",transport,0.43\nregulation of acetylcholine uptake,transport,0.712\nregulation of acetylcholine-gated cation channel activity,neural related process,0.268\nregulation of acid-sensing ion channel activity,transport,0.716\nregulation of acinar cell proliferation,cell cycle,0.746\nregulation of aconitate hydratase activity,metabolic process,0.432\nregulation of acrosomal vesicle exocytosis,transport,0.442\nregulation of acrosome reaction,metabolic process,0.37\nregulation of actin binding,protein modification/signaling,0.318\nregulation of actin cytoskeleton organization by cell-cell adhesion,cellular component organization,0.564\nregulation of actin filament binding,protein modification/signaling,0.274\nregulation of actin filament bundle assembly,cellular component organization,0.902\nregulation of actin filament length,cellular component organization,0.9\nregulation of actin filament polymerization,cellular component organization,0.964\nregulation of actin filament severing,cellular component organization,0.374\nregulation of actin filament-based movement,cellular component organization,0.26\nregulation of actin nucleation,cellular component organization,0.696\nregulation of actin phosphorylation,metabolic process,0.304\nregulation of actin polymerization or depolymerization,cellular component organization,0.956\nregulation of action potential firing pattern,neural related process,0.262\nregulation of action potential firing threshold,cellular component organization,0.21\n\"regulation of activated CD8-positive, alpha-beta T cell apoptotic process\",immune system process,0.402\nregulation of activated T cell autonomous cell death,immune system process,0.65\nregulation of activated T cell proliferation,immune system process,0.892\nregulation of activation of Janus kinase activity,protein modification/signaling,0.766\nregulation of activation of membrane attack complex,immune system process,0.604\nregulation of activation-induced cell death of T cells,immune system process,0.686\nregulation of activin receptor signaling pathway,receptor related process,0.664\nregulation of acute inflammatory response to antigenic stimulus,immune system process,0.932\nregulation of acute inflammatory response to non-antigenic stimulus,immune system process,0.616\nregulation of acyl-CoA biosynthetic process,metabolic process,0.872\nregulation of acylglycerol transport,transport,0.64\nregulation of adaptive immune memory response,immune system process,0.686\nregulation of adaxial/abaxial pattern formation,morphogenesis/development,0.24\nregulation of adenosine receptor signaling pathway,receptor related process,0.788\nregulation of adenylate cyclase activity,metabolic process,0.25\nregulation of adenylate cyclase activity involved in G protein-coupled receptor signaling pathway,receptor related process,0.33\nregulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway,receptor related process,0.774\nregulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,receptor related process,0.716\nregulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway,receptor related process,0.764\nregulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process,receptor related process,0.42\nregulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway,receptor related process,0.796\nregulation of adenylate cyclase-inhibiting opioid receptor signaling pathway,receptor related process,0.792\nregulation of adherens junction organization,cellular component organization,0.618\nregulation of adiponectin secretion,transport,0.568\nregulation of adipose tissue development,morphogenesis/development,0.542\nregulation of aggrephagy,metabolic process,0.41\nregulation of alcohol biosynthetic process,metabolic process,0.738\nregulation of aldosterone biosynthetic process,metabolic process,0.92\nregulation of aldosterone metabolic process,metabolic process,0.912\nregulation of aldosterone secretion,transport,0.452\nregulation of alkaline phosphatase activity,metabolic process,0.592\n\"regulation of all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity\",metabolic process,0.512\nregulation of amacrine cell differentiation,morphogenesis/development,0.64\nregulation of amine catabolic process,metabolic process,0.83\nregulation of amine metabolic process,metabolic process,0.86\nregulation of amine transport,transport,0.566\nregulation of amino acid import across plasma membrane,transport,0.778\nregulation of amino acid transmembrane transport,transport,0.806\nregulation of amino acid transport,transport,0.836\nregulation of amino acid uptake involved in synaptic transmission,transport,0.556\nregulation of aminoacyl-tRNA ligase activity,metabolic process,0.518\nregulation of ammonia assimilation cycle,metabolic process,0.322\nregulation of amniotic stem cell differentiation,morphogenesis/development,0.83\nregulation of amyloid precursor protein biosynthetic process,metabolic process,0.768\nregulation of amyloid precursor protein catabolic process,metabolic process,0.544\nregulation of amyloid-beta clearance,multicellular organismal process,0.48\nregulation of amyloid-beta formation,metabolic process,0.408\nregulation of anaphase-promoting complex-dependent catabolic process,metabolic process,0.534\nregulation of androgen secretion,transport,0.502\nregulation of angiotensin levels in blood,immune system process,0.254\nregulation of angiotensin metabolic process,metabolic process,0.68\nregulation of angiotensin-activated signaling pathway,receptor related process,0.62\nregulation of animal organ formation,morphogenesis/development,0.792\nregulation of anion channel activity,transport,0.758\nregulation of anterior head development,morphogenesis/development,0.598\nregulation of anterograde axonal transport of mitochondrion,transport,0.752\nregulation of anterograde dense core granule transport,transport,0.706\nregulation of anterograde synaptic vesicle transport,transport,0.614\nregulation of anti-Mullerian hormone signaling pathway,receptor related process,0.468\nregulation of antibacterial peptide biosynthetic process,immune system process,0.524\nregulation of antibacterial peptide production,immune system process,0.642\nregulation of antibody-dependent cellular cytotoxicity,immune system process,0.896\nregulation of antifungal innate immune response,immune system process,0.754\nregulation of antigen processing and presentation,immune system process,0.7\nregulation of antigen processing and presentation of endogenous peptide antigen via MHC class I,immune system process,0.476\nregulation of antigen processing and presentation of peptide antigen,immune system process,0.586\nregulation of antigen processing and presentation of peptide antigen via MHC class I,immune system process,0.61\nregulation of antigen processing and presentation of peptide antigen via MHC class II,immune system process,0.6\nregulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,immune system process,0.608\nregulation of antimicrobial humoral response,immune system process,0.868\nregulation of antimicrobial peptide biosynthetic process,immune system process,0.522\nregulation of antimicrobial peptide production,immune system process,0.662\nregulation of antral ovarian follicle growth,morphogenesis/development,0.58\nregulation of aorta morphogenesis,morphogenesis/development,0.794\nregulation of aortic smooth muscle cell differentiation,morphogenesis/development,0.79\nregulation of apolipoprotein binding,protein modification/signaling,0.356\nregulation of apoptosis involved in tissue homeostasis,cell death,0.174\nregulation of apoptotic DNA fragmentation,metabolic process,0.304\nregulation of apoptotic cell clearance,transport,0.41\nregulation of apoptotic process,cell death,0.824\nregulation of apoptotic process in bone marrow cell,cell death,0.838\nregulation of apoptotic process involved in development,morphogenesis/development,0.416\nregulation of apoptotic process involved in metanephric collecting duct development,cell death,0.422\nregulation of apoptotic process involved in metanephric nephron tubule development,cell death,0.426\nregulation of apoptotic process involved in morphogenesis,morphogenesis/development,0.446\nregulation of apoptotic process involved in outflow tract morphogenesis,cell death,0.582\nregulation of appetite,immune system process,0.234\nregulation of arachidonic acid secretion,transport,0.722\nregulation of arginase activity,metabolic process,0.468\nregulation of arginine biosynthetic process,metabolic process,0.606\nregulation of arginine catabolic process,metabolic process,0.666\nregulation of arginine metabolic process,metabolic process,0.93\nregulation of artery morphogenesis,morphogenesis/development,0.79\nregulation of aspartate secretion,transport,0.652\nregulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,metabolic process,0.47\nregulation of aspartic-type peptidase activity,metabolic process,0.466\nregulation of astrocyte activation,morphogenesis/development,0.45\nregulation of astrocyte chemotaxis,immune system process,0.358\nregulation of asymmetric cell division,cell cycle,0.396\nregulation of atrial cardiac muscle cell action potential,multicellular organismal process,0.406\nregulation of atrial cardiac muscle cell membrane depolarization,transport,0.32\nregulation of atrial cardiac muscle cell membrane repolarization,transport,0.296\nregulation of attachment of mitotic spindle microtubules to kinetochore,cell cycle,0.724\nregulation of attachment of spindle microtubules to kinetochore,cell cycle,0.91\nregulation of autophagic cell death,cell death,0.446\nregulation of autophagosome assembly,cellular component organization,0.88\nregulation of autophagosome maturation,cellular component organization,0.386\nregulation of autophagosome size,cellular component organization,0.772\nregulation of autophagy of mitochondrion in response to mitochondrial depolarization,stress response,0.678\nregulation of axo-dendritic protein transport,transport,0.738\nregulation of axon diameter,neural related process,0.196\nregulation of axon extension,neural related process,0.26\nregulation of axon extension involved in axon guidance,morphogenesis/development,0.418\nregulation of axon extension involved in regeneration,morphogenesis/development,0.612\nregulation of axon guidance,neural related process,0.306\nregulation of barbed-end actin filament capping,cellular component organization,0.894\nregulation of base-excision repair,stress response,0.508\nregulation of basement membrane assembly involved in embryonic body morphogenesis,cellular component organization,0.392\nregulation of basement membrane organization,cellular component organization,0.772\nregulation of behavioral fear response,multicellular organismal process,0.302\nregulation of beta-catenin-TCF complex assembly,cellular component organization,0.708\nregulation of bicellular tight junction assembly,cellular component organization,0.66\nregulation of bile acid biosynthetic process,metabolic process,0.914\nregulation of bile acid secretion,transport,0.592\nregulation of binding of sperm to zona pellucida,cell cycle,0.182\nregulation of biological process,metabolic process,0.34\nregulation of biological quality,cellular component organization,0.21\nregulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria,immune system process,0.524\nregulation of blastocyst development,gene regulation,0.194\nregulation of bleb assembly,cellular component organization,0.782\nregulation of blood coagulation,immune system process,0.354\nregulation of blood microparticle formation,morphogenesis/development,0.38\nregulation of blood vessel branching,morphogenesis/development,0.808\nregulation of blood vessel endothelial cell differentiation,morphogenesis/development,0.624\nregulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,cell cycle,0.652\nregulation of blood vessel remodeling,morphogenesis/development,0.69\nregulation of blood volume by renal aldosterone,morphogenesis/development,0.184\nregulation of blood volume by renin-angiotensin,multicellular organismal process,0.61\nregulation of blood-brain barrier permeability,multicellular organismal process,0.526\nregulation of bone development,morphogenesis/development,0.684\nregulation of bone mineralization,morphogenesis/development,0.724\nregulation of bone mineralization involved in bone maturation,morphogenesis/development,0.578\nregulation of bone remodeling,multicellular organismal process,0.45\nregulation of bone resorption,multicellular organismal process,0.522\nregulation of bone trabecula formation,morphogenesis/development,0.632\nregulation of brain-derived neurotrophic factor receptor signaling pathway,receptor related process,0.812\nregulation of branch elongation involved in ureteric bud branching,morphogenesis/development,0.534\nregulation of branching involved in lung morphogenesis,morphogenesis/development,0.796\nregulation of branching involved in mammary gland duct morphogenesis,morphogenesis/development,0.718\nregulation of branching involved in prostate gland morphogenesis,morphogenesis/development,0.592\nregulation of branching involved in salivary gland morphogenesis,morphogenesis/development,0.722\nregulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling,morphogenesis/development,0.18\nregulation of branching involved in salivary gland morphogenesis by extracellular matrix-epithelial cell signaling,metabolic process,0.176\nregulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling,morphogenesis/development,0.286\nregulation of branching involved in ureteric bud morphogenesis,morphogenesis/development,0.866\nregulation of branching morphogenesis of a nerve,morphogenesis/development,0.732\nregulation of brood size,multicellular organismal process,0.478\nregulation of bundle of His cell action potential,immune system process,0.106\nregulation of cAMP-dependent protein kinase activity,protein modification/signaling,0.754\nregulation of cGMP-mediated signaling,protein modification/signaling,0.552\nregulation of calcidiol 1-monooxygenase activity,metabolic process,0.754\nregulation of calcineurin-NFAT signaling cascade,protein modification/signaling,0.484\nregulation of calcineurin-mediated signaling,protein modification/signaling,0.482\nregulation of calcium import into the mitochondrion,transport,0.84\nregulation of calcium ion binding,gene regulation,0.19\nregulation of calcium ion export across plasma membrane,transport,0.794\nregulation of calcium ion import,transport,0.74\nregulation of calcium ion import across plasma membrane,transport,0.834\nregulation of calcium ion import into sarcoplasmic reticulum,transport,0.678\nregulation of calcium ion transmembrane transport,transport,0.818\nregulation of calcium ion transmembrane transport via high voltage-gated calcium channel,transport,0.732\nregulation of calcium ion transmembrane transporter activity,transport,0.672\nregulation of calcium ion transport into cytosol,transport,0.65\nregulation of calcium ion-dependent exocytosis,transport,0.442\nregulation of calcium ion-dependent exocytosis of neurotransmitter,transport,0.35\nregulation of calcium-dependent ATPase activity,metabolic process,0.27\nregulation of calcium-dependent activation of synaptic vesicle fusion,neural related process,0.2\nregulation of calcium-dependent cell-cell adhesion,cell adhesion,0.498\nregulation of calcium-independent cell-cell adhesion,cell adhesion,0.484\nregulation of calcium-mediated signaling,protein modification/signaling,0.472\nregulation of calcium:sodium antiporter activity,transport,0.722\nregulation of canonical NF-kappaB signal transduction,immune system process,0.354\nregulation of canonical Wnt signaling pathway,protein modification/signaling,0.586\nregulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,receptor related process,0.356\nregulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation,protein modification/signaling,0.364\nregulation of canonical Wnt signaling pathway involved in heart development,receptor related process,0.378\nregulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation,morphogenesis/development,0.522\nregulation of canonical Wnt signaling pathway involved in osteoblast differentiation,receptor related process,0.388\nregulation of cap-dependent translational initiation,gene regulation,0.636\nregulation of cap-independent translational initiation,gene regulation,0.66\nregulation of carbohydrate biosynthetic process,metabolic process,0.904\nregulation of carbohydrate phosphatase activity,metabolic process,0.602\nregulation of cardiac cell fate specification,morphogenesis/development,0.77\nregulation of cardiac chamber formation,morphogenesis/development,0.6\nregulation of cardiac endothelial to mesenchymal transition,morphogenesis/development,0.62\nregulation of cardiac epithelial to mesenchymal transition,morphogenesis/development,0.58\nregulation of cardiac muscle adaptation,multicellular organismal process,0.424\nregulation of cardiac muscle cell action potential,neural related process,0.242\nregulation of cardiac muscle cell action potential involved in regulation of contraction,cellular component organization,0.148\nregulation of cardiac muscle cell apoptotic process,cell death,0.868\nregulation of cardiac muscle cell contraction,multicellular organismal process,0.506\nregulation of cardiac muscle cell differentiation,morphogenesis/development,0.882\nregulation of cardiac muscle cell membrane potential,cellular component organization,0.236\nregulation of cardiac muscle cell membrane repolarization,transport,0.262\nregulation of cardiac muscle cell myoblast differentiation,morphogenesis/development,0.836\nregulation of cardiac muscle cell proliferation,morphogenesis/development,0.504\nregulation of cardiac muscle contraction,multicellular organismal process,0.692\nregulation of cardiac muscle contraction by calcium ion signaling,multicellular organismal process,0.56\nregulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,protein modification/signaling,0.216\nregulation of cardiac muscle fiber development,morphogenesis/development,0.838\nregulation of cardiac muscle hypertrophy,multicellular organismal process,0.87\nregulation of cardiac muscle hypertrophy in response to stress,multicellular organismal process,0.414\nregulation of cardiac muscle myoblast proliferation,cell cycle,0.586\nregulation of cardiac muscle tissue development,morphogenesis/development,0.598\nregulation of cardiac muscle tissue growth,morphogenesis/development,0.634\nregulation of cardiac muscle tissue regeneration,morphogenesis/development,0.46\nregulation of cardiac myofibril assembly,cellular component organization,0.56\nregulation of cardiac neural crest cell migration involved in outflow tract morphogenesis,morphogenesis/development,0.382\nregulation of cardiac vascular smooth muscle cell differentiation,morphogenesis/development,0.8\nregulation of cardiac ventricle development,morphogenesis/development,0.578\nregulation of cardioblast cell fate specification,morphogenesis/development,0.718\nregulation of cardioblast differentiation,morphogenesis/development,0.836\nregulation of cardioblast proliferation,cell cycle,0.48\nregulation of cardiolipin metabolic process,metabolic process,0.522\nregulation of cargo loading into COPII-coated vesicle,transport,0.608\nregulation of cartilage development,morphogenesis/development,0.958\nregulation of catalase activity,metabolic process,0.538\nregulation of catalytic activity,metabolic process,0.494\nregulation of catecholamine metabolic process,metabolic process,0.8\nregulation of catecholamine secretion,transport,0.554\nregulation of catecholamine uptake involved in synaptic transmission,transport,0.442\nregulation of cation channel activity,transport,0.574\nregulation of caveolin-mediated endocytosis,transport,0.454\nregulation of cell adhesion involved in sprouting angiogenesis,cell adhesion,0.292\nregulation of cell adhesion molecule production,cell adhesion,0.258\nregulation of cell chemotaxis to fibroblast growth factor,immune system process,0.284\nregulation of cell communication,protein modification/signaling,0.198\nregulation of cell communication by chemical coupling,protein modification/signaling,0.212\nregulation of cell communication by electrical coupling,protein modification/signaling,0.234\nregulation of cell communication by electrical coupling involved in cardiac conduction,cell cycle,0.232\nregulation of cell cycle G1/S phase transition,cell cycle,0.952\nregulation of cell development,morphogenesis/development,0.586\nregulation of cell diameter,morphogenesis/development,0.242\nregulation of cell differentiation,morphogenesis/development,0.542\nregulation of cell differentiation involved in embryonic placenta development,morphogenesis/development,0.746\nregulation of cell differentiation involved in phenotypic switching,morphogenesis/development,0.77\nregulation of cell fate commitment,morphogenesis/development,0.358\nregulation of cell fate determination,morphogenesis/development,0.426\nregulation of cell growth by extracellular stimulus,morphogenesis/development,0.224\nregulation of cell growth involved in cardiac muscle cell development,morphogenesis/development,0.634\nregulation of cell maturation,morphogenesis/development,0.602\nregulation of cell migration,multicellular organismal process,0.504\nregulation of cell migration involved in somitogenic axis elongation,transport,0.202\nregulation of cell motility,other,0.6\nregulation of cell population proliferation,cell cycle,0.394\nregulation of cell projection organization,cellular component organization,0.752\nregulation of cell proliferation in bone marrow,cell cycle,0.734\nregulation of cell proliferation in midbrain,cell cycle,0.704\nregulation of cell proliferation involved in embryonic placenta development,cell cycle,0.694\nregulation of cell proliferation involved in heart morphogenesis,cell cycle,0.514\nregulation of cell proliferation involved in heart valve morphogenesis,cell cycle,0.624\nregulation of cell proliferation involved in kidney morphogenesis,cell cycle,0.212\nregulation of cell proliferation involved in mesonephros development,cell cycle,0.704\nregulation of cell proliferation involved in outflow tract morphogenesis,cell cycle,0.432\nregulation of cell proliferation involved in tissue homeostasis,cell cycle,0.194\nregulation of cell-cell adhesion involved in gastrulation,cell adhesion,0.448\nregulation of cell-cell adhesion mediated by integrin,cell adhesion,0.578\nregulation of cell-substrate junction assembly,cellular component organization,0.71\nregulation of cellular amino acid biosynthetic process,metabolic process,0.592\nregulation of cellular amino acid metabolic process,metabolic process,0.906\nregulation of cellular component organization,cellular component organization,0.57\nregulation of cellular defense response,immune system process,0.342\nregulation of cellular extravasation,immune system process,0.852\nregulation of cellular glucuronidation,metabolic process,0.492\nregulation of cellular hyperosmotic salinity response,stress response,0.434\nregulation of cellular metabolic process,metabolic process,0.808\nregulation of cellular organofluorine metabolic process,metabolic process,0.684\nregulation of cellular organohalogen metabolic process,metabolic process,0.684\nregulation of cellular pH reduction,other,0.23\nregulation of cellular process,metabolic process,0.3\nregulation of cellular response to X-ray,immune system process,0.29\nregulation of cellular response to alcohol,immune system process,0.256\nregulation of cellular response to drug,immune system process,0.28\nregulation of cellular response to hepatocyte growth factor stimulus,immune system process,0.29\nregulation of cellular response to hypoxia,stress response,0.412\nregulation of cellular response to insulin stimulus,immune system process,0.252\nregulation of cellular response to macrophage colony-stimulating factor stimulus,immune system process,0.458\nregulation of cellular response to osmotic stress,stress response,0.382\nregulation of cellular response to oxidative stress,stress response,0.58\nregulation of cellular response to testosterone stimulus,immune system process,0.292\nregulation of cellular response to vascular endothelial growth factor stimulus,immune system process,0.246\nregulation of cellular response to very-low-density lipoprotein particle stimulus,immune system process,0.272\nregulation of cellular senescence,metabolic process,0.206\nregulation of central B cell tolerance induction,immune system process,0.616\nregulation of central tolerance induction,immune system process,0.612\nregulation of centriole elongation,cell cycle,0.582\nregulation of centriole-centriole cohesion,cell cycle,0.446\nregulation of centromere complex assembly,cellular component organization,0.678\nregulation of centromeric sister chromatid cohesion,cell cycle,0.668\nregulation of centrosome duplication,cell cycle,0.624\nregulation of ceramide biosynthetic process,metabolic process,0.362\nregulation of cerebellar granule cell precursor proliferation,cell cycle,0.662\nregulation of chaperone-mediated autophagy,metabolic process,0.522\nregulation of chaperone-mediated protein complex assembly,cellular component organization,0.756\nregulation of chaperone-mediated protein folding,protein modification/signaling,0.346\nregulation of chemokine (C-C motif) ligand 1 production,immune system process,0.708\nregulation of chemokine (C-C motif) ligand 20 production,immune system process,0.672\nregulation of chemokine (C-C motif) ligand 4 production,immune system process,0.714\nregulation of chemokine (C-C motif) ligand 5 production,immune system process,0.756\nregulation of chemokine (C-X-C motif) ligand 1 production,immune system process,0.742\nregulation of chemokine (C-X-C motif) ligand 2 production,immune system process,0.774\nregulation of chemokine (C-X-C motif) ligand 9 production,immune system process,0.682\nregulation of chemokine-mediated signaling pathway,receptor related process,0.524\nregulation of chloride transport,transport,0.652\nregulation of cholangiocyte apoptotic process,cell death,0.62\nregulation of cholangiocyte proliferation,cell cycle,0.7\nregulation of cholesterol biosynthetic process,metabolic process,0.938\nregulation of cholesterol import,transport,0.832\nregulation of cholesterol transport,transport,0.93\nregulation of cholesterol transporter activity,transport,0.596\nregulation of choline O-acetyltransferase activity,metabolic process,0.444\nregulation of chondrocyte development,morphogenesis/development,0.824\nregulation of chondrocyte hypertrophy,morphogenesis/development,0.61\nregulation of chorionic trophoblast cell proliferation,cell cycle,0.702\nregulation of chromatin binding,gene regulation,0.616\nregulation of chromosome condensation,cell cycle,0.522\nregulation of chronic inflammatory response,immune system process,0.552\nregulation of chronic inflammatory response to antigenic stimulus,immune system process,0.846\nregulation of chronic inflammatory response to non-antigenic stimulus,immune system process,0.602\nregulation of chylomicron remnant clearance,multicellular organismal process,0.568\nregulation of cilium assembly,cellular component organization,0.82\nregulation of cilium beat frequency,transport,0.274\nregulation of cilium beat frequency involved in ciliary motility,morphogenesis/development,0.154\nregulation of cilium movement,transport,0.264\nregulation of cilium movement involved in cell motility,other,0.178\nregulation of cilium-dependent cell motility,other,0.19\nregulation of circadian rhythm,other,0.184\nregulation of circadian sleep/wake cycle,neural related process,0.33\n\"regulation of circadian sleep/wake cycle, REM sleep\",multicellular organismal process,0.348\n\"regulation of circadian sleep/wake cycle, non-REM sleep\",multicellular organismal process,0.332\n\"regulation of circadian sleep/wake cycle, sleep\",neural related process,0.318\n\"regulation of circadian sleep/wake cycle, wakefulness\",multicellular organismal process,0.398\nregulation of citrulline biosynthetic process,metabolic process,0.632\nregulation of clathrin coat assembly,cellular component organization,0.746\nregulation of clathrin-dependent endocytosis,transport,0.458\nregulation of coagulation,multicellular organismal process,0.45\nregulation of cobalamin metabolic process,metabolic process,0.822\nregulation of cohesin loading,cell cycle,0.454\nregulation of collagen binding,gene regulation,0.214\nregulation of collagen catabolic process,metabolic process,0.792\nregulation of collagen fibril organization,cellular component organization,0.474\nregulation of collateral sprouting,morphogenesis/development,0.418\nregulation of collateral sprouting in absence of injury,morphogenesis/development,0.454\nregulation of collateral sprouting of intact axon in response to injury,neural related process,0.376\nregulation of colon smooth muscle contraction,multicellular organismal process,0.668\n\"regulation of complement activation, alternative pathway\",immune system process,0.766\n\"regulation of complement activation, classical pathway\",immune system process,0.798\n\"regulation of complement activation, lectin pathway\",immune system process,0.838\nregulation of complement-dependent cytotoxicity,cell cycle,0.248\nregulation of connective tissue growth factor production,immune system process,0.69\nregulation of connective tissue replacement,multicellular organismal process,0.608\nregulation of connective tissue replacement involved in inflammatory response wound healing,multicellular organismal process,0.468\nregulation of constitutive secretory pathway,transport,0.45\nregulation of convergent extension involved in axis elongation,morphogenesis/development,0.794\nregulation of convergent extension involved in gastrulation,morphogenesis/development,0.804\nregulation of copper ion transmembrane transport,transport,0.808\nregulation of core promoter binding,gene regulation,0.36\nregulation of corticosteroid hormone secretion,transport,0.596\nregulation of corticosterone secretion,transport,0.52\nregulation of corticotropin secretion,transport,0.414\nregulation of corticotropin-releasing hormone receptor activity,receptor related process,0.572\nregulation of corticotropin-releasing hormone secretion,transport,0.53\nregulation of cortisol biosynthetic process,metabolic process,0.608\nregulation of cortisol secretion,transport,0.518\nregulation of creatine transmembrane transporter activity,transport,0.716\nregulation of cristae formation,cellular component organization,0.496\nregulation of cyclase activity,metabolic process,0.38\nregulation of cyclic nucleotide-gated ion channel activity,transport,0.7\nregulation of cyclic-nucleotide phosphodiesterase activity,metabolic process,0.624\nregulation of cystathionine beta-synthase activity,metabolic process,0.438\nregulation of cysteine metabolic process,metabolic process,0.584\nregulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,cell death,0.362\nregulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,cell death,0.314\nregulation of cytochrome-c oxidase activity,transport,0.488\nregulation of cytokine activity,receptor related process,0.412\nregulation of cytokine production involved in inflammatory response,immune system process,0.808\n\"regulation of cytokinesis, actomyosin contractile ring assembly\",cellular component organization,0.486\nregulation of cytokinetic process,cell cycle,0.658\nregulation of cytoplasmic mRNA processing body assembly,cellular component organization,0.7\nregulation of cytoplasmic translation in response to stress,stress response,0.478\nregulation of cytoplasmic translational elongation,gene regulation,0.666\nregulation of cytoplasmic translational fidelity,cellular component organization,0.24\nregulation of cytoplasmic translational initiation,gene regulation,0.702\nregulation of cytoplasmic translational initiation in response to stress,stress response,0.516\nregulation of cytoskeleton organization,cellular component organization,0.784\nregulation of cytosolic calcium ion concentration,other,0.442\nregulation of cytotoxic T cell degranulation,immune system process,0.724\nregulation of cytotoxic T cell differentiation,immune system process,0.718\nregulation of deacetylase activity,metabolic process,0.5\nregulation of deadenylation-dependent decapping of nuclear-transcribed mRNA,gene regulation,0.672\nregulation of deadenylation-independent decapping of nuclear-transcribed mRNA,gene regulation,0.634\nregulation of death-inducing signaling complex assembly,cellular component organization,0.634\nregulation of defecation,multicellular organismal process,0.356\nregulation of defense response to bacterium,immune system process,0.512\nregulation of defense response to fungus,immune system process,0.69\nregulation of definitive erythrocyte differentiation,morphogenesis/development,0.286\nregulation of delayed rectifier potassium channel activity,transport,0.716\nregulation of dendrite extension,morphogenesis/development,0.61\nregulation of dendrite morphogenesis,morphogenesis/development,0.55\nregulation of dendritic cell antigen processing and presentation,immune system process,0.676\nregulation of dendritic cell apoptotic process,cell death,0.716\nregulation of dendritic cell chemotaxis,immune system process,0.724\nregulation of dendritic cell cytokine production,immune system process,0.898\nregulation of dendritic cell dendrite assembly,cellular component organization,0.758\nregulation of dendritic cell differentiation,immune system process,0.612\nregulation of dendritic spine development,morphogenesis/development,0.544\nregulation of dendritic spine maintenance,cellular component organization,0.458\nregulation of dendritic spine morphogenesis,neural related process,0.506\nregulation of dense core granule biogenesis,cellular component organization,0.636\nregulation of dense core granule exocytosis,transport,0.47\nregulation of dense core granule transport,transport,0.708\nregulation of deoxyribonuclease activity,metabolic process,0.34\nregulation of dermatome development,morphogenesis/development,0.866\nregulation of detection of glucose,immune system process,0.304\nregulation of determination of dorsal identity,multicellular organismal process,0.512\n\"regulation of development, heterochronic\",morphogenesis/development,0.714\nregulation of developmental pigmentation,morphogenesis/development,0.476\nregulation of developmental process,morphogenesis/development,0.4\nregulation of diacylglycerol biosynthetic process,metabolic process,0.55\nregulation of diacylglycerol kinase activity,metabolic process,0.368\nregulation of digestive system process,multicellular organismal process,0.388\nregulation of dipeptide transmembrane transport,transport,0.782\nregulation of dipeptide transport,transport,0.932\nregulation of dopamine biosynthetic process,metabolic process,0.56\nregulation of dopamine metabolic process,metabolic process,0.826\nregulation of dopamine receptor signaling pathway,receptor related process,0.802\nregulation of dopamine secretion,transport,0.528\nregulation of dopamine uptake involved in synaptic transmission,transport,0.502\nregulation of dopaminergic neuron differentiation,morphogenesis/development,0.608\nregulation of double-strand break repair via homologous recombination,stress response,0.692\nregulation of double-strand break repair via nonhomologous end joining,stress response,0.604\nregulation of double-stranded telomeric DNA binding,gene regulation,0.268\nregulation of eIF2 alpha phosphorylation by dsRNA,gene regulation,0.302\nregulation of eIF2 alpha phosphorylation by heme,protein modification/signaling,0.196\nregulation of early endosome to recycling endosome transport,transport,0.616\nregulation of eating behavior,multicellular organismal process,0.47\nregulation of ectoderm development,morphogenesis/development,0.572\nregulation of ectodermal cell fate specification,morphogenesis/development,0.614\nregulation of elastin biosynthetic process,metabolic process,0.802\nregulation of elastin catabolic process,metabolic process,0.85\nregulation of electron transfer activity,metabolic process,0.574\nregulation of embryonic cell shape,morphogenesis/development,0.726\nregulation of enamel mineralization,morphogenesis/development,0.54\nregulation of endocannabinoid signaling pathway,protein modification/signaling,0.284\nregulation of endocardial cushion to mesenchymal transition,morphogenesis/development,0.63\nregulation of endocardial cushion to mesenchymal transition involved in heart valve formation,morphogenesis/development,0.624\nregulation of endocrine process,multicellular organismal process,0.558\nregulation of endocytic recycling,transport,0.596\nregulation of endodeoxyribonuclease activity,metabolic process,0.352\nregulation of endodermal cell differentiation,morphogenesis/development,0.81\nregulation of endodermal cell fate specification,morphogenesis/development,0.744\nregulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation,gene regulation,0.336\nregulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation,ER/endosome/lysosome related process,0.15\nregulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway,cell death,0.528\nregulation of endoplasmic reticulum tubular network organization,cellular component organization,0.49\nregulation of endoribonuclease activity,gene regulation,0.342\nregulation of endosomal vesicle fusion,transport,0.358\nregulation of endosome organization,cellular component organization,0.492\nregulation of endosome size,cellular component organization,0.694\nregulation of endosome to plasma membrane protein transport,transport,0.614\nregulation of endothelial cell chemotaxis,multicellular organismal process,0.336\nregulation of endothelial cell chemotaxis to fibroblast growth factor,multicellular organismal process,0.264\nregulation of endothelial cell development,morphogenesis/development,0.674\nregulation of endothelial cell-matrix adhesion via fibronectin,cell adhesion,0.338\nregulation of endothelial tube morphogenesis,morphogenesis/development,0.812\nregulation of endothelin production,immune system process,0.7\nregulation of engulfment of apoptotic cell,transport,0.422\nregulation of entry of bacterium into host cell,viral related process,0.166\nregulation of eosinophil activation,immune system process,0.666\nregulation of eosinophil chemotaxis,immune system process,0.812\nregulation of eosinophil degranulation,immune system process,0.652\nregulation of eosinophil differentiation,immune system process,0.566\nregulation of eosinophil extravasation,immune system process,0.678\nregulation of eosinophil migration,immune system process,0.772\nregulation of ephrin receptor signaling pathway,receptor related process,0.756\nregulation of epidermal cell division,morphogenesis/development,0.188\nregulation of epidermal growth factor-activated receptor activity,protein modification/signaling,0.596\nregulation of epinephrine secretion,transport,0.598\nregulation of epithelial cell differentiation involved in kidney development,morphogenesis/development,0.758\nregulation of epithelial cell proliferation involved in lung morphogenesis,cell cycle,0.658\nregulation of epithelial cell proliferation involved in prostate gland development,cell cycle,0.518\nregulation of epithelial to mesenchymal transition,morphogenesis/development,0.75\nregulation of epithelial to mesenchymal transition involved in endocardial cushion formation,morphogenesis/development,0.606\nregulation of epithelial tube formation,morphogenesis/development,0.86\nregulation of epithelium regeneration,morphogenesis/development,0.458\nregulation of error-prone translesion synthesis,stress response,0.4\nregulation of erythrocyte apoptotic process,cell death,0.878\nregulation of erythrocyte enucleation,morphogenesis/development,0.464\nregulation of establishment of RNA localization to telomere,transport,0.402\nregulation of establishment of Sertoli cell barrier,morphogenesis/development,0.584\nregulation of establishment of T cell polarity,cellular component organization,0.338\nregulation of establishment of bipolar cell polarity,cellular component organization,0.308\nregulation of establishment of blood-brain barrier,morphogenesis/development,0.6\nregulation of establishment of endothelial barrier,morphogenesis/development,0.672\nregulation of establishment of planar polarity involved in neural tube closure,cellular component organization,0.498\nregulation of establishment of protein localization,transport,0.526\nregulation of establishment of protein localization to chromosome,transport,0.576\nregulation of establishment of protein localization to mitochondrion,cellular component organization,0.448\nregulation of establishment of protein localization to telomere,transport,0.564\nregulation of establishment of protein-containing complex localization to telomere,transport,0.418\nregulation of establishment or maintenance of cell polarity,cellular component organization,0.538\nregulation of establishment or maintenance of cell polarity regulating cell shape,morphogenesis/development,0.514\nregulation of estradiol secretion,transport,0.506\nregulation of eukaryotic translation initiation factor 4F complex assembly,cellular component organization,0.67\nregulation of excitatory postsynaptic membrane potential involved in skeletal muscle contraction,neural related process,0.334\nregulation of excitatory synapse assembly,cellular component organization,0.614\nregulation of excretion,multicellular organismal process,0.37\nregulation of exo-alpha-sialidase activity,metabolic process,0.456\nregulation of exocyst assembly,cellular component organization,0.632\nregulation of exocyst localization,cellular component organization,0.318\nregulation of exocytic insertion of neurotransmitter receptor to postsynaptic membrane,neural related process,0.27\nregulation of exocytosis,transport,0.554\nregulation of exonuclease activity,metabolic process,0.552\nregulation of exosomal secretion,transport,0.582\nregulation of extent of cell growth,cellular component organization,0.424\nregulation of extracellular exosome assembly,cellular component organization,0.784\nregulation of extracellular matrix assembly,cellular component organization,0.74\nregulation of extracellular matrix constituent secretion,transport,0.37\nregulation of extracellular matrix disassembly,cellular component organization,0.586\nregulation of extrathymic T cell differentiation,immune system process,0.776\nregulation of eye photoreceptor cell development,morphogenesis/development,0.63\nregulation of eye pigmentation,morphogenesis/development,0.404\nregulation of fast-twitch skeletal muscle fiber contraction,multicellular organismal process,0.64\nregulation of fat cell apoptotic process,cell death,0.612\nregulation of fat cell proliferation,cell cycle,0.752\nregulation of fatty acid beta-oxidation,metabolic process,0.82\nregulation of fatty acid beta-oxidation using acyl-CoA dehydrogenase,metabolic process,0.762\nregulation of fatty acid biosynthetic process,metabolic process,0.96\nregulation of fatty acid transport,transport,0.832\nregulation of fear response,multicellular organismal process,0.296\nregulation of feeding behavior,multicellular organismal process,0.366\nregulation of female gonad development,morphogenesis/development,0.586\nregulation of female receptivity,multicellular organismal process,0.51\nregulation of fermentation,metabolic process,0.436\nregulation of ferrochelatase activity,metabolic process,0.606\nregulation of ferroptosis,cell death,0.444\nregulation of ferrous iron binding,gene regulation,0.226\nregulation of fertilization,cell cycle,0.202\nregulation of fever generation,immune system process,0.444\nregulation of fibrinolysis,immune system process,0.338\nregulation of fibroblast apoptotic process,cell death,0.882\nregulation of fibroblast growth factor production,immune system process,0.652\nregulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,receptor related process,0.794\nregulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,receptor related process,0.792\nregulation of fibronectin-dependent thymocyte migration,immune system process,0.77\nregulation of filamentous growth,multicellular organismal process,0.262\nregulation of filamentous growth of a population of unicellular organisms,immune system process,0.256\nregulation of filopodium assembly,cellular component organization,0.734\nregulation of flagellated sperm motility,cell cycle,0.232\nregulation of focal adhesion disassembly,cellular component organization,0.602\nregulation of follicle-stimulating hormone secretion,transport,0.338\nregulation of forebrain neuron differentiation,morphogenesis/development,0.586\nregulation of formation of translation preinitiation complex,gene regulation,0.536\nregulation of fractalkine production,immune system process,0.708\nregulation of free ubiquitin chain polymerization,cellular component organization,0.696\n\"regulation of fructose 1,6-bisphosphate 1-phosphatase activity\",metabolic process,0.642\n\"regulation of fructose 1,6-bisphosphate metabolic process\",metabolic process,0.738\nregulation of fusion of sperm to egg plasma membrane,multicellular organismal process,0.292\nregulation of fusion of virus membrane with host plasma membrane,cellular component organization,0.42\nregulation of gamma-aminobutyric acid secretion,transport,0.634\nregulation of gamma-delta T cell activation,immune system process,0.814\nregulation of gamma-delta T cell differentiation,immune system process,0.728\nregulation of gap junction assembly,cellular component organization,0.666\nregulation of gastric acid secretion,multicellular organismal process,0.324\nregulation of gastric motility,multicellular organismal process,0.538\nregulation of gastric mucosal blood circulation,multicellular organismal process,0.642\nregulation of gastrin-induced gastric acid secretion,multicellular organismal process,0.336\nregulation of gastro-intestinal system smooth muscle contraction,multicellular organismal process,0.618\nregulation of gene expression,metabolic process,0.6\nregulation of gene silencing by regulatory ncRNA,gene regulation,0.608\nregulation of germ cell proliferation,cell cycle,0.418\nregulation of germinal center formation,immune system process,0.496\nregulation of glial cell apoptotic process,cell death,0.856\nregulation of glial cell migration,immune system process,0.266\nregulation of glial cell-derived neurotrophic factor production,immune system process,0.664\nregulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,receptor related process,0.728\nregulation of glomerular filtration,multicellular organismal process,0.566\nregulation of glomerular mesangial cell proliferation,cell cycle,0.726\nregulation of glomerulus development,morphogenesis/development,0.858\nregulation of glucagon secretion,transport,0.498\nregulation of glucan biosynthetic process,metabolic process,0.864\nregulation of glucocorticoid biosynthetic process,metabolic process,0.896\nregulation of glucocorticoid metabolic process,metabolic process,0.91\nregulation of glucocorticoid receptor signaling pathway,receptor related process,0.794\nregulation of glucocorticoid secretion,transport,0.58\nregulation of glucokinase activity,metabolic process,0.496\nregulation of gluconeogenesis,metabolic process,0.542\nregulation of glucose catabolic process to lactate via pyruvate,metabolic process,0.674\nregulation of glucose import,transport,0.69\nregulation of glucose mediated signaling pathway,receptor related process,0.568\nregulation of glucose metabolic process,metabolic process,0.886\nregulation of glucose transmembrane transport,transport,0.906\nregulation of glucosylceramidase activity,metabolic process,0.45\nregulation of glucosylceramide biosynthetic process,metabolic process,0.72\nregulation of glucosylceramide catabolic process,metabolic process,0.564\nregulation of glucuronosyltransferase activity,metabolic process,0.446\nregulation of glutamate metabolic process,metabolic process,0.694\nregulation of glutamate receptor clustering,transport,0.338\nregulation of glutamate receptor signaling pathway,receptor related process,0.726\nregulation of glutamate secretion,transport,0.628\n\"regulation of glutamate secretion, neurotransmission\",transport,0.428\nregulation of glutamate uptake involved in transmission of nerve impulse,transport,0.69\nregulation of glutamate-cysteine ligase activity,metabolic process,0.524\nregulation of glutamatergic neuron differentiation,morphogenesis/development,0.602\nregulation of glutamine family amino acid metabolic process,metabolic process,0.908\nregulation of glutamine transport,transport,0.686\nregulation of glutathione biosynthetic process,metabolic process,0.53\nregulation of glutathione peroxidase activity,metabolic process,0.518\nregulation of glycine import across plasma membrane,transport,0.744\nregulation of glycogen (starch) synthase activity,metabolic process,0.48\nregulation of glycogen biosynthetic process,metabolic process,0.866\nregulation of glycogen catabolic process,metabolic process,0.852\nregulation of glycogen metabolic process,metabolic process,0.908\n\"regulation of glycogen synthase activity, transferring glucose-1-phosphate\",metabolic process,0.524\nregulation of glycolytic process,metabolic process,0.692\nregulation of glycolytic process through fructose-6-phosphate,metabolic process,0.666\nregulation of glycoprotein biosynthetic process,metabolic process,0.694\nregulation of glycoprotein metabolic process,metabolic process,0.682\nregulation of gonad development,morphogenesis/development,0.6\nregulation of gonadotropin secretion,transport,0.328\nregulation of granulocyte colony-stimulating factor production,immune system process,0.76\nregulation of granulocyte differentiation,immune system process,0.62\nregulation of granulocyte macrophage colony-stimulating factor production,immune system process,0.562\nregulation of granulosa cell apoptotic process,cell death,0.626\nregulation of granulosa cell proliferation,cell cycle,0.744\nregulation of granzyme A production,immune system process,0.574\nregulation of granzyme B production,immune system process,0.83\nregulation of grooming behavior,neural related process,0.178\nregulation of growth hormone activity,receptor related process,0.552\nregulation of growth hormone receptor signaling pathway,receptor related process,0.814\nregulation of growth hormone secretion,transport,0.508\nregulation of growth of unicellular organism as a thread of attached cells,cell cycle,0.326\nregulation of growth rate,cellular component organization,0.166\nregulation of guanyl-nucleotide exchange factor activity,metabolic process,0.438\nregulation of guanylate cyclase activity,metabolic process,0.504\nregulation of hair cycle by canonical Wnt signaling pathway,receptor related process,0.318\nregulation of hair follicle cell proliferation,cell cycle,0.754\nregulation of hair follicle development,morphogenesis/development,0.546\nregulation of hair follicle maturation,morphogenesis/development,0.582\nregulation of hair follicle placode formation,morphogenesis/development,0.854\nregulation of heart growth,morphogenesis/development,0.608\nregulation of heart induction,morphogenesis/development,0.678\nregulation of heart induction by canonical Wnt signaling pathway,morphogenesis/development,0.544\nregulation of heart induction by regulation of canonical Wnt signaling pathway,morphogenesis/development,0.39\nregulation of heart looping,morphogenesis/development,0.792\nregulation of heart morphogenesis,morphogenesis/development,0.858\nregulation of heart rate by cardiac conduction,multicellular organismal process,0.14\nregulation of heart rate by chemical signal,multicellular organismal process,0.594\nregulation of heart rate by hormone,morphogenesis/development,0.182\nregulation of heat generation,multicellular organismal process,0.53\nregulation of hematopoietic progenitor cell differentiation,morphogenesis/development,0.532\nregulation of hematopoietic stem cell migration,morphogenesis/development,0.214\nregulation of hematopoietic stem cell proliferation,cell cycle,0.716\nregulation of heme biosynthetic process,metabolic process,0.856\nregulation of heme oxygenase activity,metabolic process,0.582\nregulation of hemocyte differentiation,morphogenesis/development,0.426\nregulation of hemoglobin biosynthetic process,metabolic process,0.782\nregulation of hemostasis,multicellular organismal process,0.566\nregulation of heparan sulfate binding,gene regulation,0.23\nregulation of heparan sulfate proteoglycan binding,protein modification/signaling,0.364\nregulation of heparan sulfate proteoglycan biosynthetic process,metabolic process,0.816\nregulation of hepatic stellate cell activation,multicellular organismal process,0.38\nregulation of hepatic stellate cell contraction,cell cycle,0.2\nregulation of hepatic stellate cell migration,morphogenesis/development,0.216\nregulation of hepatic stellate cell proliferation,cell cycle,0.722\nregulation of hepatocyte apoptotic process,cell death,0.634\nregulation of hepatocyte differentiation,morphogenesis/development,0.686\nregulation of hepatocyte growth factor production,immune system process,0.454\nregulation of hepatocyte growth factor receptor signaling pathway,receptor related process,0.856\nregulation of hepatocyte proliferation,cell cycle,0.666\nregulation of heterotypic cell-cell adhesion,cell adhesion,0.518\nregulation of hexokinase activity,metabolic process,0.374\nregulation of high voltage-gated calcium channel activity,transport,0.726\nregulation of high-density lipoprotein particle assembly,cellular component organization,0.61\nregulation of high-density lipoprotein particle clearance,multicellular organismal process,0.64\nregulation of hindgut contraction,multicellular organismal process,0.626\nregulation of hippo signaling,protein modification/signaling,0.562\nregulation of hippocampal neuron apoptotic process,cell death,0.572\nregulation of histamine secretion by mast cell,transport,0.232\nregulation of histone H2A K63-linked ubiquitination,protein modification/signaling,0.696\nregulation of histone H3-K27 methylation,gene regulation,0.57\nregulation of histone H3-K27 trimethylation,gene regulation,0.412\nregulation of histone H3-K9 acetylation,protein modification/signaling,0.518\nregulation of histone H3-K9 dimethylation,gene regulation,0.414\nregulation of histone H3-K9 methylation,gene regulation,0.648\nregulation of histone H3-K9 trimethylation,gene regulation,0.422\nregulation of histone H4 acetylation,gene regulation,0.518\nregulation of histone deacetylase activity,protein modification/signaling,0.508\nregulation of histone deacetylation,protein modification/signaling,0.612\nregulation of histone modification,gene regulation,0.614\nregulation of histone ubiquitination,protein modification/signaling,0.602\nregulation of homocysteine metabolic process,metabolic process,0.878\nregulation of homologous chromosome segregation,cell cycle,0.642\nregulation of homophilic cell adhesion,cell adhesion,0.422\nregulation of hormone levels,transport,0.332\nregulation of hormone secretion,transport,0.662\nregulation of humoral immune response,immune system process,0.862\nregulation of humoral immune response mediated by circulating immunoglobulin,immune system process,0.884\nregulation of hyaluranon cable assembly,cellular component organization,0.788\nregulation of hyaluronan biosynthetic process,metabolic process,0.442\nregulation of hydrogen peroxide biosynthetic process,metabolic process,0.648\nregulation of hydrogen peroxide catabolic process,metabolic process,0.58\nregulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway,cell death,0.548\nregulation of hydrogen peroxide-mediated programmed cell death,cell death,0.514\nregulation of hydrogen sulfide biosynthetic process,metabolic process,0.516\nregulation of hypersensitivity,immune system process,0.922\nregulation of hypoxia-induced intrinsic apoptotic signaling pathway,cell death,0.514\nregulation of hypoxia-inducible factor-1alpha signaling pathway,receptor related process,0.462\nregulation of immature T cell proliferation,immune system process,0.81\nregulation of immature T cell proliferation in thymus,immune system process,0.81\nregulation of immune complex clearance by monocytes and macrophages,immune system process,0.566\nregulation of immune response to tumor cell,immune system process,0.796\nregulation of immune system process,immune system process,0.562\nregulation of immunoglobulin mediated immune response,immune system process,0.964\nregulation of immunoglobulin production,immune system process,0.822\nregulation of immunoglobulin production in mucosal tissue,immune system process,0.754\nregulation of immunological synapse formation,immune system process,0.69\nregulation of inclusion body assembly,cellular component organization,0.838\nregulation of inflammasome-mediated signaling pathway,immune system process,0.828\nregulation of inflammatory response to wounding,immune system process,0.57\nregulation of inhibitory G protein-coupled receptor phosphorylation,protein modification/signaling,0.566\nregulation of inhibitory synapse assembly,cellular component organization,0.69\nregulation of inner ear auditory receptor cell differentiation,morphogenesis/development,0.63\nregulation of inner ear auditory receptor cell fate specification,morphogenesis/development,0.582\nregulation of inner ear receptor cell differentiation,morphogenesis/development,0.594\nregulation of inorganic anion transmembrane transport,transport,0.768\n\"regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity\",transport,0.712\nregulation of inositol phosphate biosynthetic process,metabolic process,0.878\nregulation of inositol trisphosphate biosynthetic process,metabolic process,0.902\nregulation of inositol-polyphosphate 5-phosphatase activity,metabolic process,0.626\nregulation of insulin secretion,transport,0.658\nregulation of insulin secretion involved in cellular response to glucose stimulus,transport,0.466\nregulation of integrin biosynthetic process,metabolic process,0.79\nregulation of interleukin-1 alpha production,immune system process,0.714\nregulation of interleukin-1-mediated signaling pathway,receptor related process,0.39\nregulation of interleukin-15 production,immune system process,0.724\nregulation of interleukin-16 production,immune system process,0.74\nregulation of interleukin-17-mediated signaling pathway,receptor related process,0.422\nregulation of interleukin-17A production,immune system process,0.692\nregulation of interleukin-18 production,immune system process,0.74\nregulation of interleukin-18-mediated signaling pathway,receptor related process,0.388\nregulation of interleukin-2-mediated signaling pathway,receptor related process,0.426\nregulation of interleukin-21 production,immune system process,0.73\nregulation of interleukin-23 production,immune system process,0.798\nregulation of interleukin-3 production,immune system process,0.764\nregulation of interleukin-33 production,immune system process,0.692\nregulation of interleukin-4-dependent isotype switching to IgE isotypes,immune system process,0.738\nregulation of interleukin-4-mediated signaling pathway,receptor related process,0.426\nregulation of interleukin-6-mediated signaling pathway,receptor related process,0.414\nregulation of intermediate filament depolymerization,cellular component organization,0.496\nregulation of intermediate filament polymerization or depolymerization,cellular component organization,0.668\nregulation of intestinal absorption,multicellular organismal process,0.342\nregulation of intestinal cholesterol absorption,transport,0.434\nregulation of intestinal epithelial structure maintenance,multicellular organismal process,0.536\nregulation of intestinal lipid absorption,transport,0.408\nregulation of intracellular calcium activated chloride channel activity,transport,0.728\nregulation of intracellular cholesterol transport,transport,0.834\nregulation of intracellular lipid transport,transport,0.838\nregulation of intracellular mRNA localization,transport,0.356\nregulation of intracellular pH,other,0.484\nregulation of intracellular signal transduction,protein modification/signaling,0.566\nregulation of intracellular sterol transport,transport,0.836\nregulation of intracellular transport of viral material,viral related process,0.398\nregulation of intraciliary retrograde transport,transport,0.756\nregulation of intralumenal vesicle formation,cellular component organization,0.462\nregulation of intrinsic apoptotic signaling pathway by p53 class mediator,cell death,0.812\nregulation of intrinsic apoptotic signaling pathway in response to DNA damage,cell death,0.812\nregulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide,cell death,0.568\nregulation of intrinsic apoptotic signaling pathway in response to osmotic stress,cell death,0.662\nregulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,cell death,0.68\nregulation of inward rectifier potassium channel activity,transport,0.734\nregulation of iron ion import across plasma membrane,transport,0.82\nregulation of iron ion transmembrane transport,transport,0.93\nregulation of iron ion transport,transport,0.96\nregulation of iron-sulfur cluster assembly,cellular component organization,0.628\nregulation of isomerase activity,metabolic process,0.396\nregulation of isoprenoid metabolic process,metabolic process,0.904\nregulation of isotype switching,immune system process,0.834\nregulation of isotype switching to IgA isotypes,immune system process,0.748\nregulation of isotype switching to IgE isotypes,immune system process,0.784\nregulation of kainate selective glutamate receptor activity,receptor related process,0.3\nregulation of keratinocyte apoptotic process,cell death,0.852\nregulation of keratinocyte migration,multicellular organismal process,0.422\nregulation of keratinocyte proliferation,cell cycle,0.828\nregulation of ketone biosynthetic process,metabolic process,0.87\nregulation of kidney size,morphogenesis/development,0.444\nregulation of kidney smooth muscle cell differentiation,morphogenesis/development,0.804\nregulation of killing of cells of another organism,cell death,0.19\nregulation of kinase activity,protein modification/signaling,0.712\nregulation of kinetochore assembly,cellular component organization,0.654\nregulation of lactation,morphogenesis/development,0.434\nregulation of lamellipodium morphogenesis,morphogenesis/development,0.466\nregulation of lamellipodium organization,cellular component organization,0.722\nregulation of large conductance calcium-activated potassium channel activity,transport,0.75\nregulation of late endosome to lysosome transport,transport,0.662\nregulation of lateral attachment of mitotic spindle microtubules to kinetochore,cell cycle,0.61\nregulation of lateral mesodermal cell fate specification,morphogenesis/development,0.746\nregulation of lateral motor column neuron migration,neural related process,0.288\nregulation of lens epithelial cell proliferation,cell cycle,0.748\nregulation of lens fiber cell differentiation,morphogenesis/development,0.682\nregulation of leucine import,transport,0.812\nregulation of leucine import across plasma membrane,transport,0.738\nregulation of leukocyte adhesion to arterial endothelial cell,immune system process,0.392\nregulation of leukocyte degranulation,immune system process,0.774\nregulation of leukocyte tethering or rolling,immune system process,0.782\nregulation of leukotriene production involved in inflammatory response,immune system process,0.384\nregulation of ligase activity,metabolic process,0.572\nregulation of lipase activity,metabolic process,0.684\nregulation of lipid binding,gene regulation,0.218\nregulation of lipid catabolic process,metabolic process,0.908\nregulation of lipid transport across blood-brain barrier,transport,0.478\nregulation of lipid transporter activity,transport,0.59\nregulation of lipophagy,metabolic process,0.398\nregulation of lipopolysaccharide-mediated signaling pathway,immune system process,0.326\nregulation of lipoprotein lipid oxidation,protein modification/signaling,0.35\nregulation of lipoprotein oxidation,metabolic process,0.336\nregulation of lipoprotein particle clearance,multicellular organismal process,0.668\nregulation of lncRNA transcription,gene regulation,0.842\nregulation of localization,transport,0.322\nregulation of locomotion,other,0.602\nregulation of locomotion involved in locomotory behavior,multicellular organismal process,0.402\nregulation of locomotor rhythm,multicellular organismal process,0.516\nregulation of long-chain fatty acid import across plasma membrane,transport,0.846\nregulation of long-chain fatty acid import into cell,transport,0.738\nregulation of long-term neuronal synaptic plasticity,neural related process,0.56\nregulation of long-term synaptic depression,neural related process,0.338\nregulation of long-term synaptic potentiation,neural related process,0.414\nregulation of low-density lipoprotein particle clearance,multicellular organismal process,0.64\nregulation of low-density lipoprotein particle receptor binding,receptor related process,0.358\nregulation of low-density lipoprotein particle receptor catabolic process,metabolic process,0.824\nregulation of lung blood pressure,multicellular organismal process,0.234\nregulation of lung ciliated cell differentiation,morphogenesis/development,0.672\nregulation of lung goblet cell differentiation,morphogenesis/development,0.676\nregulation of luteinizing hormone secretion,transport,0.324\nregulation of lyase activity,metabolic process,0.554\nregulation of lymphangiogenesis,morphogenesis/development,0.814\nregulation of lymphocyte anergy,immune system process,0.732\nregulation of lymphoid progenitor cell differentiation,morphogenesis/development,0.64\nregulation of lymphotoxin A production,immune system process,0.488\nregulation of lysosomal lumen pH,cellular component organization,0.44\nregulation of lysosomal membrane permeability,cellular component organization,0.776\nregulation of lysosomal protein catabolic process,metabolic process,0.676\nregulation of lysosome organization,cellular component organization,0.53\nregulation of lysosome size,cellular component organization,0.238\nregulation of mRNA 3'-end processing,gene regulation,0.658\nregulation of mRNA binding,gene regulation,0.66\nregulation of mRNA cap binding,gene regulation,0.57\nregulation of mRNA catabolic process,metabolic process,0.666\nregulation of mRNA export from nucleus,transport,0.694\nregulation of mRNA modification,gene regulation,0.53\nregulation of mRNA stability,gene regulation,0.59\nregulation of mRNA stability involved in cellular response to UV,gene regulation,0.202\nregulation of mRNA stability involved in response to stress,gene regulation,0.452\nregulation of macromolecule biosynthetic process,metabolic process,0.854\nregulation of macromolecule metabolic process,metabolic process,0.744\nregulation of macrophage antigen processing and presentation,immune system process,0.626\nregulation of macrophage chemotaxis,immune system process,0.84\nregulation of macrophage colony-stimulating factor production,immune system process,0.746\nregulation of macrophage colony-stimulating factor signaling pathway,receptor related process,0.368\nregulation of macrophage differentiation,immune system process,0.69\nregulation of macrophage fusion,morphogenesis/development,0.422\nregulation of macrophage inflammatory protein 1 alpha production,immune system process,0.676\nregulation of macrophage migration,immune system process,0.906\nregulation of macrophage migration inhibitory factor signaling pathway,receptor related process,0.43\nregulation of macrophage proliferation,cell cycle,0.452\nregulation of macrophage tolerance induction,immune system process,0.474\nregulation of macropinocytosis,transport,0.452\nregulation of maintenance of mitotic sister chromatid cohesion,cell cycle,0.722\n\"regulation of maintenance of mitotic sister chromatid cohesion, centromeric\",cell cycle,0.648\n\"regulation of maintenance of mitotic sister chromatid cohesion, telomeric\",cell cycle,0.656\nregulation of maintenance of sister chromatid cohesion,cell cycle,0.71\nregulation of male germ cell proliferation,cell cycle,0.418\nregulation of male gonad development,morphogenesis/development,0.59\nregulation of male mating behavior,multicellular organismal process,0.5\nregulation of mammary gland epithelial cell proliferation,cell cycle,0.68\nregulation of mammary stem cell proliferation,cell cycle,0.74\nregulation of mast cell activation,immune system process,0.766\nregulation of mast cell activation involved in immune response,immune system process,0.834\nregulation of mast cell apoptotic process,immune system process,0.52\nregulation of mast cell chemotaxis,immune system process,0.784\nregulation of mast cell cytokine production,immune system process,0.802\nregulation of mast cell degranulation,immune system process,0.652\nregulation of mast cell differentiation,immune system process,0.522\nregulation of mast cell proliferation,cell cycle,0.462\nregulation of maternal process involved in parturition,multicellular organismal process,0.466\nregulation of matrix metallopeptidase secretion,transport,0.634\nregulation of mature B cell apoptotic process,immune system process,0.582\nregulation of mechanoreceptor differentiation,morphogenesis/development,0.596\nregulation of mediator complex assembly,cellular component organization,0.74\nregulation of megakaryocyte differentiation,morphogenesis/development,0.452\nregulation of meiosis I,cell cycle,0.674\nregulation of meiotic DNA double-strand break formation,cell cycle,0.47\nregulation of meiotic cell cycle phase transition,cell cycle,0.852\nregulation of meiotic cell cycle process involved in oocyte maturation,cell cycle,0.588\nregulation of meiotic chromosome separation,cell cycle,0.76\nregulation of melanin biosynthetic process,metabolic process,0.836\nregulation of melanocyte differentiation,morphogenesis/development,0.778\nregulation of melanosome organization,cellular component organization,0.522\nregulation of melanosome transport,transport,0.648\nregulation of membrane depolarization,other,0.242\nregulation of membrane depolarization during action potential,cellular component organization,0.192\nregulation of membrane depolarization during cardiac muscle cell action potential,cellular component organization,0.184\nregulation of membrane hyperpolarization,cellular component organization,0.22\nregulation of membrane invagination,cellular component organization,0.524\nregulation of membrane lipid distribution,cellular component organization,0.83\nregulation of membrane lipid metabolic process,metabolic process,0.632\nregulation of membrane protein ectodomain proteolysis,metabolic process,0.486\nregulation of membrane repolarization,transport,0.294\nregulation of membrane repolarization during action potential,transport,0.192\nregulation of membrane repolarization during atrial cardiac muscle cell action potential,cellular component organization,0.176\nregulation of membrane repolarization during cardiac muscle cell action potential,cellular component organization,0.156\nregulation of membrane repolarization during ventricular cardiac muscle cell action potential,cellular component organization,0.182\nregulation of membrane tubulation,cellular component organization,0.55\nregulation of memory T cell activation,immune system process,0.754\nregulation of memory T cell differentiation,immune system process,0.88\nregulation of mesenchymal cell apoptotic process,cell death,0.68\nregulation of mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis,cell death,0.464\nregulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,cell death,0.458\nregulation of mesenchymal cell apoptotic process involved in metanephros development,cell death,0.61\nregulation of mesenchymal cell apoptotic process involved in nephron morphogenesis,cell death,0.444\nregulation of mesenchymal cell proliferation,cell cycle,0.686\nregulation of mesenchymal cell proliferation involved in lung development,cell cycle,0.71\nregulation of mesenchymal cell proliferation involved in prostate gland development,morphogenesis/development,0.434\nregulation of mesenchymal cell proliferation involved in ureter development,cell cycle,0.484\nregulation of mesenchymal stem cell differentiation,morphogenesis/development,0.848\nregulation of mesenchymal stem cell migration,cell cycle,0.262\nregulation of mesenchymal stem cell proliferation,cell cycle,0.69\nregulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,morphogenesis/development,0.576\nregulation of mesoderm development,morphogenesis/development,0.574\nregulation of mesodermal cell differentiation,morphogenesis/development,0.828\nregulation of mesodermal cell fate specification,morphogenesis/development,0.778\nregulation of mesonephros development,morphogenesis/development,0.822\nregulation of metabolic process,metabolic process,0.75\nregulation of metal ion transport,transport,0.872\nregulation of metalloendopeptidase activity,metabolic process,0.464\nregulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process,metabolic process,0.464\nregulation of metallopeptidase activity,metabolic process,0.392\nregulation of metanephric DCT cell differentiation,morphogenesis/development,0.816\nregulation of metanephric S-shaped body morphogenesis,morphogenesis/development,0.86\nregulation of metanephric cap mesenchymal cell proliferation,cell cycle,0.83\nregulation of metanephric comma-shaped body morphogenesis,morphogenesis/development,0.86\nregulation of metanephric glomerular mesangial cell proliferation,cell cycle,0.736\nregulation of metanephric glomerulus development,morphogenesis/development,0.908\nregulation of metanephric mesenchymal cell migration,cell cycle,0.152\nregulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway,receptor related process,0.604\nregulation of metanephric nephron tubule epithelial cell differentiation,morphogenesis/development,0.74\nregulation of metanephric podocyte development,morphogenesis/development,0.72\nregulation of metanephric ureteric bud development,morphogenesis/development,0.568\nregulation of metanephros development,morphogenesis/development,0.828\nregulation of metanephros size,cellular component organization,0.212\nregulation of metaphase plate congression,cell cycle,0.48\nregulation of metaphase/anaphase transition of meiosis I,cell cycle,0.768\nregulation of metaphase/anaphase transition of meiotic cell cycle,cell cycle,0.738\nregulation of miRNA catabolic process,metabolic process,0.438\nregulation of miRNA processing,gene regulation,0.696\nregulation of miRNA-mediated gene silencing,gene regulation,0.752\nregulation of microglia differentiation,immune system process,0.538\nregulation of microglial cell activation,immune system process,0.82\nregulation of microglial cell mediated cytotoxicity,immune system process,0.758\nregulation of microglial cell migration,immune system process,0.74\nregulation of microtubule anchoring at centrosome,cellular component organization,0.168\nregulation of microtubule binding,protein modification/signaling,0.396\nregulation of microtubule cytoskeleton organization,cellular component organization,0.458\nregulation of microtubule depolymerization,cellular component organization,0.594\nregulation of microtubule nucleation,cellular component organization,0.538\nregulation of microtubule nucleation by Ran protein signal transduction,protein modification/signaling,0.264\nregulation of microtubule plus-end binding,protein modification/signaling,0.296\nregulation of microtubule polymerization,cellular component organization,0.718\nregulation of microtubule polymerization or depolymerization,cellular component organization,0.536\nregulation of microtubule-based movement,transport,0.462\nregulation of microvillus assembly,cellular component organization,0.834\nregulation of microvillus length,cellular component organization,0.72\nregulation of midbrain dopaminergic neuron differentiation,morphogenesis/development,0.6\nregulation of mineralocorticoid secretion,transport,0.524\nregulation of mini excitatory postsynaptic potential,neural related process,0.4\nregulation of mismatch repair,stress response,0.514\nregulation of mitochondrial ATP synthesis coupled electron transport,metabolic process,0.352\nregulation of mitochondrial ATP synthesis coupled proton transport,metabolic process,0.514\nregulation of mitochondrial DNA metabolic process,cell cycle,0.42\nregulation of mitochondrial DNA replication,cell cycle,0.498\nregulation of mitochondrial RNA catabolic process,metabolic process,0.68\n\"regulation of mitochondrial electron transport, NADH to ubiquinone\",metabolic process,0.38\nregulation of mitochondrial fusion,cellular component organization,0.428\nregulation of mitochondrial mRNA stability,gene regulation,0.238\nregulation of mitochondrial membrane permeability involved in apoptotic process,cell death,0.454\nregulation of mitochondrial membrane permeability involved in programmed necrotic cell death,cell death,0.586\nregulation of mitochondrial transcription,gene regulation,0.856\nregulation of mitochondrial translation,gene regulation,0.598\nregulation of mitophagy,metabolic process,0.346\nregulation of mitotic DNA damage checkpoint,cell cycle,0.638\nregulation of mitotic cell cycle DNA replication,cell cycle,0.704\n\"regulation of mitotic cell cycle, embryonic\",cell cycle,0.696\nregulation of mitotic centrosome separation,cell cycle,0.768\nregulation of mitotic chromosome condensation,cell cycle,0.718\nregulation of mitotic cytokinesis,cell cycle,0.876\nregulation of mitotic cytokinetic process,cell cycle,0.558\nregulation of mitotic recombination,cell cycle,0.47\nregulation of mitotic spindle assembly,cell cycle,0.728\nregulation of mitotic spindle elongation,cell cycle,0.812\nregulation of modification of postsynaptic actin cytoskeleton,cellular component organization,0.17\nregulation of modification of postsynaptic structure,cellular component organization,0.316\nregulation of modification of synaptic structure,cellular component organization,0.334\nregulation of molecular function,metabolic process,0.33\nregulation of monoatomic anion transport,transport,0.896\nregulation of monoatomic cation transmembrane transport,transport,0.772\nregulation of monoatomic ion transmembrane transporter activity,transport,0.66\nregulation of monoatomic ion transport,transport,0.846\nregulation of monocyte aggregation,cell adhesion,0.308\nregulation of monocyte chemotactic protein-1 production,immune system process,0.782\nregulation of monocyte chemotaxis,immune system process,0.794\nregulation of monocyte differentiation,immune system process,0.6\nregulation of monocyte extravasation,immune system process,0.71\nregulation of motile cilium assembly,cellular component organization,0.782\nregulation of motor neuron apoptotic process,cell death,0.814\nregulation of motor neuron migration,neural related process,0.288\nregulation of mucus secretion,multicellular organismal process,0.296\nregulation of multicellular organismal development,morphogenesis/development,0.416\nregulation of multicellular organismal process,morphogenesis/development,0.222\nregulation of multivesicular body size,cellular component organization,0.558\nregulation of muscle atrophy,multicellular organismal process,0.494\nregulation of muscle contraction,multicellular organismal process,0.83\nregulation of muscle filament sliding,transport,0.48\nregulation of muscle filament sliding speed,transport,0.412\nregulation of muscle hyperplasia,multicellular organismal process,0.498\nregulation of muscle hypertrophy,multicellular organismal process,0.8\nregulation of muscle organ development,morphogenesis/development,0.67\nregulation of muscle system process,multicellular organismal process,0.858\nregulation of muscle tissue development,morphogenesis/development,0.648\nregulation of myelination,morphogenesis/development,0.372\nregulation of myeloid cell apoptotic process,cell death,0.754\nregulation of myeloid dendritic cell activation,immune system process,0.722\nregulation of myeloid dendritic cell chemotaxis,immune system process,0.754\nregulation of myeloid dendritic cell cytokine production,immune system process,0.852\nregulation of myeloid leukocyte mediated immunity,immune system process,0.942\nregulation of myeloid progenitor cell differentiation,morphogenesis/development,0.726\nregulation of myoblast differentiation,morphogenesis/development,0.832\nregulation of myoblast proliferation,cell cycle,0.662\nregulation of myofibroblast cell apoptotic process,cell death,0.614\nregulation of myofibroblast contraction,cellular component organization,0.216\nregulation of myofibroblast differentiation,morphogenesis/development,0.722\nregulation of myosin II filament organization,cellular component organization,0.812\nregulation of myosin light chain kinase activity,protein modification/signaling,0.724\nregulation of myosin-light-chain-phosphatase activity,protein modification/signaling,0.506\nregulation of myotome development,morphogenesis/development,0.57\nregulation of myotube differentiation,morphogenesis/development,0.89\nregulation of natural killer cell apoptotic process,cell death,0.524\nregulation of natural killer cell chemotaxis,immune system process,0.904\nregulation of natural killer cell cytokine production,immune system process,0.896\nregulation of natural killer cell degranulation,immune system process,0.764\nregulation of natural killer cell differentiation,immune system process,0.772\nregulation of natural killer cell differentiation involved in immune response,immune system process,0.772\nregulation of natural killer cell mediated cytotoxicity directed against tumor cell target,immune system process,0.92\nregulation of natural killer cell mediated immune response to tumor cell,immune system process,0.914\nregulation of natural killer cell proliferation,immune system process,0.834\nregulation of ncRNA transcription,gene regulation,0.752\nregulation of negative chemotaxis,immune system process,0.452\nregulation of nephron tubule epithelial cell differentiation,morphogenesis/development,0.756\nregulation of nerve growth factor receptor activity,receptor related process,0.644\nregulation of neural crest formation,morphogenesis/development,0.74\nregulation of neural precursor cell proliferation,cell cycle,0.508\nregulation of neural retina development,morphogenesis/development,0.772\nregulation of neuroblast migration,morphogenesis/development,0.194\nregulation of neuroblast proliferation,cell cycle,0.508\nregulation of neurofibrillary tangle assembly,cellular component organization,0.752\nregulation of neuromuscular junction development,cellular component organization,0.438\nregulation of neuromuscular synaptic transmission,neural related process,0.374\nregulation of neuron maturation,morphogenesis/development,0.542\nregulation of neuron migration,neural related process,0.346\nregulation of neuron projection arborization,morphogenesis/development,0.386\nregulation of neuron projection regeneration,neural related process,0.526\nregulation of neuron remodeling,morphogenesis/development,0.574\nregulation of neuronal action potential,neural related process,0.428\nregulation of neuronal signal transduction,protein modification/signaling,0.456\nregulation of neuronal synaptic plasticity,neural related process,0.602\nregulation of neurotransmitter receptor activity,receptor related process,0.446\nregulation of neurotransmitter receptor localization to postsynaptic specialization membrane,neural related process,0.288\n\"regulation of neurotransmitter receptor transport, endosome to postsynaptic membrane\",transport,0.354\nregulation of neurotransmitter secretion,neural related process,0.448\nregulation of neurotransmitter uptake,neural related process,0.406\nregulation of neurotrophin TRK receptor signaling pathway,receptor related process,0.692\nregulation of neurotrophin production,multicellular organismal process,0.422\nregulation of neutrophil activation,immune system process,0.664\nregulation of neutrophil apoptotic process,immune system process,0.5\nregulation of neutrophil degranulation,immune system process,0.646\nregulation of neutrophil differentiation,immune system process,0.566\nregulation of neutrophil extravasation,immune system process,0.712\nregulation of neutrophil mediated cytotoxicity,immune system process,0.77\nregulation of neutrophil mediated killing of bacterium,immune system process,0.826\nregulation of neutrophil mediated killing of fungus,immune system process,0.826\nregulation of neutrophil mediated killing of gram-negative bacterium,immune system process,0.828\nregulation of neutrophil mediated killing of symbiont cell,immune system process,0.82\nregulation of nitric oxide mediated signal transduction,protein modification/signaling,0.514\nregulation of nitric-oxide synthase activity,metabolic process,0.77\nregulation of nitrogen compound metabolic process,metabolic process,0.822\nregulation of nitrogen cycle metabolic process,metabolic process,0.36\nregulation of nitrogen utilization,immune system process,0.336\nregulation of nitrosative stress-induced intrinsic apoptotic signaling pathway,cell death,0.522\nregulation of nodal signaling pathway,receptor related process,0.588\nregulation of non-canonical NF-kappaB signal transduction,immune system process,0.418\nregulation of non-canonical Wnt signaling pathway via JNK cascade,receptor related process,0.418\nregulation of non-membrane spanning protein tyrosine kinase activity,protein modification/signaling,0.766\nregulation of norepinephrine secretion,transport,0.582\nregulation of norepinephrine uptake,transport,0.652\nregulation of nuclear migration along microtubule,transport,0.576\n\"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay\",gene regulation,0.684\n\"regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay\",gene regulation,0.7\nregulation of nuclear-transcribed mRNA poly(A) tail shortening,gene regulation,0.67\nregulation of nucleoside transport,transport,0.862\nregulation of nucleotide biosynthetic process,metabolic process,0.834\nregulation of nucleotide metabolic process,metabolic process,0.842\nregulation of nucleotide-binding oligomerization domain containing 1 signaling pathway,immune system process,0.88\nregulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,immune system process,0.898\nregulation of nucleotide-binding oligomerization domain containing signaling pathway,immune system process,0.904\nregulation of nucleus organization,cellular component organization,0.504\nregulation of nucleus size,cellular component organization,0.228\nregulation of odontoblast differentiation,morphogenesis/development,0.686\nregulation of odontogenesis,morphogenesis/development,0.908\nregulation of oligodendrocyte apoptotic process,cell death,0.626\nregulation of oligodendrocyte differentiation,morphogenesis/development,0.456\nregulation of oligodendrocyte progenitor proliferation,cell cycle,0.66\nregulation of oligopeptide transport,transport,0.84\nregulation of oocyte development,morphogenesis/development,0.752\nregulation of oocyte maturation,morphogenesis/development,0.642\nregulation of oogenesis,morphogenesis/development,0.638\nregulation of opioid receptor signaling pathway,receptor related process,0.77\nregulation of opsonization,immune system process,0.472\nregulation of optic nerve formation,morphogenesis/development,0.852\nregulation of organ growth,morphogenesis/development,0.626\nregulation of organelle organization,cellular component organization,0.724\nregulation of organelle transport along microtubule,transport,0.68\nregulation of osteoclast development,morphogenesis/development,0.428\nregulation of osteoclast proliferation,cell cycle,0.664\nregulation of otic vesicle morphogenesis,morphogenesis/development,0.84\nregulation of outer hair cell apoptotic process,cell death,0.568\nregulation of ovarian follicle development,morphogenesis/development,0.574\nregulation of ovulation,multicellular organismal process,0.538\nregulation of oxidative phosphorylation,metabolic process,0.62\nregulation of oxidative phosphorylation uncoupler activity,transport,0.692\nregulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,cell death,0.604\nregulation of oxygen metabolic process,metabolic process,0.34\nregulation of oxytocin production,gene regulation,0.43\nregulation of pancreatic A cell differentiation,morphogenesis/development,0.69\nregulation of pancreatic juice secretion,multicellular organismal process,0.384\nregulation of pancreatic stellate cell proliferation,cell cycle,0.716\nregulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,stress response,0.286\nregulation of penile erection,multicellular organismal process,0.552\nregulation of pentose-phosphate shunt,metabolic process,0.62\nregulation of peptide hormone secretion,transport,0.674\nregulation of peptide secretion,transport,0.568\nregulation of peptide transport,transport,0.826\nregulation of peptidyl-cysteine S-nitrosylation,protein modification/signaling,0.526\nregulation of peptidyl-lysine acetylation,protein modification/signaling,0.6\nregulation of peptidyl-lysine crotonylation,protein modification/signaling,0.6\nregulation of peptidyl-serine dephosphorylation,protein modification/signaling,0.56\nregulation of peptidyl-serine phosphorylation of STAT protein,protein modification/signaling,0.66\nregulation of peptidyl-threonine phosphorylation,protein modification/signaling,0.712\nregulation of peptidyl-tyrosine autophosphorylation,protein modification/signaling,0.664\nregulation of peripheral T cell tolerance induction,immune system process,0.888\nregulation of peripheral tolerance induction,immune system process,0.81\nregulation of peroxidase activity,metabolic process,0.568\nregulation of peroxisome organization,cellular component organization,0.528\nregulation of peroxisome proliferator activated receptor signaling pathway,receptor related process,0.676\nregulation of peroxisome size,metabolic process,0.248\n\"regulation of phagocytosis, engulfment\",immune system process,0.284\nregulation of phagosome maturation,cellular component organization,0.452\nregulation of phenotypic switching,cell cycle,0.164\nregulation of phosphatase activity,protein modification/signaling,0.534\nregulation of phosphate metabolic process,metabolic process,0.594\nregulation of phosphate transmembrane transport,transport,0.746\nregulation of phosphate transport,transport,0.926\nregulation of phosphatidate phosphatase activity,metabolic process,0.498\nregulation of phosphatidic acid biosynthetic process,metabolic process,0.658\nregulation of phosphatidylcholine biosynthetic process,metabolic process,0.552\nregulation of phosphatidylcholine catabolic process,metabolic process,0.884\nregulation of phosphatidylcholine metabolic process,metabolic process,0.66\nregulation of phosphatidylethanolamine metabolic process,metabolic process,0.512\nregulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction,protein modification/signaling,0.434\nregulation of phosphatidylinositol biosynthetic process,metabolic process,0.896\nregulation of phosphatidylinositol dephosphorylation,metabolic process,0.56\n\"regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity\",metabolic process,0.518\nregulation of phosphatidylserine exposure on apoptotic cell surface,cellular component organization,0.436\nregulation of phosphatidylserine metabolic process,metabolic process,0.552\nregulation of phospholipase C activity,metabolic process,0.608\nregulation of phospholipase C-activating G protein-coupled receptor signaling pathway,receptor related process,0.802\nregulation of phospholipase activity,metabolic process,0.692\nregulation of phospholipid catabolic process,metabolic process,0.902\nregulation of phospholipid efflux,transport,0.654\nregulation of phospholipid scramblase activity,cellular component organization,0.446\nregulation of phospholipid translocation,cellular component organization,0.452\nregulation of phospholipid transport,transport,0.612\nregulation of phosphoprotein phosphatase activity,protein modification/signaling,0.636\nregulation of phosphorus metabolic process,metabolic process,0.572\nregulation of phosphorylation,protein modification/signaling,0.674\nregulation of photoreceptor cell differentiation,morphogenesis/development,0.65\nregulation of piRNA transcription,gene regulation,0.864\nregulation of pigment cell differentiation,morphogenesis/development,0.778\nregulation of pigmentation,morphogenesis/development,0.456\nregulation of pinocytosis,transport,0.45\nregulation of planar cell polarity pathway involved in axis elongation,morphogenesis/development,0.356\nregulation of planar cell polarity pathway involved in neural tube closure,morphogenesis/development,0.33\nregulation of plasma cell differentiation,immune system process,0.818\nregulation of plasma lipoprotein oxidation,multicellular organismal process,0.392\nregulation of plasma lipoprotein particle levels,other,0.28\nregulation of plasma membrane bounded cell projection assembly,cellular component organization,0.92\nregulation of plasma membrane raft polarization,cellular component organization,0.55\nregulation of plasma membrane repair,cellular component organization,0.534\nregulation of plasma membrane sterol distribution,cellular component organization,0.488\nregulation of plasmacytoid dendritic cell cytokine production,immune system process,0.828\nregulation of platelet formation,morphogenesis/development,0.594\nregulation of platelet-derived growth factor production,immune system process,0.64\nregulation of platelet-derived growth factor receptor-alpha signaling pathway,receptor related process,0.766\nregulation of platelet-derived growth factor receptor-beta signaling pathway,receptor related process,0.752\nregulation of podocyte apoptotic process,cell death,0.608\nregulation of podosome assembly,cellular component organization,0.826\nregulation of polarized epithelial cell differentiation,morphogenesis/development,0.758\nregulation of polyamine biosynthetic process,metabolic process,0.856\nregulation of polyamine transmembrane transport,transport,0.766\nregulation of polynucleotide adenylyltransferase activity,metabolic process,0.446\nregulation of polysaccharide biosynthetic process,metabolic process,0.862\nregulation of polysaccharide metabolic process,metabolic process,0.91\nregulation of polysome binding,gene regulation,0.258\nregulation of positive thymic T cell selection,immune system process,0.73\nregulation of post-transcriptional gene silencing by regulatory ncRNA,gene regulation,0.768\nregulation of post-translational protein modification,protein modification/signaling,0.816\nregulation of postsynapse assembly,cellular component organization,0.654\nregulation of postsynapse organization,neural related process,0.432\nregulation of postsynapse to nucleus signaling pathway,protein modification/signaling,0.278\nregulation of postsynaptic cytosolic calcium ion concentration,cellular component organization,0.154\nregulation of postsynaptic dense core vesicle exocytosis,cellular component organization,0.12\nregulation of postsynaptic density assembly,cellular component organization,0.722\nregulation of postsynaptic density organization,cellular component organization,0.546\nregulation of postsynaptic density protein 95 clustering,protein modification/signaling,0.336\nregulation of postsynaptic membrane neurotransmitter receptor levels,neural related process,0.356\nregulation of postsynaptic membrane organization,cellular component organization,0.664\nregulation of postsynaptic membrane potential,neural related process,0.582\nregulation of postsynaptic neurotransmitter receptor activity,neural related process,0.352\nregulation of postsynaptic neurotransmitter receptor diffusion trapping,receptor related process,0.254\nregulation of postsynaptic neurotransmitter receptor internalization,neural related process,0.252\nregulation of postsynaptic specialization assembly,cellular component organization,0.746\nregulation of potassium ion export across plasma membrane,transport,0.78\nregulation of potassium ion import,transport,0.822\nregulation of potassium ion transmembrane transport,transport,0.82\nregulation of potassium ion transmembrane transporter activity,transport,0.564\nregulation of potassium ion transport,transport,0.876\nregulation of pre-miRNA processing,gene regulation,0.734\nregulation of presynapse assembly,cellular component organization,0.602\nregulation of presynapse organization,cellular component organization,0.386\nregulation of presynaptic active zone assembly,cellular component organization,0.618\nregulation of presynaptic cytosolic calcium ion concentration,cellular component organization,0.172\nregulation of presynaptic dense core granule exocytosis,cellular component organization,0.12\nregulation of presynaptic membrane organization,cellular component organization,0.486\nregulation of presynaptic membrane potential,neural related process,0.284\nregulation of primary metabolic process,metabolic process,0.782\nregulation of primary miRNA processing,gene regulation,0.716\nregulation of primitive erythrocyte differentiation,morphogenesis/development,0.28\nregulation of pro-B cell differentiation,morphogenesis/development,0.718\nregulation of pro-T cell differentiation,immune system process,0.702\nregulation of progesterone biosynthetic process,metabolic process,0.612\nregulation of progesterone secretion,transport,0.336\nregulation of programmed cell death,cell death,0.8\nregulation of proline import across plasma membrane,transport,0.74\nregulation of proline transport,transport,0.67\nregulation of pronephros size,cellular component organization,0.218\nregulation of prostaglandin biosynthetic process,metabolic process,0.914\nregulation of prostaglandin catabolic process,metabolic process,0.558\nregulation of prostaglandin secretion,transport,0.762\nregulation of prostaglandin-E synthase activity,metabolic process,0.46\nregulation of prostaglandin-endoperoxide synthase activity,metabolic process,0.722\nregulation of prostatic bud formation,morphogenesis/development,0.672\nregulation of proteasomal ubiquitin-dependent protein catabolic process,metabolic process,0.884\nregulation of protection from non-homologous end joining at telomere,stress response,0.406\nregulation of protein ADP-ribosylation,metabolic process,0.356\nregulation of protein K48-linked deubiquitination,protein modification/signaling,0.648\nregulation of protein K48-linked ubiquitination,protein modification/signaling,0.758\nregulation of protein K63-linked deubiquitination,protein modification/signaling,0.644\nregulation of protein O-linked glycosylation,protein modification/signaling,0.388\nregulation of protein activation cascade,gene regulation,0.338\nregulation of protein autoubiquitination,protein modification/signaling,0.77\n\"regulation of protein catabolic process at postsynapse, modulating synaptic transmission\",neural related process,0.26\n\"regulation of protein catabolic process at presynapse, modulating synaptic transmission\",metabolic process,0.25\nregulation of protein complex stability,cellular component organization,0.46\nregulation of protein dephosphorylation,protein modification/signaling,0.642\nregulation of protein depolymerization,cellular component organization,0.866\nregulation of protein exit from endoplasmic reticulum,ER/endosome/lysosome related process,0.718\nregulation of protein export from nucleus,transport,0.87\nregulation of protein folding,protein modification/signaling,0.228\nregulation of protein folding in endoplasmic reticulum,ER/endosome/lysosome related process,0.336\nregulation of protein geranylgeranylation,protein modification/signaling,0.472\nregulation of protein glutathionylation,protein modification/signaling,0.59\nregulation of protein glycosylation,protein modification/signaling,0.472\nregulation of protein homodimerization activity,protein modification/signaling,0.426\nregulation of protein homooligomerization,cellular component organization,0.69\nregulation of protein import,transport,0.702\nregulation of protein import into nucleus,transport,0.862\nregulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,transport,0.334\nregulation of protein insertion into mitochondrial outer membrane,transport,0.514\nregulation of protein kinase A signaling,protein modification/signaling,0.442\nregulation of protein kinase C activity,protein modification/signaling,0.73\nregulation of protein kinase C signaling,protein modification/signaling,0.474\nregulation of protein kinase D signaling,protein modification/signaling,0.618\nregulation of protein kinase activity,protein modification/signaling,0.836\nregulation of protein linear polyubiquitination,protein modification/signaling,0.76\nregulation of protein lipidation,protein modification/signaling,0.416\nregulation of protein localization,cellular component organization,0.6\nregulation of protein localization to Cajal body,transport,0.39\nregulation of protein localization to actin cortical patch,transport,0.352\nregulation of protein localization to adherens junction,cellular component organization,0.342\nregulation of protein localization to basolateral plasma membrane,transport,0.366\nregulation of protein localization to cell cortex,transport,0.326\nregulation of protein localization to cell leading edge,transport,0.356\nregulation of protein localization to cell surface,transport,0.332\nregulation of protein localization to cell-cell junction,transport,0.358\nregulation of protein localization to centrosome,transport,0.368\nregulation of protein localization to chromatin,transport,0.366\n\"regulation of protein localization to chromosome, telomeric region\",transport,0.416\nregulation of protein localization to ciliary membrane,transport,0.39\nregulation of protein localization to cilium,transport,0.414\nregulation of protein localization to early endosome,transport,0.302\nregulation of protein localization to endoplasmic reticulum,ER/endosome/lysosome related process,0.324\nregulation of protein localization to endosome,transport,0.282\nregulation of protein localization to kinetochore,transport,0.376\nregulation of protein localization to lysosome,transport,0.344\nregulation of protein localization to microtubule,transport,0.348\nregulation of protein localization to nucleolus,transport,0.416\nregulation of protein localization to phagocytic vesicle,transport,0.368\nregulation of protein localization to presynapse,transport,0.34\nregulation of protein localization to spindle pole body,cell cycle,0.264\nregulation of protein localization to synapse,neural related process,0.266\nregulation of protein metabolic process,metabolic process,0.686\nregulation of protein modification process,protein modification/signaling,0.676\nregulation of protein monoubiquitination,protein modification/signaling,0.758\nregulation of protein neddylation,protein modification/signaling,0.728\nregulation of protein oligomerization,cellular component organization,0.7\nregulation of protein oxidation,protein modification/signaling,0.544\nregulation of protein phosphorylation,protein modification/signaling,0.786\nregulation of protein polymerization,cellular component organization,0.886\nregulation of protein processing in phagocytic vesicle,gene regulation,0.376\nregulation of protein processing involved in protein targeting to mitochondrion,gene regulation,0.382\nregulation of protein refolding,protein modification/signaling,0.242\nregulation of protein serine/threonine phosphatase activity,metabolic process,0.454\nregulation of protein sumoylation,protein modification/signaling,0.694\nregulation of protein transport,transport,0.764\nregulation of protein tyrosine phosphatase activity,protein modification/signaling,0.624\nregulation of protein-containing complex assembly,cellular component organization,0.738\nregulation of protein-glutamine gamma-glutamyltransferase activity,metabolic process,0.456\nregulation of proteinase activated receptor activity,receptor related process,0.568\n\"regulation of proton-transporting ATP synthase activity, rotational mechanism\",transport,0.64\n\"regulation of proton-transporting ATPase activity, rotational mechanism\",metabolic process,0.392\nregulation of pseudohyphal growth,cellular component organization,0.366\nregulation of pseudopodium assembly,cellular component organization,0.776\nregulation of purine nucleotide biosynthetic process,metabolic process,0.58\nregulation of purine nucleotide metabolic process,metabolic process,0.686\nregulation of pyloric antrum smooth muscle contraction,multicellular organismal process,0.678\nregulation of pyrroline-5-carboxylate reductase activity,metabolic process,0.492\nregulation of pyruvate dehydrogenase activity,metabolic process,0.472\nregulation of pyruvate kinase activity,metabolic process,0.356\nregulation of quinolinate biosynthetic process,metabolic process,0.616\nregulation of rDNA heterochromatin formation,gene regulation,0.424\nregulation of rRNA catabolic process,gene regulation,0.434\nregulation of rRNA stability,gene regulation,0.642\nregulation of reactive oxygen species biosynthetic process,metabolic process,0.364\nregulation of receptor binding,receptor related process,0.22\nregulation of receptor catabolic process,metabolic process,0.518\nregulation of receptor clustering,transport,0.32\nregulation of receptor recycling,immune system process,0.236\nregulation of receptor-mediated endocytosis,receptor related process,0.416\nregulation of receptor-mediated endocytosis involved in cholesterol transport,transport,0.5\nregulation of reciprocal meiotic recombination,cell cycle,0.494\nregulation of recycling endosome localization within postsynapse,transport,0.21\nregulation of regulated secretory pathway,transport,0.398\nregulation of regulatory ncRNA processing,gene regulation,0.702\nregulation of relaxation of cardiac muscle,multicellular organismal process,0.638\nregulation of relaxation of muscle,multicellular organismal process,0.646\nregulation of relaxation of smooth muscle,multicellular organismal process,0.626\nregulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,transport,0.664\nregulation of removal of superoxide radicals,stress response,0.48\nregulation of renal albumin absorption,multicellular organismal process,0.556\nregulation of renal output by angiotensin,multicellular organismal process,0.504\nregulation of renal phosphate excretion,multicellular organismal process,0.35\nregulation of renal sodium excretion,multicellular organismal process,0.368\nregulation of renal system process,multicellular organismal process,0.586\nregulation of renal water transport,transport,0.416\nregulation of renin secretion into blood stream,transport,0.43\nregulation of respiratory burst,immune system process,0.49\nregulation of respiratory burst involved in inflammatory response,immune system process,0.62\nregulation of respiratory gaseous exchange,multicellular organismal process,0.44\nregulation of respiratory gaseous exchange by nervous system process,neural related process,0.284\nregulation of respiratory system process,multicellular organismal process,0.358\nregulation of response to DNA damage checkpoint signaling,immune system process,0.244\nregulation of response to DNA integrity checkpoint signaling,cell cycle,0.282\nregulation of response to alcohol,immune system process,0.33\nregulation of response to cell cycle checkpoint signaling,cell cycle,0.276\nregulation of response to drug,immune system process,0.282\nregulation of response to extracellular stimulus,immune system process,0.342\nregulation of response to food,immune system process,0.502\nregulation of response to macrophage colony-stimulating factor,immune system process,0.51\nregulation of response to nutrient levels,immune system process,0.172\nregulation of response to osmotic stress,stress response,0.404\nregulation of response to salt stress,stress response,0.454\nregulation of response to stimulus,response to stimulus,0.158\nregulation of response to stress,stress response,0.378\nregulation of response to tumor cell,immune system process,0.668\nregulation of response to type II interferon,immune system process,0.49\nregulation of resting membrane potential,cellular component organization,0.24\nregulation of restriction endodeoxyribonuclease activity,metabolic process,0.306\nregulation of retina development in camera-type eye,morphogenesis/development,0.568\nregulation of retinal cell programmed cell death,morphogenesis/development,0.39\nregulation of retinal ganglion cell axon guidance,neural related process,0.28\nregulation of retinoic acid biosynthetic process,metabolic process,0.692\nregulation of retinoic acid receptor signaling pathway,receptor related process,0.69\nregulation of retrograde axon cargo transport,transport,0.75\nregulation of retrograde dense core granule transport,transport,0.7\nregulation of retrograde trans-synaptic signaling by endocanabinoid,protein modification/signaling,0.28\nregulation of retrograde trans-synaptic signaling by neuropeptide,protein modification/signaling,0.276\n\"regulation of retrograde transport, endosome to Golgi\",transport,0.626\n\"regulation of retrograde vesicle-mediated transport, Golgi to ER\",transport,0.182\nregulation of reverse cholesterol transport,transport,0.652\nregulation of rhodopsin mediated signaling pathway,receptor related process,0.452\nregulation of ribonuclease activity,gene regulation,0.376\nregulation of ribonucleoprotein complex localization,transport,0.388\nregulation of ribosomal small subunit export from nucleus,transport,0.612\nregulation of ribosomal subunit export from nucleus,transport,0.632\nregulation of ribosome biogenesis,cellular component organization,0.774\nregulation of ripoptosome assembly involved in necroptotic process,cellular component organization,0.574\nregulation of ruffle assembly,cellular component organization,0.796\nregulation of ryanodine-sensitive calcium-release channel activity,transport,0.574\nregulation of saliva secretion,multicellular organismal process,0.326\nregulation of sarcomere organization,cellular component organization,0.632\nregulation of satellite cell activation involved in skeletal muscle regeneration,morphogenesis/development,0.41\nregulation of sclerotome development,morphogenesis/development,0.868\nregulation of sebum secreting cell proliferation,cell cycle,0.698\nregulation of secondary heart field cardioblast proliferation,cell cycle,0.46\nregulation of secondary metabolic process,metabolic process,0.742\nregulation of secondary metabolite biosynthetic process,metabolic process,0.574\nregulation of secretion of lysosomal enzymes,transport,0.582\nregulation of secretory granule organization,cellular component organization,0.53\nregulation of selenocysteine incorporation,gene regulation,0.596\nregulation of selenocysteine insertion sequence binding,gene regulation,0.586\nregulation of semaphorin-plexin signaling pathway,receptor related process,0.46\nregulation of sensory perception,neural related process,0.298\nregulation of sensory perception of pain,multicellular organismal process,0.276\nregulation of sequestering of triglyceride,cellular component organization,0.308\nregulation of serine C-palmitoyltransferase activity,metabolic process,0.444\nregulation of serine-type endopeptidase activity,metabolic process,0.366\nregulation of serine-type peptidase activity,metabolic process,0.356\nregulation of serotonin biosynthetic process,metabolic process,0.54\nregulation of serotonin secretion,transport,0.666\nregulation of serotonin uptake,transport,0.596\nregulation of shelterin complex assembly,cellular component organization,0.75\nregulation of short-term neuronal synaptic plasticity,neural related process,0.534\nregulation of short-term synaptic potentiation,neural related process,0.312\nregulation of siRNA processing,gene regulation,0.706\nregulation of signal transduction,protein modification/signaling,0.266\nregulation of signal transduction by receptor internalization,transport,0.398\nregulation of signaling,protein modification/signaling,0.234\nregulation of single strand break repair,stress response,0.526\nregulation of single stranded viral RNA replication via double stranded DNA intermediate,gene regulation,0.362\nregulation of single-species biofilm formation,morphogenesis/development,0.186\nregulation of single-species biofilm formation in or on host organism,cellular component organization,0.21\nregulation of single-stranded telomeric DNA binding,gene regulation,0.258\nregulation of sister chromatid cohesion,cell cycle,0.608\nregulation of skeletal muscle acetylcholine-gated channel clustering,transport,0.37\nregulation of skeletal muscle adaptation,multicellular organismal process,0.432\nregulation of skeletal muscle cell proliferation,cell cycle,0.722\nregulation of skeletal muscle contraction,multicellular organismal process,0.56\nregulation of skeletal muscle contraction by action potential,cellular component organization,0.196\nregulation of skeletal muscle contraction by calcium ion signaling,multicellular organismal process,0.394\nregulation of skeletal muscle contraction by chemo-mechanical energy conversion,multicellular organismal process,0.572\nregulation of skeletal muscle contraction by neural stimulation via neuromuscular junction,neural related process,0.144\nregulation of skeletal muscle contraction by regulation of release of sequestered calcium ion,transport,0.362\nregulation of skeletal muscle contraction via regulation of action potential,cellular component organization,0.222\nregulation of skeletal muscle fiber development,morphogenesis/development,0.766\nregulation of skeletal muscle fiber differentiation,morphogenesis/development,0.844\nregulation of skeletal muscle hypertrophy,multicellular organismal process,0.482\nregulation of skeletal muscle satellite cell proliferation,cell cycle,0.658\nregulation of skeletal muscle tissue development,morphogenesis/development,0.628\nregulation of skeletal muscle tissue growth,morphogenesis/development,0.51\nregulation of skeletal muscle tissue regeneration,morphogenesis/development,0.402\nregulation of slow-twitch skeletal muscle fiber contraction,multicellular organismal process,0.638\nregulation of small intestinal transit,multicellular organismal process,0.492\nregulation of small intestine smooth muscle contraction,multicellular organismal process,0.618\nregulation of smooth muscle cell apoptotic process,cell death,0.902\nregulation of smooth muscle cell chemotaxis,immune system process,0.294\nregulation of smooth muscle cell differentiation,morphogenesis/development,0.758\nregulation of smooth muscle cell-matrix adhesion,cell adhesion,0.346\nregulation of smooth muscle contraction,multicellular organismal process,0.828\nregulation of smooth muscle tissue development,morphogenesis/development,0.55\nregulation of smoothened signaling pathway,protein modification/signaling,0.364\nregulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,receptor related process,0.43\nregulation of snRNA transcription by RNA polymerase II,gene regulation,0.908\nregulation of sodium ion export across plasma membrane,transport,0.792\nregulation of sodium ion transmembrane transporter activity,transport,0.7\nregulation of sodium-dependent phosphate transport,transport,0.584\nregulation of sodium:proton antiporter activity,transport,0.624\nregulation of somatic stem cell division,cell cycle,0.396\nregulation of somatic stem cell population maintenance,morphogenesis/development,0.586\nregulation of somatostatin secretion,transport,0.496\nregulation of somitogenesis,morphogenesis/development,0.232\nregulation of sperm capacitation,morphogenesis/development,0.598\nregulation of spermidine biosynthetic process,metabolic process,0.51\nregulation of sphingolipid biosynthetic process,metabolic process,0.694\nregulation of sphingolipid mediated signaling pathway,protein modification/signaling,0.43\nregulation of sphingomyelin catabolic process,metabolic process,0.558\nregulation of spindle elongation,cell cycle,0.782\nregulation of spongiotrophoblast cell proliferation,cell cycle,0.21\nregulation of spontaneous neurotransmitter secretion,transport,0.376\nregulation of spontaneous synaptic transmission,neural related process,0.376\nregulation of sprouting of injured axon,morphogenesis/development,0.658\nregulation of stem cell division,cell cycle,0.444\nregulation of steroid biosynthetic process,metabolic process,0.956\nregulation of steroid hormone biosynthetic process,metabolic process,0.9\nregulation of sterol biosynthetic process,metabolic process,0.57\nregulation of sterol transport,transport,0.932\nregulation of stomach neuroendocrine cell differentiation,morphogenesis/development,0.594\nregulation of store-operated calcium channel activity,transport,0.734\nregulation of store-operated calcium entry,transport,0.64\nregulation of strand invasion,gene regulation,0.386\nregulation of stress fiber assembly,cellular component organization,0.814\nregulation of stress granule assembly,cellular component organization,0.67\nregulation of striated muscle cell apoptotic process,cell death,0.868\nregulation of striated muscle cell differentiation,morphogenesis/development,0.93\nregulation of striated muscle contraction,multicellular organismal process,0.756\nregulation of striated muscle tissue development,morphogenesis/development,0.636\nregulation of substrate adhesion-dependent cell spreading,cell adhesion,0.378\n\"regulation of substrate-dependent cell migration, cell attachment to substrate\",cell adhesion,0.236\nregulation of succinate dehydrogenase activity,metabolic process,0.48\nregulation of sulfur amino acid metabolic process,metabolic process,0.892\nregulation of sulfur metabolic process,metabolic process,0.83\nregulation of superoxide anion generation,metabolic process,0.218\nregulation of superoxide dismutase activity,metabolic process,0.526\nregulation of superoxide metabolic process,metabolic process,0.6\nregulation of supramolecular fiber organization,cellular component organization,0.91\nregulation of synapse assembly,neural related process,0.568\nregulation of synapse maturation,morphogenesis/development,0.386\nregulation of synapse pruning,cellular component organization,0.43\nregulation of synapse structural plasticity,cellular component organization,0.32\nregulation of synaptic activity,neural related process,0.248\nregulation of synaptic assembly at neuromuscular junction,cellular component organization,0.404\nregulation of synaptic membrane adhesion,cellular component organization,0.186\nregulation of synaptic plasticity by chemical substance,neural related process,0.31\nregulation of synaptic signaling by nitric oxide,protein modification/signaling,0.226\n\"regulation of synaptic transmission, GABAergic\",neural related process,0.662\n\"regulation of synaptic transmission, cholinergic\",neural related process,0.58\n\"regulation of synaptic transmission, dopaminergic\",neural related process,0.608\n\"regulation of synaptic transmission, glutamatergic\",neural related process,0.83\n\"regulation of synaptic transmission, glycinergic\",neural related process,0.582\nregulation of synaptic vesicle budding from presynaptic endocytic zone membrane,neural related process,0.196\nregulation of synaptic vesicle clustering,transport,0.3\nregulation of synaptic vesicle cycle,transport,0.404\nregulation of synaptic vesicle endocytosis,transport,0.4\nregulation of synaptic vesicle exocytosis,neural related process,0.378\nregulation of synaptic vesicle fusion to presynaptic active zone membrane,cellular component organization,0.348\nregulation of synaptic vesicle membrane organization,cellular component organization,0.612\nregulation of synaptic vesicle priming,cellular component organization,0.678\nregulation of synaptic vesicle recycling,transport,0.458\nregulation of synaptic vesicle transport,transport,0.56\nregulation of synoviocyte proliferation,cell cycle,0.69\nregulation of systemic arterial blood pressure,multicellular organismal process,0.536\nregulation of systemic arterial blood pressure by acetylcholine,protein modification/signaling,0.198\nregulation of systemic arterial blood pressure by aortic arch baroreceptor feedback,morphogenesis/development,0.17\nregulation of systemic arterial blood pressure by atrial natriuretic peptide,protein modification/signaling,0.194\nregulation of systemic arterial blood pressure by baroreceptor feedback,multicellular organismal process,0.2\nregulation of systemic arterial blood pressure by carotid body chemoreceptor signaling,morphogenesis/development,0.164\nregulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback,multicellular organismal process,0.576\nregulation of systemic arterial blood pressure by chemoreceptor signaling,multicellular organismal process,0.47\nregulation of systemic arterial blood pressure by circulatory renin-angiotensin,multicellular organismal process,0.21\nregulation of systemic arterial blood pressure by endothelin,multicellular organismal process,0.252\nregulation of systemic arterial blood pressure by ischemic conditions,multicellular organismal process,0.172\nregulation of systemic arterial blood pressure by neurotransmitter,neural related process,0.31\nregulation of systemic arterial blood pressure by norepinephrine-epinephrine,multicellular organismal process,0.288\nregulation of systemic arterial blood pressure by renin-angiotensin,multicellular organismal process,0.524\nregulation of systemic arterial blood pressure by vasopressin,protein modification/signaling,0.152\nregulation of systemic arterial blood pressure mediated by a chemical signal,multicellular organismal process,0.426\nregulation of t-SNARE clustering,transport,0.4\nregulation of t-circle formation,cell cycle,0.342\nregulation of tRNA catabolic process,metabolic process,0.416\nregulation of tRNA metabolic process,gene regulation,0.418\nregulation of tRNA methylation,metabolic process,0.496\nregulation of tRNA processing,gene regulation,0.778\nregulation of tRNA stability,gene regulation,0.624\nregulation of tau-protein kinase activity,protein modification/signaling,0.698\nregulation of telomerase RNA localization to Cajal body,transport,0.358\nregulation of telomerase RNA reverse transcriptase activity,gene regulation,0.49\nregulation of telomerase activity,cell cycle,0.398\nregulation of telomerase catalytic core complex assembly,cellular component organization,0.662\nregulation of telomere maintenance in response to DNA damage,stress response,0.436\nregulation of telomere maintenance via recombination,cell cycle,0.51\nregulation of telomere maintenance via semi-conservative replication,cell cycle,0.594\nregulation of telomere maintenance via telomerase,cell cycle,0.66\nregulation of telomere maintenance via telomere lengthening,cell cycle,0.694\nregulation of telomeric D-loop disassembly,cell cycle,0.372\nregulation of telomeric DNA binding,gene regulation,0.268\nregulation of telomeric loop disassembly,cell cycle,0.402\nregulation of tendon cell differentiation,morphogenesis/development,0.814\nregulation of terminal button organization,cellular component organization,0.448\nregulation of termination of DNA-templated transcription,gene regulation,0.6\nregulation of termination of RNA polymerase I transcription,gene regulation,0.806\nregulation of termination of RNA polymerase II transcription,gene regulation,0.63\n\"regulation of termination of RNA polymerase II transcription, poly(A)-coupled\",gene regulation,0.634\nregulation of testosterone biosynthetic process,metabolic process,0.648\nregulation of testosterone secretion,transport,0.628\nregulation of tetrapyrrole biosynthetic process,metabolic process,0.536\nregulation of tetrapyrrole metabolic process,metabolic process,0.654\nregulation of thalamus size,morphogenesis/development,0.198\nregulation of the force of heart contraction,multicellular organismal process,0.698\nregulation of the force of heart contraction by cardiac conduction,multicellular organismal process,0.232\nregulation of the force of heart contraction by chemical signal,multicellular organismal process,0.65\nregulation of the force of skeletal muscle contraction,morphogenesis/development,0.232\nregulation of thrombin-activated receptor signaling pathway,receptor related process,0.8\nregulation of thymocyte apoptotic process,cell death,0.48\nregulation of thymocyte migration,immune system process,0.84\nregulation of thyroid gland epithelial cell proliferation,cell cycle,0.728\nregulation of thyroid hormone generation,metabolic process,0.34\nregulation of thyroid hormone mediated signaling pathway,receptor related process,0.438\nregulation of thyroid-stimulating hormone secretion,transport,0.53\nregulation of tight junction disassembly,cellular component organization,0.598\nregulation of timing of anagen,morphogenesis/development,0.484\nregulation of timing of catagen,morphogenesis/development,0.5\nregulation of timing of cell differentiation,morphogenesis/development,0.766\nregulation of timing of neuron differentiation,morphogenesis/development,0.734\nregulation of timing of subpallium neuron differentiation,morphogenesis/development,0.518\nregulation of tissue remodeling,multicellular organismal process,0.492\nregulation of tolerance induction,immune system process,0.828\nregulation of tolerance induction dependent upon immune response,immune system process,0.832\nregulation of tolerance induction to self antigen,immune system process,0.594\nregulation of tolerance induction to tumor cell,immune system process,0.796\nregulation of toll-like receptor 2 signaling pathway,immune system process,0.914\nregulation of toll-like receptor 3 signaling pathway,immune system process,0.9\nregulation of toll-like receptor 5 signaling pathway,immune system process,0.872\nregulation of toll-like receptor 6 signaling pathway,immune system process,0.866\nregulation of toll-like receptor 7 signaling pathway,immune system process,0.88\nregulation of toll-like receptor 8 signaling pathway,immune system process,0.868\nregulation of toll-like receptor 9 signaling pathway,immune system process,0.888\nregulation of tongue muscle cell differentiation,morphogenesis/development,0.852\nregulation of tooth mineralization,morphogenesis/development,0.614\n\"regulation of trans-synaptic signaling by BDNF, modulating synaptic transmission\",protein modification/signaling,0.24\n\"regulation of trans-synaptic signaling by endocannabinoid, modulating synaptic transmission\",neural related process,0.244\nregulation of transcription by RNA polymerase II,gene regulation,0.766\nregulation of transcription by galactose,gene regulation,0.88\nregulation of transcription by glucose,gene regulation,0.888\nregulation of transcription from RNA polymerase II promoter by galactose,gene regulation,0.478\nregulation of transcription from RNA polymerase II promoter by glucose,gene regulation,0.48\nregulation of transcription from RNA polymerase II promoter in response to hypoxia,stress response,0.48\nregulation of transcription from RNA polymerase II promoter in response to iron,gene regulation,0.626\nregulation of transcription from RNA polymerase II promoter in response to oxidative stress,stress response,0.48\nregulation of transcription of nucleolar large rRNA by RNA polymerase I,gene regulation,0.898\nregulation of transcription regulatory region DNA binding,gene regulation,0.586\nregulation of transcription-coupled nucleotide-excision repair,cell cycle,0.174\nregulation of transcriptional start site selection at RNA polymerase II promoter,gene regulation,0.41\nregulation of transcytosis,transport,0.442\nregulation of transdifferentiation,morphogenesis/development,0.666\nregulation of transepithelial transport,transport,0.174\nregulation of transferrin receptor binding,receptor related process,0.35\nregulation of transformation of host cell by virus,viral related process,0.344\nregulation of transforming growth factor beta activation,immune system process,0.604\nregulation of transforming growth factor beta1 activation,immune system process,0.592\nregulation of transforming growth factor beta1 production,immune system process,0.81\nregulation of transforming growth factor beta2 production,immune system process,0.704\nregulation of transforming growth factor beta3 activation,immune system process,0.604\nregulation of transforming growth factor beta3 production,immune system process,0.73\nregulation of translation,gene regulation,0.518\nregulation of translation at postsynapse,gene regulation,0.566\n\"regulation of translation at postsynapse, modulating synaptic transmission\",neural related process,0.278\nregulation of translation at synapse,gene regulation,0.57\n\"regulation of translation at synapse, modulating synaptic transmission\",gene regulation,0.418\nregulation of translation by machinery localization,transport,0.232\nregulation of translation in response to endoplasmic reticulum stress,stress response,0.524\nregulation of translation in response to oxidative stress,gene regulation,0.38\nregulation of translation initiation in response to endoplasmic reticulum stress,stress response,0.494\nregulation of translation involved in cellular response to UV,cellular component organization,0.198\nregulation of translational elongation,gene regulation,0.68\nregulation of translational fidelity,cellular component organization,0.168\nregulation of translational frameshifting,gene regulation,0.624\nregulation of translational initiation by eIF2 alpha dephosphorylation,gene regulation,0.254\nregulation of translational initiation by eIF2 alpha phosphorylation,stress response,0.304\nregulation of translational initiation by iron,gene regulation,0.636\nregulation of translational initiation in response to starvation,gene regulation,0.43\nregulation of translational termination,gene regulation,0.592\nregulation of transmembrane transporter activity,transport,0.704\nregulation of transport,transport,0.604\nregulation of transport across blood-brain barrier,transport,0.432\nregulation of triglyceride biosynthetic process,metabolic process,0.868\nregulation of triglyceride catabolic process,metabolic process,0.896\nregulation of triglyceride metabolic process,metabolic process,0.892\nregulation of triglyceride transport,transport,0.644\nregulation of trophectodermal cell proliferation,cell cycle,0.456\nregulation of tryptophan metabolic process,metabolic process,0.904\nregulation of tumor necrosis factor (ligand) superfamily member 11 production,immune system process,0.724\nregulation of twitch skeletal muscle contraction,multicellular organismal process,0.664\nregulation of type B pancreatic cell apoptotic process,cell death,0.852\nregulation of type B pancreatic cell development,morphogenesis/development,0.73\nregulation of type B pancreatic cell proliferation,cell cycle,0.746\nregulation of type I hypersensitivity,immune system process,0.876\nregulation of type II hypersensitivity,immune system process,0.922\nregulation of type II interferon-mediated signaling pathway,immune system process,0.786\nregulation of type III hypersensitivity,immune system process,0.918\nregulation of type III interferon production,immune system process,0.782\nregulation of type IIa hypersensitivity,immune system process,0.922\nregulation of type IV hypersensitivity,immune system process,0.932\nregulation of tyrosinase activity,metabolic process,0.696\nregulation of tyrosine 3-monooxygenase activity,metabolic process,0.538\nregulation of ubiquinone biosynthetic process,metabolic process,0.866\nregulation of ubiquitin protein ligase activity,protein modification/signaling,0.39\nregulation of ubiquitin-dependent endocytosis,transport,0.54\nregulation of ubiquitin-protein transferase activity,protein modification/signaling,0.368\nregulation of ubiquitin-specific protease activity,metabolic process,0.39\nregulation of unsaturated fatty acid biosynthetic process,metabolic process,0.718\nregulation of urea metabolic process,metabolic process,0.778\nregulation of ureter smooth muscle cell differentiation,morphogenesis/development,0.802\nregulation of ureteric bud formation,morphogenesis/development,0.866\nregulation of urine volume,multicellular organismal process,0.536\nregulation of urothelial cell proliferation,cell cycle,0.752\nregulation of uterine smooth muscle contraction,multicellular organismal process,0.714\nregulation of uterine smooth muscle relaxation,multicellular organismal process,0.626\nregulation of vacuolar transport,transport,0.604\nregulation of vascular associated smooth muscle cell apoptotic process,cell death,0.622\nregulation of vascular associated smooth muscle cell dedifferentiation,morphogenesis/development,0.558\nregulation of vascular associated smooth muscle cell differentiation,morphogenesis/development,0.756\nregulation of vascular associated smooth muscle cell differentiation involved in phenotypic switching,morphogenesis/development,0.76\nregulation of vascular associated smooth muscle cell membrane depolarization,transport,0.338\nregulation of vascular associated smooth muscle cell migration,multicellular organismal process,0.458\nregulation of vascular associated smooth muscle contraction,multicellular organismal process,0.616\nregulation of vascular endothelial growth factor signaling pathway,receptor related process,0.46\nregulation of vascular permeability involved in acute inflammatory response,multicellular organismal process,0.202\nregulation of vascular wound healing,morphogenesis/development,0.636\nregulation of vasculogenesis,morphogenesis/development,0.652\nregulation of vasoconstriction,multicellular organismal process,0.73\nregulation of vasoconstriction by circulating norepinephrine,multicellular organismal process,0.194\nregulation of vasoconstriction by norepinephrine,multicellular organismal process,0.454\nregulation of ventricular cardiac muscle cell action potential,multicellular organismal process,0.392\nregulation of ventricular cardiac muscle cell membrane depolarization,transport,0.322\nregulation of ventricular cardiac muscle cell membrane repolarization,transport,0.29\nregulation of very-low-density lipoprotein particle clearance,multicellular organismal process,0.642\nregulation of very-low-density lipoprotein particle remodeling,cellular component organization,0.292\nregulation of vesicle docking,transport,0.298\nregulation of vesicle fusion,transport,0.342\nregulation of vesicle size,cellular component organization,0.678\nregulation of vesicle transport along microtubule,transport,0.642\nregulation of viral budding via host ESCRT complex,viral related process,0.464\nregulation of viral translation,viral related process,0.368\nregulation of vitamin D 24-hydroxylase activity,metabolic process,0.544\nregulation of vitamin D biosynthetic process,metabolic process,0.88\nregulation of vitamin D receptor signaling pathway,receptor related process,0.586\nregulation of vitamin metabolic process,metabolic process,0.926\nregulation of voltage-gated calcium channel activity,transport,0.712\nregulation of voltage-gated chloride channel activity,transport,0.746\nregulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,transport,0.614\nregulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,transport,0.628\nregulation of voltage-gated sodium channel activity,transport,0.748\nregulation of white fat cell proliferation,cell cycle,0.734\n\"regulation of wound healing, spreading of epidermal cells\",immune system process,0.294\nregulation of xenophagy,immune system process,0.352\nregulation of zinc ion transmembrane import,transport,0.824\nregulation of zinc ion transmembrane transport,transport,0.888\nregulation of zinc ion transport,transport,0.95\nregulation protein catabolic process at postsynapse,metabolic process,0.632\nregulation protein catabolic process at presynapse,metabolic process,0.634\nregulation protein catabolic process at synapse,metabolic process,0.58\nregulatory RNA binding,gene regulation,0.762\nregulatory T cell apoptotic process,cell death,0.222\nregulatory ncRNA 3'-end processing,gene regulation,0.868\nregulatory ncRNA-mediated gene silencing,gene regulation,0.612\nregulatory ncRNA-mediated heterochromatin formation,gene regulation,0.666\nregulatory ncRNA-mediated post-transcriptional gene silencing,gene regulation,0.522\nregulatory region RNA binding,gene regulation,0.724\nrelaxation of muscle,multicellular organismal process,0.608\nrelaxation of skeletal muscle,multicellular organismal process,0.146\nrelaxation of smooth muscle,multicellular organismal process,0.714\nrelaxation of vascular associated smooth muscle,protein modification/signaling,0.258\nrelease from viral latency,viral related process,0.36\nrelease of matrix enzymes from mitochondria,cell death,0.576\nrelease of sequestered calcium ion into cytosol by endoplasmic reticulum,transport,0.726\nrelease of sequestered calcium ion into cytosol by sarcoplasmic reticulum,other,0.192\nremoval of superoxide radicals,morphogenesis/development,0.17\nrenal absorption,multicellular organismal process,0.344\nrenal albumin absorption,cellular component organization,0.17\nrenal amino acid absorption,morphogenesis/development,0.198\nrenal artery morphogenesis,morphogenesis/development,0.684\nrenal capsule development,morphogenesis/development,0.958\nrenal capsule formation,morphogenesis/development,0.856\nrenal capsule morphogenesis,morphogenesis/development,0.884\nrenal capsule specification,multicellular organismal process,0.384\nrenal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure,multicellular organismal process,0.684\nrenal cortex development,morphogenesis/development,0.966\nrenal filtration,multicellular organismal process,0.596\nrenal filtration cell differentiation,morphogenesis/development,0.784\nrenal glucose absorption,morphogenesis/development,0.246\nrenal inner medulla development,morphogenesis/development,0.99\nrenal interstitial fibroblast development,morphogenesis/development,0.954\nrenal outer medulla development,morphogenesis/development,0.974\nrenal phosphate excretion,metabolic process,0.214\nrenal phosphate ion absorption,morphogenesis/development,0.224\nrenal potassium excretion,cellular component organization,0.218\nrenal protein absorption,multicellular organismal process,0.404\nrenal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure,morphogenesis/development,0.162\nrenal sodium excretion,cellular component organization,0.206\nrenal sodium ion absorption,transport,0.544\nrenal system pattern specification,morphogenesis/development,0.56\nrenal system process involved in regulation of blood volume,multicellular organismal process,0.606\nrenal system process involved in regulation of systemic arterial blood pressure,multicellular organismal process,0.552\nrenal system vasculature morphogenesis,morphogenesis/development,0.532\nrenal tubular secretion,multicellular organismal process,0.486\nrenal tubule development,morphogenesis/development,0.91\nrenal tubule morphogenesis,morphogenesis/development,0.746\nrenal urate salt excretion,metabolic process,0.336\nrenal vesicle development,morphogenesis/development,0.954\nrenal vesicle formation,morphogenesis/development,0.872\nrenal vesicle induction,morphogenesis/development,0.822\nrenal vesicle progenitor cell differentiation,morphogenesis/development,0.85\nrenal water absorption,morphogenesis/development,0.296\nrenal water homeostasis,other,0.28\nrenal water retention,cellular component organization,0.236\nrenal water transport,transport,0.714\nrenin secretion into blood stream,morphogenesis/development,0.172\nrenin-angiotensin regulation of aldosterone production,metabolic process,0.166\nreorganization of cellular membranes to establish viral sites of replication,cellular component organization,0.35\nreplacement ossification,morphogenesis/development,0.424\nreplication fork,cellular component organization,0.406\nreplication fork arrest,cell cycle,0.412\nreplication fork protection complex,protein modification/signaling,0.308\nreplication fork reversal,cellular component organization,0.292\nreplication-born double-strand break repair via sister chromatid exchange,cell cycle,0.22\nreplicative senescence,cell cycle,0.222\nreplisome,gene regulation,0.258\nreproduction,morphogenesis/development,0.246\nreproductive behavior,multicellular organismal process,0.412\nreproductive process,cell cycle,0.188\nreproductive system development,morphogenesis/development,0.904\nrescue of stalled ribosome,cellular component organization,0.354\nresolution of meiotic recombination intermediates,cellular component organization,0.186\nresolution of mitotic recombination intermediates,cell cycle,0.224\nrespirasome,metabolic process,0.428\nrespiratory basal cell differentiation,morphogenesis/development,0.674\nrespiratory burst after phagocytosis,immune system process,0.398\nrespiratory burst involved in defense response,immune system process,0.714\nrespiratory burst involved in inflammatory response,immune system process,0.612\nrespiratory chain complex,metabolic process,0.544\nrespiratory chain complex I,metabolic process,0.576\nrespiratory chain complex II,metabolic process,0.34\nrespiratory chain complex II assembly,cellular component organization,0.972\nrespiratory chain complex III,cellular component organization,0.31\nrespiratory chain complex III assembly,cellular component organization,0.91\nrespiratory chain complex IV,cellular component organization,0.326\nrespiratory chain complex IV assembly,cellular component organization,0.858\nrespiratory gaseous exchange by respiratory system,neural related process,0.194\nrespiratory system process,multicellular organismal process,0.452\nresponse to 1-oleoyl-sn-glycerol 3-phosphate,response to stimulus,0.97\nresponse to 11-deoxycorticosterone,response to stimulus,0.964\n\"response to 2,3,7,8-tetrachlorodibenzodioxine\",response to stimulus,0.942\nresponse to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine,response to stimulus,0.978\n\"response to 3,3',5-triiodo-L-thyronine\",response to stimulus,0.944\nresponse to ATP,response to stimulus,0.92\nresponse to Aroclor 1254,response to stimulus,0.924\nresponse to DNA damage checkpoint signaling,stress response,0.21\nresponse to DNA integrity checkpoint signaling,cell cycle,0.404\nresponse to G1 DNA damage checkpoint signaling,cell cycle,0.176\nresponse to Gram-negative bacterium,response to stimulus,0.862\nresponse to Gram-positive bacterium,response to stimulus,0.82\nresponse to L-arginine,response to stimulus,0.974\nresponse to L-ascorbic acid,response to stimulus,0.944\nresponse to L-glutamine,response to stimulus,0.978\nresponse to L-phenylalanine derivative,response to stimulus,0.968\nresponse to TNF agonist,response to stimulus,0.838\nresponse to Thyroglobulin triiodothyronine,response to stimulus,0.926\nresponse to Thyroid stimulating hormone,response to stimulus,0.98\nresponse to UV-A,response to stimulus,0.774\nresponse to UV-B,response to stimulus,0.696\nresponse to UV-C,response to stimulus,0.714\nresponse to abiotic stimulus,stress response,0.462\nresponse to abscisic acid,response to stimulus,0.916\nresponse to absence of light,response to stimulus,0.826\nresponse to acetate,response to stimulus,0.964\nresponse to acetylcholine,response to stimulus,0.946\nresponse to acidic pH,response to stimulus,0.798\nresponse to acrylamide,response to stimulus,0.976\nresponse to actinomycin D,response to stimulus,0.95\nresponse to aldosterone,response to stimulus,0.956\nresponse to alkaline pH,response to stimulus,0.828\nresponse to aluminum ion,response to stimulus,0.964\nresponse to amino acid,response to stimulus,0.912\nresponse to amino acid starvation,stress response,0.522\nresponse to ammonium ion,response to stimulus,0.952\nresponse to amphetamine,response to stimulus,0.918\nresponse to anesthetic,response to stimulus,0.85\nresponse to anisomycin,response to stimulus,0.928\nresponse to anoxia,response to stimulus,0.54\nresponse to antineoplastic agent,response to stimulus,0.804\nresponse to antipsychotic drug,response to stimulus,0.818\nresponse to arachidonic acid,response to stimulus,0.968\nresponse to arsenite ion,response to stimulus,0.962\nresponse to arsenite(3-),response to stimulus,0.98\nresponse to astaxanthin,response to stimulus,0.928\nresponse to auditory stimulus,response to stimulus,0.772\nresponse to azide,response to stimulus,0.95\nresponse to bacterial lipopeptide,response to stimulus,0.728\nresponse to bacterial lipoprotein,response to stimulus,0.724\nresponse to benzoic acid,response to stimulus,0.958\nresponse to bile acid,response to stimulus,0.954\nresponse to biotic stimulus,immune system process,0.35\nresponse to biotin,response to stimulus,0.95\nresponse to bisphenol A,response to stimulus,0.95\nresponse to bleomycin,response to stimulus,0.98\nresponse to blue light,response to stimulus,0.738\nresponse to butyrate,response to stimulus,0.958\nresponse to cGMP,response to stimulus,0.952\nresponse to caffeine,response to stimulus,0.916\nresponse to calcium ion,response to stimulus,0.908\nresponse to caloric restriction,response to stimulus,0.474\nresponse to camptothecin,response to stimulus,0.954\nresponse to capsazepine,response to stimulus,0.956\nresponse to carbon dioxide,response to stimulus,0.966\nresponse to carbon monoxide,response to stimulus,0.966\nresponse to catecholamine,response to stimulus,0.908\nresponse to cation stress,stress response,0.498\nresponse to cell cycle checkpoint signaling,cell cycle,0.456\nresponse to cesium ion,response to stimulus,0.974\nresponse to chemical,response to stimulus,0.302\nresponse to chlorate,response to stimulus,0.97\nresponse to chloroquine,response to stimulus,0.932\nresponse to cholecystokinin,response to stimulus,0.978\nresponse to cholesterol,response to stimulus,0.954\nresponse to cisplatin,response to stimulus,0.878\nresponse to cobalamin,response to stimulus,0.952\nresponse to cobalt ion,response to stimulus,0.926\nresponse to cocaine,response to stimulus,0.896\nresponse to copper ion,response to stimulus,0.882\nresponse to copper ion starvation,response to stimulus,0.8\nresponse to corticotropin-releasing hormone,response to stimulus,0.964\nresponse to cortisol,response to stimulus,0.804\nresponse to cortisone,response to stimulus,0.858\nresponse to cycloheximide,response to stimulus,0.916\nresponse to cytochalasin B,response to stimulus,0.96\nresponse to defenses of other organism,response to stimulus,0.806\nresponse to dehydroepiandrosterone,response to stimulus,0.96\nresponse to denervation involved in regulation of muscle adaptation,response to stimulus,0.836\nresponse to diacyl bacterial lipopeptide,response to stimulus,0.806\nresponse to diamide,response to stimulus,0.906\nresponse to dietary excess,neural related process,0.2\nresponse to disaccharide,response to stimulus,0.958\nresponse to dithiothreitol,response to stimulus,0.948\nresponse to dopamine,response to stimulus,0.94\nresponse to dsDNA,response to stimulus,0.878\nresponse to electrical stimulus,response to stimulus,0.762\nresponse to electrical stimulus involved in regulation of muscle adaptation,response to stimulus,0.854\nresponse to endogenous stimulus,response to stimulus,0.74\nresponse to endothelin,response to stimulus,0.978\nresponse to environmental enrichment,response to stimulus,0.628\nresponse to epinephrine,response to stimulus,0.856\nresponse to erythropoietin,response to stimulus,0.722\nresponse to ether,response to stimulus,0.918\nresponse to external biotic stimulus,immune system process,0.372\nresponse to external stimulus,response to stimulus,0.33\nresponse to fenofibrate,response to stimulus,0.864\nresponse to flavonoid,response to stimulus,0.968\nresponse to fluoride,response to stimulus,0.95\nresponse to folic acid,response to stimulus,0.914\nresponse to follicle-stimulating hormone,response to stimulus,0.93\nresponse to food,response to stimulus,0.802\nresponse to formaldehyde,response to stimulus,0.964\nresponse to forskolin,response to stimulus,0.966\nresponse to fructose,response to stimulus,0.902\nresponse to fungicide,response to stimulus,0.874\nresponse to fungus,response to stimulus,0.648\nresponse to genistein,response to stimulus,0.954\nresponse to gibberellin,response to stimulus,0.918\nresponse to glial cell derived neurotrophic factor,response to stimulus,0.826\nresponse to glucagon,response to stimulus,0.966\nresponse to glucose,response to stimulus,0.908\nresponse to glucoside,response to stimulus,0.966\nresponse to glyceraldehyde,response to stimulus,0.968\nresponse to glycine,response to stimulus,0.968\nresponse to glycoprotein,response to stimulus,0.908\nresponse to glycoside,response to stimulus,0.944\nresponse to gold nanoparticle,response to stimulus,0.862\nresponse to gonadotropin,response to stimulus,0.932\nresponse to gonadotropin-releasing hormone,response to stimulus,0.984\nresponse to granulocyte macrophage colony-stimulating factor,response to stimulus,0.66\nresponse to gravity,response to stimulus,0.898\nresponse to heparin,response to stimulus,0.95\nresponse to hepatocyte growth factor,response to stimulus,0.892\nresponse to herbicide,response to stimulus,0.86\nresponse to hexose,response to stimulus,0.918\nresponse to high light intensity,response to stimulus,0.742\nresponse to histamine,response to stimulus,0.82\nresponse to host,response to stimulus,0.708\nresponse to host defenses,response to stimulus,0.74\nresponse to human chorionic gonadotropin,response to stimulus,0.94\nresponse to hydrogen sulfide,response to stimulus,0.92\nresponse to hydroperoxide,response to stimulus,0.708\nresponse to hydrostatic pressure,response to stimulus,0.724\nresponse to hydroxyisoflavone,response to stimulus,0.956\nresponse to hydroxyurea,response to stimulus,0.88\nresponse to hypobaric hypoxia,response to stimulus,0.806\nresponse to immobilization stress,response to stimulus,0.636\nresponse to inactivity,response to stimulus,0.894\nresponse to indole-3-methanol,response to stimulus,0.95\nresponse to insecticide,response to stimulus,0.936\nresponse to insulin-like growth factor stimulus,response to stimulus,0.864\nresponse to interleukin-11,response to stimulus,0.698\nresponse to interleukin-12,response to stimulus,0.604\nresponse to interleukin-13,response to stimulus,0.7\nresponse to interleukin-15,response to stimulus,0.612\nresponse to interleukin-17,immune system process,0.504\nresponse to interleukin-2,response to stimulus,0.536\nresponse to interleukin-21,response to stimulus,0.726\nresponse to interleukin-3,response to stimulus,0.728\nresponse to interleukin-7,response to stimulus,0.49\nresponse to interleukin-8,response to stimulus,0.71\nresponse to interleukin-9,response to stimulus,0.582\nresponse to intra-S DNA damage checkpoint signaling,protein modification/signaling,0.172\nresponse to ionomycin,response to stimulus,0.956\nresponse to iron ion starvation,response to stimulus,0.864\nresponse to iron(II) ion,response to stimulus,0.942\nresponse to iron(III) ion,response to stimulus,0.966\nresponse to isolation stress,response to stimulus,0.65\nresponse to isoquinoline alkaloid,response to stimulus,0.898\nresponse to jasmonic acid,response to stimulus,0.834\nresponse to kainic acid,response to stimulus,0.966\nresponse to ketamine,response to stimulus,0.864\nresponse to laminar fluid shear stress,stress response,0.586\nresponse to leptin,response to stimulus,0.782\nresponse to leptomycin B,response to stimulus,0.964\nresponse to light intensity,response to stimulus,0.81\nresponse to light stimulus,stress response,0.732\nresponse to linoleic acid,response to stimulus,0.964\nresponse to lipid hydroperoxide,response to stimulus,0.708\nresponse to lipoic acid,response to stimulus,0.956\nresponse to lipoprotein particle,response to stimulus,0.908\nresponse to lipoteichoic acid,response to stimulus,0.756\nresponse to lithium ion,response to stimulus,0.95\nresponse to low light intensity stimulus,response to stimulus,0.732\nresponse to luteinizing hormone,response to stimulus,0.976\nresponse to macrophage colony-stimulating factor,response to stimulus,0.634\nresponse to magnesium ion,response to stimulus,0.94\nresponse to magnetism,response to stimulus,0.876\nresponse to manganese-induced endoplasmic reticulum stress,response to stimulus,0.792\nresponse to melanocyte-stimulating hormone,response to stimulus,0.842\nresponse to mercury ion,response to stimulus,0.952\nresponse to methamphetamine hydrochloride,response to stimulus,0.958\nresponse to methionine,response to stimulus,0.974\nresponse to methotrexate,response to stimulus,0.924\nresponse to methyl methanesulfonate,response to stimulus,0.948\nresponse to methylamine,response to stimulus,0.944\nresponse to methylglyoxal,response to stimulus,0.954\nresponse to methylmercury,response to stimulus,0.93\nresponse to mineralocorticoid,response to stimulus,0.932\nresponse to misfolded protein,response to stimulus,0.79\nresponse to mitotic cell cycle checkpoint signaling,cell cycle,0.454\nresponse to molecule of fungal origin,response to stimulus,0.76\nresponse to monoamine,response to stimulus,0.906\nresponse to morphine,response to stimulus,0.864\nresponse to muscle activity involved in regulation of muscle adaptation,response to stimulus,0.86\nresponse to muscle inactivity,response to stimulus,0.878\nresponse to muscle inactivity involved in regulation of muscle adaptation,response to stimulus,0.814\nresponse to mycophenolic acid,response to stimulus,0.916\nresponse to mycotoxin,response to stimulus,0.928\nresponse to nematode,response to stimulus,0.864\nresponse to nickel cation,response to stimulus,0.972\nresponse to nicotine,response to stimulus,0.818\nresponse to nitric oxide,response to stimulus,0.878\nresponse to nitrogen compound,response to stimulus,0.734\nresponse to nitrogen dioxide,response to stimulus,0.922\nresponse to nitroglycerin,response to stimulus,0.958\nresponse to nitrosative stress,response to stimulus,0.606\nresponse to non-ionic osmotic stress,response to stimulus,0.54\nresponse to norepinephrine,response to stimulus,0.876\nresponse to odorant,response to stimulus,0.854\nresponse to oleic acid,response to stimulus,0.964\nresponse to organic substance,response to stimulus,0.34\nresponse to organonitrogen compound,response to stimulus,0.728\nresponse to other organism,immune system process,0.37\nresponse to oxygen radical,response to stimulus,0.702\nresponse to oxygen-containing compound,response to stimulus,0.578\nresponse to oxygen-glucose deprivation,response to stimulus,0.698\nresponse to ozone,response to stimulus,0.784\nresponse to pH,response to stimulus,0.664\nresponse to pain,response to stimulus,0.762\nresponse to parathyroid hormone,response to stimulus,0.896\nresponse to peptidoglycan,response to stimulus,0.762\nresponse to phenylpropanoid,response to stimulus,0.794\nresponse to pheromone,response to stimulus,0.84\nresponse to phorbol 13-acetate 12-myristate,response to stimulus,0.944\nresponse to phosphatidylethanolamine,response to stimulus,0.97\nresponse to platelet-derived growth factor,response to stimulus,0.784\nresponse to platinum ion,response to stimulus,0.972\nresponse to potassium ion,response to stimulus,0.938\nresponse to prolactin,response to stimulus,0.982\nresponse to prostaglandin,response to stimulus,0.904\nresponse to prostaglandin D,response to stimulus,0.974\nresponse to prostaglandin E,response to stimulus,0.932\nresponse to prostaglandin F,response to stimulus,0.938\nresponse to psychosocial stress,response to stimulus,0.728\nresponse to puromycin,response to stimulus,0.96\nresponse to putrescine,response to stimulus,0.96\nresponse to pyrethroid,response to stimulus,0.814\nresponse to pyrimidine ribonucleotide,response to stimulus,0.958\nresponse to raffinose,response to stimulus,0.938\nresponse to rapamycin,response to stimulus,0.922\nresponse to redox state,response to stimulus,0.704\nresponse to salicylic acid,response to stimulus,0.902\nresponse to salt stress,stress response,0.69\nresponse to selenite ion,response to stimulus,0.948\nresponse to selenium ion,response to stimulus,0.96\nresponse to serotonin,response to stimulus,0.962\nresponse to silicon dioxide,response to stimulus,0.956\nresponse to silver ion,response to stimulus,0.974\nresponse to singlet oxygen,response to stimulus,0.676\nresponse to sodium arsenite,response to stimulus,0.932\nresponse to sodium dodecyl sulfate,response to stimulus,0.948\nresponse to sodium phosphate,response to stimulus,0.928\nresponse to sorbitol,response to stimulus,0.936\nresponse to staurosporine,response to stimulus,0.934\nresponse to stem cell factor,response to stimulus,0.696\nresponse to sterol depletion,stress response,0.56\nresponse to stilbenoid,response to stimulus,0.814\nresponse to stimulus,metabolic process,0.22\nresponse to stimulus involved in regulation of muscle adaptation,response to stimulus,0.866\nresponse to stress,stress response,0.166\nresponse to sucrose,response to stimulus,0.906\nresponse to superoxide,response to stimulus,0.688\nresponse to symbiont,response to stimulus,0.778\nresponse to symbiotic bacterium,response to stimulus,0.796\nresponse to tacrolimus,response to stimulus,0.962\nresponse to testosterone,response to stimulus,0.924\nresponse to tetrachloromethane,response to stimulus,0.854\nresponse to tetrahydrofolate,response to stimulus,0.964\nresponse to thyroid hormone,response to stimulus,0.784\nresponse to thyrotropin-releasing hormone,response to stimulus,0.978\nresponse to thyroxine,response to stimulus,0.836\nresponse to transition metal nanoparticle,response to stimulus,0.898\nresponse to triacyl bacterial lipopeptide,response to stimulus,0.816\nresponse to trichostatin A,response to stimulus,0.958\nresponse to triglyceride,response to stimulus,0.966\nresponse to type III interferon,response to stimulus,0.524\nresponse to ultrasound,response to stimulus,0.866\nresponse to vasopressin,response to stimulus,0.974\nresponse to vitamin A,response to stimulus,0.906\nresponse to vitamin B1,response to stimulus,0.938\nresponse to vitamin B2,response to stimulus,0.948\nresponse to vitamin B6,response to stimulus,0.914\nresponse to vitamin E,response to stimulus,0.954\nresponse to vitamin K,response to stimulus,0.95\nresponse to water,response to stimulus,0.876\nresponse to water deprivation,response to stimulus,0.794\nresponse to water-immersion restraint stress,response to stimulus,0.754\nresponse to wortmannin,response to stimulus,0.964\nresponse to yeast,response to stimulus,0.818\nresponse to zinc ion,response to stimulus,0.914\nresponse to zinc ion starvation,response to stimulus,0.83\nresveratrol binding,metabolic process,0.244\nreticulophagy,cellular component organization,0.202\nretina blood vessel maintenance,cellular component organization,0.188\nretina homeostasis,multicellular organismal process,0.366\nretina layer formation,morphogenesis/development,0.318\nretina morphogenesis in camera-type eye,morphogenesis/development,0.75\nretina vasculature development in camera-type eye,morphogenesis/development,0.988\nretina vasculature morphogenesis in camera-type eye,morphogenesis/development,0.87\nretinal binding,metabolic process,0.326\nretinal bipolar neuron differentiation,morphogenesis/development,0.788\nretinal blood vessel morphogenesis,morphogenesis/development,0.968\nretinal cell apoptotic process,cell death,0.802\nretinal cell programmed cell death,morphogenesis/development,0.42\nretinal cone cell apoptotic process,cell death,0.22\nretinal cone cell development,morphogenesis/development,0.192\nretinal cone cell differentiation,morphogenesis/development,0.64\nretinal dehydrogenase activity,metabolic process,0.908\nretinal metabolic process,metabolic process,0.912\nretinal pigment epithelium development,morphogenesis/development,0.728\nretinal rod cell apoptotic process,cell death,0.22\nretinal rod cell development,morphogenesis/development,0.216\nretinoic acid 4-hydroxylase activity,metabolic process,0.848\nretinoic acid binding,metabolic process,0.304\nretinoic acid biosynthetic process,metabolic process,0.948\nretinoic acid catabolic process,metabolic process,0.746\nretinoic acid receptor signaling pathway involved in somitogenesis,receptor related process,0.432\nretinoic acid-responsive element binding,gene regulation,0.306\nretinoid binding,metabolic process,0.314\nretinoid metabolic process,metabolic process,0.902\nretinol O-fatty-acyltransferase activity,metabolic process,0.884\nretinol binding,cellular component organization,0.212\nretinol isomerase activity,metabolic process,0.896\nretinol metabolic process,metabolic process,0.838\nretinol transmembrane transporter activity,cellular component organization,0.378\nretinol transport,transport,0.638\nretinyl-palmitate esterase activity,metabolic process,0.852\nretrograde axonal protein transport,transport,0.358\nretrograde axonal transport,transport,0.762\nretrograde axonal transport of mitochondrion,transport,0.404\nretrograde neuronal dense core vesicle transport,transport,0.358\nretrograde trans-synaptic signaling,protein modification/signaling,0.272\nretrograde trans-synaptic signaling by endocannabinoid,neural related process,0.228\nretrograde trans-synaptic signaling by lipid,protein modification/signaling,0.204\nretrograde trans-synaptic signaling by neuropeptide,neural related process,0.252\nretrograde trans-synaptic signaling by nitric oxide,neural related process,0.232\n\"retrograde trans-synaptic signaling by nitric oxide, modulating synaptic transmission\",neural related process,0.238\nretrograde trans-synaptic signaling by soluble gas,protein modification/signaling,0.198\nretrograde trans-synaptic signaling by trans-synaptic protein complex,protein modification/signaling,0.324\n\"retrograde transport, endosome to Golgi\",transport,0.662\n\"retrograde transport, plasma membrane to Golgi\",transport,0.382\n\"retrograde transport, vesicle recycling within Golgi\",transport,0.32\n\"retrograde transporter complex, Golgi to ER\",ER/endosome/lysosome related process,0.33\nretromer complex,cellular component organization,0.208\nretromer complex binding,metabolic process,0.238\n\"retromer, cargo-selective complex\",cellular component organization,0.258\n\"retromer, tubulation complex\",cellular component organization,0.312\nretrotransposition,gene regulation,0.438\nretrotransposon silencing,gene regulation,0.258\nretrotransposon silencing by heterochromatin formation,cellular component organization,0.308\nretrotransposon silencing by mRNA destabilization,cellular component organization,0.238\nretrotrapezoid nucleus development,morphogenesis/development,0.704\nretrotrapezoid nucleus neuron differentiation,morphogenesis/development,0.582\nreverse cholesterol transport,transport,0.41\nreversible differentiation,morphogenesis/development,0.23\nrhodopsin kinase activity,metabolic process,0.796\nrhodopsin mediated signaling pathway,receptor related process,0.36\nrhombomere 2 development,morphogenesis/development,0.83\nrhombomere 3 development,morphogenesis/development,0.818\nrhombomere 3 formation,morphogenesis/development,0.532\nrhombomere 3 morphogenesis,morphogenesis/development,0.676\nrhombomere 3 structural organization,morphogenesis/development,0.506\nrhombomere 4 development,morphogenesis/development,0.812\nrhombomere 5 development,morphogenesis/development,0.81\nrhombomere 5 formation,morphogenesis/development,0.532\nrhombomere 5 morphogenesis,morphogenesis/development,0.678\nrhombomere 5 structural organization,morphogenesis/development,0.506\nrhombomere 6 development,morphogenesis/development,0.832\nrhombomere development,morphogenesis/development,0.79\nrhombomere formation,morphogenesis/development,0.724\nrhombomere morphogenesis,morphogenesis/development,0.734\nrhombomere structural organization,morphogenesis/development,0.552\nrhythmic behavior,neural related process,0.386\nrhythmic excitation,morphogenesis/development,0.208\nrhythmic synaptic transmission,neural related process,0.334\nribbon synapse,cellular component organization,0.282\nribitol 2-dehydrogenase activity,metabolic process,0.928\n\"ribitol beta-1,4-xylosyltransferase activity\",metabolic process,0.896\nribitol phosphate metabolic process,metabolic process,0.91\nriboflavin binding,metabolic process,0.244\nriboflavin biosynthetic process,metabolic process,0.89\nriboflavin kinase activity,metabolic process,0.796\nriboflavin metabolic process,metabolic process,0.986\nriboflavin reductase (NADPH) activity,metabolic process,0.93\nriboflavin transmembrane transporter activity,cellular component organization,0.266\nriboflavin transport,transport,0.708\nribokinase activity,metabolic process,0.796\nribonuclease A activity,metabolic process,0.36\nribonuclease E activity,metabolic process,0.388\nribonuclease H2 complex,cellular component organization,0.248\nribonuclease III activity,metabolic process,0.492\nribonuclease III complex,metabolic process,0.328\nribonuclease MRP activity,metabolic process,0.448\nribonuclease MRP complex,gene regulation,0.352\nribonuclease P RNA binding,gene regulation,0.52\nribonuclease P activity,gene regulation,0.384\nribonuclease P complex,gene regulation,0.296\nribonuclease T2 activity,metabolic process,0.512\nribonuclease inhibitor activity,metabolic process,0.474\nribonucleoprotein complex,gene regulation,0.532\nribonucleoprotein complex localization,transport,0.262\nribonucleoprotein granule,cellular component organization,0.392\nribonucleoside binding,metabolic process,0.486\nribonucleoside biosynthetic process,metabolic process,0.982\nribonucleoside bisphosphate biosynthetic process,metabolic process,0.994\nribonucleoside bisphosphate catabolic process,metabolic process,0.99\nribonucleoside bisphosphate metabolic process,metabolic process,0.992\nribonucleoside catabolic process,metabolic process,0.984\nribonucleoside diphosphate biosynthetic process,metabolic process,1\nribonucleoside diphosphate catabolic process,metabolic process,0.992\nribonucleoside metabolic process,metabolic process,0.994\nribonucleoside monophosphate metabolic process,metabolic process,0.998\nribonucleoside triphosphate catabolic process,metabolic process,0.992\nribonucleoside-diphosphate reductase activity,metabolic process,0.76\n\"ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor\",metabolic process,0.902\nribonucleoside-diphosphate reductase complex,metabolic process,0.47\nribonucleotide binding,other,0.504\nribonucleotide catabolic process,metabolic process,0.99\nribose phosphate diphosphokinase activity,metabolic process,0.842\nribose phosphate diphosphokinase complex,protein modification/signaling,0.342\nribose-5-phosphate isomerase activity,metabolic process,0.896\nribosomal large subunit assembly,cellular component organization,0.948\nribosomal large subunit binding,cellular component organization,0.244\nribosomal large subunit export from nucleus,transport,0.356\nribosomal protein S6 kinase activity,metabolic process,0.542\nribosomal protein import into nucleus,transport,0.39\nribosomal small subunit export from nucleus,transport,0.338\nribosomal subunit,cellular component organization,0.498\nribosome,cellular component organization,0.346\nribosome binding,gene regulation,0.514\nribosome disassembly,cellular component organization,0.566\nribosome hibernation,morphogenesis/development,0.162\nribosome localization,transport,0.532\nribosome-associated ubiquitin-dependent protein catabolic process,metabolic process,0.63\nribosylnicotinamide kinase activity,metabolic process,0.796\nribosylnicotinate kinase activity,metabolic process,0.744\nright lung development,morphogenesis/development,0.896\nright lung morphogenesis,morphogenesis/development,0.766\nright ventricular cardiac muscle tissue morphogenesis,morphogenesis/development,0.89\nright ventricular compact myocardium morphogenesis,morphogenesis/development,0.728\nrighting reflex,morphogenesis/development,0.202\nripoptosome,cell death,0.352\nripoptosome assembly,cellular component organization,0.478\nripoptosome assembly involved in necroptotic process,cellular component organization,0.436\nrod bipolar cell differentiation,morphogenesis/development,0.682\nrod photoreceptor disc membrane,cellular component organization,0.29\nrod photoreceptor outer segment,cellular component organization,0.33\nroof of mouth development,morphogenesis/development,0.864\nroof plate formation,morphogenesis/development,0.286\nrostrocaudal neural tube patterning,morphogenesis/development,0.292\nrough endoplasmic reticulum,ER/endosome/lysosome related process,0.236\nrough endoplasmic reticulum lumen,ER/endosome/lysosome related process,0.274\nrough endoplasmic reticulum membrane,ER/endosome/lysosome related process,0.298\nruffle assembly,cellular component organization,0.468\nryanodine receptor complex,receptor related process,0.208\nryanodine-sensitive calcium-release channel activity,transport,0.51\n\"saccharopine dehydrogenase (NAD+, L-glutamate-forming) activity\",metabolic process,0.93\n\"saccharopine dehydrogenase (NAD+, L-lysine-forming) activity\",metabolic process,0.93\n\"saccharopine dehydrogenase (NADP+, L-lysine-forming) activity\",metabolic process,0.932\nsaccharopine dehydrogenase activity,metabolic process,0.874\nsagittal suture morphogenesis,morphogenesis/development,0.45\nsaliva secretion,metabolic process,0.528\nsalivary gland cavitation,morphogenesis/development,0.28\nsalivary gland morphogenesis,morphogenesis/development,0.916\nsalt transmembrane transporter activity,transport,0.734\nsarcoglycan complex,protein modification/signaling,0.28\nsarcolemma,cellular component organization,0.354\nsarcomere,cellular component organization,0.43\nsarcomerogenesis,cellular component organization,0.186\nsarcoplasm,cellular component organization,0.208\nsarcoplasmic reticulum,cellular component organization,0.16\nsarcoplasmic reticulum calcium ion transport,transport,0.762\nsarcoplasmic reticulum lumen,cellular component organization,0.576\nsarcoplasmic reticulum membrane,cellular component organization,0.648\nsarcosine catabolic process,metabolic process,0.89\nsarcosine dehydrogenase activity,metabolic process,0.896\nsarcosine metabolic process,metabolic process,0.988\nsarcosine oxidase activity,metabolic process,0.9\nsatellite DNA binding,gene regulation,0.52\nsatellite cell activation involved in skeletal muscle regeneration,morphogenesis/development,0.232\nsaturated monocarboxylic acid metabolic process,metabolic process,0.786\nscaRNA localization to Cajal body,gene regulation,0.268\nscaffold protein binding,protein modification/signaling,0.298\nscavenger receptor activity,immune system process,0.202\nscavenger receptor binding,cellular component organization,0.218\nsclerotome development,morphogenesis/development,0.876\nsebaceous gland cell differentiation,morphogenesis/development,0.928\nsebaceous gland development,morphogenesis/development,0.99\nsebum secreting cell proliferation,cell cycle,0.786\nsecalciferol 1-monooxygenase activity,metabolic process,0.626\nsecond spliceosomal transesterification activity,metabolic process,0.556\nsecondary active monocarboxylate transmembrane transporter activity,transport,0.56\nsecondary active oligopeptide transmembrane transporter activity,transport,0.66\nsecondary active organic cation transmembrane transporter activity,transport,0.412\nsecondary active sulfate transmembrane transporter activity,transport,0.616\nsecondary alcohol metabolic process,metabolic process,0.978\nsecondary heart field specification,morphogenesis/development,0.34\nsecondary lysosome,cellular component organization,0.518\nsecondary metabolic process,metabolic process,0.748\nsecondary metabolite biosynthetic process,metabolic process,0.866\nsecondary palate development,morphogenesis/development,0.864\nsecondary piRNA processing,protein modification/signaling,0.278\nsecretin receptor activity,cellular component organization,0.178\nsecretion by cell,transport,0.558\nsecretion by lung epithelial cell involved in lung growth,morphogenesis/development,0.282\nsecretion by tissue,transport,0.452\nsecretion of lysosomal enzymes,transport,0.62\nsecretory IgA immunoglobulin complex,cellular component organization,0.29\nsecretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development,morphogenesis/development,0.688\nsecretory dimeric IgA immunoglobulin complex,cellular component organization,0.272\nsecretory granule,immune system process,0.3\nsecretory granule localization,transport,0.57\nsecretory granule lumen,cellular component organization,0.602\nsecretory granule maturation,cellular component organization,0.54\nsecretory granule organization,cellular component organization,0.744\nsecretory vesicle,immune system process,0.304\nsedoheptulokinase activity,metabolic process,0.796\nsegment specification,multicellular organismal process,0.386\n\"selenide, water dikinase activity\",metabolic process,0.806\nselenium binding,metabolic process,0.232\nselenium compound metabolic process,metabolic process,0.87\nselenocystathionine gamma-lyase activity,metabolic process,0.904\nselenocysteine biosynthetic process,metabolic process,0.666\nselenocysteine catabolic process,metabolic process,0.66\nselenocysteine incorporation,gene regulation,0.252\nselenocysteine insertion sequence binding,gene regulation,0.308\nselenocysteine lyase activity,metabolic process,0.898\nselenocysteine metabolic process,metabolic process,0.978\nselenocysteine-tRNA ligase activity,metabolic process,0.82\nselenotransferase activity,metabolic process,0.892\nself proteolysis,metabolic process,0.444\nsemaphorin receptor activity,receptor related process,0.192\nsemaphorin receptor binding,receptor related process,0.486\nsemaphorin receptor complex,receptor related process,0.332\nsemaphorin-plexin signaling pathway,receptor related process,0.474\nsemaphorin-plexin signaling pathway involved in bone trabecula morphogenesis,protein modification/signaling,0.172\nsemaphorin-plexin signaling pathway involved in neuron projection guidance,receptor related process,0.392\nsemaphorin-plexin signaling pathway involved in outflow tract morphogenesis,receptor related process,0.466\nsemi-lunar valve development,morphogenesis/development,0.978\nsemicircular canal development,morphogenesis/development,0.91\nsemicircular canal formation,morphogenesis/development,0.608\nsemicircular canal fusion,morphogenesis/development,0.36\nsemicircular canal morphogenesis,morphogenesis/development,0.768\nseminal clot liquefaction,morphogenesis/development,0.312\nseminal vesicle development,morphogenesis/development,0.748\nseminal vesicle epithelium development,morphogenesis/development,0.852\nseminal vesicle morphogenesis,morphogenesis/development,0.748\nsenescence-associated heterochromatin focus,gene regulation,0.27\nsensitization,immune system process,0.248\nsensory neuron axon guidance,neural related process,0.438\nsensory neuron migration,neural related process,0.212\nsensory organ boundary specification,morphogenesis/development,0.182\nsensory organ development,morphogenesis/development,0.712\nsensory organ morphogenesis,morphogenesis/development,0.736\nsensory perception,neural related process,0.716\nsensory perception of bitter taste,protein modification/signaling,0.202\nsensory perception of chemical stimulus,neural related process,0.266\nsensory perception of cold stimulus,neural related process,0.198\nsensory perception of hot stimulus,protein modification/signaling,0.188\nsensory perception of itch,cellular component organization,0.244\nsensory perception of light stimulus,neural related process,0.332\nsensory perception of salty taste,protein modification/signaling,0.202\nsensory perception of smell,neural related process,0.172\nsensory perception of sound,neural related process,0.314\nsensory perception of sour taste,protein modification/signaling,0.202\nsensory perception of sweet taste,protein modification/signaling,0.202\nsensory perception of taste,neural related process,0.234\nsensory perception of temperature stimulus,neural related process,0.426\nsensory perception of touch,immune system process,0.192\nsensory perception of umami taste,protein modification/signaling,0.202\nsensory processing,multicellular organismal process,0.348\nsepiapterin reductase activity,metabolic process,0.934\nseptin collar,cellular component organization,0.536\nseptin complex,cell cycle,0.244\nseptin cytoskeleton,cellular component organization,0.58\nseptin cytoskeleton organization,cellular component organization,0.964\nseptin ring,cellular component organization,0.518\nseptin ring assembly,cellular component organization,0.878\nseptin ring organization,cellular component organization,0.868\nseptum primum development,morphogenesis/development,0.854\nseptum secundum development,morphogenesis/development,0.852\nseptum transversum development,morphogenesis/development,0.74\nsequence-specific DNA binding,gene regulation,0.826\nsequestering of BMP from receptor via BMP binding,receptor related process,0.42\nsequestering of BMP in extracellular matrix,receptor related process,0.23\nsequestering of TGFbeta in extracellular matrix,receptor related process,0.214\nsequestering of actin monomers,cellular component organization,0.316\nsequestering of extracellular ligand from receptor,receptor related process,0.532\nsequestering of iron ion,transport,0.224\nsequestering of metal ion,cellular component organization,0.214\nsequestering of neurotransmitter,cellular component organization,0.248\nsequestering of nodal from receptor via nodal binding,receptor related process,0.432\nsequestering of triglyceride,cellular component organization,0.262\nsequestering of zinc ion,cellular component organization,0.244\nserine C-palmitoyltransferase activity,metabolic process,0.896\nserine C-palmitoyltransferase complex,metabolic process,0.532\nserine O-acyltransferase activity,metabolic process,0.9\nserine binding,metabolic process,0.34\nserine family amino acid catabolic process,metabolic process,0.994\nserine hydrolase activity,metabolic process,0.494\nserine import across plasma membrane,transport,0.874\nserine import into mitochondrion,cellular component organization,0.204\nserine phosphorylation of STAT protein,protein modification/signaling,0.578\nserine protease inhibitor complex,protein modification/signaling,0.268\nserine racemase activity,metabolic process,0.514\nserine-pyruvate aminotransferase complex,metabolic process,0.334\nserine-pyruvate transaminase activity,metabolic process,0.896\nserine-tRNA ligase activity,metabolic process,0.82\nserine-type aminopeptidase activity,metabolic process,0.572\nserine-type carboxypeptidase activity,metabolic process,0.528\nserine-type endopeptidase activity,metabolic process,0.446\nserine-type endopeptidase complex,protein modification/signaling,0.272\nserine-type exopeptidase activity,metabolic process,0.506\nserine-type peptidase activity,metabolic process,0.392\nserine-type peptidase complex,metabolic process,0.266\nserine/threonine protein kinase complex,protein modification/signaling,0.658\nserotonergic neuron axon guidance,neural related process,0.418\nserotonergic synapse,neural related process,0.214\nserotonin binding,neural related process,0.238\nserotonin biosynthetic process,metabolic process,0.886\nserotonin metabolic process,metabolic process,0.904\nserotonin production involved in inflammatory response,immune system process,0.544\nserotonin receptor activity,neural related process,0.338\nserotonin receptor complex,receptor related process,0.332\nserotonin receptor signaling pathway,receptor related process,0.604\nserotonin secretion,transport,0.42\nserotonin secretion by mast cell,immune system process,0.324\nserotonin secretion by platelet,immune system process,0.304\nserotonin secretion involved in inflammatory response,transport,0.516\nserotonin transport,transport,0.756\nserotonin uptake,neural related process,0.368\nserotonin-activated cation-selective channel complex,cellular component organization,0.322\nserotonin:sodium:chloride symporter activity,metabolic process,0.52\nserpin family protein binding,protein modification/signaling,0.25\nserum response element binding,gene regulation,0.388\nseryl-tRNA aminoacylation,metabolic process,0.562\nsesquiterpenoid catabolic process,metabolic process,0.992\nsesquiterpenoid metabolic process,metabolic process,0.996\nsex chromatin,cellular component organization,0.302\nsex chromosome,cellular component organization,0.498\nsex determination,morphogenesis/development,0.404\nsexual reproduction,cell cycle,0.382\nsheet-forming collagen trimer,cellular component organization,0.422\nshelterin complex,cellular component organization,0.21\nshelterin complex assembly,cellular component organization,0.588\nshort-chain carboxylesterase activity,metabolic process,0.822\nshort-chain collagen trimer,cellular component organization,0.308\nshort-chain fatty acid biosynthetic process,metabolic process,0.984\nshort-chain fatty acid catabolic process,metabolic process,0.994\nshort-chain fatty acid metabolic process,metabolic process,0.988\nshort-chain fatty acid transmembrane transport,transport,0.87\nshort-chain fatty acid transmembrane transporter activity,transport,0.748\nshort-chain fatty acid transport,transport,0.98\nshort-chain-acyl-CoA dehydrogenase activity,metabolic process,0.908\nshort-term memory,morphogenesis/development,0.208\nshort-term synaptic potentiation,neural related process,0.356\nsiRNA binding,gene regulation,0.53\nsiRNA processing,gene regulation,0.724\nsiRNA transcription,gene regulation,0.576\nsiRNA-mediated gene silencing by mRNA destabilization,gene regulation,0.546\nsiRNA-mediated post-transcriptional gene silencing,gene regulation,0.488\nsiRNA-mediated retrotransposon silencing by heterochromatin formation,cellular component organization,0.356\nsialate 4-O-acetylesterase activity,metabolic process,0.9\nsialate 9-O-acetylesterase activity,metabolic process,0.9\nsialate O-acetylesterase activity,metabolic process,0.818\nsialic acid binding,metabolic process,0.232\nsialic acid transmembrane transporter activity,transport,0.652\nsialic acid transport,transport,0.718\nsialic acid:proton symporter activity,metabolic process,0.526\nsialylation,protein modification/signaling,0.326\nside of membrane,cellular component organization,0.52\nsiderophore biosynthetic process,metabolic process,0.822\nsiderophore metabolic process,metabolic process,0.804\nsiderophore transport,transport,0.962\nsiderophore-iron transmembrane transporter activity,transport,0.558\nsignal clustering,receptor related process,0.362\nsignal complex assembly,cellular component organization,0.424\nsignal peptidase complex,ER/endosome/lysosome related process,0.286\nsignal recognition particle,gene regulation,0.242\nsignal recognition particle binding,metabolic process,0.22\nsignal recognition particle receptor complex,receptor related process,0.208\n\"signal recognition particle, endoplasmic reticulum targeting\",gene regulation,0.188\nsignal release from synapse,neural related process,0.462\nsignal sequence binding,protein modification/signaling,0.208\nsignal transduction,metabolic process,0.158\nsignal transduction downstream of smoothened,protein modification/signaling,0.26\nsignal transduction involved in regulation of gene expression,gene regulation,0.258\nsignaling,metabolic process,0.178\nsignaling receptor activator activity,receptor related process,0.342\nsignaling receptor inhibitor activity,receptor related process,0.468\nsignaling receptor regulator activity,receptor related process,0.306\nsilver ion transmembrane transport,transport,0.436\nsilver ion transmembrane transporter activity,transport,0.612\nsingle base insertion or deletion binding,gene regulation,0.55\nsingle fertilization,cellular component organization,0.154\nsingle guanine insertion binding,metabolic process,0.204\nsingle strand break repair,stress response,0.638\nsingle stranded viral RNA replication via double stranded DNA intermediate,viral related process,0.314\nsingle thymine insertion binding,metabolic process,0.204\nsingle-species biofilm formation,cellular component organization,0.18\nsingle-species biofilm formation in or on host organism,gene regulation,0.238\nsingle-strand break-containing DNA binding,cell cycle,0.198\nsingle-strand selective uracil DNA N-glycosylase activity,metabolic process,0.426\nsingle-stranded 3'-5' DNA helicase activity,metabolic process,0.502\nsingle-stranded DNA 3'-5' DNA exonuclease activity,metabolic process,0.388\nsingle-stranded DNA 5'-3' DNA exonuclease activity,metabolic process,0.402\nsingle-stranded DNA endodeoxyribonuclease activity,metabolic process,0.514\nsingle-stranded DNA exodeoxyribonuclease activity,metabolic process,0.436\nsingle-stranded telomeric DNA binding,gene regulation,0.668\nsinoatrial node cell development,morphogenesis/development,0.892\nsinoatrial node cell differentiation,morphogenesis/development,0.732\nsinoatrial node cell fate commitment,morphogenesis/development,0.274\nsinoatrial node development,morphogenesis/development,0.87\nsinoatrial valve development,morphogenesis/development,0.848\nsinoatrial valve morphogenesis,morphogenesis/development,0.514\nsinus venosus development,morphogenesis/development,0.846\nsinus venosus morphogenesis,morphogenesis/development,0.39\nsister chromatid biorientation,cell cycle,0.632\nsite of DNA damage,cellular component organization,0.32\nsite of double-strand break,cell cycle,0.22\nsite of polarized growth,cellular component organization,0.412\nsite-specific DNA-methyltransferase (adenine-specific) activity,metabolic process,0.73\n\"site-specific endodeoxyribonuclease activity, specific for altered base\",metabolic process,0.566\nskeletal muscle acetylcholine-gated channel clustering,cellular component organization,0.234\nskeletal muscle adaptation,multicellular organismal process,0.45\nskeletal muscle atrophy,immune system process,0.244\nskeletal muscle cell proliferation,cell cycle,0.878\nskeletal muscle contraction,multicellular organismal process,0.6\nskeletal muscle fiber adaptation,protein modification/signaling,0.2\nskeletal muscle fiber development,morphogenesis/development,0.948\nskeletal muscle fiber differentiation,morphogenesis/development,0.908\nskeletal muscle hypertrophy,cellular component organization,0.288\nskeletal muscle myosin thick filament assembly,cellular component organization,0.544\nskeletal muscle satellite cell activation,cell cycle,0.226\nskeletal muscle satellite cell differentiation,morphogenesis/development,0.656\nskeletal muscle satellite cell maintenance involved in skeletal muscle regeneration,morphogenesis/development,0.538\nskeletal muscle satellite cell migration,transport,0.148\nskeletal muscle thin filament assembly,cellular component organization,0.55\nskeletal muscle tissue growth,metabolic process,0.178\nskeletal muscle tissue regeneration,morphogenesis/development,0.782\nskeletal myofibril assembly,morphogenesis/development,0.932\nskin morphogenesis,morphogenesis/development,0.488\nslit diaphragm,cellular component organization,0.214\nslit diaphragm assembly,cellular component organization,0.538\nslow axonal transport,transport,0.386\nslow endocytic recycling,transport,0.49\nslow-twitch skeletal muscle fiber contraction,morphogenesis/development,0.264\nsmall RNA 2'-O-methyltransferase activity,metabolic process,0.63\nsmall conductance calcium-activated potassium channel activity,metabolic process,0.216\nsmall intestinal transit,cellular component organization,0.248\nsmall intestine smooth muscle contraction,morphogenesis/development,0.176\nsmall molecule metabolic process,metabolic process,0.912\nsmall molecule sensor activity,metabolic process,0.294\nsmall nuclear ribonucleoprotein complex,gene regulation,0.586\nsmall protein activating enzyme binding,protein modification/signaling,0.52\nsmall ribosomal subunit,cellular component organization,0.458\nsmall ribosomal subunit rRNA binding,gene regulation,0.494\nsmall-subunit processome,cellular component organization,0.392\nsmall-subunit processome assembly,cellular component organization,0.428\nsmooth endoplasmic reticulum,metabolic process,0.258\nsmooth endoplasmic reticulum calcium ion homeostasis,other,0.422\nsmooth endoplasmic reticulum membrane,ER/endosome/lysosome related process,0.278\nsmooth muscle adaptation,multicellular organismal process,0.43\nsmooth muscle cell chemotaxis,immune system process,0.284\nsmooth muscle cell migration,multicellular organismal process,0.716\nsmooth muscle cell-matrix adhesion,cell adhesion,0.212\nsmooth muscle contractile fiber,cellular component organization,0.222\nsmooth muscle contraction,multicellular organismal process,0.736\nsmooth muscle contraction involved in micturition,morphogenesis/development,0.252\nsmooth muscle hyperplasia,cell cycle,0.184\nsmooth muscle hypertrophy,morphogenesis/development,0.376\nsmoothened binding,protein modification/signaling,0.37\nsmoothened signaling pathway,receptor related process,0.368\nsmoothened signaling pathway involved in dorsal/ventral neural tube patterning,protein modification/signaling,0.394\nsmoothened signaling pathway involved in lung development,protein modification/signaling,0.37\nsmoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation,protein modification/signaling,0.318\nsmoothened signaling pathway involved in regulation of secondary heart field cardioblast proliferation,protein modification/signaling,0.312\nsmoothened signaling pathway involved in spinal cord motor neuron cell fate specification,receptor related process,0.298\nsmoothened signaling pathway involved in ventral spinal cord interneuron specification,receptor related process,0.462\nsmoothened signaling pathway involved in ventral spinal cord patterning,receptor related process,0.412\nsn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity,metabolic process,0.894\nsnRNA (adenine-N6)-methylation,protein modification/signaling,0.208\nsnRNA 2'-O-methylation,gene regulation,0.68\nsnRNA binding,gene regulation,0.792\nsnRNA catabolic process,metabolic process,0.816\nsnRNA export from nucleus,transport,0.366\nsnRNA import into nucleus,transport,0.336\nsnRNA metabolic process,metabolic process,0.656\nsnRNA methylation,gene regulation,0.676\nsnRNA methyltransferase activity,metabolic process,0.664\nsnRNA modification,gene regulation,0.668\nsnRNA processing,gene regulation,0.782\nsnRNA pseudouridine synthesis,metabolic process,0.228\nsnRNA transcription by RNA polymerase II,gene regulation,0.532\nsnRNA transcription by RNA polymerase III,gene regulation,0.526\nsnRNA transport,transport,0.904\nsnRNA-activating protein complex,gene regulation,0.484\nsnRNP binding,gene regulation,0.238\nsneeze reflex,cellular component organization,0.336\nsno(s)RNA catabolic process,metabolic process,0.8\nsno(s)RNA metabolic process,metabolic process,0.592\nsno(s)RNA-containing ribonucleoprotein complex,gene regulation,0.48\nsnoRNA guided rRNA pseudouridine synthesis,cellular component organization,0.348\nsnoRNA localization,gene regulation,0.336\nsnoRNA splicing,gene regulation,0.332\nsnoRNP binding,gene regulation,0.242\nsodium channel activity,transport,0.548\nsodium channel complex,transport,0.248\nsodium channel inhibitor activity,metabolic process,0.262\nsodium channel regulator activity,metabolic process,0.286\nsodium ion binding,metabolic process,0.224\nsodium ion export across plasma membrane,transport,0.53\nsodium ion import across plasma membrane,transport,0.49\nsodium ion transmembrane transporter activity,transport,0.67\n\"sodium,bicarbonate:chloride antiporter activity\",metabolic process,0.524\nsodium-dependent multivitamin transmembrane transporter activity,metabolic process,0.514\nsodium-dependent organic anion transmembrane transporter activity,cellular component organization,0.242\nsodium-dependent organic anion transport,transport,0.716\nsodium-dependent organic cation transport,transport,0.708\nsodium-dependent phosphate transport,transport,0.698\nsodium-independent organic anion transmembrane transporter activity,cellular component organization,0.248\nsodium-independent organic anion transport,transport,0.716\nsodium:bicarbonate symporter activity,metabolic process,0.522\nsodium:chloride symporter activity,transport,0.538\nsodium:dicarboxylate symporter activity,transport,0.55\nsodium:inorganic phosphate symporter activity,metabolic process,0.518\nsodium:iodide symporter activity,metabolic process,0.526\nsodium:phosphate symporter activity,transport,0.502\nsodium:potassium-exchanging ATPase complex,cellular component organization,0.362\nsodium:potassium:chloride symporter activity,metabolic process,0.526\nsodium:proton antiporter activity,transport,0.464\nsodium:proton antiporter activity involved in regulation of cardiac muscle cell membrane potential,metabolic process,0.338\nsodium:sulfate symporter activity,metabolic process,0.526\nsoft palate development,morphogenesis/development,0.888\nsoluble NSF attachment protein activity,cellular component organization,0.296\nsolute:inorganic anion antiporter activity,transport,0.498\nsolute:monoatomic cation symporter activity,transport,0.65\nsolute:potassium antiporter activity,transport,0.584\nsolute:proton symporter activity,transport,0.536\nsolute:sodium symporter activity,transport,0.586\nsomatic cell DNA recombination,immune system process,0.518\nsomatic diversification of T cell receptor genes,immune system process,0.646\nsomatic diversification of immune receptors via germline recombination within a single locus,immune system process,0.8\nsomatic diversification of immune receptors via somatic mutation,immune system process,0.56\nsomatic diversification of immunoglobulins,immune system process,0.792\nsomatic diversification of immunoglobulins involved in immune response,immune system process,0.806\nsomatic motor neuron differentiation,morphogenesis/development,0.452\nsomatic muscle development,morphogenesis/development,0.978\nsomatic recombination of T cell receptor gene segments,immune system process,0.614\nsomatic recombination of immunoglobulin genes involved in immune response,immune system process,0.72\nsomatic sex determination,morphogenesis/development,0.522\nsomatic stem cell division,cell cycle,0.448\nsomatic stem cell population maintenance,morphogenesis/development,0.7\nsomato-dendritic dopamine secretion,neural related process,0.33\nsomatodendritic compartment,neural related process,0.526\nsomatostatin receptor activity,receptor related process,0.304\nsomatostatin receptor binding,receptor related process,0.442\nsomatostatin receptor signaling pathway,receptor related process,0.808\nsomatostatin secretion,cellular component organization,0.226\nsomatostatin signaling pathway,receptor related process,0.674\nsomatotropin secreting cell development,morphogenesis/development,0.936\nsomatotropin secreting cell differentiation,morphogenesis/development,0.692\nsomite rostral/caudal axis specification,morphogenesis/development,0.294\nsomite specification,morphogenesis/development,0.23\nsorbitol catabolic process,metabolic process,0.872\nsorbitol metabolic process,metabolic process,0.984\nsorting endosome,cellular component organization,0.184\nsour taste receptor activity,receptor related process,0.35\nspecific granule lumen,immune system process,0.282\nspecific granule membrane,immune system process,0.314\nspecification of animal organ identity,morphogenesis/development,0.648\nspecification of animal organ position,morphogenesis/development,0.458\nspecification of anterior mesonephric tubule identity,morphogenesis/development,0.226\nspecification of axis polarity,multicellular organismal process,0.39\nspecification of loop of Henle identity,multicellular organismal process,0.528\nspecification of mesonephric tubule identity,multicellular organismal process,0.426\nspecification of nephron tubule identity,multicellular organismal process,0.374\nspecification of posterior mesonephric tubule identity,morphogenesis/development,0.226\nspecification of symmetry,morphogenesis/development,0.51\nspectrin,cellular component organization,0.608\nspectrin-associated cytoskeleton,cellular component organization,0.684\nsperm DNA condensation,morphogenesis/development,0.222\nsperm DNA decondensation,cellular component organization,0.236\nsperm annulus,cellular component organization,0.398\nsperm axoneme assembly,cellular component organization,0.31\nsperm capacitation,protein modification/signaling,0.34\nsperm competition,multicellular organismal process,0.502\nsperm connecting piece,cellular component organization,0.244\nsperm cytoplasmic droplet,morphogenesis/development,0.174\nsperm displacement,cellular component organization,0.244\nsperm ejaculation,cellular component organization,0.212\nsperm end piece,cellular component organization,0.394\nsperm entry,cellular component organization,0.386\nsperm fibrous sheath,cellular component organization,0.408\nsperm flagellum,morphogenesis/development,0.224\nsperm flagellum assembly,cellular component organization,0.364\nsperm head,cellular component organization,0.208\nsperm head plasma membrane,cellular component organization,0.382\nsperm head-tail coupling apparatus,cellular component organization,0.436\nsperm individualization,cellular component organization,0.392\nsperm midpiece,cellular component organization,0.258\nsperm mitochondrial sheath,cellular component organization,0.248\nsperm mitochondrial sheath assembly,cellular component organization,0.368\nsperm mitochondrion organization,cellular component organization,0.606\nsperm motility,other,0.51\nsperm plasma membrane,cellular component organization,0.376\nsperm principal piece,cellular component organization,0.328\nsperm-egg recognition,cellular component organization,0.212\nspermatid development,morphogenesis/development,0.896\nspermatid differentiation,morphogenesis/development,0.644\nspermatid nucleus differentiation,morphogenesis/development,0.344\nspermatid nucleus elongation,cellular component organization,0.284\nspermatocyte division,metabolic process,0.216\nspermatogenesis,morphogenesis/development,0.42\nspermatogonial cell division,cell cycle,0.36\nspermatoproteasome complex,metabolic process,0.3\nspermidine acetylation,gene regulation,0.286\nspermidine binding,metabolic process,0.246\nspermidine biosynthetic process,metabolic process,0.892\nspermidine catabolic process,metabolic process,0.884\nspermidine deacetylation,protein modification/signaling,0.27\nspermidine metabolic process,metabolic process,0.95\nspermidine synthase activity,metabolic process,0.896\nspermidine transmembrane transport,transport,0.782\nspermidine transmembrane transporter activity,cellular component organization,0.286\nspermidine transport,transport,0.904\nspermidine:oxygen oxidoreductase (3-aminopropanal-forming) activity,metabolic process,0.9\nspermine acetylation,gene regulation,0.286\nspermine biosynthetic process,metabolic process,0.818\nspermine catabolic process,metabolic process,0.818\nspermine metabolic process,metabolic process,0.86\nspermine synthase activity,metabolic process,0.896\nspermine transmembrane transport,transport,0.268\nspermine transport,transport,0.91\nspermine:oxygen oxidoreductase (spermidine-forming) activity,metabolic process,0.9\nspherical high-density lipoprotein particle,gene regulation,0.184\nsphinganine biosynthetic process,metabolic process,0.888\nsphinganine kinase activity,metabolic process,0.792\nsphinganine metabolic process,metabolic process,0.96\nsphinganine-1-phosphate aldolase activity,metabolic process,0.894\nsphinganine-1-phosphate biosynthetic process,metabolic process,0.846\nsphinganine-1-phosphate metabolic process,metabolic process,0.958\nsphingoid biosynthetic process,metabolic process,0.962\nsphingoid catabolic process,metabolic process,0.964\nsphingoid metabolic process,metabolic process,0.962\nsphingolipid activator protein activity,metabolic process,0.44\nsphingolipid binding,metabolic process,0.244\nsphingolipid biosynthetic process,metabolic process,0.94\nsphingolipid delta-4 desaturase activity,metabolic process,0.9\nsphingolipid floppase activity,transport,0.428\nsphingolipid mediated signaling pathway,receptor related process,0.41\nsphingolipid transfer activity,transport,0.376\nsphingolipid translocation,transport,0.492\nsphingolipid transporter activity,transport,0.724\nsphingomyelin biosynthetic process,metabolic process,0.89\nsphingomyelin catabolic process,metabolic process,0.888\nsphingomyelin metabolic process,metabolic process,0.954\nsphingomyelin phosphodiesterase D activity,metabolic process,0.9\nsphingomyelin phosphodiesterase activator activity,metabolic process,0.37\nsphingomyelin phosphodiesterase activity,metabolic process,0.842\nsphingomyelin synthase activity,metabolic process,0.896\nsphingomyelin transfer activity,cellular component organization,0.254\nsphingosine N-acyltransferase activity,metabolic process,0.888\nsphingosine biosynthetic process,metabolic process,0.864\nsphingosine hydroxylase activity,metabolic process,0.526\nsphingosine metabolic process,metabolic process,0.966\nsphingosine-1-phosphate phosphatase activity,metabolic process,0.838\nsphingosine-1-phosphate receptor activity,protein modification/signaling,0.206\nsphingosine-1-phosphate receptor signaling pathway,receptor related process,0.612\nspike train,cellular component organization,0.206\nspinal cord anterior/posterior patterning,cellular component organization,0.268\nspinal cord association neuron differentiation,morphogenesis/development,0.522\nspinal cord development,morphogenesis/development,0.804\nspinal cord dorsal/ventral patterning,cellular component organization,0.252\nspinal cord interneuron axon guidance,neural related process,0.416\nspinal cord motor neuron cell fate specification,morphogenesis/development,0.434\nspinal cord motor neuron differentiation,morphogenesis/development,0.476\nspinal cord motor neuron migration,neural related process,0.264\nspinal cord oligodendrocyte cell differentiation,morphogenesis/development,0.448\nspinal cord oligodendrocyte cell fate specification,morphogenesis/development,0.508\nspinal cord patterning,cellular component organization,0.268\nspinal cord ventral commissure morphogenesis,morphogenesis/development,0.744\nspindle,cell cycle,0.644\nspindle assembly involved in female meiosis,cell cycle,0.636\nspindle assembly involved in female meiosis I,cellular component organization,0.4\nspindle attachment to meiosis I kinetochore,cellular component organization,0.282\nspindle disassembly,cell cycle,0.468\nspindle matrix,cellular component organization,0.376\nspindle microtubule,cellular component organization,0.388\nspindle midzone,cell cycle,0.486\nspindle pole,cell cycle,0.474\nspindle pole centrosome,cell cycle,0.35\nspine apparatus,cellular component organization,0.276\nspine apparatus assembly,cellular component organization,0.604\nspleen development,morphogenesis/development,0.72\nspleen trabecula formation,morphogenesis/development,0.258\nspliceosomal complex assembly,cellular component organization,0.766\nspliceosomal complex disassembly,cellular component organization,0.294\nspliceosomal conformational changes to generate catalytic conformation,gene regulation,0.448\nspliceosomal snRNP assembly,cellular component organization,0.882\nspliceosomal snRNP complex,gene regulation,0.464\nspliceosomal tri-snRNP complex,gene regulation,0.376\nspliceosomal tri-snRNP complex assembly,cellular component organization,0.256\nspliceosome conformational change to release U4 (or U4atac) and U1 (or U11),cellular component organization,0.292\nsplicing factor binding,gene regulation,0.52\nspongiotrophoblast cell proliferation,cell cycle,0.714\nspongiotrophoblast differentiation,morphogenesis/development,0.728\nspongiotrophoblast layer developmental growth,morphogenesis/development,0.856\nspontaneous exocytosis of neurotransmitter,neural related process,0.246\nspontaneous neurotransmitter secretion,morphogenesis/development,0.158\nspontaneous synaptic transmission,neural related process,0.34\nspot adherens junction,cellular component organization,0.382\nsprouting of injured axon,morphogenesis/development,0.7\nsqualene monooxygenase activity,metabolic process,0.932\nsqualene synthase activity,metabolic process,0.912\nsquamous basal epithelial stem cell differentiation involved in prostate gland acinus development,morphogenesis/development,0.71\nstabilization of membrane potential,cellular component organization,0.36\nstalled ribosome sensor activity,protein modification/signaling,0.18\nstarch binding,metabolic process,0.25\nstarch catabolic process,metabolic process,0.83\nstarch metabolic process,metabolic process,0.918\nstartle response,neural related process,0.31\nstearoyl-CoA 9-desaturase activity,metabolic process,0.9\nstem cell factor receptor activity,receptor related process,0.32\nstem cell factor receptor binding,receptor related process,0.402\nstem cell fate commitment,morphogenesis/development,0.69\nstem cell fate specification,morphogenesis/development,0.614\nstereocilia ankle link,cellular component organization,0.22\nstereocilia ankle link complex,cellular component organization,0.236\nstereocilia coupling link,morphogenesis/development,0.362\nstereocilia tip link,cellular component organization,0.396\nstereocilia tip-link density,cellular component organization,0.57\nstereocilium,cellular component organization,0.512\nstereocilium base,cellular component organization,0.33\nstereocilium bundle,cellular component organization,0.404\nstereocilium coat,cellular component organization,0.224\nstereocilium maintenance,morphogenesis/development,0.346\nstereocilium membrane,cellular component organization,0.394\nstereocilium shaft,cellular component organization,0.336\nstereocilium tip,cellular component organization,0.482\nsteroid 11-beta-monooxygenase activity,metabolic process,0.922\nsteroid 17-alpha-monooxygenase activity,metabolic process,0.9\nsteroid 21-monooxygenase activity,metabolic process,0.92\nsteroid 7-alpha-hydroxylase activity,metabolic process,0.876\nsteroid biosynthetic process,metabolic process,0.946\nsteroid catabolic process,metabolic process,0.97\nsteroid dehydrogenase activity,metabolic process,0.936\n\"steroid dehydrogenase activity, acting on the CH-CH group of donors\",metabolic process,0.946\n\"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor\",metabolic process,0.968\nsteroid delta-isomerase activity,metabolic process,0.896\nsteroid hormone binding,gene regulation,0.286\nsteroid hormone biosynthetic process,metabolic process,0.854\nsteroid hormone mediated signaling pathway,receptor related process,0.612\nsteroid hormone receptor complex assembly,cellular component organization,0.418\nsteroid hormone secretion,transport,0.618\nsteroid hydroxylase activity,metabolic process,0.752\nsteroid receptor RNA activator RNA binding,gene regulation,0.466\nsteroid sulfotransferase activity,metabolic process,0.898\nsterol 12-alpha-hydroxylase activity,metabolic process,0.896\nsterol 14-demethylase activity,metabolic process,0.824\nsterol 5-alpha reductase activity,metabolic process,0.486\nsterol O-acyltransferase activity,metabolic process,0.872\nsterol catabolic process,metabolic process,0.962\nsterol delta7 reductase activity,metabolic process,0.896\nsterol desaturase activity,metabolic process,0.734\nsterol esterase activity,metabolic process,0.888\nsterol metabolic process,metabolic process,0.952\nsterol response element binding,gene regulation,0.414\nsterol sensor activity,metabolic process,0.196\nsterol transfer activity,transport,0.394\nsterol transmembrane transport,transport,0.252\nsterol transport,transport,0.926\nsterol-4-alpha-carboxylate 3-dehydrogenase (decarboxylating) activity,metabolic process,0.934\nsteryl-beta-glucosidase activity,metabolic process,0.888\nstilbene catabolic process,metabolic process,0.872\nstilbene metabolic process,metabolic process,0.96\nstimulatory killer cell immunoglobulin-like receptor signaling pathway,immune system process,0.414\nstomach development,morphogenesis/development,0.98\nstomach neuroendocrine cell differentiation,morphogenesis/development,0.7\nstomach pylorus smooth muscle contraction,multicellular organismal process,0.604\nstomach smooth muscle contraction,multicellular organismal process,0.614\nstorage vacuole,cellular component organization,0.458\nstore-operated calcium channel activity,transport,0.208\nstore-operated calcium entry,cellular component organization,0.248\nstress fiber,cellular component organization,0.582\nstress granule disassembly,gene regulation,0.298\nstress response to acid chemical,response to stimulus,0.572\nstress response to cadmium ion,response to stimulus,0.794\nstress response to copper ion,response to stimulus,0.786\nstress response to metal ion,response to stimulus,0.726\nstress response to zinc ion,response to stimulus,0.794\nstress-induced mitochondrial fusion,cellular component organization,0.228\nstress-induced premature senescence,metabolic process,0.288\n\"stretch-activated, monoatomic cation-selective, calcium channel activity\",transport,0.516\nstriatal medium spiny neuron differentiation,morphogenesis/development,0.546\nstriated muscle adaptation,multicellular organismal process,0.488\nstriated muscle atrophy,multicellular organismal process,0.422\nstriated muscle cell apoptotic process,cell death,0.886\nstriated muscle cell development,morphogenesis/development,0.808\nstriated muscle contraction,multicellular organismal process,0.52\nstriated muscle dense body,cellular component organization,0.294\nstriated muscle hypertrophy,multicellular organismal process,0.728\nstriated muscle myosin thick filament,cellular component organization,0.324\nstriated muscle myosin thick filament assembly,cellular component organization,0.692\nstriated muscle thin filament,cellular component organization,0.392\nstrictosidine synthase activity,metabolic process,0.9\nstromal-epithelial cell signaling involved in prostate gland development,morphogenesis/development,0.246\nstructural constituent of bone,cellular component organization,0.326\nstructural constituent of egg coat,cellular component organization,0.262\nstructural constituent of eye lens,cellular component organization,0.334\nstructural constituent of muscle,cellular component organization,0.376\nstructural constituent of myelin sheath,cellular component organization,0.34\nstructural constituent of postsynapse,cellular component organization,0.448\nstructural constituent of postsynaptic actin cytoskeleton,cellular component organization,0.388\nstructural constituent of postsynaptic density,cellular component organization,0.326\nstructural constituent of postsynaptic intermediate filament cytoskeleton,cellular component organization,0.394\nstructural constituent of postsynaptic specialization,cellular component organization,0.328\nstructural constituent of presynapse,cellular component organization,0.384\nstructural constituent of presynaptic active zone,cellular component organization,0.308\nstructural constituent of ribosome,cellular component organization,0.368\nstructural constituent of skin epidermis,cellular component organization,0.33\nstructural constituent of synapse,cellular component organization,0.334\nstructural constituent of synapse-associated extracellular matrix,cellular component organization,0.278\nstructural constituent of tooth enamel,cellular component organization,0.338\nstructural molecule activity,cellular component organization,0.44\nstructural molecule activity conferring elasticity,cellular component organization,0.378\nsubapical complex,cellular component organization,0.394\nsubapical part of cell,cellular component organization,0.25\nsubcortical maternal complex,protein modification/signaling,0.246\nsubmandibular salivary gland formation,morphogenesis/development,0.644\nsubpallium cell proliferation in forebrain,cell cycle,0.86\nsubpallium development,morphogenesis/development,0.914\nsubpallium neuron fate commitment,morphogenesis/development,0.498\nsubstance K receptor activity,metabolic process,0.182\nsubstance K receptor binding,receptor related process,0.42\nsubstance P catabolic process,metabolic process,0.812\nsubstance P receptor activity,metabolic process,0.182\nsubstance P receptor binding,receptor related process,0.42\nsubstantia propria of cornea development,morphogenesis/development,0.994\nsubstrate localization to autophagosome,transport,0.25\n\"substrate-dependent cell migration, cell attachment to substrate\",cellular component organization,0.306\n\"substrate-dependent cell migration, cell extension\",cellular component organization,0.286\nsubstrate-dependent cerebral cortex tangential migration,neural related process,0.22\nsubstrate-independent telencephalic tangential interneuron migration,transport,0.246\nsubstrate-independent telencephalic tangential migration,neural related process,0.35\nsubtelomeric heterochromatin formation,cellular component organization,0.22\nsubthalamus development,morphogenesis/development,0.954\nsuccinate dehydrogenase (ubiquinone) activity,metabolic process,0.904\nsuccinate dehydrogenase activity,metabolic process,0.946\nsuccinate dehydrogenase complex,metabolic process,0.318\nsuccinate dehydrogenase complex (ubiquinone),metabolic process,0.446\nsuccinate metabolic process,metabolic process,0.926\nsuccinate transmembrane transport,transport,0.852\nsuccinate transmembrane transporter activity,transport,0.75\nsuccinate transport,transport,0.984\nsuccinate-CoA ligase (ADP-forming) activity,metabolic process,0.75\nsuccinate-CoA ligase (GDP-forming) activity,metabolic process,0.846\nsuccinate-CoA ligase activity,metabolic process,0.804\nsuccinate-CoA ligase complex,metabolic process,0.47\nsuccinate-CoA ligase complex (ADP-forming),metabolic process,0.316\nsuccinate-CoA ligase complex (GDP-forming),metabolic process,0.316\nsuccinate-hydroxymethylglutarate CoA-transferase activity,metabolic process,0.896\nsuccinate-semialdehyde dehydrogenase (NAD+) activity,metabolic process,0.93\nsuccinate-semialdehyde dehydrogenase [NAD(P)+] activity,metabolic process,0.974\nsuccinate-semialdehyde dehydrogenase binding,metabolic process,0.254\nsuccinyl-CoA biosynthetic process,metabolic process,0.886\nsuccinyl-CoA catabolic process,metabolic process,0.89\nsuccinyl-CoA hydrolase activity,metabolic process,0.898\nsuccinyl-CoA metabolic process,metabolic process,0.998\nsuccinyl-CoA pathway,metabolic process,0.758\nsuccinyl-CoA:3-oxo-acid CoA-transferase activity,metabolic process,0.874\nsuccinyltransferase activity,metabolic process,0.932\nsuckling behavior,morphogenesis/development,0.17\nsucrose alpha-glucosidase activity,metabolic process,0.9\nsucrose biosynthetic process,metabolic process,0.89\nsucrose catabolic process,metabolic process,0.978\nsucrose metabolic process,metabolic process,0.97\nsucrose transmembrane transporter activity,transport,0.566\nsucrose transport,transport,0.982\nsucrose:monoatomic cation symporter activity,transport,0.552\nsucrose:proton symporter activity,metabolic process,0.526\nsugar mediated signaling pathway,morphogenesis/development,0.244\nsugar transmembrane transporter activity,transport,0.702\nsugar-phosphatase activity,metabolic process,0.802\nsugar-terminal-phosphatase activity,metabolic process,0.756\nsulfate adenylyltransferase (ATP) activity,metabolic process,0.822\nsulfate adenylyltransferase activity,metabolic process,0.834\nsulfate assimilation,metabolic process,0.52\nsulfate binding,gene regulation,0.256\nsulfate transmembrane transport,transport,0.89\nsulfate transmembrane transporter activity,transport,0.622\nsulfate transport,transport,0.948\nsulfate:bicarbonate antiporter activity,metabolic process,0.526\nsulfatide binding,metabolic process,0.284\nsulfation,metabolic process,0.392\nsulfide oxidation,metabolic process,0.818\n\"sulfide oxidation, using sulfide:quinone oxidoreductase\",metabolic process,0.656\nsulfide:quinone oxidoreductase activity,metabolic process,0.894\nsulfinoalanine decarboxylase activity,metabolic process,0.896\nsulfiredoxin activity,metabolic process,0.75\nsulfite oxidase activity,metabolic process,0.902\nsulfonylurea receptor activity,receptor related process,0.206\nsulfonylurea receptor binding,receptor related process,0.448\nsulfotransferase activity,metabolic process,0.87\nsulfur amino acid catabolic process,metabolic process,0.99\nsulfur amino acid transmembrane transporter activity,transport,0.758\nsulfur amino acid transport,transport,0.924\nsulfur carrier activity,metabolic process,0.33\nsulfur compound transmembrane transporter activity,transport,0.798\nsulfur dioxygenase activity,metabolic process,0.9\nsulfur oxidation,metabolic process,0.858\nsulfur-containing amino acid secondary active transmembrane transporter activity,transport,0.668\nsulfuric ester hydrolase activity,metabolic process,0.898\nsulfurtransferase activity,metabolic process,0.954\nsumo-dependent protein binding,protein modification/signaling,0.472\nsuper elongation complex,gene regulation,0.588\nsupercoiled DNA binding,gene regulation,0.238\nsuperior olivary nucleus development,morphogenesis/development,0.88\nsuperior olivary nucleus maturation,morphogenesis/development,0.47\nsuperior temporal gyrus development,morphogenesis/development,0.976\nsuperoxide anion generation,protein modification/signaling,0.154\nsuperoxide dismutase activity,metabolic process,0.852\nsuperoxide dismutase copper chaperone activity,metabolic process,0.242\nsuperoxide metabolic process,metabolic process,0.622\nsuperoxide-generating NAD(P)H oxidase activity,metabolic process,0.918\nsuperoxide-generating NADPH oxidase activator activity,metabolic process,0.396\nsuppression by virus of host apoptotic process,cell death,0.384\nsuppression by virus of host autophagy,viral related process,0.204\nsuppression of symbiont entry into host,cellular component organization,0.148\nsupramolecular complex,cellular component organization,0.518\nsupramolecular fiber,cellular component organization,0.678\nsupramolecular polymer,cellular component organization,0.606\nsupraspliceosomal complex,gene regulation,0.352\nsuramin binding,metabolic process,0.322\nsurvivin complex,protein modification/signaling,0.186\nsusceptibility to T cell mediated cytotoxicity,morphogenesis/development,0.236\nsusceptibility to natural killer cell mediated cytotoxicity,immune system process,0.358\nsweat gland development,morphogenesis/development,0.84\nsweet taste receptor activity,receptor related process,0.68\nsweet taste receptor complex,receptor related process,0.32\nswimming,transport,0.23\nswimming behavior,morphogenesis/development,0.142\nsymbiont cell surface,cellular component organization,0.228\nsymbiont intracellular protein transport in host,transport,0.734\nsymmetric cell division,cell cycle,0.328\nsymmetric synapse,neural related process,0.542\n\"symmetric, GABA-ergic, inhibitory synapse\",neural related process,0.482\nsympathetic ganglion development,morphogenesis/development,0.958\nsympathetic nervous system development,morphogenesis/development,0.758\nsympathetic neuron axon guidance,neural related process,0.458\nsympathetic neuron projection extension,neural related process,0.458\nsympathetic neuron projection guidance,neural related process,0.398\nsynapse,neural related process,0.536\nsynapse assembly involved in innervation,cellular component organization,0.31\nsynapse maturation,neural related process,0.272\nsynapse pruning,cellular component organization,0.672\nsynapse-associated extracellular matrix,neural related process,0.278\nsynaptic assembly at neuromuscular junction,cellular component organization,0.376\nsynaptic cleft,cellular component organization,0.306\nsynaptic membrane,neural related process,0.818\nsynaptic membrane adhesion,cellular component organization,0.228\nsynaptic receptor adaptor activity,receptor related process,0.496\nsynaptic signaling,neural related process,0.698\nsynaptic signaling by nitric oxide,neural related process,0.212\nsynaptic signaling via neuropeptide,neural related process,0.256\nsynaptic target recognition,neural related process,0.286\nsynaptic transmission involved in micturition,neural related process,0.278\n\"synaptic transmission, cholinergic\",neural related process,0.784\n\"synaptic transmission, glycinergic\",neural related process,0.738\nsynaptic vesicle,cellular component organization,0.294\nsynaptic vesicle budding,cellular component organization,0.704\nsynaptic vesicle budding from endosome,morphogenesis/development,0.222\nsynaptic vesicle budding from presynaptic endocytic zone membrane,cellular component organization,0.278\nsynaptic vesicle clustering,neural related process,0.308\nsynaptic vesicle coating,cellular component organization,0.394\nsynaptic vesicle cycle,neural related process,0.488\nsynaptic vesicle cytoskeletal transport,transport,0.672\nsynaptic vesicle docking,cellular component organization,0.358\nsynaptic vesicle endosomal processing,transport,0.508\nsynaptic vesicle fusion to presynaptic active zone membrane,neural related process,0.292\nsynaptic vesicle localization,transport,0.412\nsynaptic vesicle lumen,cellular component organization,0.294\nsynaptic vesicle membrane,neural related process,0.396\nsynaptic vesicle membrane organization,cellular component organization,0.842\nsynaptic vesicle priming,neural related process,0.23\nsynaptic vesicle recycling,neural related process,0.42\nsynaptic vesicle recycling via endosome,neural related process,0.328\nsynaptic vesicle targeting,neural related process,0.224\nsynaptic vesicle to endosome fusion,cellular component organization,0.71\nsynaptic vesicle transport along microtubule,transport,0.686\nsynaptic vesicle uncoating,protein modification/signaling,0.282\nsynaptobrevin 2-SNAP-25-syntaxin-1a complex,cellular component organization,0.316\nsynaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex,cellular component organization,0.312\nsynaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex,cellular component organization,0.32\nsynaptobrevin 2-SNAP-25-syntaxin-3-complexin complex,cellular component organization,0.316\nsynaptonemal complex,cellular component organization,0.248\nsynaptonemal complex assembly,cellular component organization,0.248\nsynaptonemal complex disassembly,cellular component organization,0.326\nsynaptonemal complex organization,cellular component organization,0.732\nsynaptonemal structure,cellular component organization,0.438\nsynchronous neurotransmitter secretion,cellular component organization,0.22\nsyncytiotrophoblast cell differentiation involved in labyrinthine layer development,morphogenesis/development,0.556\nsyndecan binding,cellular component organization,0.268\nsynoviocyte proliferation,cell cycle,0.762\nsyntaxin binding,neural related process,0.304\nsyntaxin-3 binding,receptor related process,0.51\nsyntrophin complex,protein modification/signaling,0.266\nsystem development,morphogenesis/development,0.258\nsystem process,multicellular organismal process,0.394\nt-SNARE clustering,cellular component organization,0.388\nt-UTP complex,cellular component organization,0.386\ntRNA (N(6)-L-threonylcarbamoyladenosine(37)-C(2))-methylthiotransferase,metabolic process,0.878\ntRNA (adenine) methyltransferase activity,metabolic process,0.644\ntRNA (guanine) methyltransferase activity,metabolic process,0.642\ntRNA (guanine-N2-)-methyltransferase activity,metabolic process,0.868\ntRNA (guanine-N7)-methylation,cellular component organization,0.25\ntRNA (m1A) methyltransferase complex,cellular component organization,0.308\ntRNA (m7G46) methyltransferase complex,metabolic process,0.374\ntRNA (uracil-2'-O-)-methyltransferase activity,metabolic process,0.868\ntRNA 2'-O-methyltransferase activity,metabolic process,0.642\ntRNA 2'-phosphotransferase activity,metabolic process,0.678\ntRNA 3'-end processing,gene regulation,0.864\ntRNA 3'-terminal CCA addition,gene regulation,0.378\ntRNA 4-demethylwyosine alpha-amino-alpha-carboxypropyltransferase activity,metabolic process,0.896\ntRNA C3-cytosine methylation,cellular component organization,0.226\ntRNA C5-cytosine methylation,gene regulation,0.692\ntRNA N1-guanine methylation,cellular component organization,0.226\ntRNA N2-guanine methylation,cellular component organization,0.226\ntRNA acetylation,metabolic process,0.272\ntRNA aminoacylation for mitochondrial protein translation,metabolic process,0.572\ntRNA demethylase activity,metabolic process,0.486\ntRNA demethylation,protein modification/signaling,0.29\ntRNA dihydrouridine synthase activity,metabolic process,0.784\ntRNA dihydrouridine synthesis,gene regulation,0.366\ntRNA dimethylallyltransferase activity,metabolic process,0.848\ntRNA exon ligation,gene regulation,0.686\n\"tRNA exon ligation utilizing 2',3' cyclic phosphate of 5'-exon as source of linkage phosphate\",gene regulation,0.234\ntRNA export from nucleus,transport,0.834\ntRNA guanylyltransferase activity,metabolic process,0.436\ntRNA import into mitochondrion,cellular component organization,0.196\ntRNA methylthiolation,metabolic process,0.276\ntRNA methyltransferase activity,metabolic process,0.618\ntRNA methyltransferase complex,metabolic process,0.318\ntRNA modification,gene regulation,0.606\ntRNA nucleoside ribose methylation,gene regulation,0.58\ntRNA pseudouridine synthase activity,metabolic process,0.66\ntRNA pseudouridine synthesis,gene regulation,0.622\ntRNA re-export from nucleus,transport,0.356\ntRNA stabilization,metabolic process,0.206\ntRNA surveillance,gene regulation,0.556\ntRNA thio-modification,gene regulation,0.686\ntRNA threonylcarbamoyladenosine metabolic process,metabolic process,0.654\ntRNA threonylcarbamoyladenosine modification,gene regulation,0.612\ntRNA transcription,gene regulation,0.746\ntRNA transcription by RNA polymerase III,gene regulation,0.486\ntRNA transport,transport,0.912\ntRNA uridine(34) acetyltransferase activity,metabolic process,0.88\ntRNA wobble adenosine to inosine editing,cellular component organization,0.246\ntRNA wobble base 5-methoxycarbonylmethyl-2-thiouridinylation,protein modification/signaling,0.22\ntRNA wobble base cytosine methylation,cellular component organization,0.25\ntRNA wobble base modification,gene regulation,0.666\ntRNA wobble cytosine modification,gene regulation,0.648\ntRNA wobble position uridine thiolation,gene regulation,0.662\ntRNA wobble uridine modification,gene regulation,0.68\ntRNA-4-demethylwyosine synthase activity,metabolic process,0.902\ntRNA-5-taurinomethyluridine 2-sulfurtransferase,metabolic process,0.61\ntRNA-dihydrouridine20 synthase activity,metabolic process,0.916\ntRNA-guanine transglycosylation,metabolic process,0.57\ntRNA-guanosine(34) queuine transglycosylase activity,metabolic process,0.876\ntRNA-intron endonuclease activity,metabolic process,0.406\ntRNA-intron endonuclease complex,protein modification/signaling,0.366\ntRNA-specific adenosine deaminase activity,metabolic process,0.764\ntRNA-specific adenosine-34 deaminase activity,metabolic process,0.858\ntRNA-specific adenosine-37 deaminase activity,metabolic process,0.858\ntRNA-splicing ligase complex,protein modification/signaling,0.228\ntRNA-type intron splice site recognition and cleavage,gene regulation,0.464\ntRNA-uridine aminocarboxypropyltransferase activity,metabolic process,0.876\ntachykinin receptor activity,receptor related process,0.362\ntachykinin receptor signaling pathway,receptor related process,0.776\ntail-anchored membrane protein insertion into ER membrane,ER/endosome/lysosome related process,0.302\ntalin binding,cellular component organization,0.342\ntangential migration from the subventricular zone to the olfactory bulb,morphogenesis/development,0.202\ntapasin binding,transport,0.214\ntarget-directed miRNA degradation,gene regulation,0.44\ntarsal gland development,morphogenesis/development,0.994\ntaste bud development,morphogenesis/development,0.73\ntaste receptor activity,receptor related process,0.634\ntaste receptor binding,receptor related process,0.474\ntaste receptor complex,receptor related process,0.342\ntaurine binding,metabolic process,0.248\ntaurine biosynthetic process,metabolic process,0.816\ntaurine metabolic process,metabolic process,0.948\ntaurine transmembrane transporter activity,transport,0.716\ntaurine transport,transport,0.73\ntaurine:sodium symporter activity,metabolic process,0.526\ntear secretion,immune system process,0.27\ntelencephalon cell migration,neural related process,0.27\ntelencephalon glial cell migration,morphogenesis/development,0.192\ntelencephalon regionalization,morphogenesis/development,0.35\ntelethonin binding,protein modification/signaling,0.404\ntelomerase RNA localization to Cajal body,cell cycle,0.332\ntelomerase RNA reverse transcriptase activity,metabolic process,0.3\ntelomerase RNA stabilization,gene regulation,0.366\ntelomerase activity,metabolic process,0.452\ntelomerase catalytic core complex,gene regulation,0.412\ntelomerase catalytic core complex assembly,cellular component organization,0.546\ntelomerase holoenzyme complex,gene regulation,0.408\ntelomerase holoenzyme complex assembly,cellular component organization,0.884\ntelomerase inhibitor activity,gene regulation,0.212\ntelomere assembly,cellular component organization,0.65\ntelomere cap complex,cell cycle,0.232\ntelomere formation via telomerase,cellular component organization,0.22\ntelomere localization,transport,0.352\ntelomere maintenance via base-excision repair,metabolic process,0.176\ntelomere maintenance via semi-conservative replication,cell cycle,0.74\ntelomere maintenance via telomerase,cell cycle,0.602\ntelomere maintenance via telomere lengthening,cell cycle,0.648\ntelomere maintenance via telomere trimming,cellular component organization,0.314\ntelomere single strand break repair,cellular component organization,0.214\ntelomere tethering at nuclear periphery,transport,0.276\ntelomeric 3' overhang formation,morphogenesis/development,0.322\ntelomeric D-loop binding,cell cycle,0.264\ntelomeric D-loop disassembly,cellular component organization,0.344\ntelomeric DNA binding,gene regulation,0.504\ntelomeric DNA-containing double minutes formation,cellular component organization,0.244\ntelomeric G-quadruplex DNA binding,cellular component organization,0.232\ntelomeric loop disassembly,cell cycle,0.47\ntelomeric loop formation,cellular component organization,0.224\ntelomeric repeat-containing RNA binding,gene regulation,0.55\ntemperature-gated cation channel activity,immune system process,0.214\ntemperature-gated ion channel activity,transport,0.422\ntemplate for synthesis of G-rich strand of telomere DNA activity,cellular component organization,0.198\ntemplate-free RNA nucleotidyltransferase,metabolic process,0.606\ntenascin complex,cell adhesion,0.2\ntendon cell differentiation,morphogenesis/development,0.572\ntendon development,morphogenesis/development,0.982\ntendon formation,morphogenesis/development,0.392\nterminal bouton,neural related process,0.324\nterminal button organization,cellular component organization,0.548\nterminal cisterna,cellular component organization,0.18\nterminal cisterna lumen,cellular component organization,0.284\nterminal web,cellular component organization,0.378\nterminal web assembly,cellular component organization,0.662\ntermination of RNA polymerase I transcription,gene regulation,0.45\ntermination of RNA polymerase II transcription,gene regulation,0.784\n\"termination of RNA polymerase II transcription, poly(A)-coupled\",gene regulation,0.642\ntermination of RNA polymerase III transcription,gene regulation,0.564\ntermination of mitochondrial transcription,gene regulation,0.304\ntermination of signal transduction,receptor related process,0.406\nterpene catabolic process,metabolic process,0.986\nterpene metabolic process,metabolic process,0.972\nterpenoid biosynthetic process,metabolic process,0.932\nterpenoid catabolic process,metabolic process,0.946\nterpenoid transport,transport,0.792\ntertiary alcohol biosynthetic process,metabolic process,0.988\ntertiary alcohol metabolic process,metabolic process,0.994\ntertiary branching involved in mammary gland duct morphogenesis,morphogenesis/development,0.246\ntertiary granule,immune system process,0.328\ntertiary granule lumen,immune system process,0.178\ntertiary granule membrane,cellular component organization,0.18\ntestosterone 16-alpha-hydroxylase activity,metabolic process,0.88\ntestosterone 16-beta-hydroxylase activity,metabolic process,0.924\ntestosterone 17-beta-dehydrogenase (NADP+) activity,metabolic process,0.938\ntestosterone 6-beta-hydroxylase activity,metabolic process,0.88\ntestosterone biosynthetic process,metabolic process,0.854\ntestosterone dehydrogenase (NAD+) activity,metabolic process,0.934\ntestosterone dehydrogenase [NAD(P)] activity,metabolic process,0.984\ntestosterone secretion,metabolic process,0.2\ntetracycline transmembrane transport,transport,0.36\ntetracycline transmembrane transporter activity,transport,0.552\ntetrahydrobiopterin binding,metabolic process,0.578\ntetrahydrobiopterin biosynthetic process,metabolic process,0.858\ntetrahydrobiopterin metabolic process,metabolic process,0.97\ntetrahydrofolate biosynthetic process,metabolic process,0.908\ntetrahydrofolate metabolic process,metabolic process,0.946\ntetrahydrofolyl-poly(glutamate) polymer binding,metabolic process,0.232\ntetrahydrofolylpolyglutamate biosynthetic process,metabolic process,0.846\ntetrahydrofolylpolyglutamate metabolic process,metabolic process,0.936\ntetrahydrofolylpolyglutamate synthase activity,metabolic process,0.752\ntetrapyrrole binding,metabolic process,0.326\ntetrapyrrole biosynthetic process,metabolic process,0.95\ntetrapyrrole catabolic process,metabolic process,0.938\ntetraspanin-enriched microdomain,receptor related process,0.254\ntetraterpenoid biosynthetic process,metabolic process,0.99\ntetraterpenoid catabolic process,metabolic process,0.992\ntetraterpenoid metabolic process,metabolic process,0.98\ntetraterpenoid transport,transport,0.986\nthalamus development,morphogenesis/development,0.556\nthelarche,morphogenesis/development,0.232\nthermoception,multicellular organismal process,0.28\nthermosensory behavior,cellular component organization,0.226\nthermotaxis,transport,0.354\nthiamine binding,metabolic process,0.262\nthiamine diphosphate biosynthetic process,metabolic process,0.814\nthiamine diphosphate metabolic process,metabolic process,0.98\nthiamine diphosphokinase activity,metabolic process,0.822\nthiamine metabolic process,metabolic process,0.99\nthiamine phosphate phosphatase activity,metabolic process,0.848\nthiamine pyrophosphate binding,metabolic process,0.31\nthiamine pyrophosphate transmembrane transport,transport,0.664\nthiamine pyrophosphate transmembrane transporter activity,metabolic process,0.274\nthiamine transmembrane transport,transport,0.774\nthiamine transmembrane transporter activity,transport,0.694\nthiamine transport,transport,0.944\nthiamine triphosphate phosphatase activity,metabolic process,0.814\nthiamine-containing compound biosynthetic process,metabolic process,0.984\nthiamine-containing compound metabolic process,metabolic process,0.988\nthick ascending limb development,morphogenesis/development,0.934\nthigmotaxis,transport,0.304\nthiocyanate metabolic process,metabolic process,0.894\nthiocyanate peroxidase activity,metabolic process,0.926\nthioester biosynthetic process,metabolic process,0.912\nthioester metabolic process,metabolic process,0.874\nthioester transport,transport,0.964\nthioesterase binding,metabolic process,0.21\nthioether S-methyltransferase activity,metabolic process,0.896\nthiol S-methyltransferase activity,metabolic process,0.896\nthiol oxidase activity,metabolic process,0.964\nthiomorpholine-carboxylate dehydrogenase activity,metabolic process,0.934\nthiopurine S-methyltransferase activity,metabolic process,0.896\nthioredoxin peroxidase activity,metabolic process,0.89\nthioredoxin-dependent peroxiredoxin activity,metabolic process,0.91\nthioredoxin-disulfide reductase (NADP) activity,metabolic process,0.932\nthiosulfate sulfurtransferase activity,metabolic process,0.892\nthiosulfate transmembrane transporter activity,cellular component organization,0.254\nthiosulfate transport,transport,0.728\nthiosulfate-thiol sulfurtransferase activity,metabolic process,0.896\nthird ventricle development,morphogenesis/development,0.946\nthorax and anterior abdomen determination,gene regulation,0.26\nthreonine catabolic process,metabolic process,0.992\nthreonine metabolic process,metabolic process,0.994\nthreonine racemase activity,metabolic process,0.896\nthreonine transport,transport,0.962\nthreonine-tRNA ligase activity,metabolic process,0.822\nthreonine-type endopeptidase activity,metabolic process,0.446\nthreonine-type peptidase activity,metabolic process,0.488\nthreonyl-tRNA aminoacylation,metabolic process,0.558\nthrombin-activated receptor activity,receptor related process,0.484\nthrombocyte differentiation,morphogenesis/development,0.546\nthrombopoietin receptor activity,receptor related process,0.208\nthrombopoietin-mediated signaling pathway,receptor related process,0.608\nthrombospondin receptor activity,receptor related process,0.202\nthromboxane A2 receptor activity,cellular component organization,0.204\nthromboxane A2 receptor binding,receptor related process,0.5\nthromboxane A2 signaling pathway,receptor related process,0.654\nthromboxane receptor activity,receptor related process,0.59\nthromboxane-A synthase activity,metabolic process,0.894\nthymic T cell selection,immune system process,0.582\nthymidine biosynthetic process,metabolic process,0.838\nthymidine catabolic process,metabolic process,0.828\nthymidine kinase activity,metabolic process,0.796\nthymidine metabolic process,metabolic process,0.968\nthymidine phosphorylase activity,metabolic process,0.848\nthymidylate 5'-phosphatase activity,metabolic process,0.852\nthymidylate kinase activity,metabolic process,0.796\nthymidylate synthase activity,metabolic process,0.892\nthymine catabolic process,metabolic process,0.704\nthymine metabolic process,metabolic process,0.92\nthymine transport,transport,0.734\nthymocyte migration,immune system process,0.706\nthymus epithelium morphogenesis,morphogenesis/development,0.362\nthyroid gland development,morphogenesis/development,0.964\nthyroid gland epithelial cell proliferation,cell cycle,0.79\nthyroid hormone binding,metabolic process,0.242\nthyroid hormone catabolic process,metabolic process,0.802\nthyroid hormone generation,morphogenesis/development,0.204\nthyroid hormone mediated signaling pathway,protein modification/signaling,0.26\nthyroid hormone metabolic process,metabolic process,0.872\nthyroid hormone transmembrane transporter activity,cellular component organization,0.234\nthyroid hormone transport,transport,0.734\nthyroid-stimulating hormone receptor activity,cellular component organization,0.178\nthyroid-stimulating hormone secretion,metabolic process,0.25\nthyroid-stimulating hormone signaling pathway,receptor related process,0.664\nthyroid-stimulating hormone-secreting cell differentiation,morphogenesis/development,0.74\nthyrotropin-releasing hormone activity,receptor related process,0.338\nthyrotropin-releasing hormone receptor activity,cellular component organization,0.178\nthyrotropin-releasing hormone receptor binding,receptor related process,0.51\nthyroxine 5'-deiodinase activity,metabolic process,0.9\nthyroxine 5-deiodinase activity,metabolic process,0.89\ntight junction assembly,cellular component organization,0.74\ntight junction disassembly,cellular component organization,0.764\ntight junction organization,cellular component organization,0.8\ntissue development,morphogenesis/development,0.596\ntitin Z domain binding,protein modification/signaling,0.246\ntitin binding,protein modification/signaling,0.31\ntitin-telethonin complex,cellular component organization,0.266\ntocopherol omega-hydroxylase activity,metabolic process,0.924\ntocotrienol omega-hydroxylase activity,metabolic process,0.932\ntolerance induction dependent upon immune response,immune system process,0.702\ntolerance induction to lipopolysaccharide,transport,0.166\ntolerance induction to self antigen,immune system process,0.496\ntolerance induction to tumor cell,immune system process,0.776\ntoll-like receptor 5 signaling pathway,immune system process,0.46\ntoll-like receptor 6 signaling pathway,immune system process,0.428\ntoll-like receptor 7 signaling pathway,immune system process,0.716\ntoll-like receptor 8 signaling pathway,immune system process,0.498\ntoll-like receptor TLR1:TLR2 signaling pathway,receptor related process,0.556\ntoll-like receptor TLR6:TLR2 signaling pathway,receptor related process,0.548\ntongue development,morphogenesis/development,0.944\ntongue morphogenesis,morphogenesis/development,0.706\ntongue muscle cell differentiation,morphogenesis/development,0.678\ntooth eruption,cellular component organization,0.208\ntooth mineralization,morphogenesis/development,0.786\ntoxic substance binding,metabolic process,0.226\ntoxin biosynthetic process,metabolic process,0.876\ntoxin catabolic process,metabolic process,0.864\ntoxin metabolic process,metabolic process,0.796\ntoxin transmembrane transporter activity,transport,0.51\ntoxin transport,transport,0.706\ntrabecula morphogenesis,morphogenesis/development,0.888\ntrabecular meshwork development,morphogenesis/development,0.83\ntrace-amine receptor activity,receptor related process,0.546\ntrachea cartilage development,morphogenesis/development,0.982\ntrachea cartilage morphogenesis,morphogenesis/development,0.782\ntrachea formation,morphogenesis/development,0.604\ntrachea gland development,morphogenesis/development,0.822\ntrachea submucosa development,morphogenesis/development,0.864\ntracheoesophageal septum formation,morphogenesis/development,0.394\n\"trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity\",metabolic process,0.934\ntrans-2-enoyl-CoA reductase (NADPH) activity,metabolic process,0.934\ntrans-Golgi network membrane,ER/endosome/lysosome related process,0.23\ntrans-Golgi network membrane organization,cellular component organization,0.696\ntrans-Golgi network to recycling endosome transport,transport,0.36\ntrans-Golgi network transport vesicle,transport,0.234\ntrans-Golgi network transport vesicle membrane,transport,0.228\ntrans-L-3-hydroxyproline dehydratase activity,metabolic process,0.9\ntrans-hexaprenyltranstransferase activity,metabolic process,0.874\ntrans-synaptic signaling,neural related process,0.724\ntrans-synaptic signaling by BDNF,neural related process,0.234\n\"trans-synaptic signaling by BDNF, modulating synaptic transmission\",neural related process,0.264\ntrans-synaptic signaling by endocannabinoid,neural related process,0.258\n\"trans-synaptic signaling by endocannabinoid, modulating synaptic transmission\",neural related process,0.332\ntrans-synaptic signaling by lipid,neural related process,0.276\n\"trans-synaptic signaling by lipid, modulating synaptic transmission\",neural related process,0.382\ntrans-synaptic signaling by neuropeptide,neural related process,0.268\n\"trans-synaptic signaling by neuropeptide, modulating synaptic transmission\",neural related process,0.364\ntrans-synaptic signaling by nitric oxide,neural related process,0.23\n\"trans-synaptic signaling by nitric oxide, modulating synaptic transmission\",neural related process,0.344\ntrans-synaptic signaling by soluble gas,neural related process,0.214\n\"trans-synaptic signaling by soluble gas, modulating synaptic transmission\",neural related process,0.344\ntrans-synaptic signaling by trans-synaptic complex,protein modification/signaling,0.29\n\"trans-synaptic signaling by trans-synaptic complex, modulating synaptic transmission\",protein modification/signaling,0.308\n\"trans-synaptic signaling, modulating synaptic transmission\",neural related process,0.412\ntransaldolase activity,metabolic process,0.896\ntransaminase activity,metabolic process,0.9\ntranscription by RNA polymerase III,gene regulation,0.788\ntranscription cis-regulatory region binding,gene regulation,0.876\ntranscription corepressor binding,gene regulation,0.428\ntranscription elongation by RNA polymerase I,gene regulation,0.638\ntranscription elongation by mitochondrial RNA polymerase,gene regulation,0.622\ntranscription elongation factor activity,gene regulation,0.522\ntranscription elongation factor complex,gene regulation,0.6\ntranscription elongation-coupled chromatin remodeling,gene regulation,0.504\ntranscription export complex,gene regulation,0.702\ntranscription export complex 2,gene regulation,0.41\ntranscription factor AP-1 complex,gene regulation,0.702\ntranscription factor TFIIA complex,gene regulation,0.518\ntranscription factor TFIID complex,gene regulation,0.74\ntranscription factor TFIIE complex,gene regulation,0.548\ntranscription factor TFIIF complex,gene regulation,0.542\ntranscription factor TFIIH core complex,gene regulation,0.634\ntranscription factor TFIIH holo complex,gene regulation,0.438\ntranscription factor TFIIIB complex,gene regulation,0.684\ntranscription factor TFIIIC complex,gene regulation,0.646\ntranscription factor TFIIK complex,gene regulation,0.28\ntranscription factor TFTC complex,gene regulation,0.632\ntranscription initiation at RNA polymerase I promoter,gene regulation,0.698\ntranscription initiation at RNA polymerase III promoter,gene regulation,0.686\ntranscription initiation at mitochondrial promoter,gene regulation,0.204\ntranscription open complex formation at RNA polymerase II promoter,gene regulation,0.518\ntranscription preinitiation complex,gene regulation,0.298\ntranscription regulator activator activity,gene regulation,0.232\ntranscription regulator activity,gene regulation,0.646\ntranscription regulator inhibitor activity,gene regulation,0.254\ntranscription regulatory region nucleic acid binding,gene regulation,0.85\ntranscription termination site sequence-specific DNA binding,gene regulation,0.656\ntranscription-coupled nucleotide-excision repair,metabolic process,0.198\ntranscription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery,gene regulation,0.394\ntranscriptional start site selection at RNA polymerase II promoter,gene regulation,0.448\ntransdifferentiation,morphogenesis/development,0.324\ntransepithelial ammonium transport,transport,0.376\ntransepithelial chloride transport,transport,0.38\ntransepithelial water transport,transport,0.38\ntransferase activity,protein modification/signaling,0.54\n\"transferase activity, transferring nitrogenous groups\",metabolic process,0.898\n\"transferase activity, transferring sulphur-containing groups\",metabolic process,0.918\ntransferrin receptor activity,protein modification/signaling,0.24\ntransferrin receptor binding,receptor related process,0.486\ntransferrin transport,transport,0.744\ntransformation of host cell by virus,cell cycle,0.214\ntransforming growth factor beta activation,receptor related process,0.318\ntransforming growth factor beta binding,morphogenesis/development,0.156\ntransforming growth factor beta ligand-receptor complex,receptor related process,0.326\ntransforming growth factor beta receptor activity,receptor related process,0.754\n\"transforming growth factor beta receptor activity, type I\",receptor related process,0.496\n\"transforming growth factor beta receptor activity, type II\",receptor related process,0.392\n\"transforming growth factor beta receptor activity, type III\",receptor related process,0.416\ntransforming growth factor beta receptor binding,receptor related process,0.44\ntransforming growth factor beta receptor complex assembly,receptor related process,0.362\ntransforming growth factor beta1 activation,cellular component organization,0.176\ntransforming growth factor beta1 production,immune system process,0.588\ntransforming growth factor beta2 production,immune system process,0.518\ntransforming growth factor beta3 activation,cellular component organization,0.178\ntransforming growth factor beta3 production,immune system process,0.552\ntransition between fast and slow fiber,metabolic process,0.252\ntransition between slow and fast fiber,gene regulation,0.244\ntransition metal ion transmembrane transporter activity,transport,0.52\ntransitional one stage B cell differentiation,morphogenesis/development,0.408\ntransitional stage B cell differentiation,immune system process,0.688\ntransitional two stage B cell differentiation,morphogenesis/development,0.412\ntransketolase activity,metabolic process,0.654\ntransketolase or transaldolase activity,metabolic process,0.934\ntranslation,metabolic process,0.44\ntranslation activator activity,protein modification/signaling,0.286\ntranslation at presynapse,metabolic process,0.616\ntranslation at synapse,metabolic process,0.572\ntranslation elongation factor activity,cellular component organization,0.302\ntranslation elongation factor binding,gene regulation,0.186\n\"translation factor activity, non-nucleic acid binding\",metabolic process,0.26\ntranslation initiation complex,cellular component organization,0.382\ntranslation initiation factor activity,gene regulation,0.322\ntranslation initiation factor binding,protein modification/signaling,0.318\ntranslation initiation ternary complex,cellular component organization,0.244\ntranslation preinitiation complex,cellular component organization,0.472\ntranslation reinitiation,cellular component organization,0.396\ntranslation release factor activity,gene regulation,0.604\n\"translation release factor activity, codon nonspecific\",gene regulation,0.208\n\"translation release factor activity, codon specific\",cellular component organization,0.214\ntranslation release factor complex,cellular component organization,0.396\ntranslation repressor activity,gene regulation,0.514\ntranslation termination factor activity,gene regulation,0.702\ntranslational attenuation,gene regulation,0.352\ntranslational elongation,metabolic process,0.396\ntranslational frameshifting,protein modification/signaling,0.192\ntranslational readthrough,gene regulation,0.458\ntranslesion synthesis,stress response,0.546\ntranslocation of molecules into host,transport,0.294\ntranslocon complex,ER/endosome/lysosome related process,0.186\ntransmembrane ascorbate ferrireductase activity,metabolic process,0.612\ntransmembrane collagen trimer,cellular component organization,0.392\ntransmembrane monodehydroascorbate reductase activity,metabolic process,0.618\ntransmembrane receptor protein serine/threonine kinase binding,receptor related process,0.328\ntransmembrane receptor protein tyrosine kinase adaptor activity,receptor related process,0.408\ntransmembrane receptor protein tyrosine kinase inhibitor activity,receptor related process,0.43\ntransmembrane receptor protein tyrosine phosphatase signaling pathway,receptor related process,0.552\ntransmembrane signaling receptor activity,receptor related process,0.362\ntransmembrane transport,transport,0.646\ntransmembrane transporter activity,transport,0.688\ntransmembrane transporter complex,transport,0.444\ntransmembrane-ephrin receptor activity,cellular component organization,0.136\ntransmitter-gated channel activity,neural related process,0.268\ntransmitter-gated monoatomic ion channel activity,neural related process,0.306\ntransmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential,neural related process,0.402\ntransport,transport,0.496\ntransport along microtubule,transport,0.74\ntransport of viral material towards nucleus,transport,0.496\ntransport vesicle membrane,cellular component organization,0.35\ntransporter complex,transport,0.304\ntransposase activity,metabolic process,0.516\ntransposition,gene regulation,0.162\ntranssulfuration,metabolic process,0.418\ntransverse filament,cellular component organization,0.404\ntraversing start control point of mitotic cell cycle,cell cycle,0.298\ntrehalase activity,metabolic process,0.72\ntrehalose catabolic process,metabolic process,0.904\ntrehalose metabolic process,metabolic process,0.886\ntrehalose metabolism in response to stress,metabolic process,0.572\ntriacyl lipopeptide binding,metabolic process,0.254\ntricarboxylate secondary active transmembrane transporter activity,transport,0.7\ntricarboxylic acid cycle enzyme complex,metabolic process,0.514\ntricarboxylic acid transmembrane transport,transport,0.816\ntricarboxylic acid transmembrane transporter activity,transport,0.694\ntricarboxylic acid transport,transport,0.976\ntricellular tight junction,morphogenesis/development,0.274\ntricellular tight junction assembly,cellular component organization,0.63\ntricuspid valve development,morphogenesis/development,0.91\ntricuspid valve formation,morphogenesis/development,0.676\ntricuspid valve morphogenesis,morphogenesis/development,0.596\ntrigeminal ganglion development,morphogenesis/development,0.982\ntrigeminal nerve development,morphogenesis/development,0.814\ntrigeminal nerve morphogenesis,morphogenesis/development,0.542\ntrigeminal nerve structural organization,cellular component organization,0.272\ntrigeminal sensory nucleus development,morphogenesis/development,0.922\ntriglyceride acyl-chain remodeling,metabolic process,0.742\ntriglyceride binding,metabolic process,0.296\ntriglyceride biosynthetic process,metabolic process,0.856\ntriglyceride catabolic process,metabolic process,0.852\ntriglyceride homeostasis,other,0.636\ntriglyceride lipase activity,metabolic process,0.848\ntriglyceride mobilization,cellular component organization,0.21\ntriglyceride transfer activity,metabolic process,0.228\ntriglyceride transport,transport,0.646\ntriglyceride-rich lipoprotein particle clearance,multicellular organismal process,0.646\ntriglyceride-rich lipoprotein particle remodeling,cellular component organization,0.444\ntriglyceride-rich plasma lipoprotein particle,cellular component organization,0.25\ntrimethylamine monooxygenase activity,metabolic process,0.932\ntrimethylamine receptor activity,cellular component organization,0.174\ntrimethyllysine dioxygenase activity,metabolic process,0.896\ntrimming of first mannose on A branch,ER/endosome/lysosome related process,0.27\ntrimming of second mannose on A branch,ER/endosome/lysosome related process,0.27\ntrimming of terminal mannose on B branch,ER/endosome/lysosome related process,0.27\ntrimming of terminal mannose on C branch,ER/endosome/lysosome related process,0.274\ntriokinase activity,metabolic process,0.796\ntriose-phosphate isomerase activity,metabolic process,0.85\ntripartite regional subdivision,morphogenesis/development,0.272\ntripeptidase activity,metabolic process,0.546\ntripeptide aminopeptidase activity,metabolic process,0.524\ntripeptide import across plasma membrane,transport,0.46\ntripeptide transmembrane transport,transport,0.888\ntripeptide transmembrane transporter activity,metabolic process,0.304\ntripeptide transport,transport,0.934\ntripeptidyl-peptidase activity,metabolic process,0.496\ntriphosphoric monoester hydrolase activity,metabolic process,0.692\ntriplet codon-amino acid adaptor activity,gene regulation,0.506\ntriplex DNA binding,cell cycle,0.196\ntriterpenoid biosynthetic process,metabolic process,0.988\ntriterpenoid metabolic process,metabolic process,0.996\ntrochlear nerve development,morphogenesis/development,0.96\ntrochlear nerve formation,morphogenesis/development,0.412\ntrochlear nerve morphogenesis,morphogenesis/development,0.724\ntropane alkaloid metabolic process,metabolic process,0.86\ntrophectodermal cell differentiation,morphogenesis/development,0.744\ntrophectodermal cell fate commitment,morphogenesis/development,0.246\ntrophectodermal cell proliferation,cell cycle,0.232\ntrophectodermal cellular morphogenesis,morphogenesis/development,0.32\ntrophoblast cell migration,morphogenesis/development,0.256\ntrophoblast giant cell differentiation,morphogenesis/development,0.714\ntropomyosin binding,cellular component organization,0.296\ntroponin C binding,cellular component organization,0.25\ntroponin I binding,cellular component organization,0.252\ntroponin T binding,cellular component organization,0.254\ntroponin complex,cellular component organization,0.356\ntrunk neural crest cell migration,morphogenesis/development,0.212\ntrunk segmentation,cellular component organization,0.226\ntrypsinogen activation,cellular component organization,0.206\ntryptamine:oxygen oxidoreductase (deaminating) activity,metabolic process,0.9\n\"tryptophan 2,3-dioxygenase activity\",metabolic process,0.892\ntryptophan 5-monooxygenase activity,metabolic process,0.9\ntryptophan catabolic process,metabolic process,0.972\ntryptophan catabolic process to acetyl-CoA,metabolic process,0.868\ntryptophan catabolic process to indole-3-acetate,metabolic process,0.868\ntryptophan catabolic process to kynurenine,metabolic process,0.868\ntryptophan metabolic process,metabolic process,0.986\ntryptophan transport,transport,0.936\ntryptophan-tRNA ligase activity,metabolic process,0.816\ntryptophanyl-tRNA aminoacylation,metabolic process,0.572\ntube closure,morphogenesis/development,0.786\ntube development,morphogenesis/development,0.842\ntube formation,morphogenesis/development,0.854\ntube lumen cavitation,morphogenesis/development,0.876\ntube morphogenesis,morphogenesis/development,0.878\ntubular endosome,cellular component organization,0.326\ntubulin N-acetyltransferase activity,metabolic process,0.892\ntubulin complex,cellular component organization,0.462\ntubulin complex assembly,cellular component organization,0.368\ntubulin deacetylase activity,metabolic process,0.884\ntubulin-dependent ATPase activity,metabolic process,0.704\ntubulin-glutamic acid ligase activity,metabolic process,0.51\ntubulin-tyrosine carboxypeptidase,metabolic process,0.892\ntubulin-tyrosine ligase activity,metabolic process,0.752\ntubulobulbar complex,cellular component organization,0.296\ntumor necrosis factor (ligand) superfamily member 11 production,immune system process,0.538\ntumor necrosis factor binding,protein modification/signaling,0.284\ntumor necrosis factor receptor activity,receptor related process,0.488\ntumor necrosis factor receptor superfamily complex,receptor related process,0.32\ntwitch skeletal muscle contraction,multicellular organismal process,0.628\ntype 1 angiotensin receptor binding,receptor related process,0.462\ntype 1 cannabinoid receptor binding,receptor related process,0.488\ntype 1 fibroblast growth factor receptor binding,receptor related process,0.47\ntype 1 galanin receptor binding,receptor related process,0.486\ntype 1 melanin-concentrating hormone receptor binding,receptor related process,0.496\ntype 1 melanocortin receptor binding,receptor related process,0.486\ntype 1 metabotropic glutamate receptor binding,receptor related process,0.482\ntype 1 neuromedin U receptor binding,receptor related process,0.488\ntype 1 orexin receptor binding,receptor related process,0.486\ntype 1 parathyroid hormone receptor binding,receptor related process,0.496\ntype 2 angiotensin receptor binding,receptor related process,0.474\ntype 2 fibroblast growth factor receptor binding,receptor related process,0.46\ntype 2 galanin receptor binding,receptor related process,0.486\ntype 2 metabotropic glutamate receptor binding,receptor related process,0.482\ntype 2 neuromedin U receptor binding,receptor related process,0.488\ntype 2 orexin receptor binding,receptor related process,0.486\ntype 3 galanin receptor binding,receptor related process,0.486\ntype 3 melanocortin receptor binding,receptor related process,0.484\ntype 3 metabotropic glutamate receptor binding,receptor related process,0.482\ntype 4 melanocortin receptor binding,receptor related process,0.484\ntype 5 melanocortin receptor binding,receptor related process,0.488\ntype 5 metabotropic glutamate receptor binding,receptor related process,0.474\ntype B gastrin/cholecystokinin receptor binding,receptor related process,0.488\ntype B pancreatic cell apoptotic process,cell death,0.608\ntype B pancreatic cell development,morphogenesis/development,0.928\ntype B pancreatic cell differentiation,morphogenesis/development,0.7\ntype B pancreatic cell fate commitment,morphogenesis/development,0.294\ntype B pancreatic cell maturation,morphogenesis/development,0.474\ntype I activin receptor binding,receptor related process,0.49\ntype I hypersensitivity,immune system process,0.896\ntype I interferon binding,gene regulation,0.312\ntype I interferon receptor activity,immune system process,0.242\ntype I interferon receptor binding,receptor related process,0.446\ntype I pneumocyte differentiation,morphogenesis/development,0.68\ntype I transforming growth factor beta receptor binding,receptor related process,0.44\ntype II activin receptor binding,receptor related process,0.49\ntype II hypersensitivity,immune system process,0.816\ntype II interferon binding,immune system process,0.232\ntype II interferon receptor activity,immune system process,0.244\ntype II interferon receptor binding,receptor related process,0.496\ntype II pneumocyte differentiation,morphogenesis/development,0.678\ntype II transforming growth factor beta receptor binding,receptor related process,0.452\ntype III hypersensitivity,immune system process,0.644\ntype III interferon production,immune system process,0.746\ntype III interferon-mediated signaling pathway,receptor related process,0.528\ntype III intermediate filament,protein modification/signaling,0.422\ntype III transforming growth factor beta receptor binding,receptor related process,0.464\ntype IIa hypersensitivity,immune system process,0.838\ntype IV hypersensitivity,immune system process,0.616\ntyrosinase activity,metabolic process,0.82\ntyrosine 3-monooxygenase activator activity,metabolic process,0.282\ntyrosine 3-monooxygenase activity,metabolic process,0.9\ntyrosine binding,metabolic process,0.372\ntyrosine biosynthetic process,metabolic process,0.976\n\"tyrosine biosynthetic process, by oxidation of phenylalanine\",cellular component organization,0.232\ntyrosine catabolic process,metabolic process,0.98\ntyrosine metabolic process,metabolic process,0.982\ntyrosine transport,transport,0.942\ntyrosine-tRNA ligase activity,metabolic process,0.822\ntyrosyl-DNA phosphodiesterase activity,metabolic process,0.512\ntyrosyl-RNA phosphodiesterase activity,gene regulation,0.27\ntyrosyl-tRNA aminoacylation,metabolic process,0.542\nubiquinol-cytochrome-c reductase activity,metabolic process,0.526\nubiquinone binding,metabolic process,0.284\nubiquinone biosynthesis complex,metabolic process,0.284\nubiquinone biosynthetic process,metabolic process,0.978\n\"ubiquinone biosynthetic process via 3,4-dihydroxy-5-polyprenylbenzoate\",metabolic process,0.848\nubiquinone metabolic process,metabolic process,0.982\nubiquinone-6 biosynthetic process,metabolic process,0.886\nubiquinone-6 metabolic process,metabolic process,0.972\nubiquitin activating enzyme activity,metabolic process,0.528\nubiquitin conjugating enzyme activity,metabolic process,0.466\nubiquitin conjugating enzyme complex,metabolic process,0.49\nubiquitin ligase activator activity,protein modification/signaling,0.258\nubiquitin ligase complex,protein modification/signaling,0.38\nubiquitin ligase complex scaffold activity,metabolic process,0.246\nubiquitin ligase inhibitor activity,metabolic process,0.208\nubiquitin ligase-substrate adaptor activity,protein modification/signaling,0.384\nubiquitin modification-dependent histone binding,protein modification/signaling,0.46\nubiquitin-dependent endocytosis,cellular component organization,0.244\nubiquitin-dependent glycoprotein ERAD pathway,cellular component organization,0.252\nubiquitin-dependent protein binding,protein modification/signaling,0.692\nubiquitin-dependent protein catabolic process via the C-end degron rule pathway,metabolic process,0.576\nubiquitin-dependent protein catabolic process via the N-end rule pathway,metabolic process,0.61\nubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,metabolic process,0.588\nubiquitin-independent protein catabolic process via the multivesicular body sorting pathway,metabolic process,0.618\nubiquitin-like modifier activating enzyme activity,metabolic process,0.428\nubiquitin-like protein ligase activity,protein modification/signaling,0.766\nubiquitin-like protein peptidase activity,metabolic process,0.318\nubiquitin-like protein-specific endopeptidase activity,metabolic process,0.45\nubiquitin-protein transferase activator activity,metabolic process,0.41\nubiquitin-protein transferase activity,protein modification/signaling,0.734\nubiquitin-protein transferase inhibitor activity,metabolic process,0.51\nubiquitin-protein transferase regulator activity,protein modification/signaling,0.414\nubiquitin-ubiquitin ligase activity,metabolic process,0.454\nubiquitination-like modification-dependent protein binding,protein modification/signaling,0.682\nultradian rhythm,metabolic process,0.456\numbilical cord development,morphogenesis/development,0.716\numbilical cord morphogenesis,morphogenesis/development,0.588\nunconventional myosin complex,cellular component organization,0.324\nunidimensional cell growth,morphogenesis/development,0.714\nuniplex complex,cellular component organization,0.566\nuniporter activity,transport,0.528\nunmethylated CpG binding,gene regulation,0.41\nunsaturated fatty acid biosynthetic process,metabolic process,0.98\nunsaturated monocarboxylic acid metabolic process,metabolic process,0.786\nupper tip-link density,cellular component organization,0.372\nuracil DNA N-glycosylase activity,metabolic process,0.438\nuracil binding,metabolic process,0.252\nuracil catabolic process,metabolic process,0.698\nuracil metabolic process,metabolic process,0.952\nuracil transmembrane transport,transport,0.784\nuracil transmembrane transporter activity,transport,0.672\nuracil transport,transport,0.946\nurate biosynthetic process,metabolic process,0.88\nurate metabolic process,metabolic process,0.894\nurate transmembrane transporter activity,metabolic process,0.262\nurate transport,transport,0.726\nurea channel activity,cellular component organization,0.198\nurea cycle,metabolic process,0.558\nurea metabolic process,metabolic process,0.886\nurea transmembrane transport,transport,0.812\nurea transmembrane transporter activity,transport,0.624\nurea transport,transport,0.84\nureter development,morphogenesis/development,0.976\nureter epithelial cell differentiation,morphogenesis/development,0.696\nureter maturation,morphogenesis/development,0.462\nureter morphogenesis,morphogenesis/development,0.71\nureter smooth muscle cell differentiation,morphogenesis/development,0.732\nureter smooth muscle contraction,multicellular organismal process,0.604\nureter smooth muscle development,morphogenesis/development,0.994\nureter urothelium development,morphogenesis/development,0.996\nureteric bud elongation,morphogenesis/development,0.484\nureteric bud formation,morphogenesis/development,0.668\nureteric bud invasion,morphogenesis/development,0.294\nureteric bud morphogenesis,morphogenesis/development,0.736\nureteric peristalsis,metabolic process,0.178\nuridine catabolic process,metabolic process,0.894\nuridine kinase activity,metabolic process,0.796\nuridine metabolic process,metabolic process,0.984\nuridine phosphorylase activity,metabolic process,0.85\nuridine transmembrane transporter activity,transport,0.596\nuridine transport,transport,0.734\nuridylyltransferase activity,metabolic process,0.75\nurinary bladder development,morphogenesis/development,0.976\nurinary bladder smooth muscle contraction,multicellular organismal process,0.642\nurinary tract smooth muscle contraction,multicellular organismal process,0.616\nurocanate hydratase activity,metabolic process,0.9\nurokinase plasminogen activator receptor activity,cellular component organization,0.174\nurokinase plasminogen activator signaling pathway,receptor related process,0.626\nuronic acid transmembrane transport,transport,0.816\nuropod,cellular component organization,0.294\nuropod membrane,cellular component organization,0.404\nuropod organization,cellular component organization,0.686\nuroporphyrinogen III biosynthetic process,metabolic process,0.884\nuroporphyrinogen III metabolic process,metabolic process,0.972\nuroporphyrinogen decarboxylase activity,metabolic process,0.896\nuroporphyrinogen-III synthase activity,metabolic process,0.886\nurotensin II receptor activity,cellular component organization,0.178\nurothelial cell proliferation,cell cycle,0.796\nursodeoxycholate 7-beta-dehydrogenase (NAD+) activity,metabolic process,0.928\nuterine epithelium development,morphogenesis/development,0.812\nuterine gland development,morphogenesis/development,0.994\nuterine smooth muscle contraction,morphogenesis/development,0.206\nuterine smooth muscle relaxation,cellular component organization,0.17\nuterine wall breakdown,morphogenesis/development,0.208\nuterus morphogenesis,morphogenesis/development,0.742\nvacuolar HOPS complex,cellular component organization,0.38\nvacuolar localization,transport,0.476\nvacuolar lumen,cellular component organization,0.534\nvacuolar protein processing,protein modification/signaling,0.368\nvacuolar proton-transporting V-type ATPase complex,cellular component organization,0.262\nvacuolar proton-transporting V-type ATPase complex assembly,cellular component organization,0.48\n\"vacuolar proton-transporting V-type ATPase, V0 domain\",cellular component organization,0.378\n\"vacuolar proton-transporting V-type ATPase, V1 domain\",cellular component organization,0.294\nvacuolar sequestering,transport,0.476\nvacuolar transmembrane transport,transport,0.844\nvacuole,cellular component organization,0.376\nvacuole fusion,cellular component organization,0.718\n\"vacuole fusion, non-autophagic\",cellular component organization,0.352\nvacuole-isolation membrane contact site,cellular component organization,0.382\nvagina development,morphogenesis/development,0.976\nvagus nerve development,morphogenesis/development,0.81\nvagus nerve morphogenesis,morphogenesis/development,0.53\nvaline biosynthetic process,metabolic process,0.904\nvaline catabolic process,metabolic process,0.992\nvaline metabolic process,metabolic process,0.994\nvaline transport,transport,0.954\nvaline-tRNA ligase activity,metabolic process,0.822\nvalyl-tRNA aminoacylation,metabolic process,0.554\nvanadium ion transmembrane transporter activity,cellular component organization,0.25\nvanadium ion transport,transport,0.73\nvaricosity,neural related process,0.254\nvascular associated smooth muscle cell apoptotic process,cell death,0.232\nvascular associated smooth muscle cell dedifferentiation,morphogenesis/development,0.488\nvascular associated smooth muscle cell development,morphogenesis/development,0.812\nvascular associated smooth muscle cell differentiation,morphogenesis/development,0.884\nvascular associated smooth muscle cell differentiation involved in phenotypic switching,morphogenesis/development,0.198\nvascular associated smooth muscle cell migration,multicellular organismal process,0.264\nvascular endothelial cell proliferation,cell cycle,0.746\nvascular endothelial cell response to fluid shear stress,stress response,0.34\nvascular endothelial growth factor binding,metabolic process,0.18\nvascular endothelial growth factor receptor 1 binding,receptor related process,0.534\nvascular endothelial growth factor receptor 2 binding,receptor related process,0.556\nvascular endothelial growth factor receptor 3 binding,receptor related process,0.534\nvascular endothelial growth factor receptor activity,receptor related process,0.356\nvascular endothelial growth factor receptor-1 signaling pathway,receptor related process,0.416\nvascular endothelial growth factor receptor-2 signaling pathway,receptor related process,0.41\nvascular endothelial growth factor receptor-3 signaling pathway,receptor related process,0.416\nvascular wound healing,morphogenesis/development,0.342\nvasculogenesis involved in coronary vascular morphogenesis,morphogenesis/development,0.432\nvasoactive intestinal polypeptide receptor activity,cellular component organization,0.178\nvasoconstriction,multicellular organismal process,0.684\nvasodilation,multicellular organismal process,0.57\nvasomotion,metabolic process,0.202\nvasopressin receptor activity,cellular component organization,0.16\nvasopressin receptor binding,receptor related process,0.486\nvasopressin secretion,transport,0.58\nvein smooth muscle contraction,multicellular organismal process,0.25\nvenous blood vessel development,morphogenesis/development,0.848\nvenous blood vessel morphogenesis,morphogenesis/development,0.886\nvenous endothelial cell differentiation,morphogenesis/development,0.672\nventral midline determination,cellular component organization,0.222\nventral midline development,morphogenesis/development,0.878\nventral spinal cord development,morphogenesis/development,0.832\nventral spinal cord interneuron differentiation,morphogenesis/development,0.42\nventral spinal cord interneuron fate commitment,morphogenesis/development,0.438\nventral spinal cord interneuron fate determination,neural related process,0.238\nventral spinal cord interneuron specification,morphogenesis/development,0.518\nventral trunk neural crest cell migration,neural related process,0.248\nventricular cardiac muscle cell action potential,cellular component organization,0.226\nventricular cardiac muscle cell development,morphogenesis/development,0.818\nventricular cardiac muscle cell differentiation,morphogenesis/development,0.602\nventricular cardiac muscle cell membrane repolarization,transport,0.314\nventricular cardiac muscle tissue development,morphogenesis/development,0.944\nventricular cardiac muscle tissue morphogenesis,morphogenesis/development,0.902\nventricular cardiac myofibril assembly,morphogenesis/development,0.952\nventricular compact myocardium morphogenesis,morphogenesis/development,0.882\nventricular trabecula myocardium morphogenesis,morphogenesis/development,0.902\nventricular zone neuroblast division,neural related process,0.292\nvertebrate eye-specific patterning,morphogenesis/development,0.436\nvery long chain acyl-CoA hydrolase activity,metabolic process,0.88\nvery long-chain fatty acid beta-oxidation,metabolic process,0.468\nvery long-chain fatty acid biosynthetic process,metabolic process,0.914\nvery long-chain fatty acid catabolic process,metabolic process,0.992\nvery long-chain fatty acid metabolic process,metabolic process,0.954\nvery long-chain fatty acid omega-hydroxylase activity,metabolic process,0.92\nvery long-chain fatty acid-CoA ligase activity,metabolic process,0.822\nvery long-chain fatty-acyl-CoA catabolic process,metabolic process,0.896\nvery long-chain fatty-acyl-CoA metabolic process,metabolic process,0.976\nvery-long-chain enoyl-CoA reductase activity,metabolic process,0.758\nvery-long-chain-acyl-CoA dehydrogenase activity,metabolic process,0.916\nvery-low-density lipoprotein particle,immune system process,0.21\nvery-low-density lipoprotein particle assembly,cellular component organization,0.396\nvery-low-density lipoprotein particle binding,metabolic process,0.234\nvery-low-density lipoprotein particle clearance,cellular component organization,0.24\nvery-low-density lipoprotein particle receptor activity,cellular component organization,0.206\nvery-low-density lipoprotein particle receptor binding,receptor related process,0.52\nvery-low-density lipoprotein particle remodeling,metabolic process,0.234\nvesicle,cellular component organization,0.144\nvesicle cargo loading,transport,0.532\nvesicle coat,cellular component organization,0.33\nvesicle coating,cellular component organization,0.482\nvesicle cytoskeletal trafficking,transport,0.692\nvesicle docking,transport,0.318\nvesicle docking involved in exocytosis,transport,0.254\nvesicle fusion,cellular component organization,0.638\nvesicle fusion to plasma membrane,cellular component organization,0.752\nvesicle fusion with Golgi apparatus,cellular component organization,0.746\nvesicle fusion with vacuole,cellular component organization,0.386\nvesicle membrane,ER/endosome/lysosome related process,0.228\nvesicle targeting,cellular component organization,0.294\n\"vesicle targeting, rough ER to cis-Golgi\",transport,0.342\n\"vesicle targeting, to, from or within Golgi\",transport,0.324\n\"vesicle targeting, trans-Golgi to endosome\",transport,0.33\n\"vesicle targeting, trans-Golgi to periciliary membrane compartment\",cellular component organization,0.28\nvesicle tethering complex,cellular component organization,0.226\nvesicle tethering involved in exocytosis,cellular component organization,0.344\nvesicle tethering to Golgi,transport,0.316\nvesicle tethering to endoplasmic reticulum,transport,0.31\nvesicle transport along actin filament,transport,0.714\nvesicle transport along microtubule,transport,0.676\nvesicle uncoating,cellular component organization,0.716\nvesicle-mediated cholesterol transport,transport,0.782\nvesicle-mediated intercellular transport,transport,0.358\nvesicle-mediated transport,transport,0.526\nvestibular nucleus development,morphogenesis/development,0.962\nvestibular receptor cell development,morphogenesis/development,0.92\nvestibular receptor cell differentiation,morphogenesis/development,0.716\nvestibular receptor cell morphogenesis,receptor related process,0.274\nvestibular receptor cell stereocilium organization,cellular component organization,0.63\nvestibular reflex,immune system process,0.316\nvestibulocochlear nerve development,morphogenesis/development,0.736\nvestibulocochlear nerve formation,morphogenesis/development,0.318\nvestibulocochlear nerve maturation,morphogenesis/development,0.424\nvestibulocochlear nerve morphogenesis,morphogenesis/development,0.492\nvestibulocochlear nerve structural organization,morphogenesis/development,0.288\nvinculin binding,cellular component organization,0.388\nviral RNA genome packaging,gene regulation,0.364\nviral budding,cellular component organization,0.268\nviral budding from plasma membrane,cellular component organization,0.376\nviral budding via host ESCRT complex,viral related process,0.234\nviral capsid secondary envelopment,cellular component organization,0.324\nviral exocytosis,cellular component organization,0.156\nviral genome packaging,viral related process,0.292\nviral latency,immune system process,0.238\nviral mRNA export from host cell nucleus,transport,0.316\nviral penetration into host nucleus,viral related process,0.306\nviral translation,viral related process,0.398\nviral translational frameshifting,viral related process,0.222\nviral translational termination-reinitiation,cellular component organization,0.24\nvirion assembly,morphogenesis/development,0.272\nvirion attachment to host cell,cell adhesion,0.244\nvirion binding,cellular component organization,0.28\nvirus coreceptor activity,cellular component organization,0.214\nvirus maturation,cellular component organization,0.182\nvisceral mesoderm-endoderm interaction involved in midgut development,morphogenesis/development,0.218\nvisceral motor neuron differentiation,morphogenesis/development,0.472\nvisceral muscle development,morphogenesis/development,0.966\nvisceral serous pericardium development,morphogenesis/development,0.758\nvisual behavior,neural related process,0.282\nvisual learning,neural related process,0.368\nvisual perception,neural related process,0.332\nvitamin A biosynthetic process,metabolic process,0.894\nvitamin A import into cell,transport,0.43\nvitamin A metabolic process,metabolic process,0.97\nvitamin A transport,transport,0.962\nvitamin B6 biosynthetic process,metabolic process,0.982\nvitamin B6 catabolic process,metabolic process,0.966\nvitamin B6 metabolic process,metabolic process,0.98\nvitamin D 23-hydroxylase activity,metabolic process,0.744\nvitamin D 24-hydroxylase activity,metabolic process,0.718\nvitamin D 25-hydroxylase activity,metabolic process,0.71\nvitamin D binding,metabolic process,0.398\nvitamin D biosynthetic process,metabolic process,0.954\nvitamin D catabolic process,metabolic process,0.936\nvitamin D metabolic process,metabolic process,0.962\nvitamin D receptor signaling pathway,receptor related process,0.512\nvitamin D response element binding,gene regulation,0.414\nvitamin D3 25-hydroxylase activity,metabolic process,0.932\nvitamin D3 metabolic process,metabolic process,0.984\nvitamin E binding,metabolic process,0.2\nvitamin E biosynthetic process,metabolic process,0.704\nvitamin E metabolic process,metabolic process,0.848\nvitamin K biosynthetic process,metabolic process,0.966\nvitamin K catabolic process,metabolic process,0.954\nvitamin K metabolic process,metabolic process,0.884\nvitamin biosynthetic process,metabolic process,0.96\nvitamin catabolic process,metabolic process,0.948\nvitamin transmembrane transport,transport,0.822\nvitamin transmembrane transporter activity,transport,0.744\nvitamin-K-epoxide reductase (warfarin-insensitive) activity,metabolic process,0.924\nvitamin-K-epoxide reductase (warfarin-sensitive) activity,metabolic process,0.574\nvitelline membrane formation,morphogenesis/development,0.428\nvitellogenesis,immune system process,0.248\nvocal learning,morphogenesis/development,0.418\nvocalization behavior,multicellular organismal process,0.418\nvoltage-gated calcium channel activity,transport,0.456\nvoltage-gated calcium channel activity involved SA node cell action potential,cellular component organization,0.2\nvoltage-gated calcium channel activity involved in AV node cell action potential,cellular component organization,0.198\nvoltage-gated calcium channel activity involved in bundle of His cell action potential,cellular component organization,0.198\nvoltage-gated calcium channel activity involved in cardiac muscle cell action potential,transport,0.432\nvoltage-gated calcium channel activity involved in regulation of cytosolic calcium levels,transport,0.568\nvoltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels,metabolic process,0.174\nvoltage-gated calcium channel complex,transport,0.208\nvoltage-gated channel activity,transport,0.488\nvoltage-gated chloride channel activity,transport,0.538\nvoltage-gated monoatomic anion channel activity,transport,0.576\nvoltage-gated monoatomic cation channel activity,transport,0.578\nvoltage-gated monoatomic ion channel activity,transport,0.42\nvoltage-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential,cellular component organization,0.24\nvoltage-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential,neural related process,0.386\nvoltage-gated potassium channel activity,transport,0.502\nvoltage-gated potassium channel activity involved in SA node cell action potential depolarization,cellular component organization,0.198\nvoltage-gated potassium channel activity involved in SA node cell action potential repolarization,cellular component organization,0.2\nvoltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,cellular component organization,0.21\nvoltage-gated potassium channel activity involved in bundle of His cell action potential repolarization,cellular component organization,0.2\nvoltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization,transport,0.44\nvoltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,transport,0.214\nvoltage-gated potassium channel complex,transport,0.296\nvoltage-gated proton channel activity,cellular component organization,0.206\nvoltage-gated sodium channel activity,transport,0.498\nvoltage-gated sodium channel activity involved in AV node cell action potential,cellular component organization,0.202\nvoltage-gated sodium channel activity involved in Purkinje myocyte action potential,cellular component organization,0.212\nvoltage-gated sodium channel activity involved in SA node cell action potential,cellular component organization,0.202\nvoltage-gated sodium channel activity involved in bundle of His cell action potential,cellular component organization,0.202\nvoltage-gated sodium channel activity involved in cardiac muscle cell action potential,transport,0.43\nvoltage-gated sodium channel complex,cellular component organization,0.326\nvolume-sensitive anion channel activity,transport,0.486\nvolume-sensitive chloride channel activity,metabolic process,0.162\nvoluntary musculoskeletal movement,morphogenesis/development,0.164\nvoluntary skeletal muscle contraction,multicellular organismal process,0.624\nwalking behavior,multicellular organismal process,0.334\nwater channel activity,transport,0.246\nwater transmembrane transporter activity,transport,0.616\nwater-soluble vitamin biosynthetic process,metabolic process,0.952\nwater-soluble vitamin catabolic process,metabolic process,0.962\nwax biosynthetic process,metabolic process,0.896\nwax metabolic process,metabolic process,0.916\nwhite fat cell differentiation,morphogenesis/development,0.828\nwhite fat cell proliferation,cell cycle,0.804\nwide pore channel activity,transport,0.554\nwobble position ribose methylation,gene regulation,0.594\nwound healing involved in inflammatory response,immune system process,0.164\nwybutosine biosynthetic process,metabolic process,0.826\nwybutosine metabolic process,metabolic process,0.908\nxanthine biosynthetic process,metabolic process,0.846\nxanthine catabolic process,metabolic process,0.866\nxanthine dehydrogenase activity,metabolic process,0.928\nxanthine metabolic process,metabolic process,0.958\nxanthine oxidase activity,metabolic process,0.898\nxanthophyll biosynthetic process,metabolic process,0.982\nxanthophyll catabolic process,metabolic process,0.982\nxanthophyll metabolic process,metabolic process,0.988\nxenobiotic catabolic process,metabolic process,0.94\nxenobiotic detoxification by transmembrane export across the plasma membrane,cellular component organization,0.156\nxenobiotic glucuronidation,metabolic process,0.324\nxenobiotic transport,transport,0.934\nxenobiotic transport across blood-brain barrier,transport,0.376\nxenobiotic transport across blood-nerve barrier,transport,0.356\n\"xylosyl alpha-1,3-xylosyltransferase activity\",metabolic process,0.496\nxylosylprotein 4-beta-galactosyltransferase activity,metabolic process,0.896\nxylosyltransferase activity,metabolic process,0.932\nxylulokinase activity,metabolic process,0.732\nxylulose 5-phosphate biosynthetic process,metabolic process,0.982\nxylulose 5-phosphate metabolic process,metabolic process,0.944\nxylulose catabolic process,metabolic process,0.894\nxylulose metabolic process,metabolic process,0.984\nzeaxanthin biosynthetic process,metabolic process,0.888\nzeaxanthin catabolic process,metabolic process,0.89\nzeaxanthin metabolic process,metabolic process,0.994\nzeta DNA polymerase complex,cellular component organization,0.248\nzinc chaperone activity,protein modification/signaling,0.318\nzinc efflux transmembrane transporter activity,transport,0.556\nzinc export across plasma membrane,transport,0.436\nzinc ion import across plasma membrane,transport,0.474\nzinc ion import into Golgi lumen,transport,0.304\nzinc ion import into lysosome,transport,0.296\nzinc ion import into mitochondrion,transport,0.294\nzinc ion import into organelle,transport,0.812\nzinc ion import into secretory vesicle,transport,0.882\nzinc ion import into synaptic vesicle,transport,0.392\nzinc ion import into zymogen granule,transport,0.296\nzinc ion sensor activity,metabolic process,0.19\nzinc ion sequestering activity,transport,0.224\nzinc ion transmembrane transport,transport,0.896\nzinc ion transmembrane transporter activity,transport,0.612\nzinc ion transport,transport,0.982\nzinc:bicarbonate symporter activity,transport,0.508\nzinc:proton antiporter activity,metabolic process,0.524\nzona pellucida receptor complex,cellular component organization,0.446\nzonula adherens,cellular component organization,0.358\nzonula adherens assembly,cellular component organization,0.326\nzonula adherens maintenance,cellular component organization,0.198\nzygote asymmetric cell division,morphogenesis/development,0.524\n\"zygotic determination of anterior/posterior axis, embryo\",gene regulation,0.304\nzygotic specification of dorsal/ventral axis,gene regulation,0.288\nzymogen binding,metabolic process,0.43\nzymogen granule,metabolic process,0.262\nzymogen granule membrane,cellular component organization,0.232\nzymogen inhibition,gene regulation,0.392\n","type":"text"},{"name":"www/script.js","content":"Shiny.addCustomMessageHandler('showOverlay', function(message) {\n  if (message) {\n    document.getElementById('overlay').style.display = 'flex!important';\n  } else {\n    document.getElementById('overlay').style.display = 'none';\n  }\n});\n\nfunction downloadSVGAsText() {\n  const svg = document.querySelector('svg');\n  const base64doc = btoa(unescape(encodeURIComponent(svg.outerHTML)));\n  const a = document.createElement('a');\n  const e = new MouseEvent('click');\n  a.download = 'download.svg';\n  a.href = 'data:image/svg+xml;base64,' + base64doc;\n  a.dispatchEvent(e);\n}\n\nfunction downloadSVGAsPNG(e){\n  const canvas = document.createElement(\"canvas\");\n  const svg = document.querySelector('svg');\n  const base64doc = btoa(unescape(encodeURIComponent(svg.outerHTML)));\n  const w = parseInt(svg.getAttribute('width'));\n  const h = parseInt(svg.getAttribute('height'));\n  const img_to_download = document.createElement('img');\n  img_to_download.src = 'data:image/svg+xml;base64,' + base64doc;\n  console.log(w, h);\n  img_to_download.onload = function () {\n    console.log('img loaded');\n    canvas.setAttribute('width', w);\n    canvas.setAttribute('height', h);\n    const context = canvas.getContext(\"2d\");\n    //context.clearRect(0, 0, w, h);\n    context.drawImage(img_to_download,0,0,w,h);\n    const dataURL = canvas.toDataURL('image/png');\n    if (window.navigator.msSaveBlob) {\n      window.navigator.msSaveBlob(canvas.msToBlob(), \"download.png\");\n      e.preventDefault();\n    } else {\n      const a = document.createElement('a');\n      const my_evt = new MouseEvent('click');\n      a.download = 'download.png';\n      a.href = dataURL;\n      a.dispatchEvent(my_evt);\n    }\n    //canvas.parentNode.removeChild(canvas);\n  }  \n}\n\nconst downloadSVG = document.querySelector('#downloadSVG');\ndownloadSVG.addEventListener('click', downloadSVGAsText);\nconst downloadPNG = document.querySelector('#downloadPNG');\ndownloadPNG.addEventListener('click', downloadSVGAsPNG);","type":"text"},{"name":"www/style.css","content":".col-sm-8 {\n  height: 90vh !important;\n}\n.plotly {\n  height: 80vh !important;\n}\n.overlay {\n  position: fixed;\n  top: 0;\n  left: 0;\n  width: 100%;\n  height: 100%;\n  background: rgba(0, 0, 0, 0.5);\n  z-index: 1000;\n  display: none;\n  justify-content: center;\n  align-items: center;\n}\n\n.loader {\n  border: 16px solid #f3f3f3;\n  border-radius: 50%;\n  border-top: 16px solid #3498db;\n  width: 120px;\n  height: 120px;\n  -webkit-animation: spin 2s linear infinite;\n    animation: spin 2s linear infinite;\n}\n\n@-webkit-keyframes spin {\n  0% { -webkit-transform: rotate(0deg); }\n  100% { -webkit-transform: rotate(360deg); }\n}\n\n@keyframes spin {\n  0% { transform: rotate(0deg); }\n  100% { transform: rotate(360deg); }\n}","type":"text"}]
